|
4508 genotypes with 8910 annotations displayed
of selected term and subterms
|
|
Searched Term: abnormal adaptive immunity
|
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(C.FVB-1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan)
|
abnormal T cell activation
|
J:93488
|
| decreased cytotoxic T cell cytolysis
|
J:93488
|
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(B6.FVB-1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/J)
|
abnormal NK cell physiology
|
J:96123
|
| abnormal NK T cell physiology
|
J:96123
|
| impaired natural killer cell mediated cytotoxicity
|
J:125611
|
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(C.FVB-1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/J)
|
abnormal NK cell physiology
|
J:96123
|
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(NOD.FVB-1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/Jdk)
|
abnormal professional antigen presenting cell physiology
|
J:137009
|
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(B6.FVB-1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan)
|
impaired neutrophil recruitment
|
J:194800
|
5730403I07Rikem8Gpt/5730403I07Rikem8Gpt
(involves: C57BL/6JGpt)
|
abnormal regulatory T cell physiology
|
J:329871
|
| abnormal T cell physiology
|
J:329871
|
AA467197em1Nyam/AA467197em1Nyam
(C57BL/6J-AA467197em1Nyam)
|
increased IgG level
|
J:347271
|
AabprNZB/Slc/?
(involves: NZB/Slc * NZW/Slc)
|
increased B cell proliferation
|
J:87690
|
Abattm1c(EUCOMM)Hmgu/Abattm1c(EUCOMM)Hmgu
Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * DBA/2)
|
decreased T cell proliferation
|
J:333883
|
Abca1tm1Jdm/Abca1tm1Jdm
(DBA/1LacJ-Abca1tm1Jdm)
|
impaired macrophage phagocytosis
|
J:63265
|
Abca1tm1Jdm/Abca1tm1Jdm
(involves: C57BL/6 * DBA/1LacJ)
|
impaired macrophage phagocytosis
|
J:132254
|
Abca1tm1Jdm/Abca1tm1Jdm
Tgm2tm1Gml/Tgm2tm1Gml
(involves: C57BL/6 * DBA/1LacJ)
|
impaired macrophage phagocytosis
|
J:132254
|
Abcb1atm1Bor/Abcb1atm1Bor
(FVB.129P2-Abcb1atm1Bor/TacImx)
|
abnormal lymphocyte physiology
|
J:51190
|
| increased IgA level
|
J:51190
|
| increased IgE level
|
J:51190
|
| increased IgG1 level
|
J:51190
|
| increased IgG2 level
|
J:51190
|
| increased IgG2a level
|
J:51190
|
| increased IgG2b level
|
J:51190
|
| increased IgG3 level
|
J:51190
|
| increased IgM level
|
J:51190
|
| increased immunoglobulin level
|
J:51190
|
Abcb1atm1Bor/Abcb1atm1Bor
Abcb1btm1Bor/Abcb1btm1Bor
(FVBTac.129P2-Abcb1btm1Bor Abcb1atm1Bor)
|
abnormal T cell physiology
|
J:102640
|
Abcc1tm1Bor/Abcc1tm1Bor
(involves: 129P2/OlaHsd * FVB)
|
abnormal mast cell physiology
|
J:44110
|
Abcg1tm1Dgen/Abcg1tm1Dgen
(B6.129P2-Abcg1tm1Dgen)
|
abnormal macrophage physiology
|
J:117028
|
Abhd16atm1a(EUCOMM)Wtsi/Abhd16atm1a(EUCOMM)Wtsi
(involves: C57BL/6N * C57BL/6NTac)
|
abnormal macrophage physiology
|
J:232688
|
| decreased macrophage cytokine production
|
J:232688
|
Abi1tm1Pen/Abi1+
Abi2tm1Pen/Abi2tm1Pen
(Not Specified)
|
decreased T cell proliferation
|
J:104623
|
Abl1m1/Abl1m1
(involves: 129S/SvEv * C57BL/6)
|
abnormal B cell calcium ion homeostasis
|
J:148105
|
Acacatm1Dejs/Acacatm1Dejs
Tg(Cd4-cre)1Cwi/?
(involves: C57BL/6 * DBA/2)
|
abnormal T cell physiology
|
J:209886
|
Acacatm1Dejs/Acacatm1Dejs
Tg(Cd4-cre)1Cwi/?
Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6 * DBA/2)
|
increased T cell proliferation
|
J:209886
|
Ackr4tm1.1Rjbn/Ackr4tm1.1Rjbn
(B6.129S6-Ackr4tm1.1Rjbn)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:166490
|
| decreased T cell proliferation
|
J:166490
|
Acod1tm1a(KOMP)Wtsi/Acod1tm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal macrophage physiology
|
J:235002
|
Acp5tm1Ahdm/Acp5tm1Ahdm
(involves: 129S/SvEv)
|
abnormal osteoclast physiology
|
J:36232
|
Acsl6tm1.1Jeme/Acsl6tm1.1Jeme
(involves: BALB/cJ * C57BL/6)
|
abnormal microglial cell activation
|
J:267563
|
Actbtm4(cre/ERT2)Npa/Actb+
Sgpl1tm1.1Npa/Sgpl1tm1.1Npa
(involves: BALB/cJ * C57BL/6)
|
abnormal type IV hypersensitivity reaction
|
J:199525
|
Actn4tm1Mrpk/Actn4tm1Mrpk
(involves: 129 * C57BL/6)
|
abnormal lymphocyte chemotaxis
|
J:83911
|
Adatm1Mw/Adatm1Mw
(involves: 129S7/SvEvBrd)
|
abnormal dendritic cell physiology
|
J:138722
|
Adatm1Mw/Adatm1Mw
Tg(PLADA)4118Rkmb/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased immunoglobulin level
|
J:73418
|
Adam17tm1.2Bbl/Adam17tm1.2Bbl
Sox9tm3(cre)Crm/Sox9+
(B6.129(SJL)-Sox9tm3(cre)Crm Adam17tm1.2Bbl)
|
increased IgE level
|
J:229771
|
Adam17tm1Bbl/Adam17tm1Bbl
Lyz2tm1(cre)Ifo/0
(involves: 129P2/OlaHsd)
|
abnormal macrophage physiology
|
J:139846
|
Adam17tm1Ckww/Adam17tm1Ckww
(Not Specified)
|
abnormal dendritic cell physiology
|
J:138782
|
Adam17tm1Imx/Adam17tm1Imx
(B6.129-Adam17tm1Imx)
|
enhanced leukocyte tethering or rolling
|
J:174865
|
Adam17tm1Rain/Adam17tm1Rain
(involves: C57BL/6)
|
enhanced leukocyte tethering or rolling
|
J:174865
|
Adamts14Gt(511E11)Cmhd/Adamts14Gt(511E11)Cmhd
Adamts2tm1Prc/Adamts2tm1Prc
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell activation
|
J:271185
|
| increased T cell proliferation
|
J:271185
|
Adcy9Gt(OST193739)Lex/Adcy9Gt(OST193739)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased IgG1 level
|
J:103485
|
Adcyap1tm1Clw/Adcyap1tm1Clw
(B6.129S4-Adcyap1tm1Clw)
|
abnormal regulatory T cell physiology
|
J:194151
|
| abnormal T cell activation
|
J:194151
|
| increased microglial cell activation
|
J:194151
|
Adgre1m2Btlr/Adgre1m2Btlr
(C57BL/6J-Adgre1m2Btlr)
|
abnormal macrophage physiology
|
J:195410
|
Adgre1m3Btlr/Adgre1m3Btlr
(C57BL/6J-Adgre1m3Btlr)
|
abnormal macrophage physiology
|
J:234244
|
Adgre1tm1Stst/Adgre1tm1Stst
(B6.129S1-Emr1tm1Stst)
|
abnormal regulatory T cell physiology
|
J:99213
|
Adgrg3tm1Zgwg/Adgrg3tm1Zgwg
(involves: 129 * C57BL/6)
|
abnormal IgG1 level
|
J:222670
|
| abnormal IgG2 level
|
J:222670
|
| abnormal IgG level
|
J:222670
|
| abnormal immunoglobulin level
|
J:222670
|
| decreased IgA level
|
J:222670
|
| decreased IgG1 level
|
J:222670
|
| decreased IgG2b level
|
J:222670
|
| decreased IgG3 level
|
J:222670
|
| decreased IgM level
|
J:222670
|
| increased B cell apoptosis
|
J:222670
|
| increased IgG1 level
|
J:222670
|
| increased IgG2a level
|
J:222670
|
Adipoqtm1Chan/Adipoq+
(B6.129-Adipoqtm1Chan)
|
abnormal leukocyte physiology
|
J:122020
|
Adipoqtm1Chan/Adipoqtm1Chan
(B6.129-Adipoqtm1Chan)
|
abnormal leukocyte physiology
|
J:122020
|
Adora2btm1.1Msit/Adora2btm1.1Msit
(either: (involves: C57BL/6) or (involves: C57BL/6 * CD-1 * ICR))
|
abnormal macrophage physiology
|
J:169155
|
Adora2btm1Dgen/Adora2btm1Dgen
(B6.129P2-Adora2btm1Dgen)
|
abnormal dendritic cell physiology
|
J:138722
|
Adora2btm1Kra/Adora2btm1Kra
(involves: 129 * C57BL/6J)
|
abnormal leukocyte adhesion
|
J:111715
|
| abnormal leukocyte migration
|
J:111715
|
| enhanced leukocyte tethering or rolling
|
J:111715
|
Adora2btm1Till/Adora2btm1Till
(B6.129P2-Adora2btm1Till)
|
abnormal cellular extravasation
|
J:125297
|
| increased susceptibility to type I hypersensitivity reaction
|
J:125297
|
Adora3tm1(ADORA3)Msth/Adora3tm1(ADORA3)Msth
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal mast cell physiology
|
J:104494
|
| decreased mast cell degranulation
|
J:104494
|
Adora3tm1Jbsn/Adora3tm1Jbsn
(either: (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal mast cell physiology
|
J:60293
|
Adora3tm1Jbsn/Adora3tm1Jbsn
(B6.129P2-Adora3tm1Jbsn)
|
abnormal mast cell degranulation
|
J:123463
|
| impaired neutrophil recruitment
|
J:123463
|
Adrb2tm1Bkk/Adrb2tm1Bkk
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal osteoclast physiology
|
J:97566
|
Ads3NZB/Ads3NZW
(involves: NZB * NZW)
|
abnormal immunoglobulin level
|
J:7111
|
Ads3NZW/Ads3NZW
(involves: NZB * NZW)
|
abnormal immunoglobulin level
|
J:7111
|
Ads4NZB/Ads4NZW
(involves: NZB * NZW)
|
abnormal immunoglobulin level
|
J:7111
|
Ads4NZW/Ads4NZW
(involves: NZB * NZW)
|
abnormal immunoglobulin level
|
J:7111
|
Agkem1Qiz/Agkem1Qiz
(involves: C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:282052
|
Agp1NZB/Agp1NZB
(involves: NZB * NZW)
|
increased susceptibility to type III hypersensitivity reaction
|
J:6920
|
Agp1NZB/Agp1NZW
(involves: NZB * NZW)
|
increased susceptibility to type III hypersensitivity reaction
|
J:6920
|
Agp2NZB/Agp2NZW
(involves: NZB * NZW)
|
increased susceptibility to type III hypersensitivity reaction
|
J:6920
|
Agp2NZW/Agp2NZW
(involves: NZB * NZW)
|
increased susceptibility to type III hypersensitivity reaction
|
J:6920
|
Agtpbp1atms/Agtpbp1atms
(MRL/Mp-Agtpbp1atms)
|
abnormal T cell physiology
|
J:103944
|
Ahnaktm1Vtm/Ahnaktm1Vtm
(involves: 129S1/Sv * C57BL/6)
|
abnormal T cell activation
|
J:131148
|
| abnormal T-helper 1 physiology
|
J:131148
|
| decreased T cell proliferation
|
J:131148
|
Ahrtm1Bra/Ahrtm1Bra
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal Langerhans cell physiology
|
J:148870
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:148870
|
Ahrtm1Bra/Ahrtm1Bra
(B6.129-Ahrtm1Bra/J)
|
abnormal macrophage physiology
|
J:118646
|
Aicdaem1Jaych/Aicdaem1Jaych
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:305843
|
| increased IgM level
|
J:305843
|
Aicdam1Btlr/Aicdam1Btlr
(C57BL/6J-Aicdam1Btlr)
|
decreased IgE level
|
J:265155
|
| increased IgM level
|
J:265155
|
Aicdam2Btlr/Aicdam2Btlr
(C57BL/6J-Aicdam2Btlr)
|
decreased IgE level
|
J:265156
|
| increased IgM level
|
J:265156
|
Aicdatm1(cre)Mnz/Aicda+
Ightm3Mnz/Igh+
Myctm37Mnz/Myc+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:145691
|
Aicdatm1(cre)Mnz/Aicda+
Ightm3Mnz/Igh+
Myctm39Mnz/Myc+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:145691
|
Aicdatm1.1Fwa/Aicdatm1.1Fwa
(involves: 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:209271
|
| abnormal somatic hypermutation frequency
|
J:209271
|
Aicdatm1Hon/Aicda+
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:136224,
J:141427
|
| abnormal somatic hypermutation frequency
|
J:141427
|
Aicdatm1Hon/Aicdatm1.1Fwa
(involves: 129S/SvEv * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal class switch recombination
|
J:209271
|
Aicdatm1Hon/Aicdatm1Hon
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:141427,
J:73659,
J:120658
|
| abnormal somatic hypermutation frequency
|
J:136224,
J:141427
|
| decreased IgA level
|
J:169227
|
| decreased IgG1 level
|
J:169227,
J:73659
|
| decreased IgG2a level
|
J:73659
|
| decreased IgG2b level
|
J:169227
|
| decreased IgG3 level
|
J:169227
|
| decreased IgG level
|
J:169227
|
| increased IgM level
|
J:169227,
J:73659
|
Aicdatm1Hon/Aicdatm1Hon
Bcl6tm1.1Jwan/Bcl6tm1.1Jwan
(involves: 129S6/SvEvTac * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal somatic hypermutation frequency
|
J:190534
|
Aicdatm1Hon/Aicdatm1Hon
Ightm3Mnz/Ightm4.1Mnz
Trp53bp1tm1Jc/Trp53bp1tm1Jc
(involves: 129 * C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:159173
|
Aicdatm1Hon/Aicdatm1Hon
Ighmtm1.1(IGH-2)Cog/Ighm+
(involves: 129P2/OlaHsd * C57BL/6 * CBA * FVB/N)
|
abnormal B cell physiology
|
J:157575
|
Aicdatm1Hon/Aicdatm3Mnz
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:141427
|
| abnormal somatic hypermutation frequency
|
J:141427
|
Aicdatm1Hon/Aicdatm4Mnz
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:141427
|
| abnormal somatic hypermutation frequency
|
J:141427
|
Aicdatm2.1Hon/Aicdatm2.1Hon
(C57BL/6-Aicdatm2.1Hon)
|
abnormal somatic hypermutation frequency
|
J:169227
|
| decreased IgG1 level
|
J:169227
|
Aicdatm3.1Mnz/Aicdatm3.1Mnz
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:147109
|
| abnormal somatic hypermutation frequency
|
J:147109
|
Aicdatm3Mnz/Aicda+
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:141427
|
| abnormal somatic hypermutation frequency
|
J:141427
|
Aicdatm4.1Mnz/Aicdatm4.1Mnz
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:147109
|
| abnormal somatic hypermutation frequency
|
J:147109
|
Aicdatm4Mnz/Aicda+
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:141427
|
| abnormal somatic hypermutation frequency
|
J:141427
|
Aim2Gt(CSG445)Byg/Aim2Gt(CSG445)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal macrophage physiology
|
J:158969
|
Aim2Gt(CSG445)Byg/Aim2Gt(CSG445)Byg
(B6.129P2-Aim2Gt(CSG445)Byg/J)
|
decreased macrophage apoptosis
|
J:234263
|
Aim2tm1.1Vmd/Aim2tm1.1Vmd
(C57BL/6-Aim2tm1.1Vmd)
|
abnormal macrophage physiology
|
J:160545
|
Airetm1.1Doi/Airetm1.1Doi
(NOD.129S2-Airetm1.1Doi)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:135154
|
Airetm1Mand/Aire+
(NOD.129P2-Airetm1Mand)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:135154,
J:188686
|
Airetm1Mand/Airetm1.1Doi
(NOD.129-Airetm1Mand/Airetm1.1Doi)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:135154
|
Airetm1Pltn/Airetm1Pltn
(involves: 129S4/SvJae * C57BL/6)
|
increased T cell proliferation
|
J:77873
|
Airetm1Ptsn/Airetm1Ptsn
(C57BL/6-Airetm1Ptsn)
|
abnormal T cell activation
|
J:145910
|
Airetm1Ptsn/Airetm1Ptsn
(C.B6-Airetm1Ptsn)
|
abnormal adaptive immunity
|
J:174653
|
| abnormal regulatory T cell physiology
|
J:174653
|
| abnormal T-helper 1 physiology
|
J:174653
|
| abnormal T-helper 17 cell physiology
|
J:174653
|
Akap13tm1Segj/Akap13+
(involves: 129)
|
abnormal lymphocyte physiology
|
J:111574
|
| decreased IgG1 level
|
J:181088
|
Akr1a1Gt(OST222400)Lex/Akr1a1Gt(OST222400)Lex
(B6.129S5-Akr1a1Gt(OST222400)Lex)
|
abnormal osteoclast physiology
|
J:164548
|
Akt1tm1Pnt/Akt1tm1Pnt
Akt2tm1.1Mbb/Akt2tm1.1Mbb
Akt3tm1Mbb/Akt3tm1Mbb
Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd)
|
increased T cell apoptosis
|
J:135903
|
Akt1tm1Pnt/Akt1tm1Pnt
Akt2tm1.1Mbb/Akt2tm1.1Mbb
Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd)
|
increased T cell apoptosis
|
J:135903
|
Alox5tm1Bhk/Alox5tm1Bhk
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2))
|
abnormal neutrophil physiology
|
J:68714
|
| decreased susceptibility to type I hypersensitivity reaction
|
J:68714
|
| impaired neutrophil chemotaxis
|
J:68714
|
| impaired neutrophil recruitment
|
J:68714
|
Alox5aptm1Bhk/Alox5aptm1Bhk
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:39229
|
Alox5aptm1Bhk/Alox5aptm1Bhk
(involves: 129P2/OlaHsd * 129S/SvEv)
|
impaired neutrophil recruitment
|
J:39229
|
Altretm1.1Hbgl/Altretm1.1Hbgl
Foxp3tm4(YFP/icre)Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal regulatory T cell physiology
|
J:342907
|
| increased regulatory T cell apoptosis
|
J:342907
|
Angptl2tm1Yo/Angptl2tm1Yo
(B6.Cg-Angptl2tm1Yo)
|
impaired macrophage chemotaxis
|
J:152387
|
Ano5em2Huyi/Ano5em2Huyi
(C57BL/6-Ano5em2Huyi)
|
abnormal osteoclast physiology
|
J:336715
|
Anpeptm1.1Lsha/Anpeptm1.1Lsha
(B6.Cg-Anpeptm1.1Lsha)
|
abnormal macrophage physiology
|
J:163945
|
Anxa1tm1Rjf/Anxa1tm1Rjf
(Not Specified)
|
abnormal leukocyte physiology
|
J:81498
|
| impaired macrophage phagocytosis
|
J:81498
|
Anxa5tm1Epo/Anxa5tm1Epo
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:117249
|
Anxa8tm1Resc/Anxa8tm1Resc
Tg(Pgk1-cre)1Lni/0
(involves: 129 * C57BL/6J * BALB/c)
|
impaired leukocyte tethering or rolling
|
J:225224
|
Aoc3tm1Salm/Aoc3tm1Salm
(involves: 129S6/SvEvTac * 129S7/SvEvBrd)
|
abnormal cellular extravasation
|
J:95656
|
| abnormal leukocyte adhesion
|
J:95656
|
| abnormal leukocyte migration
|
J:95656
|
| impaired leukocyte tethering or rolling
|
J:95656
|
Apba3tm1.2Ski/Apba3tm1.2Ski
(B6.129-Apba3tm1.2Ski)
|
abnormal macrophage physiology
|
J:176742
|
Apctm2.1Cip/Apctm2.1Cip
Lect2tm1Ymg/Lect2tm1Ymg
Tg(Ttr-cre/Esr1*)1Vco/0
(B6.Cg-Lect2tm1Ymg Apctm2.1Cip Tg(Ttr-cre/Esr1*)1Vco)
|
abnormal neutrophil physiology
|
J:184496
|
| abnormal NK T cell physiology
|
J:184496
|
Apctm2.1Cip/Apctm2.1Cip
Tg(Ttr-cre/Esr1*)1Vco/0
(B6.Cg-Apctm2.1Cip Tg(Ttr-cre/Esr1*)1Vco)
|
abnormal NK T cell physiology
|
J:184496
|
AplfGt(RRF189)Byg/AplfGt(RRF189)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal class switch recombination
|
J:168260
|
Apobec3Gt(XN450)Byg/Apobec3Gt(XN450)Byg
(B6.129P2-Apobec3Gt(XN450)Byg)
|
abnormal immunoglobulin level
|
J:138778
|
Apobec3Gt(XN450)Byg/Apobec3Gt(XN450)Byg
(129P2/OlaHsd-Apobec3Gt(XN450)Byg)
|
abnormal immunoglobulin level
|
J:138778
|
Apobec3Gt(XN450)Byg/Apobec3Rfv3-s
H2b/H2b
(involves: A.BY * C57BL/6)
|
abnormal immunoglobulin level
|
J:138778
|
Apobec3Gt(XN450)Byg/Apobec3Rfv3-s
H2b/H2d
(involves: BALB/c * C57BL/6)
|
abnormal immunoglobulin level
|
J:138778
|
Apoetm1Bres/Apoetm1Bres
Bcl2tm1Irt/Bcl2tm1Irt
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased macrophage apoptosis
|
J:144243
|
Apoetm1Bres/Apoetm1Bres
Cx3cr1tm1Ifc/Cx3cr1tm1Ifc
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
impaired macrophage chemotaxis
|
J:81822
|
Apoetm1Bres/Apoetm1Bres
Mapk9tm1Flv/Mapk9tm1Flv
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
abnormal macrophage physiology
|
J:94044
|
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc/J)
|
abnormal B cell activation
|
J:133606
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:61564
|
| increased IgM level
|
J:61564
|
| increased immunoglobulin level
|
J:133606
|
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc)
|
abnormal dendritic cell physiology
|
J:125366
|
Apoetm1Unc/Apoetm1Unc
(B6.Cg-Apoetm1Unc Faslpr)
|
increased immunoglobulin level
|
J:133606
|
Apoetm1Unc/Apoetm1Unc
Ccr2tm1Ifc/Ccr2tm1Ifc
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
impaired macrophage chemotaxis
|
J:111471
|
Apoetm1Unc/Apoetm1Unc
Ccr5tm1Blck/Ccr5tm1Blck
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal lymphocyte physiology
|
J:128063
|
Apoetm1Unc/Apoetm1Unc
Ccr5tm1Kuz/Ccr5tm1Kuz
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal lymphocyte physiology
|
J:128063
|
Apoetm1Unc/Apoetm1Unc
Cd36tm1Mfe/Cd36tm1Mfe
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
abnormal macrophage physiology
|
J:61672
|
Apoetm1Unc/Apoetm1Unc
Cx3cl1tm1Sgs/Cx3cl1tm1Sgs
(B6.129-Apoetm1Unc Cx3cl1tm1Sgs)
|
impaired macrophage chemotaxis
|
J:95279
|
Apoetm1Unc/Apoetm1Unc
Cxcl10tm1Adl/Cxcl10tm1Adl
(B6.129-Cxcl10tm1Adl Apoetm1Unc)
|
impaired macrophage chemotaxis
|
J:166204
|
Apoetm1Unc/Apoetm1Unc
Cyp4f13Gt(OST14770)Lex/Cyp4f13Gt(OST14770)Lex
(involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6)
|
abnormal macrophage chemotaxis
|
J:289999
|
Apoetm1Unc/Apoetm1Unc
Faslpr/Faslpr
(MRL.Cg-Apoetm1Unc Faslpr)
|
increased immunoglobulin level
|
J:133606
|
Apoetm1Unc/Apoetm1Unc
Faslpr/Faslpr
(B6.Cg-Apoetm1Unc Faslpr)
|
increased IgG level
|
J:121671
|
Apoetm1Unc/Apoetm1Unc
Faslgld/Faslgld
(B6.Cg-Faslgld Apoetm1Unc)
|
impaired macrophage phagocytosis
|
J:91058
|
| increased IgG level
|
J:91058
|
Apoetm1Unc/Apoetm1Unc
Gja5tm1Mchn/Gja5tm1Mchn
Tg(TIE2-lacZ)182Sato/0
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal neutrophil physiology
|
J:162224
|
Apoetm1Unc/Apoetm1Unc
Glg1Gt(RST092)Byg/Glg1+
(B6J.129P2-Apoetm1Unc Glg1Gt(RST092)Byg)
|
impaired macrophage chemotaxis
|
J:226586
|
Apoetm1Unc/Apoetm1Unc
Hptm1Alev/Hptm1Alev
(involves: 129)
|
abnormal macrophage chemotaxis
|
J:134942
|
Apoetm1Unc/Apoetm1Unc
Il1rntm1Dih/Il1rntm1Dih
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
abnormal macrophage chemotaxis
|
J:132570
|
Apoetm1Unc/Apoetm1Unc
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal macrophage physiology
|
J:143903
|
Apoetm1Unc/Apoetm1Unc
Spp1tm1Blh/Spp1tm1Blh
(involves: 129P2/OlaHsd * 129S6/SvEvTac * Black Swiss * C57BL/6J)
|
abnormal macrophage physiology
|
J:86531
|
Appl1Gt(XM073)Byg/Appl1Gt(XM073)Byg
(B6.129P2-Appl1Gt(XM073)Byg)
|
increased T cell proliferation
|
J:164696
|
Appl1tm1.2Test/Appl1tm1.2Test
(involves: 129X1/SvJ)
|
increased T cell proliferation
|
J:164696
|
Aqp4tm1.1Mysi/Aqp4tm1.1Mysi
(involves: C57BL/6JJcl * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal microglial cell physiology
|
J:214906
|
Arg1tm1.1Pmu/Arg1tm1.1Pmu
(involves: C57BL/6 * NZB)
|
increased macrophage nitric oxide production
|
J:143229
|
Arg1tm1Ekoe/Arg1tm1Ekoe
(involves: 129P2/OlaHsd)
|
abnormal macrophage physiology
|
J:183882
|
Arg1tm1Pmu/Arg1tm1Pmu
Tg(Tek-cre)1Ywa/?
(B6.Cg-Tg(Tek-cre)1Ywa Arg1tm1Pmu)
|
abnormal macrophage physiology
|
J:143229
|
| increased macrophage nitric oxide production
|
J:143229
|
Arhgap15tm1Ehi/Arhgap15tm1Ehi
(B6.129-Arhgap15tm1Ehi)
|
abnormal neutrophil physiology
|
J:174896
|
Arhgap25tm1a(KOMP)Wtsi/Arhgap25tm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal cellular extravasation
|
J:240521
|
| abnormal neutrophil physiology
|
J:240521
|
| enhanced leukocyte migration
|
J:240521
|
| enhanced leukocyte tethering or rolling
|
J:240521
|
Arhgap45em1Ciphe/Arhgap45em1Ciphe
(C57BL/6-Arhgap45em1Ciphe)
|
decreased lymphocyte chemotaxis
|
J:309971
|
Arhgdiatm1Ytk/Arhgdiatm1Ytk
Arhgdibtm1Miyo/Arhgdibtm1Miyo
(involves: 129S/SvEv)
|
abnormal T cell physiology
|
J:140671
|
| decreased T cell proliferation
|
J:140671
|
| enhanced B cell migration
|
J:140671
|
| increased B cell proliferation
|
J:140671
|
Arhgdibtm1Len/Arhgdibtm1Len
(involves: 129S4/SvJae * C57BL/6)
|
increased B cell proliferation
|
J:42604
|
Arhgef1tm1.1Rmt/Arhgef1tm1.1Rmt
(C57BL/6-Arhgef1tm1.1Rmt)
|
abnormal marginal zone B cell physiology
|
J:113295
|
| decreased IgM level
|
J:113295
|
Arhgef1tm1Djle/Arhgef1tm1Djle
(involves: 129S4/SvJae * C57BL/6)
|
abnormal neutrophil physiology
|
J:129331
|
Arhgef1tm1Kdf/Arhgef1tm1Kdf
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal lymphocyte physiology
|
J:99463
|
| decreased B cell proliferation
|
J:99463
|
| decreased IgG level
|
J:99463
|
| decreased IgM level
|
J:99463
|
| increased T cell proliferation
|
J:99463
|
Arhgef2Gt(IST13976A8)Tigm/Arhgef2Gt(IST13976A8)Tigm
(involves: C57BL/6N)
|
abnormal macrophage physiology
|
J:209086
|
Arhgef4tm1a(KOMP)Wtsi/Arhgef4tm1a(KOMP)Wtsi
(C57BL/6N-Arhgef4tm1a(KOMP)Wtsi/Wtsi)
|
decreased IgE level
|
J:165965
|
| decreased IgG1 level
|
J:165965
|
Arhgef5tm1.1Dwu/Arhgef5tm1.1Dwu
(involves: 129S1/Sv * 129S6/SvEvTac)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:157812
|
| abnormal dendritic cell physiology
|
J:157812
|
Arhgef6tm1Kdf/Arhgef6tm1Kdf
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell physiology
|
J:137269
|
| decreased B cell proliferation
|
J:137269
|
| decreased T cell proliferation
|
J:137269
|
| enhanced B cell migration
|
J:137269
|
Arhgef12tm1.1Wet/Arhgef12tm1.1Wet
Tg(Lck-cre)548Jxm/0
(involves: 129 * C57BL/6 * CBA)
|
abnormal T cell proliferation
|
J:149560
|
Arid3atm1Pwt/Arid3atm1Pwt
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal class switch recombination
|
J:169178
|
| decreased IgG1 level
|
J:169178
|
| decreased IgM level
|
J:169178
|
Arid4atm1Alb/Arid4atm1Alb
Arid4btm1Alb/Arid4b+
(involves: 129S7/SvEvBrd)
|
hemophagocytosis
|
J:141004
|
Arigm1BALB/cByJ/?
(involves: BALB/cByJ * NZB/BlNJ)
|
increased IgM level
|
J:93737
|
Arigm2NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ)
|
increased IgM level
|
J:93737
|
Arigm3NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ)
|
increased IgM level
|
J:93737
|
Arigm4NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ)
|
increased IgM level
|
J:93737
|
Arigm5NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ)
|
increased IgM level
|
J:93737
|
Arigm6NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ)
|
increased IgM level
|
J:93737
|
Arigm7NZB/BlNJ/?
(involves: BALB/cByJ * NZB/BlNJ)
|
increased IgM level
|
J:93737
|
Arih2tm1Mak/Arih2tm1Mak
(B6.129P2-Arih2tm1Mak)
|
abnormal dendritic cell physiology
|
J:191066
|
Arrb2tm1Rjl/Arrb2tm1Rjl
(involves: 129X1/SvJ * C57BL/6)
|
abnormal lymphocyte physiology
|
J:76872
|
Art2atm1Fkn/Art2atm1Fkn
Art2btm1Fkn/Art2btm1Fkn
(NOD.129S4(B6)-Art2atm1Fkn Art2btm1Fkn/Lt)
|
decreased T cell apoptosis
|
J:108097
|
Asb2tm1.1Lutz/Asb2tm1.1Lutz
Tg(Mx1-cre)1Cgn/0
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
abnormal dendritic cell physiology
|
J:200966
|
Asf1bm1Btlr/Asf1bm1Btlr
(C57BL/6J-Asf1bm1Btlr)
|
increased IgE level
|
J:267479
|
Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu/Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu
(B6.FVB-Ash1lTn(pb-Act-RFP)1.AF0-180T25Zhu)
|
increased IgA level
|
J:208213
|
| increased IgG1 level
|
J:208213
|
| increased IgG2a level
|
J:208213
|
| increased IgG2b level
|
J:208213
|
| increased IgM level
|
J:208213
|
Asxl1tm1.1Mjxu/Asxl1+
(involves: 129 * C57BL/6)
|
abnormal neutrophil physiology
|
J:208085
|
Atf2Tg(Gzma-Klra1)7Wum/Atf2+
(involves: C57BL/6)
|
abnormal NK cell physiology
|
J:61178
|
Atf3tm1Dron/Atf3tm1Dron
(involves: 129X1/SvJ * C57BL/6)
|
abnormal T-helper 2 physiology
|
J:140112
|
| decreased IgG2a level
|
J:140112
|
Atg3tm1.1Ywh/Atg3tm1.1Ywh
Gt(ROSA)26Sortm1(cre/ERT)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJaeSor * C57BL/6)
|
increased T cell apoptosis
|
J:172749
|
Atg3tm1.1Ywh/Atg3tm1.1Ywh
Tg(Lck-cre)548Jxm/0
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * CBA)
|
decreased T cell proliferation
|
J:172749
|
| increased T cell apoptosis
|
J:172749
|
Atg5tm1Myok/Atg5tm1Myok
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S/SvEv)
|
abnormal macrophage physiology
|
J:235399
|
| increased IgG level
|
J:235399
|
Atg5tm1Nmz/Atg5tm1Nmz
Tg(Cd4-cre)1Cwi/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal T cell physiology
|
J:211733
|
| decreased T cell proliferation
|
J:211733
|
Atg7tm1Tchi/Atg7tm1Tchi
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal macrophage physiology
|
J:235399
|
| increased IgG level
|
J:235399
|
Atg7tm1Tchi/Atg7tm1Tchi
Lyz2tm1(cre)Ifo/Lyz2+
Tg(CAG-EGFP/Map1lc3b)53Nmz/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * DBA/2)
|
abnormal macrophage physiology
|
J:235399
|
Atg16l1tm1.1Mvlc/Atg16l1tm1.1Mvlc
(C57BL/6-Atg16l1tm1.1Mvlc)
|
abnormal macrophage physiology
|
J:206931
|
| increased macrophage cytokine production
|
J:206931
|
Atg16l1tm1Aki/Atg16l1tm1Aki
(involves: 129/Sv * C57BL/6)
|
abnormal macrophage physiology
|
J:141420
|
Atmm1Btlr/Atmm1Btlr
(C57BL/6J-Atmm1Btlr)
|
increased IgM level
|
J:265252
|
Atmm5Btlr/Atmm5Btlr
(C57BL/6J-Atmm5Btlr)
|
impaired macrophage phagocytosis
|
J:272824
|
Atmtm1Awb/Atmtm1Awb
(involves: 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:150435
|
Atmtm1Awb/Atmtm1Awb
Paxxem1Spj/Paxxem1Spj
(involves: A/J * C57BL/6NTac)
|
abnormal class switch recombination
|
J:236776
|
Atmtm1Bal/Atmtm1Bal
(involves: 129S4/SvJae)
|
abnormal microglial cell physiology
|
J:44190
|
| abnormal T cell physiology
|
J:35914
|
| decreased IgG2a level
|
J:35914
|
| decreased IgG2b level
|
J:35914
|
| decreased IgG3 level
|
J:35914
|
| decreased IgG level
|
J:35914
|
Atmtm1Fwa/Atmtm1Fwa
(involves: 129S4/SvJae)
|
abnormal class switch recombination
|
J:191288
|
Atmtm1Pmc/Atmtm1Pmc
Trp73tm2Mak/Trp73tm2Mak
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased thymocyte apoptosis
|
J:157905
|
Atmtm1Shzh/Atmtm2.1Fwa
Gt(ROSA)26Sortm1(cre/ERT2)Thl/Gt(ROSA)26Sor+
(involves: 129 * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:191288
|
Atmintm1.1Jhh/Atmintm1.1Jhh
Cd79atm1(cre)Reth/Cd79a+
(B6.Cg-Cd79atm1(Cre)Reth Atmintm1.1Jhh)
|
decreased IgG1 level
|
J:230105
|
| increased B cell apoptosis
|
J:230105
|
Atmintm1.1Jhh/Atmintm1.1Jhh
Cd79atm1(cre)Reth/Cd79a+
Tg(IghMyc)22Bri/0
(B6.Cg-Cd79atm1(Cre)Reth Atmintm1.1Jhh Tg(IghMyc)22Bri)
|
increased B cell apoptosis
|
J:230105
|
Atmintm1.2Jhh/Atmintm1.2Jhh
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6)
|
abnormal B cell physiology
|
J:191832
|
Atp6v1hem1Xhd/Atp6v1h+
(involves: C57BL/6)
|
abnormal osteoclast physiology
|
J:239439
|
Atp11cm1Btlr/Y
(involves: C57BL/6J)
|
decreased IgA level
|
J:171925
|
| decreased IgG1 level
|
J:171925
|
| decreased IgM level
|
J:171925
|
Avpr1atm1Sbhu/Avpr1atm1Sbhu
(involves: C57BL/6)
|
abnormal immunoglobulin level
|
J:105892
|
| decreased IgG2b level
|
J:105892
|
| increased IgG2a level
|
J:105892
|
Axltm1Grl/Axltm1Grl
Mertktm1Grl/Mertktm1Grl
Tyro3tm1Grl/Tyro3tm1Grl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal B cell activation
|
J:70420
|
| abnormal macrophage physiology
|
J:70420
|
| abnormal professional antigen presenting cell physiology
|
J:70420
|
| abnormal T cell activation
|
J:70420
|
| increased B cell proliferation
|
J:70420
|
| increased T cell proliferation
|
J:70420
|
Azi2tm1Aki/Azi2tm1Aki
(Not Specified)
|
abnormal dendritic cell physiology
|
J:204786
|
Azi2tm1Aki/Azi2tm1Aki
Tbkbp1tm1Aki/Tbkbp1tm1Aki
(Not Specified)
|
abnormal dendritic cell physiology
|
J:204786
|
B2mtm1Jae/B2mtm1Jae
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal cytotoxic T cell physiology
|
J:80910
|
B2mtm1Jae/B2mtm1Jae
Foxp3sfOtcspf/Y
(involves: 129/Rl * 129S2/SvPas)
|
increased IgG level
|
J:20865
|
| increased IgM level
|
J:20865
|
| increased immunoglobulin level
|
J:20865
|
B2mtm1Jae/B2mtm1Jae
Rr94tm3.2Litt/Rr94tm3.2Litt
(involves: 129P2/OlaHsd * 129S2/SvPas * FVB/N)
|
increased T cell proliferation
|
J:158962
|
B2mtm1Unc/B2mtm1Unc
(B6.129P2-B2mtm1Unc/DcrJ)
|
decreased IgG level
|
J:110885
|
| increased IgM level
|
J:110885
|
B2mtm1Unc/B2mtm1Unc
Cd4tm1Mak/Cd4tm1Mak
Cd8atm2.1(Cd4)Asin/Cd8atm2.1(Cd4)Asin
(involves: 129 * C57BL/6)
|
abnormal T cell physiology
|
J:180236
|
B2mtm1Unc/B2mtm1Unc
Il2tm1Hor/Il2tm1Hor
(involves: 129 * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:51450
|
B2mtm1Unc/B2mtm1Unc
Prkdcscid/Prkdcscid
(NOD.Cg-B2mtm1Unc Prkdcscid)
|
abnormal NK cell physiology
|
J:102141
|
B2mtm1Unc/B2mtm1Unc
Tg(HLA-A/H2-D/B2M)1Dvs/0
(NOD.Cg-B2mtm1Unc Tg(HLA-A/H2-D/B2M)1Dvs)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:121685
|
| abnormal cytotoxic T cell physiology
|
J:121685
|
B3gnt2Gt(OST237555)Lex/B3gnt2Gt(OST237555)Lex
(involves: 129S5/SvEvBrd * C57BL/6N)
|
abnormal macrophage physiology
|
J:125556
|
| increased T cell proliferation
|
J:125556
|
B3gnt5tm1Nari/B3gnt5tm1Nari
(involves: 129P2/OlaHsd * C57BL/6)
|
increased IgG2a level
|
J:161366
|
| increased IgG2b level
|
J:161366
|
| increased IgG level
|
J:161366
|
B4galt1tm1Yiw/B4galt1tm1Yiw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal leukocyte physiology
|
J:106669
|
| abnormal neutrophil physiology
|
J:106669
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:106669
|
| impaired macrophage chemotaxis
|
J:89125
|
| impaired neutrophil recruitment
|
J:89125
|
B4galt1tm1Yiw/B4galt1tm1Yiw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal IgM level
|
J:117891
|
| increased IgA level
|
J:117891
|
B4gat1tm1Mifu/B4gat1tm1Mifu
(B6.Cg-B4gat1tm1Mifu)
|
impaired leukocyte tethering or rolling
|
J:120722
|
B4gat1tm1Mifu/B4gat1tm1Mifu
Gcnt1tm1Jxm/Gcnt1tm1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal leukocyte migration
|
J:120722
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:120722
|
| impaired leukocyte tethering or rolling
|
J:120722
|
B9d2/Tgfb1tm1Flv/B9d2/Tgfb1tm1Flv
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal regulatory T cell physiology
|
J:204761
|
B9d2/Tgfb1tm1Flv/Tgfb1tm2Flv
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal T cell activation
|
J:123547
|
| increased T cell proliferation
|
J:123547
|
B9d2/Tgfb1tm1Flv/B9d2/Tgfb1tm1Flv
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal regulatory T cell physiology
|
J:204761
|
Baa1BALB/cJ/Baa1NZW/LacJ
(involves: BALB/cJ * NZW/LacJ)
|
increased IgM level
|
J:35434
|
Baa2BALB/cJ/Baa2NZW/LacJ
(involves: BALB/cJ * NZW/LacJ)
|
increased IgM level
|
J:35434
|
Bach2m2Anu/Bach2m2Anu
(C57BL/6NCrlAnu-Bach2m2Anu)
|
increased IgM level
|
J:104190
|
Bach2tm1Igar/Bach2tm1Igar
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell physiology
|
J:91110
|
| abnormal class switch recombination
|
J:91110
|
| abnormal somatic hypermutation frequency
|
J:91110
|
| decreased IgA level
|
J:91110
|
| decreased IgG1 level
|
J:91110
|
| decreased IgG2a level
|
J:91110
|
| decreased IgG2b level
|
J:91110
|
| decreased IgG3 level
|
J:91110
|
| decreased IgG level
|
J:91110
|
| increased IgM level
|
J:91110
|
Badtm1Sjk/Badtm1Sjk
(either: 129X1/SvJ or (involves: 129X1/SvJ * C57BL/6))
|
abnormal B cell physiology
|
J:84987
|
| abnormal T cell physiology
|
J:84987
|
Bag4tm1Yeh/Bag4tm1Yeh
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal macrophage physiology
|
J:83559
|
Bak1tm1Thsn/Bak1tm1Thsn
Baxtm1Sjk/Baxtm2Sjk
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
abnormal B cell physiology
|
J:100463
|
| increased IgA level
|
J:100463
|
| increased IgG level
|
J:100463
|
| increased IgM level
|
J:100463
|
| increased immunoglobulin level
|
J:100463
|
Bak1tm1Thsn/Bak1tm1Thsn
Baxtm2Sjk/Baxtm2Sjk
Tg(Lck-cre)1Cwi/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased thymocyte apoptosis
|
J:220951
|
Bank1tm1Kuro/Bank1tm1Kuro
(Not Specified)
|
abnormal B cell physiology
|
J:113321
|
| abnormal lymphocyte physiology
|
J:113321
|
| increased B cell proliferation
|
J:113321
|
| increased IgG2a level
|
J:113321
|
| increased IgM level
|
J:113321
|
Batf3tm1Kmm/Batf3tm1Kmm
(involves: 129S6/SvEvTac * BALB/cJ)
|
abnormal cytotoxic T cell physiology
|
J:141064
|
| abnormal dendritic cell antigen presentation
|
J:141064
|
| abnormal dendritic cell physiology
|
J:141064
|
| decreased cytotoxic T cell cytolysis
|
J:141064
|
Batf3tm1Kmm/Batf3tm1Kmm
(involves: 129S6/SvEvTac)
|
abnormal cytotoxic T cell physiology
|
J:181366
|
Batf3tm1Kmm/Batf3tm1Kmm
Id2tm1Gtbz/Id2tm1Gtbz
(B6.Cg-Batf3tm1Kmm Id2tm1Gtbz)
|
abnormal dendritic cell physiology
|
J:194760
|
Batftm1.1Ejt/Batftm1.1Ejt
(involves: 129S/Sv * C57BL/6 * FVB/N)
|
abnormal class switch recombination
|
J:160935
|
| decreased IgA level
|
J:160935
|
| decreased IgE level
|
J:160935
|
| decreased IgG1 level
|
J:160935
|
| decreased IgG2c level
|
J:160935
|
| decreased IgM level
|
J:160935
|
Bbaa5C57BL/6NCr/Bbaa5C57BL/6NCr
(involves: C3H/HeNCr * C57BL/6NCr)
|
increased IgM level
|
J:52017
|
Bbaa9C57BL/6NCr/Bbaa9C3H/HeNCr
(involves: C3H/HeNCr * C57BL/6NCr)
|
abnormal immunoglobulin level
|
J:52017
|
Bbaa9C57BL/6NCr/Bbaa9C57BL/6NCr
(involves: C3H/HeNCr * C57BL/6NCr)
|
abnormal immunoglobulin level
|
J:52017
|
Bbaa14C3H/HeJ/?
(involves: C3H/HeN * C57BL/6N)
|
increased IgG level
|
J:73060
|
Bbaa15C3H/HeN/?
(involves: C3H/HeN * C57BL/6N)
|
increased IgG level
|
J:73060
|
Bbaa19C3H/HeN/?
(involves: C3H/HeN * C57BL/6N)
|
increased IgG level
|
J:73060
|
Bbc3tm1Ast/Bbc3tm1Ast
(involves: C57BL/6 * NZB)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:132819
|
Bbs4Gt1Nk/Bbs4Gt1Nk
(involves: 129S7/SvEvBrd)
|
increased immunoglobulin level
|
J:134093
|
Bbxtm1a(EUCOMM)Wtsi/Bbxtm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
increased IgA level
|
J:213427
|
Bcap31tm1.1Bwang/Bcap31tm1.1Bwang
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased microglial cell activation
|
J:292505
|
Bcap31tm1.1Bwang/Bcap31tm1.1Bwang
Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA)
|
abnormal T cell activation
|
J:274469
|
| decreased T cell proliferation
|
J:274469
|
| increased thymocyte apoptosis
|
J:274469
|
Bcat1tm1.2Eaa/Bcat1tm1.2Eaa
(involves: C57BL/6)
|
abnormal T cell physiology
|
J:216027
|
Bcl2tm1Dlo/Bcl2tm1Dlo
(B6.129P2-Bcl2tm1Dlo)
|
abnormal lymphocyte physiology
|
J:104487,
J:73316
|
| increased B cell apoptosis
|
J:73316
|
| increased T cell apoptosis
|
J:73316
|
Bcl2tm1Dlo/Bcl2tm1Dlo
Bcl2l11tm1.1Ast/Bcl2l11+
(B6.129-Bcl2tm1Dlo Bcl2l11tm1.1Ast)
|
abnormal lymphocyte physiology
|
J:73316
|
| increased T cell apoptosis
|
J:73316
|
Bcl2tm1Dlo/Bcl2tm1Dlo
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
(B6.129-Bcl2tm1Dlo Bcl2l11tm1.1Ast)
|
abnormal lymphocyte physiology
|
J:73316
|
| decreased B cell apoptosis
|
J:73316
|
| increased T cell apoptosis
|
J:73316
|
Bcl2tm1Dlo/Bcl2tm1Dlo
Biktm1Ast/Biktm1Ast
(B6.Cg-Bcl2tm1Dlo Biktm1Ast)
|
abnormal lymphocyte physiology
|
J:104487
|
Bcl2tm1Irt/Bcl2tm1Irt
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased macrophage apoptosis
|
J:144243
|
Bcl2tm1Lbox/Bcl2tm1Lbox
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal B cell activation
|
J:114637
|
| decreased B cell proliferation
|
J:114637
|
| increased B cell apoptosis
|
J:114637
|
Bcl2tm1Sjk/Bcl2tm1Sjk
(involves: 129S2/SvPas * C57BL/6)
|
increased T cell apoptosis
|
J:15224
|
Bcl2tm1Tsu/Bcl2tm1Tsu
(involves: 129P2/OlaHsd * ICR)
|
abnormal T cell physiology
|
J:22391
|
Bcl2tm2.1Lbox/Bcl2+
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal B cell physiology
|
J:175730
|
Bcl2tm2.1Lbox/Bcl2tm2.1Lbox
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal B cell physiology
|
J:175730
|
Bcl2a1atm1.1Tac/Bcl2a1atm1.1Tac
Bcl2a1btm1.1Tac/Bcl2a1btm1.1Tac
Bcl2a1dtm1.1Tac/Bcl2a1dtm1.1Tac
(involves: BALB/cJ * C57BL/6NTac)
|
abnormal dendritic cell physiology
|
J:258915
|
Bcl2a1atm1Prys/Bcl2a1atm1Prys
(involves: 129/Sv * C57BL/6J * SJL)
|
abnormal neutrophil physiology
|
J:74478
|
Bcl2a1atm1Sen/Bcl2a1atm1Sen
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal neutrophil physiology
|
J:52127
|
Bcl2l1tm1Cant/Bcl2l1tm1Cant
(involves: 129S6/SvEvTac)
|
abnormal memory T cell physiology
|
J:77507
|
| abnormal T cell physiology
|
J:77507
|
| decreased T cell proliferation
|
J:77507
|
Bcl2l1tm1Dlo/Bcl2l1tm1.1Mam
Tg(Aicda-cre)9Mbu/0
(B6.Cg-Bcl2l1tm1Dlo/Bcl2l1tm1.1Mam Tg(Aicda-cre)9Mbu)
|
decreased IgG1 level
|
J:166069
|
Bcl2l11tm1.1Ast/Bcl2l11+
(involves: 129S1/Sv * C57BL/6)
|
abnormal lymphocyte physiology
|
J:58641
|
| increased IgA level
|
J:58641
|
| increased IgG level
|
J:58641
|
| increased IgM level
|
J:58641
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
(involves: 129S1/Sv * C57BL/6)
|
abnormal B cell proliferation
|
J:90963
|
| abnormal lymphocyte physiology
|
J:58641
|
| decreased B cell apoptosis
|
J:90963
|
| increased IgA level
|
J:58641
|
| increased IgG level
|
J:58641
|
| increased IgM level
|
J:58641
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
(B6.129S1-Bcl2l11tm1.1Ast)
|
abnormal lymphocyte physiology
|
J:73316
|
| decreased B cell apoptosis
|
J:73316
|
| decreased T cell apoptosis
|
J:73316,
J:133084
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
(involves: 129S1/Sv)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:132819
|
| decreased thymocyte apoptosis
|
J:266833
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
(B6.129S1-Bcl2l11tm1.1Ast/J)
|
decreased T cell apoptosis
|
J:153652
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
Biktm1Ast/Biktm1Ast
(B6.Cg-Bcl2l11tm1.1Ast Biktm1Ast)
|
abnormal lymphocyte physiology
|
J:103605
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
Bmftm1Rjd/Bmftm1Rjd
(B6.129S-Bcl2l11tm1.1Ast Bmftm1Rjd)
|
decreased T cell apoptosis
|
J:153652
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
Mlf1tm1Swm/Mlf1tm1Swm
(involves: 129S1/Sv * C57BL/6)
|
decreased thymocyte apoptosis
|
J:266833
|
Bcl2l11tm1Sjk/Bcl2l11tm1Sjk
(involves: 129X1/SvJ)
|
abnormal B cell physiology
|
J:100463
|
| increased immunoglobulin level
|
J:100463
|
Bcl2l11tm3Rjd/Bcl2l11tm3Rjd
(B6.129S6-Bcl2l11tm3Rjd)
|
decreased thymocyte apoptosis
|
J:137061
|
Bcl3m1Btlr/Bcl3m1Btlr
(C57BL/6J-Bcl3m1Btlr)
|
decreased IgE level
|
J:255184
|
| decreased IgG level
|
J:255184
|
Bcl3m2Btlr/Bcl3m2Btlr
(C57BL/6J-Bcl3m2Btlr)
|
decreased IgD level
|
J:264818
|
| increased IgM level
|
J:264818
|
Bcl3tm1Rsch/Bcl3tm1Rsch
(B6.Cg-Bcl3tm1Rsch)
|
abnormal macrophage physiology
|
J:116724
|
Bcl3tm1Sbn/Bcl3tm1Sbn
(involves: 129S4/SvJae * C57BL/6)
|
abnormal class switch recombination
|
J:39747
|
| abnormal cytotoxic T cell physiology
|
J:39747
|
| decreased IgG2a level
|
J:39747
|
Bcl3tm1Sbn/Bcl3tm1Sbn
(involves: 129S4/SvJae)
|
abnormal B cell physiology
|
J:207111
|
| decreased B cell proliferation
|
J:207111
|
| increased B cell proliferation
|
J:207111
|
Bcl6tm1.1Dent/Bcl6tm1.1Dent
Tg(Cd4-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6 * DBA/2 * FVB/N)
|
decreased IgG level
|
J:202372
|
Bcl6tm1.1Jwan/Bcl6tm1.1Jwan
(involves: 129S6/SvEvTac)
|
abnormal somatic hypermutation frequency
|
J:190534
|
Bcl6tm1.1Meln/Bcl6tm1.1Meln
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal adaptive immunity
|
J:194821
|
| abnormal germinal center B cell physiology
|
J:194821
|
| abnormal professional antigen presenting cell physiology
|
J:194821
|
| decreased IgG1 level
|
J:194821
|
| decreased IgG2a level
|
J:194821
|
| decreased IgG level
|
J:194821
|
Bcl6tm1.1Mtto/Bcl6tm1.1Mtto
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6 * C57BL/6JJcl)
|
abnormal memory B cell physiology
|
J:190943
|
| abnormal somatic hypermutation frequency
|
J:190943
|
Bcl6tm1.1Mtto/Bcl6tm1.1Mtto
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6JJcl * DBA/2)
|
abnormal somatic hypermutation frequency
|
J:190943
|
Bcl6tm1.1Toka/Bcl6+
Tg(TcraTcrb)425Cbn/0
(involves: BALB/c * C57BL/6 * NZB)
|
decreased T cell proliferation
|
J:174014
|
Bcl6tm1.1Toka/Bcl6tm1.1Toka
Tg(IghelMD4)4Ccg/0
(involves: C57BL/6 * NZB)
|
abnormal germinal center B cell physiology
|
J:174014
|
| increased activation-induced B cell apoptosis
|
J:174014
|
Bcl6tm1Rdf/Bcl6tm1Rdf
(involves: 129S1/Sv)
|
abnormal B cell physiology
|
J:40769
|
| abnormal T-helper 2 physiology
|
J:40769
|
| decreased IgG level
|
J:40769
|
| decreased IgM level
|
J:40769
|
Bcl6tm2Rdf/Bcl6tm2Rdf
(involves: 129S1/Sv)
|
abnormal B cell physiology
|
J:40769
|
| abnormal T-helper 2 physiology
|
J:40769
|
| decreased B cell proliferation
|
J:40769
|
| decreased IgG level
|
J:40769
|
| decreased IgM level
|
J:40769
|
Bcl6btm1Dtf/Bcl6btm1Dtf
(involves: 129P2/OlaHsd)
|
decreased T cell proliferation
|
J:99818
|
Bcl10m1Btlr/Bcl10m1Btlr
(C57BL/6J-Bcl10m1Btlr)
|
decreased IgG level
|
J:265122
|
| increased IgE level
|
J:265122
|
| increased IgM level
|
J:265122
|
Bcl10tm1Mak/Bcl10tm1Mak
(involves: 129P2/OlaHsd)
|
abnormal cytotoxic T cell physiology
|
J:67297
|
| abnormal dendritic cell physiology
|
J:111706
|
| abnormal T cell activation
|
J:67297
|
| decreased B cell proliferation
|
J:109545,
J:67297
|
| decreased IgG level
|
J:67297
|
| decreased IgM level
|
J:67297
|
| decreased immunoglobulin level
|
J:67297
|
| decreased T cell proliferation
|
J:109545,
J:67297
|
Bcl10tm1Swm/Bcl10tm1Swm
(involves: 129P2/OlaHsd)
|
abnormal marginal zone B cell physiology
|
J:85147
|
| decreased B cell proliferation
|
J:85147
|
Bcl10tm1Swm/Bcl10tm1Swm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal dendritic cell physiology
|
J:122394
|
Bcl11atm2.1Peli/Bcl11atm2.1Peli
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S1/Sv)
|
increased B cell apoptosis
|
J:194616
|
Bcl11btm1Avram/Bcl11btm1Avram
Tg(Cd4-cre)1Cwi/?
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal thymocyte activation
|
J:128515
|
Bcl11btm1Jpk/Bcl11btm1Jpk
(involves: BALB/c * C57BL/6 * CBA)
|
increased thymocyte apoptosis
|
J:83651
|
Bclaf1tm1Raz/Bclaf1+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell proliferation
|
J:158087
|
Bclaf1tm1Raz/Bclaf1tm1Raz
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell proliferation
|
J:158087
|
Bcrtm1Hkp/Bcrtm1Hkp
(involves: 129S2/SvPas)
|
abnormal neutrophil physiology
|
J:23804
|
Becn1tm1.1Bflu/Becn1tm1.1Bflu
Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:203090
|
| decreased T cell proliferation
|
J:203090
|
| increased T cell apoptosis
|
J:203090
|
Becn1tm1Ebr/Becn1tm1Ebr
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd)
|
abnormal macrophage physiology
|
J:235399
|
| increased IgG level
|
J:235399
|
Becn1tm1Smoc/Becn1tm1Smoc
Foxp3tm4(YFP/icre)Ayr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal regulatory T cell physiology
|
J:306129
|
Becn1tm1Smoc/Becn1tm1Smoc
Zfp91tm1Smoc/Zfp91tm1Smoc
Foxp3tm4(YFP/icre)Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal regulatory T cell physiology
|
J:306129
|
Bhlhe40tm1Tan/Bhlhe40tm1Tan
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:72651
|
| abnormal T cell activation
|
J:72651
|
| decreased T cell proliferation
|
J:72651
|
| increased IgE level
|
J:72651
|
| increased IgG1 level
|
J:72651
|
Bhlhe41tm1.2Cdon/Bhlhe41tm1.2Cdon
(B6.129S6-Bhlhe41tm1.2Cdon)
|
decreased T cell proliferation
|
J:157740
|
Birc2tm1Rbr/Birc2tm1Rbr
Birc3tm1.1Rbr/Birc3tm1.1Rbr
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * NZB)
|
decreased B cell apoptosis
|
J:172843
|
Birc2tm2.1Jda/Birc2tm2.1Jda
(B6.Cg-Birc2tm2.1Jda)
|
increased T cell proliferation
|
J:199221
|
Birc3tm1Jda/Birc3tm1Jda
(B6.Cg-Birc3tm1Jda)
|
decreased B cell apoptosis
|
J:166899
|
| decreased IgG1 level
|
J:166899
|
| increased B cell proliferation
|
J:166899
|
| increased IgA level
|
J:166899
|
| increased IgG3 level
|
J:166899
|
| increased IgM level
|
J:166899
|
Birc3tm1Jda/Birc3tm1Jda
(involves: 129 * C57BL/6)
|
increased T cell proliferation
|
J:199221
|
Birc3tm1Rgk/Birc3tm1Rgk
(B6.129X1-Birc3tm1Rgk)
|
abnormal macrophage physiology
|
J:144012
|
| abnormal T cell physiology
|
J:144012
|
Birc5tm1Mak/Birc5tm1Mak
Tg(Lck-cre)I57Jxm/0
(involves: 129P2/OlaHsd)
|
increased T cell apoptosis
|
J:90892
|
Birc6tm1Nai/Birc6tm1Nai
(involves: 129S4/SvJae * C57BL/6J)
|
increased thymocyte apoptosis
|
J:96768
|
Blkm1Btlr/Blkm1Btlr
(C57BL/6J-Blkm1Btlr)
|
increased IgE level
|
J:255004
|
Blmtm3Brd/Blmtm3Brd
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased IgM level
|
J:66261
|
Blmtm4Ches/Blmtm4Ches
Cd19tm1(cre)Cgn/Cd19+
Nsmce2tm2.1Ofc/Nsmce2tm2.1Ofc
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal B cell physiology
|
J:227197
|
Blmtm4Ches/Blmtm4Ches
Trp53bp1tm1Jc/Trp53bp1tm1Jc
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:194603
|
Blnkm1Btlr/Blnkm1Btlr
(C57BL/6J-Blnkm1Btlr)
|
decreased IgG level
|
J:159439
|
| decreased IgM level
|
J:159439
|
Blnkm1Btlr/Blnkm1Btlr
(involves: C57BL/6J)
|
decreased IgM level
|
J:185495
|
Blnktm1Achn/Blnk+
(involves: 129S4/SvJae * 129X1/SvJ * BALB/c * C3H * C57BL/6)
|
decreased B cell proliferation
|
J:82430
|
Blnktm1Achn/Blnk+
Btktm1Wk/Btktm1Wk
Tg(IGH-Btk)1Witt/0
(involves: 129S4/SvJae * 129X1/SvJ * BALB/c * C3H * C57BL/6)
|
abnormal B cell physiology
|
J:82430
|
| decreased B cell proliferation
|
J:82430
|
Blnktm1Achn/Blnktm1Achn
(involves: 129X1/SvJ)
|
decreased immunoglobulin level
|
J:58805
|
Blnktm1Dkit/Blnktm1Dkit
(involves: C57BL/6)
|
abnormal B cell apoptosis
|
J:143854
|
| decreased IgG3 level
|
J:143854
|
| decreased IgM level
|
J:143854
|
| increased B cell apoptosis
|
J:143854
|
Blnktm1Dkit/Blnktm1Dkit
Prkcdtm1Kin/Prkcdtm1Kin
(involves: 129P2/OlaHsd * C57BL/6 * NZB)
|
abnormal B cell proliferation
|
J:143854
|
| abnormal immunoglobulin level
|
J:143854
|
| increased B cell apoptosis
|
J:143854
|
| increased IgA level
|
J:143854
|
| increased IgG1 level
|
J:143854
|
| increased IgG2b level
|
J:143854
|
| increased IgG3 level
|
J:143854
|
| increased IgM level
|
J:143854
|
Blnktm1Kplm/Blnktm1Kplm
(involves: 129P2/OlaHsd)
|
abnormal B cell activation
|
J:61130,
J:131161
|
| decreased B cell proliferation
|
J:61130
|
| increased B cell apoptosis
|
J:131161
|
Blnktm1Kplm/Blnktm1Kplm
Plcg2tm1.1Kuro/Plcg2+
(involves: 129P2/OlaHsd)
|
abnormal B cell activation
|
J:131161
|
| increased B cell apoptosis
|
J:131161
|
Blnktm1Kplm/Blnktm1Kplm
Plcg2tm1.1Kuro/Plcg2tm1.1Kuro
(involves: 129P2/OlaHsd)
|
increased B cell apoptosis
|
J:131161
|
Blnktm1Pjln/Blnktm1Pjln
(involves: BALB/c)
|
decreased IgG3 level
|
J:58740
|
| decreased IgM level
|
J:58740
|
Blnktm1Pjln/Blnktm1Pjln
Btktm1Gsv/Y
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
decreased IgG3 level
|
J:94768
|
| decreased IgM level
|
J:94768
|
| decreased immunoglobulin level
|
J:94768
|
Blnktm1Pjln/Blnktm1Pjln
Btktm1Gsv/Y
Tg(CD19-BTK*K430R)XK24Rwhe/?
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * FVB)
|
decreased IgG3 level
|
J:94768
|
| decreased IgM level
|
J:94768
|
| decreased immunoglobulin level
|
J:94768
|
Bloc1s3rp/Bloc1s3rp
(involves: C57BL/10ScSn * C57BL/Tb)
|
abnormal NK cell physiology
|
J:6801
|
Bloc1s6pa/Bloc1s6pa
(B6.Cg-Bloc1s6pa/J)
|
abnormal NK cell physiology
|
J:6801
|
Bmal1em1Bwu/Bmal1em1Bwu
(C57BL/6-Bmal1em1Bwu)
|
abnormal macrophage physiology
|
J:340220
|
Bmal1tm1Bra/Bmal1tm1Bra
(B6.129-Bmal1tm1Bra)
|
impaired leukocyte tethering or rolling
|
J:191844
|
Bmal1tm1Bra/Bmal1tm1Bra
(involves: 129/Sv * C57BL/6)
|
decreased IgG1 level
|
J:118522
|
Bmftm1.1Ast/Bmftm1.1Ast
(B6.Cg-Bmftm1.1Anst)
|
decreased B cell apoptosis
|
J:133084
|
| decreased T cell apoptosis
|
J:133084
|
| increased immunoglobulin level
|
J:133084
|
Bmftm1Rjd/Bmftm1Rjd
(B6.129S6-Bmftm1Rjd)
|
decreased T cell apoptosis
|
J:153652
|
Bmi1tm1Brn/Bmi1tm1Brn
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB))
|
decreased IgM level
|
J:17712
|
Bmpr1atm2.1Bhr/Bmpr1atm2.1Bhr
Tg(Col1a1-cre/Esr1*)1Mis/0
(involves: 129S7/SvEvBrd)
|
abnormal osteoclast physiology
|
J:143588
|
Bmpr2tm1Kmi/Bmpr2+
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal leukocyte physiology
|
J:117167
|
Bod1lem1Bltn/Bod1lem1Bltn
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased IgG1 level
|
J:337726
|
| decreased IgG level
|
J:337726
|
Bod1lem1Bltn/Bod1lem1Bltn
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6J * C57BL/6NTac)
|
abnormal class switch recombination
|
J:337726
|
| decreased IgG1 level
|
J:337726
|
Braftm1Bbd/Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased thymocyte apoptosis
|
J:170095
|
Braftm1Bbd/Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CD-1)
|
increased thymocyte apoptosis
|
J:170095
|
Braftm1Bbd/Braf+
(B6.129-Braftm1Bbd)
|
increased thymocyte apoptosis
|
J:170095
|
Brca1tm2.1Cxd/Brca1tm2.1Cxd
Shld1em1Nus/Shld1em1Nus
(involves: 129S6/SvEvTac * C57BL/6NCrl)
|
abnormal class switch recombination
|
J:307190
|
Brca1tm2.1Cxd/Brca1tm2.1Cxd
Trp53bp1tm1Jc/Trp53bp1tm1Jc
(involves: 129 * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:307190
|
Brca1tm2Mak/Brca1tm2Mak
Tg(Lck-cre)548Jxm/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased T cell proliferation
|
J:63282
|
Brca1tm2Mak/Brca1tm2Mak
Tg(Lck-cre)548Jxm/?
Tg(TcrLCMV)327Sdz/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased T cell proliferation
|
J:63282
|
Brca2tm1Mak/Brca2tm2Mak
Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
increased T cell apoptosis
|
J:79697
|
Bsgtm1.1Znc/Bsgtm1.1Znc
Tg(Lck-cre)19Hhan/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
abnormal T cell activation
|
J:207886
|
| increased T cell proliferation
|
J:207886
|
Bst1tm1Thir/Bst1tm1Thir
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:111424
|
| decreased IgA level
|
J:111424
|
| decreased IgG3 level
|
J:111424
|
Btbd8em1Lych/Btbd8em1Lych
(involves: C57BL/6)
|
decreased macrophage cytokine production
|
J:349252
|
Btkm2Anu/Btkm2Anu
(C57BL/6NCrlAnu-Btkm2Anu)
|
increased IgM level
|
J:104190
|
Btktm1Gsv/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell calcium ion homeostasis
|
J:94768
|
| decreased IgG3 level
|
J:35769
|
| decreased IgM level
|
J:35769
|
| decreased immunoglobulin level
|
J:120989
|
Btktm1Gsv/Y
Tg(CD19-BTK*K430R)XK24Rwhe/?
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
decreased B cell apoptosis
|
J:120989
|
| decreased immunoglobulin level
|
J:120989
|
Btktm1Wk/Btktm1Wk
(involves: 129S4/SvJae * C57BL/6)
|
abnormal B cell activation
|
J:28968
|
| decreased B cell proliferation
|
J:82298
|
| decreased IgG3 level
|
J:28968,
J:82298
|
| decreased IgM level
|
J:28968,
J:82298
|
Btktm1Wk/Btktm1Wk
Cd40tm1Geha/Cd40tm1Geha
(involves: 129S4/SvJae * C57BL/6)
|
decreased B cell proliferation
|
J:82298
|
| decreased IgA level
|
J:82298
|
| decreased IgG2a level
|
J:82298
|
| decreased IgG2b level
|
J:82298
|
| decreased IgG3 level
|
J:82298
|
| decreased IgM level
|
J:82298
|
Btktm1Wk/Btktm1Wk
Tectm1Welm/Tectm1Welm
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell proliferation
|
J:66080
|
| decreased IgG2a level
|
J:66080
|
| decreased IgG3 level
|
J:66080
|
| decreased IgM level
|
J:66080
|
| decreased immunoglobulin level
|
J:66080
|
Btktm1Wk/Btktm1Wk
Tg(IGH-Btk)1Witt/0
(involves: 129S4/SvJae * 129X1/SvJ * BALB/c * C3H * C57BL/6)
|
decreased B cell proliferation
|
J:82430
|
Btkvila/Btkvila
(C57BL/6JAnu-Btkvila/AnuApb)
|
decreased IgD level
|
J:104190
|
| increased IgE level
|
J:104190
|
| increased IgG level
|
J:104190
|
Btkxid/Y
(CBA/HN-Btkxid)
|
decreased B cell proliferation
|
J:81429
|
Btkxid/Y
(involves: CBA/HN * DBA/2N)
|
decreased B cell proliferation
|
J:81429
|
Btkxid/?
(involves: BALB/c * CBA/N)
|
decreased B cell proliferation
|
J:108696
|
| decreased IgG3 level
|
J:108696
|
| decreased IgM level
|
J:108696
|
Btkxid/?
Ptpn6me/Ptpn6me
(involves: C57BL/6J * CBA/N * NFS)
|
increased IgM level
|
J:30994
|
Btkxid/?
Tg(IGH-Btk)1Witt/0
(involves: BALB/c * C3H * C57BL/6 * CBA/N)
|
decreased B cell proliferation
|
J:108696
|
| decreased IgG3 level
|
J:108696
|
| decreased IgM level
|
J:108696
|
Btkxid/?
Tg(IGH-Btk)1Witt/Tg(IGH-Btk)1Witt
(involves: BALB/c * C3H * C57BL/6 * CBA/N)
|
decreased B cell proliferation
|
J:108696
|
| decreased IgG3 level
|
J:108696
|
| decreased IgM level
|
J:108696
|
Btkxid/Btkxid
(CBA/CaHN-Btkxid/J)
|
abnormal macrophage physiology
|
J:92639
|
| abnormal neutrophil physiology
|
J:92639
|
| impaired neutrophil phagocytosis
|
J:92639
|
Btkxid/Btkxid
(involves: CBA/HN * DBA/2N)
|
abnormal B cell physiology
|
J:81429
|
| abnormal B cell proliferation
|
J:81429
|
Btkxid/Btkxid
(CBA/HN-Btkxid)
|
decreased B cell proliferation
|
J:81429
|
Btlatm1Dgra/Btlatm1Dgra
(involves: C57BL/6)
|
abnormal T cell activation
|
J:147751
|
Btlatm1Kay/Btlatm1Kay
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal T cell activation
|
J:89864
|
Btlatm1Kmm/Btlatm1Kmm
(involves: 129S/SvEv)
|
increased B cell proliferation
|
J:84084
|
| increased IgG1 level
|
J:84084
|
| increased IgG2a level
|
J:84084
|
| increased IgG2b level
|
J:84084
|
| increased T cell proliferation
|
J:84084
|
Btlatm1Kmm/Btlatm1Kmm
(B6.129S-Btlatm1Kmm)
|
abnormal T cell activation
|
J:119356
|
| decreased T cell proliferation
|
J:119356
|
| increased T cell proliferation
|
J:119356
|
Btlatm1Kmm/Btlatm1Kmm
Pdcd1tm1Hon/Pdcd1tm1Hon
(B6.129S-Pdcd1tm1Hon Btlatm1Kmm)
|
increased T cell proliferation
|
J:119356
|
Btlatm1Kmm/Btlatm1Kmm
Tg(DO11.10)10Dlo/?
(involves: 129S/SvEv * BALB/c * C3H * C57BL/6)
|
increased T cell proliferation
|
J:84084
|
Btn2a2tm1.2Wrth/Btn2a2tm1.2Wrth
(C57BL/6-Btn2a2tm1.2Wrth)
|
abnormal T-helper 1 physiology
|
J:232636
|
| abnormal T-helper 2 physiology
|
J:232636
|
| increased IgG1 level
|
J:232636
|
| increased IgG2c level
|
J:232636
|
| increased IgG level
|
J:232636
|
Bub1btm1.1Hsl/Bub1b+
(involves: 129 * C57BL/6)
|
increased B cell proliferation
|
J:201641
|
C1qtnf3tm1Yiw/C1qtnf3tm1Yiw
(involves: C57BL/6NSlc)
|
increased IgG level
|
J:211893
|
C1qtnf6tm1Yiw/C1qtnf6tm1Yiw
(B6.129P2-C1qtnf6tm1Yiw)
|
increased IgG level
|
J:227217
|
| increased susceptibility to type III hypersensitivity reaction
|
J:227217
|
C3tm1Crr/C3tm1Crr
(involves: 129S4/SvJae * C57BL/6)
|
abnormal mast cell physiology
|
J:44240
|
C3tm1Crr/C3tm1Crr
Cd59atm1Bpm/Cd59atm1Bpm
(B6.129-Cd59atm1Bpm C3tm1Crr)
|
increased T cell proliferation
|
J:122201
|
C3tm1Crr/C3tm1Crr
Tg(Ins2-TFRC/OVA)296Wehi/0
(involves: 129S4/SvJae * C57BL/6)
|
increased T cell proliferation
|
J:122114
|
C3tm1Crr/C3tm1Crr
Zbtb20Tg(PDGFB-APPSwInd)20Lms/?
(involves: 129S4/SvJae * C57BL/6)
|
increased microglial cell activation
|
J:135902
|
C3tm1Hrc/C3tm1Hrc
Lama2dy/Lama2dy
(either: (involves: 129S2/SvPas * 129P1/ReJ) or (involves: 129X1/SvJ * 129P1/ReJ))
|
decreased IgM level
|
J:102959
|
| increased IgG level
|
J:102959
|
| increased IgM level
|
J:102959
|
C3ar1tm1Raw/C3ar1tm1Raw
(B6.129X1(B6)-C3ar1tm1Raw)
|
abnormal adaptive immunity
|
J:80071
|
| abnormal eosinophil physiology
|
J:80071
|
| abnormal T-helper 2 physiology
|
J:80071
|
| decreased IgE level
|
J:80071
|
| decreased IgG1 level
|
J:80071
|
| impaired neutrophil recruitment
|
J:80071
|
| increased susceptibility to type I hypersensitivity reaction
|
J:80071
|
C5ar1tm1Cge/C5ar1tm1Cge
(involves: 129S4/SvJae)
|
impaired neutrophil recruitment
|
J:69177
|
C5ar1tm1Song/C5ar1tm1Song
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal neutrophil physiology
|
J:184056
|
C9orf72em5Lutzy/C9orf72em5Lutzy
(C57BL/6-C9orf72em5Lutzy)
|
abnormal macrophage physiology
|
J:101977
|
| abnormal microglial cell physiology
|
J:101977
|
C9orf72tm1.1Eggn/C9orf72+
(involves: C57BL/6 * C57BL/6N)
|
increased IgG level
|
J:240357
|
| increased IgM level
|
J:240357
|
C9orf72tm1.1Eggn/C9orf72tm1.1Eggn
(involves: C57BL/6 * C57BL/6N)
|
increased IgG level
|
J:240357
|
| increased IgM level
|
J:240357
|
Cabin1tm1.1Che/Cabin1tm1.1Che
(involves: 129S4/SvJae * BALB/c)
|
increased IgE level
|
J:72760
|
| increased IgG1 level
|
J:72760
|
| increased IgG2b level
|
J:72760
|
Cacnb3tm1Acv/Cacnb3tm1Acv
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:115345
|
Cacnb4lh/Cacnb4lh
(B6EiC3Sn a/A-Cacnb4lh/J)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:115345
|
Cacnb4lh/Cacnb4lh
(involves: BALB/cGn)
|
increased IgG1 level
|
J:5883
|
Cadm1Gt(Ayu21-W34)Imeg/Cadm1Gt(Ayu21-W34)Imeg
(involves: C57BL/6 * CBA/JNCrlj)
|
decreased T cell proliferation
|
J:178612
|
Calcrtm1Rda/Calcrtm1Rda
Tg(CMV-cre)1Cgn/0
(B6.Cg-Calcrtm1Rda Tg(CMV-cre)1Cgn)
|
abnormal osteoclast physiology
|
J:150982
|
Camk2gtm1.1Irt/Camk2gtm1.1Irt
(involves: C57BL/6 * C57BL/6J)
|
decreased macrophage apoptosis
|
J:154647
|
Camltm1Rjb/Camltm2Rjb
Tg(Lck-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2)
|
increased T cell apoptosis
|
J:100536
|
Capgtm1Djk/Capgtm1Djk
(involves: 129S4/SvJae)
|
abnormal macrophage physiology
|
J:86517
|
| impaired macrophage phagocytosis
|
J:86517
|
Capgtm1Djk/Capgtm1Djk
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal dendritic cell physiology
|
J:86277
|
| impaired macrophage phagocytosis
|
J:86277
|
| impaired neutrophil chemotaxis
|
J:86277
|
Capgtm1Djk/Capgtm1Djk
Gsntm1Djk/Gsntm1Djk
(involves: 129S4/SvJae)
|
abnormal macrophage physiology
|
J:86517
|
| impaired macrophage phagocytosis
|
J:86517
|
Capn1tm1Dgen/Capn1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal leukocyte adhesion
|
J:183585
|
CapopNOD/CapopNOD
(involves: C57BL/6 * NOD)
|
decreased T cell apoptosis
|
J:68151
|
Card9tm1Jrld/Card9tm1Jrld
(involves: 129P2/OlaHsd)
|
abnormal dendritic cell physiology
|
J:111706
|
Card9tm1Tks/Card9tm1Tks
(B6.129-Card9tm1Tks)
|
abnormal dendritic cell physiology
|
J:122394
|
| abnormal macrophage physiology
|
J:141143,
J:122394
|
Card9tm1Xlin/Card9tm1Xlin
(involves: 129/Sv * C57BL/6)
|
abnormal macrophage physiology
|
J:117799
|
Card11em1Welu/Card11em1Welu
(involves: C57BL/6)
|
decreased B cell proliferation
|
J:292926
|
| decreased IgG level
|
J:292926
|
| decreased IgM level
|
J:292926
|
Card11em2Welu/Card11em2Welu
(involves: C57BL/6)
|
increased B cell proliferation
|
J:292926
|
Card11m1Btlr/Card11m1Btlr
(C57BL/6J-Card11m1Btlr)
|
abnormal cytotoxic T cell physiology
|
J:139069
|
| abnormal NK cell physiology
|
J:139069
|
| abnormal T cell activation
|
J:139069
|
| decreased B cell proliferation
|
J:149767,
J:139069
|
| decreased IgG1 level
|
J:149767,
J:139069
|
| decreased IgG2a level
|
J:149767,
J:139069
|
| decreased IgG2b level
|
J:149767,
J:139069
|
| decreased IgG2c level
|
J:149767
|
| decreased IgG3 level
|
J:149767,
J:139069
|
| decreased IgM level
|
J:149767,
J:139069
|
| decreased immunoglobulin level
|
J:139069
|
| decreased T cell proliferation
|
J:149767,
J:139069
|
Card11M2Btlr/Card11M2Btlr
(involves: C57BL/6J)
|
decreased IgM level
|
J:198555
|
Card11M4Btlr/Card11M4Btlr
(C57BL/6J-Card11M4Btlr)
|
decreased IgM level
|
J:254856
|
Card11M5Btlr/Card11+
(C57BL/6J-Card11M5Btlr)
|
decreased IgM level
|
J:254879
|
Card11M5Btlr/Card11M5Btlr
(C57BL/6J-Card11M5Btlr)
|
decreased IgM level
|
J:254879
|
Card11m8Btlr/Card11m8Btlr
(C57BL/6J-Card11m8Btlr)
|
decreased IgG level
|
J:274940
|
| decreased IgM level
|
J:274940
|
Card11tm1.1Litt/Card11tm1.1Litt
Gt(ROSA)26Sortm1(cre/ERT2)Thl/Gt(ROSA)26Sor+
Tg(TcraTcrb)425Cbn/?
(involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal T cell activation
|
J:180410
|
Card11tm1.1Litt/Card11tm1.1Litt
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129P2/OlaHsd * 129X1/SvJ)
|
abnormal T cell activation
|
J:180410
|
Card11tm1Litt/Card11tm1Litt
(involves: 129P2/OlaHsd)
|
abnormal B cell proliferation
|
J:89322
|
| abnormal T cell activation
|
J:89322
|
| abnormal T cell proliferation
|
J:89322
|
| decreased IgA level
|
J:89322
|
| decreased IgG1 level
|
J:89322
|
| decreased IgG2b level
|
J:89322
|
| decreased IgG3 level
|
J:89322
|
| decreased IgM level
|
J:89322
|
| decreased immunoglobulin level
|
J:89322
|
Card11tm1Pngr/Card11tm1Pngr
(involves: 129P2/OlaHsd)
|
abnormal B cell physiology
|
J:84036
|
| abnormal T cell activation
|
J:84036
|
| decreased B cell proliferation
|
J:84036
|
| decreased IgA level
|
J:84036
|
| decreased IgE level
|
J:84036
|
| decreased IgG1 level
|
J:84036
|
| decreased IgG2a level
|
J:84036
|
| decreased IgG2b level
|
J:84036
|
| decreased IgG3 level
|
J:84036
|
| decreased IgG level
|
J:84036
|
| decreased IgM level
|
J:84036
|
| decreased immunoglobulin level
|
J:84036
|
Card11tm1Vmd/Card11+
(involves: 129S6/SvEvTac * C57BL/6N)
|
decreased B cell proliferation
|
J:95800
|
Card11tm1Vmd/Card11tm1Vmd
(involves: 129S6/SvEvTac * C57BL/6N)
|
abnormal B cell physiology
|
J:95800
|
| decreased B cell proliferation
|
J:95800
|
| decreased IgA level
|
J:95800
|
| decreased IgG1 level
|
J:95800
|
| decreased IgG2a level
|
J:95800
|
| decreased IgG2b level
|
J:95800
|
| decreased IgG3 level
|
J:95800
|
| decreased IgG level
|
J:95800
|
| decreased IgM level
|
J:95800
|
| decreased T cell proliferation
|
J:95800
|
Card11tm1Xav/Card11tm1Xav
(involves: 129 * C57BL/6)
|
abnormal T cell activation
|
J:132226
|
| decreased IgE level
|
J:132226
|
Card11unm/Card11unm
(C57BL/6JSfdAnu-Card11unm/Anu)
|
abnormal T cell activation
|
J:84042
|
| decreased IgG3 level
|
J:84042
|
| decreased IgM level
|
J:84042
|
| decreased immunoglobulin level
|
J:84042
|
| increased IgE level
|
J:84042
|
| increased immunoglobulin level
|
J:84042
|
Card19tm1Rwen/Card19tm1Rwen
Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell activation
|
J:336763
|
Card19tm1Rwen/Card19tm1Rwen
Tg(IghelMD4)4Ccg/0
Tg(ML5sHEL)5Ccg/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6JSfd)
|
decreased B cell proliferation
|
J:336763
|
| increased B cell apoptosis
|
J:336763
|
Carmil2bas/Carmil2bas
(involves: C3HeB/FeJ * C57BL/6)
|
decreased T cell proliferation
|
J:205441
|
Carmil2bas/Carmil2tm1a(KOMP)Mbp
(involves: C3HeB/FeJ * C57BL/6 * C57BL/6N)
|
decreased T cell proliferation
|
J:205441
|
Casp1tm1Flv/Casp1tm1Flv
Casp4del/Casp4del
(involves: 129S2/SvPas * C57BL/6)
|
decreased thymocyte apoptosis
|
J:24258
|
| impaired neutrophil chemotaxis
|
J:124226
|
Casp1tm1Sesh/Casp1+
Casp4del/Casp4+
(involves: 129S1/SvImJ * 129S2/SvPas * NOD)
|
abnormal macrophage physiology
|
J:99748
|
Casp1tm1Sesh/Casp1tm1Sesh
Casp4del/Casp4del
(involves: 129S2/SvPas * C57BL/6)
|
abnormal macrophage physiology
|
J:22964
|
| abnormal neutrophil physiology
|
J:80568
|
| decreased T cell apoptosis
|
J:40691
|
Casp1tm1Sesh/Casp1tm1Sesh
Casp4del/Casp4del
(C3.129S2-Casp1tm1Sesh Casp4del)
|
abnormal macrophage physiology
|
J:136368
|
Casp1tm1Sesh/Casp1tm1Sesh
Casp4del/Casp4del
(B6.129S2(NOD)-Casp1tm1Sesh Casp4del)
|
decreased macrophage apoptosis
|
J:193522
|
Casp1tm1Sesh/Casp1tm1Sesh
Casp4del/Casp4del
Slc11a1s/Slc11a1s
(B6.129S2-Casp1tm1Sesh Casp4del)
|
abnormal macrophage physiology
|
J:112400
|
Casp1tm1Sesh/Casp1tm1Sesh
Casp4del/Casp4del
Tg(Casp4)#Gne/0
(involves: 129S2/SvPas * C57BL/6 * NOD/ShiLtJ)
|
decreased macrophage apoptosis
|
J:193522
|
Casp2tm1Vaux/Casp2tm1Vaux
Casp9tm1Flv/Casp9tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
abnormal T cell physiology
|
J:91156
|
Casp2tm1Yuan/Casp2tm1Yuan
(involves: 129S4/SvJae * C57BL/6J * DBA/2)
|
abnormal B cell apoptosis
|
J:47601
|
Casp3tm1Flv/Casp3tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
abnormal osteoclast physiology
|
J:94703
|
Casp3tm1Flv/Casp3tm1Flv
Casp7tm1Flv/Casp7+
(B6.129S-Casp3tm1Flv Casp7tm1Flv)
|
decreased thymocyte apoptosis
|
J:105496
|
Casp3tm1Flv/Casp3tm1Flv
Casp7tm1Flv/Casp7tm1Flv
(B6.129S-Casp3tm1Flv Casp7tm1Flv)
|
decreased thymocyte apoptosis
|
J:105496
|
Casp4tm1.1Vmd/Casp4tm1.1Vmd
(involves: C57BL/6)
|
decreased macrophage apoptosis
|
J:193522
|
Casp8tm1.1Raz/Casp8tm1.1Raz
Ripk3tm1Vmd/Ripk3tm1Vmd
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
abnormal macrophage physiology
|
J:170815
|
| decreased macrophage apoptosis
|
J:170815
|
| decreased thymocyte apoptosis
|
J:170814
|
Casp8tm1Hed/Casp8tm1Hed
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd)
|
abnormal adaptive immunity
|
J:116713
|
| abnormal immunoglobulin level
|
J:116713
|
| decreased B cell proliferation
|
J:116713
|
Casp8tm1Hed/Casp8tm1Hed
Tg(KRT14-cre)1Efu/0
(Not Specified)
|
abnormal T cell physiology
|
J:167299
|
| increased IgE level
|
J:167299
|
| increased IgG1 level
|
J:167299
|
Casp8tm1Raz/Casp8tm1Raz
Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:82759
|
| abnormal T cell activation
|
J:107455
|
| abnormal T cell physiology
|
J:107455
|
| abnormal T cell proliferation
|
J:107455
|
| decreased T cell apoptosis
|
J:82759
|
| decreased T cell proliferation
|
J:82759
|
Casp9tm1Flv/Casp9tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
abnormal thymocyte apoptosis
|
J:49088
|
| decreased T cell apoptosis
|
J:91156
|
Casp9tm1Mak/Casp9tm1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1))
|
abnormal thymocyte apoptosis
|
J:49087
|
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6 * SJL)
|
abnormal macrophage physiology
|
J:115914
|
| abnormal neutrophil physiology
|
J:139304
|
| impaired neutrophil recruitment
|
J:115914
|
Cbfbtm1Itan/Cbfbtm1Itan
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
increased IgA level
|
J:125953
|
| increased IgE level
|
J:125953
|
| increased IgG1 level
|
J:125953
|
| increased immunoglobulin level
|
J:125953
|
Cbltm1Ddlb/Cbltm1Ddlb
(involves: 129S1/Sv)
|
abnormal T cell physiology
|
J:81965
|
Cbltm1Ddlb/Cbltm2Wlan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell activation
|
J:103366
|
| abnormal T cell physiology
|
J:103366
|
Cbltm1Wlan/Cbltm1Wlan
(involves: 129S1/Sv * C57BL/6)
|
abnormal T cell physiology
|
J:81965
|
Cbltm2Hua/Cbltm2Hua
Cblbtm1Hua/Cblbtm1Hua
Tg(Lck-cre)I57Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * ICR)
|
increased T cell proliferation
|
J:80427
|
Cblbtm1Hua/Cblbtm1Hua
(Not Specified)
|
increased T cell proliferation
|
J:89761
|
Cblbtm1Hua/Cblbtm1Hua
(B6.129P2-Cblbtm1Hua)
|
increased T cell proliferation
|
J:94685
|
Cblbtm1Hua/Cblbtm1Hua
Ubash3btm1Jni/Ubash3btm1Jni
Ubash3atm1Jni/Ubash3atm1Jni
(Not Specified)
|
increased T cell proliferation
|
J:89761
|
Cblbtm1Pngr/Cblbtm1Pngr
(involves: 129 * C57BL/6)
|
abnormal mast cell physiology
|
J:126361
|
Cblbtm1Pngr/Cblbtm1Pngr
(B6.129P2-Cblbtm1Pngr)
|
increased T cell proliferation
|
J:141390
|
Cblbtm1Pngr/Cblbtm1Pngr
Vav1tm1Tyb/Vav1tm1Tyb
Wastm1Sbs/Wastm1Sbs
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac)
|
abnormal T cell physiology
|
J:79550
|
Cblbtm1Pngr/Cblbtm1Pngr
Wastm1Sbs/Wastm1Sbs
(Not Specified)
|
abnormal T cell physiology
|
J:79550
|
Cblbtm1Wlan/Cblbtm1Wlan
(involves: 129X1/SvJ * C57BL/6)
|
abnormal mast cell physiology
|
J:126361
|
Cbx5tm1.1Ics/Cbx5tm1.1Ics
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T-helper 2 physiology
|
J:186702
|
Ccbe1tm1Mlkn/Ccbe1tm1Mlkn
(either: B6.129-Ccbe1tm1Mlkn or (involves: 129 * C57BL/6))
|
abnormal macrophage physiology
|
J:196696
|
Ccdc86tm1Hfuj/Ccdc86+
(involves: C57BL/6NTac)
|
decreased T cell apoptosis
|
J:151722
|
Ccdc88bm1Pgrs/Ccdc88bm1Pgrs
(involves: C57BL/6J * C57BL/10J)
|
decreased T cell proliferation
|
J:230618
|
Ccdc171m1Anu/Ccdc171+
(C57BL/NCrlAnu-Ccdc171m1Anu/Anu)
|
decreased IgD level
|
J:104190
|
| increased IgM level
|
J:104190
|
Ccdc171m1Anu/Ccdc171m1Anu
(C57BL/NCrlAnu-Ccdc171m1Anu/Anu)
|
decreased IgD level
|
J:104190
|
| increased IgM level
|
J:104190
|
Ccl1tm1Sman/Ccl1tm1Sman
(B6.129-Ccl1tm1Sman)
|
abnormal regulatory T cell physiology
|
J:138942
|
Ccl2tm1.1Pame/Ccl2tm1.1Pame
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
abnormal leukocyte migration
|
J:171379
|
Ccl2tm1.1Pame/Ccl2tm1.1Pame
Tg(Tek-cre)12Flv/0
(involves: C3H * C57BL/6)
|
abnormal leukocyte migration
|
J:171379
|
Ccl2tm1.1Tyos/Ccl2tm1.1Tyos
(involves: 129S1/Sv * C57BL/6)
|
abnormal neutrophil physiology
|
J:151874
|
| impaired macrophage chemotaxis
|
J:151874
|
Ccl2tm1.1Tyos/Ccl2tm1.1Tyos
(involves: 129S1/Sv)
|
abnormal dendritic cell chemotaxis
|
J:199611
|
| abnormal dendritic cell physiology
|
J:199611
|
Ccl2tm1Lex/Ccl2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
impaired macrophage chemotaxis
|
J:191510
|
Ccl2tm1Rol/Ccl2tm1Rol
(involves: 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:45920
|
| impaired macrophage chemotaxis
|
J:45920
|
Ccl2tm1Rol/Ccl2tm1Rol
(involves: 129S4/SvJae * C57BL/6)
|
abnormal macrophage chemotaxis
|
J:116878
|
| abnormal T cell physiology
|
J:116878
|
| impaired macrophage chemotaxis
|
J:108533
|
Ccl2tm1Rol/Ccl2tm1Rol
(involves: 129S4/SvJae)
|
abnormal macrophage physiology
|
J:155025
|
| impaired macrophage chemotaxis
|
J:147697
|
Ccl2tm1Rol/Ccl2tm1Rol
(B6.129S4-Ccl2tm1Rol)
|
abnormal macrophage chemotaxis
|
J:109290
|
| abnormal neutrophil physiology
|
J:151874
|
| impaired macrophage chemotaxis
|
J:151874,
J:68145,
J:118606
|
| increased IgG1 level
|
J:68145
|
| increased IgG level
|
J:147328
|
Ccl2tm1Rol/Ccl2tm1Rol
(B6.129S4-Ccl2tm1Rol/J)
|
abnormal microglial cell physiology
|
J:141739
|
Ccl2tm1Rol/Ccl2tm1Rol
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J)
|
abnormal macrophage physiology
|
J:200877
|
| increased microglial cell activation
|
J:200877
|
Ccl2tm1Rol/Ccl2tm1Rol
Tg(Ccr2-EGFP)8Pame/0
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal leukocyte migration
|
J:171379
|
Ccl3tm1Unc/Ccl3tm1Unc
(B6.129P2-Ccl3tm1Unc/J)
|
decreased susceptibility to type III hypersensitivity reaction
|
J:94599
|
Ccl3tm1Unc/Ccl3tm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased microglial cell activation
|
J:153059
|
Ccl5tm1Hso/Ccl5tm1Hso
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:75842
|
| decreased T cell proliferation
|
J:75842
|
Ccl11tm1Mer/Ccl11tm1Mer
(involves: 129S6/SvEvTac * NIH Black Swiss)
|
impaired eosinophil recruitment
|
J:38945
|
Ccl17tm1.1Ifo/Ccl17tm1.1Ifo
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:159098
|
Ccl17tm2.1(cre)Ifo/Ccl17+
Hif1atm3Rsjo/Hif1atm3Rsjo
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal leukocyte migration
|
J:187773
|
Ccl22tm1(KOMP)Vlcg/Ccl22tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal dendritic cell physiology
|
J:236051
|
Ccl27aem1Nax/Ccl27aem1Nax
Ccl27alem1Nax/Ccl27alem1Nax
Ccl27bem1Nax/Ccl27bem1Nax
(involves: C57BL/6)
|
impaired leukocyte migration
|
J:330550
|
Ccl27aem1Nax/Ccl27aem1Nax
Ccl27alem1Nax/Ccl27alem1Nax
Ccl27bem1Nax/Ccl27bem1Nax
Ccr10tm1.1Nax/Ccr10+
(involves: C57BL/6)
|
impaired leukocyte migration
|
J:330550
|
Ccl28tm1Takna/Ccl28tm1Takna
(C57BL/6J-Ccl28tm1Takna)
|
decreased IgA level
|
J:256896
|
| increased IgG level
|
J:256896
|
Ccn3tm1.1Ecan/Ccn3tm1.1Ecan
(B6.Cg-Ccn3tm1.1Ecan)
|
abnormal osteoclast physiology
|
J:158478
|
Ccnd3tm1.1(Ccnd2)Iaai/Ccnd3tm1.1(Ccnd2)Iaai
(involves: 129S6/SvEvTac)
|
decreased B cell proliferation
|
J:192031
|
| decreased T cell proliferation
|
J:192031
|
Ccnd3tm1Pisc/Ccnd3tm1Pisc
(Not Specified)
|
decreased B cell proliferation
|
J:192031
|
| decreased T cell proliferation
|
J:88120,
J:192031
|
Ccnd3tm1Pisc/Ccnd3tm1Pisc
Cdkn1btm1Mlf/Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor)
|
decreased T cell proliferation
|
J:192031
|
Ccnd3tm1Pisc/Ccnd3tm1Pisc
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv)
|
increased T cell proliferation
|
J:88120
|
Ccnd3tm1Pisc/Ccnd3tm1Pisc
Rb1tm2Brn/Rb1tm2Brn
Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA)
|
decreased T cell proliferation
|
J:192031
|
Ccr1tm1Cge/Ccr1tm1Cge
(involves: 129S4/SvJae)
|
impaired neutrophil recruitment
|
J:43569
|
| increased IgG2a level
|
J:115119
|
| increased susceptibility to type IV hypersensitivity reaction
|
J:115119
|
Ccr1tm1Cge/Ccr1tm1Cge
(involves: 129S4/SvJae * BALB/c)
|
abnormal macrophage physiology
|
J:169909
|
| increased macrophage nitric oxide production
|
J:169909
|
Ccr1tm1Gao/Ccr1tm1Gao
(involves: 129S4/SvJae * C57BL/6)
|
abnormal neutrophil physiology
|
J:41324
|
Ccr1tm1Gao/Ccr1tm1Gao
(involves: C57BL/6)
|
decreased susceptibility to type III hypersensitivity reaction
|
J:94599
|
Ccr1tm1Gao/Ccr1tm1Gao
(B6.129S4-Ccr1tm1Gao)
|
abnormal cellular extravasation
|
J:104744
|
| abnormal leukocyte adhesion
|
J:104744
|
Ccr2tm1.1Dnc/Ccr2tm1.1Dnc
(Not Specified)
|
abnormal dendritic cell chemotaxis
|
J:223508
|
Ccr2tm1Blck/Ccr2tm1Blck
(B6.129P2-Ccr2tm1Blck)
|
abnormal cellular extravasation
|
J:104744
|
| abnormal leukocyte adhesion
|
J:104744
|
Ccr2tm1Brv/Ccr2tm1Brv
(involves: 129S1/Sv * ICR)
|
impaired macrophage chemotaxis
|
J:111517
|
Ccr2tm1Ifc/Ccr2+
(involves: 129S4/SvJae * C57BL/6)
|
impaired macrophage chemotaxis
|
J:121703
|
Ccr2tm1Ifc/Ccr2tm1Ifc
(B6.129S4-Ccr2tm1Ifc/J)
|
abnormal leukocyte migration
|
J:106738
|
| abnormal leukocyte physiology
|
J:122119
|
| abnormal microglial cell physiology
|
J:106738
|
| abnormal osteoclast physiology
|
J:149360
|
Ccr2tm1Ifc/Ccr2tm1Ifc
(involves: 129S4/SvJae * C57BL/6)
|
abnormal Langerhans cell physiology
|
J:112594
|
| abnormal macrophage chemotaxis
|
J:44345
|
| abnormal microglial cell physiology
|
J:121703
|
| decreased susceptibility to type I hypersensitivity reaction
|
J:118971
|
| decreased T cell proliferation
|
J:75838
|
| impaired macrophage chemotaxis
|
J:81363,
J:44345,
J:121703
|
Ccr2tm1Ifc/Ccr2tm1Ifc
(B6.129S4-Ccr2tm1Ifc)
|
impaired leukocyte tethering or rolling
|
J:154558
|
Ccr2tm1Ifc/Ccr2tm1Ifc
Tg(APPSWE)2576Kha/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
abnormal microglial cell physiology
|
J:121703
|
Ccr2tm1Mae/Ccr2tm1Mae
(B6.129P2-Ccr2tm1Mae)
|
increased IgG level
|
J:147328
|
Ccr2tm1Mae/Ccr2tm1Mae
(involves: 129P2/OlaHsd)
|
abnormal leukocyte migration
|
J:171379
|
| impaired macrophage chemotaxis
|
J:191510,
J:151874
|
Ccr2tm1Mae/Ccr2tm1Mae
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal leukocyte physiology
|
J:162714
|
| impaired macrophage chemotaxis
|
J:162714
|
Ccr2tm2.1Ifc/Ccr2tm2.1Ifc
Cx3cr1tm1Litt/Cx3cr1+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal leukocyte physiology
|
J:166664
|
Ccr2tm2.1Ifc/Ccr2tm2.1Ifc
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal leukocyte physiology
|
J:166664
|
Ccr3tm1Cge/Ccr3tm1Cge
(involves: 129S4/SvJae * BALB/c)
|
abnormal eosinophil physiology
|
J:74509,
J:75347
|
| abnormal mast cell physiology
|
J:74509
|
| impaired eosinophil chemotaxis
|
J:74509
|
| impaired eosinophil recruitment
|
J:74509,
J:75347
|
| increased mast cell degranulation
|
J:74509
|
Ccr4tm1Pwr/Ccr4tm1Pwr
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased IgE level
|
J:120221
|
| increased IgE level
|
J:120221
|
| increased IgG1 level
|
J:120221
|
Ccr5tm1Blck/Ccr5tm1Blck
(B6.129P2-Ccr5tm1Blck)
|
abnormal cellular extravasation
|
J:104744
|
| abnormal leukocyte adhesion
|
J:104744
|
Ccr5tm1Brv/Ccr5tm1Brv
(either: (involves: 129S1/Sv * ICR) or (involves: 129S1/Sv * 129X1/SvJ * ICR))
|
increased IgG1 level
|
J:46941
|
| increased susceptibility to type IV hypersensitivity reaction
|
J:46941
|
Ccr5tm1Kuz/Ccr5tm1Kuz
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal NK T cell physiology
|
J:100869
|
| decreased microglial cell activation
|
J:153059
|
| impaired macrophage chemotaxis
|
J:153059,
J:84243,
J:64293
|
Ccr5tm1Sush/Ccr5tm1Sush
(B6.129P2-Ccr5tm1Sush)
|
abnormal leukocyte physiology
|
J:94937
|
| decreased T cell proliferation
|
J:94937
|
Ccr6tm1(EGFP)Irw/Ccr6tm1(EGFP)Irw
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal B cell physiology
|
J:120122
|
| abnormal T cell physiology
|
J:85086
|
| impaired B cell migration
|
J:120122
|
| increased T cell proliferation
|
J:85086
|
Ccr6tm1.1Jmf/Ccr6tm1.1Jmf
(B6.129-Ccr6tm1.1Jmf)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:152716
|
| abnormal dendritic cell physiology
|
J:152716
|
Ccr6tm1Gma/Ccr6tm1Gma
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:68191
|
Ccr6tm1Lira/Ccr6tm1Lira
(involves: 129)
|
abnormal T cell physiology
|
J:123150
|
Ccr6tm1Lira/Ccr6tm1Lira
(involves: 129 * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:148286
|
| abnormal macrophage physiology
|
J:124358
|
| decreased IgA level
|
J:76461
|
| decreased IgG3 level
|
J:76461
|
| decreased macrophage cytokine production
|
J:124358
|
| decreased macrophage nitric oxide production
|
J:124358
|
| increased IgM level
|
J:76461
|
Ccr6tm1Lira/Ccr6tm1Lira
(B6.129-Ccr6tm1Lira)
|
decreased IgE level
|
J:71096
|
| decreased susceptibility to type I hypersensitivity reaction
|
J:71096
|
| impaired eosinophil recruitment
|
J:71096
|
Ccr7tm1Rfor/Ccr7tm1Rfor
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal B cell activation
|
J:57976
|
| abnormal class switch recombination
|
J:57976
|
| abnormal dendritic cell physiology
|
J:57976
|
| abnormal leukocyte migration
|
J:57976
|
| abnormal T cell physiology
|
J:57976
|
| decreased IgG3 level
|
J:57976
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:57976
|
| impaired B cell migration
|
J:57976
|
| increased IgE level
|
J:57976
|
| increased IgG1 level
|
J:57976
|
| increased IgG2a level
|
J:57976
|
Ccr7tm1Rfor/Ccr7tm1Rfor
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
abnormal dendritic cell physiology
|
J:134784
|
Ccr7tm1Rfor/Ccr7tm1Rfor
(B6.129P2-Ccr7tm1Rfor)
|
abnormal dendritic cell physiology
|
J:183989
|
| abnormal leukocyte migration
|
J:93960,
J:110910
|
Ccr7tm1Rfor/Ccr7tm1Rfor
(involves: 129P2/OlaHsd)
|
abnormal dendritic cell chemotaxis
|
J:223508
|
Ccr7tm1Rfor/Ccr7tm1Rfor
Tg(DO11.10)10Dlo/?
(involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6)
|
abnormal leukocyte migration
|
J:123482
|
| abnormal regulatory T cell physiology
|
J:123482
|
Ccr10tm1Cge/Ccr10tm1Cge
(C.129S4-Ccr10tm1Cge)
|
abnormal leukocyte migration
|
J:140728
|
| decreased IgA level
|
J:140728
|
Ccrl2tm1Lex/Ccrl2tm1Lex
(involves: 129S/SvEvBrd * C57BL/6)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:140110
|
Ccrl2tm1Ssoz/Ccrl2tm1Ssoz
(B6.129-Ccrl2tm1Ssoz)
|
abnormal dendritic cell chemotaxis
|
J:165873
|
| abnormal T-helper 2 physiology
|
J:165873
|
Cd1d1tm1.1Boes/Cd1d1tm1.1Boes
(involves: C57BL/6)
|
abnormal dendritic cell antigen presentation
|
J:151699
|
| abnormal NK T cell physiology
|
J:151699
|
Cd1d1tm1.1Boes/Cd1d1tm1.1Boes
Cd74tm1Doi/Cd74tm1Doi
(involves: 129S2/SvPas * C57BL/6)
|
abnormal dendritic cell antigen presentation
|
J:151699
|
Cd1d1tm1.2Aben/Cd1d1tm1.2Aben
(B6(C)-Cd1d1tm1.2Aben/J)
|
abnormal T cell activation
|
J:177038
|
Cd1d1tm1Crw/Cd1d1tm1Crw
(B6.129S4-Cd1d1tm1Crw)
|
decreased IgG level
|
J:99107
|
Cd1d1tm1Luc/Cd1d1tm1Luc
(C.129S6-Cd1d1tm1Luc)
|
increased IgG3 level
|
J:121187
|
Cd2aptm1Shaw/Cd2aptm1Shaw
(involves: 129X1/SvJ)
|
decreased T cell proliferation
|
J:57971
|
Cd2bp2tm1.1Tbh/Cd2bp2tm1.1Tbh
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6N * CBA/J)
|
impaired macrophage phagocytosis
|
J:283435
|
Cd3em1Btlr/Cd3em1Btlr
(C57BL/6J-Cd3em1Btlr)
|
increased T cell apoptosis
|
J:132486
|
Cd3em1Btlr/Cd3em1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
Cd3etm1Mal/Cd3etm1Mal
(C57BL/6-Cd3etm1Mal)
|
abnormal regulatory T cell physiology
|
J:125748
|
Cd3gtm1.1Cage/Cd3gtm1.1Cage
(B6.129P2-Cd3gtm1.1Cage)
|
increased T cell apoptosis
|
J:153813
|
Cd3gtm1.1Cage/Cd3gtm1.1Cage
Tg(TcrLCMV)318Sdz/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)
|
abnormal T cell physiology
|
J:142387
|
Cd3gtm1Amk/Cd3gtm1Amk
(involves: 129P2/OlaHsd)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:77504
|
| abnormal T cell activation
|
J:77504
|
| abnormal T cell physiology
|
J:77504
|
| abnormal T cell proliferation
|
J:77504
|
| decreased cytotoxic T cell cytolysis
|
J:77504
|
Cd4del/Cd4del
(C57BR/cdJ-Cd4del)
|
decreased IgG level
|
J:46692
|
| decreased IgM level
|
J:46692
|
| decreased immunoglobulin level
|
J:46692
|
Cd4em1Litt/Cd4em1Litt
Rr386em1Pdi/Rr386em1Pdi
(involves: C57BL/6J)
|
abnormal lymphocyte activation involved in immune response
|
J:333574
|
Cd4tm1Doi/Cd4tm1Doi
Lag3tm1Doi/Lag3tm1Doi
(involves: 129 * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:33272
|
Cd4tm1Doi/Cd4tm1Litt
Lag3tm1Doi/Lag3+
(involves: 129 * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:33272
|
Cd4tm1Litt/Cd4tm1Litt
(involves: 129S2/SvPas)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:50435
|
| decreased T cell proliferation
|
J:50435
|
Cd4tm1Litt/Cd4tm1Litt
Foxp3sfOtcspf/Y
(involves: 129/Rl * 129S2/SvPas)
|
increased IgG level
|
J:20865
|
| increased IgM level
|
J:20865
|
Cd4tm1Litt/Cd4tm1Nik
Tg(Lck-cre)3778Nik/0
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:73479
|
| abnormal T-helper 2 physiology
|
J:73479
|
| decreased T cell proliferation
|
J:73479
|
Cd4tm1Litt/Cd4tm1Nik
Tg(Lck-cre)3785Nik/0
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:73479
|
| increased T cell apoptosis
|
J:73479
|
| increased T cell proliferation
|
J:73479
|
Cd4tm1Litt/Cd4tm1Nik
Tg(Lck-icre)3779Nik/0
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:73479
|
| decreased T cell proliferation
|
J:73479
|
Cd4tm1Mak/Cd4tm1Mak
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:68957
|
Cd4tm1Mak/Cd4tm1Mak
Cd8atm1Mak/Cd8atm1Mak
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
decreased cytotoxic T cell cytolysis
|
J:12572
|
Cd4tm1Nik/Cd4tm1Nik
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129X1/SvJ)
|
abnormal regulatory T cell physiology
|
J:152472
|
Cd5tm1.1Chra/Cd5tm1.1Chra
(involves: C57BL/6 * FVB/N)
|
abnormal T cell physiology
|
J:189919
|
| decreased T cell proliferation
|
J:189919
|
| increased T cell proliferation
|
J:189919
|
Cd5tm1.1Chra/Cd5tm1.1Chra
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: C57BL/6 * FVB/N)
|
decreased T cell proliferation
|
J:189919
|
Cd5tm1Cgn/Cd5tm1Cgn
(B6.129P2-Cd5tm1Cgn)
|
increased T cell proliferation
|
J:189919
|
Cd6tm1Linf/Cd6tm1Linf
(D1.Cg-Cd6tm1Linf)
|
abnormal B cell physiology
|
J:238478
|
| decreased B cell proliferation
|
J:238478
|
| decreased IgM level
|
J:238478
|
Cd7tm1Bfh/Cd7tm1Bfh
(B6.129-Cd7tm1Bfh)
|
decreased cytotoxic T cell cytolysis
|
J:48758
|
Cd8am2Btlr/Cd8am2Btlr
(C57BL/6J-Cd8am2Btlr)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:236677
|
| increased CD8-positive, alpha-beta memory T cell proliferation
|
J:236677
|
Cd8atm1Mak/Cd8atm1Mak
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal cytotoxic T cell physiology
|
J:68956
|
Cd8atm1Mak/Cd8atm1Mak
Il15tm1Imx/Il15tm1Imx
X/Yaa
(BXSB.Cg-Cd8atm1Mak Il15tm1Imx/Dcr)
|
increased IgG1 level
|
J:179430
|
| increased IgG2a level
|
J:179430
|
| increased IgG2b level
|
J:179430
|
Cd8b1M1Btlr/Cd8b1M1Btlr
(C57BL/6J-Cd8b1M1Btlr)
|
increased IgG level
|
J:255009
|
Cd8b1tm1Litt/Cd8b1tm1Litt
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal cytotoxic T cell physiology
|
J:112551
|
Cd14tm1Smg/Cd14tm1Smg
(C.129S1-CD14tm1Smg)
|
abnormal macrophage physiology
|
J:116691
|
| abnormal neutrophil physiology
|
J:127072
|
Cd14tm1Smg/Cd14tm1Smg
Tlr4Lps-d/Tlr4Lps-d
(C3.129S1-CD14tm1Smg)
|
abnormal macrophage physiology
|
J:116691
|
Cd19tm1(cre)Cgn/Cd19+
Ctnnbl1tm1.1Crad/Ctnnbl1tm1.1Crad
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
decreased B cell proliferation
|
J:232010
|
Cd19tm1(cre)Cgn/Cd19+
Ell2tm1.1Cmil/Ell2tm1.1Cmil
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
decreased IgA level
|
J:234692
|
| decreased IgG1 level
|
J:234692
|
| decreased IgM level
|
J:234692
|
| decreased immunoglobulin level
|
J:234692
|
Cd19tm1(cre)Cgn/Cd19+
Ell2tm2.1Cmil/Ell2tm2.1Cmil
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
decreased IgA level
|
J:234692
|
| decreased IgG1 level
|
J:234692
|
| decreased IgM level
|
J:234692
|
| decreased immunoglobulin level
|
J:234692
|
Cd19tm1(cre)Cgn/Cd19+
Ep300tm2Reck/Ep300+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
abnormal adaptive immunity
|
J:147840
|
| decreased B cell proliferation
|
J:147840
|
| increased B cell apoptosis
|
J:147840
|
| increased IgG2b level
|
J:147840
|
| increased immunoglobulin level
|
J:147840
|
Cd19tm1(cre)Cgn/Cd19+
Fastm1Ach/Fastm1Ach
(involves: 129P2/OlaHsd * BALB/c)
|
increased immunoglobulin level
|
J:123556
|
Cd19tm1(cre)Cgn/Cd19+
Gna12tm1Citb/Gna12tm1Citb
Gna13tm2.1Soff/Gna13tm2.1Soff
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6N)
|
abnormal B cell physiology
|
J:117663
|
Cd19tm1(cre)Cgn/Cd19+
Gt(ROSA)26Sortm1(ITK/SYK)Jrld/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd)
|
abnormal T cell activation
|
J:160931
|
| increased T cell proliferation
|
J:160931
|
Cd19tm1(cre)Cgn/Cd19+
Gt(ROSA)26Sortm2(CARD11*L225LI)Jrld/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd)
|
abnormal B cell activation
|
J:228288
|
| increased B cell proliferation
|
J:228288
|
Cd19tm1(cre)Cgn/Cd19+
Gt(ROSA)26Sortm2(Cd74/MOG)Awai/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:140751
|
Cd19tm1(cre)Cgn/Cd19+
Gt(ROSA)26Sortm2(Cd74/MOG)Awai/Gt(ROSA)26Sor+
Il10tm1Roer/Il10tm1Roer
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:140751
|
Cd19tm1(cre)Cgn/Cd19+
Gt(ROSA)26Sortm4(Ikbkb)Rsky/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:113365
|
| decreased B cell apoptosis
|
J:113365
|
Cd19tm1(cre)Cgn/Cd19+
Ifnar1tm1Uka/Ifnar1tm1Uka
(B6.129P2-Cd19tm1(cre)Cgn Ifnar1tm1Uka)
|
decreased IgG1 level
|
J:129128
|
| decreased IgG2a level
|
J:129128
|
| decreased IgG3 level
|
J:129128
|
| decreased IgM level
|
J:129128
|
Cd19tm1(cre)Cgn/Cd19+
Igbp1tm1Imku/Y
(involves: 129P2/OlaHsd)
|
abnormal B cell physiology
|
J:74619
|
| abnormal somatic hypermutation frequency
|
J:74619
|
| decreased B cell proliferation
|
J:74619
|
| decreased immunoglobulin level
|
J:74619
|
Cd19tm1(cre)Cgn/Cd19+
Ikbkbtm1Cgn/Ikbkbtm1.1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell proliferation
|
J:79132
|
Cd19tm1(cre)Cgn/Cd19+
Ikbkbtm2Mka/Ikbkbtm2Mka
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
abnormal B cell activation
|
J:82995
|
| decreased B cell proliferation
|
J:82995
|
| decreased IgG level
|
J:82995
|
| decreased IgM level
|
J:82995
|
| increased B cell apoptosis
|
J:82995
|
Cd19tm1(cre)Cgn/Cd19+
Ikbkgtm1.1Mpa/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell proliferation
|
J:79132
|
Cd19tm1(cre)Cgn/Cd19+
Il10tm1Roer/Il10tm1Roer
(involves: 129P2/OlaHsd)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:151551
|
Cd19tm1(cre)Cgn/Cd19+
Inpp5dtm1Rav/Inpp5dtm1Rav
Ptentm1Hwu/Ptentm1Hwu
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
abnormal B cell physiology
|
J:166155
|
| increased B cell proliferation
|
J:166155
|
Cd19tm1(cre)Cgn/Cd19+
Ltbtm1Avt/Ltbtm1Avt
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal adaptive immunity
|
J:79129
|
Cd19tm1(cre)Cgn/Cd19+
Map3k7tm1Aki/Map3k7tm1.1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:112597
|
| decreased B cell proliferation
|
J:112597
|
| decreased IgG1 level
|
J:112597
|
| decreased IgG3 level
|
J:112597
|
| decreased IgG level
|
J:112597
|
| decreased immunoglobulin level
|
J:112597
|
Cd19tm1(cre)Cgn/Cd19+
Mcl1tm2Sjk/Mcl1tm3Sjk
(involves: 129P2/OlaHsd * 129X1/SvJ)
|
increased B cell apoptosis
|
J:86906
|
Cd19tm1(cre)Cgn/Cd19+
Myd88em1.1Rsky/Myd88+
(involves: C57BL/6NTac)
|
increased IgM level
|
J:308792
|
Cd19tm1(cre)Cgn/Cd19+
Myd88em1.1Rsky/Myd88em1.1Rsky
(involves: C57BL/6NTac)
|
increased B cell proliferation
|
J:308792
|
Cd19tm1(cre)Cgn/Cd19+
Pax5tm1Mbu/Pax5tm3Mbu
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal class switch recombination
|
J:75504
|
| decreased IgG1 level
|
J:75504
|
| decreased IgG3 level
|
J:75504
|
| decreased IgG level
|
J:75504
|
| decreased immunoglobulin level
|
J:75504
|
Cd19tm1(cre)Cgn/Cd19+
Pdia3tm1Gjh/Pdia3tm1Gjh
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:112606
|
Cd19tm1(cre)Cgn/Cd19+
Prdm1tm1Clme/Prdm1tm1Clme
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
decreased IgG level
|
J:101890
|
| decreased IgM level
|
J:101890
|
| decreased immunoglobulin level
|
J:101890
|
Cd19tm1(cre)Cgn/Cd19+
Ptentm1Hwu/Ptentm1Hwu
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
abnormal B cell physiology
|
J:83213
|
| abnormal class switch recombination
|
J:114881
|
| decreased IgG level
|
J:114881
|
| increased B cell apoptosis
|
J:83213
|
| increased B cell proliferation
|
J:155314,
J:83213
|
| increased IgM level
|
J:114881
|
Cd19tm1(cre)Cgn/Cd19+
Ptpn6tm1Rsky/Ptpn6tm1Rsky
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell proliferation
|
J:123568
|
Cd19tm1(cre)Cgn/Cd19+
Rbpjtm1Hon/Rbpjtm1Hon
(involves: 129P2/OlaHsd * C57BL/6)
|
increased IgG3 level
|
J:76240
|
Cd19tm1(cre)Cgn/Cd19+
Slc3a2tm1.1Mgin/Slc3a2tm1.1Mgin
(involves: 129 * C57BL/6 * SJL)
|
abnormal B cell activation
|
J:148000
|
| abnormal B cell physiology
|
J:148000
|
| abnormal class switch recombination
|
J:148000
|
| decreased B cell proliferation
|
J:148000
|
| decreased IgG level
|
J:148000
|
| decreased IgM level
|
J:148000
|
Cd19tm1(cre)Cgn/Cd19+
Slc3a2tm1.1Mgin/Slc3a2tm1Yai
(involves: 129 * C57BL/6 * SJL)
|
decreased IgG3 level
|
J:148000
|
| decreased IgM level
|
J:148000
|
Cd19tm1(cre)Cgn/Cd19+
Tgfbr2tm1Roes/Tgfbr2tm1Roes
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal B cell physiology
|
J:90558
|
| decreased IgA level
|
J:90558
|
| increased IgG level
|
J:90558
|
| increased IgM level
|
J:90558
|
Cd19tm1(cre)Cgn/Cd19+
Tnfaip3tm1.1Awai/Tnfaip3tm1.1Awai
(involves: 129P2/OlaHsd)
|
increased B cell proliferation
|
J:175422
|
| increased IgA level
|
J:175422
|
| increased IgG2a level
|
J:175422
|
| increased IgM level
|
J:175422
|
Cd19tm1(cre)Cgn/Cd19+
Tnfaip3tm2Ama/Tnfaip3+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell apoptosis
|
J:163917
|
| increased immunoglobulin level
|
J:163917
|
Cd19tm1(cre)Cgn/Cd19+
Traf2tm1Rbr/Traf2tm1Rbr
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:132877
|
Cd19tm1(cre)Cgn/Cd19+
Traf2tm1Rbr/Traf2tm1Rbr
Traf3tm1Rbr/Traf3tm1Rbr
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal B cell physiology
|
J:132877
|
Cd19tm1(cre)Cgn/Cd19+
Traf3tm1Rbr/Traf3tm1Rbr
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal B cell physiology
|
J:132877
|
Cd19tm1(cre)Cgn/Cd19+
Ube2ntm1Aki/Ube2ntm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:112287
|
| decreased B cell proliferation
|
J:112287
|
| decreased immunoglobulin level
|
J:112287
|
| increased B cell apoptosis
|
J:112287
|
Cd19tm1(cre)Cgn/Cd19+
Wacem2Cya/Wacem2Cya
(B6.Cg-Cd19tm1(cre)Cgn Wacem2Cya)
|
decreased B cell proliferation
|
J:345327
|
| decreased IgG1 level
|
J:345327
|
| decreased IgG2b level
|
J:345327
|
| decreased IgG3 level
|
J:345327
|
| decreased IgM level
|
J:345327
|
Cd19tm1(cre)Cgn/Cd19tm1(cre)Cgn
(involves: 129P2/OlaHsd)
|
abnormal B cell physiology
|
J:27463
|
| abnormal immunoglobulin level
|
J:27463
|
| decreased IgE level
|
J:27463
|
| decreased IgG1 level
|
J:27463
|
| decreased IgM level
|
J:27463
|
Cd19tm1(cre)Cgn/Cd19tm1(cre)Cgn
Ightm1Mnz/Ightm1Mnz
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:75653
|
Cd19tm1(cre)Cgn/Cd19tm1(cre)Cgn
Ightm2Mnz/Ightm2Mnz
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:75653
|
Cd19tm1(cre/ERT2)Rsky/Cd19+
Myd88em1.1Rsky/Myd88+
(involves: 129P2/OlaHsd * C57BL/6NTac)
|
increased IgM level
|
J:308792
|
Cd19tm1Tft/Cd19tm1Tft
(Not Specified)
|
abnormal B cell physiology
|
J:27236
|
| decreased B cell proliferation
|
J:27236
|
| decreased IgA level
|
J:27236
|
| decreased IgG1 level
|
J:27236
|
| decreased IgG2a level
|
J:27236
|
| decreased IgG2b level
|
J:27236
|
| decreased IgG3 level
|
J:27236
|
| decreased IgM level
|
J:27236
|
Cd19tm1Tft/Cd19tm1Tft
(involves: 129 * C57BL/6)
|
decreased B cell proliferation
|
J:71174
|
| decreased IgA level
|
J:71174
|
| decreased IgG1 level
|
J:71174
|
| decreased IgG2b level
|
J:71174
|
| decreased IgM level
|
J:71174
|
Cd19tm1Tft/Cd19tm1Tft
(B6.Cg-Cd19tm1Tft)
|
abnormal B cell physiology
|
J:136210
|
| decreased IgA level
|
J:136210
|
| decreased IgG1 level
|
J:136210
|
| decreased IgG2a level
|
J:136210
|
| decreased IgG2b level
|
J:136210
|
| decreased IgG3 level
|
J:136210
|
| decreased IgM level
|
J:136210
|
Cd19tm1Tft/Cd19tm1Tft
Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJaeSor * C57BL/6)
|
decreased B cell proliferation
|
J:71174
|
Cd22m1Btlr/Cd22m1Btlr
(involves: C57BL/6J)
|
decreased IgM level
|
J:185495
|
Cd22m2Btlr/Cd22m2Btlr
(C57BL/6J-Cd22m2Btlr)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:215821
|
Cd22tm1.1(CD22)Lnit/Cd22tm1.1(CD22)Lnit
(involves: 129S4/SvJae)
|
abnormal B cell calcium ion homeostasis
|
J:189017
|
| abnormal B cell physiology
|
J:189017
|
| impaired B cell migration
|
J:189017
|
Cd22tm1Eac/Cd22+
Lyntm1Ard/Lyn+
Ptpn6me-v/Ptpn6+
Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
increased IgM level
|
J:110531
|
Cd22tm1Eac/Cd22tm1Eac
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell activation
|
J:37451
|
| abnormal B cell proliferation
|
J:37451,
J:132991
|
| decreased IgG1 level
|
J:37451
|
| decreased IgG3 level
|
J:37451
|
| decreased IgM level
|
J:37451
|
| increased B cell apoptosis
|
J:132991
|
Cd22tm1Lam/Cd22tm1Lam
(involves: 129 * C57BL/6)
|
abnormal B cell activation
|
J:125719
|
Cd22tm1Lam/Cd22tm1Lam
Ightm1.2Rsky/Igh+
(involves: 129 * BALB/c * C57BL/6)
|
abnormal class switch recombination
|
J:125719
|
Cd22tm1Lam/Cd22tm1Lam
Ightm1.2Rsky/Ightm1.2Rsky
(involves: 129 * BALB/c * C57BL/6)
|
abnormal B cell activation
|
J:125719
|
Cd22tm1Msn/Cd22tm1Msn
(either: (involves: 129S/SvEv * BALB/c) or (involves: 129S/SvEv * C57BL/6J))
|
abnormal B cell activation
|
J:76974
|
| abnormal B cell calcium ion homeostasis
|
J:76974
|
| abnormal immunoglobulin level
|
J:76974
|
| increased IgG2a level
|
J:76975
|
| increased IgG level
|
J:76975
|
| increased IgM level
|
J:76974
|
Cd22tm1Tft/Cd22tm1Tft
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell proliferation
|
J:92736
|
Cd22tm2Tft/Cd22tm2Tft
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased B cell proliferation
|
J:92736
|
| increased B cell proliferation
|
J:92736
|
Cd22tm2Tft/Cd22tm2Tft
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased B cell proliferation
|
J:208364
|
| increased activation-induced B cell apoptosis
|
J:208364
|
Cd22tm3Lnit/Cd22tm3Lnit
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal B cell physiology
|
J:198790
|
| increased B cell apoptosis
|
J:198790
|
| increased IgG1 level
|
J:198790
|
Cd22tm3Tft/Cd22tm3Tft
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased B cell proliferation
|
J:92736
|
| increased B cell proliferation
|
J:92736
|
Cd27tm1Jbo/Cd27tm1Jbo
(either: B6.129P2-CD27tm1Jbo or 129P2/OlaHsd-Tnfrsf7tm1Jbo)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:65516
|
| abnormal cytotoxic T cell physiology
|
J:65516
|
| abnormal T cell physiology
|
J:65516
|
Cd27tm1Jbo/Cd27tm1Jbo
(B6.129P2-Cd27tm1Jbo)
|
increased T cell apoptosis
|
J:198200
|
Cd28tm1.1Huen/Cd28tm1.1Huen
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal regulatory T cell physiology
|
J:191101
|
Cd28tm1Jmg/Cd28tm1Jmg
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
abnormal germinal center B cell physiology
|
J:124570
|
| decreased immunoglobulin level
|
J:124570
|
Cd28tm1Jmg/Cd28tm1Jmg
(B6.129X1-Cd28tm1Jmg)
|
increased susceptibility to type I hypersensitivity reaction
|
J:149888
|
Cd28tm1Jmg/Cd28tm1Mak
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
abnormal germinal center B cell physiology
|
J:124570
|
| decreased immunoglobulin level
|
J:124570
|
| decreased T cell proliferation
|
J:149888,
J:124570
|
Cd28tm1Ltu/Cd28tm1Ltu
Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased T cell proliferation
|
J:194503
|
Cd28tm1Mak/Cd28tm1Mak
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:14194
|
| abnormal class switch recombination
|
J:14194
|
| decreased IgG1 level
|
J:14194
|
| decreased IgG2b level
|
J:14194
|
| decreased immunoglobulin level
|
J:14194
|
| decreased T cell proliferation
|
J:14194
|
| increased IgG2a level
|
J:14194
|
Cd28tm1Mak/Cd28tm1Mak
(NOD.129S2-Cd28tm1Mak)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:61905
|
| increased T cell proliferation
|
J:93421
|
Cd28tm1Mak/Cd28tm1Mak
(involves: 129S2/SvPas)
|
abnormal class switch recombination
|
J:123989
|
| abnormal regulatory T cell physiology
|
J:191101
|
| decreased T cell proliferation
|
J:205441,
J:130882,
J:123989
|
Cd28tm1Mak/Cd28tm1Mak
(involves: 129S2/SvPas * NOD)
|
abnormal T-helper 1 physiology
|
J:35353
|
| abnormal T-helper 2 physiology
|
J:35353
|
| decreased IgG2a level
|
J:35353
|
| decreased T cell proliferation
|
J:35353
|
Cd28tm1Mak/Cd28tm1Mak
(involves: 129S2/SvPas * C57BL/6)
|
abnormal NK cell physiology
|
J:95353
|
| decreased T cell proliferation
|
J:149888
|
| increased susceptibility to type I hypersensitivity reaction
|
J:149888
|
| increased T cell apoptosis
|
J:149888
|
Cd28tm1Mak/Cd28tm1Mak
(B6.129S2-Cd28tm1Mak)
|
abnormal cytotoxic T cell physiology
|
J:76373
|
Cd28tm1Mak/Cd28tm1Mak
Tg(Cd4-cre)1Cwi/?
Traf6tm2Ywc/Traf6tm2Ywc
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:130882
|
Cd28tm1Mak/Cd28tm1Mak
Tg(TcrLCMV)327Sdz/0
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
decreased cytotoxic T cell cytolysis
|
J:123989
|
| decreased T cell proliferation
|
J:123989
|
Cd28tm1Mak/Cd28tm1Mak
Tnfsf9tm1Thw/Tnfsf9tm1Thw
(involves: 129 * 129S2/SvPas * C57BL/6)
|
abnormal cytotoxic T cell physiology
|
J:76373
|
Cd28tm1Pjl/Cd28tm1Pjl
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:83722
|
| abnormal cytotoxic T cell physiology
|
J:83722
|
| abnormal immunoglobulin level
|
J:83722
|
| decreased IgG1 level
|
J:83722
|
| decreased IgG2a level
|
J:83722
|
| decreased IgM level
|
J:83722
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:83722
|
Cd28tm1Pjl/Cd28tm1Pjl
Tg(DO11.10)10Dlo/0
(involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6)
|
abnormal T cell activation
|
J:25536
|
| abnormal T cell proliferation
|
J:25536
|
| abnormal thymocyte activation
|
J:25536
|
Cd28tm1Pjl/Cd28tm1Pjl
Tnfrsf9tm1Byk/Tnfrsf9tm1Byk
(either: B6.Cg-Cd28tm1Pjl Tnfrsf9tm1Byk or C.Cg-Cd28tm1Pjl Tnfrsf9tm1Byk)
|
abnormal class switch recombination
|
J:83722
|
| abnormal cytotoxic T cell physiology
|
J:83722
|
| decreased IgG1 level
|
J:83722
|
| decreased IgG2a level
|
J:83722
|
| decreased IgM level
|
J:83722
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:83722
|
Cd28tm1Shr/Cd28tm1Shr
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
decreased T cell proliferation
|
J:68642
|
Cd28tm1Shr/Cd28tm1Shr
Ctla4tm1Shr/Ctla4tm1Shr
(C.129S4-Cd28tm1Shr Ctla4tm1Shr)
|
decreased T cell proliferation
|
J:68642
|
Cd36obl/Cd36obl
(C57BL/6-Cd36obl)
|
abnormal macrophage physiology
|
J:96018
|
Cd36tm1Frm/Cd36tm1Frm
(involves: 129S4/SvJae)
|
abnormal microglial cell physiology
|
J:140907
|
Cd36tm1Frm/Cd36tm1Frm
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal macrophage physiology
|
J:80658
|
Cd36tm1Frm/Cd36tm1Frm
(B6.129S4-Cd36tm1Frm)
|
impaired macrophage phagocytosis
|
J:100140
|
Cd36tm1Mfe/Cd36tm1Mfe
(B6.129S1-Cd36tm1Mfe)
|
decreased IgG1 level
|
J:130897
|
| decreased IgG2a level
|
J:130897
|
| decreased IgG2c level
|
J:130897
|
| decreased IgG level
|
J:130897
|
| decreased IgM level
|
J:130897
|
| decreased immunoglobulin level
|
J:130897
|
Cd36tm1Mfe/Cd36tm1Mfe
(involves: 129S1/Sv)
|
abnormal macrophage chemotaxis
|
J:89664
|
Cd37tm1Hor/Cd37tm1Hor
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:63315
|
| decreased IgG1 level
|
J:63315
|
Cd38tm1Lnd/Cd38tm1Lnd
(NOD.129P2(B6)-Cd38tm1Lnd/LtJ)
|
increased T cell apoptosis
|
J:108097
|
Cd40m2Btlr/Cd40m2Btlr
(C57BL/6J-Cd40m2Btlr)
|
decreased IgG level
|
J:254828
|
Cd40tm1Arah/Cd40tm1Arah
(B6.129S1-Cd40tm1Arah)
|
abnormal immunoglobulin level
|
J:120512
|
| decreased IgE level
|
J:120512
|
| decreased IgG1 level
|
J:120512
|
| decreased IgG2b level
|
J:120512
|
| decreased IgG level
|
J:120512
|
| decreased IgM level
|
J:120512
|
| increased IgG3 level
|
J:120512
|
| increased IgM level
|
J:120512
|
Cd40tm1Geha/Cd40tm1Geha
(involves: 129S4/SvJae * C57BL/6)
|
decreased IgA level
|
J:82298
|
| decreased IgG1 level
|
J:82298
|
| decreased IgG2a level
|
J:82298
|
| decreased IgG2b level
|
J:82298
|
Cd40tm1Kik/Cd40tm1Kik
(B6.129P2-Cd40tm1Kik/J)
|
abnormal dendritic cell physiology
|
J:86998
|
Cd40tm1Kik/Cd40tm1Kik
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased IgA level
|
J:25007
|
| decreased IgE level
|
J:25007
|
| decreased IgG1 level
|
J:25007
|
| decreased IgG2a level
|
J:25007
|
| decreased IgG2b level
|
J:25007
|
| decreased IgG3 level
|
J:25007
|
| decreased immunoglobulin level
|
J:25007
|
| decreased susceptibility to type II hypersensitivity reaction
|
J:61673
|
Cd40tm1Kik/Cd40tm1Kik
Tg(Tnfsf13b)1Fma/?
(B6.Cg-Cd40tm1Kik Tg(Tnfsf13b)1Fma)
|
abnormal B cell activation
|
J:113556
|
| abnormal class switch recombination
|
J:113556
|
Cd40tm1Kik/Cd40tm1Kik
Traf3ip2tm1.1Lix/Traf3ip2tm1.1Lix
(involves: 129 * 129P2/OlaHsd * BALB/c)
|
abnormal B cell physiology
|
J:138560
|
Cd40lgm1Btlr/Y
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| decreased IgG level
|
J:185495
|
Cd40lgm1Btlr/Cd40lgm1Btlr
(C57BL/6J-Cd40lgm1Btlr)
|
decreased IgG level
|
J:162147
|
Cd40lgm1Btlr/Cd40lgm1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| decreased IgG level
|
J:185495
|
Cd40lgtm1Flv/Y
Faslpr/Faslpr
(involves: 129P2/OlaHsd * 129S2/SvPas * MRL)
|
decreased IgG level
|
J:38492
|
| decreased immunoglobulin level
|
J:38492
|
Cd40lgtm1Flv/Cd40lgtm1Flv
(involves: 129S2/SvPas * C57BL/6)
|
abnormal adaptive immunity
|
J:25010
|
| abnormal class switch recombination
|
J:25010
|
| abnormal T-helper 2 physiology
|
J:25010
|
| decreased IgA level
|
J:25010
|
| decreased IgD level
|
J:25010
|
| decreased IgE level
|
J:25010
|
| decreased IgG1 level
|
J:25010
|
| decreased IgG3 level
|
J:25010
|
| decreased immunoglobulin level
|
J:25010
|
Cd40lgtm1Flv/Cd40lgtm1Flv
Faslpr/Faslpr
(involves: 129P2/OlaHsd * 129S2/SvPas * MRL)
|
decreased IgG level
|
J:38492
|
| decreased immunoglobulin level
|
J:38492
|
Cd40lgtm1Imx/Y
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:21137
|
| decreased IgA level
|
J:21137
|
| decreased IgE level
|
J:21137
|
| decreased IgG1 level
|
J:21137
|
| decreased IgG2b level
|
J:21137
|
| decreased immunoglobulin level
|
J:21137
|
Cd40lgtm1Imx/Y
(B6.129S2-Cd40lgtm1Imx/J)
|
abnormal leukocyte adhesion
|
J:108988
|
Cd40lgtm1Parl/Y
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)
|
decreased IgM level
|
J:213459
|
| increased IgG1 level
|
J:213459
|
Cd40lgtm1Parl/Y
Tg(Tek-cre)1Ywa/0
(involves: 129 * C57BL/6 * CD-1 * SJL)
|
decreased IgA level
|
J:213459
|
| decreased IgG1 level
|
J:213459
|
| decreased IgG2a level
|
J:213459
|
| decreased IgG3 level
|
J:213459
|
| decreased IgM level
|
J:213459
|
Cd40lgtm1Parl/Cd40lgtm1Parl
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)
|
decreased IgM level
|
J:213459
|
| increased IgG1 level
|
J:213459
|
Cd40lgtm1Parl/Cd40lgtm1Parl
Tg(Tek-cre)1Ywa/0
(involves: 129 * C57BL/6 * CD-1 * SJL)
|
decreased IgA level
|
J:213459
|
| decreased IgG1 level
|
J:213459
|
| decreased IgG2a level
|
J:213459
|
| decreased IgG3 level
|
J:213459
|
| decreased IgM level
|
J:213459
|
Cd44tm1.1Ugu/Cd44tm1.1Ugu
(involves: 129/Sv * C57BL/6)
|
abnormal T-helper 1 physiology
|
J:62867
|
| abnormal T-helper 2 physiology
|
J:62867
|
Cd44tm1.1Ugu/Cd44tm1.1Ugu
(SJL.129(Cg)-Cd44tm1.1Ugu)
|
decreased T cell proliferation
|
J:199279
|
Cd44tm1Hbg/Cd44tm1Hbg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal leukocyte migration
|
J:68069
|
| abnormal neutrophil physiology
|
J:94850
|
Cd44tm1Mak/Cd44+
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal leukocyte migration
|
J:99032
|
Cd44tm1Mak/Cd44tm1Mak
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal leukocyte migration
|
J:99032
|
Cd44tm1Mak/Cd44tm1Mak
(B6.129P2-Cd44tm1Mak)
|
abnormal leukocyte migration
|
J:108245
|
| decreased activation-induced cell death of T cells
|
J:69351
|
| impaired macrophage phagocytosis
|
J:111216
|
| impaired natural killer cell mediated cytotoxicity
|
J:110889
|
Cd44tm1Mak/Cd44tm1Mak
Itgaltm1Mak/Itgaltm1Mak
(B6.129P2-Cd44tm1Mak Itgaltm1Mak)
|
impaired natural killer cell mediated cytotoxicity
|
J:110889
|
Cd44tm1Ugu/Cd44tm1Ugu
(involves: 129/Sv * C57BL/6)
|
abnormal T-helper 1 physiology
|
J:62867
|
| abnormal T-helper 2 physiology
|
J:62867
|
Cd44tm2.1Ugu/Cd44tm2.1Ugu
(B6.129-Cd44tm2.1Ugu)
|
decreased T cell proliferation
|
J:199279
|
Cd44tm2Kmz/Cd44tm2Kmz
(involves: BALB/c * DBA/1)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:114317
|
| abnormal leukocyte adhesion
|
J:114317
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:114317
|
| impaired leukocyte tethering or rolling
|
J:114317
|
| impaired neutrophil recruitment
|
J:114317
|
Cd44tm2Kmz/Cd44tm2Kmz
Selltm2Hyn/Selltm2Hyn
(involves: 129S2/SvPas * BALB/c * DBA/1)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:114317
|
| abnormal leukocyte adhesion
|
J:114317
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:114317
|
| impaired leukocyte tethering or rolling
|
J:114317
|
| impaired neutrophil recruitment
|
J:114317
|
Cd47tm1Fpl/Cd47tm1Fpl
(involves: 129S7/SvEvBrd)
|
impaired neutrophil recruitment
|
J:148196
|
Cd47tm1Fpl/Cd47tm1Fpl
(B6.129S7-Cd47tm1Fpl)
|
abnormal neutrophil physiology
|
J:36489
|
| impaired granulocyte bactericidal activity
|
J:36489
|
| impaired neutrophil chemotaxis
|
J:36489
|
| impaired neutrophil phagocytosis
|
J:36489
|
Cd48tm1Rsr/Cd48tm1Rsr
(B6.129S4-Cd48tm1Rsr)
|
abnormal T cell activation
|
J:53718
|
| decreased T cell proliferation
|
J:53718
|
Cd53tm1.1Nmg/Cd53tm1.1Nmg
(involves: C57BL/6J)
|
abnormal B cell physiology
|
J:260065
|
Cd59atm1Bpm/Cd59atm1Bpm
(B6.129-Cd59atm1Bpm)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:119703,
J:123582
|
| decreased B cell proliferation
|
J:119703
|
| decreased IgG level
|
J:119703
|
| increased T cell proliferation
|
J:122201
|
Cd68tm1Shnd/Cd68tm1Shnd
(either: B6.129-Cd68tm1Shnd or (involves: 129S1/Sv * 129X1/SvJ))
|
abnormal dendritic cell antigen presentation
|
J:175275
|
Cd68tm1Xfen/Cd68tm1Xfen
(C57BL/6J-Cd68tm1Xfen)
|
abnormal osteoclast physiology
|
J:178120
|
Cd69tm1Fsm/Cd69tm1Fsm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased IgG2a level
|
J:61329
|
| increased IgM level
|
J:61329
|
Cd69tm1Naka/Cd69tm1Naka
(C.129P2-Cd69tm1Naka)
|
impaired neutrophil chemotaxis
|
J:84940
|
| impaired neutrophil recruitment
|
J:84940
|
Cd69tm1Naka/Cd69tm1Naka
(B6.129P2-Cd69tm1Naka)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:184704
|
| abnormal memory T cell physiology
|
J:184704
|
| abnormal T cell physiology
|
J:184704
|
Cd70tm1.1Jda/Cd70tm1.1Jda
(B6.Cg-Cd70tm1.1Jda)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:193042
|
| abnormal T cell physiology
|
J:193042
|
Cd72b/Cd72b
Faslpr/Faslpr
(involves: C57BL/6 * C57BL/6JJmsSlc * MRL/Mp)
|
decreased IgG level
|
J:204782
|
Cd72c/Cd72c
(involves: C57BL/6 * MRL)
|
increased B cell proliferation
|
J:204782
|
Cd72c/Cd72c
Faslpr/Faslpr
(involves: C57BL/6 * C57BL/6JJmsSlc * MRL/Mp)
|
increased IgG level
|
J:204782
|
Cd72tm1Jrp/Cd72tm1Jrp
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal B cell activation
|
J:76990
|
| abnormal B cell calcium ion homeostasis
|
J:76990
|
| increased B cell proliferation
|
J:76990
|
| increased IgM level
|
J:76990
|
Cd72tm1Jrp/Cd72tm1Jrp
Tg(BCL2)22Wehi/0
(either: (involves: 129P2/OlaHsd * C57BL/6JWehi * SJL/JWehi) or (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6JWehi * SJL/JWehi))
|
abnormal B cell physiology
|
J:76990
|
Cd72tm1Tsub/Cd72tm1Tsub
(involves: C57BL/6J)
|
increased B cell proliferation
|
J:204782
|
Cd74tm1Doi/Cd74tm1Doi
(involves: 129S2/SvPas)
|
abnormal dendritic cell antigen presentation
|
J:151699
|
Cd74tm1Doi/Cd74tm1Doi
H2-DMatm1Doi/H2-DMatm1Doi
(involves: 129S2/SvPas * C57BL/6)
|
abnormal professional antigen presenting cell physiology
|
J:42482
|
Cd74tm1Eae/Cd74tm1Eae
(involves: 129S2/SvPas)
|
decreased B cell proliferation
|
J:113050,
J:132865
|
| decreased IgM level
|
J:113050
|
Cd74tm1Liz/Cd74tm1Liz
(involves: 129S/SvEv * C57BL/6J)
|
decreased T cell proliferation
|
J:72243
|
Cd74tm1Liz/Cd74tm1Liz
(B6.129S-Cd74tm1Liz)
|
abnormal T-helper 1 physiology
|
J:125654
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:125654
|
| decreased T cell proliferation
|
J:28966
|
Cd74tm1Liz/Cd74tm1Liz
(involves: 129S/SvEv * BALB/cAn)
|
abnormal dendritic cell antigen presentation
|
J:110927
|
| abnormal professional antigen presenting cell physiology
|
J:113714
|
Cd74tm1Liz/Cd74tm1Liz
(involves: 129S/SvEv * BALB/c * C57BL)
|
abnormal dendritic cell antigen presentation
|
J:110927
|
| abnormal T cell proliferation
|
J:110927
|
Cd74tm1Liz/Cd74tm1Liz
(involves: 129S/SvEv * C57BL * C57BL/10 * C57BR)
|
abnormal dendritic cell antigen presentation
|
J:110927
|
| abnormal T cell proliferation
|
J:110927
|
Cd74tm2Liz/Cd74tm1Liz
(involves: 129S/SvEv * C57BL/6)
|
increased T cell proliferation
|
J:28966
|
Cd79am1Anu/Cd79am1Anu
(involves: C57BL/6JSfdAnu * C57BL/10Sg * C57BR/cd)
|
decreased IgG level
|
J:104190
|
Cd79am1Btlr/Cd79am1Btlr
(involves: C57BL/6J * C57BL/10J)
|
decreased IgG level
|
J:174338
|
| decreased IgM level
|
J:174338
|
Cd79am1Btlr/Cd79am1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| decreased IgG level
|
J:185495
|
| decreased IgM level
|
J:185495
|
Cd79am2Btlr/Cd79am2Btlr
(C57BL/6J-Cd79am2Btlr)
|
decreased IgM level
|
J:254836
|
Cd79atm1(cre)Reth/Cd79a+
Commd3tm1.1Ksuz/Commd3tm1.1Ksuz
(involves: BALB/c * C57BL/6NSlc * SJL)
|
abnormal follicular B cell physiology
|
J:278399
|
| decreased IgG1 level
|
J:278399
|
| decreased IgG2b level
|
J:278399
|
| decreased IgG2c level
|
J:278399
|
| decreased IgM level
|
J:278399
|
Cd79atm1(cre)Reth/Cd79a+
Commd8tm1.1Ksuz/Commd8tm1.1Ksuz
(involves: BALB/c * C57BL/6NSlc * SJL)
|
abnormal follicular B cell physiology
|
J:278399
|
| decreased IgG1 level
|
J:278399
|
| decreased IgG2b level
|
J:278399
|
| decreased IgG2c level
|
J:278399
|
| decreased IgG3 level
|
J:278399
|
| decreased IgM level
|
J:278399
|
Cd79atm1(cre)Reth/Cd79a+
Ctnnbl1tm1.1Crad/Ctnnbl1tm1.1Crad
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)
|
abnormal B cell proliferation
|
J:232010
|
| abnormal class switch recombination
|
J:232010
|
| decreased B cell proliferation
|
J:232010
|
Cd79atm1(cre)Reth/Cd79a+
Eif4btm1.1Tnr/Eif4btm1.1Tnr
Eif4htm1c(EUCOMM)Wtsi/Eif4htm1c(EUCOMM)Wtsi
(involves: BALB/c * C57BL/6 * C57BL/6N)
|
decreased IgG1 level
|
J:344730
|
Cd79atm1(cre)Reth/Cd79a+
Huwe1tm1.1Mak/Y
(B6.Cg-Cd79atm1(cre)Reth Huwe1tm1.1Mak)
|
abnormal class switch recombination
|
J:181705
|
| decreased B cell proliferation
|
J:181705
|
| decreased IgA level
|
J:181705
|
| decreased IgG1 level
|
J:181705
|
| decreased IgG2a level
|
J:181705
|
| decreased IgG3 level
|
J:181705
|
| decreased IgM level
|
J:181705
|
| increased B cell apoptosis
|
J:181705
|
Cd79atm1(cre)Reth/Cd79a+
Huwe1tm1.1Mak/Y
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal class switch recombination
|
J:181705
|
| decreased IgG1 level
|
J:181705
|
| decreased IgM level
|
J:181705
|
Cd79atm1(cre)Reth/Cd79a+
Inpp5dtm1Rav/Inpp5dtm1Rav
(involves: 129 * BALB/c * C57BL/6)
|
increased IgG level
|
J:178833
|
Cd79atm1(cre)Reth/Cd79a+
Nr4a1tm1Pcn/Nr4a1tm1Pcn
(involves: 129 * BALB/c)
|
increased B cell proliferation
|
J:306652
|
Cd79atm1(cre)Reth/Cd79a+
Nr4a1tm1Pcn/Nr4a1tm1Pcn
Nr4a3em1Juz/Nr4a3em1Juz
(involves: 129 * BALB/c * C57BL/6)
|
decreased B cell apoptosis
|
J:306652
|
| increased B cell proliferation
|
J:306652
|
Cd79atm1(cre)Reth/Cd79a+
Orai1tm1Smua/Orai1tm1Smua
(involves: BALB/c * C57BL/6J)
|
abnormal B cell activation
|
J:345485
|
| abnormal B cell physiology
|
J:345485
|
Cd79atm1(cre)Reth/Cd79a+
Orai1tm1Smua/Orai1tm1Smua
Orai3em1.1Treb/Orai3em1.1Treb
(involves: BALB/c * C57BL/6J * C57BL/6N)
|
abnormal B cell activation
|
J:345485
|
| abnormal B cell physiology
|
J:345485
|
| decreased B cell proliferation
|
J:345485
|
Cd79atm1(cre)Reth/Cd79a+
Orai3em1.1Treb/Orai3em1.1Treb
(involves: BALB/c * C57BL/6J * C57BL/6N)
|
abnormal B cell activation
|
J:345485
|
Cd79atm1(cre)Reth/Cd79a+
Phf5atm1.1Oux/Phf5atm1.1Oux
(involves: BALB/c * C57BL/6J)
|
abnormal B cell physiology
|
J:345807
|
Cd79atm1(cre)Reth/Cd79a+
Slc39a10tm1.1Tfk/Slc39a10tm1.1Tfk
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6J)
|
decreased IgA level
|
J:213935
|
| decreased IgE level
|
J:213935
|
| decreased IgG1 level
|
J:213935
|
| decreased IgG2b level
|
J:213935
|
| decreased IgG2c level
|
J:213935
|
| decreased IgG3 level
|
J:213935
|
| decreased IgM level
|
J:213935
|
| decreased immunoglobulin level
|
J:213935
|
Cd79atm1(cre)Reth/Cd79a+
Wastm1.1Ldn/Y
(involves: BALB/c * C57BL/6)
|
abnormal B cell physiology
|
J:182528
|
| increased IgM level
|
J:182528
|
Cd79atm1(cre)Reth/Cd79a+
Wastm1.1Ldn/Was+
(involves: BALB/c * C57BL/6)
|
abnormal B cell proliferation
|
J:182528
|
Cd79atm1(cre)Reth/Cd79a+
Wastm1.1Ldn/Wastm1.1Ldn
(involves: BALB/c * C57BL/6)
|
abnormal B cell physiology
|
J:182528
|
| increased IgM level
|
J:182528
|
Cd79atm1.1Cgn/Cd79atm1.1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell activation
|
J:71100
|
| decreased IgG1 level
|
J:71100
|
Cd79atm1.1Rsky/Cd79atm1.1Rsky
(involves: C57BL/6)
|
decreased IgG2b level
|
J:179254
|
| decreased IgG2c level
|
J:179254
|
| decreased IgG3 level
|
J:179254
|
| increased IgG2b level
|
J:179254
|
| increased IgG2c level
|
J:179254
|
Cd79atm2Cgn/Cd79atm2Cgn
(involves: C57BL/6 * C.B-20)
|
decreased immunoglobulin level
|
J:80885
|
Cd79atm4Cgn/Cd79atm4.1Cgn
Tg(Cr2-cre)3Cgn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased IgD level
|
J:91091
|
| decreased IgM level
|
J:91091
|
Cd79atm5.1Cgn/Cd79a+
Ightm1.2Rsky/Igh+
(involves: 129 * BALB/c * C57BL/6)
|
abnormal class switch recombination
|
J:125719
|
Cd79atm5.1Cgn/Cd79atm5.1Cgn
Ightm1.2Rsky/Igh+
(involves: 129 * BALB/c * C57BL/6)
|
abnormal class switch recombination
|
J:125719
|
Cd79atm5.1Cgn/Cd79atm5.1Cgn
Ightm1.2Rsky/Ightm1.2Rsky
(involves: 129 * BALB/c * C57BL/6)
|
abnormal class switch recombination
|
J:125719
|
Cd79atm6Cgn/Cd79atm6Cgn
(involves: C57BL/6)
|
abnormal B cell physiology
|
J:113407
|
| abnormal immunoglobulin level
|
J:113407
|
| decreased B cell proliferation
|
J:113407
|
| decreased IgG2a level
|
J:113407
|
| decreased IgG3 level
|
J:113407
|
| decreased IgM level
|
J:113407
|
Cd79bm1Ghost/Cd79bm1Ghost
(B10.Cg-Ptprca Cd79bm1Ghost H2a)
|
decreased IgA level
|
J:157450
|
| decreased IgG level
|
J:157450
|
Cd79btm1Gzmn/Cd79btm1Gzmn
(involves: 129/Sv * C57BL/6)
|
decreased IgG1 level
|
J:124400
|
| increased IgD level
|
J:124400
|
| increased IgM level
|
J:124400
|
Cd79btm2.1Mnz/Cd79btm2.1Mnz
(involves: 129/Sv * C57BL/6)
|
abnormal B cell activation
|
J:66840
|
Cd79btm3Mnz/Cd79btm3Mnz
(involves: 129/Sv * C57BL/6)
|
abnormal B cell physiology
|
J:128768
|
| decreased B cell proliferation
|
J:128768
|
Cd80tm1Lbgn/Cd80tm1Lbgn
(C3.Cg-Cd80tm1Lbgn)
|
abnormal T cell physiology
|
J:110947
|
Cd80tm1Shr/Cd80tm1Shr
(involves: 129S4/SvJae)
|
abnormal immunoglobulin level
|
J:39089
|
| decreased B cell proliferation
|
J:74662
|
Cd80tm1Shr/Cd80tm1Shr
Cd86tm1Shr/Cd86tm1Shr
(B6.129S4-Cd80tm1Shr Cd86tm1Shr)
|
decreased T cell proliferation
|
J:57613
|
Cd80tm1Shr/Cd80tm1Shr
Cd86tm2Shr/Cd86tm2Shr
(involves: 129S4/SvJae)
|
abnormal T cell physiology
|
J:57090
|
| abnormal T cell proliferation
|
J:57090
|
| decreased IgG1 level
|
J:39089
|
| decreased IgG2a level
|
J:39089
|
| decreased IgG level
|
J:39089
|
| increased IgG3 level
|
J:39089
|
| increased IgM level
|
J:39089
|
Cd80tm1Shr/Cd80tm1Shr
Cd86tm2Shr/Cd86tm2Shr
(involves: 129S4/SvJae * NOD)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:61905
|
Cd80tm1Shr/Cd80tm1Shr
Cd86tm2Shr/Cd86tm2Shr
Ctla4tm1Shr/Ctla4tm1Shr
(involves: 129S4/SvJae * BALB/c)
|
abnormal T cell physiology
|
J:57090
|
| increased T cell proliferation
|
J:57090
|
Cd81tm1Geha/Cd81tm1Geha
(involves: 129S4/SvJae * C57BL/6)
|
increased B cell proliferation
|
J:43975
|
| increased IgA level
|
J:43975
|
| increased IgG3 level
|
J:43975
|
| increased IgM level
|
J:43975
|
Cd81tm1Lvy/Cd81tm1Lvy
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal T-helper 2 physiology
|
J:40394
|
| decreased IgG1 level
|
J:40394
|
| decreased IgG level
|
J:40394
|
Cd81tm1Lvy/Cd81tm1Lvy
(CByJ.129-Cd81tm1Lvy)
|
abnormal T-helper 2 physiology
|
J:46171
|
| decreased susceptibility to type I hypersensitivity reaction
|
J:46171
|
Cd81tm1Tmiy/Cd81tm1Tmiy
(involves: 129/Sv * C57BL/6)
|
abnormal macrophage physiology
|
J:83795
|
| abnormal T cell proliferation
|
J:41830
|
| decreased B cell proliferation
|
J:41830
|
| increased B cell proliferation
|
J:41830
|
Cd81tm1Tmiy/Cd81tm1Tmiy
Cd9tm1Mek/Cd9tm1Mek
(involves: 129/Sv * C57BL/6)
|
abnormal macrophage physiology
|
J:83795
|
Cd82tm1Kjbr/Cd82tm1Kjbr
(Not Specified)
|
abnormal cellular extravasation
|
J:326451
|
| abnormal neutrophil physiology
|
J:326451
|
| impaired leukocyte tethering or rolling
|
J:326451
|
Cd83lcd4/Cd83lcd4
(involves: C57BL/6J)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:92721
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:92721
|
| decreased T cell proliferation
|
J:92721
|
Cd83tm1Tft/Cd83tm1Tft
(involves: 129S4/SvJae * C57BL/6)
|
decreased IgA level
|
J:75700
|
| decreased IgG1 level
|
J:75700
|
| decreased IgG2a level
|
J:75700
|
| decreased IgG2b level
|
J:75700
|
| decreased IgG3 level
|
J:75700
|
| decreased IgM level
|
J:75700
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:75700
|
Cd84tm1Pls/Cd84tm1Pls
(C57BL/6J-Cd84tm1Pls)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:157915
|
| decreased IgG level
|
J:157915
|
Cd84tm1Pls/Cd84tm1Pls
Tg(TcraTcrb)425Cbn/?
(B6.Cg-Cd84tm1Pls Tg(TcraTcrb)425Cbn)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:157915
|
Cd86tm1Shr/Cd86tm1Shr
(NOD.129S4-Cd86tm1Shr)
|
abnormal T cell proliferation
|
J:142046
|
| decreased T cell proliferation
|
J:93421
|
Cd86tm1Shr/Cd86tm1Shr
(involves: 129S4/SvJae)
|
decreased IgG level
|
J:39089
|
Cd86tm1Shr/Cd86tm1Shr
(B6.129S4-Cd86tm1Shr)
|
decreased T cell proliferation
|
J:57613
|
Cd93tm1Mbo/Cd93tm1Mbo
(either: 129/Sv or B6.129-Cd93tm1Mbo or (involves: 129/Sv * C57BL/6))
|
impaired macrophage phagocytosis
|
J:88610
|
Cd96tm1.1Mjs/Cd96tm1.1Mjs
(B6.129P2(Cg)-Cd96tm1.1Mjs)
|
abnormal NK cell physiology
|
J:209990
|
Cd99l2tm1.1Dvst/Cd99l2tm1.1Dvst
Tg(Tek-cre)1Ywa/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
|
abnormal cellular extravasation
|
J:193021
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:193021
|
Cd99l2tm1.2Dvst/Cd99l2tm1.2Dvst
(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
|
abnormal cellular extravasation
|
J:193021
|
Cd151tm1Lka/Cd151tm1Lka
(C57BL/6-Cd151tm1Lka)
|
abnormal T cell proliferation
|
J:91605
|
Cd163tm1(KOMP)Vlcg/Cd163tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal macrophage chemotaxis
|
J:224919
|
Cd177tm1(KOMP)Vlcg/Cd177tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal neutrophil physiology
|
J:225335
|
Cd180tm1Kmiy/Cd180tm1Kmiy
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased IgG2b level
|
J:137066
|
| decreased IgG3 level
|
J:137066
|
Cd180tm1Kmiy/Cd180tm1Kmiy
(involves: 129P2/OlaHsd * C57BL/6 * NZB * NZW)
|
decreased IgG2a level
|
J:137066
|
| decreased IgG3 level
|
J:137066
|
Cd180tm1Kmiy/Cd180tm1Kmiy
Faslpr/Faslpr
(MRL.Cg-Cd180tm1Kmiy Faslpr)
|
decreased IgG2a level
|
J:137066
|
| decreased IgG3 level
|
J:137066
|
Cd200tm1Jods/Cd200tm1Jods
(C57BL/6-Cd200tm1Jods)
|
abnormal macrophage physiology
|
J:65982
|
| abnormal microglial cell physiology
|
J:65982
|
Cd200r1tm1.1Rmgo/Cd200r1tm1.1Rmgo
(C57BL/6-Cd200r1tm1.1Rmgo)
|
abnormal dendritic cell physiology
|
J:134313
|
| abnormal professional antigen presenting cell physiology
|
J:135069
|
Cd200r1tm1.1Rmgo/Cd200r1tm1.1Rmgo
Tg(tetO/CMV-CD200)1Rmgo/Tg(tetO/CMV-CD200)1Rmgo
(involves: C57BL/6)
|
abnormal dendritic cell physiology
|
J:134313
|
Cd200r1tm1Eakj/Cd200r1tm1Eakj
(Not Specified)
|
abnormal macrophage physiology
|
J:326965
|
Cd207tm1(Hbegf/EGFP)Bjec/Cd207+
(involves: C57BL/6 * SJL)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:137517
|
Cd207tm1(Hbegf/EGFP)Bjec/Cd207+
(involves: C57BL/6)
|
abnormal type IV hypersensitivity reaction
|
J:179630
|
Cd207tm1.1Cfg/Cd207tm1.1Cfg
(involves: C57BL/6)
|
decreased IgA level
|
J:217719
|
| decreased IgG1 level
|
J:217719
|
| decreased IgG2a level
|
J:217719
|
| decreased IgG3 level
|
J:217719
|
| decreased IgM level
|
J:217719
|
Cd207tm2.1(cre)Bjec/Cd207+
Tgfbr1tm1.1Karl/Tgfbr1tm1.1Karl
(involves: 129S4/SvJaeSor * C57BL/6)
|
abnormal type IV hypersensitivity reaction
|
J:179630
|
Cd209atm1.1Cfg/Cd209atm1.1Cfg
(involves: C57BL/6)
|
decreased IgG2b level
|
J:217719
|
| increased T cell proliferation
|
J:217719
|
Cd209btm1.1Cfg/Cd209btm1.1Cfg
(involves: C57BL/6)
|
impaired macrophage phagocytosis
|
J:288225
|
| increased IgG2b level
|
J:217719
|
| increased IgG3 level
|
J:217719
|
| increased IgM level
|
J:217719
|
Cd209btm1Anjm/Cd209btm1Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal macrophage physiology
|
J:94698
|
| impaired macrophage phagocytosis
|
J:94698
|
Cd209dtm1.1Cfg/Cd209dtm1.1Cfg
(involves: C57BL/6)
|
increased B cell proliferation
|
J:217719
|
Cd226tm1.1Cln/Cd226tm1.1Cln
(B6.129P2-Cd226tm1.1Cln)
|
decreased T cell proliferation
|
J:159749
|
| impaired natural killer cell mediated cytotoxicity
|
J:159749
|
Cd226tm1.1Cln/Cd226tm1.1Cln
Tg(TcraTcrb)1100Mjb/0
(B6.Cg-Cd226tm1.1Cln Tg(TcraTcrb)1100Mjb)
|
abnormal T cell activation
|
J:159749
|
| decreased cytotoxic T cell cytolysis
|
J:159749
|
| decreased T cell proliferation
|
J:159749
|
Cd226tm1Shib/Cd226tm1Shib
(involves: BALB/c)
|
decreased cytotoxic T cell cytolysis
|
J:165704
|
| impaired natural killer cell mediated cytotoxicity
|
J:165704
|
Cd244aChip/Cd244a+
(C57BL/6J-Cd244aChip)
|
abnormal NK cell physiology
|
J:196519
|
| impaired natural killer cell mediated cytotoxicity
|
J:196519
|
Cd244aChip/Cd244aChip
(C57BL/6J-Cd244aChip)
|
abnormal NK cell physiology
|
J:196519
|
| impaired natural killer cell mediated cytotoxicity
|
J:196519
|
Cd244atm1Kmle/Cd244atm1Kmle
(involves: C57BL/6)
|
impaired natural killer cell mediated cytotoxicity
|
J:166054
|
| increased natural killer cell mediated cytotoxicity
|
J:92740
|
Cd247m1Btlr/Cd247m1Btlr
(C57BL/6J-Cd247m1Btlr)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:158794
|
Cd247tm1Lov/Cd247tm1Lov
(involves: 129S4/SvJae)
|
abnormal T-helper 1 physiology
|
J:46914
|
Cd247tm1Lov/Cd247tm1Lov
Fcer1gtm1Rav/Fcer1gtm1Rav
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal T cell activation
|
J:46914
|
| abnormal T-helper 1 physiology
|
J:46914
|
| impaired natural killer cell mediated cytotoxicity
|
J:64764
|
Cd247tm1Mal/Cd247tm1Mal
(involves: C57BL/6)
|
abnormal thymocyte activation
|
J:110847
|
Cd247tm1Mal/Cd247tm1Mal
Lcktm1Mak/Lcktm1Mak
(involves: 129S2/SvPas * C57BL/6)
|
abnormal thymocyte activation
|
J:110847
|
Cd247tm1Mhu/Cd247tm1Mhu
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased T cell proliferation
|
J:15579
|
Cd247tm1Tks/Cd247tm1Tks
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell proliferation
|
J:15271
|
Cd247tm1Tks/Cd247tm1Tks
(B6.129P2-Cd247tm1Tks)
|
abnormal NK cell physiology
|
J:66403
|
| increased natural killer cell mediated cytotoxicity
|
J:66403
|
Cd247tm2.1Lov/Cd247tm2.1Lov
(Not Specified)
|
abnormal regulatory T cell physiology
|
J:192915
|
| abnormal T cell physiology
|
J:192915
|
| decreased thymocyte apoptosis
|
J:192915
|
Cd274tm1Igu/Cd274tm1Igu
Vsirtm1Lex/Vsirtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal T cell activation
|
J:222944
|
Cd274tm1Lpc/Cd274tm1Lpc
(B6.129S-Cd274tm1Lpc)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:89781
|
| decreased T cell apoptosis
|
J:89781
|
Cd274tm1Lpc/Cd274tm1Lpc
(involves: 129S/SvEv * C57BL/6)
|
abnormal dendritic cell physiology
|
J:152305
|
| decreased T cell apoptosis
|
J:136330
|
| increased IgG1 level
|
J:162539
|
| increased IgG2c level
|
J:162539
|
Cd274tm1Lpc/Cd274tm1Lpc
(C.129S-Cd274tm1Lpc)
|
abnormal regulatory T cell physiology
|
J:165841
|
| abnormal T follicular helper cell physiology
|
J:165841
|
| decreased IgG1 level
|
J:165841
|
| decreased IgG2a level
|
J:165841
|
| increased T cell proliferation
|
J:165841
|
Cd274tm1Shr/Cd274tm1Shr
Pdcd1lg2tm3Shr/Pdcd1lg2tm3Shr
(C.B6-Cd274tm1Shr Pdcd1lg2tm3Shr)
|
abnormal dendritic cell physiology
|
J:123785
|
Cd276tm1Lpc/Cd276tm1Lpc
(B6.129-Cd276tm1Lpc)
|
abnormal T-helper 1 physiology
|
J:237700
|
| abnormal T-helper 2 physiology
|
J:237700
|
| increased susceptibility to type I hypersensitivity reaction
|
J:237700
|
Cd276tm1Lpc/Cd276tm1Lpc
(D1J.129-Cd276tm1Lpc)
|
abnormal T-helper 1 physiology
|
J:237700
|
| abnormal T-helper 17 cell physiology
|
J:237700
|
Cd276tm1Mak/Cd276tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T-helper 1 physiology
|
J:84973
|
| increased T cell proliferation
|
J:84973
|
Cd276tm1Mak/Cd276tm1Mak
(C.129P2-Cd276tm1Mak)
|
abnormal T-helper 1 physiology
|
J:84973
|
Cd300atm1Shib/Cd300atm1Shib
(B6JJcl.C-Cd300atm1Shib)
|
abnormal mast cell physiology
|
J:189144
|
Cd300c2tm1Shib/Cd300c2tm1Shib
(B6.Cg-Cd300c2tm1Shib)
|
increased B cell proliferation
|
J:177613
|
Cd300lftm1Toki/Cd300lftm1Toki
(Not Specified)
|
abnormal mast cell physiology
|
J:190979
|
| increased susceptibility to type I hypersensitivity reaction
|
J:190979
|
Cd302tm1.1Dnjh/Cd302tm1.1Dnjh
(involves: C57BL/6)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:301848
|
| abnormal dendritic cell physiology
|
J:301848
|
Cdh5tm3(Cdh5/Ctnna1)Dvst/Cdh5tm3(Cdh5/Ctnna1)Dvst
(involves: 129 * C57BL/6)
|
abnormal cellular extravasation
|
J:177191
|
| abnormal leukocyte migration
|
J:177191
|
Cdh5tm4(Cdh5/Fkbp,Ptprb/Mtor*)Dvst/Cdh5tm4(Cdh5/Fkbp,Ptprb/Mtor*)Dvst
(involves: C57BL/6)
|
abnormal cellular extravasation
|
J:178759
|
| impaired neutrophil recruitment
|
J:178759
|
Cdh5tm5Dvst/Cdh5tm5Dvst
(B6.Cg-Cdh5tm5Dvst)
|
abnormal cellular extravasation
|
J:209801
|
Cdh5tm6Dvst/Cdh5tm6Dvst
(B6.Cg-Cdh5tm6Dvst)
|
abnormal cellular extravasation
|
J:209801
|
Cdh17tm1Ohn/Cdh17tm1Ohn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased IgG level
|
J:96738
|
Cdk6tm1Bbd/Cdk6tm1Bbd
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
decreased T cell proliferation
|
J:92529
|
Cdk6tm1Phin/Cdk6tm1Phin
(involves: 129S4/SvJae)
|
abnormal thymocyte activation
|
J:144975
|
| decreased thymocyte apoptosis
|
J:144975
|
Cdk6tm3.1Phin/Cdk6tm3.1Phin
(involves: 129 * C57BL/6 * FVB/N)
|
increased T cell apoptosis
|
J:174697
|
Cdkn1atm1Led/Cdkn1atm1Led
(involves: 129S6/SvEvTac)
|
increased T cell proliferation
|
J:76041
|
Cdkn1atm1Led/Cdkn1atm1Led
Gadd45atm1Ajf/Gadd45atm1Ajf
(either: (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6))
|
abnormal T cell activation
|
J:76041
|
| increased IgG1 level
|
J:76041
|
| increased IgM level
|
J:76041
|
| increased T cell proliferation
|
J:76041
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(B6;129S2-Cdkn1atm1Tyj/J)
|
impaired macrophage chemotaxis
|
J:108569
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
increased IgG1 level
|
J:60292
|
| increased T cell proliferation
|
J:60292
|
Cdkn1btm1Jro/Cdkn1btm1Jro
(involves: 129S4/SvJaeSor * C57BL/6)
|
decreased T cell proliferation
|
J:71780
|
Cdkn1btm1Mlf/Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor * C57BL/6J)
|
increased T cell proliferation
|
J:33400
|
Cdkn1btm1Mlf/Cdkn1btm1Mlf
Myctm1Atp/Myc+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * FVB/N)
|
decreased T cell proliferation
|
J:73369
|
Cdkn2ctm1Yxi/Cdkn2ctm1Yxi
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal T cell physiology
|
J:50053
|
Ceacam1tm1Rsb/Ceacam1tm1Rsb
Tg(Lck-cre)1Cwi/0
(involves: 129)
|
increased T cell proliferation
|
J:116136
|
Cebpbtm1.1Acle/Cebpbtm1.1Acle
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal osteoclast physiology
|
J:150006
|
Cebpbtm1Aki/Cebpbtm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal macrophage physiology
|
J:153025
|
| abnormal T-helper 1 physiology
|
J:153025
|
Cebpbtm1Kish/Cebpbtm1Kish
(involves: 129P2/OlaHsd)
|
abnormal macrophage physiology
|
J:77003
|
| impaired macrophage phagocytosis
|
J:77003
|
Cebpbtm1Pfj/Cebpbtm1Pfj
(involves: 129S1/Sv * C57BL/6)
|
abnormal osteoclast physiology
|
J:150006
|
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * MF1)
|
abnormal macrophage physiology
|
J:25215
|
| abnormal T-helper 1 physiology
|
J:25215
|
| abnormal T-helper 2 physiology
|
J:25215
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:25215
|
| increased IgG level
|
J:25215
|
Cebpetm1Kgx/Cebpetm1Kgx
(involves: 129S6/SvEvTac * NIH Black Swiss)
|
abnormal neutrophil physiology
|
J:76024
|
Cebpetm1Kgx/Cebpetm1Kgx
(involves: 129S6/SvEvTac)
|
abnormal neutrophil physiology
|
J:76024
|
Cebpgtm1Aki/Cebpgtm1Aki
(involves: 129P2/OlaHsd)
|
abnormal NK cell physiology
|
J:58801
|
| impaired natural killer cell mediated cytotoxicity
|
J:58801
|
Cfhtm1Mbo/Cfhtm1Mbo
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to type III hypersensitivity reaction
|
J:78193
|
Cflartm1Ywh/Cflartm1Ywh
Tg(Lck-cre)548Jxm/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * CBA)
|
increased thymocyte apoptosis
|
J:100558
|
Cgastm1a(EUCOMM)Hmgu/Cgastm1a(EUCOMM)Hmgu
(C57BL/6N-Cgastm1a(EUCOMM)Hmgu)
|
abnormal dendritic cell physiology
|
J:201167
|
| abnormal macrophage physiology
|
J:201167
|
| abnormal plasmacytoid dendritic cell physiology
|
J:201167
|
Ch25htm1Rus/Ch25htm1Rus
(B6.129S6-Ch25htm1Rus)
|
increased IgA level
|
J:170807
|
| increased IgG2a level
|
J:170807
|
| increased IgG2b level
|
J:170807
|
| increased IgG3 level
|
J:170807
|
Chd4tm1.1Kge/Chd4tm1.1Kge
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * SJL)
|
abnormal T cell physiology
|
J:109547
|
Chd4tm1.1Kge/Chd4tm1.2Kge
Tg(CAG-Bgeo/GFP)21Lbe/0
Tg(Lck-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
decreased T cell proliferation
|
J:109547
|
Chd4tm1.2Kge/Chd4tm1.2Kge
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
decreased T cell proliferation
|
J:109547
|
Chi3l1tm1Eli/Chi3l1tm1Eli
(B6.Cg-Chi3l1tm1Eli)
|
abnormal dendritic cell physiology
|
J:148490
|
| abnormal plasmacytoid dendritic cell physiology
|
J:148490
|
| abnormal T-helper 2 physiology
|
J:148490
|
| decreased IgE level
|
J:148490
|
| impaired eosinophil recruitment
|
J:148490
|
| impaired neutrophil recruitment
|
J:148490
|
| increased T cell apoptosis
|
J:148490
|
Chi3l1tm1Eli/Chi3l1tm1Eli
Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/0
(involves: C57BL/6 * CBA)
|
abnormal T-helper 2 physiology
|
J:148490
|
Chrm1tm1Jwe/Chrm1tm1Jwe
(involves: 129S6/SvEvTac * CF-1)
|
decreased cytotoxic T cell cytolysis
|
J:106393
|
Chrna4tm1Jpc/Chrna4tm1Jpc
(involves: C57BL/6)
|
decreased IgG level
|
J:103908
|
| decreased immunoglobulin level
|
J:103908
|
| increased IgG level
|
J:103908
|
Chrna7tm1Bay/Chrna7tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased IgG level
|
J:103908
|
| decreased immunoglobulin level
|
J:103908
|
Chrnb2tm1Jpc/Chrnb2tm1Jpc
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal immunoglobulin level
|
J:103908
|
| decreased immunoglobulin level
|
J:103908
|
| increased B cell proliferation
|
J:103908
|
| increased IgG level
|
J:103908
|
Chst1tm1(KOMP)Vlcg/Chst1tm1(KOMP)Vlcg
Chst2tm1Tmu/Chst2tm1Tmu
Chst4tm1Sdr/Chst4tm1Sdr
(involves: 129S2/SvPas * C57BL/6NTac)
|
abnormal leukocyte migration
|
J:204813
|
Chst2tm1Tmu/Chst2tm1Tmu
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal leukocyte migration
|
J:92231
|
| abnormal leukocyte physiology
|
J:92231
|
Chst2tm1Tmu/Chst2tm1Tmu
Chst4tm1Sdr/Chst4tm1Sdr
(involves: 129S2/SvPas)
|
abnormal leukocyte migration
|
J:204813
|
Chst3tm1Tmu/Chst3tm1Tmu
(involves: 129S2/SvPas)
|
increased T cell proliferation
|
J:217719
|
Chst4tm1Mifu/Chst4tm1Mifu
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal leukocyte migration
|
J:113195
|
| impaired leukocyte tethering or rolling
|
J:113195
|
Chst4tm1Mifu/Chst4tm1Mifu
Gcnt1tm1Jxm/Gcnt1tm1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal leukocyte migration
|
J:113195
|
| impaired leukocyte tethering or rolling
|
J:113195
|
Chst4tm1Sdr/Chst4tm1Sdr
(involves: C57BL/6)
|
abnormal leukocyte adhesion
|
J:86759
|
| abnormal leukocyte migration
|
J:86759
|
Chuktm1Lex/Chuktm1Lex
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S/SvEvBrd)
|
impaired macrophage chemotaxis
|
J:159873
|
| impaired neutrophil chemotaxis
|
J:159873
|
| impaired neutrophil recruitment
|
J:159873
|
Chuktm1Mka/Chuktm1Mka
(B6.129-Chuktm1Mka)
|
abnormal B cell physiology
|
J:113556
|
Chuktm2Mka/Chuktm2Mka
(B6.Cg-Chuktm2Mka)
|
abnormal B cell physiology
|
J:113556
|
Chuktm2Mka/Chuktm2Mka
Tg(Tnfsf13b)1Fma/?
(B6.Cg-Chuktm2Mka Tg(Tnfsf13b)1Fma)
|
abnormal B cell activation
|
J:113556
|
Cia27DBA/1J/?
(involves: DBA/1J * FVB/N)
|
increased IgG level
|
J:116665,
J:94347
|
Cigs2tm1.1Anse/Cigs2+
Il4tm1(CD2)Mmrs/Il4+
(involves: 129 * BALB/cJ * C57BL/6)
|
decreased IgE level
|
J:181313
|
| decreased IgG1 level
|
J:181313
|
Cigs2tm1.1Anse/Cigs2tm1.1Anse
(involves: BALB/cJ * C57BL/6)
|
abnormal class switch recombination
|
J:181313
|
| decreased IgE level
|
J:181313
|
| decreased IgG1 level
|
J:181313
|
| increased IgG2b level
|
J:181313
|
Cigs2tm1.1Kubo/Cigs2tm1.1Kubo
(B6.Cg-Cigs2tm1.1Kubo)
|
abnormal mast cell physiology
|
J:129048
|
| abnormal neutrophil physiology
|
J:129048
|
Ciitatm1Ccum/Ciitatm1Ccum
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal B cell physiology
|
J:96421
|
| abnormal CD4-positive, alpha-beta T cell physiology
|
J:31601
|
| abnormal dendritic cell physiology
|
J:96421
|
| abnormal lymphocyte physiology
|
J:96421
|
| abnormal MHC II cell surface expression on macrophages
|
J:31601
|
| abnormal T cell physiology
|
J:31601
|
| decreased T cell proliferation
|
J:31601
|
Ciitatm1Jpyt/Ciitatm1Jpyt
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased IgG level
|
J:57100
|
| increased IgM level
|
J:57100
|
Ciitatm1Jpyt/Ciitatm1Jpyt
(B6.129P2-Ciitatm1Jpyt)
|
abnormal T-helper 1 physiology
|
J:125654
|
Ciitatm2Wrth/Ciitatm2Wrth
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal immunoglobulin level
|
J:92170
|
Cimap2Retro/Cimap2+
(involves: C57BL/6J)
|
increased cytotoxic T cell cytolysis
|
J:223336
|
Cimap2Retro/Cimap2Retro
(involves: C57BL/6J)
|
increased cytotoxic T cell cytolysis
|
J:223336
|
| increased T cell proliferation
|
J:223336
|
Cimap2tm1a(KOMP)Wtsi/Cimap2+
(involves: C57BL/6)
|
decreased cytotoxic T cell cytolysis
|
J:223336
|
Cinda1BALB/c/?
(involves: BALB/c * CcS-4/Dem)
|
increased T cell proliferation
|
J:40728
|
Cinda2STS/A/?
(involves: BALB/c * CcS-4/Dem)
|
increased T cell proliferation
|
J:40728
|
Cinda3O20/A/Cinda3O20/A
(involves: O20/A * OcB-9/Dem)
|
decreased T cell proliferation
|
J:95917
|
Cinda3OcB9/Dem/Cinda3O20/A
(involves: O20/A * OcB-9/Dem)
|
increased T cell proliferation
|
J:95917
|
Cinda4OcB9/Dem/Cinda4O20/A
(involves: O20/A * OcB-9/Dem)
|
increased T cell proliferation
|
J:95917
|
Cinda4OcB9/Dem/Cinda4OcB9/Dem
(involves: O20/A * OcB-9/Dem)
|
increased T cell proliferation
|
J:95917
|
Cinda5OcB9/Dem/Cinda5O20/A
(involves: O20/A * OcB-9/Dem)
|
increased T cell proliferation
|
J:95917
|
Cinda5OcB9/Dem/Cinda5OcB9/Dem
(involves: O20/A * OcB-9/Dem)
|
increased T cell proliferation
|
J:95917
|
Cishtm1.1Cdon/Cishtm1.1Cdon
Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * DBA/2)
|
increased susceptibility to type I hypersensitivity reaction
|
J:204829
|
Cishtm1.2Cdon/Cishtm1.2Cdon
(B6.129S6(Cg)-Cishtm1.2Cdon)
|
increased susceptibility to type I hypersensitivity reaction
|
J:204829
|
| increased T cell proliferation
|
J:204829
|
Cks1btm1Sir/Cks1btm1Sir
Tg(IghMyc)22Bri/?
(involves: C57BL * C57BL/6 * SJL)
|
decreased B cell proliferation
|
J:121564
|
Clcn2tm1Tjj/Clcn2tm1Tjj
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal microglial cell physiology
|
J:122365
|
Clcn3tm1Lamb/Clcn3tm1Lamb
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal neutrophil physiology
|
J:112692
|
| impaired neutrophil phagocytosis
|
J:112692
|
Clcn3tm1Tjj/Clcn3tm1Tjj
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal microglial cell physiology
|
J:77635
|
Clcn7tm1.1Teti/Clcn7+
(involves: 129S2/SvPas * C57BL/6)
|
abnormal osteoclast physiology
|
J:203761
|
Clcn7tm1Tjj/Clcn7tm1Tjj
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal osteoclast physiology
|
J:67273
|
Clcn7tm2Tjj/Clcn7tm2Tjj
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal osteoclast physiology
|
J:67273
|
Clcn7tm4.1Tjj/Clcn7tm4.1Tjj
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal osteoclast physiology
|
J:160702
|
Clec1atm1Yiw/Clec1atm1Yiw
(involves: C57BL/6J * C57BL/6NSlc)
|
abnormal dendritic cell antigen presentation
|
J:329240
|
| decreased CD8-positive, alpha-beta memory T cell proliferation
|
J:329240
|
Clec4a2tm1.1Cfg/Clec4a2tm1.1Cfg
(involves: C57BL/6)
|
increased B cell proliferation
|
J:217719
|
| increased IgG2a level
|
J:217719
|
| increased IgG2b level
|
J:217719
|
| increased IgG3 level
|
J:217719
|
Clec4a2tm1Yiw/Clec4a2tm1Yiw
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased IgG1 level
|
J:217720
|
| increased IgG3 level
|
J:217720
|
| increased IgG level
|
J:217720
|
Clec4b1em#Tsak/Clec4b1em#Tsak
(involves: C57BL/6N)
|
abnormal adaptive immunity
|
J:258645
|
Clec4dtm1.1Cfg/Clec4dtm1.1Cfg
(involves: C57BL/6)
|
decreased B cell proliferation
|
J:217719
|
| decreased T cell proliferation
|
J:217719
|
Clec4dtm1.1Shoy/Clec4dtm1.1Shoy
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased IgG level
|
J:203159
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:203159
|
Clec4etm1.1Cfg/Clec4etm1.1Cfg
(B6.Cg-Clec4etm1.1Cfg)
|
abnormal macrophage physiology
|
J:136334
|
Clec4etm1Tks/Clec4etm1Tks
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased IgG level
|
J:203159
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:203159
|
Clec4ftm1Ymed/Clec4ftm1Ymed
(B6.129S7-Clec4ftm1Ymed)
|
abnormal macrophage cytokine production
|
J:203199
|
Clec4ntm1.2Mgne/Clec4ntm1.2Mgne
(involves: C57BL/6 * C57BL/6J)
|
abnormal macrophage physiology
|
J:209284
|
| abnormal neutrophil physiology
|
J:209284
|
| impaired macrophage phagocytosis
|
J:209284
|
| impaired neutrophil phagocytosis
|
J:209284
|
Clec7atm1.1Bpip/Clec7atm1.1Bpip
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal macrophage physiology
|
J:203908
|
| impaired macrophage phagocytosis
|
J:203908
|
Clec7atm1Gdb/Clec7atm1Gdb
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal macrophage physiology
|
J:116669
|
| abnormal neutrophil physiology
|
J:116669
|
Clec7atm1Yiw/Clec7atm1Yiw
(C.129P2-Clec7atm1Yiw)
|
abnormal dendritic cell physiology
|
J:116670
|
| abnormal macrophage physiology
|
J:116670
|
Clec7atm1Yiw/Clec7atm1Yiw
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal dendritic cell physiology
|
J:122394
|
Clec7atm1Yiw/Clec7atm1Yiw
Myd88tm1Aki/Myd88tm1Aki
(involves: 129P2/OlaHsd * BALB/cA * C57BL/6J)
|
abnormal dendritic cell physiology
|
J:116670
|
Clec9atm1.1Crs/Clec9atm1.1Crs
(C57BL/6-Clec9atm1.1Crs)
|
abnormal dendritic cell antigen presentation
|
J:178441
|
Clec9atm1Crs/Clec9atm1Crs
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal dendritic cell antigen presentation
|
J:147472
|
Clec12atm1Jrld/Clec12atm1Jrld
(B6J.129-Clec12atm1Jrld)
|
abnormal neutrophil physiology
|
J:210326
|
Clic4tm1.1Yus/Clic4tm1.1Yus
(involves: 129S4/SvJae * C57BL/6J)
|
impaired macrophage phagocytosis
|
J:183611
|
Cln3em1Dprc/Cln3em1Dprc
(C57BL/6-Cln3em1Dprc)
|
increased microglial cell activation
|
J:294634
|
Cln3tm1Nbm/Cln3tm1Nbm
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal dendritic cell physiology
|
J:233445
|
| abnormal macrophage physiology
|
J:233445
|
| decreased macrophage cytokine production
|
J:233445
|
Clnktm1Rygo/Clnktm1Rygo
(B6.129P2-Clnktm1Rygo)
|
abnormal NK T cell physiology
|
J:131738
|
| increased natural killer cell mediated cytotoxicity
|
J:131738
|
Clnktm1Rygo/Clnktm1Rygo
(involves: 129P2/OlaHsd * BALB/c)
|
increased natural killer cell mediated cytotoxicity
|
J:131621
|
Clnktm1Rygo/Clnktm1Rygo
Lcp2tm1Geha/Lcp2tm1Geha
(involves: 129P2/OlaHsd * 129S4/SvJae * BALB/c)
|
impaired natural killer cell mediated cytotoxicity
|
J:131621
|
Clnktm1Vei/Clnktm1Vei
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal mast cell physiology
|
J:91590
|
| increased natural killer cell mediated cytotoxicity
|
J:91590
|
ClppGt(IST11134F10)Tigm/ClppGt(IST11134F10)Tigm
(involves: C57BL/6N)
|
abnormal T cell activation
|
J:203140
|
ClppGt(IST13563G11)Tigm/ClppGt(IST13563G11)Tigm
(involves: C57BL/6N)
|
abnormal T cell activation
|
J:203140
|
Clptm1ltm1d(EUCOMM)Wtsi/Clptm1l+
(involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6N)
|
abnormal class switch recombination
|
J:265892
|
Cltatm1.2Fmb/Cltatm1.2Fmb
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:235591
|
Cma1tm1Mfg/Cma1tm1Mfg
(either: (involves: 129 * C57BL/6) or (involves: 129 * BALB/c))
|
abnormal mast cell physiology
|
J:98963
|
Cmahtm1Avrk/Cmahtm1Avrk
Dock2m1Hsd/Dock2m1Hsd
(B6NHsd.Cg-Dock2m1Hsd Cmahtm1Avrk)
|
abnormal B cell activation
|
J:144035
|
Cmahtm1Avrk/Cmahtm1Avrk
Dock2m1Hsd/Dock2m1Hsd
Siaetm1.2Avrk/Siaetm1.2Avrk
(B6NHsd.Cg-Siaetm1.2Avrk Dock2m1Hsd Cmahtm1Avrk)
|
abnormal B cell activation
|
J:144035
|
Cmahtm1Ykoz/Cmahtm1Ykoz
(B6.129P2-Cmahtm1Ykoz)
|
abnormal B cell physiology
|
J:121365
|
| abnormal T cell physiology
|
J:121365
|
| increased B cell proliferation
|
J:121365
|
| increased IgG1 level
|
J:121365
|
Cmklr1tm1Dgen/Cmklr1tm1Dgen
(B6.Cg-Cmklr1tm1Dgen)
|
abnormal dendritic cell physiology
|
J:157190
|
| abnormal macrophage chemotaxis
|
J:157190
|
| abnormal professional antigen presenting cell physiology
|
J:157190
|
Cmklr1tm1Drg/Cmklr1tm1Drg
(Not Specified)
|
impaired macrophage chemotaxis
|
J:133968
|
| impaired neutrophil recruitment
|
J:133968
|
Cmtm7tm2a(EUCOMM)Hmgu/Cmtm7+
Rag1tm1Fwa/Rag1tm1Fwa
(chimera involves: C57BL/6 * C57BL/6N)
|
abnormal B cell physiology
|
J:207033
|
| decreased B cell proliferation
|
J:207033
|
| decreased IgG2b level
|
J:207033
|
| decreased IgM level
|
J:207033
|
Cnmdtm1Ska/Cnmdtm1Ska
(involves: C57BL/6 * CBA)
|
abnormal osteoclast physiology
|
J:81137
|
Cnn2tm1.2Jin/Cnn2tm1.2Jin
(B6.129X1-Cnn2tm1.2Jin)
|
abnormal macrophage chemotaxis
|
J:141867
|
| abnormal macrophage physiology
|
J:141867
|
Cnpy3tm1Kmiy/Cnpy3tm1Kmiy
(involves: C57BL/6)
|
abnormal lymphocyte physiology
|
J:128513
|
| abnormal macrophage physiology
|
J:128513
|
Cnr2tm1Zim/Cnr2tm1Zim
(involves: 129 * C57BL/6)
|
abnormal macrophage physiology
|
J:62417
|
Col1a1tm1(tetO-Irf4)Sing/Col1a1tm1(tetO-Irf4)Sing
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
Irf4tm1Mak/Irf4+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal class switch recombination
|
J:203903
|
Col1a1tm1(tetO-Irf4)Sing/Col1a1tm1(tetO-Irf4)Sing
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
Irf4tm1Mak/Irf4tm1Mak
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal class switch recombination
|
J:203903
|
Col1a1tm1(tetO-Yod1*)Hpl/Col1a1tm1(tetO-Yod1*)Hpl
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sortm1(rtTA*M2)Jae
(involves: 129S4/SvJae * C57BL/6)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:194608
|
| abnormal professional antigen presenting cell physiology
|
J:194608
|
Col1a1tm1(tetO-Yod1*)Hpl/Col1a1tm1(tetO-Yod1*)Hpl
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sortm1(rtTA*M2)Jae
Tap1tm1Arp/Tap1tm1Arp
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
abnormal professional antigen presenting cell physiology
|
J:194608
|
Col1a1tm1Jae/Col1a1tm1Jae
(involves: 129S4/SvJae * C57BL/6)
|
abnormal osteoclast physiology
|
J:53079
|
Col17a1tm1.1(COL17A1)Zliu/Col17a1tm1.1(COL17A1)Zliu
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased mast cell degranulation
|
J:261781
|
Col17a1tm1Tiin/Col17a1tm1Tiin
(involves: C57BL/6)
|
increased IgE level
|
J:220622
|
Colgalt2tm1.1Hwei/Colgalt2tm1.1Hwei
(involves: C57BL/6J)
|
increased T cell apoptosis
|
J:310468
|
Copatm1.1Shum/Copa+
(B6(CBA)-Copatm1.1Shum)
|
abnormal T cell activation
|
J:288425
|
Copg1em1Geha/Copg1em1Geha
(involves: C57BL/6)
|
abnormal B cell physiology
|
J:345528
|
| abnormal IgG level
|
J:345528
|
| increased T cell apoptosis
|
J:345528
|
Cops5tm1Rpar/Cops5tm1Rpar
Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)
|
increased T cell apoptosis
|
J:132114
|
Cops6Gt(RRI087)Byg/Cops6+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased thymocyte apoptosis
|
J:172038
|
Cops8tm1Nwe/Cops8tm1.1Nwe
Tg(Cd4-cre)1Cwi/?
(involves: 129S1/Sv * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:126339
|
| abnormal T cell activation
|
J:126339
|
| decreased T cell proliferation
|
J:126339
|
Coro1akoy/Coro1akoy
(C57BL/6-Coro1akoy)
|
abnormal T cell physiology
|
J:141431
|
Coro1aptcd/Coro1aptcd
(B6.CTS-Coro1aptcd)
|
abnormal T cell activation
|
J:141431
|
| abnormal T cell physiology
|
J:141431
|
| increased T cell apoptosis
|
J:141431
|
Coro1aptcd/Coro1atm1Achn
(B6.Cg-Coro1aptcd Coro1atm1Achn)
|
abnormal T cell activation
|
J:141431
|
| abnormal T cell physiology
|
J:141431
|
Coro1atm1Achn/Coro1atm1Achn
(involves: 129X1/SvJ * C57BL/6)
|
abnormal leukocyte migration
|
J:111593
|
Coro1atm1Achn/Coro1atm1Achn
(B6.129X1-Coro1atm1Achn)
|
increased T cell apoptosis
|
J:141431
|
Coro1atm1Achn/Coro1atm1Achn
(involves: 129X1/SvJ)
|
increased mast cell degranulation
|
J:177785
|
Coro1atm1Achn/Coro1atm1Achn
Coro1btm1.1Nfoe/Coro1btm1.1Nfoe
(involves: 129X1/SvJ * C57BL/6N)
|
increased mast cell degranulation
|
J:177785
|
| increased susceptibility to type I hypersensitivity reaction
|
J:177785
|
Coro1atm1Jpie/Coro1atm1Jpie
(involves: 129 * C57BL/6)
|
abnormal T cell activation
|
J:133258
|
| abnormal thymocyte activation
|
J:133258
|
| decreased T cell proliferation
|
J:133258
|
| impaired macrophage phagocytosis
|
J:133404
|
Cox10tm1Ctm/Cox10tm1Ctm
Slc6a3tm1.1(cre)Bkmn/?
(B6.Cg-Cox10tm1Ctm Slc6a3tm1.1(cre)Bkmn)
|
increased microglial cell activation
|
J:231810
|
Cpa3tm3(icre)Hrr/Cpa3+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:178942
|
Cr2M1Btlr/Cr2M1Btlr
(C57BL/6J-Cr2M1Btlr)
|
decreased IgG level
|
J:267527
|
Cr2tm1.1Jhws/Cr2tm1.1Jhws
(Not Specified)
|
abnormal germinal center B cell physiology
|
J:205353
|
| decreased IgG2b level
|
J:205353
|
| decreased IgG2c level
|
J:205353
|
| decreased IgG3 level
|
J:205353
|
| decreased IgM level
|
J:205353
|
Cr2tm1Crr/Cr2tm1Crr
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased IgG2a level
|
J:31942
|
| decreased IgG2b level
|
J:31942
|
| decreased IgG3 level
|
J:31942
|
| decreased IgG level
|
J:31942,
J:69452
|
| decreased IgM level
|
J:69452
|
| decreased immunoglobulin level
|
J:69452
|
Cr2tm1Hmo/Cr2tm1Hmo
(involves: 129S7/SvEvBrd)
|
decreased IgG level
|
J:35112
|
| decreased IgM level
|
J:35112
|
Cr2tm1Hmo/Cr2tm1Hmo
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal B cell activation
|
J:151991
|
| abnormal B cell physiology
|
J:151991
|
| abnormal class switch recombination
|
J:151991
|
Cr2tm1Tft/Cr2tm1Tft
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal adaptive immunity
|
J:95979
|
| decreased IgG1 level
|
J:95979
|
| decreased IgG2b level
|
J:95979
|
| decreased IgG3 level
|
J:95979
|
| decreased IgG level
|
J:95979
|
| decreased IgM level
|
J:95979
|
Cr2tm2.1(HLA-A)Crr/Cr2tm2.1(HLA-A)Crr
(involves: C57BL/6)
|
abnormal B cell physiology
|
J:151991
|
| abnormal class switch recombination
|
J:151991
|
Cr2tm2.1(HLA-A)Crr/Cr2tm2.1(HLA-A)Crr
Tg(IghelMD4)4Ccg/?
(involves: C57BL/6)
|
abnormal B cell activation
|
J:151991
|
Cr2tm2.1Jhws/Cr2tm2.1Jhws
(B6.129-Cr2tm2.1Jhws)
|
abnormal germinal center B cell physiology
|
J:205353
|
| decreased IgG3 level
|
J:205353
|
| decreased IgM level
|
J:205353
|
| increased IgM level
|
J:205353
|
Cracr2atm1.1Ygwa/Cracr2atm1.1Ygwa
Tg(Cd4-cre)1Cwi/0
(B6.Cg-Cracr2atm1.1Ygwa Tg(Cd4-cre)1Cwi)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:259523
|
Crhtm1Maj/Crhtm1Maj
(involves: 129S2/SvPas * C57BL/6)
|
abnormal professional antigen presenting cell physiology
|
J:98419
|
| decreased T cell proliferation
|
J:98419
|
Crl1A/WySnJ/Crl1A/WySnJ
(B10.A-H2a/SgSnJ)
|
abnormal B cell physiology
|
J:5442
|
Crl1AKR/J/Crl1AKR/J
(involves: AKR/J * DBA/2J)
|
abnormal B cell physiology
|
J:5442
|
Crl1DBA/2J/Crl1DBA/2J
(involves: AKR/J * DBA/2J)
|
abnormal B cell physiology
|
J:5442
|
Crlf2tm1Wjl/Crlf2tm1Wjl
(involves: BALB/c)
|
abnormal T cell proliferation
|
J:107431
|
| decreased immunoglobulin level
|
J:107431
|
Crtamtm1Achn/Crtamtm1Achn
(involves: 129 * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:145314
|
| abnormal T cell activation
|
J:145314
|
| abnormal T-helper 1 physiology
|
J:145314
|
| increased T cell proliferation
|
J:145314
|
Crtc1tm1a(EUCOMM)Wtsi/Crtc1+
(C57BL/6N-Crtc1tm1a(EUCOMM)Wtsi/Ics)
|
increased IgG2b level
|
J:165965
|
Cry1tm1Jhjh/Cry1tm1Jhjh
Cry2tm1Jhjh/Cry2tm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell activation
|
J:159504
|
Cry2tm1Jhjh/Cry2tm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal osteoclast physiology
|
J:163112
|
Csf1op/Csf1op
(B6C3Fe a/a-Csf1op/J)
|
abnormal Langerhans cell physiology
|
J:112594
|
Csf1op/Csf1op
(B6;C3Fe a/a-Csf1op/J)
|
impaired macrophage chemotaxis
|
J:147697
|
Csf1op/Csf1op
Galctwi/Galctwi
(involves: C3HeB/Fe * C57BL/6J * CE/J)
|
impaired macrophage chemotaxis
|
J:170081
|
Csf1rtm1Ers/Csf1rtm1Ers
(FVB.129X1-Csf1rtm1Ers)
|
abnormal Langerhans cell physiology
|
J:112594
|
Csf2tm1Ard/Csf2tm1Ard
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal leukocyte physiology
|
J:86386
|
| abnormal MHC II cell surface expression on macrophages
|
J:86386
|
| impaired macrophage chemotaxis
|
J:86386
|
Csf2tm1Dran/Csf2tm1Dran
Ifngtm1Ts/Ifngtm1Ts
Il3tm1Glli/Il3tm1Glli
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)
|
increased IgE level
|
J:83086
|
| increased IgG1 level
|
J:83086
|
| increased immunoglobulin level
|
J:83086
|
Csf2tm1Dran/Csf2tm1Dran
Il3tm1Glli/Il3tm1Glli
(B6.129S2-Csf2tm1Dran Il3tm1Glli)
|
abnormal leukocyte physiology
|
J:83086
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:67404
|
Csf2tm1Dran/Csf2tm1Dran
Il3tm1Glli/Il3tm1Glli
(C.129S2-Csf2tm1Dran Il3tm1Glli)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:67404
|
Csf2raem1Szut/Csf2raem1Szut
(C57BL/6-Csf2raem1Szut)
|
impaired macrophage phagocytosis
|
J:322934
|
Csf2rbtm1Clsc/Csf2rbtm1Clsc
Csf2rb2tm1Cgb/Csf2rb2tm1Cgb
(C.129S1-Csf2rb2tm1Cgb Csf2rbtm1Clsc)
|
abnormal dendritic cell physiology
|
J:130939
|
| abnormal plasmacytoid dendritic cell physiology
|
J:130939
|
| abnormal T cell activation
|
J:130939
|
| abnormal T cell physiology
|
J:130939
|
| decreased susceptibility to type I hypersensitivity reaction
|
J:130939
|
| decreased T cell proliferation
|
J:130939
|
| impaired eosinophil recruitment
|
J:130939
|
| increased IgG1 level
|
J:130939
|
Csf2rbtm1Mur/Csf2rbtm1Mur
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal eosinophil physiology
|
J:35829
|
Csf2rbtm1Mur/Csf2rbtm1Mur
(involves: 129P2/OlaHsd)
|
abnormal eosinophil physiology
|
J:24122
|
Csf2rbtm1Mur/Csf2rbtm1Mur
Il3tm1Tyb/Il3tm1Tyb
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
abnormal eosinophil physiology
|
J:35829
|
Csf3tm1Ard/Csf3tm1Ard
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal neutrophil physiology
|
J:20400
|
Csf3rtm1Link/Csf3rtm1Link
(involves: 129X1/SvJ)
|
impaired neutrophil chemotaxis
|
J:79825
|
Csf3rtm1Link/Csf3rtm1Link
(B6.129X1-Csf3rtm1Link)
|
impaired neutrophil chemotaxis
|
J:79567
|
Csf3rtm2Link/Csf3rtm2Link
(B6.129X1-Csf3rtm2Link)
|
abnormal neutrophil physiology
|
J:79567
|
Csf3rtm4(Epor)Link/Csf3rtm4(Epor)Link
(involves: 129X1/SvJ * C57BL/6)
|
impaired neutrophil chemotaxis
|
J:79825
|
Csf3rtm4(Epor)Link/Csf3rtm4(Epor)Link
(B6.129X1-Csf3rtm4(Epor)Link)
|
impaired neutrophil chemotaxis
|
J:79567
|
Csktm1Tara/Csktm2Tara
Elanetm1(cre)Roes/Elane+
(involves: 129P2/OlaHsd * CB20 * C57BL/6)
|
abnormal granulocyte physiology
|
J:89716
|
Cspg4tm1Wbst/Cspg4tm1Wbst
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal macrophage physiology
|
J:184220
|
Ctl1NZB/BlN/Ctl1C57BL/10
(involves: C57BL/10 * NZB/BlN)
|
abnormal T cell physiology
|
J:6736
|
Ctla4tm1All/Ctla4tm1All
Rag1tm1Mom/Rag1tm1Mom
Tg(TcrAND)53Hed/0
(involves: 129S/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal T cell activation
|
J:119845
|
| increased T cell proliferation
|
J:119845
|
Ctla4tm1All/Ctla4tm1All
Tg(TcrAND)53Hed/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal T cell activation
|
J:119845
|
Ctla4tm1Saka/Ctla4tm1Saka
Foxp3tm1(cre)Saka/Y
(involves: BALB/c)
|
abnormal immunoglobulin level
|
J:140085
|
| abnormal regulatory T cell physiology
|
J:140085
|
| increased IgE level
|
J:140085
|
| increased IgG level
|
J:140085
|
Ctla4tm1Shr/Ctla4tm1Shr
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
increased T cell proliferation
|
J:30393
|
Ctla4tm1Shr/Ctla4tm1Shr
(B6.129S4-Ctla4tm1Shr)
|
abnormal regulatory T cell physiology
|
J:146644
|
| abnormal T cell physiology
|
J:146644
|
Ctla4tm1Shr/Ctla4tm1Shr
Rag2tm1Fwa/Rag2tm1Fwa
Tg(DO11.10)10Dlo/0
(involves: 129S/Sv * BALB/c * C3H * C57BL/6)
|
abnormal T cell physiology
|
J:110446
|
Ctla4tm1Shr/Ctla4tm1Shr
Tg(DO11.10)10Dlo/0
(involves: 129S4/SvJae * BALB/c * C3H * C57BL/6)
|
abnormal T cell physiology
|
J:57090
|
| increased T cell proliferation
|
J:57090
|
Ctnnb1tm1(Nfkbia)Rsu/Ctnnb1+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal macrophage physiology
|
J:71744
|
Ctnnb1tm2(Nfkbia)Rsu/Ctnnb1+
Tg(CMV-cre)1Cgn/0
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
abnormal macrophage physiology
|
J:71744
|
Ctnnb1tm2Kem/Ctnnb1+
Ppargtm1.1(tTA)Jmgr/Pparg+
Tg(tetO-cre)1Jaw/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal osteoclast physiology
|
J:178340
|
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Ppargtm1.1(tTA)Jmgr/Pparg+
Tg(tetO-cre)1Jaw/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal osteoclast physiology
|
J:178340
|
Ctps1tm1c(KOMP)Wtsi/Ctps1tm1c(KOMP)Wtsi
Commd10Tg(Vav1-icre)A2Kio/0
(B6.Cg-Ctps1tm1c(KOMP)Wtsi Commd10Tg(Vav1-icre)A2Kio)
|
decreased T cell proliferation
|
J:348981
|
Ctps1tm1c(KOMP)Wtsi/Ctps1tm1c(KOMP)Wtsi
Ctps2tm1c(EUCOMM)Hmgu/Ctps2+
Tg(Cd4-cre)1Cwi/0
(involves: 129S/Sv * C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:348981
|
Ctps1tm1c(KOMP)Wtsi/Ctps1tm1c(KOMP)Wtsi
Ctps2tm1c(EUCOMM)Hmgu/Ctps2tm1c(EUCOMM)Hmgu
Tg(Cd4-cre)1Cwi/0
(involves: 129S/Sv * C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:348981
|
Ctps1tm1c(KOMP)Wtsi/Ctps1tm1c(KOMP)Wtsi
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(B6.Cg-Ctps1tm1c(KOMP)Wtsi Gt(ROSA)26Sortm1(cre/ERT2)Tyj)
|
decreased IgM level
|
J:348981
|
| decreased T cell proliferation
|
J:348981
|
Ctps1tm1c(KOMP)Wtsi/Ctps1tm1c(KOMP)Wtsi
Tg(Cd4-cre)1Cwi/0
(involves: 129S/Sv * C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:348981
|
Ctps1tm1c(KOMP)Wtsi/Ctps1tm1c(KOMP)Wtsi
Tg(Cd4-cre)1Cwi/0
Foxp3sf/Y
Rag1tm1Mom/Rag1+
(mixed)
|
decreased T cell proliferation
|
J:348981
|
Ctps1tm1c(KOMP)Wtsi/Ctps1tm1c(KOMP)Wtsi
Tg(Cd8a-cre)1Itan/0
(B6(129S4)-Ctps1tm1c(KOMP)Wtsi Tg(Cd8a-cre)1Itan)
|
decreased T cell proliferation
|
J:348981
|
Ctsctm1Ley/Ctsctm1Ley
(either: 129X1/SvJ-Ctsctm1Ley or (involves: 129X1/SvJ * C57BL/6))
|
abnormal cytotoxic T cell physiology
|
J:77312
|
| abnormal T cell physiology
|
J:77312
|
Ctsctm1Ley/Ctsctm1Ley
(B6.129X1-Ctsctm1Ley)
|
abnormal leukocyte migration
|
J:131520
|
| impaired neutrophil recruitment
|
J:131520
|
CtseC57BL/6JOlaHsd/CtseC57BL/6JOlaHsd
(involves: 129S2/SvPasHsd * C57BL/6JOlaHsd)
|
abnormal dendritic cell antigen presentation
|
J:128538
|
| abnormal dendritic cell physiology
|
J:128538
|
Ctsetm1Kjy/Ctse+
(involves: C57BL/6)
|
increased IgE level
|
J:108745
|
Ctsetm1Kjy/Ctsetm1Kjy
(involves: C57BL/6)
|
increased IgE level
|
J:108745
|
Ctsktm1(cre)Ska/Ctsk+
Esr1tm1Mma/Esr1tm1Mma
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
abnormal osteoclast physiology
|
J:127179
|
Ctsktm1(cre)Ska/Ctsk+
Plekhm1tm1.1Hzhao/Plekhm1tm1.1Hzhao
(involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal osteoclast physiology
|
J:236517
|
Ctsktm1(cre)Ska/Ctsk+
Snx10tm1c(EUCOMM)Raba/Snx10tm1c(EUCOMM)Raba
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal osteoclast physiology
|
J:224711
|
Ctsktm1.1Rbar/Ctsktm1.1Rbar
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal osteoclast physiology
|
J:194492
|
Ctsktm1Mbs/Ctsktm1Mbs
(B6.129-Ctsktm1Mbs)
|
abnormal osteoclast physiology
|
J:128098
|
Ctsktm1Psa/Ctsktm1Psa
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal osteoclast physiology
|
J:50934
|
Ctsltm1Alpk/Ctsltm1Alpk
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal osteoclast physiology
|
J:99755
|
Ctssm1Btlr/Ctssm1Btlr
(C57BL/6J-Ctssm1Btlr)
|
decreased IgG level
|
J:267491
|
Ctsstm1Eae/Ctsstm1Eae
(involves: C57BL/6 * DBA/1LacJ)
|
abnormal B lymphocyte antigen presentation
|
J:53399
|
Ctsstm1Hap/Ctsstm1Hap
(B6.129S2-Ctsstm1Hap)
|
abnormal B cell physiology
|
J:96401
|
| abnormal professional antigen presenting cell physiology
|
J:96401
|
| abnormal T cell physiology
|
J:96401
|
| decreased IgG level
|
J:96401
|
| decreased IgM level
|
J:96401
|
Ctsstm1Hap/Ctsstm1Hap
Ldlrtm1Her/Ldlrtm1Her
(B6.129S-Ctsstm1Hap Ldlrtm1Her)
|
abnormal leukocyte migration
|
J:82520
|
Cttntm1.2Dvst/Cttntm1.2Dvst
(either: B6.Cg-Cttntm1.2Dvst or (involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA/2 * SJL))
|
abnormal cellular extravasation
|
J:177602
|
| abnormal leukocyte adhesion
|
J:177602
|
| abnormal leukocyte migration
|
J:177602
|
| abnormal neutrophil physiology
|
J:177602
|
Cuedc2tm1Qxia/Cuedc2tm1Qxia
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
abnormal macrophage physiology
|
J:211782
|
| increased macrophage cytokine production
|
J:211782
|
Cx3cl1tm1.1Yono/Cx3cl1tm1.1Yono
(involves: C57BL/6J)
|
abnormal dendritic cell physiology
|
J:271242
|
Cx3cl1tm1Sgs/Cx3cl1tm1Sgs
Ldlrtm1Her/Ldlrtm1Her
(involves: B6.129S4-Cx3cl1tm1Sgs * B6.129S7-Ldlrtm1Her/J)
|
impaired macrophage chemotaxis
|
J:95279
|
Cx3cr1tm1Ifc/Cx3cr1tm1Ifc
(involves: 129S4/SvJae * C57BL/6)
|
abnormal NK cell physiology
|
J:82033
|
| impaired macrophage chemotaxis
|
J:82033
|
Cx3cr1tm1Litt/Cx3cr1+
Psen1tm1Mpm/Psen1tm1Mpm
Tg(APPSwe,tauP301L)1Lfa/0
Tg(Thy1-YFP)HJrs/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal microglial cell physiology
|
J:159680
|
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal leukocyte physiology
|
J:162714
|
| impaired macrophage chemotaxis
|
J:162714
|
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(involves: 129P2/OlaHsd)
|
abnormal dendritic cell physiology
|
J:271242,
J:95694
|
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(B6.129P2-Cx3cr1tm1Litt)
|
abnormal leukocyte physiology
|
J:124722
|
| abnormal microglial cell physiology
|
J:110266,
J:265696
|
| abnormal NK cell physiology
|
J:129712
|
Cxcl5tm1Gscw/Cxcl5tm1Gscw
(involves: 129)
|
abnormal neutrophil physiology
|
J:162629
|
Cxcl9tm1Jmf/Cxcl9tm1Jmf
(either: B6.129S4-Cxcl9tm1Jmf or (involves: 129S4/SvJae * C57BL/6))
|
decreased IgG level
|
J:121818
|
| decreased immunoglobulin level
|
J:121818
|
Cxcl10tm1Adl/Cxcl10tm1Adl
(involves: 129S4/SvJae * 129X1/SvJ)
|
decreased IgG2a level
|
J:75584
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:75584
|
Cxcl10tm1Adl/Cxcl10tm1Adl
(involves: 129S4/SvJae * C57BL/6)
|
abnormal T cell physiology
|
J:75584
|
Cxcl12tm3.1(HBEGF/EGFP)Tng/Cxcl12+
(B6.Cg-Cxcl12tm3.1(HBEGF/EGFP)Tng)
|
increased B cell apoptosis
|
J:164657
|
Cxcl13tm1Cys/Cxcl13tm1Cys
(involves: 129X1/SvJ * C57BL/6)
|
abnormal B cell physiology
|
J:78282
|
Cxcl13tm1Cys/Cxcl13tm1Cys
(B6.129X1-Cxcl13tm1Cys)
|
impaired B cell migration
|
J:118931
|
Cxcl13tm1Mmi/Cxcl13tm1Mmi
(involves: C57BL/6)
|
abnormal B cell physiology
|
J:84804
|
| abnormal leukocyte adhesion
|
J:84804
|
| abnormal leukocyte migration
|
J:84804
|
Cxcr2tm1Mwm/Cxcr2+
(C.129S2(B6)-Cxcr2tm1Mwm/J)
|
impaired neutrophil recruitment
|
J:63935
|
Cxcr2tm1Mwm/Cxcr2tm1Mwm
(involves: 129S2/SvPas * C57BL/6J)
|
impaired neutrophil chemotaxis
|
J:19570
|
Cxcr2tm1Mwm/Cxcr2tm1Mwm
(C.129S2(B6)-Cxcr2tm1Mwm/J)
|
abnormal eosinophil physiology
|
J:73947
|
| abnormal leukocyte physiology
|
J:94170
|
| abnormal neutrophil physiology
|
J:93946,
J:73947
|
| abnormal NK T cell physiology
|
J:66399
|
| abnormal T cell physiology
|
J:73947
|
| abnormal T-helper 1 physiology
|
J:73947
|
| abnormal T-helper 2 physiology
|
J:73947
|
| impaired neutrophil chemotaxis
|
J:65905,
J:72824
|
| impaired neutrophil recruitment
|
J:65425,
J:63935,
J:93116
|
| increased IgE level
|
J:73947
|
Cxcr2tm1Mwm/Cxcr2tm1Mwm
(involves: 129S2/SvPas * BALB/c)
|
abnormal neutrophil physiology
|
J:113489
|
Cxcr2tm1Rmra/Cxcr2tm1Rmra
Tg(Mx1-cre)1Cgn/0
(involves: 129S/SvEv * C57BL/6 * C57BL/6NTac * CBA)
|
abnormal neutrophil physiology
|
J:204482
|
Cxcr3tm1Wwh/Y
(B6.Cg-Cxcr3tm1Wwh)
|
abnormal cellular extravasation
|
J:107646
|
| impaired macrophage chemotaxis
|
J:107646
|
Cxcr3tm1Wwh/Cxcr3tm1Wwh
(B6.Cg-Cxcr3tm1Wwh)
|
abnormal cellular extravasation
|
J:96905,
J:107646
|
| impaired macrophage chemotaxis
|
J:107646
|
Cxcr4tm1.1Bala/Cxcr4+
(B6.129S2-Cxcr4tm1.1Bala)
|
abnormal NK cell physiology
|
J:178789
|
| decreased B cell apoptosis
|
J:186735
|
| increased IgG level
|
J:186735
|
| increased IgM level
|
J:186735
|
| increased immunoglobulin level
|
J:186735
|
Cxcr4tm1Yiw/Cxcr4tm1Yiw
Tg(Lck-cre)1Jtak/0
(involves: 129P2/OlaHsd)
|
abnormal leukocyte migration
|
J:164872
|
Cxcr4tm1Yzo/Cxcr4tm1Yzo
(Not Specified)
|
abnormal B cell physiology
|
J:167314
|
Cxcr4tm2Yzo/Cxcr4tm2Yzo
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd)
|
decreased immunoglobulin level
|
J:94911
|
Cxcr4tm3.1Yzo/Cxcr4tm3.1Yzo
(Not Specified)
|
abnormal B cell physiology
|
J:167314
|
Cxcr5tm1.1Namt/Cxcr5tm1.1Namt
Tg(Itgax-cre)1-1Reiz/0
(involves: C57BL/6 * C57BL/6J * CBA)
|
abnormal dendritic cell chemotaxis
|
J:241561
|
Cxcr5tm1Lipp/Cxcr5tm1Lipp
(involves: 129S2/SvPas * CD-1)
|
abnormal leukocyte migration
|
J:37126
|
Cybanmf333/Cybanmf333
(A.B6 Tyr+-Cybanmf333/J)
|
abnormal neutrophil physiology
|
J:132359
|
Cybatm1Dgh/Cybatm1Dgh
(B6.Cg-Cybatm1Dgh)
|
abnormal T cell activation
|
J:231269
|
Cybbtm1.1Abk/Cybbtm1.1Abk
Lyz2tm1(cre)Ifo/?
(B6.Cg-Lyz2tm1(cre)Ifo Cybbtm1.1Abk)
|
abnormal macrophage chemotaxis
|
J:245699
|
Cybbtm1Din/Y
(involves: 129S/SvEv * C57BL/6)
|
abnormal macrophage physiology
|
J:22868
|
| abnormal neutrophil physiology
|
J:22868
|
Cybbtm1Din/Cybbtm1Din
(B6.129S-Cybbtm1Din/J)
|
abnormal macrophage physiology
|
J:235399
|
| increased IgG level
|
J:235399
|
Cyldtm1.1Awai/Cyldtm1.1Awai
(Not Specified)
|
abnormal B cell physiology
|
J:126113
|
| abnormal class switch recombination
|
J:126113
|
| decreased IgG3 level
|
J:126113
|
| decreased IgM level
|
J:126113
|
| increased IgA level
|
J:126113
|
| increased IgG1 level
|
J:126113
|
| increased IgG2a level
|
J:126113
|
| increased IgG2b level
|
J:126113
|
Cyp4v3em1Xsu/Cyp4v3em1Xsu
(C57BL/6J-Cyp4v3em1Xsu)
|
increased microglial cell activation
|
J:321817
|
Cyp7b1tm1Rus/Cyp7b1tm1Rus
(involves: 129S/SvEv * C57BL/6J)
|
decreased IgA level
|
J:170807
|
Cyp11a1tm2Bcc/Cyp11a1tm2Bcc
(Not Specified)
|
decreased T cell apoptosis
|
J:133007
|
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129S6/SvEvTac * C57BL/6)
|
increased IgG level
|
J:92438
|
Cyrenem1Vokh/Cyrenem1Vokh
(C57BL/6-Cyrenem1Vokh)
|
abnormal class switch recombination
|
J:306598
|
Cyrentm1.1(KOMP)Vlcg/Cyrentm1.1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal class switch recombination
|
J:265834
|
Cyribtm1c(KOMP)Wtsi/Cyribtm1d(KOMP)Wtsi
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * BcA17/Skmn * C57BL/6N)
|
abnormal neutrophil physiology
|
J:282597
|
Cysltr1tm1Ykn/Cysltr1tm1Ykn
(involves: C57BL/6)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:77087
|
Cysltr2tm1Ykn/Cysltr2tm1Ykn
(C57BL/6-Cysltr2tm1Ykn)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:94488
|
Cyth2tm1d(EUCOMM)Wtsi/Cyth2tm1d(EUCOMM)Wtsi
(involves: C57BL/6N)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:307633
|
Cytiptm1Tes/Cytiptm1Tes
(involves: 129S1/Sv * FVB/N)
|
abnormal cellular extravasation
|
J:110320
|
| abnormal leukocyte migration
|
J:110320
|
Dapp1Gt(OST111213)Lex/Dapp1Gt(OST111213)Lex
(B6.Cg-Dapp1Gt(OST111213)Lex)
|
decreased B cell proliferation
|
J:110009
|
| decreased IgG3 level
|
J:110009
|
Dapp1tm1Mnz/Dapp1tm1Mnz
(B6.129P2-Dapp1tm1Mnz)
|
abnormal B cell activation
|
J:86182
|
| decreased B cell proliferation
|
J:86182
|
| decreased IgG3 level
|
J:86182
|
| decreased IgM level
|
J:86182
|
DbnlGt(betageo)11Byg/DbnlGt(betageo)11Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell activation
|
J:119847
|
| abnormal T cell physiology
|
J:119847
|
| decreased IgG1 level
|
J:119847
|
| decreased IgM level
|
J:119847
|
| decreased immunoglobulin level
|
J:119847
|
| decreased T cell proliferation
|
J:119847
|
Dbr1Gt(YTA280)Byg/Dbr1+
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:223318
|
Dckm1Btlr/Dckm1Btlr
(C57BL/6J-Dckm1Btlr)
|
decreased IgG level
|
J:236696
|
| increased IgE level
|
J:236696
|
Dckmemi/Dckmemi
(C57BL/6J-Dckmemi)
|
increased T cell apoptosis
|
J:184080
|
| increased T cell proliferation
|
J:184080
|
Dclre1cm1Btlr/Dclre1cm1Btlr
(C57BL/6J-Dclre1cm1Btlr)
|
decreased IgM level
|
J:217790
|
Dclre1ctm2.1Jpdv/Dclre1ctm2.2Jpdv
Tg(Cr2-cre)3Cgn/0
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:153841
|
Dclre1ctm2Mcow/Dclre1ctm2Mcow
(involves: 129/Sv * C57BL/6)
|
abnormal leukocyte physiology
|
J:96535
|
| decreased B cell proliferation
|
J:96535
|
| decreased T cell proliferation
|
J:96535
|
Dcstamptm1Suda/Dcstamptm1Suda
(Not Specified)
|
abnormal macrophage physiology
|
J:100555
|
| abnormal osteoclast physiology
|
J:100555
|
Ddit3tm1Dron/Ddit3tm1Dron
(B6.129-Ddit3tm1Dron)
|
abnormal macrophage activation involved in immune response
|
J:153833
|
| decreased macrophage apoptosis
|
J:153833
|
Ddx46em1Caox/Ddx46+
(involves: C57BL/6J)
|
abnormal macrophage physiology
|
J:271836
|
| increased macrophage cytokine production
|
J:271836
|
Def6Gt(OST307148)Lex/Def6Gt(OST307148)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased T cell apoptosis
|
J:106469
|
| increased IgG level
|
J:106469
|
| increased immunoglobulin level
|
J:106469
|
Del(1Aim2-Ifi205)1Stsn/Del(1Aim2-Ifi205)1Stsn
(B6(129S4)-Del(1Aim2-Ifi205)1Stsn)
|
decreased macrophage apoptosis
|
J:234263
|
Del(3Cd1d2-Cd1d1)1Crw/Del(3Cd1d2-Cd1d1)1Crw
(involves: 129S4/SvJae * C57BL/6)
|
abnormal NK T cell physiology
|
J:112657
|
Del(3Cd1d2-Cd1d1)1Sbp/Del(3Cd1d2-Cd1d1)1Sbp
(involves: 129S6/SvEvTac)
|
abnormal dendritic cell antigen presentation
|
J:151699
|
Del(6Gimap5-Gimap3)1Yout/Del(6Gimap5-Gimap3)1Yout
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal T cell physiology
|
J:209926
|
Del(7Mrgpra2a-Mrgpra2b)1Xzd/Del(7Mrgpra2a-Mrgpra2b)1Xzd
(C57BL/6J-Del(7Mrgpra2a-Mrgpra2b)1Xzd)
|
abnormal neutrophil physiology
|
J:332494
|
Del(9Casp1-Casp4)1Bhk/Del(9Casp1-Casp4)1Bhk
(129-Del(9Casp1-Casp4)1Bhk)
|
abnormal macrophage physiology
|
J:189777
|
Del(10Prmt2-Col6a1)1Yah/+
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal macrophage physiology
|
J:167506
|
Del(10Prtn3-Elane)1Deje/Del(10Prtn3-Elane)1Deje
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)
|
abnormal neutrophil physiology
|
J:137674
|
| impaired neutrophil recruitment
|
J:137674
|
Del(11Cxcl16-Zmynd15)1Ifc/Del(11Cxcl16-Zmynd15)1Ifc
(B6.129S-Ldlrtm1Her Del(11Cxcl16-Zmynd15)1Ifc)
|
abnormal macrophage physiology
|
J:123851
|
Del(11Jmjd6-Mettl23)1Ysfk/Del(11Jmjd6-Mettl23)1Ysfk
(involves: C57BL/6)
|
impaired macrophage chemotaxis
|
J:90288
|
| impaired macrophage phagocytosis
|
J:90288
|
Del(14Ltb4r2-Ltb4r1)1Bodd/Del(14Ltb4r2-Ltb4r1)1Bodd
(involves: 129S4/SvJaeSor * C57BL/6)
|
impaired neutrophil chemotaxis
|
J:163271
|
Del(14Trim13-Dleu2)4Rdf/Del(14Trim13-Dleu2)4Rdf
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
abnormal B cell proliferation
|
J:156946
|
Del(17Trem1-Trem3)1Jkt/Del(17Trem1-Trem3)1Jkt
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
impaired neutrophil chemotaxis
|
J:194295
|
Dennd1btm1.2Achn/Dennd1btm1.2Achn
(involves: C57BL/6)
|
abnormal T-helper 2 physiology
|
J:229307
|
Dgkatm1Xpz/Dgkatm1Xpz
Dgkztm1Gak/Dgkztm1Gak
(involves: 129 * 129X1/SvJ * C57BL/6)
|
abnormal thymocyte activation
|
J:113564
|
Dgkztm1Gak/Dgkztm1Gak
(involves: 129X1/SvJ * C57BL/6)
|
abnormal macrophage physiology
|
J:293120
|
| abnormal T cell activation
|
J:85149
|
| abnormal T cell physiology
|
J:85149
|
| increased T cell proliferation
|
J:85149
|
Dh/Dh+
(B6.CBA-Dh)
|
decreased immunoglobulin level
|
J:5834
|
Dh/Dh+
Foxn1nu/Foxn1nu
(involves: N:NIH(S))
|
increased IgA level
|
J:6062
|
Dh/Dh+
H2d/H2d
(NZB.Cg-Dh)
|
decreased B cell proliferation
|
J:12036
|
| decreased IgG1 level
|
J:12036
|
| decreased IgG level
|
J:12036
|
| decreased IgM level
|
J:12036
|
| increased T cell proliferation
|
J:12036
|
Dhrs4tm1Lex/Dhrs4tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased IgG2a level
|
J:171883
|
Dhx15tm1c(EUCOMM)Wtsi/Dhx15tm1c(EUCOMM)Wtsi
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C3H * C57BL/6N)
|
decreased B cell proliferation
|
J:284624
|
Dhx58tm1Itl/Dhx58tm1Itl
(C57BL/6-Dhx58tm1Itl)
|
increased T cell apoptosis
|
J:187386
|
Diaph1M1Btlr/Diaph1+
(C57BL/6J-Diaph1M1Btlr)
|
decreased IgE level
|
J:254820
|
Diaph1M1Btlr/Diaph1M1Btlr
(C57BL/6J-Diaph1M1Btlr)
|
decreased IgE level
|
J:254820
|
Diaph1tm1.1Sna/Diaph1tm1.1Sna
(B6.Cg-Diaph1tm1.1Sna)
|
abnormal leukocyte migration
|
J:126090
|
| decreased T cell proliferation
|
J:126090
|
Dicer1tm1Bdh/Dicer1tm1Bdh
Aicdatm1(cre)Njen/Aicda+
(involves: 129 * C57BL/6)
|
abnormal germinal center B cell physiology
|
J:181782
|
| decreased immunoglobulin level
|
J:181782
|
Dicer1tm1Bdh/Dicer1tm1Bdh
Tg(Foxp3-EGFP/icre)1aJbs/0
(involves: 129 * NOD/ShiLt)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:138808
|
| abnormal regulatory T cell physiology
|
J:138808
|
Dicer1tm1Dli/Dicer1tm1Dli
Tg(Cd4-cre)1Cwi/?
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal cytotoxic T cell physiology
|
J:100546
|
| abnormal T-helper 1 physiology
|
J:100546
|
| abnormal T-helper 2 physiology
|
J:100546
|
| decreased T cell proliferation
|
J:100546
|
| increased T cell apoptosis
|
J:100546
|
Dis3tm1.1Uba/Dis3tm1.1Uba
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
abnormal class switch recombination
|
J:302856
|
Dkk3tm1Cni/Dkk3tm1Cni
(involves: 129X1/SvJ * C57BL/6)
|
increased IgM level
|
J:106922
|
Dlg1tm1Rlh/Dlg1tm1Rlh
Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:191788
|
| abnormal T-helper 1 physiology
|
J:191788
|
| abnormal T-helper 2 physiology
|
J:191788
|
Dlk1tm1Srba/Dlk1tm1Srba
(involves: 129X1/SvJ * C57BL/6)
|
increased IgG1 level
|
J:145076
|
| increased IgG2a level
|
J:145076
|
| increased IgG2b level
|
J:145076
|
| increased IgG2c level
|
J:145076
|
| increased IgG3 level
|
J:145076
|
| increased IgM level
|
J:145076
|
| increased immunoglobulin level
|
J:145076
|
Dll1tm1Gos/Dll1+
(C3Fe.129-Dll1tm1Gos)
|
decreased IgA level
|
J:150183
|
| decreased IgG1 level
|
J:150183
|
| decreased IgG2b level
|
J:150183
|
| decreased IgG3 level
|
J:150183
|
Dmtf1tm1Cjs/Dmtf1tm1Cjs
(involves: 129/Sv * C57BL/6)
|
abnormal T cell physiology
|
J:63444
|
Dnmt3btm1Enl/Dnmt3btm6Enl
(involves: 129S4/SvJae * C57BL/6)
|
increased thymocyte apoptosis
|
J:106540
|
Dnmt3btm1Enl/Dnmt3btm7Enl
(involves: 129S4/SvJae * C57BL/6)
|
increased thymocyte apoptosis
|
J:106540
|
Dnmt3btm6Enl/Dnmt3btm6Enl
(involves: 129S4/SvJae * C57BL/6)
|
increased thymocyte apoptosis
|
J:106540
|
Dnmt3btm6Enl/Dnmt3btm7Enl
(involves: 129S4/SvJae * C57BL/6)
|
increased thymocyte apoptosis
|
J:106540
|
Dnmt3btm7Enl/Dnmt3btm7Enl
(involves: 129S4/SvJae * C57BL/6)
|
increased thymocyte apoptosis
|
J:106540
|
Dock2m1Btlr/Dock2m1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| decreased IgG level
|
J:185495
|
Dock2m1Hsd/Dock2m1Hsd
Siaetm1.2Avrk/Siaetm1.2Avrk
(B6NHsd.Cg-Siaetm1.2Avrk Dock2m1Hsd)
|
abnormal B cell activation
|
J:144035
|
| abnormal immunoglobulin level
|
J:144035
|
| increased B cell proliferation
|
J:144035
|
| increased IgE level
|
J:144035
|
| increased IgG1 level
|
J:144035
|
| increased IgG2a level
|
J:144035
|
| increased IgG2b level
|
J:144035
|
| increased IgG3 level
|
J:144035
|
| increased IgM level
|
J:144035
|
Dock2m2Btlr/Dock2m2Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| decreased IgG level
|
J:185495
|
Dock2m6Btlr/Dock2m6Btlr
(C57BL/6J-Dock2m6Btlr)
|
decreased IgE level
|
J:236689
|
Dock2m7Btlr/Dock2m7Btlr
(C57BL/6J-Dock2m7Btlr)
|
increased IgE level
|
J:255181
|
Dock2tm1Tsas/Dock2tm1Tsas
(involves: C57BL/6)
|
abnormal leukocyte migration
|
J:71005
|
Dock2tm1Tsas/Dock2tm1Tsas
(B6.Cg-Dock2tm1Tsas)
|
impaired neutrophil chemotaxis
|
J:113266
|
Dock2tm1Tsas/Dock2tm1Tsas
Tg(Tcra2B4)1Mmd/?
Tg(Tcrb2B4)1Mmd/?
(involves: C57BL/6)
|
abnormal T cell physiology
|
J:84581
|
Dock3tm1Dasc/Dock3tm1Dasc
(B6.Cg-Dock3tm1Dasc)
|
abnormal microglial cell physiology
|
J:144341
|
Dock8m1Anu/Dock8m1Anu
(C57BL/6NCrlAnu-Dock8m1Anu)
|
decreased IgM level
|
J:104190
|
Dock8m1Btlr/Dock8m1Btlr
(C57BL/6J-Dock8m1Btlr)
|
decreased IgG level
|
J:234247
|
Dock8m2Anu/Dock8m2Anu
(C57BL/6NCrlAnu-Dock8m2Anu)
|
decreased IgM level
|
J:104190
|
Dock8M3Btlr/Dock8M3Btlr
(C57BL/6J-Dock8M3Btlr)
|
decreased IgG level
|
J:272531
|
Dock8pri/Dock8pri
(involves: C57BL/6JAnu)
|
abnormal cellular extravasation
|
J:238772
|
Dock8tm1Ysfk/Dock8tm1Ysfk
(B6.Cg-Dock8tm1Ysfk)
|
abnormal dendritic cell physiology
|
J:185165
|
| decreased IgG level
|
J:185165
|
| decreased T cell proliferation
|
J:185165
|
Dock10tm1a(EUCOMM)Hmgu/Dock10tm1a(EUCOMM)Hmgu
(C57BL/6N-Dock10tm1a(EUCOMM)Hmgu/Ieg)
|
abnormal B cell physiology
|
J:236911
|
| abnormal follicular B cell physiology
|
J:236911
|
Dock10tm1Thar/Dock10tm1Thar
(involves: C57BL/6)
|
abnormal microglial cell chemotaxis
|
J:300632
|
| impaired macrophage chemotaxis
|
J:300632
|
Dock11tm1Thar/Dock11tm1Thar
(involves: C57BL/6)
|
impaired macrophage chemotaxis
|
J:300632
|
Dok1tm1Ppp/Dok1tm1Ppp
(129S1/Sv-Dok1tm1Ppp)
|
abnormal T cell proliferation
|
J:95640
|
Dok1tm1Ppp/Dok1tm1Ppp
Dok2tm1Ppp/Dok2tm1Ppp
(129S1/Sv-Dok1tm1Ppp Dok2tm1Ppp)
|
abnormal leukocyte physiology
|
J:95334
|
Dok1tm1Yyam/Dok1tm1Yyam
(involves: 129S4/SvJae * C57BL/6)
|
decreased IgM level
|
J:95641
|
| increased B cell proliferation
|
J:95641
|
Dok1tm1Yyam/Dok1tm1Yyam
Dok2tm1Yyam/Dok2tm1Yyam
(B6.129-Dok1tm1Yyam Dok2tm1Yyam)
|
abnormal leukocyte physiology
|
J:95335
|
Dok1tm1Yyam/Dok1tm1Yyam
Dok2tm1Yyam/Dok2tm1Yyam
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal macrophage physiology
|
J:163407
|
Dok1tm1Yyam/Dok1tm1Yyam
Dok2tm1Yyam/Dok2tm1Yyam
Dok3tm1Brs/Dok3tm1Brs
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal macrophage physiology
|
J:163407
|
Dok2tm1Ppp/Dok2tm1Ppp
(129S1/Sv-Dok2tm1Ppp)
|
abnormal granulocyte physiology
|
J:95334
|
Dok3tm1Kplm/Dok3tm1Kplm
(involves: 129P2/OlaHsd)
|
abnormal B cell calcium ion homeostasis
|
J:280795
|
| abnormal B cell physiology
|
J:280795
|
| increased B cell proliferation
|
J:280795
|
| increased IgG3 level
|
J:280795
|
| increased IgM level
|
J:280795
|
Drd1tm2Jcd/Drd1+
Tg(Camk2a-cre)2Gsc/0
(involves: 129S4/SvJae * FVB/N)
|
abnormal microglial cell physiology
|
J:120070
|
Droshatm1Litt/Droshatm1.1Litt
Foxp3tm4(YFP/icre)Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal T cell activation
|
J:138683
|
Droshatm1Litt/Droshatm1.1Litt
Foxp3tm4(YFP/icre)Ayr/Foxp3tm4(YFP/icre)Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal T cell activation
|
J:138683
|
Dsg3bal/Dsg3bal
(C57BL/6J-Dsg3bal/J)
|
increased IgE level
|
J:18223
|
Dsg4lah-J/Dsg4lah-J
(involves: DBA/1LacJ)
|
increased IgE level
|
J:83117
|
Dtnbp1sdy-Btlr/Dtnbp1sdy-Btlr
(C57BL/6J-Dtnbp1sdy-Btlr)
|
impaired natural killer cell mediated cytotoxicity
|
J:133620
|
Dtx1tm1.1Mzl/Dtx1tm1.1Mzl
Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal thymocyte activation
|
J:151605
|
| increased T cell proliferation
|
J:151605
|
Dtx1tm1.2Mzl/Dtx1tm1.2Mzl
(B6.129-Dtx1tm1.2Mzl)
|
abnormal lymphocyte physiology
|
J:151605
|
| abnormal regulatory T cell physiology
|
J:151605
|
| abnormal thymocyte activation
|
J:151605
|
| decreased thymocyte apoptosis
|
J:151605
|
| increased B cell proliferation
|
J:151605
|
| increased T cell proliferation
|
J:151605
|
Ducm1129X1/SvJ/Ducm1129X1/SvJ
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal professional antigen presenting cell physiology
|
J:86617
|
Ducm1129X1/SvJ/Ducm1C57BL/6J
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal professional antigen presenting cell physiology
|
J:86617
|
Dusp1tm1Brv/Dusp1tm1Brv
(involves: 129S2/SvPas * various)
|
increased mast cell degranulation
|
J:125919
|
| increased susceptibility to type I hypersensitivity reaction
|
J:125919
|
Dusp2tm1Cmac/Dusp2tm1Cmac
(B6.Cg-Dusp2tm1Cmac)
|
abnormal macrophage activation involved in immune response
|
J:112609
|
| abnormal mast cell physiology
|
J:112609
|
Dusp4Gt(XG164)Byg/Dusp4Gt(XG164)Byg
(B6.129P2-Dusp4Gt(XG164)Byg)
|
increased T cell proliferation
|
J:180366
|
Dusp4tm1Jmol/Dusp4tm1Jmol
(involves: 129)
|
decreased B cell apoptosis
|
J:140567
|
Dusp4tm1Plev/Dusp4tm1Plev
(involves: 129/Sv * C57BL/6)
|
abnormal macrophage physiology
|
J:170774
|
| decreased IgG2a level
|
J:170774
|
| increased IgG1 level
|
J:170774
|
Dusp5tm1.1Achn/Dusp5tm1.1Achn
(involves: C57BL/6NCrl)
|
increased T cell proliferation
|
J:218203
|
Dusp5tm1.1Achn/Dusp5tm1.1Achn
Rag2tm1.1Cgn/Rag2tm1.1Cgn
(involves: C57BL/6NCrl)
|
abnormal eosinophil physiology
|
J:218203
|
Dusp5tm1a(KOMP)Wtsi/Dusp5tm1a(KOMP)Wtsi
(C57BL/6-Dusp5tm1a(KOMP)Wtsi)
|
abnormal T cell physiology
|
J:240637
|
| increased T cell apoptosis
|
J:240637
|
| increased T cell proliferation
|
J:240637
|
Dusp5tm1d(KOMP)Wtsi/Dusp5tm1d(KOMP)Wtsi
(B6(Cg)-Dusp5tm1d(KOMP)Wtsi)
|
increased T cell apoptosis
|
J:240637
|
Dusp10tm1Flv/Dusp10tm1Flv
(involves: 129S6/SvEvTac)
|
abnormal adaptive immunity
|
J:92104
|
| decreased T cell proliferation
|
J:92104
|
| increased susceptibility to type I hypersensitivity reaction
|
J:92104
|
Dusp11Gt(BB0198)Wtsi/Dusp11Gt(BB0198)Wtsi
(B6.129P2-Dusp11Gt(BB0198)Wtsi)
|
abnormal macrophage activation involved in immune response
|
J:301503
|
| increased macrophage cytokine production
|
J:301503
|
Dusp14Gt(OST210117)Lex/Dusp14Gt(OST210117)Lex
(B6.129S5-Dusp14Gt(OST210117)Lex)
|
abnormal T cell activation
|
J:209403
|
| increased T cell proliferation
|
J:209403
|
Dusp22tm1Tht/Dusp22tm1Tht
(B6.129S7-Dusp22tm1Tht)
|
abnormal B cell activation
|
J:213253
|
| abnormal T cell activation
|
J:213253
|
| decreased B cell proliferation
|
J:213253
|
| decreased IgG3 level
|
J:213253
|
| decreased IgM level
|
J:213253
|
| decreased immunoglobulin level
|
J:213253
|
| increased T cell proliferation
|
J:213253
|
Dyrk1atm1Jdc/Dyrk1atm1Jdc
Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6J * C57BL/6NTac * CBA/J)
|
increased T cell apoptosis
|
J:223138
|
E2f1tm1Meg/E2f1tm1Meg
(involves: 129S4/SvJae * C57BL/6)
|
decreased T cell proliferation
|
J:76318
|
E2f2tm1Zubi/E2f2tm1Zubi
(involves: 129S1/Sv * C57BL/6)
|
increased T cell proliferation
|
J:76318
|
E2f2tm1Zubi/E2f2tm1Zubi
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * DBA/2J)
|
increased T cell proliferation
|
J:76318
|
Ebag9tm1Rehm/Ebag9tm1Rehm
(either: (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal cytotoxic T cell physiology
|
J:152534
|
| abnormal memory T cell physiology
|
J:152534
|
Ebf1m1Btlr/Ebf1m1Btlr
(C57BL/6J-Ebf1m1Btlr)
|
decreased IgD level
|
J:265157
|
Ebf1m2Btlr/Ebf1m2Btlr
(C57BL/6J-Ebf1m2Btlr)
|
decreased IgD level
|
J:265158
|
| decreased IgM level
|
J:265158
|
| increased IgM level
|
J:265158
|
Ebf1m6Btlr/Ebf1m6Btlr
(C57BL/6J-Ebf1m6Btlr)
|
decreased IgD level
|
J:272842
|
Ebf1tm1.1Rug/Ebf1tm1.1Rug
Polr2atm1(cre/ERT2)Bbd/Polr2a+
(involves: C57BL/6 * SJL)
|
abnormal germinal center B cell physiology
|
J:182210
|
| decreased B cell proliferation
|
J:182210
|
| decreased IgG1 level
|
J:182210
|
| decreased IgG3 level
|
J:182210
|
| increased B cell apoptosis
|
J:182210
|
Ebf1tm1Rug/Ebf1tm1Rug
(involves: 129S2/SvPas)
|
decreased IgM level
|
J:52607
|
Ebi3Gt716Lex/Ebi3Gt716Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal T cell activation
|
J:286951
|
Ebi3tm1Nkma/Ebi3tm1Nkma
Faslpr/Faslpr
(MRL.Cg-Ebi3tm1Nkma Faslpr)
|
increased IgE level
|
J:181669
|
| increased IgG1 level
|
J:181669
|
| increased IgG level
|
J:181669
|
| increased immunoglobulin level
|
J:181669
|
Ecm1tm1Bsun/Ecm1tm1Bsun
(involves: 129 * C57BL/6)
|
abnormal T-helper 2 physiology
|
J:168252
|
| decreased IgE level
|
J:168252
|
| decreased susceptibility to type I hypersensitivity reaction
|
J:168252
|
Edil3tm1Tq/Edil3tm1Tq
(B6.129S6-Edil3tm1Tq)
|
abnormal cellular extravasation
|
J:141063
|
| abnormal leukocyte adhesion
|
J:141063
|
| abnormal neutrophil physiology
|
J:141063
|
| enhanced leukocyte tethering or rolling
|
J:141063
|
Edil3tm1Tq/Edil3tm1Tq
Itgaltm1Bll/Itgaltm1Bll
(involves: 129 * C57BL/6)
|
abnormal cellular extravasation
|
J:141063
|
| abnormal neutrophil physiology
|
J:141063
|
Ednrbtm1Nrd/Ednrbtm1Nrd
Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/Gt(ROSA)26Sor+
H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * CBA/J)
|
decreased IgA level
|
J:233811
|
Eef1a2wst/Eef1a2wst
(B6C3Fe a/a-Eef1a2wst/J)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:6766
|
Efhd2tm1(KOMP)Vlcg/Efhd2tm1(KOMP)Vlcg
(C57BL/6-Efhd2tm1(KOMP)Vlcg)
|
increased IgE level
|
J:228565
|
| increased IgG1 level
|
J:228565
|
| increased IgG2a level
|
J:228565
|
| increased IgM level
|
J:228565
|
Efnb1tm1.1Jwu/Efnb1tm1.1Jwu
Efnb2tm1.1Jwu/Efnb2tm1.1Jwu
Tg(Lck-cre)I540Jxm/0
(B6.Cg-Efnb2tm1.1Jwu Efnb1tm1.1Jwu Tg(Lck-cre)I540Jxm)
|
increased thymocyte apoptosis
|
J:178148
|
Efstm1Kale/Efs+
(either: (involves: 129X1/SvJ) or (involves: 129X1/SvJ * C57BL/6J))
|
increased IgA level
|
J:103757
|
| increased IgG level
|
J:103757
|
Efstm1Kale/Efstm1Kale
(either: (involves: 129X1/SvJ) or (involves: 129X1/SvJ * C57BL/6J))
|
abnormal T cell physiology
|
J:103757
|
| increased IgA level
|
J:103757
|
| increased IgG level
|
J:103757
|
| increased immunoglobulin level
|
J:103757
|
Egfrtm1Dwt/Egfrtm1Dwt
Sox9tm3(cre)Crm/Sox9+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd)
|
increased IgE level
|
J:229771
|
Egr1tm1Jmi/Egr1tm1Jmi
(involves: 129 * C57BL/6)
|
abnormal microglial cell physiology
|
J:135238
|
Ehmt2tm1.1Cza/Ehmt2tm1.1Cza
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
decreased IgG1 level
|
J:160938
|
| increased IgG2a level
|
J:160938
|
Eif2ak2tm1Cwe/Eif2ak2tm1Cwe
(involves: 129S/SvEv * C57BL/6)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:66112
|
| increased T cell proliferation
|
J:66112
|
Eif2ak4m1Btlr/Eif2ak4m1Btlr
(C57BL/6J-Eif2ak4m1Btlr)
|
abnormal macrophage physiology
|
J:173669
|
Eif2ak4tm1.2Dron/Eif2ak4tm1.2Dron
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal dendritic cell physiology
|
J:120813
|
Eif2b5tm1Itl/Eif2b5tm1Itl
(involves: 129S/SvEv)
|
abnormal microglial cell physiology
|
J:192103
|
Eif4a1tm1.1Bea/Eif4a1tm1.1Bea
Tg(Fcer2a-cre)5Mbu/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased B cell proliferation
|
J:344730
|
| decreased IgG1 level
|
J:344730
|
Elanetm1(cre)Roes/Elanetm1(cre)Roes
(involves: 129S6/SvEvTac)
|
impaired neutrophil recruitment
|
J:137674
|
Elanetm1Sds/Elanetm1Sds
(129X1/SvJ-Elanetm1Sds)
|
abnormal neutrophil physiology
|
J:47420
|
Elavl1tm1.1Atas/Elavl1tm1.1Atas
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129X1/SvJ * C57BL/6)
|
decreased T cell proliferation
|
J:207013
|
Elavl1tm1.1Dkon/Elavl1tm1.1Dkon
Lyz2tm1(cre)Ifo/Lyz2+
(B6.129P2-Elavl1tm1.1Dkon Lyz2tm1(cre)Ifo)
|
abnormal macrophage chemotaxis
|
J:184388
|
Elavl1tm1Dkon/Elavl1tm1Dkon
Tg(Lck-cre)I57Jxm/0
(B6.Cg-Elavl1tm1Dkon Tg(Lck-cre)I57Jxm)
|
abnormal T cell physiology
|
J:148866
|
| abnormal thymocyte activation
|
J:148866
|
Elavl1tm1Thla/Elavl1tm1Thla
Gt(ROSA)26Sortm1(cre/ERT2)Alj/Gt(ROSA)26Sor+
(involves: 129)
|
abnormal B cell physiology
|
J:155109
|
| decreased B cell apoptosis
|
J:155109
|
| increased T cell apoptosis
|
J:155109
|
Elf1tm1Jml/Elf1tm1Jml
(Not Specified)
|
abnormal B cell physiology
|
J:100734
|
Elf4em1Hdu/Elf4em1Hdu
(C57BL/6-Elf4em1Hdu)
|
abnormal macrophage physiology
|
J:328935
|
Elf4tm1Nim/Elf4tm1Nim
(B6.129S1-Elf4tm1Nim)
|
abnormal lymphocyte physiology
|
J:79568
|
| abnormal NK cell physiology
|
J:79568
|
| decreased cytotoxic T cell cytolysis
|
J:79568
|
| impaired natural killer cell mediated cytotoxicity
|
J:79568
|
| increased B cell proliferation
|
J:79568
|
| increased T cell proliferation
|
J:79568
|
Elmo1M1Btlr/Elmo1M1Btlr
(C57BL/6J-Elmo1M1Btlr)
|
decreased IgM level
|
J:265231
|
Emv72a/Emv72a
(involves: BALB/cAnNCr * C57BL/6NCr)
|
abnormal cytotoxic T cell physiology
|
J:194735
|
Emv72b/Emv72b
(CAnNCr.B6NCr-Emv72b)
|
abnormal cytotoxic T cell physiology
|
J:194735
|
Emv72b/Emv72b
(involves: BALB/cAnNCr * C57BL/6NCr)
|
abnormal cytotoxic T cell physiology
|
J:194735
|
Endoutm1Tft/Endoutm1Tft
Tg(IghelMD4)4Ccg/0
Tg(ML5sHEL)5Ccg/0
(involves: 129S/SvEv * C57BL/6 * C57BL/6JSfd)
|
decreased activation-induced B cell apoptosis
|
J:208364
|
Enpp3tm1Ktak/Enpp3tm1Ktak
(either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c * C57BL/6))
|
abnormal basophil physiology
|
J:223825
|
| abnormal mast cell physiology
|
J:223825
|
| increased IgE level
|
J:223825
|
| increased susceptibility to type I hypersensitivity reaction
|
J:223825
|
Entpd1tm1Rdr/Entpd1tm1Rdr
(involves: 129S2/SvPas)
|
abnormal neutrophil physiology
|
J:129091
|
Eomestm1.1Bflu/Eomestm1.1Bflu
Tbx21tm1Glm/Tbx21tm1Glm
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2 * SJL)
|
abnormal leukocyte migration
|
J:163822
|
Eomestm1.1Bflu/Eomestm1.1Bflu
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal leukocyte migration
|
J:163822
|
Eomestm1Srnr/Eomestm1Srnr
Tbx21tm1Srnr/Tbx21tm1Srnr
Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal leukocyte physiology
|
J:137655
|
Epcamtm1.1Mcu/Epcamtm1.1Mcu
Tg(CD207-cre)1Dhka/0
(involves: 129 * C57BL/6 * C57BL/6J * SJL/J)
|
abnormal Langerhans cell physiology
|
J:182665
|
| increased susceptibility to type IV hypersensitivity reaction
|
J:182665
|
Ephb6tm1Jwu/Ephb6tm1Jwu
(involves: 129)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:94701
|
| decreased T cell proliferation
|
J:94701
|
Erap1tm1.1Gnie/Erap1tm1.1Gnie
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal cytotoxic T cell physiology
|
J:143988
|
| decreased T cell proliferation
|
J:143988
|
Erap1tm1Iay/Erap1tm1Iay
(involves: C57BL/6)
|
abnormal cytotoxic T cell physiology
|
J:111047
|
Erap1tm1Luc/Erap1tm1Luc
(involves: 129S6/SvEvTac)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:122479
|
| abnormal lymphocyte physiology
|
J:122479
|
Erap1tm1Nsha/Erap1tm1Nsha
(B6.129S6-Erap1tm1Nsha)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:112389,
J:116606
|
Erars1DBA/2J/?
(involves: BXD2/TyJ * C57BL/6J * DBA/2J)
|
increased immunoglobulin level
|
J:96064
|
Erars2C57BL/6J/?
(involves: BXD2/TyJ * C57BL/6J * DBA/2J)
|
increased immunoglobulin level
|
J:96064
|
Ercc1tm1Jhjh/Ercc1tm1Jhjh
(involves: C57BL/6 * FVB/N)
|
abnormal class switch recombination
|
J:92471
|
| decreased B cell proliferation
|
J:92471
|
Ercc6l2em1Mengf/Ercc6l2em1Mengf
(Not Specified)
|
abnormal class switch recombination
|
J:311900
|
| decreased IgA level
|
J:311900
|
| decreased IgG1 level
|
J:311900
|
| decreased IgG2b level
|
J:311900
|
| decreased IgG3 level
|
J:311900
|
| decreased IgG level
|
J:311900
|
Ercc6l2em2Mengf/Ercc6l2em2Mengf
(Not Specified)
|
abnormal class switch recombination
|
J:311900
|
Ero1aGt(XST171)Byg/Ero1aGt(XST171)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal macrophage physiology
|
J:153833
|
| decreased macrophage apoptosis
|
J:153833
|
Esamtm1Dvst/Esamtm1Dvst
(B6.129-Esam1tm1Dvst)
|
abnormal cellular extravasation
|
J:124397
|
| abnormal leukocyte migration
|
J:124397
|
Esm1tm1.1Rha/Esm1tm1.1Rha
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * C57BL/6NTac)
|
abnormal cellular extravasation
|
J:246778
|
Espnje/?
f/f
Hps6ru/Hps6ru
(JE/LeJ)
|
abnormal mast cell degranulation
|
J:37255
|
Esr1tm1.1Lja/Esr1tm1.1Mma
(involves: 129P2/OlaHsd * 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
abnormal osteoclast physiology
|
J:128135
|
Esr1tm1.1Mma/Esr1tm1.1Mma
(involves: 129S2/SvPas * C57BL/6)
|
abnormal immunoglobulin level
|
J:171276
|
Esr1tm1.1Ohl/Esr1tm1.1Ohl
(involves: 129S2/SvPas * C57BL/6)
|
abnormal immunoglobulin level
|
J:171276
|
Esr1tm1.1Scma/Esr1tm1.1Scma
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)
|
abnormal osteoclast physiology
|
J:156947
|
Esr1tm1Arnal/Esr1tm1Arnal
(involves: C57BL/6)
|
abnormal immunoglobulin level
|
J:171276
|
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal class switch recombination
|
J:82423
|
| abnormal immunoglobulin level
|
J:82423
|
| increased IgG3 level
|
J:88156
|
Esr1tm1Ksk/Esr1tm1Ksk
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal class switch recombination
|
J:82423
|
| abnormal immunoglobulin level
|
J:82423
|
Ess2tm1.1Nbioc/Ess2tm1.1Nbioc
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6N * DBA/2)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:339504
|
Ets1tm1.1Dds/Ets1+
(129S6/SvEvTac-Ets1tm1.1Dds)
|
decreased thymocyte apoptosis
|
J:121460
|
Ets1tm1.1Dds/Ets1tm1.1Dds
(129S6/SvEvTac-Ets1tm1.1Dds)
|
decreased thymocyte apoptosis
|
J:121460
|
Ets1tm1Fwa/Ets1tm1Fwa
(B6.129S4-Ets1tm1Fwa)
|
decreased B cell proliferation
|
J:93845
|
| increased B cell apoptosis
|
J:93845
|
Ets1tm2Jml/Ets1tm2Jml
(involves: 129X1/SvJ * C57BL/6)
|
abnormal leukocyte physiology
|
J:50627
|
| abnormal NK cell physiology
|
J:50627
|
| abnormal T cell activation
|
J:50627
|
| decreased T cell proliferation
|
J:50627
|
| impaired natural killer cell mediated cytotoxicity
|
J:50627
|
Evltm1Lfr/Evltm1Lfr
(involves: 129X1/SvJ * C57BL/6)
|
abnormal leukocyte migration
|
J:94077
|
Exo1tm2Wed/Exo1tm2Wed
(involves: 129 * C57BL/6)
|
abnormal class switch recombination
|
J:198719
|
| abnormal somatic hypermutation frequency
|
J:198719
|
Exph5tm1Tiz/Exph5tm1Tiz
(B6NJcl.Cg-Exph5tm1Tiz/Tiz)
|
abnormal T-helper 2 physiology
|
J:313415
|
| increased susceptibility to type I hypersensitivity reaction
|
J:313415
|
Extl1em1Caox/Extl1em1Caox
Tg(Itgax-cre)1-1Reiz/0
(involves: C57BL/6 * CBA)
|
abnormal dendritic cell chemotaxis
|
J:333437
|
| abnormal dendritic cell migration
|
J:333437
|
| abnormal dendritic cell physiology
|
J:333437
|
| increased IgG level
|
J:333437
|
| increased immunoglobulin level
|
J:333437
|
Ezh2tm1Tara/Ezh2tm1Tara
Ighg1tm1(cre)Cgn/Ighg1+
(involves: 129P2/OlaHsd)
|
decreased B cell proliferation
|
J:199122
|
| decreased IgG1 level
|
J:199122
|
| decreased IgG2b level
|
J:199122
|
| decreased IgG3 level
|
J:199122
|
F2rl1tm1Cgh/F2rl1tm1Cgh
(involves: 129S4/SvJae * C57BL/6)
|
impaired leukocyte tethering or rolling
|
J:76626
|
F2rl1tm1Jkaw/F2rl1tm1Jkaw
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:106127
|
F2rl1tm1Mslb/F2rl1tm1Mslb
(involves: 129X1/SvJ * C57BL/6)
|
decreased IgE level
|
J:79757
|
F3tm1.1Dwr/F3tm1.1Dwr
(involves: 129S1/Sv * 129X1/SvJ * MF1 * Swiss)
|
abnormal cellular extravasation
|
J:91165
|
| abnormal leukocyte adhesion
|
J:91165
|
| impaired leukocyte tethering or rolling
|
J:91165
|
F3tm1Gjb/F3+
(involves: 129X1/SvJ * C57BL/6)
|
abnormal macrophage physiology
|
J:128891
|
F11rtm1.1Dej/F11rtm1.1Dej
(Not Specified)
|
abnormal dendritic cell physiology
|
J:92592
|
| increased susceptibility to type IV hypersensitivity reaction
|
J:92592
|
Faddtm2.1Wnt/Faddtm2.1Wnt
Tg(Cd4-cre)1Cwi/?
(B6.Cg-Tg(Cd4-cre)1Cwi Faddtm2.1Wnt)
|
abnormal T cell proliferation
|
J:162312
|
| abnormal thymocyte apoptosis
|
J:162312
|
Fads2tm1Wst/Fads2tm1Wst
(involves: 129P2/OlaHsd)
|
abnormal macrophage physiology
|
J:140341
|
Faimtm1Kplm/Faimtm1Kplm
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell apoptosis
|
J:164184
|
| increased thymocyte apoptosis
|
J:164184
|
Fam3dem1Wko/Fam3dem1Wko
(C57BL/6-Fam3dem1Wko)
|
abnormal neutrophil physiology
|
J:304594
|
Fam72atm1.1(KOMP)Vlcg/Fam72atm1.1(KOMP)Vlcg
(C57BL/6NTac-Fam72atm1.1(KOMP)Vlcg)
|
abnormal class switch recombination
|
J:326431
|
| abnormal somatic hypermutation frequency
|
J:326431
|
| increased B cell apoptosis
|
J:326431
|
Fam72atm1.1(KOMP)Vlcg/Fam72atm1.1(KOMP)Vlcg
Msh2tm1Mak/Msh2tm1Mak
(C57BL/6NTac-Fam72atm1.1(KOMP)Vlcg Msh2tm1Mak)
|
abnormal class switch recombination
|
J:326431
|
| abnormal somatic hypermutation frequency
|
J:326431
|
Fam76bGt(IST14004H1)Tigm/Fam76bGt(IST14004H1)Tigm
(C57BL/6-Fam76bGt(IST14004H1)Tigm)
|
abnormal macrophage physiology
|
J:358021
|
| increased microglial cell activation
|
J:358021
|
Fam210bem1Cya/Fam210bem1Cya
(involves: C57BL/6N)
|
increased IgG level
|
J:351618
|
Farp2tm1Akum/Farp2tm1Akum
(B6.Cg-Farp2tm1Akum)
|
abnormal osteoclast physiology
|
J:166376
|
Faslpr-cg/Faslpr-cg
(CBA/KlJms-Faslpr-cg/J)
|
increased IgG level
|
J:24805,
J:81770
|
| increased IgM level
|
J:24805,
J:81770
|
| increased immunoglobulin level
|
J:24805
|
Faslpr/Faslpr
(MRL/Mp-Faslpr)
|
abnormal cytotoxic T cell physiology
|
J:7488
|
| abnormal T cell physiology
|
J:8267
|
| abnormal T cell proliferation
|
J:8267
|
| abnormal T-helper 2 physiology
|
J:6257
|
| abnormal type III hypersensitivity reaction
|
J:28885
|
| increased IgA level
|
J:28885
|
| increased IgG1 level
|
J:13757,
J:28885
|
| increased IgG2a level
|
J:13757,
J:28885
|
| increased IgG2b level
|
J:28885
|
| increased IgG level
|
J:27634
|
| increased IgM level
|
J:28885
|
| increased immunoglobulin level
|
J:13757,
J:28885,
J:6257
|
Faslpr/Faslpr
(MRL/MpJ-Faslpr/J)
|
abnormal immunoglobulin level
|
J:122315
|
| decreased IgG level
|
J:122315
|
| increased IgG level
|
J:92084
|
| increased immunoglobulin level
|
J:122315,
J:7454
|
Faslpr/Faslpr
(involves: C3H * MRL/Mp)
|
increased susceptibility to type III hypersensitivity reaction
|
J:34296
|
Faslpr/Faslpr
(B6.MRL-Faslpr/J)
|
abnormal NK cell physiology
|
J:115033
|
| decreased B cell apoptosis
|
J:135830
|
Faslpr/Faslpr
(MRL-Faslpr)
|
abnormal T-helper 2 physiology
|
J:6257
|
| increased IgG level
|
J:126261
|
| increased IgM level
|
J:126261
|
| increased immunoglobulin level
|
J:6257
|
Faslpr/Faslpr
(C3.MRL-Faslpr/J)
|
abnormal B cell activation
|
J:7454
|
| increased immunoglobulin level
|
J:7454
|
Faslpr/Faslpr
(B6.MRL-Faslpr)
|
increased immunoglobulin level
|
J:7454
|
Faslpr/Faslpr
(AK.MRL-Faslpr)
|
increased immunoglobulin level
|
J:7454
|
Faslpr/Faslpr
(C3.MRL-Faslpr)
|
abnormal T cell physiology
|
J:8267
|
| abnormal T cell proliferation
|
J:8267
|
Faslpr/Faslpr
(MRL/MpJ-Faslpr)
|
abnormal leukocyte adhesion
|
J:126009
|
| impaired leukocyte tethering or rolling
|
J:126009
|
| increased immunoglobulin level
|
J:125114
|
Faslpr/Faslpr
(involves: MRL/Mp)
|
decreased macrophage apoptosis
|
J:154647
|
Faslpr/Faslpr
(involves: C57BL/6 * MRL/Mp)
|
increased IgA level
|
J:73396
|
| increased IgG1 level
|
J:73396
|
| increased IgG2a level
|
J:73396
|
| increased IgG2b level
|
J:73396
|
| increased IgG3 level
|
J:73396
|
| increased IgM level
|
J:73396
|
Faslpr/Faslpr
Fcer1gtm1Tks/Fcer1gtm1Tks
(MRL.Cg-Fcer1gtm1Tks Faslpr)
|
decreased susceptibility to type III hypersensitivity reaction
|
J:106188
|
| increased IgG level
|
J:106188
|
Faslpr/Faslpr
Havcr1tm1Kuch/Havcr1tm1Kuch
(B6.Cg-Havcr1tm1Kuch Faslpr)
|
abnormal immunoglobulin level
|
J:186484
|
| increased IgG1 level
|
J:186484
|
| increased IgG2a level
|
J:186484
|
| increased IgG2b level
|
J:186484
|
| increased IgG3 level
|
J:186484
|
Faslpr/Faslpr
Ifnar1tm1Agt/Ifnar1tm1Agt
(MRL.Cg-Ifnar1tm1Agt Faslpr)
|
increased IgA level
|
J:92084
|
| increased IgG2b level
|
J:92084
|
| increased IgG3 level
|
J:92084
|
| increased IgG level
|
J:92084
|
| increased IgM level
|
J:92084
|
Faslpr/Faslpr
Ifnar1tm1Agt/Ifnar1tm1Agt
Ifngr1tm1Agt/Ifngr1tm1Agt
(MRL.Cg-Ifngr1tm1Agt Ifnar1tm1Agt Faslpr)
|
decreased IgG level
|
J:92084
|
| increased IgG level
|
J:92084
|
Faslpr/Faslpr
Ifngtm1Ts/Ifng+
(MRL.Cg-Ifngtm1Ts Faslpr)
|
abnormal macrophage chemotaxis
|
J:123834
|
Faslpr/Faslpr
Ifngtm1Ts/Ifngtm1Ts
(MRL.Cg-Ifngtm1Ts Faslpr)
|
abnormal macrophage chemotaxis
|
J:123834
|
Faslpr/Faslpr
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd * DBA/1 * MRL/Mp)
|
decreased IgA level
|
J:39600
|
| decreased IgG2a level
|
J:39600
|
| decreased IgG2b level
|
J:39600
|
| decreased IgM level
|
J:39600
|
| decreased immunoglobulin level
|
J:39600
|
Faslpr/Faslpr
Ifngr1tm1Agt/Ifngr1tm1Agt
(MRL.Cg-Ifngr1tm1Agt Faslpr)
|
decreased IgA level
|
J:92084
|
| decreased IgG2a level
|
J:92084
|
| decreased IgG2b level
|
J:92084
|
| decreased IgG3 level
|
J:92084
|
| decreased IgM level
|
J:92084
|
| increased IgG1 level
|
J:92084
|
| increased IgG level
|
J:92084
|
Faslpr/Faslpr
Ighmtm1Cgn/Ighmtm1Cgn
(involves: 129S2/SvPas * C57BL/6 * MRL/Mp)
|
abnormal immunoglobulin level
|
J:119584
|
| decreased IgM level
|
J:119584
|
Faslpr/Faslpr
Il4tm1Cgn/Il4tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6J * MRL/Mp)
|
decreased IgA level
|
J:39600
|
| decreased IgE level
|
J:39600
|
| decreased IgG1 level
|
J:39600
|
| decreased IgG3 level
|
J:39600
|
| decreased immunoglobulin level
|
J:39600
|
Faslpr/Faslpr
Il27ratm1Mak/Il27ratm1Mak
(MRL.Cg-Il27ratm1Mak Faslpr)
|
abnormal T-helper 2 physiology
|
J:122148
|
| decreased IgG2a level
|
J:122148
|
| increased IgE level
|
J:122148
|
| increased IgG1 level
|
J:122148
|
Faslpr/Faslpr
Itfg2Gt(OST215121)Lex/Itfg2Gt(OST215121)Lex
(involves: 129S5/SvEvBrd * C57BL/6J * MRL/Mp)
|
increased IgG2a level
|
J:205951
|
| increased IgM level
|
J:205951
|
Faslpr/Faslpr
Nos2tm1Mrl/Nos2tm1Mrl
(involves: 129S7/SvEvBrd * MRL)
|
abnormal immunoglobulin level
|
J:42666
|
| decreased IgG level
|
J:42666
|
| decreased IgM level
|
J:42666
|
Faslpr/Faslpr
Pou2af1tm1Pmt/Pou2af1tm1Pmt
(involves: 129P2/OlaHsd * C57BL/6 * MRL)
|
decreased immunoglobulin level
|
J:125114
|
Faslpr/Faslpr
Selptm1Bay/Selptm1Bay
(MRL.Cg-Selptm1Bay Faslpr)
|
abnormal leukocyte adhesion
|
J:126009
|
| impaired leukocyte tethering or rolling
|
J:126009
|
Faslpr/Faslpr
Spp1tm1Rit/Spp1tm1Rit
(involves: 129S7/SvEvBrd * C57BL/6 * MRL/Mp)
|
increased IgA level
|
J:73396
|
| increased IgG1 level
|
J:73396
|
| increased IgG2a level
|
J:73396
|
| increased IgG2b level
|
J:73396
|
| increased IgG3 level
|
J:73396
|
| increased IgM level
|
J:73396
|
Faslpr/Faslpr
Tcratm1Mjo/Tcratm1Mjo
(involves: 129P2/OlaHsd * 129S2/SvPas * MRL)
|
decreased immunoglobulin level
|
J:38492
|
Faslpr/Faslpr
Tg(CD2-Foxj1)#Stlp/0
(MRL.Cg-Faslpr Tg(CD2-Foxj1)#Stlp)
|
abnormal T cell physiology
|
J:122222
|
Faslpr/Faslpr
Tlr7tm1Flv/Y
(involves: 129S1/Sv * C57BL/6 * MRL/Mp)
|
abnormal B cell activation
|
J:113557
|
| abnormal plasmacytoid dendritic cell physiology
|
J:113557
|
| decreased IgG2a level
|
J:113557
|
| decreased IgG3 level
|
J:113557
|
Faslpr/Faslpr
Tlr9tm1Aki/Tlr9tm1Aki
(B6.Cg-Tlr9tm1Aki Faslpr)
|
decreased IgM level
|
J:135036
|
| increased IgG level
|
J:135036
|
Faslpr/Faslpr
Tlr9tm1Aki/Tlr9tm1Aki
(MRL.Cg-Tlr9tm1Aki Faslpr)
|
abnormal B cell activation
|
J:113557
|
| abnormal plasmacytoid dendritic cell physiology
|
J:113557
|
| increased IgG2a level
|
J:113557
|
| increased IgG3 level
|
J:113557
|
| increased IgG level
|
J:113557
|
Faslpr/Faslpr
Tnfrsf9tm1Byk/Tnfrsf9tm1Byk
(MRL.Cg-Tnfrsf9tm1Byk Faslpr)
|
increased immunoglobulin level
|
J:127197
|
Fastm1Ach/Fastm1Ach
Tg(Itgax-cre,-EGFP)4097Ach/?
(Not Specified)
|
increased IgG level
|
J:123556
|
| increased IgM level
|
J:123556
|
| increased immunoglobulin level
|
J:123556
|
Fastm1Cgn/Fastm1Cgn
Tg(Cd4-cre)1Cwi/0
(B6.Cg-Tg(Cd4-cre)1Cwi Fastm1Cgn)
|
increased T cell apoptosis
|
J:114948
|
Fastm1Dlo/Fastm1Dlo
(involves: 129P2/OlaHsd * C57BL/6)
|
increased immunoglobulin level
|
J:31847
|
Fastm1Osa/Fastm1Osa
(involves: 129P2/OlaHsd * C57BL/6)
|
increased IgG1 level
|
J:32125
|
| increased IgG2a level
|
J:32125
|
| increased IgG2b level
|
J:32125
|
| increased IgG3 level
|
J:32125
|
| increased IgG level
|
J:32125
|
Fasldel1Hong/Fasldel1Hong
(either: (involves: 129 * BALB/c * C57BL/6) or (involves: 129X1/SvJ * C3H/HeJ * C57BL/6))
|
increased IgG level
|
J:112563
|
| increased IgM level
|
J:112563
|
Faslgld/Faslgld
(C3H/HeJ-Faslgld/J)
|
decreased cytotoxic T cell cytolysis
|
J:17698
|
| increased IgA level
|
J:7306,
J:29572
|
| increased IgG1 level
|
J:7306
|
| increased IgG2a level
|
J:7306
|
| increased IgG2b level
|
J:7306
|
| increased IgG level
|
J:29572
|
| increased IgM level
|
J:7306,
J:29572
|
| increased immunoglobulin level
|
J:7306,
J:29572
|
Faslgld/Faslgld
(B6Smn.C3-Faslgld/J)
|
abnormal NK cell physiology
|
J:115033
|
| abnormal osteoclast physiology
|
J:127179
|
Faslgld/Faslgld
(C3H/HeJ-Faslgld)
|
abnormal T cell physiology
|
J:8267
|
| abnormal T cell proliferation
|
J:8267
|
Faslgld/Faslgld
(involves: C3H/HeJ * C57BL/6)
|
increased IgE level
|
J:153501
|
| increased IgG1 level
|
J:153501
|
| increased IgG2a level
|
J:153501
|
| increased IgG2b level
|
J:153501
|
| increased IgG level
|
J:153501
|
Faslgld/Faslgld
(involves: C3H/HeJ)
|
abnormal osteoclast physiology
|
J:156947
|
Faslgld/Faslgld
(B6.C3-Faslgld)
|
impaired macrophage phagocytosis
|
J:91058
|
Faslm2Btlr/Faslm2Btlr
(C57BL/6J-Faslm2Btlr)
|
decreased IgG level
|
J:224659
|
Fasltm1.1Ast/Fasltm1.1Ast
(involves: BALB/cJ * C57BL/6)
|
decreased cytotoxic T cell cytolysis
|
J:153501
|
| increased IgA level
|
J:153501
|
| increased IgE level
|
J:153501
|
| increased IgG1 level
|
J:153501
|
| increased IgG2a level
|
J:153501
|
| increased IgG2b level
|
J:153501
|
| increased IgG level
|
J:153501
|
| increased IgM level
|
J:153501
|
| increased immunoglobulin level
|
J:153501
|
Fasltm1.1Cgm/Fasltm1.1Cgm
(involves: 129S2/SvPas * C57BL/6 * C57BL/6N)
|
increased B cell proliferation
|
J:168406
|
| increased IgM level
|
J:168406
|
| increased T cell proliferation
|
J:168406
|
Fasltm1.1Lest/Fasltm1.1Lest
(involves: 129 * C57BL/6)
|
increased IgG level
|
J:87990
|
Fasltm2.1Ast/Fasltm2.1Ast
(involves: BALB/cJ * C57BL/6)
|
abnormal cytotoxic T cell physiology
|
J:153501
|
Fastktm1.1Andp/Fastktm1.1Andp
(B6.129S6-Fastktm1.1Andp)
|
abnormal neutrophil physiology
|
J:160443
|
Fblim1tm1.1Chen/Fblim1tm1.1Chen
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
abnormal osteoclast physiology
|
J:186501
|
Fbn1Tsk/Fbn1+
(B6.Cg-Fbn1Tsk)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:7185
|
Fbxw7tm1Kei/Fbxw7tm1Kei
Tg(Lck-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell activation
|
J:128523
|
| increased T cell apoptosis
|
J:128523
|
Fcamrtm1Shib/Fcamrtm1Shib
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal marginal zone B cell physiology
|
J:150824
|
| abnormal somatic hypermutation frequency
|
J:150824
|
Fcamrtm2Shib/Fcamrtm2Shib
(BALB/c-Fcamrtm2Shib)
|
abnormal marginal zone B cell physiology
|
J:150824
|
Fcer1atm1Ftl/Fcer1atm1Ftl
(CBy.129S2-Fcer1atm1Ftl)
|
abnormal mast cell physiology
|
J:120702
|
Fcer1atm1Knt/Fcer1atm1Knt
(either: (involves: 129 * C57BL/6) or (involves: 129 * C57BL/6 * DBA/2))
|
abnormal mast cell physiology
|
J:39250
|
| decreased susceptibility to type I hypersensitivity reaction
|
J:113572,
J:39250
|
Fcer1atm1Knt/Fcer1atm1Knt
(involves: 129 * BALB/c)
|
abnormal mast cell physiology
|
J:78659
|
| increased susceptibility to type I hypersensitivity reaction
|
J:78659
|
Fcer1atm1Knt/Fcer1atm1Knt
Fcer2atm1Max/Fcer2atm1Max
(B6.Cg-Fcer1atm1Knt Fcer2atm1Max)
|
abnormal mast cell physiology
|
J:144620
|
Fcer1atm1Knt/Fcer1atm1Knt
Fcer2atm1Max/Fcer2atm1Max
Fcgr1tm1Jsv/Fcgr1tm1Jsv
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Fcgr3tm1Jsv/Fcgr3tm1Jsv
(B6.Cg-Fcgr2btm1Ttk Fcgr3tm1Jsv Fcer1atm1Knt Fcgr1tm1Jsv Fcer2atm1Max)
|
abnormal macrophage physiology
|
J:144620
|
| abnormal mast cell physiology
|
J:144620
|
| increased susceptibility to type I hypersensitivity reaction
|
J:144620
|
Fcer1atm1Knt/Fcer1atm1Knt
Tg(FCER1A)1Bhk/?
(B6.129-Fcer1atm1Knt Tg(FCER1A)1Bhk)
|
abnormal macrophage physiology
|
J:144620
|
Fcer1atm1Knt/Fcer1atm1Knt
Tg(SV40/HTLV-FCER1A)1Bhk/0
(either: (involves: 129 * C57BL/6) or (involves: 129 * C57BL/6 * DBA/2))
|
abnormal type I hypersensitivity reaction
|
J:113572
|
Fcer1gtm1Rav/Fcer1gtm1Rav
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal dendritic cell antigen presentation
|
J:83995
|
| abnormal immunoglobulin level
|
J:78659
|
| abnormal mast cell physiology
|
J:39248
|
| abnormal NK cell physiology
|
J:39248
|
| decreased susceptibility to type I hypersensitivity reaction
|
J:78659,
J:39248
|
| impaired macrophage phagocytosis
|
J:39248
|
| increased IgE level
|
J:78659
|
Fcer1gtm1Rav/Fcer1gtm1Rav
Del(7Tyrobp-Hcst)1Ttk/Del(7Tyrobp-Hcst)1Ttk
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)
|
abnormal osteoclast physiology
|
J:147155
|
Fcer1gtm1Rav/Fcer1gtm1Rav
Hexbtm1Rlp/Hexbtm1Rlp
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
increased immunoglobulin level
|
J:87617
|
Fcer1gtm1Rav/Fcer1gtm1Rav
Tg(Ins2-TFRC/OVA)296Wehi/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell proliferation
|
J:122114
|
Fcer1gtm1Rav/Fcer1gtm1Rav
Tyrobptm1Lll/Tyrobptm1Lll
(involves: 129P2/OlaHsd)
|
abnormal osteoclast physiology
|
J:147155
|
Fcer1gtm1Tks/Fcer1gtm1Tks
(involves: C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:112160
|
| abnormal macrophage physiology
|
J:141143
|
| abnormal NK cell physiology
|
J:111365
|
| abnormal NK T cell physiology
|
J:111365
|
| decreased IgG1 level
|
J:112160
|
| decreased IgG2a level
|
J:112160
|
| decreased IgG2b level
|
J:112160
|
| decreased IgG3 level
|
J:112160
|
| decreased IgG level
|
J:112160
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:112160
|
| decreased T cell proliferation
|
J:112160
|
| impaired macrophage phagocytosis
|
J:50023
|
| impaired natural killer cell mediated cytotoxicity
|
J:111365
|
Fcer2aHie/Fcer2aHie
(NZB)
|
increased IgE level
|
J:93999
|
Fcer2atm1Kik/Fcer2atm1Kik
(involves: 129P2/OlaHsd * C57BL/6)
|
increased immunoglobulin level
|
J:129296
|
Fcer2atm1Max/Fcer2atm1Max
(involves: C57BL/6)
|
abnormal macrophage chemotaxis
|
J:57738
|
| decreased IgG1 level
|
J:18952
|
| decreased IgG2b level
|
J:18952
|
| impaired eosinophil recruitment
|
J:57738
|
| increased IgE level
|
J:57738,
J:18952,
J:107857
|
| increased IgM level
|
J:18952
|
| increased susceptibility to type I hypersensitivity reaction
|
J:57738
|
Fcer2atm1Max/Fcer2atm1Max
Ighg1tm1.1Pyu/Ighg1+
(involves: 129 * BALB/cJ * C57BL/6 * C57BL/6J)
|
decreased IgG1 level
|
J:198154
|
| decreased IgG2c level
|
J:198154
|
| decreased IgG level
|
J:198154
|
| increased IgE level
|
J:198154
|
| increased IgG2a level
|
J:198154
|
| increased susceptibility to type I hypersensitivity reaction
|
J:198154
|
Fcer2atm1Max/Fcer2atm1Max
Ighg1tm1.1Pyu/Ighg1tm1.1Pyu
(involves: 129 * BALB/cJ * C57BL/6 * C57BL/6J)
|
abnormal immunoglobulin level
|
J:198154
|
| decreased IgG2c level
|
J:198154
|
| decreased IgG level
|
J:198154
|
| increased IgE level
|
J:198154
|
| increased IgG2a level
|
J:198154
|
| increased susceptibility to type I hypersensitivity reaction
|
J:198154
|
Fcer2atm1Putt/Fcer2a+
(involves: 129S/SvEv * C57BL/6)
|
increased IgE level
|
J:69547
|
Fcer2atm1Putt/Fcer2atm1Putt
(involves: 129S/SvEv * C57BL/6)
|
abnormal B cell proliferation
|
J:69547
|
Fcgr1tm1Hoga/Fcgr1tm1Hoga
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal macrophage antigen presentation
|
J:86281
|
| impaired macrophage phagocytosis
|
J:86281
|
| increased IgG level
|
J:86281
|
Fcgr1tm1Jgjw/Fcgr1tm1Jgjw
(involves: 129 * C57BL/6)
|
abnormal dendritic cell antigen presentation
|
J:112436
|
Fcgr1tm1Jsv/Fcgr1tm1Jsv
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal dendritic cell antigen presentation
|
J:83995
|
| abnormal macrophage physiology
|
J:83995
|
| abnormal type I hypersensitivity reaction
|
J:83995
|
Fcgr1tm1Jsv/Fcgr1tm1Jsv
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Fcgr3tm1Jsv/Fcgr3tm1Jsv
(involves: 129P2/OlaHsd * 129S4/SvJae * BALB/c * C57BL/6)
|
impaired macrophage phagocytosis
|
J:83995
|
Fcgr2btm1.2Jsv/Fcgr2btm1.2Jsv
Sle16C57BL/6/Sle16C57BL/6
(involves: C57BL/6 * FVB/N)
|
abnormal adaptive immunity
|
J:179175
|
| increased immunoglobulin level
|
J:179175
|
Fcgr2btm1Kgcs/Fcgr2b+
(involves: C57BL/6)
|
decreased B cell apoptosis
|
J:190890
|
| increased IgG1 level
|
J:190890
|
| increased IgG3 level
|
J:190890
|
| increased IgM level
|
J:190890
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk
(involves: 129S4/SvJae)
|
abnormal mast cell physiology
|
J:31133
|
| increased IgA level
|
J:31133
|
| increased IgG1 level
|
J:31133
|
| increased IgG2a level
|
J:31133
|
| increased IgG2b level
|
J:31133
|
| increased IgG3 level
|
J:31133
|
| increased IgG level
|
J:31133
|
| increased IgM level
|
J:31133
|
| increased susceptibility to type I hypersensitivity reaction
|
J:31133
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk
(B6.129S4-Fcgr2btm1Ttk)
|
increased immunoglobulin level
|
J:64152
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Sle21129P2/Ola/Sle21129P2/Ola
(B6.129S4-Fcgr2btm1Ttk)
|
abnormal adaptive immunity
|
J:179175
|
| increased IgG2a level
|
J:179175
|
| increased immunoglobulin level
|
J:179175
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Traf3ip2tm1Sbn/Traf3ip2+
(involves: 129 * 129S4/SvJae * C57BL/6)
|
increased IgG level
|
J:191090
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Traf3ip2tm1Sbn/Traf3ip2tm1Sbn
(involves: 129 * 129S4/SvJae * C57BL/6)
|
increased IgG level
|
J:191090
|
Fcgr3tm1Jsv/Fcgr3tm1Jsv
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal dendritic cell antigen presentation
|
J:83995
|
| abnormal type I hypersensitivity reaction
|
J:83995
|
| decreased mast cell degranulation
|
J:35057
|
| decreased susceptibility to type II hypersensitivity reaction
|
J:35057
|
| impaired macrophage phagocytosis
|
J:35057
|
| impaired natural killer cell mediated cytotoxicity
|
J:35057
|
Fcgr3tm1Jsv/Fcgr3tm1Jsv
(B6.129P2-Fcgr3tm1Jsv/J)
|
abnormal neutrophil physiology
|
J:78297
|
| impaired neutrophil recruitment
|
J:78297
|
Fcgr3tm1Ttk/Fcgr3tm1Ttk
(involves: 129X1/SvJ)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:107371
|
Fcgrttm1Dcr/Fcgrttm1Dcr
(either: 129 or (involves: 129 * C57BL/6))
|
decreased IgG level
|
J:94189
|
Fcgrttm1Dcr/Fcgrttm1Dcr
(B6.129X1-Fcgrttm1Dcr/DcrJ)
|
decreased IgG level
|
J:110885
|
Fcgrttm1Esw/Fcgrttm1Esw
Tg(Tek-cre)1Ywa/0
(B6.Cg-Tg(Tek-cre)1Ywa Fcgrttm1Esw)
|
decreased IgG1 level
|
J:146640
|
Fcmrtm1.2Khl/Fcmrtm1.2Khl
(involves: C57BL/6)
|
abnormal granulocyte physiology
|
J:194323
|
| increased T cell apoptosis
|
J:174871
|
Fcmrtm1Mak/Fcmrtm1Mak
(B6.129S2-Fcmrtm1Mak)
|
abnormal granulocyte physiology
|
J:194323
|
| impaired granulocyte bactericidal activity
|
J:194323
|
Fcmrtm1Ohno/Fcmrtm1Ohno
(B6.129-Fcmrtm1Ohno)
|
abnormal immunoglobulin level
|
J:190117
|
| decreased IgG1 level
|
J:190117
|
| decreased IgM level
|
J:190117
|
| increased IgG3 level
|
J:190117
|
| increased IgM level
|
J:190117
|
Fcrlatm1.1Cln/Fcrlatm1.1Cln
(involves: 129P2/OlaHsd * C57BL/6)
|
increased IgG1 level
|
J:163261
|
Fcrlbtm1Pdb/Fcrlbtm1Pdb
(B6.129-Fcrlbtm1Pdb)
|
increased IgG1 level
|
J:165408
|
Fermt3tm2.1Ref/Fermt3tm2.1Ref
Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal T cell physiology
|
J:203436
|
Festm1Mcs/Festm1Mcs
(involves: 129X1/SvJ)
|
abnormal macrophage physiology
|
J:64748
|
Ffar2tm1Dgen/Ffar2tm1Dgen
(involves: C57BL/6)
|
abnormal granulocyte physiology
|
J:153951
|
| abnormal neutrophil physiology
|
J:153951
|
| impaired neutrophil chemotaxis
|
J:153951
|
| impaired neutrophil phagocytosis
|
J:153951
|
Ffar2tm2Lex/Ffar2tm2Lex
(involves: 129S7/SvEvBrd * C57BL/6)
|
impaired neutrophil chemotaxis
|
J:157383
|
Fgfr1tm1Upir/Fgfr1tm1Upir
Fgfr2tm1Dor/Fgfr2tm1Dor
Tg(KRT5-cre)5132Jlj/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6J * DBA/2J)
|
increased IgE level
|
J:158802
|
| increased IgG1 level
|
J:158802
|
| increased IgG2a level
|
J:158802
|
Fgfr3tm3.1Cxd/Fgfr3tm3.1Cxd
(involves: 129S6/SvEvTac)
|
abnormal osteoclast physiology
|
J:69849
|
Fggtm2Jld/Fggtm2Jld
(involves: 129P2/OlaHsd * Black Swiss * C57BL/6)
|
abnormal neutrophil physiology
|
J:90908
|
Fgl2tm1Pam/Fgl2tm1Pam
(B6.129X1-Fgl2tm1Pam)
|
abnormal B cell physiology
|
J:130895
|
| abnormal dendritic cell physiology
|
J:130895
|
| abnormal regulatory T cell physiology
|
J:130895
|
| abnormal T cell physiology
|
J:130895
|
| decreased dendritic cell apoptosis
|
J:130895
|
| increased IgA level
|
J:130895
|
| increased IgG level
|
J:130895
|
| increased IgM level
|
J:130895
|
| increased T cell proliferation
|
J:130895
|
Fgrtm1Hev/Fgrtm1Hev
Hcktm1Hev/Hcktm1Hev
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal macrophage physiology
|
J:59037
|
| impaired macrophage phagocytosis
|
J:16994
|
Fgrtm1Hev/Fgrtm1Hev
Hcktm1Hev/Hcktm1Hev
Lyntm1Sor/Lyntm1Sor
(B6.Cg-Hcktm1Hev Fgrtm1Hev Lyntm1Sor)
|
abnormal neutrophil physiology
|
J:113463
|
Fkbp11Gt(OST298786)Lex/Fkbp11Gt(OST298786)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased immunoglobulin level
|
J:103485
|
Flgft/Flgft
(B6.Cg-Flgft)
|
increased IgE level
|
J:202453,
J:151110
|
| increased IgG1 level
|
J:151110
|
| increased IgG2a level
|
J:151110
|
| increased IgG level
|
J:151110
|
Flgft/Flgft
Tmem79ma/Tmem79ma
(involves: CBA/CaGr)
|
increased IgE level
|
J:202453
|
Flgtm1Amag/Flgtm1Amag
(involves: 129S6/SvEvTac * BALB/c * C57BL/6NTac)
|
increased IgE level
|
J:198332
|
| increased IgG1 level
|
J:198332
|
| increased susceptibility to type IV hypersensitivity reaction
|
J:198332
|
Fli1tm1.1Dkw/Fli1tm1.1Dkw
(B6.129S6-Fli1tm1.1Dkw)
|
abnormal class switch recombination
|
J:137876
|
| decreased B cell proliferation
|
J:137876
|
| decreased IgG1 level
|
J:137876
|
| decreased IgG3 level
|
J:137876
|
Flot1tm1.1Arte/Flot1tm1.1Arte
(involves: C57BL/6J)
|
abnormal leukocyte physiology
|
J:166672
|
| impaired neutrophil chemotaxis
|
J:166672
|
| impaired neutrophil recruitment
|
J:166672
|
Flt1tm1Msh/Flt1tm1Msh
(involves: 129S4/SvJae * C57BL/6J)
|
impaired macrophage chemotaxis
|
J:49507
|
Flt3m1Btlr/Flt3m1Btlr
(C57BL/6J-Flt3m1Btlr)
|
abnormal dendritic cell antigen presentation
|
J:159599
|
| abnormal dendritic cell physiology
|
J:159599
|
| abnormal macrophage physiology
|
J:105543
|
| abnormal NK cell physiology
|
J:159599
|
Flt3ltm1Imx/Flt3ltm1Imx
(C57BL/6-Flt3ltm1Imx)
|
increased IgM level
|
J:62536
|
Flt3ltm1Imx/Flt3ltm1Imx
(involves: C57BL/6)
|
abnormal dendritic cell antigen presentation
|
J:223508
|
| abnormal dendritic cell chemotaxis
|
J:223508
|
| abnormal memory T cell physiology
|
J:189122
|
| abnormal T-helper 1 physiology
|
J:189122
|
Fmnl1tm1.2Sdb/Fmnl1tm1.2Sdb
Lyz2tm1(cre)Ifo/Lyz2tm1(cre)Ifo
(involves: C3H * C57BL/6 * FVB/N)
|
abnormal macrophage physiology
|
J:250144
|
| impaired macrophage chemotaxis
|
J:250144
|
Fnip1Gt(RRM154)Byg/Fnip1Gt(RRM154)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased B cell apoptosis
|
J:189078
|
Fnip1LPAB.1/Fnip1LPAB.1
(C57BL/6J-Fnip1LPAB.1)
|
abnormal B cell physiology
|
J:187318
|
| decreased IgE level
|
J:187318
|
| decreased IgG1 level
|
J:187318
|
| decreased IgG2a level
|
J:187318
|
| decreased IgG level
|
J:187318
|
| decreased IgM level
|
J:187318
|
| increased B cell apoptosis
|
J:187318
|
Fnip1LPAB.1/Fnip1LPAB.1
Tg(IghMyc)22Bri/0
(involves: C57BL * C57BL/6J * SJL)
|
increased B cell apoptosis
|
J:187318
|
Fnip1m1Btlr/Fnip1m1Btlr
(C57BL/6J-Fnip1m1Btlr)
|
decreased IgM level
|
J:234285
|
Fnip1tm1.2Baba/Fnip1tm1.2Baba
(involves: C57BL/6 * C57BL/6J * FVB/N * SJL)
|
increased B cell apoptosis
|
J:189078
|
Fostm1Wag/Fostm1Wag
(involves: 129S2/SvPas * C57BL/6)
|
abnormal macrophage physiology
|
J:118693
|
| increased macrophage apoptosis
|
J:118693
|
| increased macrophage cytokine production
|
J:118693
|
Fosl2tm2.1Wag/Fosl2tm2.1Wag
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal osteoclast physiology
|
J:137646
|
Foxn1nu-str/Foxn1nu-str
(AKR/J-Foxn1nu-str/J)
|
decreased immunoglobulin level
|
J:30715
|
Foxn1nu/Foxn1nu
(involves: CBA)
|
abnormal T cell activation
|
J:202299
|
Foxn1nu/Foxn1nu
Tgfb1tm1Doe/Tgfb1tm1Doe
(involves: 129S2/SvPas * BALB/c * CF-1)
|
abnormal T cell physiology
|
J:99033
|
Foxn1nu/Foxn1tm1.1Dmsu
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129/Sv * C57BL/6 * CBA * SJL)
|
increased thymocyte apoptosis
|
J:159773
|
Foxo1tm1.1Stlp/Foxo1tm1.1Stlp
Tg(Lck-cre)1Cwi/0
(involves: 129S4/SvJae)
|
decreased T cell proliferation
|
J:154205
|
| decreased thymocyte apoptosis
|
J:154205
|
Foxo1tm1Flv/Foxo1tm1Flv
Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)
|
abnormal regulatory T cell physiology
|
J:189962
|
| increased T cell proliferation
|
J:189962
|
Foxo1tm1Flv/Foxo1tm1Flv
Tg(Cd4-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:147057
|
| abnormal CD8-positive, alpha-beta T cell physiology
|
J:147057
|
| abnormal T cell activation
|
J:147057
|
| abnormal T cell physiology
|
J:147057
|
| increased T cell proliferation
|
J:147057
|
Foxo3Gt(XAO26)Byg/Foxo3Gt(XAO26)Byg
(involves: 129P2/OlaHsd)
|
abnormal T cell activation
|
J:93593
|
| abnormal T cell physiology
|
J:93593
|
| increased T cell proliferation
|
J:93593
|
Foxo6tm1(KOMP)Vlcg/Foxo6tm1(KOMP)Vlcg
(B6J.B6NTac-Foxo6tm1(KOMP)Vlcg)
|
impaired macrophage chemotaxis
|
J:236585
|
Foxp1tm1.1Pwt/Foxp1tm1.1Pwt
Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal T cell activation
|
J:156832
|
| increased T cell apoptosis
|
J:156832
|
Foxp1tm1Rao/Foxp1tm1Rao
(B6.129-Foxp1tm1Rao)
|
abnormal B cell physiology
|
J:112644
|
Foxp3sf/Y
(either: 129Rl.Cg-Foxp3sf or (involves: 101/Rl * C3Hf/Rl * STOCK MR))
|
abnormal B cell physiology
|
J:11262
|
| increased IgG level
|
J:11262
|
| increased IgM level
|
J:11262
|
Foxp3sf/Y
(B6.Cg-Foxp3sf)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:82560
|
Foxp3tm1(CD2/CD52)Shori/Foxp3tm1(CD2/CD52)Shori
(involves: C57BL/6)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:171378
|
Foxp3tm1.1Ayr/Foxp3tm1.1Ayr
Mir146tm1.1Bal/Mir146tm1.1Bal
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal lymphocyte physiology
|
J:167922
|
Foxp3tm1.1Mal/Foxp3tm1.1Mal
Lattm1.1Mal/Lattm1.1Mal
(involves: 129S2/SvPas * C57BL/6)
|
abnormal regulatory T cell physiology
|
J:131351
|
Foxp3tm1Tch/Y
(C.129X1-Foxp3tm1Tch)
|
abnormal lymphocyte physiology
|
J:117165
|
| increased IgE level
|
J:117165
|
| increased IgG1 level
|
J:117165
|
Foxp3tm1Tch/Y
(B6.129X1-Foxp3tm1Tch)
|
increased IgE level
|
J:117165
|
Foxp3tm2Ayr/Foxp3+
Rnf128tm1Cdon/Rnf128tm1Cdon
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal regulatory T cell physiology
|
J:160681
|
Foxp3tm2Flv/Y
(involves: C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:118631
|
| abnormal CD8-positive, alpha-beta T cell physiology
|
J:118631
|
Foxp3tm3(HBEGF/GFP)Ayr/Foxp3tm3(HBEGF/GFP)Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:117743
|
| abnormal dendritic cell physiology
|
J:117743
|
Foxp3tm3Tch/Y
(C.129X1-Foxp3tm3Tch)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:120636
|
| abnormal lymphocyte physiology
|
J:120636
|
| abnormal regulatory T cell physiology
|
J:120636
|
| increased T cell proliferation
|
J:120636
|
Foxp3tm3Tch/Foxp3+
(C.129X1-Foxp3tm3Tch)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:120636
|
| increased T cell apoptosis
|
J:120636
|
Foxp3tm4(YFP/icre)Ayr/Y
Zfp91tm1Smoc/Zfp91tm1Smoc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal regulatory T cell physiology
|
J:306129
|
Foxp3tm4(YFP/icre)Ayr/Foxp3+
Nr4a2tm1.1Pcn/Nr4a2tm1.1Pcn
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal regulatory T cell physiology
|
J:205658
|
Foxp3tm4(YFP/icre)Ayr/Foxp3tm4(YFP/icre)Ayr
Ikzf4tm1Djr/Ikzf4tm1Djr
(involves: 129S1/Sv * 129X1/SvJ)
|
increased immunoglobulin level
|
J:294549
|
Foxp3tm9(EGFP/cre/ERT2)Ayr/Foxp3+
Il1r2tm1.1Mchc/Il1r2tm1.1Mchc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6NTac)
|
abnormal adaptive immunity
|
J:347877
|
| increased IgG level
|
J:347877
|
Foxq1sa/Foxq1sa
(involves: 101/Rl * C3H/Rl)
|
impaired natural killer cell mediated cytotoxicity
|
J:7649
|
Fpr1tm1Gao/Fpr1tm1Gao
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired neutrophil chemotaxis
|
J:53354
|
Fpr2tm1.2Jimw/Fpr2tm1.2Jimw
(B6.129X1-Fpr2tm1.2Jimw)
|
abnormal dendritic cell physiology
|
J:160074
|
| decreased IgE level
|
J:160074
|
| decreased IgG1 level
|
J:160074
|
| decreased IgG2b level
|
J:160074
|
| decreased immunoglobulin level
|
J:160074
|
| impaired macrophage chemotaxis
|
J:160074
|
| impaired neutrophil chemotaxis
|
J:160074
|
Fpr2tm1.2Jimw/Fpr2tm1.2Jimw
(involves: 129X1/SvJ)
|
abnormal dendritic cell chemotaxis
|
J:199611
|
| abnormal dendritic cell physiology
|
J:199611
|
Fpr2tm1Rjf/Fpr2tm1Rjf
(involves: 129S/SvEv * C57BL/6)
|
abnormal neutrophil physiology
|
J:159658
|
| impaired macrophage chemotaxis
|
J:159658
|
Fscn1Gt(OST124903)Lex/Fscn1Gt(OST124903)Lex
(B6.129S5-Fscn1Gt(OST124903)Lex)
|
abnormal dendritic cell chemotaxis
|
J:169408
|
| abnormal dendritic cell physiology
|
J:169408
|
| abnormal Langerhans cell physiology
|
J:169408
|
Fts/Fts+
(B6.Cg-Fts)
|
abnormal T cell physiology
|
J:108193
|
Furintm1Jwmc/Furintm1Jwmc
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal regulatory T cell physiology
|
J:204761
|
FusGt(U3NeoSV1)HO14Ggh/FusGt(U3NeoSV1)HO14Ggh
(B6.129S2-FusGt(U3NeoSV1)HO14Ggh)
|
abnormal immunoglobulin level
|
J:60213
|
Fut4tm1Jbl/Fut4tm1Jbl
(B6.129S2-Fut4tm1Jbl)
|
impaired leukocyte tethering or rolling
|
J:79397
|
Fut4tm1Jbl/Fut4tm1Jbl
Fut7tm1Jbl/Fut7tm1Jbl
(B6.129S2-Fut7tm1Jbl Fut4tm1Jbl)
|
abnormal leukocyte migration
|
J:79397
|
| abnormal leukocyte physiology
|
J:79397
|
| abnormal neutrophil physiology
|
J:79397
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:79388
|
| impaired leukocyte tethering or rolling
|
J:79397
|
Fut7tm1Jbl/Fut7tm1Jbl
(involves: 129S2/SvPas * C57BL/6J * DBA/2J)
|
abnormal granulocyte physiology
|
J:35023
|
| abnormal leukocyte adhesion
|
J:35023
|
| abnormal leukocyte migration
|
J:35023
|
| abnormal leukocyte physiology
|
J:35023
|
| abnormal leukocyte tethering or rolling
|
J:35023
|
| impaired neutrophil recruitment
|
J:35023
|
Fut7tm1Jbl/Fut7tm1Jbl
(B6.129S2-Fut7tm1Jbl)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:79388,
J:74776
|
| impaired neutrophil recruitment
|
J:79397
|
Fyb1tm1Gak/Fyb1tm1Gak
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal leukocyte adhesion
|
J:111368
|
| abnormal T cell physiology
|
J:126545
|
| decreased T cell proliferation
|
J:111368,
J:126545
|
Fyntm1Rmp/Fyntm1Rmp
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T cell activation
|
J:70886
|
| abnormal thymocyte activation
|
J:70886
|
| decreased T cell proliferation
|
J:70886
|
Fyntm1Rmp/Fyntm1Rmp
(B6.129S2-Fyntm1Rmp)
|
abnormal eosinophil physiology
|
J:114287
|
| decreased IgE level
|
J:114287
|
| increased susceptibility to type I hypersensitivity reaction
|
J:114287
|
Fyntm1Sor/Fyntm1Sor
(either: 129S7/SvEvBrd-Fyntm1Sor or (involves: 129S7/SvEvBrd * C57BL/6J))
|
abnormal T cell physiology
|
J:2242
|
| abnormal thymocyte activation
|
J:2242
|
| decreased T cell proliferation
|
J:2242
|
| increased IgG2a level
|
J:2242
|
| increased IgM level
|
J:2242
|
Fyntm1Sor/Fyntm1Sor
(B6.129S7-Fyntm1Sor)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:93886
|
| abnormal NK cell physiology
|
J:187430
|
| abnormal T cell proliferation
|
J:93886
|
| decreased IgE level
|
J:93886
|
Fyntm1Sor/Fyntm1Sor
(involves: 129S7/SvEvBrd)
|
abnormal macrophage physiology
|
J:80658
|
Fyntm1Sor/Fyntm1Sor
Lcktm1Litt/Lcktm1.1Litt
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129S7/SvEvBrd * 129X1/SvJ)
|
abnormal regulatory T cell physiology
|
J:152472
|
| decreased T cell proliferation
|
J:152472
|
G6pc2tm1.1Pesa/G6pc2tm1.1Pesa
(NOD.129S2-G6pc2tm1.1Pesa)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:160286
|
| decreased T cell proliferation
|
J:160286
|
G6pc3tm1Jyc/G6pc3tm1Jyc
(involves: 129S4/SvJae * C57BL/6)
|
abnormal neutrophil physiology
|
J:120741
|
| impaired granulocyte bactericidal activity
|
J:120741
|
Gab2tm1Hhg/Gab2tm1Hhg
(involves: 129S4/SvJae)
|
decreased mast cell degranulation
|
J:70424
|
| decreased susceptibility to type I hypersensitivity reaction
|
J:70424
|
Gab2tm1Thir/Gab2tm1Thir
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal mast cell physiology
|
J:75092
|
Gab2tm3.1Thir/Gab2tm3.1Thir
(involves: 129T/SvJcl * C57BL/6Jcl)
|
decreased mast cell degranulation
|
J:178045
|
| decreased susceptibility to type I hypersensitivity reaction
|
J:178045
|
Gab2tm4.1Thir/Gab2tm4.1Thir
(involves: 129T/SvJcl * C57BL/6Jcl)
|
decreased mast cell degranulation
|
J:178045
|
| decreased susceptibility to type I hypersensitivity reaction
|
J:178045
|
Gab3em1Khoe/Gab3em1Khoe
(C57BL/6-Gab3em1Khoe)
|
abnormal NK cell physiology
|
J:291290
|
Gab3m1Khoe/Gab3m1Khoe
(C57BL/6-Gab3m1Khoe)
|
abnormal NK cell physiology
|
J:291290
|
Gabpb2Gt(RRJ488)Byg/Gabpb2Gt(RRJ488)Byg
(involves: 129P2/OlaHsd)
|
increased B cell proliferation
|
J:141846
|
| increased IgG1 level
|
J:141846
|
| increased IgM level
|
J:141846
|
Gadd45atm1Ajf/Gadd45atm1Ajf
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129X1/SvJ * C57BL/6))
|
increased IgG1 level
|
J:76041
|
| increased IgM level
|
J:76041
|
| increased T cell proliferation
|
J:76041
|
Gadd45btm1Flv/Gadd45btm1Flv
(involves: 129S6/SvEvTac)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:87396
|
| abnormal dendritic cell physiology
|
J:87396
|
| abnormal T-helper 1 physiology
|
J:87396
|
| abnormal T-helper 2 physiology
|
J:87396
|
Gadd45btm1Flv/Gadd45btm1Flv
(B6.129S6-Gadd45btm1Flv)
|
abnormal T-helper 1 physiology
|
J:118837
|
| increased T cell proliferation
|
J:118837
|
Gadd45btm1Flv/Gadd45btm1Flv
Gadd45gtm1Flv/Gadd45gtm1Flv
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6)
|
increased IgG1 level
|
J:118837
|
| increased IgM level
|
J:118837
|
Gadd45gtm1Flv/Gadd45gtm1Flv
(involves: 129S1/Sv)
|
abnormal NK cell physiology
|
J:87396
|
| abnormal T-helper 1 physiology
|
J:69475
|
| abnormal type IV hypersensitivity reaction
|
J:69475
|
Galctwi/Galctwi
(B6.CE-Galctwi/J)
|
abnormal osteoclast physiology
|
J:165361
|
Galctwi/Galctwi
Glb1tm1Adz/Glb1tm1Adz
(involves: 129P2/OlaHsd * C57BL/6J * CE/J)
|
abnormal macrophage physiology
|
J:63197
|
Galnt1tm1.1Jxm/Galnt1tm1.1Jxm
(B6NHsd.Cg-Galnt1tm1.1Jxm)
|
decreased IgG level
|
J:128982
|
| impaired leukocyte tethering or rolling
|
J:128982
|
Gapttm1.1Wz/Gapttm1.1Wz
(Not Specified)
|
increased B cell proliferation
|
J:138146
|
| increased IgG2b level
|
J:138146
|
| increased IgG3 level
|
J:138146
|
| increased IgM level
|
J:138146
|
Gata3tm1Iho/Gata3tm1Iho
Tg(Lck-cre)1Cwi/0
(involves: BALB/c)
|
increased T cell apoptosis
|
J:86996
|
Gata3tm1Jfz/Gata3tm1Jfz
Tg(Tnfrsf4-cre)1Nik/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased IgE level
|
J:93538
|
Gba1tm1Rlp/Gba1tm1Rlp
(involves: 129S4/SvJae * C57BL/6)
|
increased IgG level
|
J:76409
|
Gbp2btm1Tigm/Gbp2btm1Tigm
(B6.129S5-Gbp2btm1Tigm/Jdmm)
|
abnormal macrophage physiology
|
J:172364
|
Gbp5tm1Tigm/Gbp5tm1Tigm
(B6.Cg-Gbp5tm1Tigm)
|
impaired neutrophil recruitment
|
J:183942
|
Gcnt1tm1Jxm/Gcnt1tm1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal leukocyte migration
|
J:113195
|
| impaired leukocyte tethering or rolling
|
J:113195
|
Gcnt3tm1.1Jxm/Gcnt3tm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased IgA level
|
J:149909
|
| decreased IgG1 level
|
J:149909
|
| decreased IgG2a level
|
J:149909
|
| decreased IgG2b level
|
J:149909
|
Gfi1Gen/Gfi1+
(C57BL/6J-Gfi1Gen)
|
abnormal NK cell physiology
|
J:182679
|
| decreased NK cell degranulation
|
J:182679
|
Gfi1tm1Wep/Gfi1tm1Wep
(B6.129-Gfi1tm1Wep)
|
abnormal T cell proliferation
|
J:117105
|
Gfi1tm1Wep/Gfi1tm1Wep
Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal T cell proliferation
|
J:117105
|
| abnormal T-helper 2 physiology
|
J:117105
|
ggld/ggld
(MRL/MpJ-Faslpr/J-ggld)
|
decreased IgG1 level
|
J:14258
|
Ggta1tm1Jbl/Ggta1+
Ightm1Jiac/Ightm1Jiac
Igktm1Jiac/Igktm1Jiac
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
abnormal B cell physiology
|
J:133032
|
Ggta1tm1Jbl/Ggta1tm1Jbl
(involves: 129S2/SvPas)
|
abnormal immunoglobulin level
|
J:113488
|
| decreased IgG level
|
J:90851
|
| increased IgM level
|
J:90851
|
Gimap1m1Btlr/Gimap1m1Btlr
(C57BL/6J-Gimap1m1Btlr)
|
decreased IgD level
|
J:267546
|
| increased IgM level
|
J:267546
|
Gimap1tm1.1Gwb/Gimap1tm1.1Gwb
Tg(CD2-icre)4Kio/0
(involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:160782
|
| abnormal CD8-positive, alpha-beta T cell physiology
|
J:160782
|
Gimap4tm1Jcbs/Gimap4tm1Jcbs
(B6.129P2-Gimap4tm1Jcbs)
|
abnormal T cell physiology
|
J:135744
|
Gimap5m1Btlr/Gimap5m1Btlr
(involves: C57BL/6J)
|
abnormal B cell physiology
|
J:160090
|
| abnormal B cell proliferation
|
J:160090
|
| abnormal NK T cell physiology
|
J:160090
|
| decreased B cell proliferation
|
J:160090
|
| decreased IgG1 level
|
J:160090
|
| decreased IgG2a level
|
J:160090
|
| decreased IgG2b level
|
J:160090
|
| decreased IgG3 level
|
J:160090
|
| decreased IgG level
|
J:160090
|
| decreased IgM level
|
J:160090
|
Gimap6tm1.1Gwb/Gimap6tm1.1Gwb
Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal T cell physiology
|
J:262059
|
| increased T cell apoptosis
|
J:262059
|
Git2Gt(XG510)Byg/Git2Gt(XG510)Byg
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129 * C57BL/6J * DBA/2J)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:160613
|
| abnormal CD8-positive, alpha-beta T cell physiology
|
J:160613
|
Git2tm1Hsb/Git2tm1Hsb
(involves: C57BL/6 * CBA)
|
abnormal neutrophil physiology
|
J:112663
|
| impaired neutrophil chemotaxis
|
J:112663
|
Gja1tm1.1Kwi/Gja1+
(involves: 129P2/OlaHsd)
|
abnormal neutrophil physiology
|
J:129091
|
Gja1tm1Kwi/Gja1tm5(cre/ERT)Kwi
(involves: 129P2/OlaHsd)
|
abnormal neutrophil physiology
|
J:129091
|
Gkn2tm1.1(KOMP)Vlcg/Gkn2tm1.1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal T-helper 1 physiology
|
J:234656
|
Glb1tm1Jmat/Glb1tm1Jmat
(involves: C57BL/6 * CBA * ICR)
|
abnormal macrophage chemotaxis
|
J:102576
|
Glg1Gt(RST092)Byg/Glg1+
(B6J.129P2-Glg1Gt(RST092)Byg)
|
abnormal cellular extravasation
|
J:226586
|
| abnormal leukocyte adhesion
|
J:226586
|
| enhanced leukocyte tethering or rolling
|
J:226586
|
Glt8d2tm1Lex/Glt8d2tm1Lex
(B6;129S5-Glt8d2tm1Lex/Mmucd)
|
abnormal adaptive immunity
|
J:171883
|
| decreased IgG1 level
|
J:171883
|
| decreased IgG2a level
|
J:171883
|
Gm614tm1.1Cya/Gm614tm1.1Cya
Ighg1tm1(cre)Cgn/Ighg1+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)
|
increased B cell apoptosis
|
J:307345
|
Gm36723em1Flv/Gm36723em1Flv
(C57BL/6-Gm36723em1Flv)
|
abnormal NK cell physiology
|
J:258967
|
| impaired natural killer cell mediated cytotoxicity
|
J:258967
|
Gm40600em1Cya/Gm40600em1Cya
(C57BL/6-Gm40600em1Cya)
|
decreased IgA level
|
J:311878
|
| decreased IgE level
|
J:311878
|
| decreased IgG1 level
|
J:311878
|
| decreased IgG2b level
|
J:311878
|
| decreased IgG2c level
|
J:311878
|
| decreased IgG3 level
|
J:311878
|
| decreased IgG level
|
J:311878
|
| decreased IgM level
|
J:311878
|
| increased IgA level
|
J:311878
|
| increased IgE level
|
J:311878
|
| increased IgG1 level
|
J:311878
|
| increased IgG2b level
|
J:311878
|
| increased IgG2c level
|
J:311878
|
| increased IgG3 level
|
J:311878
|
| increased IgG level
|
J:311878
|
| increased IgM level
|
J:311878
|
Gmfgtm1Jyw/Gmfgtm1Jyw
(B6.Cg-Gmfgtm1Jyw)
|
abnormal marginal zone B cell physiology
|
J:345500
|
| decreased lymphocyte chemotaxis
|
J:345500
|
| impaired B cell migration
|
J:345500
|
| increased IgM level
|
J:345500
|
Gmnntm1.1Kio/Gmnntm1.2Kio
Tg(CD2-icre)4Kio/0
(involves: 129S4/SvJae * C57BL/10 * CBA/Ca)
|
decreased T cell proliferation
|
J:159657
|
Gna11tm1Soff/Gna11tm1Soff
(involves: 129S7/SvEvBrd)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:146132
|
Gna11tm1Soff/Gna11tm1Soff
Gnaqtm2Soff/Gnaqtm2Soff
Tg(Tek-icre/ERT2)1Soff/?
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:146132
|
Gna12tm1.1Cgh/Gna12tm1.1Cgh
Gna13tm2Cgh/Gna13tm2Cgh
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
decreased B cell apoptosis
|
J:174313
|
Gna12tm1Citb/Gna12tm1Citb
Gna13tm2.1Soff/Gna13tm2.1Soff
Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:149560
|
| increased susceptibility to type IV hypersensitivity reaction
|
J:149560
|
| increased T cell proliferation
|
J:149560
|
Gnai2tm1Lbi/Gnai2tm1Lbi
(involves: 129S7/SvEvBrd)
|
abnormal neutrophil physiology
|
J:121471
|
| increased IgA level
|
J:30507
|
| increased IgG level
|
J:30507
|
| increased immunoglobulin level
|
J:30507
|
| increased T cell proliferation
|
J:30507
|
Gnai2tm1Lbi/Gnai2tm1Lbi
(either: 129 or (involves: 129S7/SvEvBrd * C57BL/6J))
|
increased IgG level
|
J:24434
|
| increased IgM level
|
J:24434
|
Gnai2tm1Lbi/Gnai2tm1Lbi
(B6.129S7-Gnai2tm1Lbi)
|
abnormal cellular extravasation
|
J:120069
|
| abnormal eosinophil physiology
|
J:120069
|
| abnormal leukocyte adhesion
|
J:120069
|
| abnormal T cell physiology
|
J:121161
|
Gnai3tm1Lbi/Gnai3tm1Lbi
(B6.129S-Gnai3tm1Lbi)
|
abnormal T cell physiology
|
J:121161
|
Gnptabtm1Kkol/Gnptabtm1Kkol
(involves: 129 * C57BL/6)
|
abnormal osteoclast physiology
|
J:202751
|
Gon4ljusty/Gon4ljusty
(C3HeB/FeJ-Gon4ljusty)
|
decreased immunoglobulin level
|
J:163412
|
Gpa33tm1Jkhh/Gpa33tm1Jkhh
(B6.129-Gpa33tm1Jkhh)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:224768
|
Gpnmbtm1Ari/Gpnmbtm1Ari
(C57BL/6-Gpnmbtm1Ari)
|
abnormal dendritic cell physiology
|
J:215931
|
Gpr15tm1.1Litt/Gpr15tm1.1Litt
(B6.129P2-Gpr15tm1.1Litt)
|
abnormal regulatory T cell physiology
|
J:199126
|
Gpr15lgtm1Lex/Gpr15lgtm1Lex
(B6;129S5-Gpr15lgtm1Lex/Mmucd)
|
increased IgG2a level
|
J:171883
|
Gpr31btm1Ktak/Gpr31btm1Ktak
(B6.Cg-Gpr31btm1Ktak)
|
abnormal dendritic cell physiology
|
J:271242
|
Gpr34tm1.1Shbg/Gpr34tm1.1Shbg
(B6.Cg-Gpr34tm1.1Shbg)
|
abnormal leukocyte migration
|
J:168120
|
| increased susceptibility to type IV hypersensitivity reaction
|
J:168120
|
Gpr55tm1.1Mijr/Gpr55tm1.1Mijr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal osteoclast physiology
|
J:153225
|
Gpr65tm1Witt/Gpr65tm1Witt
(B6.Cg-Gpr65tm1Witt)
|
abnormal leukocyte physiology
|
J:96112
|
Gpr65tm1Witt/Gpr65tm1Witt
(C.Cg-Gpr65tm1Witt)
|
abnormal leukocyte physiology
|
J:96112
|
Gpr65Tn(sb-lacZ,GFP)T1.88Jtak/Gpr65Tn(sb-lacZ,GFP)T1.88Jtak
(B6.Cg-Gpr65Tn(sb-lacZ,GFP)T1.88Jtak)
|
abnormal macrophage physiology
|
J:146233
|
Gpr68tm1.1Yaxu/Gpr68tm1.1Yaxu
(B6.Cg-Gpr68tm1.1Yaxu)
|
abnormal osteoclast physiology
|
J:149315
|
Gpr68tm1.1Yaxu/Gpr68tm1.1Yaxu
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
abnormal macrophage physiology
|
J:149315
|
| abnormal osteoclast physiology
|
J:149315
|
Gpr68tm1Yaxu/Gpr68tm1Yaxu
(involves: C57BL/6)
|
abnormal macrophage physiology
|
J:149315
|
| abnormal osteoclast physiology
|
J:149315
|
Gpr84tm1Lex/Gpr84tm1Lex
(involves: 129S/SvEvBrd * C57BL/6)
|
abnormal T-helper 2 physiology
|
J:186985
|
Gpr132tm1Witt/Gpr132tm1Witt
(B6.129X1-Gpr132tm1Witt)
|
impaired macrophage chemotaxis
|
J:96613
|
Gpr132tm1Witt/Gpr132tm1Witt
(involves: 129X1/SvJ * BALB/c)
|
abnormal lymphocyte physiology
|
J:69473
|
| increased B cell proliferation
|
J:69473
|
| increased IgA level
|
J:69473
|
| increased IgG1 level
|
J:69473
|
| increased immunoglobulin level
|
J:69473
|
| increased T cell proliferation
|
J:69473
|
Gpr132tm1Witt/Gpr132tm1Witt
Ldlrtm1Her/Ldlrtm1Her
(B6.129-Ldlrtm1Her Gpr132tm1Witt)
|
decreased macrophage apoptosis
|
J:100498
|
Gpr174tm1Cys/Y
(B6.129-Gpr174tm1Cys)
|
abnormal regulatory T cell physiology
|
J:222307
|
| increased T cell proliferation
|
J:222307
|
Gpr183tm1.1Cys/Gpr183tm1.1Cys
(B6.129P2-Gpr183tm1.1Cys)
|
abnormal follicular B cell physiology
|
J:151077
|
Gpr183tm1.2Rbr/Gpr183tm1.2Rbr
(involves: C57BL/6 * FVB/N * SJL)
|
abnormal B cell physiology
|
J:151883
|
Gpr183tm1.2Rbr/Gpr183tm1.2Rbr
Ightm1Rbr/Ightm1Rbr
Tg(IgkHyHEL10)1Rbr/0
(involves: C57BL/6 * FVB/N * SJL)
|
abnormal B cell physiology
|
J:151883
|
| abnormal B cell proliferation
|
J:151883
|
| decreased IgG1 level
|
J:151883
|
| decreased IgM level
|
J:151883
|
| impaired B cell migration
|
J:151883
|
Gpsm3Gt(IST12408A1)Tigm/Gpsm3Gt(IST12408A1)Tigm
(involves: C57BL/6N)
|
abnormal leukocyte migration
|
J:193270
|
| abnormal leukocyte physiology
|
J:193270
|
Graptm1Gsf/Graptm1Gsf
(B6.129-Graptm1Gsf)
|
increased T cell proliferation
|
J:76243
|
Grb2tm1Lnit/Grb2tm1Lnit
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * BALB/cJ)
|
abnormal B cell physiology
|
J:171222
|
| abnormal memory B cell physiology
|
J:171222
|
| decreased IgG3 level
|
J:171222
|
| decreased IgG level
|
J:171222
|
| increased B cell apoptosis
|
J:171222
|
| increased B cell proliferation
|
J:171222
|
| increased IgM level
|
J:171222
|
Grhl3tm1a(EUCOMM)Wtsi/Grhl3+
(C57BL/6N-Grhl3tm1a(EUCOMM)Wtsi/Ics)
|
decreased IgE level
|
J:165965
|
Grk2tm1Gwd/Grk2tm1Gwd
Cd79atm1(cre)Reth/Cd79a+
(involves: 129 * BALB/c * C57BL/6)
|
abnormal B cell physiology
|
J:176118
|
Grk2tm1Gwd/Grk2tm1Mca
Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal T cell physiology
|
J:176118
|
| impaired leukocyte tethering or rolling
|
J:176118
|
Grk6tm1.1Mca/Grk6tm1.1Mca
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal B cell physiology
|
J:76872
|
| abnormal T cell physiology
|
J:76872
|
Grk6tm1.1Mca/Grk6tm1.1Mca
(B6.129S4-Grk6tm1.1Mca)
|
impaired macrophage phagocytosis
|
J:225063
|
| increased IgG level
|
J:225063
|
Grntm1.1Aidi/Grntm1.1Aidi
(involves: C57BL/6 * C57BL/6J)
|
abnormal macrophage physiology
|
J:156824
|
| abnormal microglial cell physiology
|
J:156824
|
Grntm1.1Far/Grntm1.1Far
(involves: 129S4/SvJae * FVB/N)
|
abnormal macrophage physiology
|
J:170823
|
Grntm2.1Far/Grntm2.1Far
(involves: 129S4/SvJae * C57BL/6)
|
abnormal macrophage physiology
|
J:259651
|
Gsdmdem1Fcw/Gsdmdem2Fcw
(involves: C57BL/6)
|
abnormal macrophage apoptosis
|
J:226781
|
Gsdmdem3Fcw/Gsdmdem3Fcw
(involves: C57BL/6)
|
abnormal macrophage apoptosis
|
J:226781
|
Gsdmdem4Fcw/Gsdmdem4Fcw
(C57BL/6N-Gsdmdem4Fcw/J)
|
abnormal macrophage apoptosis
|
J:101977
|
Gsntm1Djk/Gsntm1Djk
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
abnormal osteoclast physiology
|
J:60625
|
| impaired neutrophil chemotaxis
|
J:24346
|
| impaired neutrophil recruitment
|
J:24346
|
Gt(ROSA)26Sortm1(CAG-Bcl3,-EGFP)Hoev/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:208980
|
| decreased B cell apoptosis
|
J:208980
|
| decreased B cell proliferation
|
J:208980
|
| decreased IgG1 level
|
J:208980
|
| decreased IgG2b level
|
J:208980
|
| decreased IgG3 level
|
J:208980
|
| decreased IgM level
|
J:208980
|
Gt(ROSA)26Sortm1(cre/ERT2)Thl/Gt(ROSA)26Sor+
Mcl1tm1Ywh/Mcl1tm1Ywh
(involves: 129/Sv * 129S6/SvEvTac * C57BL/6)
|
increased T cell apoptosis
|
J:137400
|
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
Il1r2tm1.1Mchc/Il1r2tm1.1Mchc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6NTac)
|
abnormal adaptive immunity
|
J:347877
|
| increased IgG level
|
J:347877
|
Gt(ROSA)26Sortm1(DTA)Lky/Gt(ROSA)26Sor+
Il13tm1(YFP/cre)Lky/Il13tm1(YFP/cre)Lky
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
decreased IgG1 level
|
J:178986
|
Gt(ROSA)26Sortm1(DTA)Lky/Gt(ROSA)26Sortm1(DTA)Lky
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:133382
|
Gt(ROSA)26Sortm1(ETV6/SYK)Hjum/Gt(ROSA)26Sor+
Cd79atm3(cre/ERT2)Reth/Cd79a+
(involves: 129S6/SvEvTac * BALB/c)
|
increased B cell apoptosis
|
J:208904
|
| increased B cell proliferation
|
J:208904
|
| increased IgM level
|
J:208904
|
Gt(ROSA)26Sortm1(ETV6/SYK)Hjum/Gt(ROSA)26Sor+
Cd79atm3(cre/ERT2)Reth/Cd79a+
Tg(BCL2)22Wehi/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6JWehi * SJL/JWehi)
|
abnormal B cell physiology
|
J:208904
|
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Ighg1tm1(cre)Cgn/Ighg1+
Prdm1tm2Masu/Prdm1tm2Masu
(involves: 129P2/OlaHsd * 129X1/SvJ)
|
abnormal germinal center B cell physiology
|
J:167612
|
| decreased IgG1 level
|
J:167612
|
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Plcg1tm1Gcrp/Plcg1tm1Rwen
Tg(Cd4-cre)1Cwi/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal regulatory T cell physiology
|
J:157757
|
| abnormal T cell activation
|
J:157757
|
| decreased T cell proliferation
|
J:157757
|
| increased T cell apoptosis
|
J:157757
|
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Rev3ltm1.1Diaz/Rev3ltm1.1Diaz
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129X1/SvJ * BALB/c * C57BL/6 * C57BL/6NTac)
|
abnormal class switch recombination
|
J:188723
|
| abnormal somatic hypermutation frequency
|
J:188723
|
| decreased B cell proliferation
|
J:188723
|
Gt(ROSA)26Sortm1(gp80,EGFP)Eces/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+
(either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6) or (involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6))
|
abnormal class switch recombination
|
J:172031
|
| decreased B cell apoptosis
|
J:172031
|
| decreased IgA level
|
J:172031
|
| decreased IgG1 level
|
J:172031
|
| decreased IgG2a level
|
J:172031
|
| decreased IgG3 level
|
J:172031
|
| increased IgE level
|
J:172031
|
Gt(ROSA)26Sortm1(gp80,EGFP)Eces/Gt(ROSA)26Sor+
Ighg1tm1(cre)Cgn/Ighg1+
(either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6) or (involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6))
|
abnormal class switch recombination
|
J:172031
|
| decreased IgA level
|
J:172031
|
| decreased IgG1 level
|
J:172031
|
| decreased IgG2a level
|
J:172031
|
| decreased IgG2b level
|
J:172031
|
| decreased IgG3 level
|
J:172031
|
| increased IgE level
|
J:172031
|
Gt(ROSA)26Sortm1(ITK/SYK)Jrld/Gt(ROSA)26Sor+
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal T cell activation
|
J:160931
|
| increased T cell proliferation
|
J:160931
|
Gt(ROSA)26Sortm1(MAML1)Wsp/Gt(ROSA)26Sor+
Tg(Cd4-cre)1Cwi/0
(B6.Cg-Tg(Cd4-cre)1Cwi Gt(ROSA)26Sortm1(MAML1)Wsp)
|
abnormal immunoglobulin level
|
J:113262
|
| abnormal T-helper 1 physiology
|
J:113262
|
| abnormal T-helper 2 physiology
|
J:113262
|
Gt(ROSA)26Sortm1(Nfatc2*)Rao/Gt(ROSA)26Sor+
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal T cell activation
|
J:148341
|
Gt(ROSA)26Sortm1.1(CAG-Trp53*,-EGFP)Medz/Gt(ROSA)26Sortm1.1(CAG-Trp53*,-EGFP)Medz
(involves: C57BL/6)
|
decreased thymocyte apoptosis
|
J:158953
|
Gt(ROSA)26Sortm1.1(Ubc-BCL3)Sbn/Gt(ROSA)26Sor+
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6)
|
decreased B cell proliferation
|
J:207111
|
Gt(ROSA)26Sortm2(CAG-Notch2*)Uzs/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)
|
abnormal marginal zone B cell physiology
|
J:179036
|
| decreased IgG1 level
|
J:179036
|
| decreased IgG3 level
|
J:179036
|
| decreased IgM level
|
J:179036
|
| increased B cell proliferation
|
J:179036
|
Gt(ROSA)26Sortm2(ITK/Syk)Hjum/Gt(ROSA)26Sor+
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal immunoglobulin level
|
J:207306
|
| increased IgA level
|
J:207306
|
| increased IgG level
|
J:207306
|
| increased IgM level
|
J:207306
|
Gt(ROSA)26Sortm2(ITK/Syk)Hjum/Gt(ROSA)26Sor+
Tg(Lck-cre)I57Jxm/0
(involves: 129S6/SvEvTac * ICR)
|
abnormal immunoglobulin level
|
J:207306
|
| increased IgA level
|
J:207306
|
| increased IgG level
|
J:207306
|
| increased IgM level
|
J:207306
|
Gt(ROSA)26Sortm2(Lmp1/CD40)Uzs/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal B cell activation
|
J:137122
|
| abnormal B cell physiology
|
J:137122
|
| abnormal class switch recombination
|
J:137122
|
| abnormal T cell activation
|
J:137122
|
| increased B cell proliferation
|
J:137122
|
Gt(ROSA)26Sortm2(Mirn150)Rsky/Gt(ROSA)26Sortm2(Mirn150)Rsky
(involves: C57BL/6 * SJL/J)
|
increased B cell apoptosis
|
J:127234
|
Gt(ROSA)26Sortm2(Nfatc2*)Rao/Gt(ROSA)26Sor+
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal T cell activation
|
J:148341
|
Gt(ROSA)26Sortm2.1(Mirn150)Rsky/Gt(ROSA)26Sortm2.1(Mirn150)Rsky
(involves: C57BL/6 * SJL/J)
|
increased B cell apoptosis
|
J:127234
|
Gt(ROSA)26Sortm2Sho/Gt(ROSA)26Sor+
Lef1tm1Hhx/Lef1tm1Hhx
Tg(GZMB-cre)1Jcb/0
(involves: 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
abnormal memory T cell physiology
|
J:189838
|
Gt(ROSA)26Sortm3(CAG-Il17a)Awai/Gt(ROSA)26Sor+
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal neutrophil physiology
|
J:144710
|
Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky/Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky
Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal B cell activation
|
J:133215
|
| abnormal CD4-positive, alpha-beta T cell physiology
|
J:133215
|
| abnormal immunoglobulin level
|
J:133215
|
| abnormal T cell activation
|
J:133215
|
| increased B cell proliferation
|
J:133215
|
| increased IgG2a level
|
J:133215
|
| increased IgG2b level
|
J:133215
|
| increased IgG3 level
|
J:133215
|
| increased IgM level
|
J:133215
|
Gt(ROSA)26Sortm4(Ikbkb)Rsky/Gt(ROSA)26Sor+
Ighg1tm1(cre)Cgn/Ighg1+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased IgG1 level
|
J:167612
|
| increased IgM level
|
J:167612
|
Gt(ROSA)26Sortm4(Ikbkb)Rsky/Gt(ROSA)26Sor+
Ighg1tm1(cre)Cgn/Ighg1+
Prdm1tm2Masu/Prdm1tm2Masu
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal germinal center B cell physiology
|
J:167612
|
| decreased IgG1 level
|
J:167612
|
Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky/Gt(ROSA)26Sortm13(CAG-MYC,-CD2*)Rsky
Ighg1tm1(cre)Cgn/Ighg1+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:191824
|
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
Map3k14tm1.1Gne/Map3k14tm1.1Gne
(B6(Cg)-Map3k14tm1.1Gne Gt(ROSA)26Sortm9(cre/ESR1)Arte)
|
abnormal immunoglobulin level
|
J:240453
|
| decreased B cell proliferation
|
J:240453
|
| decreased IgA level
|
J:240453
|
| decreased IgG1 level
|
J:240453
|
| decreased IgM level
|
J:240453
|
Gt(ROSA)26Sortm10(Lmp1)Rsky/Gt(ROSA)26Sor+
(involves: BALB/cJ)
|
increased B cell proliferation
|
J:181546
|
Gt(ROSA)26Sortm10(Lmp1)Rsky/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * BALB/cJ)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:181546
|
| increased B cell proliferation
|
J:181546
|
Gt(ROSA)26Sortm11(Lmp1)Rsky/Gt(ROSA)26Sor+
(involves: C57BL/6)
|
increased B cell proliferation
|
J:181546
|
Gt(ROSA)26Sortm11(Lmp1)Rsky/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:181546
|
| abnormal CD8-positive, alpha-beta T cell physiology
|
J:181546
|
| increased B cell proliferation
|
J:181546
|
Gt(ROSA)26Sortm11(Lmp1)Rsky/Gt(ROSA)26Sor+
Cd19tm1(cre/ERT2)Rsky/Cd19+
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal T cell physiology
|
J:217520
|
Gzmatm1Ley/Gzmatm1Ley
(involves: 129X1/SvJ * C57BL/6)
|
decreased cytotoxic T cell cytolysis
|
J:49361
|
Gzmatm1Simn/Gzmatm1Simn
Gzmbtm1Ley/Gzmbtm1Ley
(involves: 129S2/SvPas * C57BL/6)
|
abnormal leukocyte physiology
|
J:44204
|
Gzmbtm1Ley/Gzmbtm1Ley
(involves: 129S2/SvPas * C57BL/6J)
|
decreased cytotoxic T cell cytolysis
|
J:23560
|
Gzmbtm1Ley/Gzmbtm1Ley
(B6.129S2-Gzmbtm1Ley)
|
impaired natural killer cell mediated cytotoxicity
|
J:113213
|
Gzmbtm1Ley/Gzmbtm1Ley
(involves: 129X1/SvJ)
|
abnormal NK cell physiology
|
J:126114
|
| decreased T cell apoptosis
|
J:126114
|
Gzmbtm1Ley/Gzmbtm1Ley
Serpinb9tm1.1Pib/Serpinb9tm1.1Pib
(involves: 129S2/SvPas * BALB/cJ * C57BL/6J)
|
decreased cytotoxic T cell apoptosis
|
J:252016
|
Gzmbtm1Ley/Gzmbtm1Ley
Serpinb9tm1Arp/Serpinb9tm1Arp
(involves: 129S2/SvPas * C57BL/6)
|
abnormal cytotoxic T cell physiology
|
J:113349
|
Gzmbtm2.1Ley/Gzmbtm2.1Ley
(129X1/SvJ-Gzmbtm2.1Ley)
|
decreased cytotoxic T cell cytolysis
|
J:96538
|
Gzmbtm2Ley/Gzmbtm2Ley
(129X1/SvJ-Gzmbtm2Ley)
|
decreased cytotoxic T cell cytolysis
|
J:96538
|
H2-Aab-tm1Blt/H2-Aab-tm1Blt
(C57BL/6-H2-Aab-tm1Blt)
|
abnormal MHC II cell surface expression on macrophages
|
J:67924
|
H2-Ab1b-tm1.1Jssh/H2-Ab1b-tm1.1Jssh
(C57BL/6-H2-Ab1b-tm1.1Jssh)
|
abnormal dendritic cell antigen presentation
|
J:201198
|
H2-Ab1b-tm1.1Sish/H2-Ab1b-tm1.1Sish
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal dendritic cell physiology
|
J:157516
|
H2-Ab1b-tm1Doi/H2-Ab1b-tm1Doi
(involves: 129S2/SvPas * C57BL/6)
|
abnormal B cell physiology
|
J:65736
|
| abnormal CD4-positive, alpha-beta T cell physiology
|
J:65736
|
| abnormal T cell physiology
|
J:65736
|
| decreased IgG1 level
|
J:65736
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
(involves: 129S2/SvPas * C57BL/6J)
|
decreased IgG level
|
J:74418
|
| increased IgM level
|
J:74418
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
(B6.129S2-H2-Ab1b-tm1Gru)
|
abnormal B cell physiology
|
J:91341
|
| abnormal lymphocyte physiology
|
J:91341
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
(involves: 129S2/SvPas * C57BL/6)
|
decreased IgG1 level
|
J:67941
|
| decreased IgM level
|
J:67941
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(Ab1TL)1Gru/0
(B6.Cg-H2-Ab1b-tm1Gru Tg(Ab1TL)1Gru)
|
abnormal macrophage antigen presentation
|
J:91341
|
| abnormal professional antigen presenting cell physiology
|
J:91341
|
H2-Ab1b-tm1Koni/H2-Ab1b-tm1.1Koni
Tg(Tek-cre)12Flv/0
(involves: 129X1/SvJ * C3H * C57BL/6 * C57BL/6J)
|
abnormal T cell activation
|
J:131774
|
H2-Ab1b-tm1Wug/H2-Ab1b-tm1Wug
(involves: C57BL/6)
|
abnormal B cell physiology
|
J:204951
|
| abnormal dendritic cell physiology
|
J:204951
|
H2-Ab1b-tm1Wug/H2-Ab1b-tm1Wug
Cd19tm1(cre)Cgn/Cd19+
(involves: 129S2/SvPas * C57BL/6)
|
abnormal B cell physiology
|
J:204951
|
| abnormal dendritic cell physiology
|
J:204951
|
H2-Ab1bm12/H2-Ab1bm12
(B6(C)-H2-Ab1bm12/KhEgJ)
|
abnormal T cell physiology
|
J:100123
|
H2-Ab1bm12/H2-Ab1bm12
(NZB.B6(C)-H2-Ab1bm12)
|
abnormal immunoglobulin level
|
J:104189
|
H2-D1b-tm1Bpe/H2-D1b-tm1Bpe
H2-K1b-tm1Bpe/H2-K1b-tm1Bpe
(B6.129P-H2-D1b-tm1Bpe H2-K1b-tm1Bpe)
|
abnormal cytotoxic T cell physiology
|
J:118960
|
H2-D1b-tm1Bpe/H2-D1b-tm1Bpe
H2-K1b-tm1Bpe/H2-K1b-tm1Bpe
Klra1tm1.1Wyok/Klra1tm1.1Wyok
Tg(H2-Dd)28Bee/0
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6NTac * DBA/2)
|
abnormal NK cell physiology
|
J:252851
|
H2-D1bm14/H2-D1bm14
(C57BL/6)
|
abnormal T cell activation
|
J:97717
|
H2-DMatm1Doi/H2-DMatm1Doi
(involves: 129S2/SvPas * C57BL/6)
|
abnormal professional antigen presenting cell physiology
|
J:31624
|
H2-DMatm1Liz/H2-DMatm1Liz
(involves: BALB/cJ)
|
abnormal professional antigen presenting cell physiology
|
J:111565,
J:113714
|
H2-DMatm1Lkrl/H2-DMatm1Lkrl
(involves: 129P2/OlaHsd)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:31786
|
| abnormal professional antigen presenting cell physiology
|
J:31786
|
H2-DMatm1Luc/H2-DMatm1Luc
(involves: 129S4/SvJae)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:31625
|
H2-DMatm1Luc/H2-DMatm1Luc
(B6.129S4-H2-Dmatm1Luc)
|
abnormal T-helper 1 physiology
|
J:125654
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:125654
|
H2-DMatm2Liz/H2-DMatm2Liz
(involves: C57BL/6 * C57BL/10 * C57BR * CBA)
|
abnormal professional antigen presenting cell physiology
|
J:111565
|
| decreased T cell proliferation
|
J:111565
|
H2-M3tm1Crw/H2-M3tm1Crw
(B6.129-H2-M3tm1Crw)
|
abnormal cytotoxic T cell physiology
|
J:118960
|
| decreased macrophage nitric oxide production
|
J:118960
|
| impaired natural killer cell mediated cytotoxicity
|
J:118960
|
H2-Oatm1Lkar/H2-Oatm1Lkar
(involves: 129P2/OlaHsd)
|
increased IgG1 level
|
J:85084
|
H2-T23tm1Cant/H2-T23tm1Cant
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:142087,
J:123555
|
| abnormal memory T cell physiology
|
J:123555
|
H2-T23tm2Cant/H2-T23tm2Cant
(involves: 129S6/SvEvTac)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:123555
|
H2-T23tm2Cant/H2-T23tm2Cant
(B6.129S6-H2-T23tm2Cant)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:142087
|
H2-T23tm2Cant/H2-T23tm2Cant
Tg(Tcra2D2,Tcrb2D2)1Kuch/?
(involves: 129S6/SvEvTac)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:142087
|
H2-T23tm3Cant/H2-T23tm3Cant
Tg(Tcra2D2,Tcrb2D2)1Kuch/?
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:142087
|
H2-T23tm3Cant/H2-T23tm3Cant
Tg(TcraTcrb)425Cbn/?
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:142087
|
H2b/H2b
Nfkbidtm1Clay/Nfkbidtm1Clay
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcraN15,TcrbN15)L2Elre/?
(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6)
|
abnormal thymocyte activation
|
J:132071
|
| decreased T cell proliferation
|
J:132071
|
H2b/H2b
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcraN15,TcrbN15)L2Elre/?
(involves: 129S/SvEv * C57BL/6)
|
abnormal cytotoxic T cell physiology
|
J:133112
|
| increased T cell proliferation
|
J:133112
|
H2d/H2d
Trap1atm1.1Jvde/Y
(involves: 129 * BALB/cJ * C57BL/10 * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:180807
|
H2dlAb1-Ea/H2dlAb1-Ea
(involves: 129S2/SvPas * C57BL/6)
|
abnormal immunoglobulin level
|
J:57484
|
| decreased IgG1 level
|
J:57484
|
| decreased IgG2a level
|
J:57484
|
| increased IgM level
|
J:57484
|
H2q/?
Ncf1m1J/Ncf1m1J
(B6.Cg-Ncf1m1J H2q)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:92437
|
H2u/H2u
Tg(TCRA)B1Jg/?
Tg(TCRB)C14Jg/?
(involves: C57BL/6 * C57BL/10SnSg * DBA/2 * PL/J)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:92991
|
H2axtm1Fwa/H2axtm1Fwa
(involves: 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:84879
|
H2axtm1Nus/H2axtm1Nus
(Not Specified)
|
abnormal class switch recombination
|
J:194603,
J:120658
|
| decreased IgG level
|
J:73342
|
Havcr1tm1Kuch/Havcr1tm1Kuch
(B6.Cg-Havcr1tm1Kuch)
|
abnormal B cell physiology
|
J:186484
|
| abnormal CD4-positive, alpha-beta T cell physiology
|
J:186484
|
| abnormal dendritic cell physiology
|
J:186484
|
Havcr2tm1Bmed/Havcr2tm1Bmed
(B6.Cg-Havcr2tm1Bmed)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:189839
|
| decreased activation-induced cell death of T cells
|
J:189839
|
| decreased T cell proliferation
|
J:189839
|
Hax1tm1.1Gach/Hax1tm1.1Gach
(involves: BALB/c)
|
decreased IgG2a level
|
J:174159
|
Hbnr2SWR/Hbnr2SWR
(involves: CBA * SWR)
|
decreased IgE level
|
J:85787
|
Hbnr6SWR/Hbnr6SWR
(involves: CBA * SWR)
|
increased IgE level
|
J:85787
|
Hbnr7CBA/Hbnr7SWR
(involves: CBA * SWR)
|
decreased IgG1 level
|
J:85787
|
Hbnr7SWR/Hbnr7SWR
(involves: CBA * SWR)
|
decreased IgG2b level
|
J:85787
|
Hcktm1Ern/Hcktm1Ern
(involves: 129S1/Sv * C57BL/6)
|
abnormal macrophage physiology
|
J:111432
|
Hcktm1Hev/Hcktm1Hev
(involves: 129S7/SvEvBrd * C57BL/6J)
|
impaired macrophage phagocytosis
|
J:16994
|
Hcktm1Hev/Hcktm1Hev
(B6.129S7-Hcktm1Hev)
|
abnormal neutrophil physiology
|
J:113463
|
Hcls1tm1Wtn/Hcls1tm1Wtn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:28146
|
| decreased T cell proliferation
|
J:28146
|
Hcls1tm2Wtn/Hcls1tm2Wtn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:28146
|
| decreased T cell proliferation
|
J:28146
|
Hcsttm1.1Cln/Hcsttm1.1Cln
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
impaired natural killer cell mediated cytotoxicity
|
J:80426
|
Hcsttm1.1Cln/Hcsttm1.1Cln
(B6.129P2-Hcsttm1.1Cln)
|
abnormal osteoclast physiology
|
J:147155
|
Hcsttm1.1Cln/Hcsttm1.1Cln
Tyrobptm1Lll/Tyrobptm1Lll
(B6.Cg-Hcsttm1.1Cln Tyrobptm1Lll)
|
abnormal NK T cell physiology
|
J:147867
|
Hcsttm1.1Dnax/Hcsttm1.1Dnax
(involves: C57BL/6)
|
abnormal NK T cell physiology
|
J:147867,
J:148086
|
| impaired natural killer cell mediated cytotoxicity
|
J:148086
|
Hdac1tm1.1Pmt/Hdac1tm1.1Pmt
Hdac2tm1.1Pmt/Hdac2tm1.1Pmt
Cd79atm1(cre)Reth/Cd79a+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * FVB/N)
|
increased B cell apoptosis
|
J:157903
|
Hdac1tm1.1Pmt/Hdac1tm1.1Pmt
Hdac2tm1.1Pmt/Hdac2tm1.1Pmt
Tg(Fcer2a-cre)5Mbu/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA * FVB/N)
|
decreased B cell proliferation
|
J:157903
|
| increased B cell apoptosis
|
J:157903
|
Hdac1tm1.1Shmc/Hdac1tm1.1Shmc
Hdac2tm1.1Shmc/Hdac2tm1.1Shmc
Tg(Lck-cre)1Cwi/0
(involves: 129S7/SvEvBrd)
|
increased T cell proliferation
|
J:194769
|
| increased thymocyte apoptosis
|
J:194769
|
Hdac6tm1.1Pmt/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased IgG level
|
J:132629
|
| decreased IgM level
|
J:132629
|
Hdac6tm1.1Pmt/Hdac6tm1.1Pmt
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased IgG level
|
J:132629
|
| decreased IgM level
|
J:132629
|
Hellstm1a(EUCOMM)Wtsi/Hellstm1a(EUCOMM)Wtsi
(C57BL/6N-Hellstm1a(EUCOMM)Wtsi/Ieg)
|
decreased IgG1 level
|
J:165965
|
Hexbtm1Rlp/Hexbtm1Rlp
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
increased immunoglobulin level
|
J:87617
|
Hif1atm3Rsjo/Hif1atm3Rsjo
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
abnormal leukocyte physiology
|
J:117348
|
| abnormal macrophage physiology
|
J:107682
|
| impaired macrophage chemotaxis
|
J:107682
|
Hif1atm3Rsjo/Hif1atm3Rsjo
Tg(Itgax-cre)1-1Reiz/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal leukocyte migration
|
J:187773
|
Hivep3tm1Glm/Hivep3tm1Glm
(Not Specified)
|
abnormal osteoclast physiology
|
J:184764
|
Hmgb1tm1.1Ttg/Hmgb1tm1.1Ttg
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd)
|
abnormal macrophage physiology
|
J:205499
|
| impaired macrophage phagocytosis
|
J:205499
|
| increased macrophage apoptosis
|
J:205499
|
Hmgn5tm1.2Mbus/Y
(involves: 129S4/SvJae * C57BL/6J)
|
decreased IgE level
|
J:199604
|
| increased IgA level
|
J:199604
|
Hmgn5tm1.2Mbus/Hmgn5tm1.2Mbus
(involves: 129S4/SvJae * C57BL/6J)
|
decreased IgE level
|
J:199604
|
| increased IgA level
|
J:199604
|
Hmgxb4tm1.2Zhji/Hmgxb4tm1.2Zhji
(B6(Cg)-Hmgxb4tm1.2Zhji)
|
decreased macrophage nitric oxide production
|
J:302603
|
Hnrnpdtm1Rjsc/Hnrnpdtm1Rjsc
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal macrophage physiology
|
J:116112
|
Hnrnpltm1.1Tmo/Hnrnpltm1.1Tmo
Tg(Lck-cre)548Jxm/0
(B6.Cg-Hnrnpltm1.1Tmo Tg(Lck-cre)548Jxm)
|
increased T cell proliferation
|
J:188749
|
Hnrnpllthdr/Hnrnpllthdr
(C57BL/6JSfdAnu-Hnrnpllthdr/Anu)
|
abnormal memory T cell physiology
|
J:142641
|
Hoxc4tm2.1Mrc/Hoxc4tm2.1Mrc
(involves: 129S/SvEv * C57BL/6)
|
abnormal class switch recombination
|
J:148278
|
| abnormal somatic hypermutation frequency
|
J:148278
|
| decreased IgA level
|
J:148278
|
| decreased IgE level
|
J:148278
|
| decreased IgG1 level
|
J:148278
|
| decreased IgG2a level
|
J:148278
|
| decreased IgG2b level
|
J:148278
|
| decreased IgG3 level
|
J:148278
|
| decreased IgM level
|
J:148278
|
Hpgdstm1Urad/Hpgdstm1Urad
(B6.129-Hpgdstm1Urad)
|
increased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Hprt1b-m3/Y
Impdh1tm1Bmi/Impdh1tm1Bmi
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased cytotoxic T cell cytolysis
|
J:85443
|
| decreased T cell proliferation
|
J:85443
|
Hprt1b-m3/Y
Impdh2tm1Bmi/Impdh2+
(involves: 129P2/OlaHsd)
|
abnormal cytotoxic T cell physiology
|
J:86045
|
Hprt1tm1(CAG-Tgfbr1*)Lba/Y
Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal T cell activation
|
J:148747
|
Hprt1tm1(CAG-Tgfbr1*)Lba/Hprt1tm1(CAG-Tgfbr1*)Lba
Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal T cell activation
|
J:148747
|
Hps1ep/Hps1ep
(involves: C3HeB/FeJ * C57BL/6J)
|
abnormal macrophage physiology
|
J:7869
|
Hps1ep/Hps1ep
(B6.C3Fe-Hps1ep/J)
|
abnormal NK cell physiology
|
J:6801
|
Hpsetm1.2Mdh/Hpsetm1.2Mdh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal dendritic cell chemotaxis
|
J:209913
|
| impaired eosinophil recruitment
|
J:209913
|
Hrhr/Hrhr
(HRS/J)
|
decreased T cell proliferation
|
J:6375
|
HrUSP/HrUSP
(either: (involves: A/J * BALB/c) or (involves: BALB/c * C57BL/6) or (involves: BALB/c * DBA/2))
|
abnormal immunoglobulin level
|
J:21316
|
| decreased IgM level
|
J:21316
|
| increased IgG level
|
J:21316
|
Hrh1tm1Wtn/Hrh1tm1Wtn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell proliferation
|
J:111704
|
| decreased IgG3 level
|
J:111704
|
| decreased IgM level
|
J:111704
|
| decreased T cell proliferation
|
J:111704
|
Hrh1tm1Wtn/Hrh1tm1Wtn
(B6.129P2-Hrh1tm1Wtn)
|
increased IgG level
|
J:110367
|
| increased IgM level
|
J:110367
|
Hrh4tm1Lex/Hrh4+
(involves: 129S/SvEv * C57BL/6)
|
abnormal mast cell physiology
|
J:132140
|
Hrh4tm1Lex/Hrh4tm1Lex
(involves: 129S/SvEv * C57BL/6)
|
abnormal mast cell physiology
|
J:131785
|
Hrh4tm1Lex/Hrh4tm1Lex
(involves: 129S/SvEv * BALB/c)
|
abnormal dendritic cell physiology
|
J:131785
|
| decreased IgE level
|
J:131785
|
| decreased IgG1 level
|
J:131785
|
Hsd17b11Gt(OST237628)Lex/Hsd17b11Gt(OST237628)Lex
(B6;129S5-Hsd17b11Gt(OST237628)Lex/Mmucd)
|
increased IgG2a level
|
J:171883
|
Hsd17b14tm1Lex/Hsd17b14tm1Lex
(B6;129S5-Hsd17b14tm1Lex/Mmucd)
|
increased IgG2a level
|
J:171883
|
Hsh2dtm1Viss/Hsh2dtm1Viss
(B6.129-Hsh2dtm1Viss)
|
increased T cell proliferation
|
J:111408
|
Hsh2dtm1Viss/Hsh2dtm1Viss
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:111408
|
| abnormal CD8-positive, alpha-beta T cell physiology
|
J:111408
|
Hsp90aa1tm1.1Udon/Hsp90aa1tm1.1Udon
(involves: C57BL/6)
|
abnormal dendritic cell antigen presentation
|
J:177143
|
| abnormal dendritic cell physiology
|
J:177143
|
Hsp90b1tm1Zhli/Hsp90b1tm1.1Zhli
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S/SvEv)
|
abnormal macrophage physiology
|
J:118427
|
Hspa13tm1.1Smoc/Hspa13tm1.1Smoc
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S * C57BL/6)
|
abnormal class switch recombination
|
J:303927
|
| abnormal somatic hypermutation frequency
|
J:303927
|
| decreased IgA level
|
J:303927
|
| decreased IgE level
|
J:303927
|
| decreased IgG1 level
|
J:303927
|
| decreased IgG2b level
|
J:303927
|
| decreased IgG2c level
|
J:303927
|
| decreased IgG3 level
|
J:303927
|
| decreased IgG level
|
J:303927
|
| decreased IgM level
|
J:303927
|
Hspb1tm1.1Jdn/Hspb1tm1.1Jdn
(B6.129S2(Cg)-Hspb1tm1.1Jdn)
|
abnormal macrophage physiology
|
J:209117
|
| abnormal neutrophil physiology
|
J:209117
|
Hvcn1Gt(RRN293)Byg/Hvcn1Gt(RRN293)Byg
(B6.129P2-Hvcn1Gt(RRN293)Byg)
|
abnormal macrophage physiology
|
J:148032
|
| abnormal neutrophil physiology
|
J:148032
|
Ica1tm1Mdos/Ica1tm1Mdos
(NOD.129-Ica1tm1Mdos)
|
abnormal T cell physiology
|
J:83526
|
Icam1tm1Alb/Icam1tm1Alb
(B6.Cg-Icam1tm1Alb)
|
abnormal leukocyte adhesion
|
J:100242
|
| abnormal leukocyte tethering or rolling
|
J:100242
|
Icam1tm1Bay/Icam1tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal cellular extravasation
|
J:14565
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:14565
|
Icam1tm1Bay/Icam1tm1Bay
(B6.129S7-Icam1tm1Bay)
|
abnormal cellular extravasation
|
J:48271
|
| abnormal leukocyte migration
|
J:24239
|
| abnormal leukocyte tethering or rolling
|
J:48271
|
Icam1tm1Bay/Icam1tm1Bay
(either: B6.129S7-Icam1tm1Bay or (involves: 129S7/SvEvBrd * C57BL/6))
|
abnormal leukocyte tethering or rolling
|
J:31374
|
Icam1tm1Bay/Icam1tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
impaired neutrophil recruitment
|
J:112286
|
Icam1tm1Bay/Icam1tm1Bay
Seletm2Alb/Seletm2Alb
Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
impaired neutrophil chemotaxis
|
J:112286
|
Icam1tm1Bay/Icam1tm1Bay
Selltm1Tft/Selltm1Tft
(B6.129-Selltm1Tft Icam1tm1Bay)
|
abnormal cellular extravasation
|
J:48271
|
| abnormal leukocyte tethering or rolling
|
J:48271
|
| abnormal macrophage physiology
|
J:124291
|
| abnormal mast cell physiology
|
J:124291
|
| impaired macrophage chemotaxis
|
J:124291
|
Icam1tm1Bay/Icam1tm1Bay
Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal leukocyte migration
|
J:24239
|
Icam1tm1Bay/Icam1tm1Bay
Selptm1Bay/Selptm1Bay
(either: B6.129S7-Selptm1Bay Icam1tm1Bay or (involves: 129S7/SvEvBrd * C57BL/6))
|
impaired leukocyte tethering or rolling
|
J:31374
|
Icam1tm1Jcgr/Icam1tm1Jcgr
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
abnormal T cell physiology
|
J:18743
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:18743
|
Icam1tm1Jcgr/Icam1tm1Jcgr
Vcam1tm1Dmil/Vcam1tm1Dmil
(involves: 129S4/SvJae * C57BL/6)
|
impaired macrophage chemotaxis
|
J:227109
|
Icam2tm1Jcgr/Icam2tm1Jcgr
(involves: 129S4/SvJae * C57BL/6)
|
abnormal eosinophil physiology
|
J:54748
|
IchsC57BL/6J/IchsC57BL/6J
(involves: A/J * C57BL/6J * C57BL/6JOlaHsd)
|
abnormal type I hypersensitivity reaction
|
J:63737
|
IchsC57BL/6JOlaHsd/IchsC57BL/6JOlaHsd
(involves: A/J * C57BL/6J * C57BL/6JOlaHsd)
|
abnormal type I hypersensitivity reaction
|
J:63737
|
Icostm1.1Wks/Icostm1.1Wks
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell physiology
|
J:155586
|
| abnormal class switch recombination
|
J:155586
|
| decreased IgA level
|
J:155586
|
| decreased IgG1 level
|
J:155586
|
| decreased IgG2b level
|
J:155586
|
| decreased IgG2c level
|
J:155586
|
Icostm1Dgry/Icostm1Dgry
(B6.129P2-Icostm1Dgry)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:123477
|
| abnormal T cell physiology
|
J:123477
|
| decreased IgG level
|
J:123477
|
Icostm1Flv/Icostm1Flv
(involves: 129/Sv * C57BL/6)
|
abnormal immunoglobulin level
|
J:87123
|
| abnormal T-helper 2 physiology
|
J:87123
|
| decreased IgE level
|
J:87123
|
| decreased IgG1 level
|
J:87123
|
Icostm1Flv/Icostm1Flv
(NOD.129S1-Icostm1Flv)
|
decreased IgG level
|
J:131529
|
Icostm1Mak/Icostm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:66702
|
| abnormal class switch recombination
|
J:66702
|
| abnormal T cell physiology
|
J:66702
|
| decreased IgA level
|
J:155586
|
| decreased IgE level
|
J:66702
|
| decreased IgG1 level
|
J:66702,
J:155586
|
| decreased IgG2b level
|
J:155586
|
| decreased IgG2c level
|
J:155586
|
| decreased T cell proliferation
|
J:66702
|
Icostm1Shr/Icostm1Shr
(Not Specified)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:87124
|
| abnormal immunoglobulin level
|
J:87124
|
| decreased IgE level
|
J:87124
|
| decreased IgG1 level
|
J:87124
|
| decreased IgG2a level
|
J:87124
|
| decreased IgG level
|
J:87124
|
| increased IgG3 level
|
J:87124
|
Icostm1Tkan/Icostm1Tkan
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal NK cell physiology
|
J:95353
|
Icosltm1Cdon/Icosltm1Cdon
(involves: 129S6/SvEvTac)
|
abnormal immunoglobulin level
|
J:86697
|
| abnormal T-helper 2 physiology
|
J:86697
|
| decreased IgE level
|
J:86697
|
| decreased IgG1 level
|
J:86697
|
| decreased IgG2a level
|
J:86697
|
| decreased IgG level
|
J:86697
|
| decreased IgM level
|
J:86697
|
Icosltm1Kplm/Icosltm1Kplm
(involves: 129P2/OlaHsd)
|
decreased IgA level
|
J:84893
|
| decreased IgG2a level
|
J:84893
|
| decreased IgG2b level
|
J:84893
|
Icosltm1Mak/Icosltm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:84668
|
| decreased IgG1 level
|
J:84668
|
Id2tm1Ago/Id2tm1Ago
Tg(TcraTcrb)1100Mjb/0
(B6.Cg-Id2tm1Ago Tg(TcraTcrb)1100Mjb)
|
abnormal T cell activation
|
J:116119
|
Id3tm1Zhu/Id3tm1Zhu
(involves: 129/Sv * C57BL/6)
|
abnormal T cell physiology
|
J:56950
|
| decreased B cell proliferation
|
J:56950
|
| decreased immunoglobulin level
|
J:56950
|
Idd4.3C57L/Idd4.3C57L
(involves: C57L/J * NOD)
|
abnormal macrophage physiology
|
J:118951
|
Idd4C57BL/6/Idd4C57BL/6
(involves: C57BL/6 * DBA/2)
|
increased T cell proliferation
|
J:25969
|
Idd4C57BL/6/Idd4C57BL/6
(involves: C57BL/6 * NOD)
|
increased T cell proliferation
|
J:25969
|
Idd6C57BL/6/Idd6NOD
(involves: C57BL/6 * NOD)
|
decreased T cell proliferation
|
J:72360
|
Idd6NOD/Idd6NOD
(involves: C57BL/6 * NOD)
|
decreased T cell proliferation
|
J:72360
|
Idd6NOD/Idd6NOD
(B6.NOD-Idd6)
|
abnormal NK cell physiology
|
J:85823
|
Idd10NOD/ShiLt/Idd10NOD/ShiLt
Idd3NOD/Idd3NOD
(B6.NOD-Idd3NOD Idd10NOD/Lt)
|
abnormal NK T cell physiology
|
J:85823
|
Idd13NOD/ShiLt/Idd13NOD/ShiLt
(B6.NOD-Idd13)
|
abnormal NK T cell physiology
|
J:85823
|
Ido1tm1Alm/Ido1tm1Alm
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal dendritic cell physiology
|
J:120813
|
Ido1tm1Alm/Ido1tm1Alm
(involves: 129X1/SvJ * C57BL/6J * FVB/N)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:211949
|
Ido1tm1Alm/Ido1tm1Alm
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal macrophage physiology
|
J:282516
|
Ido2em1Lamn/Ido2em1Lamn
(involves: BALB/c * C57BL/6J)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:342726
|
Ido2em2Lamn/Ido2em2Lamn
(involves: BALB/c * C57BL/6J)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:342726
|
Ido2tm1.2Gcp/Ido2tm1.2Gcp
(involves: C57BL/6J * FVB/N)
|
abnormal regulatory T cell physiology
|
J:211949
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:211949
|
Iduatm1Efn/Iduatm1Efn
(involves: C57BL/6)
|
abnormal microglial cell physiology
|
J:81974
|
Ier3tm1Mxw/Ier3tm1Mxw
(involves: 129 * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:157504
|
| abnormal macrophage physiology
|
J:157504
|
| impaired macrophage phagocytosis
|
J:157504
|
Ifi30tm1Cres/Ifi30tm1Cres
(involves: 129S1/Sv * C57BL/6)
|
abnormal professional antigen presenting cell physiology
|
J:72708
|
Ifih1Rgsc422/Ifih1+
(D2JJcl.B6JJcl-Ifih1Rgsc422)
|
abnormal dendritic cell antigen presentation
|
J:209917
|
| abnormal macrophage activation involved in immune response
|
J:209917
|
| abnormal T cell activation
|
J:209917
|
| increased IgA level
|
J:209917
|
| increased IgG level
|
J:209917
|
| increased IgM level
|
J:209917
|
| increased immunoglobulin level
|
J:209917
|
Ifih1tm1Aki/Ifih1tm1Aki
(involves: 129/Sv * C57BL/6)
|
abnormal dendritic cell physiology
|
J:137522
|
Ifit1tm1(KOMP)Vlcg/Ifit1tm1(KOMP)Vlcg
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal T cell physiology
|
J:205203
|
Ifit2tm1.1Ebsb/Ifit2tm1.1Ebsb
(B6.129P2(C)-Ifit2tm1.1Ebsb)
|
increased IgE level
|
J:233986
|
| increased IgG1 level
|
J:233986
|
| increased IgG3 level
|
J:233986
|
| increased IgM level
|
J:233986
|
Ifitm1tm1.1Ieg/Ifitm1tm1.1Ieg
(B6.129P2-Ifitm1tm1.1Ieg)
|
increased IgE level
|
J:192287
|
Ifnar1m1Btlr/Ifnar1m1Btlr
(C57BL/6J-Ifnar1m1Btlr)
|
abnormal macrophage physiology
|
J:142790
|
Ifnar1tm1Agt/Ifnar1tm1Agt
(involves: 129S2/SvPas)
|
abnormal dendritic cell physiology
|
J:114555
|
| abnormal immunoglobulin level
|
J:101427
|
| abnormal NK cell physiology
|
J:79552,
J:139001
|
| impaired natural killer cell mediated cytotoxicity
|
J:79552
|
Ifnar1tm1Agt/Ifnar1tm1Agt
(B6.129S2-Ifnar1tm1Agt)
|
impaired natural killer cell mediated cytotoxicity
|
J:118750
|
Ifnar1tm1Agt/Ifnar1tm1Agt
(involves: 129S2/SvPas * 129S6/SvEvTac)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:54482
|
Ifnar1tm1Agt/Ifnar1tm1Agt
(involves: 129S2/SvPas * BALB/c)
|
decreased T cell apoptosis
|
J:291874
|
Ifnar1tm1Agt/Ifnar1tm1Agt
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S2/SvPas * 129S7/SvEvBrd)
|
abnormal immunoglobulin level
|
J:101427
|
Ifnar1tm1Agt/Ifnar1tm1Agt
Myd88tm1Aki/Myd88tm1Aki
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal leukocyte migration
|
J:171379
|
Ifnar1tm1Agt/Ifnar1tm1Agt
Ythdf3em1Caox/Ythdf3em1Caox
(involves: C57BL/6J)
|
abnormal macrophage physiology
|
J:276397
|
Ifnar1tm1Pjh/Ifnar1tm1Pjh
(involves: 129S2/SvPas * BALB/c)
|
abnormal macrophage physiology
|
J:36004
|
Ifnar1tm1Pjh/Ifnar1tm1Pjh
(B6.129S2-Ifnar1tm1Pjh)
|
impaired natural killer cell mediated cytotoxicity
|
J:125812
|
Ifnar2m1Btlr/Ifnar2m1Btlr
(C57BL/6J-Ifnar2m1Btlr)
|
abnormal macrophage physiology
|
J:147329
|
Ifnar2tm1Pjh/Ifnar2tm1Pjh
(B6.Cg-Ifnar2tm1Pjh)
|
impaired natural killer cell mediated cytotoxicity
|
J:125812
|
Ifnar2tm1Pjh/Ifnar2tm1Pjh
(involves: C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:132662
|
| abnormal cytotoxic T cell physiology
|
J:132662
|
| decreased IgG1 level
|
J:132662
|
| decreased IgG2a level
|
J:132662
|
| decreased IgG level
|
J:132662
|
Ifnb1tm1Acgp/Ifnb1tm1Acgp
(involves: 129P2/OlaHsd)
|
increased T cell proliferation
|
J:86527
|
Ifnb1tm1Acgp/Ifnb1tm1Acgp
(B6.129P2-Ifnb1tm1Acgp)
|
abnormal macrophage physiology
|
J:136368
|
Ifnb1tm1Tl/Ifnb1tm1Tl
(B10.129P2-Ifnb1tm1Tl)
|
abnormal macrophage physiology
|
J:83021
|
| abnormal microglial cell physiology
|
J:83021
|
Ifngtm1.1Hayg/Ifngtm1.1Hayg
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal T cell activation
|
J:220784
|
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal macrophage physiology
|
J:66802
|
| abnormal MHC II cell surface expression on macrophages
|
J:66802
|
| abnormal NK cell physiology
|
J:66802,
J:115033
|
| abnormal type IV hypersensitivity reaction
|
J:55740
|
Ifngtm1Ts/Ifngtm1Ts
(NOD.129S7(B6)-Ifngtm1Ts/DvsJ)
|
abnormal cytotoxic T cell physiology
|
J:72818
|
| abnormal diapedesis
|
J:72818
|
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd)
|
abnormal immunoglobulin level
|
J:29170
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:29170
|
| impaired natural killer cell mediated cytotoxicity
|
J:73948
|
| increased IgG1 level
|
J:110721
|
Ifngtm1Ts/Ifngtm1Ts
(B6.129S7-Ifngtm1Ts/J)
|
abnormal dendritic cell antigen presentation
|
J:134949
|
| abnormal dendritic cell chemotaxis
|
J:134949
|
| abnormal dendritic cell physiology
|
J:134949
|
| abnormal immunoglobulin level
|
J:45665
|
| abnormal Langerhans cell physiology
|
J:134949
|
| abnormal macrophage chemotaxis
|
J:136628
|
| abnormal type IV hypersensitivity reaction
|
J:45665
|
| increased susceptibility to type IV hypersensitivity reaction
|
J:118730
|
Ifngtm1Ts/Ifngtm1Ts
(B6.129S7-Ifngtm1Ts)
|
abnormal B cell physiology
|
J:112084
|
| abnormal immunoglobulin level
|
J:18801
|
| decreased IgG2a level
|
J:18801
|
| decreased IgG3 level
|
J:18801
|
| increased IgE level
|
J:18801
|
| increased IgG1 level
|
J:18801,
J:112048
|
Ifngtm1Ts/Ifngtm1Ts
(C.129S7-Ifngtm1Ts)
|
abnormal immunoglobulin level
|
J:45665
|
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd * BALB/c)
|
decreased IgE level
|
J:114213
|
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd * DBA/1 * MRL/Mp)
|
decreased IgA level
|
J:39600
|
| decreased IgG2a level
|
J:39600
|
| decreased IgG2b level
|
J:39600
|
| decreased IgG3 level
|
J:39600
|
| decreased IgM level
|
J:39600
|
| decreased immunoglobulin level
|
J:39600
|
Ifngtm1Ts/Ifngtm1Ts
(C.129S7(B6)-Ifngtm1Ts/J)
|
abnormal adaptive immunity
|
J:115144
|
| abnormal cytotoxic T cell physiology
|
J:115144
|
| abnormal macrophage physiology
|
J:115144
|
| abnormal NK cell physiology
|
J:115144
|
| abnormal uterine NK cell physiology
|
J:56503
|
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd * A/WySn * C57BL/10SnSg * Swiss)
|
decreased IgG2a level
|
J:119207
|
| decreased IgG level
|
J:119207
|
| increased IgG1 level
|
J:119207
|
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S7/SvEvBrd)
|
abnormal immunoglobulin level
|
J:38363,
J:101427
|
| abnormal uterine NK cell physiology
|
J:56503
|
| decreased IgG2a level
|
J:38363
|
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal cytotoxic T cell physiology
|
J:63815
|
| decreased IgG2a level
|
J:63815
|
| decreased IgG3 level
|
J:63815
|
Ifngr1tm1Agt/Ifngr1tm1Agt
(involves: 129S7/SvEvBrd * DBA/1OlaHsd)
|
decreased IgG2a level
|
J:40634
|
Ifngr1tm1Agt/Ifngr1tm1Agt
Tg(GZMB-Tax)#Lera/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal osteoclast physiology
|
J:147601
|
Ifngr2tm1Pbro/Ifngr2tm1Pbro
(involves: 129S1/Sv)
|
abnormal class switch recombination
|
J:48016
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:48016
|
Ifngr2tm1Pbro/Ifngr2tm1Pbro
(NOD.129S1-Ifngr2tm1Pbro)
|
abnormal cytotoxic T cell physiology
|
J:72818
|
| abnormal diapedesis
|
J:72818
|
| abnormal T-helper 2 physiology
|
J:65986
|
Igf1rtm1Jcbr/Igf1rtm1Jcbr
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(B6.Cg-Ndor1Tg(UBC-cre/ERT2)1Ejb Igf1rtm1Jcbr)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:241924
|
Igf1rtm2Arge/Igf1rtm2Arge
Tg(BGLAP-cre)1Clem/0
(involves: 129 * FVB/N)
|
abnormal osteoclast physiology
|
J:80190
|
Igh-7tm1.1Lam/Igh-7tm1.1Lam
(involves: BALB/c)
|
decreased IgE level
|
J:146733
|
Igh-7tm1Gach/Igh-7tm1Gach
(BALB/c-Igh-7tm1Gach)
|
enhanced B cell migration
|
J:143266
|
| increased IgE level
|
J:143266
|
Igh-7tm1Lam/Igh-7tm1Lam
(involves: BALB/c)
|
decreased IgE level
|
J:146733
|
Igh-7tm1Lcwu/Igh-7tm1Lcwu
(involves: C57BL/6)
|
decreased IgE level
|
J:161452
|
Igh-7tm1Led/Igh-7tm1Led
(C.129S4-Igh-7tm1Led)
|
impaired eosinophil recruitment
|
J:133373
|
Igh-7tm1Led/Igh-7tm1Led
Lyntm1Ard/Lyntm1Ard
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
increased IgA level
|
J:161523
|
| increased IgM level
|
J:161523
|
Igh-8tm1.1Aak/Igh-8tm1.1Aak
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:171251
|
Igh-8tm1Aak/Igh-8tm1Aak
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:107063
|
Igh-8tm1Schr/Igh-8tm1Schr
(involves: 129P2/OlaHsd * Black Swiss)
|
increased IgM level
|
J:49847
|
Igh-8tm1Schr/Igh-8tm1Schr
(C.129P2(BKSW)-Igh-8tm1Schr)
|
increased IgG level
|
J:75577
|
| increased IgM level
|
J:75577
|
Igh-8tm2(Ighg1)Aak/Igh-8tm2(Ighg1)Aak
(involves: 129S2/SvPas)
|
abnormal class switch recombination
|
J:130574
|
| decreased IgG3 level
|
J:130574
|
Igh-Jtm1(Ighel)Cys/Igh-Jtm1(Ighel)Cys
Myd88tm1Aki/Myd88tm1Aki
Igkj1tm1(IgkHyHEL10)Mnz/0
(involves: 129P2/OlaHsd)
|
increased IgM level
|
J:115059
|
Igh-Jtm1(VDJ-KL25)Zbz/Igh-J+
(involves: C57BL/6 * C57BL/6J * BALB/cJ)
|
increased IgG level
|
J:86411
|
| increased IgM level
|
J:86411
|
Igh-Jtm1.1Lave/Igh-Jtm1.1Lave
(Not Specified)
|
abnormal immunoglobulin level
|
J:179317
|
| decreased IgM level
|
J:155798
|
| increased IgG level
|
J:155798
|
Igh-Jtm1.1Lave/Igh-Jtm1.1Lave
Igk-Jtm1.1Lave/Igk-Jtm1.1Lave
(Not Specified)
|
abnormal B cell physiology
|
J:205708
|
| abnormal immunoglobulin level
|
J:179317
|
Igh-Jtm1Dim/Igh-J+
Igk-Jtm1Dim/Igk-J+
(involves: 129S4/SvJae * C57BL/6)
|
increased IgG level
|
J:107241
|
| increased IgM level
|
J:107241
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased IgM level
|
J:70038
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGH@yH1)2BJkbv/0
Tg(IGK@yK1)9.2CJkbv/0
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin level
|
J:23827
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGH@yH1)2BJkbv/Tg(IGH@yH1)2BJkbv
Tg(IGK@yK1)9.2CJkbv/Tg(IGK@yK1)9.2CJkbv
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin level
|
J:137738
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGH@yH2)J9.2Jkbv/0
Tg(IGK@yK2)J23.1Jkbv/0
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal immunoglobulin level
|
J:70620
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGH@yH2)J9.2Jkbv/0
Tg(IGK@yK2)J23.1Jkbv/Tg(IGK@yK2)J23.1Jkbv
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin level
|
J:137738
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGH@yH2BM)7Amgn/0
Tg(IGK@yK2)J23.1Jkbv/0
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin level
|
J:139792
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGH@yH2CM)2Amgn/0
Tg(IGK@yK2)J23.1Jkbv/0
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin level
|
J:139792
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGH@yHG1/2)1Amgn/0
Tg(IGK@yK2)J23.1Jkbv/0
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin level
|
J:139792
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGH@yHG4)1Amgn/0
Tg(IGK@yK2)J23.1Jkbv/0
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin level
|
J:139792
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Tg(IGH@yH1)2BJkbv/0
Tg(IGK@yK1)9.2CJkbv/0
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin level
|
J:23827
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Tg(IGH@yH1)2BJkbv/Tg(IGH@yH1)2BJkbv
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin level
|
J:137738
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Tg(IGH@yH2)J9.2Jkbv/0
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin level
|
J:137738
|
Igh-Jtm1Mcdl/Igh-Jtm1Mcdl
Igk-Jtm1Mcdl/Igk-Jtm1Mcdl
Rag1tm1Mom/Rag1tm1Mom
Tg(DO11.10)10Dlo/?
(involves: 129S/Sv * BALB/c * C3H * C57BL/6)
|
increased IgE level
|
J:100072
|
| increased IgG level
|
J:100072
|
Igh-Jtm2.1(4E10)Lave/Igh-Jtm2.1(4E10)Lave
(involves: C57BL/6)
|
decreased IgG1 level
|
J:205708
|
| decreased IgG2b level
|
J:205708
|
| decreased IgG3 level
|
J:205708
|
| decreased IgG level
|
J:205708
|
| decreased IgM level
|
J:205708
|
Igh-Jtm2.1(4E10)Lave/Igh-Jtm2.1(4E10)Lave
Igk-Jtm2.1(4E10)Lave/Igk-Jtm2.1(4E10)Lave
(involves: C57BL/6)
|
abnormal B cell physiology
|
J:205708
|
Igh-Jtm3.1(48d)Lave/Igh-Jtm3.1(48d)Lave
(involves: C57BL/6)
|
decreased IgG1 level
|
J:205708
|
| decreased IgG2b level
|
J:205708
|
| decreased IgM level
|
J:205708
|
Igh-Vtm1Jjk/Igh-Vtm1Jjk
(involves: 129S4/SvJae * C57BL/6)
|
abnormal adaptive immunity
|
J:62284
|
IghdeltaD/Igh+
(involves: C57BL/6 * DBA/2)
|
decreased immunoglobulin level
|
J:95981
|
IghdeltaD/IghdeltaD
(involves: C57BL/6 * DBA/2)
|
abnormal immunoglobulin level
|
J:95981
|
| decreased IgG1 level
|
J:95981
|
| increased IgA level
|
J:95981
|
Ightm1(Myc)Janz/Igh+
(involves: 129X1/SvJ * C57BL/6)
|
increased B cell apoptosis
|
J:96785
|
| increased B cell proliferation
|
J:96785
|
Ightm1.1(b12)Nemz/Ightm1.1(b12)Nemz
(involves: C57BL/6N * FVB/N)
|
decreased IgM level
|
J:205766
|
Ightm1.1(b12)Nemz/Ightm1.1(b12)Nemz
Igktm1.1(b12)Nemz/Igktm1.1(b12)Nemz
(involves: C57BL/6N * C57BL/6NTac * FVB/N)
|
decreased IgM level
|
J:205766
|
Ightm1.1(Rr361-HBB)Aak/Ightm1.1(Rr361-HBB)Aak
(129.129S2(Cg)-Ightm1.1(Rr361-HBB)Aak)
|
abnormal class switch recombination
|
J:333279
|
| decreased IgA level
|
J:333279
|
| decreased IgE level
|
J:333279
|
| decreased IgG1 level
|
J:333279
|
| decreased IgG2a level
|
J:333279
|
| decreased IgG2b level
|
J:333279
|
Ightm1.1Hws/Ightm1.1Hws
(BALB/cJ-Ightm1.1Hws)
|
decreased IgM level
|
J:119391
|
| decreased immunoglobulin level
|
J:119391
|
Ightm1.1Hws/Ightm1.1Hws
(involves: BALB/c)
|
increased IgG3 level
|
J:142069
|
| increased IgM level
|
J:142069
|
Ightm1.1Rsky/Ightm1.1Rsky
(BALB/c-Ightm1.1Rsky)
|
abnormal class switch recombination
|
J:125719
|
| decreased IgM level
|
J:125719
|
Ightm1.1Twin/Ightm1.1Twin
(involves: 129 * 129S4/SvJae * C57BL/6)
|
abnormal marginal zone B cell physiology
|
J:174233
|
| decreased IgG3 level
|
J:174233
|
| decreased IgG level
|
J:174233
|
| decreased IgM level
|
J:174233
|
Ightm1.1Vmd/Igh+
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:201147
|
Ightm1.1Vmd/Ightm1.1Vmd
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:201147
|
| decreased IgG1 level
|
J:201147
|
| decreased IgG3 level
|
J:201147
|
| increased IgE level
|
J:201147
|
Ightm1.2Rsky/Igh+
(BALB/c-Ightm1.2Rsky)
|
increased IgG1 level
|
J:125719
|
Ightm1.2Rsky/Ightm1.2Rsky
(BALB/c-Ightm1.2Rsky)
|
abnormal B cell activation
|
J:125719
|
| abnormal B cell proliferation
|
J:125719
|
| decreased IgA level
|
J:125719
|
| decreased IgD level
|
J:125719
|
| decreased IgE level
|
J:125719
|
| decreased IgM level
|
J:125719
|
| decreased immunoglobulin level
|
J:125719
|
Ightm1.2Rsky/Ightm1.2Rsky
Tg(CD19-cre/ERT2)1Cgn/?
(involves: BALB/c)
|
abnormal B cell activation
|
J:125719
|
| abnormal class switch recombination
|
J:125719
|
Ightm1Cog/Ightm1Cog
(involves: 129S2/SvPas * C57BL/6)
|
decreased IgA level
|
J:80654
|
| decreased IgE level
|
J:80654
|
| decreased IgG1 level
|
J:80654
|
| decreased IgG2a level
|
J:80654
|
| decreased IgG2b level
|
J:80654
|
| decreased IgG3 level
|
J:80654
|
| decreased IgM level
|
J:80654
|
| decreased immunoglobulin level
|
J:80654
|
Ightm1Cys/Igh+
Tg(Igk)5Cys/0
(B6.Cg-Ightm1Cys Tg(Igk)5Cys)
|
abnormal B cell physiology
|
J:118931
|
Ightm1Ktom/Ightm1Ktom
(involves: ICR)
|
abnormal B cell physiology
|
J:59894
|
| abnormal immunoglobulin level
|
J:178635
|
Ightm1Ktom/Ightm1Ktom
Igktm1Ktom/Igktm1Ktom
Tc(HSA14)SC20Ktom/0
Tc(HSA2)W23Ktom/0
(involves: C57BL/6NCrlj * CBA/JNCrlj * ICR)
|
abnormal B cell physiology
|
J:59894
|
Ightm1Ktom/Ightm1Ktom
Tc(HSA2)W23Ktom/0
(involves: C57BL/6NCrlj * CBA/JNCrlj * ICR)
|
abnormal B cell physiology
|
J:59894
|
Ightm1Mnz/Ightm1Mnz
(B6.129P2-Ightm1Mnz)
|
abnormal B cell physiology
|
J:75653
|
| increased B cell apoptosis
|
J:75653
|
| increased B cell proliferation
|
J:75653
|
| increased IgG level
|
J:75653
|
| increased IgM level
|
J:75653
|
Ightm1Mnz/Ightm1Mnz
Dis3tm1.1Uba/Dis3tm1.1Uba
Aicdatm1(cre)Uba/Aicda+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:302856
|
Ightm1Mnz/Ightm1Mnz
Lyntm1Sor/Lyntm1Sor
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)
|
abnormal B cell physiology
|
J:75653
|
| increased B cell proliferation
|
J:75653
|
Ightm1Rbr/Igh+
Tg(IgkHyHEL10)1Rbr/0
(involves: C57BL/6)
|
increased IgA level
|
J:132538
|
| increased IgG1 level
|
J:132538
|
| increased IgG2a level
|
J:132538
|
| increased IgG2b level
|
J:132538
|
| increased IgG3 level
|
J:132538
|
| increased IgM level
|
J:132538
|
| increased immunoglobulin level
|
J:132538
|
Ightm2.1(4E10)Nemz/Ightm2.1(4E10)Nemz
Igktm2.1(4E10)Nemz/Igktm2.1(4E10)Nemz
(involves: C57BL/6 * C57BL/6N * C57BL/6NTac * FVB/N)
|
decreased IgG level
|
J:101977
|
| decreased IgM level
|
J:101977
|
Ightm2.1Fwa/Ightm2.1Fwa
(involves: 129S/SvEv * C57BL/6)
|
abnormal class switch recombination
|
J:161437
|
| abnormal somatic hypermutation frequency
|
J:161437
|
| decreased IgG1 level
|
J:161437
|
| increased IgE level
|
J:161437
|
Ightm2.1Hws/Ightm2.1Hws
(involves: BALB/c * C57BL/6NCrl * DBA/2NCrl)
|
decreased IgG level
|
J:124421
|
| decreased IgM level
|
J:124421
|
Ightm2.1Hws/Ightm2.1Hws
(involves: BALB/c)
|
decreased IgM level
|
J:142069
|
Ightm2Cgn/Igh+
Igktm2Rsky/Igk+
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:150435
|
Ightm2Cgn/Igh+
Igktm2Rsky/Igk+
Prkdcscid/Prkdcscid
(involves: 129P2/OlaHsd * BALB/c * C57BL/Ka)
|
abnormal class switch recombination
|
J:150435
|
Ightm2Cgn/Igh+
Rr158tm1Cgn/Rr158tm1Cgn
Arhgef1tm1.1Rmt/Arhgef1tm1.1Rmt
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell migration
|
J:113295
|
Ightm2Cgn/Ightm2Cgn
Igktm1Rsky/Igktm1Rsky
Lig4tm1Fwa/Lig4tm1Fwa
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:126758
|
Ightm2Cgn/Ightm2Cgn
Igktm1Rsky/Igktm1Rsky
Trp53tm1Tyj/Trp53tm1Tyj
Xrcc4tm1Fwa/Xrcc4tm1Fwa
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:126758
|
Ightm2Mnz/Ightm2Mnz
(B6.129P2-Ightm2Mnz)
|
increased B cell proliferation
|
J:75653
|
| increased IgG level
|
J:75653
|
| increased IgM level
|
J:75653
|
Ightm2Mnz/Ightm2Mnz
Lyntm1Sor/Lyntm1Sor
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)
|
abnormal B cell physiology
|
J:75653
|
| increased B cell proliferation
|
J:75653
|
Ightm3Hws/Ightm3Hws
(involves: BALB/c)
|
abnormal immunoglobulin level
|
J:142069
|
| decreased IgG1 level
|
J:142069
|
| decreased IgG2a level
|
J:142069
|
| decreased IgG2b level
|
J:142069
|
| decreased IgM level
|
J:142069
|
| increased IgM level
|
J:142069
|
Ightm4.1Cog/Ightm4.1Cog
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal class switch recombination
|
J:184094
|
| decreased IgA level
|
J:184094
|
| increased IgM level
|
J:184094
|
Ightm4Cog/Igh+
(involves: 129S2/SvPas * C57BL/6)
|
decreased IgM level
|
J:109988
|
| increased IgA level
|
J:109988
|
Ightm5.1Cgn/Ightm5.1Cgn
(BALB/c-Ightm5.1Cgn)
|
abnormal B cell activation
|
J:88472
|
Ightm7(VHB1-8)Cgn/Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:48835
|
Ightm8(VHB1-8)Cgn/Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:48835
|
Ightm9(VHB1-8)Cgn/Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:48835
|
Ightm12Cgn/Ightm12Cgn
(involves: 129P2/OlaHsd)
|
abnormal somatic hypermutation frequency
|
J:66031
|
Ighatm1(Myc)Janz/Igha+
(involves: 129S1/Sv * C57BL/6)
|
increased B cell apoptosis
|
J:90901
|
| increased B cell proliferation
|
J:90901
|
Ighatm1(Myc)Janz/Igha+
Tg(Igk-V21-Bax)1967Bvn/0
(involves: 129S1/Sv * C57BL/6 * FVB/N)
|
abnormal B cell apoptosis
|
J:90901
|
| increased IgG level
|
J:90901
|
| increased IgM level
|
J:90901
|
Ighatm1Grh/Ighatm1Grh
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal dendritic cell physiology
|
J:125472
|
| abnormal immunoglobulin level
|
J:125472
|
| abnormal memory T cell physiology
|
J:125472
|
| abnormal T cell activation
|
J:53217
|
| decreased IgA level
|
J:53217,
J:125472
|
| decreased IgE level
|
J:53217
|
| decreased IgG3 level
|
J:53217
|
| decreased T cell proliferation
|
J:125472
|
| increased IgG1 level
|
J:53217,
J:125472
|
| increased IgG2a level
|
J:53217
|
| increased IgG2b level
|
J:53217
|
| increased IgG level
|
J:53217
|
| increased IgM level
|
J:53217,
J:125472
|
Ighatm2Grh/Ighatm2Grh
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal class switch recombination
|
J:72521
|
Ighddmit/Ighddmit
(C57BL/6JAnu-Ighddmit/AnuApb)
|
abnormal immunoglobulin level
|
J:104190
|
IghdM1Btlr/IghdM1Btlr
(C57BL/6J-IghdM1Btlr)
|
decreased IgD level
|
J:255202
|
Ighdm2Btlr/Ighdm2Btlr
(C57BL/6J-Ighdm2Btlr)
|
decreased IgD level
|
J:255203
|
Ighdtm1Cgn/Ighdtm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased IgE level
|
J:64281
|
Ighdtm1Lam/Ighdtm1Lam
(involves: 129S2/SvPas * C57BL/6)
|
abnormal B cell physiology
|
J:111020
|
| decreased IgG2b level
|
J:111020
|
| increased IgA level
|
J:111020
|
IgheM1Btlr/IgheM1Btlr
(C57BL/6J-IgheM1Btlr)
|
decreased IgE level
|
J:267480
|
Ighg1em1Wliu/Ighg1em1Wliu
(C57BL/6-Ighg1em1Wliu)
|
increased IgG1 level
|
J:266937
|
Ighg1tm1(cre)Cgn/Ighg1+
Irf4tm1Rdf/Irf4tm1.1Rdf
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
abnormal class switch recombination
|
J:112643
|
| decreased IgG1 level
|
J:112643
|
Ighg1tm1(cre)Cgn/Ighg1+
Myd88em1.1Rsky/Myd88+
(involves: 129P2/OlaHsd * C57BL/6NTac)
|
abnormal somatic hypermutation frequency
|
J:308792
|
| increased IgM level
|
J:308792
|
Ighg1tm1.1Ksho/Ighg1+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:39568
|
| decreased IgG1 level
|
J:39568
|
Ighg1tm1.1Ksho/Ighg1tm1.1Ksho
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:39568
|
| decreased IgG1 level
|
J:39568
|
Ighg1tm1.1Pyu/Ighg1+
(B6.C(Cg)-Ighg1tm1.1Pyu)
|
decreased IgG1 level
|
J:198154
|
| decreased IgG2c level
|
J:198154
|
| increased IgE level
|
J:198154
|
| increased IgG2a level
|
J:198154
|
| increased susceptibility to type I hypersensitivity reaction
|
J:198154
|
Ighg1tm1.1Pyu/Ighg1tm1.1Pyu
(B6.C(Cg)-Ighg1tm1.1Pyu)
|
decreased IgG1 level
|
J:198154
|
| decreased IgG2c level
|
J:198154
|
| increased IgE level
|
J:198154
|
| increased IgG2a level
|
J:198154
|
| increased IgG2b level
|
J:198154
|
| increased susceptibility to type I hypersensitivity reaction
|
J:198154
|
Ighg1tm1Ksho/Ighg1+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:39568
|
| decreased IgG1 level
|
J:39568
|
Ighg1tm1Ksho/Ighg1tm1Ksho
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:39568
|
| decreased IgG1 level
|
J:39568
|
Ighg1tm2Cgn/Ighg1+
((C57BL/6 x 129P2/OlaHsd)F1)
|
abnormal class switch recombination
|
J:146428
|
| decreased IgG1 level
|
J:146428
|
Ighg1tm3Cgn/Ighg1+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal class switch recombination
|
J:166887
|
| decreased IgG1 level
|
J:166887
|
Ighg2cem1Wliu/Ighg2cem1Wliu
(C57BL/6J-Ighg2cem1Wliu)
|
abnormal dendritic cell physiology
|
J:322180
|
| abnormal macrophage activation involved in immune response
|
J:322180
|
| abnormal macrophage physiology
|
J:322180
|
| increased IgG2c level
|
J:322180
|
Ighg2cem2Wliu/Ighg2cem2Wliu
(C57BL/6J-Ighg2cem2Wliu)
|
abnormal macrophage activation involved in immune response
|
J:322180
|
| decreased IgG2c level
|
J:322180
|
| impaired macrophage phagocytosis
|
J:322180
|
Ighmtm1(Bcl6)Rdf/?
(involves: 129/Sv * C57BL/6)
|
abnormal B cell proliferation
|
J:98937
|
| decreased immunoglobulin level
|
J:98937
|
Ighmtm1.1(IGH-2)Cog/Ighmtm1.1(IGH-2)Cog
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
decreased B cell proliferation
|
J:157575
|
| decreased IgA level
|
J:157575
|
| decreased IgG1 level
|
J:157575
|
| decreased IgG2a level
|
J:157575
|
| decreased IgG3 level
|
J:157575
|
| decreased IgG level
|
J:157575
|
| decreased IgM level
|
J:157575
|
| increased B cell proliferation
|
J:157575
|
Ighmtm1.1Aak/Ighmtm1.1Aak
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:171251
|
Ighmtm1Cgn/Ighmtm1Cgn
(involves: 129S2/SvPas * C57BL/6)
|
decreased IgM level
|
J:64298
|
Ighmtm1Cgn/Ighmtm1Cgn
(B6.129S2-Ighmtm1Cgn/J)
|
decreased IgE level
|
J:125656
|
| decreased IgG1 level
|
J:125656
|
| decreased IgG level
|
J:119584,
J:125656
|
| decreased immunoglobulin level
|
J:119584
|
Ighmtm1Cgn/Ighmtm1Cgn
(involves: 129S2/SvPas)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:112160
|
| decreased IgA level
|
J:157450
|
| decreased IgG level
|
J:157450
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:112160
|
| decreased T cell proliferation
|
J:112160
|
Ighmtm1Cgn/Ighmtm1Cgn
(NOD.129S2-Ighmtm1Cgn/DvsJ)
|
abnormal T cell proliferation
|
J:80859
|
Ighmtm1Cgn/Ighmtm1Cgn
Igkctm1Bgmn/Igkctm1Bgmn
Igltm2.1Bgmn/Igltm2.1Bgmn
(involves: 129)
|
decreased IgG level
|
J:130864
|
| decreased IgM level
|
J:130864
|
Ighmtm1Cgn/Ighmtm1Cgn
Tg(IghelMD4)4Ccg/Tg(IghelMD4)4Ccg
(NOD.Cg-Ighmtm1Cgn Tg(IghelMD4)4Ccg/DvsJ)
|
abnormal B lymphocyte antigen presentation
|
J:80859
|
| abnormal T cell proliferation
|
J:80859
|
Ighmtm1Che/Ighmtm1Che
(involves: 129S4/SvJae * C57BL/6)
|
abnormal B cell physiology
|
J:47425
|
| decreased IgG1 level
|
J:47425
|
| decreased IgG2b level
|
J:47425
|
| decreased IgM level
|
J:47425
|
| increased IgA level
|
J:47425
|
| increased IgG2a level
|
J:47425
|
| increased IgG3 level
|
J:47425
|
Ighmtm1Msn/Ighm+
(involves: 129S/SvEv)
|
decreased IgM level
|
J:49405
|
Ighmtm1Msn/Ighmtm1Msn
(involves: 129S/SvEv)
|
decreased IgG1 level
|
J:49405
|
| decreased IgM level
|
J:49405
|
| increased IgG3 level
|
J:49405
|
Ighmtm1Msn/Ighmtm1Msn
(B6.129S-Ighmtm1Msn)
|
decreased IgM level
|
J:80656
|
Ighmtm1Msn/Ighmtm1Msn
Tg(Igh-6)1Msn/?
(B6.129S-Ighmtm1Msn)
|
decreased IgM level
|
J:80656
|
Ighmtm1Sls/Ighmtm1Sls
(Not Specified)
|
abnormal class switch recombination
|
J:99465
|
| decreased IgG1 level
|
J:99465
|
| decreased IgG2b level
|
J:99465
|
| decreased IgG3 level
|
J:99465
|
| decreased IgG level
|
J:99465
|
| increased IgM level
|
J:99465
|
Ighmtm2.1Bgmn/Ighmtm2.1Bgmn
(involves: 129/Sv * C57BL/6 * CBA)
|
decreased immunoglobulin level
|
J:118453
|
Ighmtm3Bgmn/Ighmtm3Bgmn
(involves: 129)
|
abnormal B cell activation
|
J:131633
|
| decreased B cell proliferation
|
J:131633
|
| decreased IgM level
|
J:131633
|
Ighmtm3Bgmn/Ighmtm3Bgmn
Igkctm1Bgmn/Igkctm1Bgmn
Igltm2.1Bgmn/Igltm2.1Bgmn
(involves: 129P2/OlaHsd * 129/Sv)
|
decreased IgG level
|
J:130864
|
| decreased IgM level
|
J:130864
|
Ighmtm4Bgmn/Ighmtm4Bgmn
(involves: 129)
|
abnormal B cell activation
|
J:131633
|
| decreased B cell proliferation
|
J:131633
|
| decreased IgM level
|
J:131633
|
Igk-Jtm1Cog/Igk-Jtm1Cog
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:110100
|
Igkctm1(IGKC)Mnz/Rr166tm4.1Wtg
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
abnormal B cell physiology
|
J:193015
|
| abnormal immunoglobulin level
|
J:193015
|
Igkctm1Bgmn/Igkctm1Bgmn
Igltm2.1Bgmn/Igltm2.1Bgmn
(involves: 129P2/OlaHsd)
|
decreased IgG level
|
J:130864
|
| decreased IgM level
|
J:130864
|
Igkctm1Jkbv/Igkctm1Jkbv
(Not Specified)
|
abnormal immunoglobulin level
|
J:137738
|
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGK@yK1)9.2CJkbv/0
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin level
|
J:137738
|
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGK@yK1)9.2CJkbv/Tg(IGK@yK1)9.2CJkbv
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin level
|
J:137738
|
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGK@yK2)J23.1Jkbv/0
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin level
|
J:137738
|
Igll1tm1Cgn/Igll1tm1Cgn
(involves: 129S2/SvPas * C57BL/6)
|
decreased IgG1 level
|
J:64284
|
| decreased IgG2b level
|
J:64284
|
| decreased IgG3 level
|
J:64284
|
| decreased IgG level
|
J:64284
|
Ignpq1BALB/cAJcl/Ignpq1HIGA/Nsc
(involves: BALB/cAJcl * HIGA/Nsc)
|
increased IgA level
|
J:116904
|
Ignpq1HIGA/Nsc/Ignpq1HIGA/Nsc
(involves: BALB/cAJcl * HIGA/Nsc)
|
increased IgA level
|
J:116904
|
Ignpq2BALB/cAJcl/Ignpq2HIGA/Nsc
(involves: BALB/cAJcl * HIGA/Nsc)
|
increased IgA level
|
J:116904
|
Ignpq2HIGA/Nsc/Ignpq2HIGA/Nsc
(involves: BALB/cAJcl * HIGA/Nsc)
|
increased IgA level
|
J:116904
|
Ikbipem1Bcgen/Ikbipem1Bcgen
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd)
|
decreased macrophage cytokine production
|
J:282971
|
Ikbkbem1Macc/Ikbkb+
(involves: C57BL/6NCrl)
|
abnormal T cell activation
|
J:290616
|
Ikbkbem1Macc/Ikbkbem1Macc
(involves: C57BL/6NCrl)
|
abnormal T cell activation
|
J:290616
|
IkbkbM1Btlr/Ikbkb+
(C57BL/6J-IkbkbM1Btlr)
|
abnormal B cell physiology
|
J:225271
|
IkbkbM1Btlr/IkbkbM1Btlr
(C57BL/6J-IkbkbM1Btlr)
|
abnormal B cell physiology
|
J:225271
|
Ikbkbtm1Lex/Ikbkbtm1Lex
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S/SvEvBrd)
|
impaired macrophage chemotaxis
|
J:159873
|
| impaired neutrophil chemotaxis
|
J:159873
|
| impaired neutrophil recruitment
|
J:159873
|
Ikbkbtm2Cgn/Ikbkbtm2.1Cgn
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased IgE level
|
J:85810
|
Ikbkbtm2Mka/Ikbkbtm2.1Mka
Tg(Vil-cre)1Mka/0
(involves: 129/Sv * C57BL/6)
|
impaired neutrophil recruitment
|
J:83313
|
Ikbkbtm2Mka/Ikbkbtm2Mka
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129/Sv * 129P2/OlaHsd)
|
increased macrophage apoptosis
|
J:80159
|
Ikbkgtm1.1Chtr/Y
Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N * SJL)
|
abnormal NK cell physiology
|
J:151485
|
| abnormal NK T cell physiology
|
J:151485
|
Ikbkgtm1.1Chtr/Ikbkgtm1.1Chtr
Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N * SJL)
|
abnormal NK cell physiology
|
J:151485
|
| abnormal NK T cell physiology
|
J:151485
|
Ikbkgtm1.1Mpa/Y
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
increased T cell apoptosis
|
J:85810
|
Ikzf1m1Btlr/Ikzf1m1Btlr
(C57BL/6J-Ikzf1m1Btlr)
|
abnormal natural killer cell mediated cytotoxicity
|
J:265249
|
| increased IgG level
|
J:265249
|
Ikzf1tm1Kast/Ikzf1tm1Kast
(involves: 129S2/SvPas)
|
abnormal B cell activation
|
J:82813
|
| decreased B cell proliferation
|
J:82813
|
| decreased IgG3 level
|
J:82813
|
Ikzf1tm1Kge/Ikzf1+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal thymocyte activation
|
J:29355
|
| increased T cell proliferation
|
J:29355
|
Ikzf1tm1Kge/Ikzf1+
(involves: 129S4/SvJae * BALB/c)
|
abnormal thymocyte activation
|
J:29355
|
| increased T cell proliferation
|
J:29355
|
Ikzf1tm2Kge/Ikzf1tm2Kge
(involves: 129S4/SvJae)
|
increased T cell proliferation
|
J:37317
|
Ikzf1tm3Kge/Ikzf1tm3Kge
Tg(CD2-icre)4Kio/?
(involves: C57BL/10 * CBA/Ca)
|
abnormal B cell physiology
|
J:209927
|
| impaired B cell migration
|
J:209927
|
Ikzf1tm3Kge/Ikzf1tm3Kge
Tg(CD19-cre/ERT2)1Cgn/?
(Not Specified)
|
abnormal B cell apoptosis
|
J:209927
|
Ikzf2tm1.1Etms/Ikzf2tm1.1Etms
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal regulatory T cell physiology
|
J:160098
|
Ikzf3tm1Kge/Ikzf3tm1Kge
(involves: 129S4/SvJae * C57BL/6)
|
abnormal type III hypersensitivity reaction
|
J:81805
|
| decreased IgG2b level
|
J:50626
|
| decreased IgG3 level
|
J:50626
|
| decreased IgM level
|
J:50626
|
| increased B cell proliferation
|
J:50626
|
| increased IgE level
|
J:50626
|
| increased IgG1 level
|
J:50626
|
| increased IgG2a level
|
J:50626
|
| increased T cell proliferation
|
J:50626
|
Ikzf4tm1.1Etms/Ikzf4tm1.1Etms
(Not Specified)
|
decreased T cell proliferation
|
J:295208
|
Il1atm1Yiw/Il1atm1Yiw
Il1btm1Yiw/Il1btm1Yiw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:165513
|
Il1atm1Yiw/Il1atm1Yiw
Il1btm1Yiw/Il1btm1Yiw
(involves: 129S1/Sv * 129X1/SvJ * BALB/c)
|
impaired neutrophil recruitment
|
J:50775
|
Il1btm1Dch/Il1btm1Dch
(involves: 129S2/SvPas)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:33465
|
Il1btm1Lvp/Il1btm1Lvp
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal lymphocyte physiology
|
J:67001
|
Il1btm1Lvp/Il1btm1Lvp
(involves: 129S7/SvEvBrd)
|
abnormal macrophage physiology
|
J:136368
|
Il1r1tm1Imx/Il1r1tm1Imx
(involves: 129S7/SvEvBrd)
|
abnormal neutrophil physiology
|
J:113110
|
Il1r1tm1Imx/Il1r1tm1Imx
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal neutrophil physiology
|
J:112999
|
Il1r1tm1Imx/Il1r1tm1Imx
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(involves: 129S7/SvEvBrd * C57BL/6)
|
impaired neutrophil recruitment
|
J:126652
|
Il1r1tm1Quan/Il1r1tm1Quan
(involves: C57BL/6)
|
abnormal microglial cell activation
|
J:219864
|
Il1r1tm1Quan/Il1r1tm1Quan
Lyz2tm1(cre)Ifo/Lyz2tm1(cre)Ifo
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal microglial cell activation
|
J:219864
|
Il1r1tm1Quan/Il1r1tm1Quan
Tg(Tek-cre)12Flv/0
(involves: C3H * C57BL/6)
|
abnormal microglial cell activation
|
J:219864
|
Il1r1tm1Roml/Il1r1tm1Roml
(involves: 129S1/Sv * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:42373
|
Il1r1tm1Roml/Il1r1tm1Roml
(C.Cg-Il1r1tm1Roml)
|
decreased immunoglobulin level
|
J:82863
|
| decreased T cell proliferation
|
J:82863
|
Il1r1tm1Roml/Il1r1tm1Roml
(involves: 129S1/Sv * BALB/c)
|
impaired neutrophil chemotaxis
|
J:124226
|
Il1r2tm1.2Mchc/Il1r2tm1.2Mchc
(involves: BALB/cJ * C57BL/6J * C57BL/6NTac)
|
abnormal T cell physiology
|
J:347877
|
Il1r2tm1Yiw/Il1r2tm1Yiw
(B6.129P2-Il1r2tm1Yiw)
|
abnormal macrophage physiology
|
J:274653
|
| increased macrophage cytokine production
|
J:274653
|
Il1rl1tm1Anjm/Il1rl1tm1Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal eosinophil physiology
|
J:61108
|
| abnormal T-helper 2 physiology
|
J:61108
|
Il1rl1tm1Anjm/Il1rl1tm1Anjm
(involves: 129P2/OlaHsd)
|
decreased IgE level
|
J:159464
|
Il1rl2tm1Hblu/Il1rl2tm1Hblu
(involves: 129 * C57BL/6)
|
abnormal dendritic cell physiology
|
J:296074
|
| abnormal macrophage activation involved in immune response
|
J:296074
|
Il1rntm1.1Cga/Il1rntm1.1Cga
Lyz2tm1(cre)Ifo/Lyz2+
(D1.Cg-Il1rntm1.1Cga Lyz2tm1(cre)Ifo)
|
increased T cell proliferation
|
J:162760
|
Il2m1/Il2m1
(MRL/MpJ)
|
abnormal T cell activation
|
J:75331
|
Il2tm1Hor/Il2tm1Hor
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:39981,
J:39989,
J:15573
|
| abnormal class switch recombination
|
J:15573
|
| abnormal cytotoxic T cell physiology
|
J:39981
|
| abnormal lymphocyte physiology
|
J:15223
|
| abnormal thymocyte activation
|
J:37220,
J:39989
|
| decreased cytotoxic T cell cytolysis
|
J:15573,
J:26198,
J:26861
|
| decreased T cell proliferation
|
J:39989,
J:26198
|
| impaired natural killer cell mediated cytotoxicity
|
J:15573
|
| increased B cell proliferation
|
J:16662
|
| increased IgA level
|
J:15223
|
| increased IgE level
|
J:16662
|
| increased IgG1 level
|
J:39989,
J:15223,
J:16662
|
| increased IgG2a level
|
J:16662
|
| increased IgG2b level
|
J:16662
|
| increased T cell proliferation
|
J:15223,
J:16662
|
Il2tm1Hor/Il2tm1Hor
(C.129P2-Il2tm1Hor)
|
abnormal regulatory T cell physiology
|
J:112603
|
| increased B cell proliferation
|
J:29799
|
| increased IgG level
|
J:29799
|
| increased T cell proliferation
|
J:29799
|
Il2tm1Hor/Il2tm1Hor
(B6.129P2-Il2tm1Hor)
|
increased T cell proliferation
|
J:28924
|
Il2tm1Hor/Il2tm1Hor
(B6.129P2-Il2tm1Hor/J)
|
abnormal T cell activation
|
J:190168
|
| abnormal T cell proliferation
|
J:190168
|
Il2tm1Hor/Il2tm1Hor
Il4tm1Cgn/Il4tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased cytotoxic T cell cytolysis
|
J:26861
|
| decreased IgG level
|
J:16662,
J:26861
|
| increased B cell proliferation
|
J:16662
|
| increased T cell proliferation
|
J:16662
|
Il2tm1Hor/Il2tm1Hor
Tg(DO11.10)10Dlo/?
(C.Cg-Il2tm1Hor Tg(DO11.10)10Dlo)
|
abnormal regulatory T cell physiology
|
J:88349
|
| increased T cell proliferation
|
J:88349
|
Il2tm1Hor/Il2tm1Hor
Tg(Pgk1-HA)1.1Vbo/?
Tg(Tcra/Tcrb)1Vbo/?
(C.Cg-Il2tm1Hor Tg(Pgk1-HA)1.1Vbo Tg(Tcra/Tcrb)1Vbo)
|
abnormal regulatory T cell physiology
|
J:112603
|
Il2raM1J/Il2raM1J
(involves: 129S4/SvJae * C57BL/6)
|
abnormal regulatory T cell physiology
|
J:268677
|
Il2ratm1Dw/Il2ratm1Dw
(involves: 129S4/SvJae * C57BL/6)
|
abnormal B cell physiology
|
J:64279
|
| abnormal T cell physiology
|
J:64279
|
| increased IgA level
|
J:64279
|
| increased IgG1 level
|
J:64279
|
| increased IgG2a level
|
J:64279
|
| increased IgG2b level
|
J:64279
|
| increased IgG level
|
J:64279
|
Il2ratm1Dw/Il2ratm1Dw
(B6.129S4-Il2ratm1Dw)
|
abnormal regulatory T cell physiology
|
J:125748
|
| abnormal T cell activation
|
J:125748
|
Il2ratm1Dw/Il2ratm1Dw
Tg(Pgk1-HA)1.1Vbo/?
Tg(Tcra/Tcrb)1Vbo/?
(C.Cg-Il2ratm1Dw Tg(Pgk1-HA)1.1Vbo Tg(Tcra/Tcrb)1Vbo)
|
abnormal regulatory T cell physiology
|
J:112603
|
Il2rbm2Btlr/Il2rbm2Btlr
(C57BL/6J-Il2rbm2Btlr)
|
increased IgE level
|
J:272832
|
Il2rbM3Btlr/Il2rbM3Btlr
(C57BL/6J-Il2rbM3Btlr)
|
increased IgM level
|
J:272833
|
Il2rbtm1Mak/Il2rbtm1Mak
(either: (involves: 129P2/OlaHsd) or (involves: 129S2/SvPas))
|
abnormal B cell activation
|
J:25940
|
| abnormal T cell activation
|
J:25940
|
| increased IgE level
|
J:25940
|
| increased IgG1 level
|
J:25940
|
Il2rbtm1Mak/Il2rbtm1Mak
(B6.129-Il2rbtm1Mak)
|
abnormal T cell activation
|
J:113547
|
| decreased T cell proliferation
|
J:113547
|
Il2rbtm1Mak/Il2rbtm1Mak
(C.129-Il2rbtm1Mak)
|
abnormal T cell activation
|
J:113547
|
| decreased T cell proliferation
|
J:113547
|
Il2rgtm1Cgn/Y
(involves: 129 * CB20)
|
abnormal class switch recombination
|
J:22521
|
| abnormal thymocyte activation
|
J:22521
|
| decreased IgE level
|
J:22521
|
| decreased IgM level
|
J:22521
|
| decreased T cell proliferation
|
J:22521
|
| impaired natural killer cell mediated cytotoxicity
|
J:22521
|
Il2rgtm1Cgn/Il2rgtm1Cgn
(involves: 129 * CB20)
|
abnormal class switch recombination
|
J:22521
|
| abnormal thymocyte activation
|
J:22521
|
| decreased IgE level
|
J:22521
|
| decreased IgM level
|
J:22521
|
| decreased T cell proliferation
|
J:22521
|
| impaired natural killer cell mediated cytotoxicity
|
J:22521
|
Il2rgtm1Sug/Y
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129S6/SvEvTac * C57BL/6))
|
abnormal immunoglobulin level
|
J:31167
|
| decreased IgG3 level
|
J:31167
|
| decreased IgG level
|
J:31167
|
Il2rgtm1Wjl/Y
(involves: 129S4/SvJae * C57BL/6)
|
abnormal basophil physiology
|
J:24117
|
| abnormal mast cell physiology
|
J:24117
|
| abnormal thymocyte activation
|
J:24117
|
| decreased immunoglobulin level
|
J:24117
|
| decreased T cell proliferation
|
J:24117
|
| impaired natural killer cell mediated cytotoxicity
|
J:24117
|
Il2rgtm1Wjl/Y
Prkdcscid/Prkdcscid
(NOD.Cg-Prkdcscid Il2rgtm1Wjl/Sz)
|
decreased immunoglobulin level
|
J:109833
|
Il2rgtm1Wjl/Y
Rag1tm1Mom/Rag1tm1Mom
(NOD.Cg-Rag1tm1Mom Il2rgtm1Wjl/SzJ)
|
abnormal adaptive immunity
|
J:140388
|
Il2rgtm1Wjl/Il2rgtm1Wjl
(B6.129S4-Il2rgtm1Wjl/J)
|
abnormal dendritic cell physiology
|
J:123902
|
Il2rgtm1Wjl/Il2rgtm1Wjl
Prkdcscid/Prkdcscid
(NOD.Cg-Prkdcscid Il2rgtm1Wjl/Sz)
|
decreased immunoglobulin level
|
J:109833
|
Il3tm1Glli/Il3tm1Glli
(either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6))
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:80640
|
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T-helper 2 physiology
|
J:89095
|
| decreased IgE level
|
J:113543,
J:72587
|
| decreased IgG1 level
|
J:72587
|
| decreased IgG level
|
J:89095
|
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
(C.129P2/OlaHsd-Il4/Il13tm3Anjm)
|
decreased IgE level
|
J:91403
|
| increased IgG2a level
|
J:91403
|
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
(involves: 129P2/OlaHsd * BALB/c)
|
decreased IgG1 level
|
J:178986
|
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T-helper 2 physiology
|
J:89095
|
| decreased IgE level
|
J:113543,
J:72587
|
| decreased IgG1 level
|
J:72587
|
| decreased IgG level
|
J:89095
|
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
(C.129P2/OlaHsd-Il4/Il13tm3Anjm)
|
decreased IgE level
|
J:91403
|
| increased IgG2a level
|
J:91403
|
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
(involves: 129P2/OlaHsd * BALB/c)
|
decreased IgG1 level
|
J:178986
|
Il4tm1(CD2)Mmrs/Il4tm1(CD2)Mmrs
(involves: 129)
|
decreased IgE level
|
J:178986
|
| decreased IgG1 level
|
J:178986
|
Il4tm1.1Wep/Il4+
(C.129P2-Il4tm1.1Wep)
|
decreased IgE level
|
J:138827
|
Il4tm1.1Wep/Il4+
Stat6tm1Gru/Stat6tm1Gru
(C.129-Stat6tm1Gru Il4tm1.1Wep)
|
decreased IgE level
|
J:138827
|
| impaired eosinophil recruitment
|
J:138827
|
Il4tm1.1Wep/Il4tm1.1Wep
(C.129P2-Il4tm1.1Wep)
|
decreased IgE level
|
J:138827
|
| impaired eosinophil recruitment
|
J:138827
|
Il4tm1.1Wep/Il4tm1.1Wep
Stat6tm1Gru/Stat6tm1Gru
(C.129-Stat6tm1Gru Il4tm1.1Wep)
|
decreased IgE level
|
J:138827
|
| impaired eosinophil recruitment
|
J:138827
|
Il4tm1Cgn/Il4tm1Cgn
(B6.Cg-Il4tm1Cgn)
|
abnormal T-helper 2 physiology
|
J:89095
|
Il4tm1Cgn/Il4tm1Cgn
(involves: 129P2/OlaHsd * NOD)
|
decreased IgG1 level
|
J:85924
|
Il4tm1Cgn/Il4tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased IgE level
|
J:704
|
| decreased IgG1 level
|
J:704
|
Il4tm1Cgn/Il4tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6J * MRL/Mp)
|
decreased IgE level
|
J:39600
|
| decreased IgG1 level
|
J:39600
|
Il4tm1Cgn/Il4tm1Cgn
(involves: 129P2/OlaHsd * A/WySn * C57BL/10SnSg * Swiss)
|
decreased IgG1 level
|
J:119207
|
| increased IgG2a level
|
J:119207
|
Il4tm1Kopf/Il4tm1Kopf
(involves: 129S2/SvPas * C57BL/6)
|
decreased IgE level
|
J:14593
|
| decreased IgG1 level
|
J:14593
|
| increased IgG level
|
J:14593
|
Il4tm1Kopf/Il4tm1Kopf
(involves: 129S2/SvPas)
|
decreased IgE level
|
J:113065
|
Il4tm1Kopf/Il4tm1Kopf
Lyntm1Ard/Lyntm1Ard
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
decreased IgE level
|
J:161523
|
| decreased IgG1 level
|
J:161523
|
| increased IgA level
|
J:161523
|
| increased IgG2a level
|
J:161523
|
| increased IgG2b level
|
J:161523
|
| increased IgM level
|
J:161523
|
Il4tm1Lky/Il4+
Lattm1.1Mal/Lattm1.1Mal
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T-helper 2 physiology
|
J:151840
|
Il4tm1Lky/Il4tm1Lky
Itktm1Litt/Itktm1Litt
(involves: 129S4/SvJae * BALB/c * C57BL/6J)
|
abnormal T-helper 2 physiology
|
J:129883
|
Il4tm1Nnt/Il4tm1Nnt
(C57BL/6-Il4tm1Nnt/J)
|
abnormal T-helper 2 physiology
|
J:37196
|
| decreased IgE level
|
J:37196
|
| decreased IgG1 level
|
J:37196
|
| decreased IgM level
|
J:37196
|
| increased IgA level
|
J:37196
|
Il4tm1Rao/Il4tm1Rao
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal mast cell physiology
|
J:78089
|
| abnormal T-helper 2 physiology
|
J:78089
|
Il4tm2.1Kubo/Il4tm2.1Kubo
(B6.Cg-Il4tm2.1Kubo)
|
decreased IgE level
|
J:167446
|
| decreased IgG1 level
|
J:167446
|
| impaired eosinophil recruitment
|
J:167446
|
| increased IgG2c level
|
J:167446
|
Il4tm2Nnt/Il4tm2Nnt
(BALB/c-Il4tm2Nnt/J)
|
abnormal dendritic cell antigen presentation
|
J:141937
|
| decreased IgE level
|
J:31486
|
| decreased IgG1 level
|
J:31486
|
Il4raM1Btlr/Il4raM1Btlr
(C57BL/6J-Il4raM1Btlr)
|
decreased IgE level
|
J:267558
|
Il4raM2Btlr/Il4raM2Btlr
(C57BL/6J-Il4raM2Btlr)
|
decreased IgE level
|
J:272804
|
Il4ratm1Fbb/Il4ratm1Fbb
(involves: BALB/cJ)
|
abnormal macrophage physiology
|
J:114751
|
| impaired macrophage chemotaxis
|
J:114751
|
Il4ratm1Fbb/Il4ratm2Fbb
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal macrophage physiology
|
J:114751
|
Il4ratm1Sz/Il4ratm1Sz
(BALB/c-Il4ratm1Sz/J)
|
abnormal T-helper 2 physiology
|
J:43656
|
| decreased IgE level
|
J:43656
|
| decreased IgG1 level
|
J:43656
|
| increased IgG2a level
|
J:43656
|
Il4ratm1Sz/Il4ratm1Sz
(BALB/c-Il4ratm1Sz)
|
increased IgG2a level
|
J:110429
|
Il4ratm1Tch/Il4ratm1Tch
(involves: 129X1/SvJ * BALB/c)
|
decreased T cell proliferation
|
J:86215
|
| increased IgE level
|
J:86215
|
| increased IgG level
|
J:86215
|
Il4ratm2Tch/Il4ratm2Tch
(C.129X1-Il4ratm2Tch)
|
abnormal T-helper 2 physiology
|
J:152376
|
| increased IgE level
|
J:152376
|
| increased susceptibility to type I hypersensitivity reaction
|
J:152376
|
Il4ratm3.1Tch/Il4ratm3.1Tch
(C.129X1-Il4ratm3.1Tch)
|
abnormal macrophage activation involved in immune response
|
J:160806
|
| increased IgE level
|
J:160806
|
| increased susceptibility to type I hypersensitivity reaction
|
J:160806
|
Il5tm1Anjm/Il5tm1Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal mast cell physiology
|
J:113543
|
| decreased IgE level
|
J:113543
|
Il5tm1Anjm/Il5tm1Anjm
Il9tm1Anjm/Il9tm1Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal mast cell physiology
|
J:113543
|
| decreased IgE level
|
J:113543
|
Il5tm2Anjm/Il5tm2Anjm
Il9tm1Anjm/Il9tm1Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal immunoglobulin level
|
J:113543
|
Il5ratm1Ktk/Il5ratm1Ktk
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased IgA level
|
J:33140
|
| decreased IgG3 level
|
J:33140
|
| decreased IgM level
|
J:33140
|
| decreased immunoglobulin level
|
J:33140
|
Il5ratm1Ktk/Il5ratm1Ktk
(B6.129P2-Il5ratm1Ktk)
|
decreased B cell proliferation
|
J:89849
|
| decreased IgA level
|
J:89849
|
| decreased IgG1 level
|
J:89849
|
| decreased IgG3 level
|
J:89849
|
| decreased IgM level
|
J:89849
|
Il5ratm1Ktk/Il5ratm1Ktk
Lyntm1Tya/Lyntm1Tya
(involves: 129P2/OlaHsd * C57BL/6)
|
increased IgA level
|
J:91089
|
| increased IgM level
|
J:91089
|
| increased immunoglobulin level
|
J:91089
|
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6)
|
decreased cytotoxic T cell cytolysis
|
J:17360
|
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas)
|
abnormal T cell physiology
|
J:159479
|
Il6tm1Mur/Il6tm1Mur
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal neutrophil physiology
|
J:25684
|
Il6tm1Mur/Il6tm1Mur
(B6.129P2(B6)-Il6tm1Mur)
|
abnormal microglial cell physiology
|
J:85581
|
| abnormal osteoclast physiology
|
J:65093
|
Il6tm1Poli/Il6tm1Poli
(involves: 129S/SvEv * MF1)
|
abnormal macrophage physiology
|
J:79314
|
| abnormal neutrophil physiology
|
J:79314
|
| abnormal osteoclast physiology
|
J:17249
|
| abnormal T-helper 1 physiology
|
J:79314
|
| abnormal T-helper 2 physiology
|
J:79314
|
| decreased IgA level
|
J:79314
|
| decreased IgE level
|
J:79314
|
| increased IgG2a level
|
J:79314
|
Il6tm1Poli/Il6tm1Poli
(involves: 129S/SvEv * C57BL/6)
|
impaired neutrophil recruitment
|
J:68063
|
Il6tm1Poli/Il6tm1Poli
(CAnNCrl.129S(Cg)-Il6tm1Poli)
|
abnormal B cell proliferation
|
J:42869
|
Il6ratm1Saj/Il6ratm1Saj
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:159479
|
Il6sttm1Ard/Il6sttm1Ard
(involves: 129S1/Sv * C57BL/6)
|
decreased IgA level
|
J:79555
|
| decreased IgG level
|
J:79555
|
| decreased immunoglobulin level
|
J:79555
|
Il6sttm1Kish/Il6sttm1Kish
(involves: 129P2/OlaHsd * CD-1)
|
abnormal osteoclast physiology
|
J:88710
|
Il6sttm1Thir/Il6sttm1Thir
(Not Specified)
|
abnormal B cell physiology
|
J:59922
|
| abnormal dendritic cell antigen presentation
|
J:113335
|
| increased IgG2a level
|
J:59922
|
| increased IgG2b level
|
J:59922
|
Il6sttm1Thir/Il6sttm1Thir
(involves: 129 * C57BL/6)
|
abnormal T cell activation
|
J:133059
|
| abnormal thymocyte activation
|
J:133059
|
| increased IgA level
|
J:133059
|
| increased IgG1 level
|
J:133059
|
| increased IgG2a level
|
J:133059
|
| increased IgG2b level
|
J:133059
|
Il6sttm1Wme/Il6sttm1Wme
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal immunoglobulin level
|
J:67677
|
| increased IgE level
|
J:67677
|
| increased IgG level
|
J:67677
|
Il6sttm2Thir/Il6sttm2Thir
(Not Specified)
|
abnormal dendritic cell antigen presentation
|
J:113335
|
| decreased IgG1 level
|
J:59922
|
| decreased IgG2a level
|
J:59922
|
| decreased IgG2b level
|
J:59922
|
| increased IgM level
|
J:59922
|
Il6sttm3Thir/Il6sttm3Thir
(Not Specified)
|
decreased IgA level
|
J:59922
|
| decreased IgG2a level
|
J:59922
|
| decreased IgG2b level
|
J:59922
|
Il7tm2.1Iku/Il7tm2.1Iku
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA)
|
abnormal NK T cell physiology
|
J:190615
|
Il7rtm1Abra/Il7rtm1Abra
(B6.129S4-Il7rtm1Abra)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:125360
|
| abnormal T cell proliferation
|
J:125360
|
Il7rtm1Imx/Il7rtm1Imx
Tg(Lck-Il7r)1676Trma/?
(involves: 129S7/SvEvBrd * C57BL/6 * SJL)
|
decreased T cell proliferation
|
J:66400
|
| increased thymocyte apoptosis
|
J:66400
|
Il9rtm1Jcrd/Il9rtm1Jcrd
(involves: C57BL/6)
|
abnormal regulatory T cell physiology
|
J:151907
|
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal Langerhans cell physiology
|
J:51636
|
| abnormal type IV hypersensitivity reaction
|
J:35510
|
| decreased T cell proliferation
|
J:125760
|
| increased IgE level
|
J:62283
|
| increased IgG1 level
|
J:62283
|
| increased IgG2a level
|
J:62283
|
| increased susceptibility to type IV hypersensitivity reaction
|
J:51636
|
Il10tm1Cgn/Il10tm1Cgn
(B6.129P2-Il10tm1Cgn/J)
|
abnormal regulatory T cell physiology
|
J:125748
|
Il10tm1Cgn/Il10tm1Cgn
Il27ratm1Mak/Il27ratm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T-helper 1 physiology
|
J:136179
|
| abnormal T-helper 2 physiology
|
J:136179
|
Il10tm1Cgn/Il10tm1Cgn
Vdrtm1Mbd/Vdrtm1Mbd
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:107077
|
| decreased T cell proliferation
|
J:107077
|
| increased T cell apoptosis
|
J:107077
|
Il10tm1Roer/Il10tm1Roer
Foxp3tm4(YFP/icre)Ayr/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal regulatory T cell physiology
|
J:134513
|
| abnormal type IV hypersensitivity reaction
|
J:134513
|
Il10raNZW/Il10ra+
((NZB x NZW)F1)
|
increased IgG level
|
J:102087
|
Il12atm1Cab/Il12atm1Cab
(B6.129S4-Il12atm1Cab)
|
abnormal NK cell physiology
|
J:79552
|
Il12atm1Jm/Il12atm1Jm
(129S1/Sv-Il12atm1Jm)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:34164
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:34164
|
Il12atm1Jm/Il12atm1Jm
(C.129S1-Il12atm1Jm)
|
impaired natural killer cell mediated cytotoxicity
|
J:125611
|
Il12atm1Jm/Il12atm1Jm
(involves: 129S1/Sv)
|
abnormal NK cell physiology
|
J:139001
|
Il12atm1Jm/Il12atm1Jm
Il12btm1Jm/Il12btm1Jm
(B6.129S1-Il12atm1Jm Il12btm1Jm)
|
impaired natural killer cell mediated cytotoxicity
|
J:125611
|
Il12btm1Jm/Il12btm1Jm
(B6.129S1-Il12btm1Jm/J)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:111568
|
| abnormal granulocyte physiology
|
J:111568
|
| abnormal lymphocyte physiology
|
J:120806
|
| abnormal macrophage physiology
|
J:111568
|
| abnormal NK cell physiology
|
J:120806
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:120806
|
Il12btm1Jm/Il12btm1Jm
(129S1/Sv-Il12btm1Jm)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:34164
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:34164
|
Il12btm1Jm/Il12btm1Jm
(involves: 129S1/SvImJ)
|
abnormal T-helper 1 physiology
|
J:46514
|
| impaired natural killer cell mediated cytotoxicity
|
J:46514
|
Il12btm1Jm/Il12btm1Jm
Il18tm1Aki/Il18tm1Aki
(involves: 129P2/OlaHsd * 129S1/SvImJ)
|
abnormal T-helper 1 physiology
|
J:46514
|
| impaired natural killer cell mediated cytotoxicity
|
J:46514
|
Il12rb1tm1Jm/Il12rb1tm1Jm
(involves: 129S1/Sv * C57BL/6J)
|
abnormal lymphocyte physiology
|
J:42105
|
Il12rb2Ifnm-d/Il12rb2Ifnm-d
Tlr4lps-del/Tlr4lps-del
(C57BL/10ScCr)
|
abnormal dendritic cell physiology
|
J:91014
|
| abnormal granulocyte physiology
|
J:91014
|
| abnormal macrophage physiology
|
J:91014
|
| abnormal NK cell physiology
|
J:91014
|
Il12rb2tm1Jm/Il12rb2tm1Jm
(either: (involves: 129S1/Sv * BALB/cByJ) or (involves: 129S1/Sv * C57BL/6J))
|
abnormal lymphocyte physiology
|
J:65891
|
| abnormal NK cell physiology
|
J:65891
|
Il12rb2tm1Jm/Il12rb2tm1Jm
(B6;129S1-Il12rb2tm1Jm/J)
|
abnormal B cell activation
|
J:106805
|
| abnormal T cell activation
|
J:106805
|
Il13tm1.1Anjm/Il13tm1.1Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased IgE level
|
J:67965
|
| increased IgG2b level
|
J:67965
|
| increased IgM level
|
J:67965
|
Il13tm1.1Anjm/Il13tm1.1Anjm
(C.129P2-Il13tm1.1Anjm)
|
abnormal dendritic cell antigen presentation
|
J:141937
|
| decreased IgE level
|
J:91403
|
| increased IgG2a level
|
J:91403
|
Il13tm1.1Anjm/Il13tm1.1Anjm
Tg(DO11.10)10Dlo/0
(involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:91403
|
Il13tm2Anjm/Il13tm2Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T-helper 2 physiology
|
J:89095
|
Il13tm2Anjm/Il13tm2Anjm
(C.129P2(B6)-Il13tm2Anjm)
|
abnormal type I hypersensitivity reaction
|
J:123772
|
| increased susceptibility to type I hypersensitivity reaction
|
J:123772
|
Il13tm2Anjm/Il13tm2Anjm
(involves: 129)
|
decreased IgE level
|
J:67965
|
| increased IgG2b level
|
J:67965
|
| increased IgM level
|
J:67965
|
Il13tm2Anjm/Il13tm2Anjm
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal macrophage physiology
|
J:176092
|
| impaired eosinophil recruitment
|
J:126675
|
| impaired neutrophil recruitment
|
J:105813
|
Il13tm2Anjm/Il13tm2Anjm
(B6.129P2-Il13tm2Anjm)
|
abnormal leukocyte physiology
|
J:131969
|
Il13ra1tm1Twy/Y
(C.Cg-Il13ra1tm1Twy)
|
abnormal T-helper 2 physiology
|
J:130488
|
| decreased IgE level
|
J:130488
|
| increased IgA level
|
J:130488
|
| increased IgG1 level
|
J:130488
|
| increased IgG3 level
|
J:130488
|
Il13ra2tm1Gru/Il13ra2tm1Gru
(C.Cg-Il13ra2tm1Gru)
|
abnormal macrophage physiology
|
J:82376
|
| increased IgA level
|
J:82376
|
| increased IgE level
|
J:82376
|
| increased IgG2a level
|
J:82376
|
| increased IgG2b level
|
J:82376
|
Il15tm1Imx/Il15tm1Imx
(involves: C57BL/6)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:95221
|
| decreased IgG level
|
J:97620
|
| decreased IgM level
|
J:97620
|
| decreased immunoglobulin level
|
J:97620
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:87137
|
| impaired natural killer cell mediated cytotoxicity
|
J:97620
|
Il15tm1Imx/Il15tm1Imx
(C57BL/6-Il15tm1Imx)
|
abnormal dendritic cell physiology
|
J:123902
|
Il15ratm1.1Nsl/Il15ratm1.1Nsl
(involves: 129X1/SvJ * C57BL/6)
|
abnormal T cell apoptosis
|
J:73738
|
| increased thymocyte apoptosis
|
J:73738
|
Il15ratm1.1Nsl/Il15ratm1.1Nsl
(B6.129X1-Il15ratm1.1Nsl)
|
abnormal T cell activation
|
J:92705
|
| abnormal T cell proliferation
|
J:92705
|
| increased T cell proliferation
|
J:92705
|
Il15ratm1.1Nsl/Il15ratm1.1Nsl
Tg(TcrAND)53Hed/?
(involves: 129X1/SvJ * C57BL/6 * SJL)
|
increased T cell proliferation
|
J:92705
|
Il15ratm1Ama/Il15ratm1Ama
(involves: 129X1/SvJ)
|
abnormal NK cell physiology
|
J:119213
|
| decreased T cell proliferation
|
J:142570
|
| impaired natural killer cell mediated cytotoxicity
|
J:142570
|
Il15ratm1Ama/Il15ratm2.1Ama
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J)
|
abnormal NK cell physiology
|
J:155298
|
Il15ratm1Ama/Il15ratm2.1Ama
Tg(Itgax-cre)1-1Reiz/0
(involves: 129X1/SvJ * C57BL/6J * CBA)
|
abnormal NK cell physiology
|
J:155298
|
Il15ratm1Wjl/Il15ratm1Wjl
(involves: 129 * C57BL/6)
|
abnormal T cell physiology
|
J:142570
|
| decreased T cell proliferation
|
J:142570
|
Il16tm1Korn/Il16tm1Korn
(either: B6.129X1-Il16tm1Korn or C.129X1-Il16tm1Korn)
|
abnormal T cell physiology
|
J:97739
|
Il17a/Il17ftm1.1Impr/Il17a/Il17ftm1.1Impr
(involves: C57BL/6)
|
increased T cell proliferation
|
J:187400
|
Il17a/Il17ftm1.1Impr/Il17a/Il17ftm1.1Impr
(involves: C57BL/6)
|
increased T cell proliferation
|
J:187400
|
Il17atm1Cdon/Il17atm1Cdon
(involves: C57BL/6)
|
decreased IgG1 level
|
J:136279
|
| decreased IgG2a level
|
J:136279
|
| decreased IgG2b level
|
J:136279
|
| decreased IgM level
|
J:136279
|
Il17atm1Yiw/Il17atm1Yiw
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased IgG level
|
J:79127
|
| decreased immunoglobulin level
|
J:79127
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:79127
|
Il17atm1Yiw/Il17atm1Yiw
(involves: 129P2/OlaHsd * BALB/cA * C57BL/6J)
|
abnormal Langerhans cell physiology
|
J:79127
|
| decreased IgE level
|
J:79127
|
| decreased IgG1 level
|
J:79127
|
| decreased immunoglobulin level
|
J:79127
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:79127
|
Il17atm1Yiw/Il17atm1Yiw
Il17ftm2Yiw/Il17ftm2Yiw
(involves: 129P2/OlaHsd * BALB/c)
|
decreased IgG3 level
|
J:143719
|
| increased IgG1 level
|
J:143719
|
| increased IgG2a level
|
J:143719
|
| increased IgG2b level
|
J:143719
|
Il17atm1Yiw/Il17atm1Yiw
Il17ftm2Yiw/Il17ftm2Yiw
(B6.129P2-Il17atm1Yiw Il17ftm2Yiw)
|
decreased IgG3 level
|
J:143719
|
| increased IgG1 level
|
J:143719
|
| increased IgG2a level
|
J:143719
|
| increased IgG2b level
|
J:143719
|
Il17bem1Cya/Il17bem1Cya
(C57BL/6-Il17bem1Cya)
|
increased macrophage cytokine production
|
J:339366
|
Il17ftm1Cdon/Il17ftm1Cdon
(involves: C57BL/6)
|
increased IgG2a level
|
J:136279
|
Il17ratm1Koll/Il17ratm1Koll
(involves: 129 * C57BL/6)
|
impaired neutrophil recruitment
|
J:71097
|
Il17ratm1Koll/Il17ratm1Koll
(involves: 129)
|
impaired neutrophil recruitment
|
J:136279
|
Il17rbtm1Anjm/Il17rbtm1Anjm
(BALB/c-Il17rbtm1Anjm)
|
decreased IgE level
|
J:159464
|
Il17rbtm1Anjm/Il17rbtm1Anjm
Il1rl1tm1Anjm/Il1rl1tm1Anjm
(involves: 129P2/OlaHsd * BALB/c)
|
decreased IgE level
|
J:159464
|
Il18tm1Aki/Il18tm1Aki
(involves: 129P2/OlaHsd)
|
abnormal macrophage physiology
|
J:112400
|
| abnormal T-helper 1 physiology
|
J:46514
|
| impaired natural killer cell mediated cytotoxicity
|
J:46514
|
Il18tm1Aki/Il18tm1Aki
(B6.129P2-Il18tm1Aki)
|
impaired neutrophil chemotaxis
|
J:125285
|
Il18tm1Aki/Il18tm1Aki
Tg(KRT14-CASP1)1Miz/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased IgE level
|
J:78602
|
| decreased IgG1 level
|
J:78602
|
Il18bptm1.1(KOMP)Vlcg/Il18bptm1.1(KOMP)Vlcg
(involves: C57BL/6N)
|
abnormal macrophage activation involved in immune response
|
J:261967
|
Il18r1tm1Aki/Il18r1tm1Aki
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal T-helper 1 physiology
|
J:70298
|
| impaired natural killer cell mediated cytotoxicity
|
J:70298
|
Il18raptm1Yeh/Il18raptm1Yeh
(Not Specified)
|
abnormal leukocyte physiology
|
J:98417
|
Il20tm1Lex/Il20tm1Lex
(B6;129S5-Il20tm1Lex/Mmucd)
|
abnormal type IV hypersensitivity reaction
|
J:171883
|
Il20rbtm1Uwe/Il20rbtm1Uwe
(B6.129P2-Il20rbtm1Uwe)
|
abnormal cytotoxic T cell physiology
|
J:143497
|
| abnormal T-helper 1 physiology
|
J:143497
|
| increased T cell proliferation
|
J:143497
|
Il20rbtm1Uwe/Il20rbtm1Uwe
(C.129P2-Il20rbtm1Uwe)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:143497
|
Il21tm1Lex/Il21tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:137867
|
| abnormal germinal center B cell physiology
|
J:137867
|
| decreased IgG1 level
|
J:137867
|
Il21tm1Llit/Il21tm1Llit
(involves: 129 * C57BL/6J)
|
abnormal class switch recombination
|
J:114783
|
| increased IgE level
|
J:114783
|
Il21rtm1Day/Il21rtm1Day
(involves: BALB/c * C57BL/6)
|
abnormal dendritic cell physiology
|
J:144708
|
| abnormal Langerhans cell physiology
|
J:144708
|
| abnormal memory T cell physiology
|
J:76043
|
| abnormal NK cell physiology
|
J:76043
|
| abnormal plasmacytoid dendritic cell physiology
|
J:144708
|
| abnormal T cell activation
|
J:76043
|
| abnormal T cell physiology
|
J:76043
|
| abnormal thymocyte activation
|
J:76043
|
| decreased cytotoxic T cell cytolysis
|
J:76043
|
| decreased IgE level
|
J:144708
|
| decreased IgG1 level
|
J:76043,
J:144708
|
| decreased IgG2a level
|
J:144708
|
| decreased IgG2b level
|
J:76043
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:144708
|
| impaired natural killer cell mediated cytotoxicity
|
J:76043
|
| increased IgE level
|
J:76043
|
Il21rtm1Day/Il21rtm1Day
(C57BL/6-Il21rtm1Day)
|
abnormal T-helper 2 physiology
|
J:111712
|
| decreased IgG1 level
|
J:111712
|
| decreased IgG2b level
|
J:111712
|
Il21rtm1Kopf/Il21rtm1Kopf
(involves: 129/Sv * BALB/c)
|
abnormal immunoglobulin level
|
J:137508
|
| abnormal lymphocyte physiology
|
J:137508
|
| decreased IgA level
|
J:137508
|
| decreased IgG1 level
|
J:137508
|
| impaired eosinophil recruitment
|
J:137508
|
| increased IgE level
|
J:137508
|
Il21rtm1Kopf/Il21rtm1Kopf
(B6.129-Il21rtm1Kopf)
|
abnormal immunoglobulin level
|
J:137508
|
| abnormal leukocyte physiology
|
J:137508
|
| abnormal lymphocyte physiology
|
J:137508
|
| abnormal T-helper 1 physiology
|
J:137508
|
| abnormal T-helper 2 physiology
|
J:137508
|
| decreased IgA level
|
J:137508
|
| decreased IgG1 level
|
J:137508
|
| impaired eosinophil recruitment
|
J:137508
|
| increased IgE level
|
J:137508
|
Il21rtm1Wjl/Il21rtm1Wjl
(involves: 129 * C57BL/6)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:95221
|
| abnormal immunoglobulin level
|
J:80474
|
| decreased cytotoxic T cell cytolysis
|
J:95221
|
| decreased IgG1 level
|
J:80474
|
| decreased IgG2a level
|
J:80474
|
| decreased IgG2b level
|
J:80474
|
| decreased IgG3 level
|
J:80474
|
| increased IgE level
|
J:80474
|
Il21rtm1Wjl/Il21rtm1Wjl
(NOD.Cg-Il21rtm1Wjl)
|
decreased T cell proliferation
|
J:139075
|
Il21rtm1Wjl/Il21rtm1Wjl
Il4tm1Cgn/Il4tm1Cgn
(involves: 129 * C57BL/6)
|
abnormal immunoglobulin level
|
J:80474
|
| decreased IgA level
|
J:80474
|
| decreased IgG1 level
|
J:80474
|
| decreased IgG2a level
|
J:80474
|
| decreased IgG2b level
|
J:80474
|
| decreased IgG3 level
|
J:80474
|
| decreased IgM level
|
J:80474
|
Il23atm1.1Thak/Il23atm1.1Thak
(C57BL/6-Il23atm1.1Thak)
|
decreased T cell proliferation
|
J:143970
|
Il23atm1Dnax/Il23atm1Dnax
(involves: 129 * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:95542
|
Il23atm1Dnax/Il23atm1Dnax
(B6.Cg-Il23atm1Dnax)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:111568
|
| abnormal granulocyte physiology
|
J:111568
|
| abnormal macrophage physiology
|
J:111568
|
Il23atm1Ngh/Il23atm1Ngh
(involves: 129S/SvEv * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:88235
|
| abnormal memory T cell physiology
|
J:88235
|
| decreased IgA level
|
J:88235
|
| decreased IgG2a level
|
J:88235
|
| decreased immunoglobulin level
|
J:88235
|
Il23atm1Ngh/Il23atm1Ngh
(involves: 129 * C57BL/6)
|
abnormal memory T cell physiology
|
J:120806
|
Il23rtm1.1Kuch/Il23rtm1.1Kuch
(involves: C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:151907
|
Il23rtm1Kuch/Il23rtm1Kuch
(C57BL/6-Il23rtm1Kuch)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:148248
|
Il25tm1.1Cdon/Il25tm1.1Cdon
(involves: 129S6/SvEvTac)
|
increased susceptibility to type I hypersensitivity reaction
|
J:158594
|
Il25tm1Anjm/Il25tm1Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
increased IgE level
|
J:123748
|
Il25tm1Dart/Il25tm1Dart
(C57BL/6-Il25tm1Dart)
|
decreased IgG2a level
|
J:123808
|
Il27tm1Cua/Il27tm1Cua
(C57BL/6-Il27tm1Cua)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:147706
|
Il27ratm1Fjs/Il27ratm1Fjs
(B6.Cg-Il27ratm1Fjs)
|
abnormal T-helper 1 physiology
|
J:94856
|
Il27ratm1Mak/Il27ratm1Mak
(B6.129P2-Il27ratm1Mak)
|
abnormal T-helper 1 physiology
|
J:116610,
J:89509
|
| increased T cell proliferation
|
J:89509
|
Il31ratm1Ngh/Il31ratm1Ngh
(involves: C57BL/6)
|
abnormal macrophage physiology
|
J:123198
|
| increased IgE level
|
J:123198
|
| increased T cell proliferation
|
J:123198
|
Il33tm1(KOMP)Vlcg/Il33tm1(KOMP)Vlcg
(C57BL/6-Il33tm1(KOMP)Vlcg)
|
impaired macrophage chemotaxis
|
J:232676
|
Il33tm1Aki/Il33tm1Aki
(involves: 129X1/SvJ * C57BL/6)
|
abnormal T-helper 2 physiology
|
J:182160
|
| decreased IgE level
|
J:182160
|
Il34tm1b(EUCOMM)Wtsi/Il34tm1b(EUCOMM)Wtsi
(involves: BALB/cJ * C57BL/6N)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:187643
|
Il36gtm1Lex/Il36gtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased macrophage apoptosis
|
J:264077
|
Il36gtm1Lex/Il36gtm1Lex
(involves: 129S5/SvEvBrd)
|
impaired neutrophil recruitment
|
J:280917
|
Il36gtm1Lex/Il36gtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal macrophage activation involved in immune response
|
J:296074
|
| impaired macrophage phagocytosis
|
J:296074
|
Ilktm1Star/Ilktm2Star
Tg(Acp5-cre)1Star/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal osteoclast physiology
|
J:197593
|
Imh1NZB/Imh1NZB
(involves: NZB * NZW)
|
increased IgM level
|
J:26266
|
Imh1NZB/Imh1NZW
(involves: NZB * NZW)
|
increased IgM level
|
J:26266
|
Immp2lTg(HLA-A/H2-D)2Enge/?
((C57BL/6 x CBA)F1)
|
abnormal cytotoxic T cell physiology
|
J:31937
|
Impdh1tm1Bmi/Impdh1tm1Bmi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased T cell proliferation
|
J:85443
|
Impdh1tm1Bmi/Impdh1tm1Bmi
Impdh2tm1Bmi/Impdh2+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal cytotoxic T cell physiology
|
J:85443
|
| decreased T cell proliferation
|
J:85443
|
Imraq1DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
increased IgG level
|
J:100370
|
Imraq2DBA/2J/?
Imraq3C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
increased IgG level
|
J:100370
|
Imrfq1C57BL/6J/?
Imrfq2C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
increased IgG level
|
J:100370
|
Inca1tm1Cmt/Inca1tm1Cmt
(involves: 129 * C57BL/6N)
|
increased IgA level
|
J:175667
|
Ing1Gt(OST206270)Lex/Ing1Gt(OST206270)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased thymocyte apoptosis
|
J:118602
|
Inpp5del20/Inpp5del20
(B6.129-Inpp5del20)
|
increased IgG2a level
|
J:173266
|
| increased IgM level
|
J:173266
|
| increased immunoglobulin level
|
J:173266
|
Inpp5dm1Btlr/Inpp5dm1Btlr
(C57BL/6J-Inpp5dm1Btlr)
|
abnormal eosinophil physiology
|
J:140987
|
| abnormal neutrophil physiology
|
J:140987
|
| decreased cytotoxic T cell cytolysis
|
J:140987
|
| impaired natural killer cell mediated cytotoxicity
|
J:140987
|
Inpp5dtm1.1Wgk/Inpp5dtm1.1Wgk
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal leukocyte physiology
|
J:94861
|
Inpp5dtm1Dmt/Inpp5dtm1Dmt
(involves: 129P2/OlaHsd)
|
abnormal leukocyte physiology
|
J:77739
|
Inpp5dtm1Rav/Inpp5dtm1Rav
Tg(Cd4-cre)1Cwi/?
(involves: C57BL/6 * DBA/2)
|
abnormal cytotoxic T cell physiology
|
J:122796
|
Inpp5dtm1Rkh/Inpp5dtm1Rkh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal macrophage chemotaxis
|
J:48193
|
Inpp5dtm1Rkh/Inpp5dtm1Rkh
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:110864
|
| abnormal CD8-positive, alpha-beta T cell physiology
|
J:110864
|
| abnormal macrophage chemotaxis
|
J:110864
|
| abnormal osteoclast physiology
|
J:78771
|
| abnormal T cell physiology
|
J:110864
|
| enhanced B cell migration
|
J:110864
|
| increased mast cell degranulation
|
J:120426
|
Inpp5dtm1Wgk/Inpp5dtm1.1Wgk
Tg(Mx1-cre)1Cgn/0
(B6.Cg-Inpp5dtm1Wgk/Inpp5dtm1.1Wgk Tg(Mx1-cre)1Cgn)
|
abnormal leukocyte physiology
|
J:144110
|
Ins1tm1Jja/Ins1tm1Jja
Ins2tm1Mnt/Ins2tm1Mnt
Tg(Aire-cre)1Mnt/0
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
abnormal T cell physiology
|
J:152798
|
Ip6k2tm1.1Snyd/Ip6k2tm1.1Snyd
(B6.129-Ip6k2tm1.1Snyd)
|
abnormal B cell physiology
|
J:212482
|
Irak1tm1Jth/Y
Irak2tm1Aki/Irak2tm1Aki
(involves: 129/Sv * C57BL/6)
|
abnormal dendritic cell physiology
|
J:136290
|
| abnormal macrophage physiology
|
J:136290
|
Irak2tm1Aki/Irak2tm1Aki
(involves: 129/Sv * C57BL/6)
|
abnormal macrophage physiology
|
J:136290
|
Irak3tm1Flv/Irak3tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
abnormal osteoclast physiology
|
J:98035
|
Irak3tm1Flv/Irak3tm1Flv
(NOD.129S1(B6)-Irak3tm1Flv)
|
abnormal dendritic cell physiology
|
J:229884
|
| abnormal professional antigen presenting cell physiology
|
J:229884
|
| abnormal T cell activation
|
J:229884
|
Irak4tm1Aki/Irak4tm1Aki
(involves: 129X1/SvJ * C57BL/6)
|
decreased B cell proliferation
|
J:125729
|
Irak4tm1Yeh/Irak4tm1Yeh
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal macrophage physiology
|
J:76098
|
| abnormal NK cell physiology
|
J:76098
|
| decreased B cell proliferation
|
J:76098
|
Irak4tm2Aki/Irak4tm2Aki
(involves: 129X1/SvJ * C57BL/6)
|
decreased B cell proliferation
|
J:125729
|
Irf1M1Btlr/Irf1+
(C57BL/6J-Irf1M1Btlr)
|
impaired natural killer cell mediated cytotoxicity
|
J:162995
|
Irf1M1Btlr/Irf1M1Btlr
(C57BL/6J-Irf1M1Btlr)
|
impaired natural killer cell mediated cytotoxicity
|
J:162995
|
Irf1tm1Cwe/Irf1tm1Cwe
(involves: 129/Sv * C57BL/6)
|
abnormal immunoglobulin level
|
J:101427
|
| abnormal macrophage physiology
|
J:43086
|
Irf1tm1Cwe/Irf1tm1Cwe
(involves: 129)
|
abnormal T cell proliferation
|
J:84367
|
Irf1tm1Mak/Irf1tm1Mak
(B6.129S2-Irf1tm1Mak/J)
|
abnormal lymphocyte physiology
|
J:91927
|
Irf2tm1Mak/Irf2tm1Mak
(either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * C57BL/6J * DBA/2))
|
decreased B cell proliferation
|
J:64286
|
| decreased IgG2a level
|
J:64286
|
Irf4m1Btlr/Irf4m1Btlr
(C57BL/6J-Irf4m1Btlr)
|
abnormal B cell activation
|
J:160882
|
| decreased IgG level
|
J:160882
|
| decreased IgM level
|
J:160882
|
Irf4m1Btlr/Irf4m1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| decreased IgG level
|
J:185495
|
| decreased IgM level
|
J:185495
|
Irf4M2Btlr/Irf4+
(C57BL/6J-Irf4M2Btlr)
|
abnormal B cell activation
|
J:234245
|
| decreased IgG level
|
J:234245
|
| decreased IgM level
|
J:234245
|
Irf4M2Btlr/Irf4M2Btlr
(C57BL/6J-Irf4M2Btlr)
|
abnormal B cell activation
|
J:234245
|
| decreased IgG level
|
J:234245
|
| decreased IgM level
|
J:234245
|
Irf4tm1.1Rdf/Irf4tm1.1Rdf
(involves: 129S1/Sv * 129S4/SvJae * C57BL/6)
|
abnormal B cell physiology
|
J:112643
|
| decreased B cell proliferation
|
J:112643
|
| decreased IgG1 level
|
J:112643
|
Irf4tm1Mak/Irf4tm1Mak
(involves: 129P2/OlaHsd)
|
decreased B cell proliferation
|
J:42683
|
| decreased immunoglobulin level
|
J:42683
|
| decreased T cell proliferation
|
J:42683
|
Irf4tm1Rdf/Irf4tm1.1Rdf
(involves: 129S1/Sv * 129S4/SvJae * C57BL/6)
|
abnormal B cell physiology
|
J:112643
|
Irf5tm1Ttg/Irf5tm1Ttg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T-helper 1 physiology
|
J:97567
|
Irf7tm1Ttg/Irf7tm1Ttg
(involves: 129P2/OlaHsd)
|
abnormal T cell physiology
|
J:97662
|
Irf8tm1Hor/Irf8tm1Hor
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal cytotoxic T cell physiology
|
J:36038
|
| increased immunoglobulin level
|
J:36038
|
Irf8tm1Hor/Irf8tm1Hor
Irf4tm1Mak/Irf4tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased IgM level
|
J:84577
|
Irs1tm1Tka/Irs1tm1Tka
(involves: C57BL/6 * CBA)
|
abnormal osteoclast physiology
|
J:61479
|
Itchtm1.1Alta/Itchtm1.1Alta
Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal immunoglobulin level
|
J:204685
|
| abnormal regulatory T cell physiology
|
J:204685
|
| abnormal T-helper 2 physiology
|
J:204685
|
| increased IgA level
|
J:204685
|
| increased IgE level
|
J:204685
|
| increased IgG1 level
|
J:204685
|
| increased regulatory T cell apoptosis
|
J:204685
|
Itfg2Gt(OST215121)Lex/Itfg2Gt(OST215121)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal B cell activation
|
J:205951
|
| decreased IgE level
|
J:205951
|
| decreased IgG1 level
|
J:205951
|
| decreased IgG2a level
|
J:205951
|
| decreased IgG2b level
|
J:205951
|
| decreased IgG3 level
|
J:205951
|
Itga4tm1Mgin/Itga4tm1Mgin
(B6.129-Itga4tm1Mgin)
|
abnormal B cell physiology
|
J:106471
|
| abnormal lymphocyte physiology
|
J:106471
|
| abnormal T cell physiology
|
J:106471
|
| impaired macrophage chemotaxis
|
J:106471
|
Itga4tm1Mshi/Itga4tm1Mshi
(C57BL/6-Itga4tm1Mshi)
|
abnormal cellular extravasation
|
J:144092
|
| abnormal leukocyte adhesion
|
J:144092
|
| abnormal leukocyte migration
|
J:144092
|
Itga6tm1Son/Itga6tm1Son
(involves: 129P2/OlaHsd * FVB)
|
abnormal T cell physiology
|
J:50235
|
Itgadtm1.1Zimm/Itgadtm1.1Zimm
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal macrophage physiology
|
J:130908
|
Itgadtm1Bll/Itgadtm1Bll
(B6.129S7-Itgadtm1Bll)
|
abnormal T cell activation
|
J:90954
|
| decreased T cell proliferation
|
J:90954
|
Itgaltm1.1Mshi/Itgaltm1.1Mshi
(involves: C57BL/6)
|
abnormal diapedesis
|
J:168533
|
| abnormal leukocyte adhesion
|
J:168533
|
| abnormal leukocyte migration
|
J:168533
|
| enhanced leukocyte tethering or rolling
|
J:168533
|
Itgaltm1Bll/Itgal+
(involves: 129S7/SvEvBrd)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:267548
|
Itgaltm1Bll/Itgaltm1Bll
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal cellular extravasation
|
J:83226
|
| abnormal leukocyte adhesion
|
J:83226
|
| abnormal leukocyte migration
|
J:83226
|
Itgaltm1Bll/Itgaltm1Bll
(B6.129S7-Itgaltm1Bll)
|
abnormal leukocyte adhesion
|
J:100242
|
| abnormal leukocyte tethering or rolling
|
J:100242
|
| decreased T cell proliferation
|
J:90954
|
| impaired natural killer cell mediated cytotoxicity
|
J:90954
|
Itgaltm1Bll/Itgaltm1Bll
(involves: 129S7/SvEvBrd)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:267548
|
| abnormal cellular extravasation
|
J:141063
|
| abnormal leukocyte adhesion
|
J:141063
|
| abnormal neutrophil physiology
|
J:141063
|
Itgaltm1Hlz/Itgaltm1Hlz
(involves: 129P2/OlaHsd)
|
abnormal cellular extravasation
|
J:99286
|
| abnormal leukocyte adhesion
|
J:99286
|
| abnormal T cell activation
|
J:99286
|
| decreased cytotoxic T cell cytolysis
|
J:99286
|
Itgaltm1Hogg/Itgaltm1Hogg
(involves: 129P2/OlaHsd)
|
abnormal leukocyte adhesion
|
J:82587
|
| abnormal leukocyte migration
|
J:82587
|
Itgaltm1Mak/Itgaltm1Mak
(B6.129P2-Itgaltm1Mak)
|
impaired natural killer cell mediated cytotoxicity
|
J:110889
|
Itgaltm1Wpfl/Itgaltm1Wpfl
(involves: 129)
|
abnormal cytotoxic T cell physiology
|
J:37160
|
| abnormal leukocyte physiology
|
J:37160
|
| abnormal lymphocyte physiology
|
J:37160
|
Itgamtm1Bll/Itgamtm1Bll
(B6.129S7-Itgamtm1Bll)
|
abnormal leukocyte adhesion
|
J:100242
|
| abnormal T cell activation
|
J:90954
|
| decreased T cell proliferation
|
J:90954
|
Itgamtm1Bll/Itgamtm1Bll
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal cellular extravasation
|
J:83226
|
| abnormal leukocyte adhesion
|
J:83226
|
| abnormal leukocyte migration
|
J:83226
|
| abnormal neutrophil physiology
|
J:39092
|
| impaired neutrophil phagocytosis
|
J:39092
|
Itgamtm1Myd/Itgamtm1Myd
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal leukocyte adhesion
|
J:38052
|
| impaired neutrophil phagocytosis
|
J:38052
|
Itgamtm1Myd/Itgamtm1Myd
(B6.129S4-Itgamtm1Myd)
|
abnormal neutrophil physiology
|
J:113463
|
Itgamtm1Myd/Itgamtm1Myd
(involves: 129S4/SvJae)
|
impaired leukocyte tethering or rolling
|
J:198197
|
| impaired neutrophil phagocytosis
|
J:155479
|
Itgamtm1Myd/Itgamtm1Myd
Syktm1Tyb/Syktm1.2Tara
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
impaired granulocyte bactericidal activity
|
J:155479
|
Itgamtm1Rws/Itgamtm1Rws
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal macrophage physiology
|
J:65847
|
Itgavtm1Blb/Itgavtm1Blb
Itgb1tm1Ref/Itgb1tm1Ref
Itgb2tm2Bay/Itgb2tm2Bay
Itgb7tm1Cgn/Itgb7tm1Cgn
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal cellular extravasation
|
J:134784
|
| abnormal dendritic cell physiology
|
J:134784
|
Itgavtm2Hyn/Itgavtm2.1Hyn
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * FVB)
|
impaired macrophage phagocytosis
|
J:125508
|
Itgavtm2Hyn/Itgavtm2.1Hyn
Tg(Tek-cre)1Ywa/?
(involves: 129S2/SvPas * C57BL/6 * FVB * SJL)
|
impaired macrophage phagocytosis
|
J:125508
|
Itgaxtm1Bll/Itgaxtm1Bll
(B6.129S7-Itgaxtm1Bll)
|
increased T cell proliferation
|
J:122187
|
Itgb2m3Btlr/Itgb2m3Btlr
(C57BL/6J-Itgb2m3Btlr)
|
abnormal cytotoxic T cell cytolysis
|
J:265126
|
| decreased IgG level
|
J:265126
|
| impaired natural killer cell mediated cytotoxicity
|
J:265126
|
| increased IgE level
|
J:265126
|
Itgb2tm1.1Arte/Itgb2tm1.1Arte
(involves: C57BL/6NTac)
|
abnormal T cell physiology
|
J:202261
|
| decreased T cell proliferation
|
J:202261
|
Itgb2tm1Bay/Itgb2tm1Bay
(involves: 129S7/SvEvBrd * PL/J)
|
abnormal T cell activation
|
J:109598
|
Itgb2tm2Bay/Itgb2tm2Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal leukocyte physiology
|
J:48542
|
| abnormal neutrophil physiology
|
J:48542
|
| abnormal T cell proliferation
|
J:48542
|
| increased IgA level
|
J:48542
|
| increased IgG level
|
J:48542
|
| increased IgM level
|
J:48542
|
| increased immunoglobulin level
|
J:48542
|
Itgb2tm2Bay/Itgb2tm2Bay
(involves: 129S7/SvEvBrd)
|
decreased T cell proliferation
|
J:90954
|
Itgb2tm2Bay/Itgb2tm2Bay
(B6.129S7-Itgb2tm2Bay)
|
abnormal leukocyte adhesion
|
J:83226
|
| abnormal leukocyte migration
|
J:83226
|
Itgb2tm2Bay/Itgb2tm2Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
impaired neutrophil recruitment
|
J:112286
|
Itgb2tm2Bay/Itgb2tm2Bay
(PL.129S7-Itgb2tm2Bay)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:109598
|
Itgb3tm1Hyn/Itgb3tm1Hyn
(involves: 129S2/SvPas * C57BL/6)
|
abnormal macrophage physiology
|
J:119666
|
| impaired macrophage chemotaxis
|
J:119666
|
Itgb3tm1Hyn/Itgb3tm1Hyn
(involves: 129S2/SvPas)
|
abnormal osteoclast physiology
|
J:60672
|
Itgb3tm1Hyn/Itgb3tm1Hyn
(involves: 129S2/SvPas * BALB/c)
|
increased IgG level
|
J:131241
|
Itgb7tm1Cgn/Itgb7tm1Cgn
(involves: C57BL/6)
|
abnormal lymphocyte physiology
|
J:34306
|
| impaired leukocyte tethering or rolling
|
J:34306
|
Itgb7tm1Cgn/Itgb7tm1Cgn
(C57BL/6-Itgb7tm1Cgn/J)
|
abnormal leukocyte migration
|
J:127413
|
Itgb7tm1Mshi/Itgb7tm1Mshi
(involves: C57BL/6)
|
abnormal leukocyte adhesion
|
J:127413
|
| abnormal leukocyte migration
|
J:127413
|
Itkm1Btlr/Itkm1Btlr
(C57BL/6J-Itkm1Btlr)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:236673
|
| abnormal CD8-positive, alpha-beta T cell physiology
|
J:236673
|
| increased CD8-positive, alpha-beta memory T cell proliferation
|
J:236673
|
| increased IgE level
|
J:236673
|
Itktm1Litt/Itktm1Litt
(involves: 129S4/SvJae * C57BL/6J)
|
decreased T cell proliferation
|
J:31230
|
Itktm1Litt/Itktm1Litt
(involves: 129S4/SvJae)
|
decreased T cell proliferation
|
J:54449
|
Itktm1Litt/Itktm1Litt
(B6.129S4-Itktm1Litt)
|
decreased T cell proliferation
|
J:141390
|
Itktm1Litt/Itktm1Litt
Tg(DO11.10)10Dlo/0
(involves: 129S4/SvJae * BALB/c * C3H * C57BL/6J)
|
abnormal T-helper 2 physiology
|
J:129883
|
Itktm1Litt/Itktm1Litt
Txktm1Pls/Txktm1Pls
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
decreased T cell proliferation
|
J:54449
|
Itktm1Litt/Itktm1Litt
Vav1tm2Bbd/Vav1tm2Bbd
(B6.129-Itktm1Litt Vav1tm2Bbd)
|
abnormal T cell physiology
|
J:141390
|
| increased T cell apoptosis
|
J:141390
|
Itktm1Ljb/Itktm1Ljb
(involves: 129 * C57BL/6)
|
abnormal T cell activation
|
J:48231
|
Itktm1Ljb/Itktm1Ljb
(B10.129-Itktm1Ljb)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:113408
|
| increased IgE level
|
J:148531
|
Itktm1Ljb/Itktm1Ljb
Txktm1Pls/Txktm1Pls
(B6.129-Txktm1Pls Itktm1Ljb)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:113408
|
Itln1em1Cya/Itln1em1Cya
(involves: C57BL/6)
|
abnormal osteoclast physiology
|
J:282124
|
ItpkbT-less/ItpkbT-less
(C57BL/6-ItpkbT-less)
|
abnormal T cell physiology
|
J:89286
|
Itpkbtm1Ssch/Itpkbtm1Ssch
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal thymocyte activation
|
J:86257
|
| decreased IgG1 level
|
J:86257
|
| decreased IgG2a level
|
J:86257
|
| decreased IgG2b level
|
J:86257
|
| decreased IgG level
|
J:86257
|
Itpkbtm1Ssch/Itpkbtm1Ssch
Itpkctm1Ssch/Itpkctm1Ssch
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal thymocyte activation
|
J:86257
|
Jagn1tm1c(EUCOMM)Hmgu/Jagn1tm1c(EUCOMM)Hmgu
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6N * C57BL/10 * CBA/Ca)
|
abnormal neutrophil physiology
|
J:214828
|
| impaired neutrophil chemotaxis
|
J:214828
|
| impaired neutrophil recruitment
|
J:214828
|
Jak1M1Mhda/Jak1+
(C3HeB/FeJ-Jak1M1Mhda)
|
increased IgA level
|
J:199153
|
| increased IgG1 level
|
J:199153
|
| increased IgG2a level
|
J:199153
|
| increased IgM level
|
J:199153
|
| increased immunoglobulin level
|
J:199153
|
Jak3m1Btlr/Jak3m1Btlr
(C57BL/6J-Jak3m1Btlr)
|
decreased IgG level
|
J:217795
|
| increased IgE level
|
J:217795
|
Jak3m3Btlr/Jak3m3Btlr
(C57BL/6J-Jak3m3Btlr)
|
decreased IgG level
|
J:225935
|
Jak3m6Btlr/Jak3m6Btlr
(C57BL/6J-Jak3m6Btlr)
|
decreased IgG level
|
J:272400
|
Jak3m8Btlr/Jak3m8Btlr
(C57BL/6J-Jak3m8Btlr)
|
decreased IgG level
|
J:274939
|
| decreased IgM level
|
J:274939
|
Jak3tm1Flv/Jak3tm1Flv
(involves: 129S1/Sv)
|
abnormal T cell proliferation
|
J:95794
|
Jak3tm1Ljb/Jak3tm1Ljb
(involves: 129S4/SvJae * C57BL/6)
|
abnormal leukocyte physiology
|
J:90510
|
| abnormal lymphocyte physiology
|
J:90510
|
| abnormal T cell activation
|
J:29722
|
| decreased IgG level
|
J:29722
|
| decreased T cell proliferation
|
J:29722
|
Jak3tm1Ljb/Jak3tm1Ljb
(involves: 129S4/SvJae)
|
abnormal T cell activation
|
J:128694,
J:56629
|
| abnormal T cell physiology
|
J:128694
|
| decreased T cell proliferation
|
J:128694
|
Jak3tm1Ljb/Jak3tm1Ljb
(B6;129S4-Jak3tm1Ljb/J)
|
abnormal dendritic cell physiology
|
J:123902
|
Jak3tm1Ljb/Jak3tm1Ljb
Tg(Lck-Jak3)1Ljb/0
(involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/10)
|
decreased T cell proliferation
|
J:128694
|
Jak3tm1Ljb/Jak3tm1Ljb
Tg(Lck-Jak3)2Ljb/0
(involves: 129S4/SvJae * C3H * C57BL/6)
|
abnormal T cell activation
|
J:56629
|
Jak3tm1Ljb/Jak3tm1Ljb
Tg(Lck-Jak3)2Ljb/0
(involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/10)
|
abnormal T cell activation
|
J:128694
|
| abnormal T cell physiology
|
J:128694
|
| decreased T cell proliferation
|
J:128694
|
Jak3tm1Tks/Jak3+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal leukocyte physiology
|
J:31231
|
Jak3tm1Tks/Jak3tm1Tks
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell physiology
|
J:31231
|
JchainMat1/?
MijuC3HeB/FeJ/MijuC57BL/6J
(involves: C3HeB/FeJ * C57BL/6J)
|
increased IgA level
|
J:91062
|
Jchaintm1Jse/Jchaintm1Jse
(involves: 129X1/SvJ)
|
abnormal B cell physiology
|
J:75843
|
| increased IgA level
|
J:34042,
J:75843
|
Jchaintm1Tl/Jchaintm1Tl
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
decreased IgG level
|
J:71355
|
| decreased IgM level
|
J:71355
|
| increased IgA level
|
J:71355
|
Jchaintm3Tl/Jchain+
(involves: 129P2/OlaHsd)
|
abnormal B cell physiology
|
J:56158
|
| decreased IgM level
|
J:49168,
J:56158
|
| increased IgA level
|
J:56158
|
Jchaintm3Tl/Jchaintm3Tl
(involves: 129P2/OlaHsd)
|
abnormal B cell physiology
|
J:56158
|
| decreased IgG level
|
J:49168
|
| decreased IgM level
|
J:49168,
J:56158
|
| increased IgA level
|
J:49168,
J:56158
|
Jdp2tm1Aki/Jdp2tm1Aki
(Not Specified)
|
abnormal neutrophil physiology
|
J:191061
|
Jmjd6tm1Gbf/Jmjd6tm1Gbf
(C57BL/6-Ptdsrtm1Gbf)
|
abnormal macrophage activation involved in immune response
|
J:98905
|
Jph4tm1Hta/Jph4tm1Hta
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal T cell activation
|
J:230995
|
Junbtm3Wag/Junbtm3Wag
Tg(KRT5-cre)1Tak/0
(involves: 129/Sv * 129P2/OlaHsd * C3H * C57BL/6)
|
increased IgE level
|
J:155575
|
Jundtm1Mya/Jundtm1Mya
(either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6))
|
abnormal T-helper 2 physiology
|
J:89085
|
| increased T cell proliferation
|
J:89085
|
Kat5tm1Jwl/Kat5+
Tg(IghMyc)22Bri/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL * C57BL/6 * SJL)
|
abnormal B cell physiology
|
J:125164
|
Kcnk13em1(IMPC)H/Kcnk13em1(IMPC)H
(involves: C57BL/6NTac)
|
abnormal microglial cell physiology
|
J:256020
|
Kcnn4tm1Jemn/Kcnn4tm1Jemn
(involves: 129S1/Sv * C57BL/6J)
|
abnormal T cell physiology
|
J:94478
|
Kctd9em1Beij/Kctd9em1Beij
(BALB/c-Kctd9em1Beij)
|
abnormal NK cell physiology
|
J:281803
|
| impaired natural killer cell mediated cytotoxicity
|
J:281803
|
Kdm6btm1Aki/Kdm6btm1Aki
(involves: 129X1/SvJ * C57BL/6)
|
impaired eosinophil recruitment
|
J:164690
|
Kittm1.1Bsm/Kittm1.1Bsm
(involves: 129S1/Sv * BALB/c * C57BL/6J * FVB/N)
|
abnormal mast cell physiology
|
J:61141
|
Kittm2Bsm/Kit+
(involves: 129X1/SvJ * C57BL/6J)
|
increased mast cell degranulation
|
J:83616
|
Kittm3.1Bsm/Kittm3.1Bsm
(involves: 129S1/Sv * C57BL/6)
|
abnormal mast cell physiology
|
J:90485
|
KitW-37J/KitW
(involves: C57BL/6 * C57BL/6J * WB)
|
abnormal mast cell physiology
|
J:27513
|
KitW-42J/KitW
(involves: C57BL/6 * C57BL/6J * WB)
|
abnormal mast cell physiology
|
J:27513
|
KitW-Jic/KitW
(involves: C57BL/6 * WB)
|
abnormal mast cell physiology
|
J:27513
|
KitW-n/KitW
(involves: WB)
|
abnormal mast cell physiology
|
J:27513
|
KitW-sh/KitW-sh
(involves: 101/H * C3H/HeH)
|
decreased mast cell degranulation
|
J:157470
|
KitW-sh/KitW-sh
(involves: C57BL/6J)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:197334
|
KitW-sh/KitW-sh
(B6.Cg-KitW-sh/HNihrJaeBsmGlliJ)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:275367
|
KitW-sh/KitW-sh
Lyntm1Ard/Lyntm1Ard
(involves: 101 * 129P2/OlaHsd * C3H/HeH)
|
increased IgA level
|
J:161523
|
| increased IgE level
|
J:161523
|
| increased IgG2b level
|
J:161523
|
| increased IgM level
|
J:161523
|
KitW/KitW-v
((WB/ReJ x C57BL/6J-KitW-v/J)F1-KitW/KitW-v/J)
|
impaired neutrophil recruitment
|
J:123463
|
KitW/KitW-v
((WB KitW x B6.Cg-KitW-v)F1)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Klf2tm2Ling/Klf2tm2Ling
Tg(Cd4-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
increased IgE level
|
J:151604
|
| increased IgG1 level
|
J:151604
|
Klf13tm1Kren/Klf13tm1Kren
(B6.129-Klf13tm1Kren)
|
decreased thymocyte apoptosis
|
J:145839
|
Klhl6tm1Sato/Klhl6tm1Sato
(either: (involves: 129T2/SvEms) or (involves: BALB/c) or (involves: CD-1))
|
abnormal adaptive immunity
|
J:101363
|
Klra1tm1.1Wyok/Klra1tm1.1Wyok
(involves: BALB/cJ * C57BL/6NTac)
|
abnormal natural killer cell mediated cytotoxicity
|
J:252851
|
Klra8Cmv1-r/Klra8Cmv1-r
(C.B6-Klra8Cmv1-r)
|
decreased IgG1 level
|
J:97203
|
| decreased IgG2a level
|
J:97203
|
| decreased IgG2b level
|
J:97203
|
| decreased IgG3 level
|
J:97203
|
| decreased IgG level
|
J:97203
|
| increased IgM level
|
J:97203
|
Klra15tm1.1Apma/Klra15tm1.1Apma
(B6.129-Klra15tm1.1Apma)
|
impaired natural killer cell mediated cytotoxicity
|
J:189106
|
Klra17tm1.1Apma/Klra17tm1.1Apma
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal plasmacytoid dendritic cell physiology
|
J:152288
|
Klrb1btm1.1Apma/Klrb1btm1.1Apma
(B6.Cg-Klrb1btm1.1Apma)
|
abnormal NK cell physiology
|
J:222057
|
Klre1tm1Tgi/Klre1tm1Tgi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired natural killer cell mediated cytotoxicity
|
J:92262
|
Klrk1tm1.1Bpol/Klrk1tm1.1Bpol
(C57BL/6-Klrk1tm1.1Bpol)
|
abnormal NK cell physiology
|
J:151878
|
| impaired natural killer cell mediated cytotoxicity
|
J:151878
|
Klrk1tm1Dhr/Klrk1tm1Dhr
(involves: C57BL/6 * CD-1)
|
impaired natural killer cell mediated cytotoxicity
|
J:134509
|
Klrk1tm1Dhr/Klrk1tm1Dhr
(B6.Cg-Klrk1tm1Dhr/J)
|
increased natural killer cell mediated cytotoxicity
|
J:221188
|
Kmt2dtm1.1Kaig/Kmt2dtm1.1Kaig
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased IgG1 level
|
J:228913
|
| decreased IgM level
|
J:228913
|
| increased B cell proliferation
|
J:228913
|
Kmt2etm1Apa/Kmt2etm1Apa
(129S6/SvEvTac-Kmt2etm1Apa)
|
abnormal neutrophil physiology
|
J:145445
|
Kmt5btm1Jnw/Kmt5btm1Jnw
Kmt5ctm1.1Jnw/Kmt5ctm1.1Jnw
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129/Sv * C57BL/6J * C57BL/10 * CBA/Ca)
|
abnormal class switch recombination
|
J:139510
|
Kprptm1Msug/Kprp+
(involves: C57BL/6)
|
increased IgE level
|
J:286659
|
Krastm4Tyj/Kras+
Tg(MUC1)79.24Gend/0
(involves: 129S4/SvJae * C57BL/6)
|
increased IgG level
|
J:154046
|
| increased IgM level
|
J:154046
|
Ksr1tm1Shaw/Ksr1tm1Shaw
(Not Specified)
|
decreased T cell proliferation
|
J:75739
|
Ksr1tm1Shaw/Ksr1tm1Shaw
Tg(DO11.10)10Dlo/0
(involves: BALB/c * C3H * C57BL/6)
|
decreased T cell proliferation
|
J:75739
|
Lacc1em1Arkr/Lacc1em1Arkr
(C57BL/6NTac-Lacc1em1Arkr)
|
abnormal macrophage physiology
|
J:244365
|
Lacc1em2Arkr/Lacc1em2Arkr
(C57BL/6NTac-Lacc1em2Arkr)
|
abnormal macrophage physiology
|
J:244365
|
Lacc1em3Arkr/Lacc1em3Arkr
(C57BL/6NTac-Lacc1em3Arkr)
|
abnormal macrophage physiology
|
J:244365
|
Lacc1em4Arkr/Lacc1em4Arkr
(C57BL/6NTac-Lacc1em4Arkr)
|
abnormal macrophage physiology
|
J:244365
|
Lacc1tm1a(KOMP)Wtsi/Lacc1tm1a(KOMP)Wtsi
(involves: C57BL/6N * C57BL/6NTac)
|
abnormal macrophage physiology
|
J:244365
|
Lag3tm1Daav/Lag3tm1Daav
Tg(Foxp3-EGFP/cre)1cJbs/0
(NOD.Cg-Lag3tm1Daav Tg(Foxp3-EGFP/cre)1cJbs)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:260063
|
Lag3tm1Doi/Lag3tm1Doi
(involves: 129S2/SvPas * C57BL/6)
|
abnormal NK cell physiology
|
J:32509
|
| abnormal T cell physiology
|
J:89653
|
Lair1tm1.1Jco/Lair1tm1.1Jco
(involves: C57BL/6)
|
decreased IgG1 level
|
J:180203
|
Lair1tm1Jco/Lair1tm1Jco
Tg(Cd4-cre)1Cwi/?
(involves: C57BL/6 * DBA/2)
|
decreased IgG2a level
|
J:180203
|
| decreased IgG2b level
|
J:180203
|
Lama2dy/Lama2dy
(involves: 129P1/ReJ)
|
increased IgG level
|
J:102959
|
| increased IgM level
|
J:102959
|
Lama5tm1Lsor/Lama5tm1Lsor
Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
abnormal marginal zone B cell physiology
|
J:198783
|
| increased IgM level
|
J:198783
|
Laptm5tm1Jow/Laptm5tm1Jow
(C57BL/6-Laptm5tm1Jow)
|
abnormal T cell activation
|
J:137841
|
| abnormal type IV hypersensitivity reaction
|
J:137841
|
| increased T cell proliferation
|
J:137841
|
Lat2tm1Mal/Lat2tm1Mal
(involves: 129S2/SvPas)
|
abnormal mast cell physiology
|
J:93950
|
Lat2tm1Wz/Lat2tm1Wz
(involves: C57BL/6)
|
abnormal mast cell physiology
|
J:93951
|
Lat2tm1Wz/Lat2tm1Wz
(B6.Cg-Lat2tm1Wz)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:116157
|
| abnormal T cell physiology
|
J:116157
|
| increased T cell proliferation
|
J:116157
|
Lat2tm1Wz/Lat2tm1Wz
(Not Specified)
|
abnormal T cell physiology
|
J:181866
|
| increased mast cell degranulation
|
J:181866
|
Lat2tm2Wz/Lat2tm2Wz
Tg(Lck-cre)548Jxm/0
(involves: C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:116157
|
Lat2tm3.1Wz/Lat2tm3.1Wz
(B6.Cg-Lat2tm3.1Wz)
|
abnormal T cell physiology
|
J:181866
|
| increased mast cell degranulation
|
J:181866
|
Lattm1.1Lov/Lattm1.1Lov
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal immunoglobulin level
|
J:77099
|
| abnormal T cell physiology
|
J:77099
|
| decreased T cell proliferation
|
J:77099
|
| increased IgE level
|
J:77099
|
| increased IgG1 level
|
J:77099
|
| increased IgM level
|
J:77099
|
| increased T cell proliferation
|
J:77099
|
Lattm1.1Mal/Lattm1.1Mal
(involves: 129S2/SvPas)
|
abnormal B cell activation
|
J:77098
|
| abnormal T-helper 2 physiology
|
J:125722
|
| increased IgE level
|
J:125722,
J:77098
|
| increased IgG1 level
|
J:262891,
J:125722,
J:77098
|
| increased IgM level
|
J:125722
|
| increased T cell proliferation
|
J:77098
|
Lattm1.1Mal/Lattm1.1Mal
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T cell proliferation
|
J:131351
|
| abnormal T-helper 2 physiology
|
J:131351
|
Lattm1.1Mal/Lattm6.1(HBEGF/EGFP)Mal
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T-helper 2 physiology
|
J:151840
|
Lattm1Les/Lattm1.1Wz
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal T cell physiology
|
J:147946
|
Lattm1Les/Lattm1Les
Lat2tm1Wz/Lat2tm1Wz
(involves: C57BL/6)
|
abnormal mast cell physiology
|
J:93951
|
Lattm1Les/Lattm1Les
Tg(CD2-LAT2)1Wz/0
(Not Specified)
|
abnormal B cell physiology
|
J:116964
|
| abnormal leukocyte physiology
|
J:116964
|
| increased IgG1 level
|
J:116964
|
| increased IgM level
|
J:116964
|
Lattm2.1Mal/Lattm2.1Mal
(involves: 129S2/SvPas)
|
abnormal B cell activation
|
J:94074
|
| abnormal T cell activation
|
J:94074
|
| abnormal thymocyte activation
|
J:94074
|
| increased IgE level
|
J:94074
|
| increased IgG1 level
|
J:94074
|
| increased immunoglobulin level
|
J:94074
|
Lattm2.1Mal/Lattm2.1Mal
Lat2tm1Mal/Lat2tm1Mal
(involves: 129S2/SvPas)
|
abnormal mast cell physiology
|
J:93950
|
Lattm3.1Mal/Lattm3.1Mal
(involves: 129S2/SvPas)
|
abnormal thymocyte activation
|
J:94074
|
Lattm4.1Mal/Lattm4.1Mal
(involves: 129P2/OlaHsd)
|
abnormal thymocyte activation
|
J:94074
|
Lattm4.1Mal/Lattm4.1Mal
Tg(Lck*F505)3073Rmp/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal T-helper 2 physiology
|
J:151840
|
| increased IgE level
|
J:151840
|
| increased IgG1 level
|
J:151840
|
Lattm4.1Mal/Lattm6.1(HBEGF/EGFP)Mal
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
abnormal T-helper 2 physiology
|
J:151840
|
Lattm6.1(HBEGF/EGFP)Mal/?
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcraH-Y,TcrbH-Y)1Pas/?
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
abnormal T cell physiology
|
J:138401
|
Lattm6.1(HBEGF/EGFP)Mal/Lattm6.1(HBEGF/EGFP)Mal
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T cell activation
|
J:151840
|
| abnormal T-helper 2 physiology
|
J:151840
|
Lax1tm1Wz/Lax1tm1Wz
(involves: C57BL/6)
|
abnormal B cell calcium ion homeostasis
|
J:98403
|
| abnormal B cell physiology
|
J:98403
|
| abnormal T cell activation
|
J:98403
|
| abnormal T cell physiology
|
J:98403
|
| increased IgE level
|
J:98403
|
| increased IgG1 level
|
J:98403
|
| increased IgG2a level
|
J:98403
|
Laynem1Romd/Laynem1Romd
Tg(Cd8a-cre,-GFP)1Yzo/0
(involves: C57BL/6)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:302853
|
Lbca1C57BL/6Igc/Lbca1C57BL/6Igc
(involves: BALB/cIgc * C57BL/6Igc)
|
abnormal B cell activation
|
J:139348
|
| increased B cell proliferation
|
J:139348
|
Lbca2BALB/cIgc/Lbca2C57BL/6Igc
(involves: BALB/cIgc * C57BL/6Igc)
|
abnormal B cell activation
|
J:139348
|
| increased B cell proliferation
|
J:139348
|
Lbca2C57BL/6Igc/Lbca2C57BL/6Igc
(involves: BALB/cIgc * C57BL/6Igc)
|
abnormal B cell activation
|
J:139348
|
| increased B cell proliferation
|
J:139348
|
Lbptm1Buru/Lbptm1Buru
(involves: 129S1/Sv * 129X1/SvJ * BALB/c)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:67090
|
Lbptm1Buru/Lbptm1Buru
(B6.129-Lbptm1Buru)
|
abnormal neutrophil physiology
|
J:129411
|
Lbrlym3/Lbrlym3
(C57BL/6-Lbrlym3)
|
abnormal B cell physiology
|
J:180355
|
| abnormal T cell physiology
|
J:180355
|
| decreased T cell proliferation
|
J:180355
|
Lbw2NZW/LacScr/Lbw2NZW/LacScr
(involves: NZB * NZW)
|
decreased IgG level
|
J:98150
|
| decreased IgM level
|
J:98150
|
Lbw4NZW/LacScr/?
(involves: C57BL/6J * NZM2410/Aeg)
|
decreased immunoglobulin level
|
J:52863
|
Lckm1Btlr/Lckm1Btlr
(C57BL/6J-Lckm1Btlr)
|
decreased cytotoxic T cell cytolysis
|
J:144695
|
Lckm2Btlr/Lckm2Btlr
(C57BL/6J-Lckm2Btlr)
|
decreased IgG level
|
J:203759
|
Lcktm1.1Litt/Lcktm1.1Litt
(Not Specified)
|
abnormal immunoglobulin level
|
J:152472
|
Lcktm1Dbs/Lcktm1Dbs
(involves: C3H * C57BL/6)
|
decreased T cell proliferation
|
J:114660
|
Lcktm1Dbs/Lcktm1Dbs
Tg(TcraTcrb)1100Mjb/0
(involves: C3H * C57BL/6)
|
decreased T cell proliferation
|
J:114660
|
Lcktm1Litt/Lcktm1.1Litt
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129X1/SvJ)
|
abnormal regulatory T cell physiology
|
J:152472
|
| decreased T cell proliferation
|
J:152472
|
Lcktm1Mak/Lcktm1Mak
(involves: 129S2/SvPas)
|
abnormal thymocyte activation
|
J:110847
|
| decreased IgG1 level
|
J:1119
|
| increased IgG2a level
|
J:1119
|
| increased IgG3 level
|
J:1119
|
| increased IgM level
|
J:1119
|
Lcktm1Mak/Lcktm1Mak
(B6.129S2-Lcktm1Mak)
|
decreased cytotoxic T cell cytolysis
|
J:111646
|
Lcn2tm1Mrgr/Lcn2tm1Mrgr
(129(B6)-Lcn2tm1Mrgr)
|
abnormal mast cell physiology
|
J:173490
|
| decreased thymocyte apoptosis
|
J:173490
|
Lcn2tm1Mrgr/Lcn2tm1Mrgr
(B6.129-Lcn2tm1Mrgr)
|
abnormal mast cell physiology
|
J:173490
|
Lcn2tm1Mrgr/Lcn2tm1Mrgr
(involves: 129 * C57BL/6)
|
abnormal mast cell physiology
|
J:173490
|
Lcp1tm1Erjb/Lcp1tm1Erjb
(involves: 129X1/SvJ)
|
abnormal macrophage physiology
|
J:161042
|
| abnormal neutrophil physiology
|
J:161042
|
Lcp2m1Khoe/Lcp2m1Khoe
(C57BL/6J-Lcp2m1Khoe)
|
abnormal NK cell physiology
|
J:196519
|
| impaired natural killer cell mediated cytotoxicity
|
J:196519
|
Lcp2tm1.1Wz/Lcp2tm1.1Wz
(B6.Cg-Lcp2tm1.1Wz)
|
decreased T cell proliferation
|
J:150304
|
Lcp2tm1Geha/Lcp2tm1Geha
(involves: 129S4/SvJae)
|
impaired natural killer cell mediated cytotoxicity
|
J:131621
|
Lcp2tm2Gak/Lcp2tm2Gak
Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased T cell apoptosis
|
J:107467
|
Lcp2tm3Gak/Lcp2tm3Gak
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal T cell activation
|
J:132995
|
Lcp2tm3Gak/Lcp2tm3Gak
Tg(TcrAND)53Hed/?
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal thymocyte activation
|
J:132995
|
Lcp2tm4Gak/Lcp2tm4Gak
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
abnormal T cell activation
|
J:132995
|
Lcp2tm4Gak/Lcp2tm4Gak
Tg(TcrAND)53Hed/?
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal thymocyte activation
|
J:132995
|
Lcp2tm5(Lat/Lcp2)Gak/Lcp2tm5(Lat/Lcp2)Gak
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal thymocyte activation
|
J:147721
|
Lcp2twm/Lcp2twm
(C57BL/6JSfdAnu-Lcp2twm/Anu)
|
abnormal T cell physiology
|
J:104190
|
| increased IgE level
|
J:104190
|
| increased IgG level
|
J:104190
|
Ldlrtm1Her/Ldlrtm1Her
Lrp1tm2Her/Lrp1tm2Her
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
impaired macrophage phagocytosis
|
J:137404
|
Ldlrtm1Her/Ldlrtm1Her
Lrp1tm2Her/Lrp1tm2Her
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)
|
abnormal microglial cell physiology
|
J:144185
|
Ldlrtm1Her/Ldlrtm1Her
Pfn1tm1Wit/Pfn1+
(B6.129S-Ldlrtm1Her Pfn1tm1Wit)
|
impaired macrophage chemotaxis
|
J:140294
|
Ldlrtm1Her/Ldlrtm1Her
Tbx21tm1Glm/Tbx21tm1Glm
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)
|
decreased IgG level
|
J:96110
|
| increased IgM level
|
J:96110
|
Ldlrtm1Her/Ldlrtm1Her
Tg(H2-K-AKR1B1)1Tj/0
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)
|
abnormal macrophage physiology
|
J:100916
|
Ldlrtm1Her/Ldlrtm1Her
Tlr2tm1Kir/Tlr2tm1Kir
(B6.129-Tlr2tm1Kir Ldlrtm1Her)
|
abnormal cellular extravasation
|
J:131783
|
Ldlrtm1Her/Ldlrtm1Her
Vwftm1Wgr/Vwftm1Wgr
(B6.129S-Vwftm1Wgr Ldlrtm1Her)
|
impaired leukocyte tethering or rolling
|
J:106677
|
Lect2tm1Ymg/Lect2tm1Ymg
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal leukocyte physiology
|
J:90961
|
| increased T cell apoptosis
|
J:90961
|
Lef1tm1Hhx/Lef1tm1Hhx
Tcf7tm1Cle/Tcf7tm1Cle
Gt(ROSA)26Sortm2Sho/Gt(ROSA)26Sor+
Tg(GZMB-cre)1Jcb/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
abnormal memory T cell physiology
|
J:189838
|
Lepob/Lepob
(involves: STOCK Mlphln a Tgfawa1 Cdh23v Ednrbs)
|
abnormal microglial cell physiology
|
J:115569
|
Lepob/Lepob
(involves: C57BL/6)
|
decreased T cell proliferation
|
J:164339
|
Leprm7Btlr/Leprm7Btlr
(C57BL/6J-Leprm7Btlr)
|
increased IgE level
|
J:236685
|
Leprtm4Mgmj/Leprtm4Mgmj
(B6.Cg-Leprtm4Mgmj)
|
decreased T cell proliferation
|
J:164339
|
Lgals2tm1.1Cfg/Lgals2tm1.1Cfg
(involves: C57BL/6)
|
increased IgG2b level
|
J:217719
|
| increased IgG3 level
|
J:217719
|
| increased susceptibility to type IV hypersensitivity reaction
|
J:217719
|
Lgals3tm1Ftl/Lgals3tm1Ftl
(B6.129S2-Lgals3tm1Ftl)
|
abnormal dendritic cell physiology
|
J:109126
|
| increased IgG level
|
J:109126
|
Lgals3tm1Ftl/Lgals3tm1Ftl
(involves: 129S2/SvPas * C57BL/6)
|
abnormal leukocyte physiology
|
J:60741
|
| abnormal macrophage physiology
|
J:60741
|
| increased macrophage apoptosis
|
J:60741
|
Lgals3tm1Poi/Lgals3tm1Poi
(involves: 129/Sv * C57BL/6 * SJL)
|
abnormal macrophage physiology
|
J:131971
|
| impaired macrophage chemotaxis
|
J:131971
|
| impaired macrophage phagocytosis
|
J:131407
|
| impaired neutrophil recruitment
|
J:131407
|
Lgals9tm1.1Cfg/Lgals9tm1.1Cfg
(involves: C57BL/6)
|
increased B cell proliferation
|
J:217719
|
Lgmntm1Cptr/Lgmntm1Cptr
(B6.129S6-Lgmntm1Cptr)
|
abnormal adaptive immunity
|
J:155339
|
Lgmntm1Ihn/Lgmntm1Ihn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal macrophage physiology
|
J:143886
|
| abnormal NK cell physiology
|
J:143886
|
Liftm1Phb/Lif+
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:77410
|
Liftm1Phb/Liftm1Phb
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:77410
|
Liftm1Stw/Liftm1Stw
(involves: 129S1/Sv * MF1)
|
abnormal osteoclast physiology
|
J:137646
|
Lig4m1Btlr/Lig4m1Btlr
(C57BL/6J-Lig4m1Btlr)
|
decreased IgD level
|
J:267684
|
| decreased IgG level
|
J:267684
|
Lig4tm1Fwa/Lig4tm1Fwa
Tg(Cr2-cre)3Cgn/0
Xrcc4tm2Fwa/Xrcc4tm2Fwa
(involves: 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:126758
|
Lig4tm2.1Fwa/Lig4tm2.1Fwa
(involves: 129S6/SvEvTac)
|
abnormal B cell activation
|
J:157574
|
| abnormal T cell activation
|
J:157574
|
| decreased IgA level
|
J:157574
|
| decreased IgG2b level
|
J:157574
|
| decreased IgG3 level
|
J:157574
|
| decreased IgG level
|
J:157574
|
| decreased IgM level
|
J:157574
|
| decreased immunoglobulin level
|
J:157574
|
| decreased T cell proliferation
|
J:157574
|
| increased T cell apoptosis
|
J:157574
|
Lig4tm3.1Fwa/Lig4tm3.1Fwa
Tg(Cr2-cre)3Cgn/0
(Not Specified)
|
abnormal class switch recombination
|
J:157537
|
Lilrb4atm1Eol/Lilrb4atm1Eol
(B6.129P2-Lilrb4atm1Eol)
|
abnormal cellular extravasation
|
J:129969
|
| abnormal leukocyte physiology
|
J:129969
|
| decreased IgE level
|
J:129969
|
| increased mast cell degranulation
|
J:129969
|
Lilrb4atm1Hrk/Lilrb4atm1Hrk
(involves: 129/Sv * BALB/c)
|
abnormal mast cell physiology
|
J:70491
|
| increased mast cell degranulation
|
J:70491
|
| increased susceptibility to type I hypersensitivity reaction
|
J:70491
|
Lilrb4atm1Ttk/Lilrb4atm1Ttk
(B6.129X1-Lilrb4atm1Ttk)
|
abnormal dendritic cell antigen presentation
|
J:141234
|
Limd1tm1Gdl/Limd1tm1Gdl
(involves: 129X1/SvJ)
|
abnormal macrophage physiology
|
J:118130
|
| abnormal osteoclast physiology
|
J:118130
|
Litaftm1.1Ics/Litaftm1.1Ics
(Not Specified)
|
impaired macrophage chemotaxis
|
J:186411
|
ll/ll
X/Yaa
(BXSB/MpJScr-ll)
|
decreased IgG level
|
J:10973
|
Lmbr1lem1Btlr/Lmbr1lem1Btlr
(C57BL/6J-Lmbr1lem1Btlr)
|
abnormal cytotoxic T cell physiology
|
J:274568
|
| decreased IgD level
|
J:274568
|
| decreased IgG level
|
J:274568
|
| decreased IgM level
|
J:274568
|
| impaired natural killer cell mediated cytotoxicity
|
J:274568
|
| increased IgM level
|
J:274568
|
Lmbr1lm1Btlr/Lmbr1lm1Btlr
(C57BL/6J-Lmbr1lm1Btlr)
|
abnormal cytotoxic T cell physiology
|
J:274568
|
| decreased IgE level
|
J:274568
|
| decreased IgG level
|
J:274568
|
| decreased IgM level
|
J:274568
|
| impaired natural killer cell mediated cytotoxicity
|
J:274568
|
Lmo4tm1Slp/Lmo4tm1Slp
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129S1/Sv * C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal lymphocyte physiology
|
J:282740
|
Lmo4tm1Slp/Lmo4tm1Slp
Yeats4em1Zfa/Yeats4em1Zfa
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129S1/Sv * C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal lymphocyte physiology
|
J:282740
|
Lmr3BALB/cHeA/?
(involves: BALB/cHeA * STS/A)
|
increased IgE level
|
J:82715
|
Lmr5BALB/cHeA/?
(involves: BALB/cHeA * STS/A)
|
increased IgE level
|
J:82715
|
Lmr8BALB/cHeA/?
(involves: BALB/cHeA * STS/A)
|
increased IgE level
|
J:82717
|
Lmr9BALB/cHeA/?
(involves: BALB/cHeA * STS/A)
|
increased IgE level
|
J:82717
|
Lmr9CcS20/Dem/?
(involves: BALB/cHeA * STS/A)
|
decreased IgE level
|
J:82717
|
Lmr10BALB/cHeA/?
(involves: BALB/cHeA * STS/A)
|
increased IgE level
|
J:82717
|
Lmr10CcS20/Dem/?
(involves: BALB/cHeA * STS/A)
|
decreased IgE level
|
J:82717
|
Lmr11BALB/cHeA/Lmr11BALB/cHeA
Lmr8CcS20/Dem/Lmr8CcS20/Dem
(involves: BALB/cHeA * STS/A)
|
decreased IgE level
|
J:82717
|
Lmr12BALB/cHeA/?
(involves: BALB/cHeA * STS/A)
|
decreased IgE level
|
J:82717
|
Lmr12CcS16/Dem/?
(involves: BALB/cHeA * STS/A)
|
increased IgE level
|
J:82717
|
Lmr13BALB/cHeA/?
(involves: BALB/cHeA * STS/A)
|
decreased IgE level
|
J:82717
|
Lmr14BALB/cHeA/Lmr14BALB/cHeA
Lmr5BALB/cHeA/?
(involves: BALB/cHeA * STS/A)
|
increased IgE level
|
J:82715
|
Lmr14BALB/cHeA/Lmr14BALB/cHeA
Lmr5BALB/cHeA/Lmr5BALB/cHeA
(involves: BALB/cHeA * STS/A)
|
increased IgE level
|
J:82717
|
Lmr14CcS16/Dem/Lmr14CcS16/Dem
Lmr5BALB/cHeA/?
(involves: BALB/cHeA * STS/A)
|
increased IgE level
|
J:82715
|
Lmr14CcS16/Dem/Lmr14CcS16/Dem
Lmr5BALB/cHeA/Lmr5BALB/cHeA
(involves: BALB/cHeA * STS/A)
|
increased IgE level
|
J:82717
|
Lpar2tm1Dgen/Lpar2tm1Dgen
(B6.Cg-Lpar2tm1Dgen)
|
abnormal dendritic cell physiology
|
J:184061
|
| increased IgE level
|
J:184061
|
| increased susceptibility to type I hypersensitivity reaction
|
J:184061
|
Lppl1C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal leukocyte physiology
|
J:90647
|
Lpxntm1b(EUCOMM)Hmgu/Lpxntm1b(EUCOMM)Hmgu
(C57BL/6N-Lpxntm1b(EUCOMM)Hmgu/Wtsi)
|
decreased IgM level
|
J:305662
|
LrbaGt(OST69142)Lex/LrbaGt(OST69142)Lex
(involves: 129 * 129S5/SvEvBrd)
|
abnormal NK cell physiology
|
J:237187
|
| impaired natural killer cell mediated cytotoxicity
|
J:237187
|
Lrch1em1Hwa/Lrch1em1Hwa
(Not Specified)
|
abnormal cellular extravasation
|
J:238772
|
Lrfn2Tg(CD2-Myb/en)5Kmw/Lrfn2+
(involves: C57BL/10 * CBA)
|
decreased T cell proliferation
|
J:126456
|
Lrfn2Tg(CD2-Myb/en)5Kmw/Lrfn2Tg(CD2-Myb/en)5Kmw
(involves: C57BL/10 * CBA)
|
decreased T cell proliferation
|
J:126456
|
Lrp12em1Gpt/Lrp12em1Gpt
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6JGpt * DBA/2)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:338432
|
| enhanced leukocyte migration
|
J:338432
|
Lrrc8atm1.1Geha/Lrrc8atm1.1Geha
(B6.129S1(Cg)-Lrrc8atm1.1Geha)
|
abnormal T cell physiology
|
J:211308
|
| decreased T cell proliferation
|
J:211308
|
| increased IgG2a level
|
J:211308
|
| increased thymocyte apoptosis
|
J:211308
|
Lrrc32tm1.1Hfuj/Lrrc32tm1.1Hfuj
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac * DBA/2)
|
abnormal regulatory T cell physiology
|
J:204761
|
Lrrk1tm1.1Smo/Lrrk1tm1.1Smo
(involves: 129S/Sv)
|
abnormal osteoclast physiology
|
J:208677
|
Lsp1tm1Jejb/Lsp1tm1Jejb
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal cellular extravasation
|
J:96022
|
| abnormal leukocyte physiology
|
J:68128
|
| impaired neutrophil chemotaxis
|
J:68128
|
Lta4htm1Bhk/Lta4htm1Bhk
(involves: 129P2/OlaHsd * 129S/SvEv)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:58985
|
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(involves: 129)
|
decreased IgA level
|
J:31129
|
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(B6.129-Lta/Tnftm1Eug)
|
decreased IgG1 level
|
J:115034
|
| decreased IgG2a level
|
J:115034
|
| decreased IgG3 level
|
J:115034
|
| impaired macrophage phagocytosis
|
J:115034
|
| increased IgM level
|
J:115034
|
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(involves: 129)
|
decreased IgA level
|
J:31129
|
Lta/Tnftm1Eug/Lta/Tnftm1Eug
(B6.129-Lta/Tnftm1Eug)
|
decreased IgG1 level
|
J:115034
|
| decreased IgG2a level
|
J:115034
|
| decreased IgG3 level
|
J:115034
|
| impaired macrophage phagocytosis
|
J:115034
|
| increased IgM level
|
J:115034
|
Lta/Tnftm1Jods/Lta/Tnftm1Jods
(C57BL/6J-Lta/Tnftm1Jods)
|
decreased immunoglobulin level
|
J:43602
|
Lta/Tnftm1Jods/Lta/Tnftm1Jods
(C57BL/6J-Lta/Tnftm1Jods)
|
decreased immunoglobulin level
|
J:43602
|
Ltatm1.1Sned/Ltatm1.1Sned
(B6.129-Ltatm1.1Sned)
|
abnormal class switch recombination
|
J:109621
|
Ltatm1Dch/Ltatm1Dch
(B6.129S2-Ltatm1Dch)
|
abnormal class switch recombination
|
J:80616
|
| decreased IgG level
|
J:80616
|
| increased IgM level
|
J:80616
|
Ltatm1Dch/Ltatm1Dch
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:109621
|
Ltatm1Tab/Ltatm1Tab
(either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * CF-1))
|
decreased IgA level
|
J:28061
|
| increased IgM level
|
J:28061
|
Ltb4r1tm1Adl/Ltb4r1tm1Adl
(involves: 129S4/SvJae * C57BL/6)
|
abnormal leukocyte adhesion
|
J:63873
|
| abnormal leukocyte migration
|
J:63873
|
| abnormal macrophage physiology
|
J:63873
|
| abnormal neutrophil physiology
|
J:63873
|
| impaired eosinophil recruitment
|
J:63873
|
| impaired neutrophil chemotaxis
|
J:63873
|
Ltb4r1tm1Bodd/Ltb4r1tm1Bodd
(either: (involves: 129S4/SvJaeSor * BALB/c ) or (involves: 129S4/SvJaeSor * C57BL/6))
|
impaired neutrophil chemotaxis
|
J:163271
|
Ltb4r1tm1Tksh/Ltb4r1tm1Tksh
(B6.Cg-Ltb4r1tm1Tksh)
|
decreased IgE level
|
J:118995
|
| decreased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Ltb4r1tm1Tksh/Ltb4r1tm1Tksh
(C.Cg-Ltb4r1tm1Tksh)
|
abnormal mast cell physiology
|
J:133998
|
Ltb4r1tm1Tksh/Ltb4r1tm1Tksh
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal granulocyte physiology
|
J:118995
|
Ltb4r2tm1Tksh/Ltb4r2tm1Tksh
(C.Cg-Ltb4r2tm1Tksh)
|
abnormal mast cell physiology
|
J:133998
|
Ltb4r2tm1Tksh/Ltb4r2tm1Tksh
(B6.Cg-Ltb4r2tm1Tksh)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Ltb/Tnf/Ltatm1Dvk/Ltb/Tnf/Ltatm1Dvk
(B6.Cg-Ltb/Tnf/Ltatm1Dvk)
|
abnormal class switch recombination
|
J:80616
|
| decreased IgG level
|
J:80616
|
Ltb/Tnf/Ltatm1Dvk/Ltb/Tnf/Ltatm1Dvk
(B6.Cg-Ltb/Tnf/Ltatm1Dvk)
|
abnormal class switch recombination
|
J:80616
|
| decreased IgG level
|
J:80616
|
Ltb/Tnf/Ltatm1Dvk/Ltb/Tnf/Ltatm1Dvk
(B6.Cg-Ltb/Tnf/Ltatm1Dvk)
|
abnormal class switch recombination
|
J:80616
|
| decreased IgG level
|
J:80616
|
Ltbtm1Flv/Ltbtm1Flv
(involves: 129S1/Sv * C57BL/6J)
|
decreased IgA level
|
J:39746
|
Ltbtm1Kpf/Ltbtm1Kpf
(B6.129P2-Ltbtm1Kpf)
|
abnormal class switch recombination
|
J:80616
|
| decreased IgG level
|
J:80616
|
| increased IgM level
|
J:80616
|
Ltbtm1Krn/Ltbtm1Krn
(C57BL/6-Ltbtm1Krn)
|
decreased IgG1 level
|
J:78229
|
| decreased IgG2a level
|
J:78229
|
| increased IgM level
|
J:78229
|
Ltbrm1Btlr/Ltbrm1Btlr
(C57BL/6J-Ltbrm1Btlr)
|
abnormal B cell physiology
|
J:212068
|
Ltbrm2Btlr/Ltbrm2Btlr
(C57BL/6J-Ltbrm2Btlr)
|
abnormal IgG level
|
J:254823
|
Ltbrm3Btlr/Ltbrm3Btlr
(C57BL/6J-Ltbrm3Btlr)
|
impaired natural killer cell mediated cytotoxicity
|
J:264642
|
Ltbrtm1.1Thhe/Ltbrtm1.1Thhe
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal macrophage physiology
|
J:183109
|
Ltbrtm1Kpf/Ltbrtm1Kpf
(involves: 129P2/OlaHsd)
|
decreased IgE level
|
J:86810
|
Ltc4stm1Blam/Ltc4stm1Blam
(involves: 129S7/SvEvBrd * BALB/c)
|
abnormal type I hypersensitivity reaction
|
J:87909
|
Ltc4stm1Blam/Ltc4stm1Blam
(B6.129S7-Ltc4stm1Blam)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Ly6atm1Pmf/Ly6atm1Pmf
(B6.129P2-Ly6atm1Pmf)
|
abnormal immunoglobulin level
|
J:42594
|
| abnormal T cell proliferation
|
J:42594
|
Ly9tm1Mckn/Ly9tm1Mckn
(involves: 129/Sv * C57BL/6)
|
decreased T cell proliferation
|
J:105482
|
Ly75tm1Mnz/Ly75tm1Mnz
(Not Specified)
|
abnormal cytotoxic T cell physiology
|
J:97289
|
Ly86tm1Kmiy/Ly86tm1Kmiy
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell proliferation
|
J:109720
|
| decreased IgG2b level
|
J:137066
|
| decreased IgG3 level
|
J:137066
|
| increased IgG level
|
J:109720
|
| increased IgM level
|
J:109720
|
Ly96m1Btlr/Ly96m1Btlr
(C57BL/6J-Ly96m1Btlr)
|
decreased macrophage apoptosis
|
J:265259
|
Ly96tm1Kmiy/Ly96tm1Kmiy
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal macrophage physiology
|
J:92494
|
| decreased B cell proliferation
|
J:92494
|
| impaired neutrophil recruitment
|
J:92479
|
LynM2Btlr/Lyn+
(C57BL/6J-LynM2Btlr)
|
decreased IgG level
|
J:217146
|
| decreased IgM level
|
J:217146
|
LynM2Btlr/LynM2Btlr
(C57BL/6J-LynM2Btlr)
|
decreased IgG level
|
J:217146
|
| decreased IgM level
|
J:217146
|
Lynm4Btlr/Lynm4Btlr
(C57BL/6J-Lynm4Btlr)
|
decreased IgG level
|
J:272816
|
Lynmld4/Lynmld4
(involves: C57BL/6)
|
abnormal B cell activation
|
J:144799
|
| increased IgE level
|
J:144799
|
| increased IgM level
|
J:144799
|
Lyntm1.1Calo/Lyntm1.1Calo
Tg(Itgax-cre)1-1Reiz/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal dendritic cell physiology
|
J:200745
|
| abnormal leukocyte physiology
|
J:200745
|
| abnormal T cell activation
|
J:200745
|
Lyntm1Ard/Lyntm1Ard
(involves: 129P2/OlaHsd)
|
increased IgA level
|
J:161523
|
| increased IgE level
|
J:161523
|
| increased IgG2b level
|
J:161523
|
| increased IgM level
|
J:161523
|
Lyntm1Ard/Lyntm1Ard
(B6.129P2-Lyntm1Ard)
|
abnormal B cell activation
|
J:144799
|
Lyntm1Ard/Lyntm1Ard
Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell activation
|
J:110531
|
| increased IgM level
|
J:110531
|
Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJae)
|
increased B cell proliferation
|
J:42037
|
Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJaeSor)
|
abnormal dendritic cell physiology
|
J:200745
|
| abnormal macrophage physiology
|
J:80658
|
| abnormal microglial cell physiology
|
J:80658
|
| increased B cell proliferation
|
J:146161
|
| increased IgA level
|
J:146161
|
| increased IgM level
|
J:146161
|
Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJaeSor * C57BL/6)
|
increased B cell proliferation
|
J:71174
|
| increased IgA level
|
J:71174
|
| increased IgG1 level
|
J:71174
|
| increased IgG2b level
|
J:71174
|
| increased IgG level
|
J:71174
|
| increased IgM level
|
J:71174
|
Lyntm1Tya/Lyntm1Tya
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:29751
|
| abnormal class switch recombination
|
J:29751
|
| decreased B cell proliferation
|
J:29751
|
| increased IgA level
|
J:29751
|
| increased IgM level
|
J:29751
|
| increased immunoglobulin level
|
J:29751
|
Lynweeb/Lynweeb
(C57BL/6-Lynweeb)
|
increased B cell proliferation
|
J:146161
|
| increased IgM level
|
J:146161
|
Lystbg-2Btlr/Lystbg-2Btlr
(C57BL/6J-Lystbg-2Btlr)
|
abnormal NK cell physiology
|
J:133617
|
Lystbg-5Btlr/Lyst+
(C57BL/6J-Lystbg-5Btlr)
|
impaired macrophage phagocytosis
|
J:217864
|
Lystbg-5Btlr/Lystbg-5Btlr
(C57BL/6J-Lystbg-5Btlr)
|
impaired macrophage phagocytosis
|
J:217864
|
Lystbg-Btlr/Lystbg-Btlr
(C57BL/6J-Lystbg-Btlr)
|
abnormal NK cell physiology
|
J:133616
|
Lystbg-J/Lystbg-J
(C57BL/6J-Lystbg-J/J)
|
impaired natural killer cell mediated cytotoxicity
|
J:34814
|
Lystbg-J/Lystbg-J
Prkdcscid/Prkdcscid
(B6.Cg-Lystbg-J Prkdcscid/Sz)
|
decreased immunoglobulin level
|
J:34814
|
| impaired natural killer cell mediated cytotoxicity
|
J:34814
|
Lystbg/Lystbg
(B6.C3Rl-Lystbg)
|
decreased cytotoxic T cell cytolysis
|
J:6692
|
| impaired natural killer cell mediated cytotoxicity
|
J:6302,
J:6213
|
Lystbg/Lystbg
(B6.C3Rl-Lystbg/J)
|
abnormal NK cell physiology
|
J:6801
|
Lyve1tm1.1(EGFP/cre)Cys/Lyve1+
Sphk1tm2Cgh/Sphk1tm2Cgh
Sphk2tm1.1Cgh/Sphk2tm1.1Cgh
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal leukocyte migration
|
J:156826
|
Lyz2tm1(cre)Ifo/Lyz2+
Nsd3tm1.1Caox/Nsd3tm1.1Caox
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * SJL)
|
decreased macrophage cytokine production
|
J:251909
|
Lyz2tm1(cre)Ifo/Lyz2+
Pdcd10tm1Wami/Pdcd10tm1Wami
(involves: 129 * 129P2/OlaHsd * C57BL/6)
|
abnormal neutrophil physiology
|
J:256076
|
Lyz2tm1(cre)Ifo/Lyz2+
Pikfyvetm1b(EUCOMM)Hmgu/Pikfyvetm1b(EUCOMM)Hmgu
(involves: 129P2/OlaHsd * C57BL/6N)
|
increased susceptibility to type I hypersensitivity reaction
|
J:244776
|
Lyz2tm1(cre)Ifo/Lyz2tm1(cre)Ifo
Nrrostm1Wouy/Nrrostm1Wouy
(involves: 129P2/OlaHsd)
|
abnormal cellular extravasation
|
J:209569
|
X/m1Nish
(involves: C57BL/6N)
|
decreased IgG level
|
J:204833
|
| decreased IgM level
|
J:204833
|
| decreased T cell proliferation
|
J:204833
|
Madcam1tm1.2Nwag/Madcam1tm1.2Nwag
(B6.129P2-Madcam1tm1.2Nwag)
|
abnormal B cell physiology
|
J:169739
|
| decreased IgA level
|
J:169739
|
Magtm1Rod/Magtm1Rod
(involves: 129S1/Sv * 129X1/SvJ)
|
increased B cell proliferation
|
J:217719
|
Magt1Gt(IST13422E1)Tigm/Y
(involves: C57BL/6N)
|
increased B cell proliferation
|
J:260923
|
Malt1m2Btlr/Malt1+
(C57BL/6J-Malt1m2Btlr)
|
decreased IgM level
|
J:224671
|
Malt1m2Btlr/Malt1m2Btlr
(C57BL/6J-Malt1m2Btlr)
|
decreased IgG level
|
J:224671
|
| decreased IgM level
|
J:224671
|
Malt1m3Btlr/Malt1+
(C57BL/6J-Malt1m3Btlr)
|
decreased IgM level
|
J:224672
|
Malt1m3Btlr/Malt1m3Btlr
(C57BL/6J-Malt1m3Btlr)
|
decreased IgG level
|
J:224672
|
| decreased IgM level
|
J:224672
|
Malt1tm1Mak/Malt1tm1Mak
(involves: 129P2/OlaHsd)
|
abnormal dendritic cell physiology
|
J:111706
|
| decreased IgG level
|
J:109545
|
| decreased IgM level
|
J:109545
|
| decreased T cell proliferation
|
J:109545
|
Malt1tm1Vmd/Malt1tm1Vmd
(involves: C57BL/6N)
|
abnormal T cell proliferation
|
J:86770
|
| decreased immunoglobulin level
|
J:86770
|
Man2a1tm1Jxm/Man2a1tm1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased IgA level
|
J:74579
|
| increased IgG level
|
J:74579
|
| increased IgM level
|
J:74579
|
Man2c1tm1.1Tbec/Man2c1tm1.1Tbec
(B6N.129P2-Man2c1tm1.1Tbec)
|
abnormal microglial cell activation
|
J:205550
|
Map2k3tm1Flv/Map2k3tm1Flv
(involves: 129S1/Sv)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:85266
|
| decreased T cell apoptosis
|
J:85266
|
Map2k6tm1Flv/Map2k6tm1Flv
(involves: 129S1/Sv)
|
abnormal thymocyte apoptosis
|
J:85266
|
Map3k2tm1Bisu/Map3k2tm1Bisu
(Not Specified)
|
abnormal T cell activation
|
J:78072
|
| increased T cell proliferation
|
J:78072
|
Map3k3tm1Bisu/Map3k3tm2Bisu
Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA)
|
abnormal T cell physiology
|
J:145923
|
| abnormal T cell proliferation
|
J:145923
|
Map3k3tm1Kuro/Map3k3tm1Kuro
Tg(Lck-cre)1Jtak/0
(involves: C57BL/6)
|
decreased T cell proliferation
|
J:147103
|
Map3k4tm1Flv/Map3k4tm1Flv
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal T-helper 1 physiology
|
J:90112
|
Map3k7tm1Aki/Map3k7tm1Aki
Tg(Lck-cre)1Jtak/0
(involves: 129P2/OlaHsd)
|
abnormal T cell activation
|
J:112837
|
| decreased T cell proliferation
|
J:112837
|
Map3k7tm1Aki/Map3k7tm1Aki
Tg(Lck-cre)1Jtak/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:238318
|
| abnormal regulatory T cell physiology
|
J:238318
|
Map3k7tm1Zjc/Map3k7tm1Zjc
Tg(Lck-cre)548Jxm/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA)
|
increased thymocyte apoptosis
|
J:111794
|
Map3k8M1Btlr/Map3k8M1Btlr
(C57BL/6J-Map3k8M1Btlr)
|
impaired natural killer cell mediated cytotoxicity
|
J:140986
|
Map3k8m3Btlr/Map3k8+
(C57BL/6J-Map3k8m3Btlr)
|
decreased macrophage cytokine production
|
J:224668
|
Map3k8m3Btlr/Map3k8m3Btlr
(C57BL/6J-Map3k8m3Btlr)
|
decreased macrophage cytokine production
|
J:224668
|
Map3k8tm1Tmat/Map3k8tm1Tmat
(involves: 129S/SvEv * C57BL/6)
|
abnormal dendritic cell antigen presentation
|
J:92844
|
| decreased IgE level
|
J:92844
|
| decreased IgG1 level
|
J:92844
|
| increased IgG2a level
|
J:92844
|
| increased T cell proliferation
|
J:92844
|
Map3k14aly/Map3k14aly
(involves: C57BL/6J)
|
abnormal dendritic cell antigen presentation
|
J:128211
|
| abnormal dendritic cell physiology
|
J:128211
|
| abnormal T cell activation
|
J:38580
|
| decreased IgE level
|
J:135748
|
Map3k14aly/Map3k14aly
(involves: AEJ/GnRk * C57BL/6J)
|
decreased IgA level
|
J:16865,
J:54529
|
| decreased IgG level
|
J:16865,
J:54529
|
| decreased IgM level
|
J:16865,
J:54529
|
Map3k14m1Btlr/Map3k14m1Btlr
(C57BL/6J-Map3k14m1Btlr)
|
abnormal B cell activation
|
J:152065
|
| decreased IgG level
|
J:152065
|
Map3k14m1Btlr/Map3k14m1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| decreased IgG level
|
J:185495
|
Map3k14tm1.2Gne/Map3k14tm1.2Gne
(B6(Cg)-Map3k14tm1.2Gne)
|
abnormal B cell physiology
|
J:240453
|
| decreased IgA level
|
J:240453
|
Map3k14tm1Rds/Map3k14tm1Rds
(involves: 129/Sv * C57BL/6)
|
decreased IgA level
|
J:68125
|
| decreased IgG2b level
|
J:68125
|
| decreased immunoglobulin level
|
J:68125
|
Map3k14tm1Rds/Map3k14tm1Rds
(involves: 129)
|
abnormal class switch recombination
|
J:188560
|
Map4k1tm1Ssaw/Map4k1tm1Ssaw
(B6.Cg-Map4k1tm1Ssaw)
|
abnormal dendritic cell antigen presentation
|
J:150295
|
| abnormal dendritic cell physiology
|
J:150295
|
Map4k1tm1Tht/Map4k1tm1Tht
(involves: 129S7/SvEvBrd)
|
increased T cell proliferation
|
J:116613
|
Map4k3Gt(RRO270)Byg/Map4k3Gt(RRO270)Byg
(involves: 129P2/OlaHsd)
|
decreased IgG1 level
|
J:177642
|
| decreased IgG2a level
|
J:177642
|
| decreased IgG2b level
|
J:177642
|
| decreased IgG3 level
|
J:177642
|
| decreased IgM level
|
J:177642
|
| decreased immunoglobulin level
|
J:177642
|
| decreased T cell proliferation
|
J:177642
|
Map4k5Gt(OST218153)Lex/Map4k5Gt(OST218153)Lex
(B6;129S5-Map4k5Gt(OST218153)Lex/Ieg)
|
increased IgG1 level
|
J:82809
|
Mapk1tm1Hed/Mapk1tm1Hed
Mapk3tm1Gpg/Mapk3tm1Gpg
Tg(Lck-cre)1Cwi/0
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal T cell proliferation
|
J:113280
|
Mapk1tm1Hed/Mapk1tm1Hed
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:113280
|
Mapk3tm1Gpg/Mapk3tm1Gpg
(involves: 129)
|
decreased T cell proliferation
|
J:58468
|
Mapk8tm1Flv/Mapk8tm1Flv
(involves: 129S1/Sv)
|
increased T cell proliferation
|
J:51510
|
Mapk8tm1Rjd/Mapk8tm1Rjd
Mapk9tm2.1Rjd/Mapk9tm2.1Rjd
Lyz2tm1(cre)Ifo/Lyz2+
(B6J.Cg-Lyz2tm1(cre)Ifo Mapk9tm2.1Rjd Mapk8tm1Rjd)
|
abnormal macrophage physiology
|
J:192551
|
| decreased macrophage cytokine production
|
J:192551
|
| impaired macrophage chemotaxis
|
J:192551
|
Mapk8tm1Wag/Mapk8+
Mapk9tm1Mka/Mapk9+
(involves: 129)
|
abnormal T cell activation
|
J:78190
|
| decreased T cell apoptosis
|
J:78190
|
| decreased T cell proliferation
|
J:78190
|
Mapk8tm1Wag/Mapk8+
Mapk9tm1Mka/Mapk9tm1Mka
(involves: 129)
|
abnormal T cell activation
|
J:78190
|
| decreased T cell apoptosis
|
J:78190
|
| decreased T cell proliferation
|
J:78190
|
Mapk8tm1Wag/Mapk8tm1Wag
(involves: 129P2/OlaHsd)
|
abnormal T cell activation
|
J:78190
|
| decreased T cell apoptosis
|
J:78190
|
| decreased T cell proliferation
|
J:78190
|
Mapk8tm1Wag/Mapk8tm1Wag
Mapk9tm1Mka/Mapk9+
(involves: 129)
|
abnormal T cell activation
|
J:78190
|
| decreased T cell apoptosis
|
J:78190
|
| decreased T cell proliferation
|
J:78190
|
Mapk9tm1Mka/Mapk9tm1Mka
(either: (involves: 129S2/SvPas) or (involves: 129S1/Sv * 129X1/SvJ))
|
abnormal T cell activation
|
J:78129
|
| decreased T cell apoptosis
|
J:78129
|
| decreased T cell proliferation
|
J:78129
|
Mapk11tm1Jda/Mapk11tm1Jda
Mapk14tm1Jda/Mapk14tm1Jda
(involves: 129 * C57BL/6)
|
decreased T cell proliferation
|
J:165966
|
Mapk14tm1Jda/Mapk14tm1Jda
(B6.Cg-Mapk14tm1Jda)
|
abnormal T-helper 1 physiology
|
J:146088
|
| decreased T cell proliferation
|
J:146088
|
Mapkapk2tm1Mgl/Mapkapk2tm1Mgl
(involves: 129S * C57BL/6)
|
impaired macrophage phagocytosis
|
J:76161
|
Mar1tm1Wtg/Mar1+
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:68024
|
Mar1tm1Wtg/Mar1tm1Wtg
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:68024
|
Marchf1tm1.1Sish/Marchf1tm1.1Sish
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal B cell physiology
|
J:119918
|
| abnormal dendritic cell antigen presentation
|
J:201198,
J:157516
|
Marchf5tm1.1Ygi/Marchf5tm1.1Ygi
Tg(Emx1-cre)#Ito/0
(involves: C57BL/6)
|
increased microglial cell activation
|
J:284572
|
Marchf7Gt(ROSABetageo)1Summ/Marchf7+
(involves: BALB/c)
|
increased T cell proliferation
|
J:96167
|
Marchf7Gt(ROSABetageo)1Summ/Marchf7Gt(ROSABetageo)1Summ
(involves: BALB/c)
|
increased T cell proliferation
|
J:96167
|
Marcksl1tm1Fsh/Marcksl1tm1Fsh
(involves: 129S4/SvJae)
|
abnormal macrophage physiology
|
J:115146
|
Marcotm1Ktry/Marcotm1Ktry
(B6.129S6-Marcotm1Ktry)
|
abnormal macrophage physiology
|
J:115081
|
| impaired macrophage phagocytosis
|
J:115081
|
Marcotm1Ktry/Marcotm1Ktry
Msr1tm1Csk/Msr1tm1Csk
(B6.129-Marcotm1Ktry Msr1tm1Csk)
|
abnormal macrophage physiology
|
J:122271
|
| increased IgM level
|
J:122271
|
Marcotm1Spt/Marcotm1Spt
(C57BL/6-Marcotm1Spt)
|
abnormal dendritic cell chemotaxis
|
J:204315
|
| abnormal dendritic cell physiology
|
J:204315
|
Mark2tm1Hpw/Mark2tm1Hpw
(involves: 129X1/SvJ * C57BL/6)
|
decreased B cell proliferation
|
J:68830
|
| decreased IgG3 level
|
J:68830
|
| decreased IgM level
|
J:68830
|
| increased B cell proliferation
|
J:68830
|
Matr3em1Tcp/Matr3em1Tcp
(C57BL/6J-Matr3em1Tcp)
|
increased microglial cell activation
|
J:298091
|
Mavstm1Aki/Mavstm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased IgG1 level
|
J:130954
|
| decreased IgG2a level
|
J:130954
|
| decreased IgG level
|
J:130954
|
Mavstm1Aki/Mavstm1Aki
(involves: 129S/SvEv * C57BL/6)
|
abnormal dendritic cell physiology
|
J:162888
|
| abnormal macrophage physiology
|
J:162888
|
| increased IgG2a level
|
J:162888
|
| increased IgG level
|
J:162888
|
| increased IgM level
|
J:162888
|
Mavstm1Aki/Mavstm1Aki
Ticam1tm1Aki/Ticam1tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased cytotoxic T cell cytolysis
|
J:130954
|
| decreased IgG1 level
|
J:130954
|
| decreased IgG2a level
|
J:130954
|
| decreased IgG level
|
J:130954
|
Mavstm1Camb/Mavstm1Camb
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal B cell calcium ion homeostasis
|
J:180356
|
| decreased B cell proliferation
|
J:180356
|
Mavstm1Zjc/Mavstm1Zjc
(involves: 129/Sv * C57BL/6)
|
abnormal dendritic cell physiology
|
J:110905
|
| abnormal macrophage physiology
|
J:110905
|
Mbd2tm1Bh/Mbd2tm1Bh
(NOD.129P2(B6)-Mbd2tm1Bh)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:323838
|
| increased T cell proliferation
|
J:323838
|
Mbl1tm1Kata/Mbl1tm1Kata
Mbl2tm1Kata/Mbl2tm1Kata
(involves: 129 * C57BL/6)
|
impaired macrophage phagocytosis
|
J:97686,
J:98124
|
Mbl1tm1Rala/Mbl1tm1Rala
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal immunoglobulin level
|
J:145279
|
| decreased IgG2b level
|
J:145279
|
| decreased IgM level
|
J:145279
|
| increased IgG1 level
|
J:145279
|
| increased IgG2a level
|
J:145279
|
| increased IgG3 level
|
J:145279
|
Mbpshi/Mbpshi
(involves: BALB/c * C3HeB/Fe * SWV)
|
increased T cell proliferation
|
J:48412
|
Mbtps1wrt/Mbtps1wrt
(C57BL/6J-Mbtps1wrt)
|
decreased cytotoxic T cell cytolysis
|
J:94077
|
Mcamtm1Lex/Mcamtm1Lex
(involves: 129S/SvEvBrd)
|
decreased macrophage cytokine production
|
J:193167
|
Mcemp1em1Jngj/Mcemp1em1Jngj
(C57BL/6-Mcemp1em1Jngj)
|
abnormal type I hypersensitivity reaction
|
J:335318
|
Mcl1tm1Dmta/Mcl1tm1Dmta
Tg(Aicda-cre)9Mbu/0
(B6.Cg-Mcl1tm1Dmta Tg(Aicda-cre)9Mbu)
|
decreased IgG1 level
|
J:166069
|
Mcl1tm1Yen/Mcl1tm1Yen
(B6.129-Mcl1tm1Yen)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:146246
|
Mcl1tm1Ywh/Mcl1tm1Ywh
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
abnormal neutrophil physiology
|
J:137502
|
| impaired neutrophil recruitment
|
J:137502
|
Mcl1tm1Ywh/Mcl1tm1Ywh
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
increased T cell apoptosis
|
J:137400
|
Mcl1tm1Ywh/Mcl1tm1Ywh
Tg(Lck-cre)548Jxm/0
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * CBA)
|
increased T cell apoptosis
|
J:137400
|
Mcl1tm2Sjk/Mcl1tm3Sjk
Tg(Lck-cre)1Cwi/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
increased T cell apoptosis
|
J:86906
|
Mcl1tm3Sjk/Mcl1tm3Sjk
Tg(Cpa3-cre)3Glli/0
(involves: 129X1/Sv * C57BL/6)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:179080
|
Mcm3aptm1Imku/Mcm3aptm1Imku
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal germinal center B cell physiology
|
J:88276
|
| decreased B cell proliferation
|
J:88276
|
| decreased IgG level
|
J:88276
|
Mcoln1tm1Sasl/Mcoln1tm1Sasl
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal macrophage physiology
|
J:189070
|
Mcoln2tm1e.1(KOMP)Wtsi/Mcoln2tm1e.1(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
impaired macrophage chemotaxis
|
J:239875
|
| impaired neutrophil chemotaxis
|
J:239875
|
Mcph1tm1.2Kali/Mcph1tm1.2Kali
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal T cell physiology
|
J:156371
|
Mcpt4tm1Mabr/Mcpt4tm1Mabr
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal mast cell physiology
|
J:84839
|
Mdc1Gt(OST441263)Lex/Mdc1Gt(OST441263)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal class switch recombination
|
J:137341
|
Mdktm1Tmu/Mdktm1Tmu
(B6.129S2-Mdktm1Tmu)
|
abnormal macrophage chemotaxis
|
J:102069
|
| impaired neutrophil chemotaxis
|
J:102069
|
Mdm2tm2.1Snj/Mdm2tm2.1Snj
(involves: 129S4/SvJae * C57BL/6)
|
decreased thymocyte apoptosis
|
J:189297
|
Mdm4tm1.1Wahl/Mdm4tm1.1Wahl
(involves: 129S/Sv * C57BL/6)
|
decreased thymocyte apoptosis
|
J:150341
|
Mef2ctm1Jjs/Mef2ctm1Jjs
Mir223tm1Fcam/Mir223tm1Fcam
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * C57BL/6)
|
abnormal neutrophil physiology
|
J:140009
|
Mefvtm1Chae/Mefvtm1Chae
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6))
|
decreased macrophage apoptosis
|
J:82763
|
Mep1atm1Bond/Mep1atm1Bond
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal leukocyte physiology
|
J:145037
|
Mertktm1Gkm/Mertktm1Gkm
(NOD.129P2-Mertktm1Gkm)
|
increased T cell apoptosis
|
J:147153
|
Mertktm1Gkm/Mertktm1Gkm
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(NOD.Cg-Mertktm1Gkm Tg(TcraBDC2.5,TcrbBDC2.5)1Doi)
|
increased T cell apoptosis
|
J:147153
|
Metrnltm1d(KOMP)Wtsi/Metrnltm1d(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
decreased IgG level
|
J:268270
|
| increased IgM level
|
J:268270
|
Mex3btm1.2Mbld/Mex3btm1.2Mbld
(involves: C57BL/6 * CBA)
|
impaired macrophage phagocytosis
|
J:213588
|
Mfge8Gt(KST227)Byg/Mfge8Gt(KST227)Byg
(B6.129P2-Mfge8Gt(KST227)Byg)
|
impaired macrophage phagocytosis
|
J:98314
|
Mfge8Gt(KST227)Byg/Mfge8Gt(KST227)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
impaired macrophage phagocytosis
|
J:107106
|
Mfge8tm1Osa/Mfge8tm1Osa
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired macrophage phagocytosis
|
J:90633
|
Mfge8tm1Osa/Mfge8tm1Osa
Timd4tm1Osa/Timd4tm1Osa
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired macrophage phagocytosis
|
J:187181
|
Mfn1tm2Dcc/Mfn1tm2Dcc
Mfn2tm3Dcc/Mfn2tm3Dcc
Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6 * C57BL/6J * DBA/2)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:339075
|
Mfngtm1.1Cfg/Mfngtm1.1Cfg
(involves: C57BL/6)
|
increased B cell proliferation
|
J:217719
|
Mfsd2atm1Dls/Mfsd2atm1Dls
(B6.Cg-Mfsd2atm1Dls)
|
abnormal microglial cell activation
|
J:234197
|
Mfsd2btm1a(KOMP)Wtsi/Mfsd2btm1a(KOMP)Wtsi
(C57BL/6-Mfsd2btm1a(KOMP)Wtsi)
|
increased susceptibility to type I hypersensitivity reaction
|
J:250123
|
Mgat5tm1Jwd/Mgat5tm1Jwd
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal leukocyte physiology
|
J:94864
|
| abnormal T cell physiology
|
J:60960
|
Mgat5btm1.1Cfg/Mgat5btm1.1Cfg
(involves: 129S6/SvEvTac)
|
increased IgG2b level
|
J:217719
|
Micu1em#Fink/Micu1em#Fink
(C57BL/6N-Micu1em#Fink)
|
increased B cell apoptosis
|
J:238984
|
Miga2tm1a(KOMP)Wtsi/Miga2tm1a(KOMP)Wtsi
Pnp2em1Smoc/Pnp2em1Smoc
(C57BL/6-Miga2tm1a(KOMP)Wtsi Pnp2em1Smoc)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:339075
|
Miga2tm1c(KOMP)Wtsi/Miga2tm1c(KOMP)Wtsi
Tg(Cd4-cre)1Cwi/0
(B6.Cg-Miga2tm1c(KOMP)Wtsi Tg(Cd4-cre)1Cwi)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:339075
|
MijuC3HeB/FeJ/MijuC57BL/6J
(involves: C3HeB/FeJ * C57BL/6J)
|
increased IgA level
|
J:91062
|
Milr1tm1Shib/Milr1tm1Shib
(involves: C57BL/6N)
|
decreased mast cell degranulation
|
J:161854
|
| increased susceptibility to type I hypersensitivity reaction
|
J:161854
|
Mir21atm1.1Mer/Mir21atm1.1Mer
(involves: 129S1/Sv * C57BL/6 * FVB/N)
|
increased susceptibility to type I hypersensitivity reaction
|
J:179235
|
Mir21atm1.1Mer/Mir21atm1.1Mer
(B6.129S1-Mir21atm1.1Mer)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:179235
|
Mir33tm1.1Koho/Mir33tm1.1Koho
(involves: C57BL/6)
|
abnormal macrophage physiology
|
J:165420
|
Mir125atm1Smoc/Mir125atm1Smoc
(involves: C57BL/6)
|
abnormal regulatory T cell physiology
|
J:224880
|
Mir142tm1Teyo/Mir142tm1Teyo
(involves: C57BL/6)
|
decreased mast cell degranulation
|
J:211850
|
Mir146tm1.1Bal/Mir146tm1.1Bal
(involves: C57BL/6)
|
abnormal regulatory T cell physiology
|
J:167922
|
Mir146tm1.1Bal/Mir146tm1.1Bal
(involves: C57BL/6 * FVB/N)
|
abnormal macrophage physiology
|
J:173671
|
| abnormal T cell activation
|
J:173671
|
| increased macrophage nitric oxide production
|
J:173671
|
Mir146tm1.1Lfl/Mir146tm1.1Lfl
Mir146btm1.1Lfl/Mir146btm1.1Lfl
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
increased IgG level
|
J:266124
|
Mir146tm1.1Lfl/Mir146tm1.1Lfl
Tg(Cr2-cre)3Cgn/0
(involves: C57BL/6)
|
increased IgG1 level
|
J:266124
|
| increased IgG level
|
J:266124
|
Mir146tm2.1Bal/Mir146tm2.1Bal
(involves: 129S1/Sv * C57BL/6 * FVB/N)
|
abnormal macrophage physiology
|
J:173671
|
| abnormal T cell activation
|
J:173671
|
| increased macrophage nitric oxide production
|
J:173671
|
Mir148atm2942.1Arte/Mir148atm2942.1Arte
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased IgA level
|
J:307366
|
| decreased IgG level
|
J:307366
|
| decreased IgM level
|
J:307366
|
Mir148atm2942.1Arte/Mir148atm2942.1Arte
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal B cell physiology
|
J:307366
|
Mir148atm2942.2Arte/Mir148atm2942.2Arte
(involves: C57BL/6 * FVB/N)
|
abnormal B cell physiology
|
J:307366
|
Mir150tm1Rsky/Mir150tm1Rsky
(involves: C57BL/6)
|
increased IgA level
|
J:127234
|
| increased IgG1 level
|
J:127234
|
| increased IgG2b level
|
J:127234
|
| increased IgM level
|
J:127234
|
Mir155tm1.1Brd/Mir155tm1.1Brd
(B6.Cg-Mir155tm1.1Brd Tyrc-Brd)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:121095
|
| abnormal dendritic cell physiology
|
J:121095
|
| decreased IgG1 level
|
J:121095
|
Mir155tm1.1Rsky/Mir155tm1.1Rsky
(involves: 129 * C57BL/6)
|
abnormal B cell physiology
|
J:121084
|
| abnormal germinal center B cell physiology
|
J:121084
|
| abnormal T cell physiology
|
J:121084
|
Mir155tm1.1Rsky/Mir155tm1.1Rsky
(B6.Cg-Mir155tm1Rsky/J)
|
abnormal T cell physiology
|
J:226678
|
Mir155tm1Brd/Mir155tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal B cell physiology
|
J:121095
|
| abnormal class switch recombination
|
J:121095
|
| decreased IgM level
|
J:121095
|
Mir155tm1Rsky/Mir155tm1Rsky
(involves: 129 * C57BL/6)
|
abnormal class switch recombination
|
J:136224
|
Mir223tm1Fcam/Mir223tm1Fcam
(involves: 129S4/SvJae * C57BL/6)
|
abnormal granulocyte physiology
|
J:140009
|
| abnormal neutrophil physiology
|
J:140009
|
Mir511em1Clib/Mir511em1Clib
(C57BL/6J-Mir511em1Clib)
|
abnormal macrophage physiology
|
J:345580
|
Mirc1tm1.1Aven/Mirc1tm1.1Aven
(involves: 129S4/SvJae * C57BL/6 * SJL/J)
|
increased B cell apoptosis
|
J:223213
|
Mirc1tm1.2Tyj/Mirc1tm1.2Tyj
(involves: 129S4/SvJae * C57BL/6 * FVB/N * SJL)
|
increased B cell apoptosis
|
J:134861
|
Mirc1tm1.3Tyj/Mirc1tm1.3Tyj
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
increased B cell apoptosis
|
J:134861
|
Mirc1tm1Tyj/Mirc1tm1Tyj
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA * SJL)
|
increased B cell apoptosis
|
J:134861
|
Mirc1tm2.1Aven/Mirc1tm2.1Aven
Tg(IghMyc)22Bri/?
(involves: 129S4/SvJae * C57BL/6 * SJL/J)
|
increased B cell apoptosis
|
J:223213
|
Mirc1tm3.1Aven/Mirc1tm3.1Aven
(involves: 129S4/SvJae * C57BL/6 * SJL/J)
|
increased B cell apoptosis
|
J:223213
|
Mirc13tm1.1Mtm/Mirc13tm1.1Mtm
(Not Specified)
|
abnormal macrophage activation involved in immune response
|
J:256444
|
Mirc14tm1.2Flv/Mirc14tm1.2Flv
(involves: C57BL/6 * C57BL/6N * FVB/N * SJL)
|
abnormal T cell physiology
|
J:203157
|
| decreased T cell proliferation
|
J:203157
|
| decreased thymocyte apoptosis
|
J:203157
|
Mirc14tm1.2Flv/Mirc14tm1.2Flv
Tg(Cd4-TcraDN32D3)1Aben/0
(involves: C57BL/6 * C57BL/6N * FVB/N * SJL)
|
abnormal NK T cell physiology
|
J:203157
|
Mirc30tm1.2Rdf/Mirc30tm1.2Rdf
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
abnormal B cell proliferation
|
J:156946
|
Mirc40tm1Jzb/Mirc40tm1Jzb
(Not Specified)
|
increased microglial cell activation
|
J:244554
|
MitfMi-Or/MitfMi-Or
(involves: 101/Rl * C3H/Rl)
|
abnormal osteoclast physiology
|
J:30149
|
Mitfmi-tg/Mitfmi-tg
(B6.Cg-Mitfmi-tg)
|
abnormal mast cell physiology
|
J:53161
|
Mitfmi-vit/Mitfmi-vit
(C57BL/6J-Mitfmi-vit)
|
abnormal Langerhans cell physiology
|
J:102101
|
MitfMi/MitfMi
(B6.Cg-MitfMi)
|
abnormal mast cell physiology
|
J:53161
|
Mlh1m1Btlr/Mlh1m1Btlr
(C57BL/6J-Mlh1m1Btlr)
|
increased IgM level
|
J:265206
|
Mlh1m2Btlr/Mlh1m2Btlr
(C57BL/6J-Mlh1m2Btlr)
|
decreased IgE level
|
J:265207
|
| increased IgM level
|
J:265207
|
Mlh1m3Btlr/Mlh1m3Btlr
(C57BL/6J-Mlh1m3Btlr)
|
decreased IgE level
|
J:265208
|
| increased IgM level
|
J:265208
|
Mlklem1Jhan/Mlklem1Jhan
(involves: C57BL/6)
|
abnormal macrophage physiology
|
J:204622
|
Mmdtm1Beij/Mmdtm1Beij
(Not Specified)
|
increased macrophage apoptosis
|
J:304637
|
Mmetm1Cge/Mmetm1Cge
(B6.129S4-Mmetm1Cge)
|
increased susceptibility to type I hypersensitivity reaction
|
J:66854
|
Mmp3tm1Mrl/Mmp3tm1Mrl
(either: 129S7/SvEvBrd or (involves: 129S7/SvEvBrd * C57BL/6))
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:93706
|
Mmp3tm1Mrl/Mmp3tm1Mrl
(involves: 129S7/SvEvBrd * C57BL/10ScSn * RIII)
|
abnormal lymphocyte physiology
|
J:55723
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:55723
|
Mmp7tm1Lmm/Mmp7tm1Lmm
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ)
|
abnormal macrophage physiology
|
J:124841
|
| impaired macrophage chemotaxis
|
J:124841
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac)
|
abnormal dendritic cell physiology
|
J:84293
|
| abnormal Langerhans cell physiology
|
J:76157
|
| decreased IgE level
|
J:84293
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(FVB.129S6-Mmp9tm1Tvu)
|
abnormal neutrophil physiology
|
J:104644
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129/Sv * 129S6/SvEvTac)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:55723
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac * C57BL/6)
|
increased IgE level
|
J:88065
|
| increased T cell proliferation
|
J:88065
|
Mmp12tm1Sds/Mmp12tm1Sds
(involves: 129X1/SvJ)
|
abnormal macrophage physiology
|
J:32902
|
Mmp14tm1Hbh/Mmp14tm1Hbh
(involves: 129P2/OlaHsd * Black Swiss)
|
abnormal osteoclast physiology
|
J:57969,
J:86538
|
Mmp14tm1Ktry/Mmp14tm1Ktry
(involves: 129X1/SvJ)
|
abnormal dendritic cell physiology
|
J:138782
|
Mmp19tm1Rase/Mmp19tm1Rase
(B6.129P2-Mmp19tm1Rase)
|
abnormal T cell activation
|
J:137128
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:137128
|
| decreased T cell proliferation
|
J:137128
|
Mmp24tm1Otin/Mmp24tm1Otin
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal mast cell degranulation
|
J:153230
|
| increased mast cell degranulation
|
J:153230
|
Mmp25Gt(IST14198E10)Tigm/Mmp25Gt(IST14198E10)Tigm
(involves: C57BL/6N)
|
abnormal macrophage activation involved in immune response
|
J:347009
|
| abnormal neutrophil physiology
|
J:347009
|
| increased IgG level
|
J:347009
|
Mmp28tm1Mani/Mmp28tm1Mani
(B6.129X1-Mmp28tm1Mani)
|
abnormal macrophage chemotaxis
|
J:145912
|
| impaired neutrophil recruitment
|
J:145912
|
Mnx1tm4(cre)Tmj/Mnx1+
Tardbptm1.1Ckjs/Tardbptm1.2Cjks
(involves: 129S1/Sv * C57BL/6J)
|
increased microglial cell activation
|
J:190254
|
Mogtm1Reid/Mogtm1Reid
(129/Sv-Mogtm1Reid)
|
abnormal T-helper 1 physiology
|
J:86663
|
| increased T cell proliferation
|
J:86663
|
Mol1BALB/cByJ/Mol1BALB/cByJ
(involves: BALB/cByJ * C57BL/6ByJ)
|
decreased B cell proliferation
|
J:58921
|
Morrbidem1Flv/Morrbidem1Flv
(C57BL/6N-Morrbidem1Flv)
|
abnormal eosinophil physiology
|
J:236609
|
| abnormal leukocyte physiology
|
J:236609
|
| abnormal neutrophil physiology
|
J:236609
|
Mpotm1Lus/Mpotm1Lus
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal neutrophil physiology
|
J:67586
|
Mpotm1Lus/Mpotm1Lus
(B6.129X1-Mpotm1Lus)
|
abnormal neutrophil physiology
|
J:112488
|
Mpotm1Mae/Mpotm1Mae
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal neutrophil physiology
|
J:53993
|
Mpp1tm1Ahc/Mpp1tm1Ahc
(B6.129-Mpp1tm1Ahc)
|
abnormal neutrophil physiology
|
J:154749
|
| impaired neutrophil chemotaxis
|
J:154749
|
Mpztm1Msch/Mpz+
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal macrophage chemotaxis
|
J:67581
|
| abnormal T-helper 1 physiology
|
J:82432
|
Mr1tm1Gfn/Mr1tm1Gfn
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal B cell physiology
|
J:113083
|
Mrc1tm1Mnz/Mrc1tm1Mnz
(involves: 129P2/OlaHsd)
|
abnormal macrophage physiology
|
J:124290
|
Mrc1tm1Mnz/Mrc1tm1Mnz
Mrc2tm1Cmi/Mrc2tm1Cmi
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
abnormal macrophage physiology
|
J:124290
|
Mre11atm1.1Rchd/Mre11atm1.1Rchd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal class switch recombination
|
J:184053
|
Mrgprb2em1Xzd/Mrgprb2em1Xzd
(C57BL/6-Mrgprb2em1Xzd)
|
decreased mast cell degranulation
|
J:219209
|
Ms4a1tm1Tft/Ms4a1tm1Tft
(involves: 129 * C57BL/6)
|
abnormal B cell calcium ion homeostasis
|
J:88933
|
| abnormal B cell physiology
|
J:88933
|
Ms4a2tm1Chr/Ms4a2tm1Chr
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal mast cell physiology
|
J:53106
|
| decreased susceptibility to type I hypersensitivity reaction
|
J:53106
|
Ms4a2tm1Knt/Ms4a2tm1Knt
(involves: 129 * BALB/c)
|
abnormal mast cell physiology
|
J:47138
|
| decreased susceptibility to type I hypersensitivity reaction
|
J:47138
|
Ms4a2tm1Knt/Ms4a2tm1Knt
Tg(SV40/HTLV-FCER1A)1Bhk/0
(involves: 129 * BALB/c)
|
abnormal mast cell physiology
|
J:47138
|
| decreased susceptibility to type I hypersensitivity reaction
|
J:47138
|
Ms4a4aem1Wwz/Ms4a4aem1Wwz
(C57BL/6NCrl-Ms4a4aem1Wwz)
|
abnormal macrophage physiology
|
J:296429
|
| impaired eosinophil recruitment
|
J:296429
|
Ms4a7em1.1Jddl/Ms4a7em1.1Jddl
(B6.Cg-Ms4a7em1.1Jddl)
|
abnormal macrophage physiology
|
J:347975
|
Msh2tm1Htr/Msh2tm1Htr
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:80893
|
| abnormal somatic hypermutation frequency
|
J:155454
|
| decreased IgG1 level
|
J:80893
|
| decreased IgG3 level
|
J:80893
|
Msh2tm1Htr/Msh2tm1Htr
Pcnatm1Jcbs/Pcnatm1Jcbs
(involves: 129P2/OlaHsd)
|
abnormal somatic hypermutation frequency
|
J:155454
|
Msh2tm1Mak/Msh2tm1Mak
(C57BL/6NTac-Msh2tm1Mak)
|
abnormal class switch recombination
|
J:326431
|
| abnormal somatic hypermutation frequency
|
J:326431
|
Msh2tm1Rak/Msh2tm1Rak
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:56764
|
Msh2tm1Wed/Msh2tm1Wed
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:86278
|
| decreased IgG level
|
J:86278
|
Msh6m1Btlr/Msh6m1Btlr
(C57BL/6J-Msh6m1Btlr)
|
decreased IgE level
|
J:255208
|
Msntm1Sts/Y
(involves: 129S4/SvJae * C57BL/6)
|
impaired leukocyte migration
|
J:189837
|
Msr1tm1Csk/Msr1tm1Csk
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal macrophage physiology
|
J:91911
|
Msr1tm1Csk/Msr1tm1Csk
Scarf1tm1Ishi/Scarf1tm1Ishi
(involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6J)
|
abnormal macrophage physiology
|
J:91911
|
Mst1tm1Jab/Mst1tm1Jab
(involves: 129P2/OlaHsd * Black Swiss)
|
abnormal macrophage physiology
|
J:46185
|
Mst1rtm1.1Sew/Mst1rtm1.1Sew
(involves: 129/Ola * CD-1 * NIH Black Swiss)
|
abnormal macrophage physiology
|
J:75503
|
| abnormal type IV hypersensitivity reaction
|
J:75503
|
Mst1rtm1Ber/Mst1rtm1Ber
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal macrophage physiology
|
J:76451
|
| abnormal type IV hypersensitivity reaction
|
J:76451
|
Mst1rtm1Sjd/Mst1r+
(either: (involves: 129 * C57BL/6) or (involves: 129 * CD-1) or (involves: 129 * NIH Black Swiss))
|
abnormal macrophage physiology
|
J:54903
|
Mt1tm1Bri/Mt1tm1Bri
Mt2tm1Bri/Mt2tm1Bri
(involves: 129S7/SvEvBrd)
|
abnormal microglial cell physiology
|
J:53929
|
Mt1tm1Bri/Mt1tm1Bri
Mt2tm1Bri/Mt2tm1Bri
(129S7/SvEvBrd-Mt1tm1Bri Mt2tm1Bri/J)
|
abnormal lymphocyte physiology
|
J:110643
|
| increased IgG level
|
J:110643
|
| increased IgM level
|
J:110643
|
| increased thymocyte apoptosis
|
J:57169
|
Mta2tm1.1Yzha/Mta2tm1.1Yzha
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
increased T cell proliferation
|
J:137101
|
Mta2tm1Yzha/Mta2tm1Yzha
Tg(Lck-cre)#Zhu/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
increased T cell proliferation
|
J:137101
|
Mtdhtm1.2Dsar/Mtdhtm1.2Dsar
(either: B6.129(FVB)-Mtdhtm1.2Dsar or (129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N))
|
decreased macrophage proliferation
|
J:216688
|
Mtmr4tm1a(EUCOMM)Wtsi/Mtmr4+
(Not Specified)
|
decreased IgE level
|
J:165965
|
Mtortm1.2Koz/Mtortm1.2Koz
Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:150108
|
Mtortm1Lgm/Mtortm1Lgm
(involves: 129S1/Sv * C57BL/6)
|
abnormal B cell physiology
|
J:168600
|
| abnormal T cell physiology
|
J:168600
|
| decreased B cell proliferation
|
J:168600
|
| decreased IgG level
|
J:168600
|
| decreased IgM level
|
J:168600
|
| impaired B cell migration
|
J:168600
|
Mtss1Gt(CSC156)Byg/Mtss1Gt(CSC156)Byg
(B6.129P2-Mtss1Gt(CSC156)Byg)
|
abnormal B cell physiology
|
J:186118
|
Muc5btm1.2Evns/Muc5btm1.2Evns
(B6.129S1-Muc5btm1.2Evns)
|
abnormal professional antigen presenting cell physiology
|
J:207159
|
| impaired macrophage phagocytosis
|
J:207159
|
| increased macrophage apoptosis
|
J:207159
|
Mxd1tm1Rne/Mxd1tm1Rne
(involves: 129S4/SvJaeSor * C57BL/6)
|
abnormal B cell physiology
|
J:45945
|
Mxi1tm1Rdp/Mxi1tm1Rdp
(involves: 129/Sv * C57BL/6J * SJL)
|
increased T cell proliferation
|
J:48236
|
Mybl1tm1Epr/Mybl1tm1Epr
(involves: 129 * C57BL/6)
|
decreased IgG1 level
|
J:67604
|
| decreased IgG2a level
|
J:67604
|
| decreased IgG3 level
|
J:67604
|
Myctm1Atp/Myc+
(involves: 129P2/OlaHsd * FVB/N)
|
decreased T cell proliferation
|
J:73369
|
Myctm1Atp/Myc+
(B6.129P2-Myctm1Atp)
|
abnormal NK cell physiology
|
J:132730
|
| decreased T cell proliferation
|
J:132730
|
Myctm1Atp/Myctm2.1Atp
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
decreased T cell proliferation
|
J:73369
|
Myctm1Lbox/Myctm1Lbox
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
increased B cell apoptosis
|
J:97900
|
| increased B cell proliferation
|
J:97900
|
Myctm2.1Atp/Myc+
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
decreased T cell proliferation
|
J:73369
|
Myctm2Fwa/Myctm2Fwa
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
decreased B cell proliferation
|
J:67222
|
Mycltm1.1Kmm/Mycltm1.1Kmm
(B6.129S6(C)-Mycltm1.1Kmm)
|
abnormal dendritic cell physiology
|
J:206430
|
Myd88lkd/Myd88lkd
(C57BL/6-Myd88lkd)
|
abnormal adaptive immunity
|
J:110094
|
| abnormal macrophage physiology
|
J:110094
|
Myd88poc/Myd88poc
(C57BL/6-Myd88poc)
|
abnormal macrophage physiology
|
J:110094
|
Myd88tm1.1Defr/Myd88tm1.1Defr
(B6.129P2(SJL)-Myd88tm1.1Defr)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:224849
|
| abnormal macrophage physiology
|
J:224849
|
| abnormal microglial cell physiology
|
J:224849
|
Myd88tm1.1Medz/Myd88tm1.1Medz
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:209373
|
| abnormal memory T cell physiology
|
J:209373
|
| abnormal T-helper 1 physiology
|
J:209373
|
| abnormal T-helper 17 cell physiology
|
J:209373
|
Myd88tm1Aki/Myd88tm1Aki
(Not Specified)
|
abnormal dendritic cell physiology
|
J:96773
|
| abnormal macrophage physiology
|
J:96773
|
| abnormal NK cell physiology
|
J:88906
|
| abnormal NK T cell physiology
|
J:88906
|
| abnormal T cell physiology
|
J:96773
|
| decreased B cell proliferation
|
J:96773
|
Myd88tm1Aki/Myd88tm1Aki
(B6.129P2-Myd88tm1Aki)
|
abnormal dendritic cell physiology
|
J:116670,
J:118954
|
| abnormal macrophage physiology
|
J:116670
|
| abnormal NK cell physiology
|
J:139001
|
| abnormal T cell physiology
|
J:97662
|
Myd88tm1Aki/Myd88tm1Aki
(involves: 129P2/OlaHsd)
|
abnormal dendritic cell physiology
|
J:174941,
J:137522
|
| abnormal macrophage physiology
|
J:174941
|
| abnormal neutrophil physiology
|
J:145345
|
| increased IgA level
|
J:210086
|
| increased IgE level
|
J:115059
|
| increased IgG1 level
|
J:115059
|
Myd88tm1Aki/Myd88tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal dendritic cell physiology
|
J:122394
|
| abnormal macrophage physiology
|
J:141143,
J:117688
|
| decreased IgG2b level
|
J:137066
|
| decreased IgG3 level
|
J:137066
|
| decreased IgG level
|
J:137066
|
Myd88tm1Aki/Myd88tm1Aki
Ticam1tm1Aki/Ticam1+
(B6.129P2-Myd88tm1Aki Ticam1tm1Aki)
|
decreased macrophage cytokine production
|
J:140485
|
| decreased macrophage nitric oxide production
|
J:140485
|
Myd88tm1Aki/Myd88tm1Aki
Ticam1tm1Aki/Ticam1tm1Aki
(involves: 129P2/OlaHsd)
|
abnormal dendritic cell physiology
|
J:174941
|
| abnormal macrophage physiology
|
J:174941
|
Myd88tm1Aki/Myd88tm1Aki
Ticam1tm1Aki/Ticam1tm1Aki
(B6.129P2-Myd88tm1Aki Ticam1tm1Aki)
|
decreased macrophage cytokine production
|
J:140485
|
| decreased macrophage nitric oxide production
|
J:140485
|
Myd88tm1Defr/Myd88tm1Defr
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal NK cell physiology
|
J:139001
|
Myd88tm1Defr/Myd88tm1Defr
Tg(Itgax-cre)1-1Reiz/0
(B6.Cg-Myd88tm1Defr Tg(Itgax-cre)1-1Reiz)
|
abnormal dendritic cell antigen presentation
|
J:139001
|
| abnormal dendritic cell physiology
|
J:139001
|
| abnormal NK cell physiology
|
J:139001
|
| decreased IgG1 level
|
J:139001
|
| decreased IgG2b level
|
J:139001
|
| decreased IgG2c level
|
J:139001
|
Myh9tm5Rsad/Myh9tm5Rsad
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal leukocyte migration
|
J:164684
|
| abnormal T cell physiology
|
J:164684
|
Myh9tm5Rsad/Myh9tm5Rsad
Tg(Lck-cre)#Nik/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:164684
|
| abnormal leukocyte adhesion
|
J:164684
|
| abnormal leukocyte migration
|
J:164684
|
| abnormal T cell physiology
|
J:164684
|
Myo1ftm1.1Flv/Myo1ftm1.1Flv
(involves: 129S6/SvEvTac)
|
impaired neutrophil chemotaxis
|
J:113020
|
Myo1gtm1.2Mfk/Myo1gtm1.2Mfk
(Not Specified)
|
abnormal B cell physiology
|
J:209304
|
| impaired B cell migration
|
J:209304
|
Myo1gtm1.2Mfk/Myo1gtm1.2Mfk
(involves: C57BL/6 * FVB/N * SJL)
|
abnormal T cell physiology
|
J:212451
|
Myo1gtm1.2Mfk/Myo1gtm1.2Mfk
Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6 * FVB/N * SJL)
|
abnormal T cell physiology
|
J:212451
|
Myo9btm1.2Bah/Myo9btm1.2Bah
(B6.Cg-Myo9btm1.2Bah)
|
abnormal macrophage physiology
|
J:162326
|
| impaired macrophage chemotaxis
|
J:162326
|
mypy/mypy
(C57BL/6J-mypy)
|
abnormal macrophage physiology
|
J:105543
|
Mysm1tm1a(KOMP)Wtsi/Mysm1tm1a(KOMP)Wtsi
(Not Specified)
|
increased IgG2b level
|
J:165965
|
N4bp1tm1.2Vmd/N4bp1tm1.2Vmd
(involves: C57BL/6)
|
abnormal macrophage physiology
|
J:297419
|
Nabp2tm1.1Kkha/Nabp2tm1.1Kkha
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
increased thymocyte apoptosis
|
J:195140
|
Nba4NZB/Nba4NZB
(involves: NZB * SWR)
|
increased IgG3 level
|
J:96263
|
Nba4NZB/Nba4SWR
(involves: NZB * SWR)
|
increased IgG3 level
|
J:96263
|
Nba5NZB/Nba5NZB
(C57BL/6-Nba5 Yaa)
|
increased susceptibility to type III hypersensitivity reaction
|
J:95829
|
Nba10NZB/?
(involves: C57BL/6 * NZB * SB/Le)
|
increased susceptibility to type III hypersensitivity reaction
|
J:95829
|
Nba10NZB/Nba10NZB
Tg(Tnfsf13b)1Fma/0
(involves: C57BL/6 * DBA/2J * NZB)
|
increased IgG level
|
J:134128
|
| increased IgM level
|
J:134128
|
Nba10NZB/Nba10NZB
X/Yaa
(C57BL/6-Nba2 Yaa)
|
increased susceptibility to type III hypersensitivity reaction
|
J:95829
|
Nbntm1Nus/Nbntm2Nus
Tg(CD19-cre/ERT2)1Cgn/0
(Not Specified)
|
abnormal B cell physiology
|
J:96102
|
| decreased B cell proliferation
|
J:96102
|
| decreased IgG1 level
|
J:96102
|
| decreased IgG2a level
|
J:96102
|
| decreased IgG2b level
|
J:96102
|
| decreased IgG3 level
|
J:96102
|
| decreased IgG level
|
J:96102
|
Nbr1tm1Whca/Nbr1tm1Whca
(B6.129P2-Nbr1tm1Whca)
|
abnormal osteoclast physiology
|
J:162412
|
Nbwa2NZB/?
(involves: BALB/c * NZB * NZW)
|
increased IgG level
|
J:88464
|
| increased IgM level
|
J:88464
|
Nceh1tm1Ishi/Nceh1tm1Ishi
(B6.129S7-Nceh1tm1Ishi)
|
abnormal macrophage physiology
|
J:152385
|
Ncf1m1J/Ncf1m1J
(B6.Cg-Dock7m +/+ Leprdb/J)
|
abnormal macrophage physiology
|
J:83428
|
| impaired granulocyte bactericidal activity
|
J:83428
|
Ncf1tm1Hbd/Ncf1tm1Hbd
(involves: 129)
|
abnormal neutrophil physiology
|
J:77597,
J:74593
|
Ncf4tm1Pth/Ncf4tm2Pth
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal neutrophil physiology
|
J:119217
|
Ncf4tm2Pth/Ncf4tm2Pth
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal neutrophil physiology
|
J:121820
|
Nckap1lm1Iri/Nckap1lm1Iri
(involves: C57BL/6)
|
decreased T cell proliferation
|
J:141377
|
| impaired macrophage phagocytosis
|
J:141377
|
| impaired neutrophil chemotaxis
|
J:141377
|
| impaired neutrophil phagocytosis
|
J:141377
|
Ncoa3tm1Jxu/Ncoa3tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased B cell proliferation
|
J:109522
|
| increased T cell proliferation
|
J:109522
|
Ncr1m1J/Ncr1m1J
Pepcb/Pepcb
Ptprca/Ptprca
(B6.SJL-Ptprca Pepcb/BoyJ)
|
abnormal NK cell physiology
|
J:257226
|
Ncr1noe/Ncr1noe
(involves: C57BL/6J)
|
abnormal NK cell physiology
|
J:179728
|
Ncr1tm1.1(icre)Viv/Ncr1tm1.1(icre)Viv
(involves: C57BL/6)
|
abnormal NK cell physiology
|
J:179728
|
Ncr1tm1Oman/Ncr1tm1Oman
(involves: 129S1/Sv * 129X1/SvJ)
|
impaired natural killer cell mediated cytotoxicity
|
J:112394
|
Ndfip1Gt(RRD002)Byg/Ndfip1Gt(RRD002)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell physiology
|
J:116617
|
| abnormal T-helper 2 physiology
|
J:116617
|
| increased T cell proliferation
|
J:116617
|
Ndfip1Gt(RRD002)Byg/Ndfip1Gt(RRD002)Byg
(involves: 129P2/OlaHsd)
|
abnormal T cell physiology
|
J:205692
|
| increased T cell proliferation
|
J:205692
|
Ndrg2tm1.1Hori/Ndrg2tm1.1Hori
(B6.129-Ndrg2tm1.1Hori)
|
abnormal microglial cell chemotaxis
|
J:214686
|
Ndst1tm1Je/Ndst1tm1Je
Tg(Tek-cre)1Ywa/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal leukocyte adhesion
|
J:100456
|
| abnormal leukocyte migration
|
J:100456
|
| impaired leukocyte tethering or rolling
|
J:100456
|
Ndst2tm1Lkj/Ndst2tm1Lkj
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased mast cell degranulation
|
J:57121
|
Ndst2tm1Rls/Ndst2tm1Rls
(Not Specified)
|
decreased mast cell degranulation
|
J:57120
|
Nedd4Gt(XA209)Byg/Nedd4Gt(XA209)Byg
(involves: 129P2/OlaHsd)
|
abnormal T cell activation
|
J:143560
|
| decreased IgG1 level
|
J:143560
|
| decreased IgG2b level
|
J:143560
|
| decreased IgG3 level
|
J:143560
|
| decreased T cell proliferation
|
J:143560
|
| increased IgM level
|
J:143560
|
Nedd4Gt(XB398)Byg/Nedd4Gt(XB398)Byg
(involves: 129P2/OlaHsd)
|
decreased IgG1 level
|
J:143560
|
| decreased IgG2b level
|
J:143560
|
| decreased IgG3 level
|
J:143560
|
| decreased T cell proliferation
|
J:143560
|
| increased IgM level
|
J:143560
|
Nedd9tm1Miku/Nedd9tm1Miku
(B6.CBA-Nedd9tm1Miku)
|
abnormal follicular B cell physiology
|
J:116716
|
| abnormal leukocyte migration
|
J:116716
|
| abnormal T cell physiology
|
J:116716
|
Neil3tm1Bjor/Neil3tm1Bjor
(involves: 129 * C57BL/6)
|
decreased microglial cell activation
|
J:180177
|
Nek7M1Btlr/Nek7+
(C57BL/6J-Nek7M1Btlr)
|
abnormal macrophage physiology
|
J:226677
|
Nek7M1Btlr/Nek7M1Btlr
(C57BL/6J-Nek7M1Btlr)
|
abnormal macrophage physiology
|
J:226677
|
Nf1tm1Tyj/Nf1+
(involves: 129S2/SvPas)
|
abnormal mast cell physiology
|
J:142439
|
| increased mast cell degranulation
|
J:142439
|
Nf1tm1Tyj/Nf1+
Pak1tm1Cher/Pak1tm1Cher
(involves: 129S2/SvPas * C57BL/6)
|
abnormal mast cell physiology
|
J:142439
|
Nfat5tm1.1Joar/Nfat5tm1.1Joar
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal T cell physiology
|
J:148271
|
Nfat5tm1Snh/Nfat5+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal immunoglobulin level
|
J:91482
|
| decreased IgG level
|
J:91482
|
| decreased T cell proliferation
|
J:91482
|
Nfatc1tm1Glm/Nfatc1tm2Glm
(chimera involves: 129S2/SvPas)
|
abnormal B cell physiology
|
J:78376
|
| abnormal immunoglobulin level
|
J:78376
|
| abnormal lymphocyte physiology
|
J:78376
|
| abnormal T cell physiology
|
J:78376
|
| abnormal T-helper 2 physiology
|
J:78376
|
| decreased IgE level
|
J:78376
|
| decreased IgG1 level
|
J:78376
|
| decreased IgG2b level
|
J:78376
|
| decreased IgG3 level
|
J:78376
|
| decreased immunoglobulin level
|
J:78376
|
| increased IgA level
|
J:78376
|
| increased IgG2a level
|
J:78376
|
| increased IgM level
|
J:78376
|
| increased immunoglobulin level
|
J:78376
|
Nfatc1tm1Rao/Nfatc1tm1Rao
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c)
|
abnormal B cell calcium ion homeostasis
|
J:177319
|
| abnormal class switch recombination
|
J:177319
|
| abnormal marginal zone B cell physiology
|
J:177319
|
| decreased B cell proliferation
|
J:177319
|
| increased B cell apoptosis
|
J:177319
|
Nfatc1tm1Rao/Nfatc1tm1Rao
Nfatc2tm1Rao/Nfatc2tm1Rao
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c)
|
abnormal B cell physiology
|
J:177319
|
Nfatc1tm1Rao/Nfatc1tm1Rao
Tg(Fcer2a-cre)5Mbu/0
(involves: C57BL/6 * CBA)
|
abnormal B cell physiology
|
J:177319
|
| abnormal class switch recombination
|
J:177319
|
| decreased B cell proliferation
|
J:177319
|
| decreased IgG2a level
|
J:177319
|
| decreased IgG3 level
|
J:177319
|
| decreased IgM level
|
J:177319
|
| increased IgM level
|
J:177319
|
Nfatc2tm1Rao/Nfatc2tm1Rao
(B6.Cg-Nfatc2tm1Rao)
|
abnormal mast cell physiology
|
J:78089
|
Nfatc2tm1Rao/Nfatc2tm1Rao
Nfatc3tm1Grc/Nfatc3tm1Grc
Tg(Lck-cre)I57Jxm/0
(involves: ICR)
|
increased T cell apoptosis
|
J:141917
|
Nfatc2tm1Srf/Nfatc2tm1Srf
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:110686
|
| abnormal lymphocyte physiology
|
J:110686
|
| abnormal T cell physiology
|
J:110686
|
Nfatc2tm1Srf/Nfatc2tm1Srf
(involves: 129P2/OlaHsd)
|
abnormal T cell physiology
|
J:45252
|
Nfatc2tm1Srf/Nfatc2tm1Srf
(B6.Cg-Nfatc2tm1Srf)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:86279
|
| abnormal T-helper 1 physiology
|
J:86279
|
| abnormal T-helper 2 physiology
|
J:86279
|
| increased IgE level
|
J:86279
|
| increased IgG1 level
|
J:86279
|
| increased immunoglobulin level
|
J:86279
|
Nfatc2iptm1.1Glm/Nfatc2iptm1.1Glm
(either: B6.129-Nfatc2iptm1.1Glm or C.129-Nfatc2iptm1.1Glm)
|
abnormal T-helper 2 physiology
|
J:157559
|
Nfatc3tm1Grc/Nfatc3tm1Grc
Tg(Lck-cre)I57Jxm/0
(involves: ICR)
|
increased T cell apoptosis
|
J:141917
|
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * ICR)
|
abnormal macrophage physiology
|
J:118068
|
| increased IgG level
|
J:104016
|
| increased IgM level
|
J:104016
|
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal leukocyte adhesion
|
J:150597
|
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk
(B6.129X1-Nfe2l2tm1Ywk/J)
|
abnormal neutrophil physiology
|
J:233699
|
Nfil3tm1.1Brad/Nfil3tm1.1Brad
(B6.Cg-Nfil3tm1.1Brad)
|
impaired natural killer cell mediated cytotoxicity
|
J:152774
|
Nfil3tm1Look/Nfil3tm1Look
(B6.129X1-Nfil3tm1Look)
|
impaired natural killer cell mediated cytotoxicity
|
J:155677
|
Nfil3tm1Pbro/Nfil3tm1Pbro
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal class switch recombination
|
J:156521
|
| decreased IgE level
|
J:156521
|
| decreased IgG1 level
|
J:156521
|
Nfil3tm1Pbro/Nfil3tm1Pbro
(B6.129S6-Nfil3tm1Pbro)
|
increased macrophage cytokine production
|
J:209365
|
Nfkb1M1Btlr/Nfkb1+
(C57BL/6J-Nfkb1M1Btlr)
|
decreased IgG level
|
J:216054
|
Nfkb1M1Btlr/Nfkb1M1Btlr
(C57BL/6J-Nfkb1M1Btlr)
|
decreased IgG level
|
J:216054
|
Nfkb1m2Btlr/Nfkb1+
(C57BL/6J-Nfkb1m2Btlr)
|
decreased IgM level
|
J:254822
|
Nfkb1m2Btlr/Nfkb1m2Btlr
(C57BL/6J-Nfkb1m2Btlr)
|
decreased IgE level
|
J:254822
|
| decreased IgG level
|
J:254822
|
| decreased IgM level
|
J:254822
|
Nfkb1M3Btlr/Nfkb1+
(C57BL/6J-Nfkb1M3Btlr)
|
decreased IgE level
|
J:254821
|
| decreased IgG level
|
J:254821
|
Nfkb1M3Btlr/Nfkb1M3Btlr
(C57BL/6J-Nfkb1M3Btlr)
|
decreased IgE level
|
J:254821
|
| decreased IgG level
|
J:254821
|
Nfkb1M5Btlr/Nfkb1M5Btlr
(C57BL/6J-Nfkb1M5Btlr)
|
decreased IgE level
|
J:272117
|
Nfkb1M6Btlr/Nfkb1M6Btlr
(C57BL/6J-Nfkb1M6Btlr)
|
decreased IgE level
|
J:272148
|
Nfkb1tm1a(KOMP)Wtsi/Nfkb1tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased IgA level
|
J:213427
|
| decreased IgG1 level
|
J:213427
|
Nfkb1tm1Bal/Nfkb1tm1Bal
(B6;129P-Nfkb1tm1Bal/J)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:118907
|
| abnormal dendritic cell physiology
|
J:118907
|
| abnormal macrophage physiology
|
J:118907
|
| abnormal professional antigen presenting cell physiology
|
J:118907
|
Nfkb1tm1Bal/Nfkb1tm1Bal
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:30268
|
| decreased B cell proliferation
|
J:37184,
J:30268
|
| decreased IgA level
|
J:37184
|
| decreased IgE level
|
J:37184
|
| decreased IgG1 level
|
J:37184
|
| decreased IgM level
|
J:30268
|
| decreased immunoglobulin level
|
J:37184
|
Nfkb1tm1Bal/Nfkb1tm1Bal
(B6.Cg-Nfkb1tm1Bal/J)
|
abnormal B cell physiology
|
J:113556
|
Nfkb1tm1Bal/Nfkb1tm1Bal
Nfkb2tm1Sbn/Nfkb2tm1Sbn
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
abnormal macrophage physiology
|
J:45119
|
Nfkb1tm1Bal/Nfkb1tm1Bal
Tg(Tnfsf13b)1Fma/?
(B6.Cg-Nfkb1tm1Bal Tg(Tnfsf13b)1Fma)
|
abnormal B cell activation
|
J:113556
|
| abnormal class switch recombination
|
J:113556
|
Nfkb1tm1Brv/Nfkb1tm1Brv
(involves: 129S1/Sv)
|
abnormal lymphocyte physiology
|
J:46912
|
| decreased IgG3 level
|
J:46912
|
| decreased T cell proliferation
|
J:46912
|
| increased B cell proliferation
|
J:46912
|
| increased IgE level
|
J:46912
|
| increased IgG1 level
|
J:46912
|
| increased immunoglobulin level
|
J:46912
|
Nfkb1tm1Sley/Nfkb1tm1Sley
(involves: 129S4/SvJae * 129S8/SvEv)
|
decreased T cell proliferation
|
J:142340
|
Nfkb2Lym1/Nfkb2Lym1
(involves: BALB/c)
|
abnormal class switch recombination
|
J:154812
|
| decreased B cell proliferation
|
J:154812
|
| decreased IgA level
|
J:154812
|
| decreased IgG1 level
|
J:154812
|
| decreased IgG2b level
|
J:154812
|
| decreased IgM level
|
J:154812
|
| decreased immunoglobulin level
|
J:154812
|
Nfkb2tm1Brv/Nfkb2tm1Brv
(involves: 129S1/Sv * C57BL/6)
|
increased B cell proliferation
|
J:43469
|
| increased T cell proliferation
|
J:43469
|
Nfkb2tm1Sbn/Nfkb2tm1Sbn
(involves: 129S4/SvJae * C57BL/6)
|
abnormal class switch recombination
|
J:45437
|
| abnormal immunoglobulin level
|
J:45437
|
| decreased IgA level
|
J:45437
|
| decreased IgG1 level
|
J:45437
|
| decreased IgG2a level
|
J:45437
|
| decreased IgG2b level
|
J:45437
|
| increased IgM level
|
J:45437
|
Nfkb2tm2Brv/Nfkb2tm2Brv
(involves: 129S1/Sv * C57BL/6)
|
decreased B cell proliferation
|
J:76380
|
| decreased IgA level
|
J:76380
|
| decreased IgG1 level
|
J:76380
|
| decreased IgG3 level
|
J:76380
|
| increased IgG2a level
|
J:76380
|
| increased IgM level
|
J:76380
|
Nfkb2tm2Brv/Nfkb2tm2Brv
Tg(Tnfsf13b)1Fma/?
(B6.Cg-Nfkb2tm2Brv Tg(Tnfsf13b)1Fma)
|
abnormal B cell activation
|
J:113556
|
Nfkbiatm1.1Pjc/Nfkbiatm1.1Pjc
(involves: C57BL/6)
|
abnormal T cell activation
|
J:163686
|
| increased T cell apoptosis
|
J:163686
|
| increased T cell proliferation
|
J:163686
|
Nfkbiatm1.1Smiy/Nfkbiatm1.1Smiy
(B6.129-Nfkbiatm1.1Smiy)
|
decreased B cell proliferation
|
J:168977
|
| decreased IgA level
|
J:168977
|
| decreased IgG1 level
|
J:168977
|
| decreased IgG2b level
|
J:168977
|
| increased activation-induced B cell apoptosis
|
J:168977
|
Nfkbiatm1Bal/Nfkbiatm1Bal
Nfkbietm1Syme/Nfkbietm1Syme
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA/2)
|
increased B cell apoptosis
|
J:88142
|
| increased T cell apoptosis
|
J:88142
|
Nfkbiatm1Fey/Nfkbiatm1Fey
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased T cell proliferation
|
J:110817
|
| increased B cell proliferation
|
J:110817
|
| increased IgA level
|
J:110817
|
| increased IgE level
|
J:110817
|
| increased IgG level
|
J:110817
|
Nfkbiatm1Stw/Nfkbiatm1Stw
(involves: 129S1/Sv)
|
abnormal macrophage physiology
|
J:32527
|
Nfkbidm1Btlr/Nfkbidm1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| decreased B cell proliferation
|
J:185495
|
| decreased IgG1 level
|
J:185495
|
| decreased IgG3 level
|
J:185495
|
| decreased IgG level
|
J:185495
|
| decreased IgM level
|
J:185495
|
| increased B cell apoptosis
|
J:185495
|
Nfkbidtm1a(EUCOMM)Wtsi/Nfkbidtm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
abnormal class switch recombination
|
J:185495
|
| decreased IgG level
|
J:185495
|
| decreased IgM level
|
J:185495
|
Nfkbidtm1Clay/Nfkbidtm1Clay
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal NK cell physiology
|
J:132071
|
| abnormal thymocyte activation
|
J:132071
|
| decreased T cell proliferation
|
J:132071
|
Nfkbietm1Syme/Nfkbietm1Syme
(either: (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) or (involves: 129P2/OlaHsd * C57BL/6))
|
increased IgG1 level
|
J:88538
|
| increased IgM level
|
J:88538
|
Nfkbiztm1Aki/Nfkbiztm1Aki
(involves: 129P2/OlaHsd)
|
abnormal leukocyte physiology
|
J:91297
|
| increased immunoglobulin level
|
J:194832
|
Nfkbiztm1Aki/Nfkbiztm1Aki
(C.129P2-Nfkbiztm1Aki)
|
increased IgE level
|
J:141704
|
Nfkbiztm1Mamo/Nfkbiztm1Mamo
(involves: 129S7/SvEvBrd)
|
increased IgE level
|
J:95040
|
Nhej1tm1.1Ics/Nhej1tm1.1Ics
(involves: 129 * C57BL/6)
|
increased thymocyte apoptosis
|
J:194422
|
Nhej1tm1.1Ics/Nhej1tm1.1Ics
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
decreased thymocyte apoptosis
|
J:194422
|
Nhej1tm1Fwa/Nhej1tm1Fwa
(involves: 129)
|
abnormal class switch recombination
|
J:138774
|
| decreased IgG1 level
|
J:138774
|
| decreased IgG3 level
|
J:138774
|
| increased IgM level
|
J:138774
|
Niban3tm1Jyw/Niban3tm1Jyw
(B6.Cg-Niban3tm1Jyw)
|
abnormal B cell calcium ion homeostasis
|
J:282961
|
| abnormal class switch recombination
|
J:282961
|
| decreased IgA level
|
J:282961
|
| decreased IgG2c level
|
J:282961
|
| increased B cell proliferation
|
J:282961
|
| increased IgG1 level
|
J:282961
|
| increased IgG3 level
|
J:282961
|
| increased IgG level
|
J:282961
|
| increased IgM level
|
J:282961
|
Ninj1tm1Gto/Ninj1tm1Gto
(B6.129P2-Ninj1tm1Gto)
|
abnormal leukocyte adhesion
|
J:209516
|
| abnormal leukocyte physiology
|
J:209516
|
| impaired macrophage chemotaxis
|
J:209516
|
Nipal3tm1Pbfd/Nipal3tm1Pbfd
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
|
decreased IgM level
|
J:152829
|
| increased IgA level
|
J:152829
|
| increased IgE level
|
J:152829
|
| increased IgG2a level
|
J:152829
|
| increased IgM level
|
J:152829
|
Nkx2-3tm1Hha/Nkx2-3tm1Hha
(involves: 129S4/SvJae)
|
abnormal leukocyte migration
|
J:62129
|
Nkx2-3tm1Rph/Nkx2-3tm1Rph
(involves: 129S1/Sv * C57BL/6)
|
abnormal leukocyte migration
|
J:64018
|
Nlrc4tm1Nnz/Nlrc4tm1Nnz
(involves: 129 * C57BL/6J)
|
abnormal macrophage physiology
|
J:112671,
J:117251
|
Nlrc5tm1.1Ggaur/Nlrc5tm1.1Ggaur
(involves: BALB/cJ)
|
abnormal T cell physiology
|
J:184076
|
Nlrp1am1Btlr/Nlrp1am1Btlr
(C57BL/6J-Nlrp1am1Btlr)
|
increased IgE level
|
J:265173
|
| increased macrophage apoptosis
|
J:265173
|
Nlrp1am2Btlr/Nlrp1am2Btlr
(C57BL/6J-Nlrp1am2Btlr)
|
increased macrophage apoptosis
|
J:265174
|
Nlrp1aNeut1/Nlrp1aNeut1
(C.B6-Nlrp1aNeut1)
|
increased macrophage cytokine production
|
J:191055
|
Nlrp1btm1Bhk/Nlrp1btm1Bhk
(129S6/SvEvTac-Nlrp1btm1Bhk)
|
abnormal macrophage physiology
|
J:189777
|
Nlrp3M7Btlr/Nlrp3+
(C57BL/6J-Nlrp3M7Btlr)
|
abnormal macrophage cytokine production
|
J:216048
|
Nlrp3M7Btlr/Nlrp3M7Btlr
(C57BL/6J-Nlrp3M7Btlr)
|
abnormal macrophage cytokine production
|
J:216048
|
Nlrp3tm1Flv/Nlrp3tm1Flv
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal macrophage physiology
|
J:113333
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:113333
|
Nlrp3tm1Hhf/Nlrp3+
Tg(CAG-cre/Esr1*)5Amc/?
(involves: 129/Sv * C57BL/6 * CBA)
|
abnormal dendritic cell antigen presentation
|
J:150054
|
| abnormal dendritic cell physiology
|
J:150054
|
| abnormal macrophage physiology
|
J:150054
|
Nlrp3tm1Wstr/Nlrp3+
(involves: C57BL/6)
|
abnormal dendritic cell physiology
|
J:150053
|
| abnormal macrophage physiology
|
J:150053
|
| increased susceptibility to type IV hypersensitivity reaction
|
J:150053
|
Nlrp3tm2Hhf/Nlrp3+
Tg(CAG-cre/Esr1*)5Amc/?
(involves: 129/Sv * C57BL/6 * CBA)
|
abnormal dendritic cell physiology
|
J:150054
|
| abnormal macrophage physiology
|
J:150054
|
Nlrp6tm1Flv/Nlrp6tm1Flv
(B6.Cg-Nlrp6tm1Flv)
|
increased IgA level
|
J:173245
|
| increased IgG2c level
|
J:173245
|
Nlrp10tm1Seis/Nlrp10tm1Seis
(B6.Cg-Nlrp10tm1Seis)
|
abnormal adaptive immunity
|
J:183989
|
| abnormal dendritic cell physiology
|
J:183989
|
| abnormal T-helper 2 physiology
|
J:183989
|
| decreased IgG1 level
|
J:183989
|
Nlrp12tm1Jpyt/Nlrp12tm1Jpyt
(B6.Cg-Nlrp12tm1Jpyt)
|
abnormal leukocyte migration
|
J:164725
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:164725
|
| impaired neutrophil chemotaxis
|
J:164725
|
Nlrx1tm1Jpyt/Nlrx1tm1Jpyt
(involves: C57BL/6 * C57BL/6J)
|
abnormal macrophage physiology
|
J:173995
|
| abnormal neutrophil physiology
|
J:173995
|
Nme2Gt(69C10)Cmhd/Nme2Gt(69C10)Cmhd
(B6.129-Nme2Gt(69C10)Cmhd)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:167387
|
| abnormal T-helper 1 physiology
|
J:167387
|
| abnormal T-helper 2 physiology
|
J:167387
|
Nmt1tm1.1Poru/Nmt1tm1.1Poru
Nmt2tm1.1Poru/Nmt2tm1.1Poru
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
decreased T cell proliferation
|
J:226234
|
| increased T cell apoptosis
|
J:226234
|
Noa/Noa+
(NOA)
|
increased IgE level
|
J:43274
|
Noc2ltm1.1Arte/Noc2ltm1.1Arte
Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal T cell proliferation
|
J:216490
|
| increased thymocyte apoptosis
|
J:216490
|
Nod1tm1Inoh/Nod1tm1Inoh
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal macrophage physiology
|
J:132126,
J:118808
|
Nod1tm1Inoh/Nod1tm1Inoh
Nod2tm1Flv/Nod2tm1Flv
(involves: 129 * 129P2/OlaHsd * C57BL/6)
|
abnormal macrophage physiology
|
J:132126
|
Nod2tm1Daph/Nod2tm1Daph
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal macrophage physiology
|
J:157879
|
Nod2tm1Flv/Nod2tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
abnormal macrophage physiology
|
J:132126,
J:96035
|
| decreased IgG level
|
J:96035
|
Nod2tm1Flv/Nod2tm1Flv
(involves: 129S1/Sv)
|
abnormal T-helper 1 physiology
|
J:147177
|
| impaired macrophage phagocytosis
|
J:147177
|
| impaired neutrophil phagocytosis
|
J:147177
|
Nod2tm1Pmu/Nod2tm1Pmu
(involves: BALB/c * C57BL/6)
|
abnormal macrophage physiology
|
J:86264
|
Nos1tm1Plh/Nos1tm1Plh
(involves: 129S4/SvJae)
|
abnormal leukocyte adhesion
|
J:55936
|
| abnormal neutrophil physiology
|
J:55936
|
| enhanced leukocyte tethering or rolling
|
J:55936
|
Nos1tm1Plh/Nos1tm1Plh
Nos2tm1Mrl/Nos2tm1Mrl
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * 129S7/SvEvBrd)
|
abnormal osteoclast physiology
|
J:150159
|
Nos2tm1Lau/Nos2tm1Lau
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal adaptive immunity
|
J:90903
|
| increased T cell proliferation
|
J:90903
|
Nos2tm1Liew/Nos2tm1Liew
(involves: 129P2/Ola * MF1)
|
abnormal T-helper 1 physiology
|
J:25755
|
| increased T cell proliferation
|
J:25755
|
Nos2tm1Mrl/Nos2tm1Mrl
(involves: 129S7/SvEvBrd)
|
abnormal macrophage physiology
|
J:120499
|
| increased IgG2a level
|
J:51635
|
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae)
|
abnormal leukocyte adhesion
|
J:55936
|
| abnormal neutrophil physiology
|
J:55936
|
| enhanced leukocyte tethering or rolling
|
J:55936
|
Nos3tm1Unc/Nos3tm1Unc
(B6.129P2-Nos3tm1Unc/J)
|
abnormal osteoclast physiology
|
J:129477
|
Notch1tm2Pst/Notch1tm2Pst
(B6.Cg-Notch1tm2Pst)
|
increased T cell apoptosis
|
J:131563
|
Notch2tm1.1Hhi/Notch2tm1.1Hhi
Tg(Cd8a-cre)1Itan/0
(involves: C57BL/6 * CBA)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:141009
|
| abnormal cytotoxic T cell physiology
|
J:141009
|
Npc1m1N/Npc1m1N
(involves: BALB/c * C57BL/6 * CBA)
|
increased microglial cell activation
|
J:144240
|
Npc1m1N/Npc1m1N
(BALB/c-Npc1m1N)
|
abnormal microglial cell activation
|
J:221855
|
| increased microglial cell activation
|
J:221855
|
Npc1nmf164/Npc1nmf164
(C57BL/6J-Npc1nmf164/J)
|
increased microglial cell activation
|
J:179744
|
Npc1tm1.1Dso/Npc1tm1.1Dso
(B6.129-Npc1tm1.1Dso)
|
abnormal microglial cell activation
|
J:221855
|
| increased microglial cell activation
|
J:221855
|
Npc2tm1Plob/Npc2tm1Plob
(C.129S1-Npc2tm1Plob)
|
abnormal NK cell physiology
|
J:125609
|
| abnormal T cell physiology
|
J:125609
|
Npffr2tm1.2Ics/Npffr2tm1.2Ics
(involves: C57BL/6N)
|
abnormal macrophage activation involved in immune response
|
J:245025
|
| decreased macrophage proliferation
|
J:245025
|
Npr1tm1Gar/Npr1tm1Gar
(B6.129S7-Npr1tm1Gar)
|
impaired neutrophil chemotaxis
|
J:70496
|
Npy1rtm1.1Wpg/Npy1rtm1.1Wpg
(involves: 129X1/SvJ * C57BL/6)
|
abnormal immunoglobulin level
|
J:118850
|
| abnormal macrophage physiology
|
J:118850
|
| abnormal professional antigen presenting cell physiology
|
J:118850
|
| abnormal T cell activation
|
J:118850
|
| abnormal T-helper 1 physiology
|
J:118850
|
| decreased IgG2a level
|
J:118850
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:118850
|
| increased IgA level
|
J:118850
|
| increased IgG2b level
|
J:118850
|
| increased IgM level
|
J:118850
|
| increased immunoglobulin level
|
J:118850
|
Nr1h2tm1.1Gstr/Nr1h2tm1.1Gstr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased microglial cell activation
|
J:278794
|
Nr3c1tm1.1Jda/Nr3c1+
Tg(Lck-cre)548Jxm/0
(B6.Cg-Nr3c1tm1.1Jda Tg(Lck-cre)548Jxm)
|
decreased thymocyte apoptosis
|
J:189951
|
Nr3c1tm1.1Jda/Nr3c1tm1.1Jda
Tg(Lck-cre)548Jxm/0
(B6.Cg-Nr3c1tm1.1Jda Tg(Lck-cre)548Jxm)
|
decreased thymocyte apoptosis
|
J:189951
|
Nr3c1tm1Ljm/Nr3c1tm1Ljm
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal thymocyte apoptosis
|
J:82174
|
Nr3c1tm2.1Gsc/Nr3c1+
(B6.129P2-Nr3c1tm2.1Gsc)
|
decreased T cell apoptosis
|
J:126427
|
Nr3c1tm2Gsc/Nr3c1tm2Gsc
Tg(Lck-cre)I57Jxm/0
(B6.Cg-Nr3c1tm2Gsc Tg(Lck-cre)I57Jxm)
|
decreased T cell apoptosis
|
J:137157
|
Nr4a1tm1Jmi/Nr4a1tm1Jmi
(involves: 129S2/SvPas)
|
decreased B cell apoptosis
|
J:306652
|
| increased B cell proliferation
|
J:306652
|
Nr4a1tm1Pcn/Nr4a1tm1Pcn
Tg(Cr2-cre)3Cgn/0
(involves: 129)
|
increased B cell proliferation
|
J:306652
|
Nrp1tm1Ddg/Nrp1tm1Ddg
(involves: 129P2/OlaHsd)
|
abnormal dendritic cell physiology
|
J:161856
|
| abnormal T cell physiology
|
J:161856
|
Nsmaftm1Mkr/Nsmaftm1Mkr
(involves: 129P2/OlaHsd)
|
abnormal T cell physiology
|
J:54972
|
Nsrp1tm1.1Cdj/Nsrp1tm1.1Cdj
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
increased T cell apoptosis
|
J:306261
|
| increased T cell proliferation
|
J:306261
|
Ntan1tm1Avar/Ntan1tm1Avar
(involves: 129)
|
abnormal T cell physiology
|
J:62140
|
Ntrk1tm1Tes/Ntrk1tm1Tes
Tg(Tuba1-cre)1Tes/0
(involves: 129S1/Sv)
|
abnormal mast cell physiology
|
J:93578
|
| increased IgG1 level
|
J:93578
|
| increased IgG2a level
|
J:93578
|
| increased IgM level
|
J:93578
|
| increased immunoglobulin level
|
J:93578
|
Nudctm1c(KOMP)Mbp/Nudctm1c(KOMP)Mbp
Tg(Rho-icre)1Ck/0
(involves: C57BL/6 * C57BL/6N * SJL)
|
increased microglial cell activation
|
J:346299
|
Nudcd3em1(IMPC)Wtsi/Nudcd3em1(IMPC)Wtsi
(C57BL/6N-Nudcd3em1(IMPC)Wtsi/Wtsi)
|
increased IgE level
|
J:351330
|
| increased IgG2b level
|
J:351330
|
| increased IgM level
|
J:351330
|
Nuggctm1Diaz/Nuggctm1Diaz
Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: C57BL/6 * C57BL/6J * CBA)
|
abnormal somatic hypermutation frequency
|
J:190402
|
Nup98tm1Bmaf/Nup98+
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal MHC II cell surface expression on macrophages
|
J:110907
|
| decreased IgG1 level
|
J:110907
|
| decreased IgG level
|
J:110907
|
| decreased T cell proliferation
|
J:110907
|
| increased T cell proliferation
|
J:110907
|
Nup210tm1.1Mdan/Nup210tm1.1Mdan
(B6.Cg-Nup210tm1.1Mdan)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:282451
|
| abnormal T cell activation
|
J:282451
|
Nup210tm1Mdan/Nup210tm1Mdan
Tg(Cd4-cre/ERT2)11Gnri/0
(involves: 129X1/SvJ * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:282451
|
Oca2p-3Btlr/Oca2p-3Btlr
(C57BL/6J-Oca2p-3Btlr)
|
abnormal NK cell physiology
|
J:133623
|
Ogttm1Gwh/Y
Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
increased T cell apoptosis
|
J:93112
|
Olahem1Kedk/Olahem1Kedk
(involves: C57BL/6)
|
abnormal macrophage physiology
|
J:353571
|
Orai1Gt(XL922)Byg/Orai1+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal mast cell physiology
|
J:130479
|
Orai1Gt(XL922)Byg/Orai1Gt(XL922)Byg
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal mast cell physiology
|
J:130479
|
| decreased susceptibility to type I hypersensitivity reaction
|
J:130479
|
Orai1tm1.1Hjm/Orai1tm1.1Hjm
Orai2tm1.1(KOMP)Vlcg/Orai2tm1.1(KOMP)Vlcg
Tg(Cd4-cre)1Cwi/0
(B6.Cg-Tg(Cd4-cre)1Cwi Orai1tm1.1Hjm Orai2tm1.1(KOMP)Vlcg)
|
abnormal T cell physiology
|
J:241365
|
| decreased IgG level
|
J:241365
|
Orai1tm1.1Hjm/Orai1tm1.1Hjm
Tg(Cd4-cre)1Cwi/0
(B6.Cg-Orai1tm1.1Hjm Tg(Cd4-cre)1Cwi)
|
abnormal T cell physiology
|
J:241365
|
Orai1tm1Rao/Orai1+
(C57BL/6-Orai1tm1Rao)
|
abnormal B cell activation
|
J:139730
|
| abnormal T cell activation
|
J:139730
|
Orai1tm1Rao/Orai1tm1Rao
(involves: C57BL/6NTac * ICR)
|
abnormal B cell activation
|
J:139730
|
| abnormal mast cell physiology
|
J:139730
|
| abnormal T cell activation
|
J:139730
|
| abnormal thymocyte activation
|
J:139730
|
Orai2tm1.1(KOMP)Vlcg/Orai2tm1.1(KOMP)Vlcg
(B6.Cg-Orai2tm1.1(KOMP)Vlcg)
|
abnormal macrophage physiology
|
J:241365
|
| abnormal T cell physiology
|
J:241365
|
Orai2tm1.1Itl/Orai2tm1.1Itl
Tg(Cma1-cre)#Roer/0
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N)
|
increased susceptibility to type I hypersensitivity reaction
|
J:278536
|
Orai2tm1.2Itl/Orai2tm1.2Itl
(involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6 * C57BL/6N)
|
abnormal mast cell physiology
|
J:278536
|
| increased mast cell degranulation
|
J:278536
|
Ormdl1em1Pdra/Ormdl1em1Pdra
Ormdl3em1Pdra/Ormdl3em1Pdra
(C57BL/6-Ormdl1em1Pdra Ormdl3em1Pdra)
|
abnormal mast cell physiology
|
J:349248
|
Ormdl2em1Pdra/Ormdl2em1Pdra
Ormdl3em1Pdra/Ormdl3em1Pdra
(C57BL/6-Ormdl2em1Pdra Ormdl3em1Pdra)
|
abnormal mast cell physiology
|
J:328837
|
| abnormal type I hypersensitivity reaction
|
J:328837
|
| increased mast cell degranulation
|
J:328837
|
Ormdl3em1Pdra/Ormdl3em1Pdra
(C57BL/6-Ormdl3em1Pdra)
|
abnormal mast cell physiology
|
J:328837
|
| abnormal type I hypersensitivity reaction
|
J:328837
|
| increased mast cell degranulation
|
J:328837
|
Oscartm1Ywc/Oscartm1Ywc
Tyrobptm1Ttk/Tyrobptm1Ttk
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal osteoclast physiology
|
J:178250
|
Otub1tm1c(EUCOMM)Hmgu/Otub1tm1c(EUCOMM)Hmgu
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)
|
abnormal B cell activation
|
J:280549
|
| increased IgA level
|
J:280549
|
| increased IgG2a level
|
J:280549
|
| increased IgG2b level
|
J:280549
|
| increased IgM level
|
J:280549
|
| increased immunoglobulin level
|
J:280549
|
Otud7btm1(NCOM)Cmhd/Otud7btm1(NCOM)Cmhd
(involves: C57BL/6N)
|
abnormal granulocyte physiology
|
J:209709
|
Otud7btm1Dgen/Otud7btm1Dgen
(involves: 129 * C57BL/6)
|
decreased activation-induced B cell apoptosis
|
J:194553
|
| increased B cell proliferation
|
J:194553
|
| increased IgA level
|
J:194553
|
Oxsr1tm1.1Arte/Oxsr1+
(involves: 129S/SvEvBrd)
|
abnormal dendritic cell physiology
|
J:191351
|
P2rx4tm1Ando/P2rx4tm1Ando
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal neutrophil physiology
|
J:311564
|
P2rx4tm1Dgen/P2rx4tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal macrophage physiology
|
J:145232
|
P2rx7tm1Gab/P2rx7tm1Gab
(B6.129P2-P2rx7tm1Gab/J)
|
abnormal mast cell physiology
|
J:190651
|
P2rx7tm1Ipch/P2rx7tm1Ipch
(involves: 129 * C57BL/6)
|
abnormal macrophage physiology
|
J:118561
|
P2rx7tm1Lex/P2rx7tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal macrophage physiology
|
J:145020
|
P2ry6tm1.1Brob/P2ry6tm1.1Brob
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal macrophage physiology
|
J:169742
|
P2ry6tm1Jabo/P2ry6tm1Jabo
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: 129 * C57BL/6 * C57BL/6NTac)
|
decreased IgE level
|
J:179177
|
| decreased T cell apoptosis
|
J:179177
|
| increased T cell proliferation
|
J:179177
|
P4hbtm1.1Geno/P4hbtm1.2Geno
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd)
|
impaired neutrophil recruitment
|
J:197556
|
Pacsin1Gt(OST287788)Lex/Pacsin1Gt(OST287788)Lex
(B6.129S5-Pacsin1Gt(OST287788)Lex)
|
abnormal plasmacytoid dendritic cell physiology
|
J:187784
|
Padi2tm1Lex/Padi2tm1Lex
(B6.129S5-Padi2tm1Lex)
|
abnormal mast cell physiology
|
J:190651
|
Padi4tm1.1Kmow/Padi4tm1.1Kmow
(involves: BALB/cJ * C57BL/6)
|
abnormal neutrophil physiology
|
J:174934
|
Padi4tm1.1Ywan/Padi4tm1.1Ywan
(involves: 129S4/SvJae)
|
abnormal neutrophil physiology
|
J:165718
|
| impaired neutrophil phagocytosis
|
J:165718
|
Pak1tm1Cher/Pak1tm1Cher
(B6.129S2-Pak1tm1Cher)
|
abnormal mast cell physiology
|
J:142439
|
| decreased mast cell degranulation
|
J:145444
|
Panx1tm1.2Vmd/Panx1tm1.2Vmd
(C57BL/6N-Panx1tm1.2Vmd)
|
abnormal T cell physiology
|
J:173213
|
Parltm1.1Bdes/Parltm1.1Bdes
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased T cell apoptosis
|
J:116017
|
Parp1tm1Jmdm/Parp1tm1Jmdm
(involves: 129S2/SvPas * C57BL/6)
|
abnormal leukocyte migration
|
J:117701
|
Parp1tm1Zqw/Parp1tm1Zqw
(129S-Parp1tm1Zqw/J)
|
abnormal microglial cell physiology
|
J:96548
|
Parp1tm2Zqw/Parp1tm2Zqw
(either: (involves: 129P2/OlaHsd * 129/Sv) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal macrophage physiology
|
J:93479
|
Parp14Gt(OST415485)Lex/Parp14Gt(OST415485)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased B cell proliferation
|
J:146533
|
| decreased IgA level
|
J:146533
|
| increased B cell apoptosis
|
J:146533
|
| increased B cell proliferation
|
J:146533
|
Pawrtm1Jmos/Pawrtm1Jmos
(involves: 129/Sv * CD-1)
|
abnormal T-helper 2 physiology
|
J:85495
|
| increased B cell proliferation
|
J:85495
|
| increased T cell proliferation
|
J:85495
|
Pax5m1Btlr/Pax5m1Btlr
(C57BL/6J-Pax5m1Btlr)
|
decreased IgA level
|
J:220072
|
| decreased IgG1 level
|
J:220072
|
| decreased IgG2a level
|
J:220072
|
| decreased IgG2b level
|
J:220072
|
| decreased IgG level
|
J:220072
|
| decreased IgM level
|
J:220072
|
Pax5m3Btlr/Pax5m3Btlr
(C57BL/6J-Pax5m3Btlr)
|
decreased IgG level
|
J:254825
|
| decreased IgM level
|
J:254825
|
Pax5m4Btlr/Pax5m4Btlr
(C57BL/6J-Pax5m4Btlr)
|
decreased IgD level
|
J:265140
|
Pax5M5Btlr/Pax5M5Btlr
(C57BL/6J-Pax5M5Btlr)
|
decreased IgD level
|
J:265141
|
Pax5tm1Mbu/Pax5tm1Mbu
(involves: 129S2/SvPas * C57BL/6)
|
decreased immunoglobulin level
|
J:113076
|
Pax5tm1Mbu/Pax5tm1Mbu
(involves: 129S2/SvPas)
|
abnormal B cell physiology
|
J:123629
|
| enhanced B cell migration
|
J:123629
|
Pbrm1tm1Zhwa/Pbrm1tm1Zhwa
Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:236906
|
Pcaretm1Kpal/Pcaretm1Kpal
(involves: C57BL/6J * C57BL/6NTac)
|
increased microglial cell activation
|
J:220866
|
Pcgf2tm1Hko/Pcgf2tm1Hko
(involves: BALB/c * C57BL/6)
|
abnormal T-helper 2 physiology
|
J:71268
|
Pcnatm1.1Mdsc/Pcnatm1.1Mdsc
Tg(Pcna*K164R)1Mdsc/0
(involves: FVB/N)
|
abnormal class switch recombination
|
J:141098
|
| abnormal somatic hypermutation frequency
|
J:141098
|
Pcnatm1Jcbs/Pcnatm1Jcbs
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:125916
|
Pcnatm1Jcbs/Pcnatm1Jcbs
(involves: 129P2/OlaHsd)
|
abnormal somatic hypermutation frequency
|
J:155454,
J:177630
|
Pcnatm1Jcbs/Pcnatm1Jcbs
Ungtm1Tld/Ungtm1Tld
(involves: 129P2/OlaHsd)
|
abnormal somatic hypermutation frequency
|
J:155454
|
Pctptm1Bor/Pctptm1Bor
(B6.129P2-Pctptm1Bor)
|
abnormal macrophage physiology
|
J:115284
|
| increased macrophage apoptosis
|
J:115284
|
Pcyt1atm1Irt/Pcyt1atm1Irt
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * C57BL/6J)
|
abnormal macrophage physiology
|
J:65639
|
Pdap1em1Rkuhn/Pdap1em1Rkuhn
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)
|
abnormal B cell physiology
|
J:298705
|
| abnormal class switch recombination
|
J:298705
|
| abnormal somatic hypermutation frequency
|
J:298705
|
| increased B cell apoptosis
|
J:298705
|
Pdcd1tm1.1Shr/Pdcd1tm1.1Shr
Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6)
|
decreased T cell proliferation
|
J:153040
|
| increased T cell proliferation
|
J:153040
|
Pdcd1tm1Hon/Pdcd1tm1Hon
(involves: 129S2/SvPas * C57BL/6)
|
abnormal immunoglobulin level
|
J:50688
|
| increased B cell proliferation
|
J:50688
|
| increased IgA level
|
J:50688
|
| increased IgG2b level
|
J:50688
|
| increased IgG3 level
|
J:50688
|
Pdcd1tm1Hon/Pdcd1tm1Hon
(involves: 129S2/SvPas)
|
abnormal T cell activation
|
J:222944
|
| increased IgA level
|
J:222944
|
| increased IgM level
|
J:222944
|
Pdcd1tm1Hon/Pdcd1tm1Hon
Vsirtm1Lex/Vsirtm1Lex
(involves: 129S2/SvPas * 129S5/SvEvBrd * C57BL/6)
|
abnormal T cell activation
|
J:222944
|
| increased IgA level
|
J:222944
|
| increased IgM level
|
J:222944
|
Pdcd1lg2tm1Dmp/Pdcd1lg2tm1Dmp
(involves: 129X1/SvJ * 129S1/Sv * C57BL/6)
|
abnormal dendritic cell antigen presentation
|
J:84457
|
Pdcd1lg2tm1Dmp/Pdcd1lg2tm1Dmp
(C.129-Pdcd1lg2tm1Dmp)
|
abnormal cytotoxic T cell physiology
|
J:99212
|
| decreased IgG2a level
|
J:99212
|
| decreased T cell proliferation
|
J:99212
|
Pdcd1lg2tm1Shr/Pdcd1lg2tm1Shr
(involves: 129/Sv * 129S4/SvJae)
|
increased IgG2a level
|
J:113851
|
| increased IgM level
|
J:113851
|
Pdcd1lg2tm2Shr/Pdcd1lg2tm2Shr
(C.B6-Pdcd1lg2tm2Shr)
|
abnormal dendritic cell physiology
|
J:123785
|
Pdcd1lg2tm3Shr/Pdcd1lg2tm3Shr
(involves: C57BL/6 * NOD/MrkTac)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:123785
|
Pde4btm1Mct/Pde4b+
Pde4dtm1Mct/Pde4dtm1Mct
(involves: 129P2/OlaHsd * C57BL/6)
|
impaired neutrophil recruitment
|
J:94853
|
Pde4btm1Mct/Pde4btm1Mct
(involves: 129P2/OlaHsd * C57BL/6)
|
impaired neutrophil chemotaxis
|
J:94853
|
| impaired neutrophil recruitment
|
J:94853
|
Pde4btm1Mct/Pde4btm1Mct
Pde4dtm1Mct/Pde4d+
(involves: 129P2/OlaHsd * C57BL/6)
|
impaired neutrophil recruitment
|
J:94853
|
Pde4dtm1Mct/Pde4dtm1Mct
(involves: 129P2/OlaHsd * C57BL/6)
|
impaired neutrophil chemotaxis
|
J:94853
|
| impaired neutrophil recruitment
|
J:94853
|
Pdia6em1Btlr/Pdia6m1Btlr
(involves: C57BL/6J)
|
abnormal T cell physiology
|
J:288824
|
Pdlim2tm1Gru/Pdlim2tm1Gru
(Not Specified)
|
abnormal T-helper 1 physiology
|
J:99108
|
Pdpk1tm1.1Mlw/Pdpk1tm1.1Mlw
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
(involves: 129X1/SvJ * C57BL/6)
|
abnormal T cell physiology
|
J:226194
|
Pdpk1tm1Mlw/Pdpk1tm1Mlw
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:165626
|
Pecam1tm1Mak/Pecam1tm1Mak
(D1.129P2-Pecam1tm1Mak)
|
abnormal leukocyte physiology
|
J:106275
|
Peli1tm1Tigm/Peli1tm1Tigm
(involves: 129/Sv * C57BL/6)
|
decreased B cell proliferation
|
J:152781
|
| increased B cell apoptosis
|
J:152781
|
Peli2tm1.1Arte/Peli2tm1.1Arte
(involves: C57BL/6)
|
increased macrophage apoptosis
|
J:265431
|
Peli3tm1.1Arte/Peli3tm1.1Arte
(involves: C57BL/6NTac)
|
abnormal dendritic cell physiology
|
J:188556
|
| abnormal macrophage cytokine production
|
J:188556
|
Penk-rstm1Pig/Penk-rstm1Pig
(B6.129-Penk-rstm1Pig)
|
abnormal T-helper 2 physiology
|
J:62435
|
Perptm1Att/Perptm1Att
(involves: 129S4/SvJae)
|
decreased thymocyte apoptosis
|
J:86549
|
Pfdn1Gt(GTR1.3)1Rul/Pfdn1Gt(GTR1.3)1Rul
(involves: 129)
|
abnormal B cell activation
|
J:137415
|
| abnormal T cell activation
|
J:137415
|
Pfkfb3tm1.1Pec/Pfkfb3tm1.1Pec
Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * CBA)
|
abnormal macrophage physiology
|
J:296552
|
Pgam5tm1d(EUCOMM)Wtsi/Pgam5tm1d(EUCOMM)Wtsi
(involves: C57BL/6N)
|
abnormal macrophage activation involved in immune response
|
J:240016
|
Pgap3tm1.1Ymra/Pgap3tm1.1Ymra
(involves: 129 * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:181221
|
| decreased T cell proliferation
|
J:181221
|
| increased T cell proliferation
|
J:181221
|
Pgap3tm1.1Ymra/Pgap3tm1.1Ymra
(B6.Cg-Pgap3tm1.1Ymra)
|
decreased B cell proliferation
|
J:203443
|
| impaired macrophage phagocytosis
|
J:203443
|
Pgdtm1.1Pse/Pgdtm1.1Pse
Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal regulatory T cell physiology
|
J:313817
|
| increased IgA level
|
J:313817
|
| increased IgD level
|
J:313817
|
| increased IgE level
|
J:313817
|
| increased IgG2a level
|
J:313817
|
| increased IgG3 level
|
J:313817
|
| increased IgM level
|
J:313817
|
| increased susceptibility to type I hypersensitivity reaction
|
J:313817
|
Pgdtm1.1Pse/Pgdtm1.1Pse
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:306553
|
Pgdtm1.1Pse/Pgdtm1.1Pse
Tg(Cd4-cre)1Cwi/0
Tg(TcraTcrb)8Rest/0
(involves: C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:306553
|
Pgdtm1.1Pse/Pgdtm1.1Pse
Tg(Cd4-cre)1Cwi/0
Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6 * DBA/2)
|
abnormal cytotoxic T cell physiology
|
J:306553
|
Pgftm1Pec/Pgftm1Pec
(involves: 129)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:81388
|
Pglyrp1tm1.1Lky/Pglyrp1tm1.1Lky
(B6.129S4-Pglyrp1tm1.1Lky)
|
abnormal neutrophil physiology
|
J:171412
|
Pglyrp1tm1Rdz/Pglyrp1tm1Rdz
(involves: 129S5/SvEvBrd)
|
abnormal neutrophil physiology
|
J:84680
|
| impaired granulocyte bactericidal activity
|
J:84680
|
Pglyrp2tm1Lky/Pglyrp2tm1Lky
(involves: 129S4/SvJae * C57BL/6)
|
abnormal macrophage physiology
|
J:159600
|
PhexSka1/PhexSka1
(C57BL/6-PhexSka1)
|
abnormal osteoclast physiology
|
J:79953
|
Pi4kam1Btlr/Pi4kam1Btlr
(C57BL/6J-Pi4kam1Btlr)
|
decreased macrophage apoptosis
|
J:265261
|
Pigatm1Tak/Pigatm1Tak
Tg(FES-cre)31Bsl/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA/Ca)
|
abnormal T cell activation
|
J:162065
|
| abnormal T cell physiology
|
J:162065
|
Pigrtm1Fejo/Pigrtm1Fejo
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal immunoglobulin level
|
J:57987
|
| decreased IgA level
|
J:57987
|
| increased IgA level
|
J:57987
|
| increased IgG level
|
J:57987
|
Pigrtm1Fejo/Pigrtm1Fejo
(involves: 129 * C57BL/6)
|
increased IgA level
|
J:140515
|
Pigrtm1Ohw/Pigrtm1Ohw
(involves: 129X1/SvJ * C57BL/6J)
|
decreased IgA level
|
J:58454
|
| increased IgA level
|
J:58454
|
| increased IgE level
|
J:58454
|
| increased IgG level
|
J:58454
|
Pigrtm1Ohw/Pigrtm1Ohw
(B6.129X1-Pigrtm1Ohw)
|
abnormal lymphocyte physiology
|
J:97824
|
| decreased IgA level
|
J:108538
|
| increased IgA level
|
J:108538,
J:97824
|
Pigrtm1Ohw/Pigrtm1Ohw
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J)
|
increased IgA level
|
J:97824
|
Pigrtm1Rast/Pigrtm1Rast
(C57BL/6-Pigrtm1Rast)
|
abnormal immunoglobulin level
|
J:81984
|
| decreased IgA level
|
J:81984
|
| increased IgA level
|
J:81984
|
| increased IgG level
|
J:81984
|
Pik3ap1m1Btlr/Pik3ap1m1Btlr
(involves: C57BL/6J)
|
decreased IgM level
|
J:185495
|
Pik3ap1m2Btlr/Pik3ap1m2Btlr
(C57BL/6J-Pik3ap1m2Btlr)
|
increased IgM level
|
J:255271
|
Pik3ap1tm1Kuro/Pik3ap1tm1Kuro
(involves: 129P2/OlaHsd)
|
decreased B cell proliferation
|
J:84669
|
| decreased IgG2b level
|
J:75075
|
| decreased IgG3 level
|
J:75075
|
| decreased IgM level
|
J:75075
|
| decreased immunoglobulin level
|
J:75075
|
Pik3c2aGt(OST288105)Lex/Pik3c2aGt(OST288105)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased IgA level
|
J:169710
|
| increased IgG level
|
J:169710
|
| increased IgM level
|
J:169710
|
Pik3c3tm1.1Flv/Pik3c3tm1.1Flv
Tg(Cd8a-cre)1Itan/0
(involves: C57BL/6 * C57BL/6N)
|
increased T cell apoptosis
|
J:184753
|
Pik3cdGt(OST451938)Lex/Pik3cdGt(OST451938)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased IgG1 level
|
J:103485
|
Pik3cdm2Btlr/Pik3cd+
(C57BL/6J-Pik3cdm2Btlr)
|
decreased IgG level
|
J:236693
|
| decreased IgM level
|
J:236693
|
Pik3cdm2Btlr/Pik3cdm2Btlr
(C57BL/6J-Pik3cdm2Btlr)
|
decreased IgG level
|
J:236693
|
| decreased IgM level
|
J:236693
|
| increased IgE level
|
J:236693
|
Pik3cdtm1.1Bvan/Pik3cdtm1.1Bvan
(involves: 129P2/OlaHsd * BALB/c)
|
decreased IgA level
|
J:78412
|
| decreased IgM level
|
J:78412
|
| decreased immunoglobulin level
|
J:78412
|
Pik3cdtm1Jni/Pik3cdtm1Jni
(involves: 129P2/OlaHsd)
|
abnormal B cell calcium ion homeostasis
|
J:80614
|
| decreased B cell proliferation
|
J:80614
|
| decreased immunoglobulin level
|
J:80614
|
Pik3cdtm1Jni/Pik3cdtm1Jni
Pik3cgtm1Pngr/Pik3cgtm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased cytotoxic T cell cytolysis
|
J:124330
|
Pik3cdtm1Tnr/Pik3cdtm1Tnr
(involves: 129S4/SvJae)
|
abnormal B cell physiology
|
J:113491
|
| decreased B cell proliferation
|
J:113491,
J:79133
|
| decreased IgG1 level
|
J:79133
|
| decreased IgG2a level
|
J:79133
|
| decreased IgG2b level
|
J:79133
|
| decreased IgG3 level
|
J:79133
|
| decreased IgM level
|
J:79133
|
Pik3cdtm1Tnr/Pik3cdtm1Tnr
Pik3cgtm1Pngr/Pik3cgtm1Pngr
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal T cell physiology
|
J:125791
|
Pik3cdtm1Tnr/Pik3cdtm1Tnr
Pik3cgtm1Pngr/Pik3cgtm1Pngr
(B6.129-Pik3cdtm1Tnr Pik3cgtm1Pngr)
|
impaired neutrophil chemotaxis
|
J:134324
|
| impaired neutrophil recruitment
|
J:134324
|
Pik3cdtm1Tnr/Pik3cdtm1Tnr
Ptentm2.1Ppp/Ptentm2.1Ppp
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJae * C57BL/6)
|
abnormal class switch recombination
|
J:130950
|
Pik3cdtm2.1Tnr/Pik3cdtm2.1Tnr
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased IgE level
|
J:164283
|
Pik3cdtm2.1Tnr/Pik3cdtm2.1Tnr
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal adaptive immunity
|
J:164283
|
| decreased IgG1 level
|
J:164283
|
Pik3cdtm2.1Tnr/Pik3cdtm2.1Tnr
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)
|
decreased IgG1 level
|
J:164283
|
Pik3cgtm1Dwu/Pik3cgtm1Dwu
(Not Specified)
|
decreased immunoglobulin level
|
J:60348
|
| impaired neutrophil chemotaxis
|
J:60348
|
Pik3cgtm1Dwu/Pik3cgtm1Dwu
(B6.Cg-Pik3cgtm1Dwu)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:131923
|
Pik3cgtm1Dwu/Pik3cgtm1Dwu
Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:131923
|
Pik3cgtm1Ehi/Pik3cgtm1Ehi
(Not Specified)
|
impaired macrophage chemotaxis
|
J:91945
|
| impaired neutrophil recruitment
|
J:91945
|
Pik3cgtm1Lste/Pik3cgtm1Lste
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal neutrophil physiology
|
J:147259
|
| impaired neutrophil chemotaxis
|
J:147259
|
| impaired neutrophil recruitment
|
J:147259
|
Pik3cgtm1Lste/Pik3cgtm1Lste
(involves: 129P2/OlaHsd)
|
impaired neutrophil chemotaxis
|
J:238900
|
Pik3cgtm1Pngr/Pik3cgtm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal neutrophil physiology
|
J:60347
|
| abnormal T cell activation
|
J:60347
|
| abnormal T cell physiology
|
J:60347
|
| abnormal T-helper 2 physiology
|
J:60347
|
| decreased cytotoxic T cell cytolysis
|
J:124330
|
| decreased T cell proliferation
|
J:60347
|
| impaired neutrophil chemotaxis
|
J:60347
|
| impaired neutrophil recruitment
|
J:60347
|
Pik3cgtm1Pngr/Pik3cgtm1Pngr
(B6.129P2-Pik3cgtm1Pngr)
|
impaired neutrophil chemotaxis
|
J:134324
|
Pik3cgtm1Wym/Pik3cgtm1Wym
(either: 129/Sv-Pik3cgtm1Wym or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal leukocyte physiology
|
J:60349
|
| abnormal neutrophil physiology
|
J:60349
|
| impaired macrophage chemotaxis
|
J:60349
|
| impaired neutrophil chemotaxis
|
J:60349
|
| impaired neutrophil recruitment
|
J:60349
|
Pik3cgtm1Wym/Pik3cgtm1Wym
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal neutrophil physiology
|
J:147259
|
| impaired neutrophil chemotaxis
|
J:238900
|
| impaired neutrophil recruitment
|
J:147259
|
Pik3cgtm2Ehi/Pik3cgtm2Ehi
(Not Specified)
|
abnormal macrophage physiology
|
J:124856
|
| impaired macrophage chemotaxis
|
J:124856
|
| impaired neutrophil chemotaxis
|
J:124856
|
Pik3r1tm1Dfr/Pik3r1tm1Dfr
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased B cell proliferation
|
J:52229
|
Pik3r1tm1Dfr/Pik3r1tm1Dfr
Plcg2tm1Jni/Plcg2tm1Jni
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
increased B cell apoptosis
|
J:104166
|
Pik3r1tm1Tka/Pik3r1tm1Tka
(involves: C57BL/6 * CBA)
|
abnormal B cell physiology
|
J:113491
|
| decreased B cell proliferation
|
J:113491,
J:52228
|
Pik3r5tm1Lste/Pik3r5tm1Lste
(involves: 129P2/OlaHsd * C57BL/6)
|
impaired neutrophil chemotaxis
|
J:147259
|
| impaired neutrophil recruitment
|
J:147259
|
Pik3r5tm1Lste/Pik3r5tm1Lste
(involves: 129P2/OlaHsd)
|
impaired neutrophil chemotaxis
|
J:238900
|
Pik3r6tm1.1Lste/Pik3r6tm1.1Lste
(Not Specified)
|
abnormal neutrophil physiology
|
J:238900
|
Pilratm1Osb/Pilratm1Osb
(B6.129-Pilratm1Osb)
|
abnormal leukocyte adhesion
|
J:191085
|
| abnormal neutrophil physiology
|
J:191085
|
Pim1tm1Pwl/Pim1tm1Pwl
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal mast cell physiology
|
J:15259,
J:14715
|
Pim1tm1Pwl/Pim1tm1Pwl
Pim2tm1Brn/Pim2tm1Brn
Pim3tm1Brn/Pim3tm1Brn
(involves: 129P/Ola * FVB/N)
|
decreased B cell proliferation
|
J:91592
|
| decreased T cell proliferation
|
J:91592
|
Pim2tm1Brn/Pim2tm1Brn
(involves: 129P/Ola * FVB/N)
|
decreased T cell proliferation
|
J:91592
|
Pip4k2ctm1b(KOMP)Wtsi/Pip4k2ctm1b(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
abnormal T cell activation
|
J:234283
|
| increased IgG3 level
|
J:234283
|
| increased T cell proliferation
|
J:234283
|
Pip5k1btm1Tssk/Pip5k1btm1Tssk
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal mast cell physiology
|
J:97991
|
| increased susceptibility to type I hypersensitivity reaction
|
J:97991
|
Pip5k1ctm1.2Ref/Pip5k1ctm1.2Ref
Tg(TcraTcrb)425Cbn/0
(involves: BALB/c * C57BL/6)
|
abnormal T cell physiology
|
J:164732
|
| increased T cell proliferation
|
J:164732
|
Pirbtm1Ttk/Pirbtm1Ttk
(involves: 129X1/SvJ)
|
abnormal B cell activation
|
J:76770
|
| abnormal leukocyte physiology
|
J:76770
|
| abnormal T cell physiology
|
J:76770
|
| abnormal T-helper 2 physiology
|
J:76770
|
| increased B cell proliferation
|
J:76770
|
Pitx3eyl/Pitx3eyl
(involves: C3H/He * C57BL/6)
|
abnormal immunoglobulin level
|
J:156878
|
| decreased IgG3 level
|
J:156878
|
| decreased IgM level
|
J:156878
|
Pkn1tm1Kik/Pkn1tm1Kik
(B6.129P2-Pkn1tm1Kik)
|
abnormal germinal center B cell physiology
|
J:193187
|
| abnormal somatic hypermutation frequency
|
J:193187
|
| decreased activation-induced B cell apoptosis
|
J:193187
|
| increased B cell proliferation
|
J:193187
|
| increased IgG1 level
|
J:193187
|
| increased IgG2a level
|
J:193187
|
| increased IgG2b level
|
J:193187
|
| increased IgM level
|
J:193187
|
Pknox1Gt(OST71835)Lex/Pknox1Gt(OST71835)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased T cell apoptosis
|
J:103769
|
Pknox1tm1Ngc/Pknox1+
Tg(IghMyc)22Bri/0
(involves: C57BL * SJL)
|
decreased B cell apoptosis
|
J:192251
|
| increased B cell proliferation
|
J:192251
|
Pla2g2dtm1.1Mhg/Pla2g2dtm1.1Mhg
(B6NCrSlc.Cg-Pla2g2dtm1.1Mhg)
|
abnormal cytotoxic T cell physiology
|
J:229035
|
| abnormal dendritic cell migration
|
J:229035
|
| abnormal dendritic cell physiology
|
J:201008
|
| increased susceptibility to type IV hypersensitivity reaction
|
J:201008
|
Pla2g3tm1Murm/Pla2g3tm1Murm
(involves: 129S/SvEv * C57BL/6)
|
decreased mast cell degranulation
|
J:197334
|
| decreased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Pla2g4atm1Jvb/Pla2g4atm1Jvb
(involves: 129S4/SvJae)
|
increased mast cell degranulation
|
J:54619
|
Pla2g4atm1Tksh/Pla2g4atm1Tksh
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to type I hypersensitivity reaction
|
J:39254
|
Pla2g4atm1Tksh/Pla2g4atm1Tksh
(NOD.129P2(B6)-Pla2g4atm1Tksh)
|
abnormal macrophage physiology
|
J:99775
|
Pla2g5tm1Jarm/Pla2g5tm1Jarm
(involves: 129 * C57BL/6J)
|
abnormal macrophage physiology
|
J:89490
|
Pla2g5tm1Jarm/Pla2g5tm1Jarm
(involves: 129 * BALB/c)
|
impaired macrophage phagocytosis
|
J:110309
|
Pla2g5tm1Jarm/Pla2g5tm1Jarm
(C.129-Pla2g5tm1Jarm)
|
impaired macrophage phagocytosis
|
J:110309
|
Pla2g5tm1Jarm/Pla2g5tm1Jarm
(involves: 129 * C57BL/6)
|
impaired macrophage phagocytosis
|
J:110309
|
Pla2g5tm1Jarm/Pla2g5tm1Jarm
(B6.129-Pla2g5tm1Jarm)
|
impaired macrophage phagocytosis
|
J:110309
|
Pla2g10Gt712Lex/Pla2g10Gt712Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased IgE level
|
J:125607
|
Pla2g10tm1Kiku/Pla2g10tm1Kiku
(B6.129P2-Pla2g10tm1Kiku)
|
abnormal neutrophil physiology
|
J:155082
|
| impaired neutrophil chemotaxis
|
J:155082
|
Pla2g15tm1.1Jash/Pla2g15tm1.1Jash
(involves: 129S1/Sv * C57BL/6)
|
abnormal macrophage physiology
|
J:111561
|
Plac8tm1Bhk/Plac8tm1Bhk
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal neutrophil physiology
|
J:145277
|
Plac8tm1Bhk/Plac8tm1Bhk
(129S/SvEv-Plac8tm1Bhk)
|
abnormal neutrophil physiology
|
J:145277
|
Plattm1Mlg/Plattm1Mlg
(involves: 129S2/SvPas)
|
abnormal microglial cell physiology
|
J:144185
|
Plautm1Mlg/Plautm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
abnormal macrophage physiology
|
J:17427
|
| abnormal neutrophil physiology
|
J:75573,
J:91980
|
| impaired granulocyte bactericidal activity
|
J:91980
|
| impaired macrophage chemotaxis
|
J:63134
|
| impaired neutrophil phagocytosis
|
J:91980
|
Plautm1Mlg/Plautm1Mlg
(B6.Cg-Plautm1Mlg)
|
decreased T cell proliferation
|
J:75303
|
| impaired macrophage chemotaxis
|
J:68083
|
Plaurtm1Jld/Plaurtm1Jld
(involves: 129P2/OlaHsd * Black Swiss)
|
abnormal macrophage physiology
|
J:26874
|
Plaurtm1Mlg/Plaurtm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
abnormal macrophage physiology
|
J:31253
|
| abnormal neutrophil physiology
|
J:75573,
J:91980
|
| impaired neutrophil phagocytosis
|
J:91980
|
Plcb2tm1Dwu/Plcb2tm1Dwu
(involves: 129)
|
abnormal leukocyte physiology
|
J:41948
|
Plcb2tm1Dwu/Plcb2tm1Dwu
Plcb3tm1Dwu/Plcb3tm1Dwu
(involves: 129S1/Sv)
|
abnormal neutrophil physiology
|
J:60348
|
| increased immunoglobulin level
|
J:60348
|
Plcd1tm1.1Kfu/Plcd1tm1.1Kfu
Tg(KRT14-cre)1Amc/0
(involves: C57BL/6 * C57BL/6JJcl * CBA)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:205633
|
Plcg1tm1Gcrp/Plcg1tm1Rwen
Tg(Cd4-cre)1Cwi/0
(either: B6.Cg-Plcg1tm1Gcrp/Plcg1tm1Rwen Tg(Cd4-cre)1Cwi or (involves: 129X1/SvJ * C57BL/6 * DBA/2))
|
abnormal T cell activation
|
J:157757
|
| increased T cell proliferation
|
J:157757
|
Plcg2Ali5/Plcg2+
(C3HeB/FeJ-Plcg2Ali5)
|
abnormal B cell physiology
|
J:97930
|
Plcg2Ali5/Plcg2+
(involves: C57BL/6J * C3HeB/FeJ-Plcg2Ali5)
|
abnormal B cell physiology
|
J:97930
|
Plcg2Ali5/Plcg2Ali5
(involves: C57BL/6J * C3HeB/FeJ-Plcg2Ali5)
|
abnormal B cell physiology
|
J:97930
|
Plcg2em1Msasn/Plcg2em1Msasn
(B6.Cg-Plcg2em1Msasn/J)
|
impaired macrophage phagocytosis
|
J:308279
|
Plcg2m1Btlr/Plcg2m1Btlr
(C57BL/6J-Plcg2m1Btlr)
|
decreased IgM level
|
J:165702
|
Plcg2m1Btlr/Plcg2m1Btlr
(involves: C57BL/6J)
|
decreased IgM level
|
J:185495
|
Plcg2M3Btlr/Plcg2M3Btlr
(C57BL/6J-Plcg2M3Btlr)
|
decreased IgM level
|
J:265101
|
Plcg2tm1.1Kuro/Plcg2tm1.1Kuro
(B6.Cg-Plcg2tm1.1Kuro)
|
impaired natural killer cell mediated cytotoxicity
|
J:131621
|
Plcg2tm1.1Kuro/Plcg2tm1.1Kuro
(Not Specified)
|
abnormal NK cell physiology
|
J:187430
|
Plcg2tm1Jni/Plcg2tm1Jni
(involves: 129P2/OlaHsd)
|
abnormal B cell calcium ion homeostasis
|
J:80614
|
| abnormal dendritic cell chemotaxis
|
J:157619
|
| abnormal dendritic cell physiology
|
J:157619
|
| decreased B cell proliferation
|
J:80614
|
| increased B cell apoptosis
|
J:86373
|
Plcg2tm1Jni/Plcg2tm1Jni
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:117023
|
| impaired natural killer cell mediated cytotoxicity
|
J:100716
|
| increased B cell proliferation
|
J:117023
|
Plcg2tm1Kuro/Plcg2tm1Kuro
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased B cell proliferation
|
J:63744
|
Plcl2tm1Tta/Plcl2tm1Tta
(involves: 129P2/OlaHsd)
|
abnormal adaptive immunity
|
J:85960
|
| abnormal B cell calcium ion homeostasis
|
J:85960
|
| increased B cell proliferation
|
J:85960
|
| increased IgM level
|
J:85960
|
Pld2tm1.1Mjow/Pld2tm1.1Mjow
(Not Specified)
|
abnormal neutrophil physiology
|
J:183062
|
Pld3em1Nemz/Pld3em1Nemz
Pld4tm1.2Nemz/Pld4tm1.2Nemz
(B6.Cg-Pld3em1Nemz Pld4tm1.1Nemz)
|
hemophagocytosis
|
J:281205
|
Pld4thss/Pld4thss
(BALB/cJ-Pld4thss/GrsrJ)
|
abnormal immunoglobulin level
|
J:278304
|
| increased IgA level
|
J:278304
|
| increased IgE level
|
J:278304
|
| increased IgG2b level
|
J:278304
|
| increased IgG3 level
|
J:278304
|
| increased IgG level
|
J:278304
|
| increased IgM level
|
J:278304
|
Plectm3Gwi/Plectm3Gwi
(involves: 129P2/OlaHsd)
|
abnormal T cell physiology
|
J:104701
|
| impaired macrophage chemotaxis
|
J:104701
|
Plekhf1tm1.1Caox/Plekhf1tm1.1Caox
Lyz2tm1(cre)Ifo/Lyz2+
(B6.Cg-Plekhf1tm1.1Caox Lyz2tm1(cre)Ifo)
|
abnormal macrophage physiology
|
J:277440
|
Plekhm1tm1.2Hzhao/Plekhm1tm1.2Hzhao
(involves: 129S1/Sv * C57BL/6J)
|
abnormal osteoclast physiology
|
J:236517
|
Plekho2em1Lzhn/Plekho2em1Lzhn
(C57BL/6-Plekho2em1Lzhn)
|
increased macrophage apoptosis
|
J:270531
|
Plet1tm1Cupe/Plet1tm1Cupe
(Not Specified)
|
abnormal dendritic cell migration
|
J:271548
|
Plgtm1Jld/Plgtm1Jld
(B6.129P2-Plgtm1Jld/J)
|
abnormal microglial cell physiology
|
J:141739
|
Plgrkttm1Lmls/Plgrkttm1Lmls
(B6.Cg-Plgrkttm1Lmls)
|
abnormal macrophage physiology
|
J:282437
|
| impaired leukocyte migration
|
J:282437
|
| impaired macrophage chemotaxis
|
J:282437
|
plt/plt
(involves: DDD/1)
|
abnormal leukocyte migration
|
J:47819,
J:47460
|
plt/plt
(C.DDD-plt)
|
abnormal T cell activation
|
J:119345
|
plt/plt
(B6.DDD-plt)
|
abnormal leukocyte migration
|
J:93960
|
plt/plt
(either: B6.DDD-plt or C.DDD-plt)
|
abnormal leukocyte migration
|
J:110910
|
Plxna1tm1Kik/Plxna1tm1Kik
(either: B6.Cg-Plxna1tm1Kik or C.Cg-Plxna1tm1Kik)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:110786
|
| abnormal dendritic cell physiology
|
J:110786
|
Plxna1tm1Kik/Plxna1tm1Kik
(Not Specified)
|
abnormal dendritic cell physiology
|
J:161856
|
Plxna1tm1Kik/Plxna1tm1Kik
Tg(TcraTcrb)425Cbn/?
(involves: BALB/c * C57BL/6)
|
decreased T cell proliferation
|
J:161856
|
PlyidHIGA/Nsc/PlyidHIGA/Nsc
(involves: BALB/cA * HIGA/Nsc)
|
increased IgA level
|
J:91769
|
Pmepa1em1Akt/Pmepa1em1Akt
(C57BL/6N-Pmepa1em1Akt)
|
abnormal osteoclast physiology
|
J:329578
|
Pms2tm1.1Wed/Pms2tm1.1Wed
(involves: 129S6/SvEvTac * C57BL/6NCr)
|
abnormal class switch recombination
|
J:162378
|
Pms2tm1Lisk/Pms2tm1Lisk
(involves: 129S2/SvPas)
|
abnormal class switch recombination
|
J:162378
|
Pnliprp2tm1Gru/Pnliprp2tm1Gru
(involves: 129S2/SvPas * BALB/c)
|
decreased cytotoxic T cell cytolysis
|
J:51627
|
Pnpbata/Pnpbata
(C57BL/6JSfdAnu-Pnpbata)
|
decreased B cell proliferation
|
J:104190
|
Pnpe/Pnpe
(C57BL/6J-Pnpe)
|
abnormal leukocyte physiology
|
J:39328
|
Pnpf/Pnpf
(C57BL/6J-Pnpf)
|
abnormal leukocyte physiology
|
J:39328
|
Pnpg/Pnpg
(involves: C57BL/6 * DBA/2J)
|
abnormal leukocyte physiology
|
J:39328
|
PnpM1Btlr/PnpM1Btlr
(C57BL/6J-PnpM1Btlr)
|
increased IgM level
|
J:265147
|
Pnptm1Cmr/Pnptm1Cmr
(involves: 129)
|
decreased cytotoxic T cell cytolysis
|
J:62870
|
| increased thymocyte apoptosis
|
J:62870
|
Polbtm1.1Jbsw/Polb+
(involves: 129/Sv * C57BL/6)
|
increased IgG level
|
J:206872
|
Polbtm1.1Jbsw/Polbtm1.1Jbsw
(involves: 129/Sv * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:206872
|
| increased IgG level
|
J:206872
|
Pole3em3Tbo/Pole3em3Tbo
(FVB-Pole3em3Tbo)
|
increased thymocyte apoptosis
|
J:298827
|
Pole3em4Tbo/Pole3em4Tbo
(FVB-Pole3em4Tbo)
|
increased thymocyte apoptosis
|
J:298827
|
Polhtm1Crey/Polhtm1Crey
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:98037
|
Polhtm1Crey/Polhtm1Crey
Polid/Polid
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:98037
|
Polhtm1Fmh/Polhtm1Fmh
(involves: C57BL/6)
|
abnormal B cell physiology
|
J:99721
|
Polmtm1Crey/Polmtm1Crey
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell proliferation
|
J:85190
|
Polqtm1Jcs/Polqtm1Jcs
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal somatic hypermutation frequency
|
J:103365
|
Polqtm1Jow/Polqtm1Jow
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
|
abnormal B cell physiology
|
J:101409
|
| abnormal somatic hypermutation frequency
|
J:101409
|
| decreased IgG1 level
|
J:101409
|
| decreased IgG level
|
J:101409
|
| decreased IgM level
|
J:101409
|
| decreased immunoglobulin level
|
J:101409
|
Polqtm2Jow/Polqtm2Jow
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:115989
|
Pomt1Gt(OST194127)Lex/Pomt1+
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased IgG level
|
J:103485
|
Pon2Gt(XE661)Byg/Pon2Gt(XE661)Byg
(B6.129P2-Pon2Gt(XE661)Byg)
|
abnormal macrophage chemotaxis
|
J:116935
|
| abnormal macrophage physiology
|
J:116935
|
Pou2af1tm1Pjln/Pou2af1tm1Pjln
(C57BL/6-Pou2af1tm1Pjln)
|
decreased IgA level
|
J:37085
|
| decreased IgG1 level
|
J:37085
|
| decreased IgG2a level
|
J:37085
|
| decreased IgG2b level
|
J:37085
|
| decreased IgG3 level
|
J:37085
|
Pou2af1tm1Pjln/Pou2af1tm1Pjln
(involves: C57BL/6)
|
abnormal T-helper 1 physiology
|
J:123039
|
| abnormal T-helper 2 physiology
|
J:123039
|
| increased B cell apoptosis
|
J:67362
|
Pou2af1tm1Pjln/Pou2af1tm1Pjln
Tg(tetO-Pou2af1)1Pjln/0
Tg(tTA)1Pjln/0
(involves: C57BL/6)
|
decreased immunoglobulin level
|
J:67362
|
Pou2af1tm1Pmt/Pou2af1tm1Pmt
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased immunoglobulin level
|
J:125114
|
Pou2af1tm1Pmt/Pou2af1tm1Pmt
Ikzf3tm1Kge/Ikzf3tm1Kge
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
decreased IgA level
|
J:81805
|
| decreased IgD level
|
J:81805
|
| decreased IgE level
|
J:81805
|
| decreased IgG level
|
J:81805
|
| decreased IgM level
|
J:81805
|
| decreased immunoglobulin level
|
J:81805
|
Pou2af1tm1Rgr/Pou2af1tm1Rgr
(either: (involves: 129P2/OlaHsd) or (involves: 129S1/Sv))
|
decreased B cell proliferation
|
J:35785
|
| decreased IgA level
|
J:35785
|
| decreased IgE level
|
J:35785
|
| decreased IgG1 level
|
J:35785
|
| decreased IgG2a level
|
J:35785
|
| decreased IgG2b level
|
J:35785
|
| decreased IgG3 level
|
J:35785
|
| decreased IgG level
|
J:35785
|
| decreased immunoglobulin level
|
J:35785
|
| increased B cell proliferation
|
J:114816
|
| increased IgM level
|
J:35785
|
Pou2f2tm1Bal/Pou2f2+
(involves: 129S2/SvPas)
|
decreased IgG1 level
|
J:4555
|
| decreased IgM level
|
J:4555
|
Pou2f2tm1Bal/Pou2f2tm1Bal
(involves: 129S2/SvPas * C57BL/6)
|
decreased immunoglobulin level
|
J:88240
|
Pou2f2tm1Bal/Pou2f2tm1Bal
(involves: 129S2/SvPas)
|
decreased IgG1 level
|
J:4555
|
| decreased IgM level
|
J:4555
|
Pou2f2tm1Lmc/Pou2f2tm1Lmc
(involves: C57BL/6)
|
decreased immunoglobulin level
|
J:88240
|
Ppargtm1.1Gonz/Ppargtm1.1Gonz
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)
|
abnormal macrophage activation involved in immune response
|
J:168799
|
| impaired macrophage phagocytosis
|
J:168799
|
| increased IgG level
|
J:168799
|
| increased IgM level
|
J:168799
|
Ppargtm1.1Gonz/Ppargtm1.1Gonz
Tg(Mx1-cre)1Cgn/?
(involves: 129X1/SvJ * C57BL/6 * CBA * FVB/N)
|
abnormal macrophage physiology
|
J:75777
|
Ppargtm1Tka/Pparg+
(involves: C57BL/6 * CBA)
|
leukostasis
|
J:116269
|
Ppargtm1Tka/Pparg+
(involves: C57BL/6 * CBA * ICR)
|
abnormal B cell physiology
|
J:58222
|
| increased B cell proliferation
|
J:58222
|
| increased IgG level
|
J:58222
|
| increased IgM level
|
J:58222
|
Ppbptm1(KOMP)Vlcg/Ppbptm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal leukocyte migration
|
J:198197
|
| abnormal leukocyte physiology
|
J:198197
|
Ppiatm1Lubn/Ppiatm1Lubn
(129S6.129P2-Ppiatm1Lubn)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:93591
|
| increased IgE level
|
J:93591
|
| increased IgG1 level
|
J:93591
|
| increased immunoglobulin level
|
J:93591
|
| increased susceptibility to type I hypersensitivity reaction
|
J:93591
|
Ppm1dtm1Lad/Ppm1dtm1Lad
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased B cell proliferation
|
J:74284
|
| decreased T cell proliferation
|
J:74284
|
Ppp1r18em1Mgin/Ppp1r18em1Mgin
(B6J.B6N-Ppp1r18em1Mgin)
|
abnormal T cell physiology
|
J:331428
|
| impaired leukocyte migration
|
J:331428
|
Ppp1r18em3Mgin/Ppp1r18em3Mgin
(B6J.B6N-Ppp1r18em3Mgin)
|
abnormal T cell physiology
|
J:331428
|
| impaired leukocyte migration
|
J:331428
|
Ppp2r2dem1Gct/Ppp2r2dem1Gct
Tg(Lck-icre)3779Nik/0
(involves: C57BL/6 * DBA/2)
|
abnormal regulatory T cell physiology
|
J:308373
|
Ppp2r3ctm1Imku/Ppp2r3ctm1Imku
Tg(CD19-cre/ERT2)1Cgn/?
(involves: C57BL/6)
|
abnormal B cell activation
|
J:100706
|
| decreased B cell proliferation
|
J:100706
|
Ppp3catm1Jse/Ppp3catm1Jse
(either: (involves: 129S4/SvJae * Black Swiss) or (involves: 129S4/SvJae * C57BL/6))
|
decreased T cell proliferation
|
J:71750
|
Ppp3cbM1Btlr/Ppp3cb+
(C57BL/6J-Ppp3cbM1Btlr)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:236670
|
| abnormal CD8-positive, alpha-beta T cell physiology
|
J:236670
|
| abnormal NK cell physiology
|
J:236670
|
| increased CD8-positive, alpha-beta memory T cell proliferation
|
J:236670
|
Ppp3cbM1Btlr/Ppp3cbM1Btlr
(C57BL/6J-Ppp3cbM1Btlr)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:236670
|
| abnormal CD8-positive, alpha-beta T cell physiology
|
J:236670
|
| abnormal NK cell physiology
|
J:236670
|
| increased CD8-positive, alpha-beta memory T cell proliferation
|
J:236670
|
Ppp3cbm2Btlr/Ppp3cb+
(C57BL/6J-Ppp3cbm2Btlr)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:236671
|
| abnormal CD8-positive, alpha-beta T cell physiology
|
J:236671
|
| increased CD8-positive, alpha-beta memory T cell proliferation
|
J:236671
|
Ppp3cbm2Btlr/Ppp3cbm2Btlr
(C57BL/6J-Ppp3cbm2Btlr)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:236671
|
| abnormal CD8-positive, alpha-beta T cell physiology
|
J:236671
|
| abnormal NK cell physiology
|
J:236671
|
| increased CD8-positive, alpha-beta memory T cell proliferation
|
J:236671
|
Ppp3cbtm1Jmk/Ppp3cbtm1Jmk
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased T cell proliferation
|
J:77729
|
Ppp3cbtm1Jmk/Ppp3cbtm1Jmk
(involves: 129S6/SvEvTac)
|
decreased T cell proliferation
|
J:109586
|
Ppp4ctm1Tht/Ppp4ctm1Tht
Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA)
|
abnormal T cell activation
|
J:117684
|
Ppt1tm1.1Dprc/Ppt1tm1.1Dprc
(involves: 129S6/SvEvTac * BALB/cJ * C57BL/6)
|
abnormal microglial cell activation
|
J:213552
|
Pram1tm1Gak/Pram1tm1Gak
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal neutrophil physiology
|
J:95253
|
Prap1tm1Lex/Prap1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased immunoglobulin level
|
J:171883
|
Prcdtm1Vya/Prcdtm1Vya
(B6.Cg-Prcdtm1Vya)
|
increased microglial cell activation
|
J:276708
|
Prdm1tm1Clme/Prdm1tm1Clme
Tg(Itgax-cre)1-1Reiz/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:178876
|
| abnormal germinal center B cell physiology
|
J:178876
|
| increased IgG level
|
J:178876
|
| increased immunoglobulin level
|
J:178876
|
Prdx1tm1Rave/Prdx1tm1Rave
(involves: 129S6/SvEvTac * C57BL/6)
|
impaired natural killer cell mediated cytotoxicity
|
J:84677
|
Prex1tm1Dwu/Prex1tm1Dwu
(Not Specified)
|
impaired neutrophil chemotaxis
|
J:102213
|
Prex1tm1Hcew/Prex1tm1Hcew
(involves: 129P2/OlaHsd * C57BL/6)
|
impaired neutrophil chemotaxis
|
J:102214
|
| impaired neutrophil recruitment
|
J:102214
|
Prf1tm1Clrk/Prf1tm1Clrk
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased cytotoxic T cell cytolysis
|
J:21531
|
Prf1tm1Sdz/Prf1+
(A.B6-Prf1tm1Sdz)
|
impaired natural killer cell mediated cytotoxicity
|
J:211842
|
Prf1tm1Sdz/Prf1tm1Sdz
(C57BL/6-Prf1tm1Sdz)
|
abnormal leukocyte physiology
|
J:17986
|
| abnormal NK cell physiology
|
J:113213
|
| decreased cytotoxic T cell cytolysis
|
J:17986
|
| impaired natural killer cell mediated cytotoxicity
|
J:17986
|
Prf1tm1Sdz/Prf1tm1Sdz
(C57BL/6-Prf1tm1Sdz/J)
|
abnormal cytotoxic T cell physiology
|
J:193137
|
| abnormal lymphocyte physiology
|
J:120427
|
| abnormal macrophage activation involved in immune response
|
J:92260
|
| abnormal T cell activation
|
J:92260
|
| decreased cytotoxic T cell cytolysis
|
J:193137
|
| decreased NK cell degranulation
|
J:193137
|
Prf1tm1Sdz/Prf1tm1Sdz
(involves: BALB/c * C57BL/6)
|
impaired natural killer cell mediated cytotoxicity
|
J:73948
|
Prf1tm1Sdz/Prf1tm1Sdz
(A.B6-Prf1tm1Sdz)
|
impaired natural killer cell mediated cytotoxicity
|
J:211842
|
Prf1tm1Tsc/Prf1+
(involves: 129S2/SvPas)
|
decreased cytotoxic T cell cytolysis
|
J:21731
|
| impaired natural killer cell mediated cytotoxicity
|
J:21731
|
Prf1tm1Tsc/Prf1tm1Tsc
(involves: 129S2/SvPas)
|
decreased cytotoxic T cell cytolysis
|
J:21731
|
| impaired natural killer cell mediated cytotoxicity
|
J:21731
|
Prf1tm1Tsc/Prf1tm1Tsc
(129X1.129S2-Prf1tm1Tsc)
|
abnormal NK cell physiology
|
J:126114
|
| decreased T cell apoptosis
|
J:126114
|
Primpolem1Nki/Primpolem1Nki
(C57BL/6-Primpolem1Nki)
|
abnormal somatic hypermutation frequency
|
J:242620
|
Prkar1atm2Gsm/Prkar1atm2Gsm
Tg(Cr2-cre)3Cgn/0
(involves: 129X1/SvJ * C57BL/6)
|
abnormal class switch recombination
|
J:147785
|
PrkcbM1Btlr/Prkcb+
(C57BL/6J-PrkcbM1Btlr)
|
decreased IgM level
|
J:164864
|
PrkcbM1Btlr/PrkcbM1Btlr
(C57BL/6J-PrkcbM1Btlr)
|
decreased IgM level
|
J:164864
|
PrkcbM1Btlr/PrkcbM1Btlr
(involves: C57BL/6J)
|
decreased IgM level
|
J:185495
|
PrkcbM2Btlr/Prkcb+
(C57BL/6J-PrkcbM2Btlr)
|
decreased IgM level
|
J:217791
|
PrkcbM2Btlr/PrkcbM2Btlr
(C57BL/6J-PrkcbM2Btlr)
|
decreased IgM level
|
J:217791
|
PrkcbM3Btlr/Prkcb+
(C57BL/6J-PrkcbM3Btlr)
|
decreased IgM level
|
J:217793
|
PrkcbM3Btlr/PrkcbM3Btlr
(C57BL/6J-PrkcbM3Btlr)
|
decreased IgM level
|
J:217793
|
PrkcbM5Btlr/PrkcbM5Btlr
(C57BL/6J-PrkcbM5Btlr)
|
decreased IgM level
|
J:274861
|
Prkcbtilc/Prkcb+
(involves: C57BL/6JSfdAnu)
|
decreased IgG3 level
|
J:221236
|
| decreased IgM level
|
J:221236
|
Prkcbtilc/Prkcbtilc
(C57BL/6JSfdAnu-Prkcbtilc/AnuApb)
|
decreased IgM level
|
J:104190
|
Prkcbtilc/Prkcbtilc
(involves: C57BL/6JSfdAnu)
|
decreased B cell proliferation
|
J:221236
|
| decreased IgG3 level
|
J:221236
|
| decreased IgM level
|
J:221236
|
Prkcbtm1Tara/Prkcb+
(involves: 129)
|
decreased IgG3 level
|
J:34818
|
| decreased IgM level
|
J:34818
|
Prkcbtm1Tara/Prkcbtm1Tara
(involves: 129)
|
decreased B cell proliferation
|
J:34818
|
| decreased IgG3 level
|
J:34818
|
| decreased IgM level
|
J:34818
|
Prkcdm2Btlr/Prkcdm2Btlr
(C57BL/6J-Prkcdm2Btlr)
|
increased IgM level
|
J:265146
|
Prkcdtm1.1Chou/Prkcdtm1.1Chou
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal neutrophil physiology
|
J:217880
|
Prkcdtm1Kin/Prkcdtm1Kin
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal immunoglobulin level
|
J:143854
|
| increased B cell proliferation
|
J:76135,
J:143854
|
| increased IgA level
|
J:76135,
J:143854
|
| increased IgG1 level
|
J:76135,
J:143854
|
| increased IgM level
|
J:143854
|
Prkcdtm1Msg/Prkcdtm1Msg
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal neutrophil physiology
|
J:91377
|
Prkcdtm1Qxu/Prkcdtm1Qxu
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell apoptosis
|
J:76134
|
| increased IgA level
|
J:76134
|
| increased IgG1 level
|
J:76134
|
| increased IgM level
|
J:76134
|
Prkcdtm1Qxu/Prkcdtm1Qxu
Tg(IghelMD4)4Ccg/0
Tg(ML5sHEL)5Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:76134
|
| abnormal B cell proliferation
|
J:76134
|
Prkcetm1Bsca/Prkcetm1Bsca
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased macrophage apoptosis
|
J:103337
|
| decreased macrophage nitric oxide production
|
J:103337
|
| decreased T cell proliferation
|
J:103337
|
Prkchtm1.2Gasc/Prkchtm1.2Gasc
(involves: C57BL/6 * FVB/N * SJL)
|
decreased T cell proliferation
|
J:186080
|
Prkchtm1.2Gasc/Prkchtm1.2Gasc
Prkcqtm1Litt/Prkcqtm1Litt
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
decreased T cell proliferation
|
J:186080
|
Prkcqm1Btlr/Prkcqm1Btlr
(C57BL/6J-Prkcqm1Btlr)
|
decreased IgG level
|
J:255214
|
Prkcqm2Btlr/Prkcqm2Btlr
(C57BL/6J-Prkcqm2Btlr)
|
decreased IgG level
|
J:255216
|
Prkcqtm1.1Bai/Prkcqtm1.1Bai
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal T cell physiology
|
J:83733
|
| decreased T cell proliferation
|
J:83733
|
Prkcqtm1Litt/Prkcqtm1Litt
(involves: 129P2/OlaHsd)
|
abnormal T cell activation
|
J:83922
|
| decreased T cell proliferation
|
J:83922,
J:123989
|
Prkcqtm1Litt/Prkcqtm1Litt
(B6.129P2-Prkcqtm1Litt)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:94285
|
| abnormal T-helper 2 physiology
|
J:94285
|
| decreased T cell proliferation
|
J:94285
|
Prkcqtm1Litt/Prkcqtm1Litt
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell proliferation
|
J:186080
|
| increased T cell apoptosis
|
J:141128
|
Prkcqtm1Litt/Prkcqtm1Litt
(either: (involves: 129/Sv * 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))
|
decreased T cell apoptosis
|
J:141930
|
| decreased T cell proliferation
|
J:141930
|
Prkcqtm1Litt/Prkcqtm1Litt
Tcratm1Mom/Tcratm1Mom
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
decreased T cell proliferation
|
J:135589
|
Prkcqtm1Litt/Prkcqtm1Litt
Tg(DO11.10)10Dlo/0
(involves: 129 * BALB/c * C3H * C57BL/6)
|
decreased T cell apoptosis
|
J:141930
|
Prkcqtm1Litt/Prkcqtm1Litt
Tg(TcrLCMV)327Sdz/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased cytotoxic T cell cytolysis
|
J:123989
|
| decreased T cell proliferation
|
J:123989
|
Prkd2tm1.1Daca/Prkd2tm1.1Daca
(involves: C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:166867
|
| abnormal CD8-positive, alpha-beta T cell physiology
|
J:166867
|
| decreased IgG1 level
|
J:166867
|
| decreased IgM level
|
J:166867
|
Prkdcm1Btlr/Prkdcm1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| decreased IgG level
|
J:185495
|
| decreased IgM level
|
J:185495
|
Prkdcm2Btlr/Prkdcm2Btlr
(C57BL/6J-Prkdcm2Btlr)
|
abnormal B cell physiology
|
J:204502
|
| decreased IgG level
|
J:204502
|
| decreased IgM level
|
J:204502
|
Prkdcm3Btlr/Prkdcm3Btlr
(C57BL/6J-Prkdcm3Btlr)
|
decreased IgG level
|
J:224665
|
Prkdcm7Btlr/Prkdcm7Btlr
(C57BL/6J-Prkdcm7Btlr)
|
decreased IgG level
|
J:255223
|
PrkdcM11Btlr/Prkdc+
(C57BL/6J-PrkdcM11Btlr)
|
increased IgM level
|
J:255270
|
PrkdcM11Btlr/PrkdcM11Btlr
(C57BL/6J-PrkdcM11Btlr)
|
increased IgM level
|
J:255270
|
Prkdcscid/Prkdcscid
(C.BKa-Prkdcscid)
|
decreased B cell proliferation
|
J:6958
|
| decreased IgG level
|
J:6958
|
| decreased immunoglobulin level
|
J:6958,
J:22026
|
| decreased T cell proliferation
|
J:6958
|
Prkdcscid/Prkdcscid
(NOD.Cg-Prkdcscid)
|
decreased immunoglobulin level
|
J:22026
|
| impaired natural killer cell mediated cytotoxicity
|
J:22026
|
Prkdcscid/Prkdcscid
(B6.Cg-Prkdcscid/Sz)
|
abnormal NK cell physiology
|
J:34814
|
| decreased immunoglobulin level
|
J:34814
|
Prkdcscid/Prkdcscid
(involves: BALB/c * C57BL/6 * C57BL/Ka)
|
abnormal NK cell physiology
|
J:115033
|
Prkdctm1Gcl/Prkdctm1Gcl
(involves: 129S1/Sv)
|
decreased thymocyte apoptosis
|
J:126920
|
Prkdctm1Get/Prkdctm1Get
(involves: 129S4/SvJae * Black Swiss)
|
decreased IgM level
|
J:50222
|
Prph2em1Sal/Prph2em1Sal
(C57BL/6J-Prph2em1Sal)
|
increased microglial cell activation
|
J:342243
|
Prps2tm1a(KOMP)Wtsi/Y
(involves: C57BL/6N)
|
abnormal B cell physiology
|
J:214383
|
Prps2tm1a(KOMP)Wtsi/Y
Tg(IghMyc)22Bri/0
(involves: C57BL/6N * SJL)
|
abnormal B cell physiology
|
J:214383
|
| increased B cell apoptosis
|
J:214383
|
Prss57tm1.1Gne/Prss57tm1.1Gne
(C57BL/6N-Prss57tm1.1Gne)
|
abnormal mast cell physiology
|
J:301479
|
Prss57tm1Lex/Prss57tm1Lex
(involves: 129S5/SvEvBrd)
|
abnormal mast cell physiology
|
J:301479
|
Prtn3tm1.1Hrlu/Prtn3tm1.1Hrlu
(involves: C57BL/6)
|
abnormal neutrophil physiology
|
J:217636
|
Psaptm1Ggb/Psaptm1Ggb
(involves: 129S/SvEv * C57BL/6J)
|
abnormal microglial cell physiology
|
J:121761
|
Psaptm1Juma/Psaptm1Juma
(FVB.129S-Psaptm1Juma)
|
abnormal microglial cell physiology
|
J:121761
|
Psen1tm1Bdes/Psen1+
Psen2tm1Bdes/Psen2tm1Bdes
(involves: 129P2/OlaHsd)
|
increased immunoglobulin level
|
J:91235
|
Psmb8tm1Hjf/Psmb8tm1Hjf
(involves: 129P2/OlaHsd)
|
abnormal dendritic cell antigen presentation
|
J:180765
|
Psmb10tm1Mgro/Psmb10tm1Mgro
(involves: 129S2/SvPas * C57BL/6)
|
abnormal cytotoxic T cell physiology
|
J:125058
|
| decreased T cell proliferation
|
J:125058
|
Psmb10tm1Mgro/Psmb10tm1Mgro
Psmb9/Psmb8tm1Klr/Psmb9/Psmb8tm1Klr
(B6.129-Psmb10tm1Mgro Psmb9/Psmb8tm1Klr)
|
abnormal B lymphocyte antigen presentation
|
J:180765
|
| abnormal dendritic cell antigen presentation
|
J:180765
|
Psmb10tm1Mgro/Psmb10tm1Mgro
Psmb9/Psmb8tm1Klr/Psmb9/Psmb8tm1Klr
(B6.129-Psmb10tm1Mgro Psmb9/Psmb8tm1Klr)
|
abnormal B lymphocyte antigen presentation
|
J:180765
|
| abnormal dendritic cell antigen presentation
|
J:180765
|
Psmb10Tub6/Psmb10+
(C3HeB/FeJ-Psmb10Tub6)
|
abnormal T cell activation
|
J:261081
|
Psmb10Tub6/Psmb10Tub6
(C3HeB/FeJ-Psmb10Tub6)
|
decreased immunoglobulin level
|
J:261081
|
Psmb11tm1(Psmb8)Khog/Psmb11tm1(Psmb8)Khog
(involves: C57BL/6)
|
increased T cell proliferation
|
J:196156
|
Psme2tm1Yya/Psme2tm1Yya
(involves: 129P2/OlaHsd)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:58875
|
| decreased cytotoxic T cell cytolysis
|
J:58875
|
Pstpip1tm1Spg/Pstpip1tm1Spg
(involves: 129S/SvEv * C57BL/6)
|
abnormal T cell physiology
|
J:101977
|
Pstpip2Lupo/Pstpip2Lupo
(either: (involves: C3HeB/FeJ) or (involves: C3HeB/FeJ * C57BL/6J))
|
increased IgE level
|
J:125785
|
| increased IgG1 level
|
J:125785
|
| increased IgG2a level
|
J:125785
|
| increased IgG level
|
J:125785
|
Ptafrtm1Tksh/Ptafrtm1Tksh
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to type I hypersensitivity reaction
|
J:88505
|
Ptentm1Engc/Ptentm1Engc
(involves: CD-1)
|
abnormal microglial cell physiology
|
J:210487
|
Ptentm1Hwu/Ptentm1Hwu
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
abnormal macrophage chemotaxis
|
J:148947
|
| abnormal neutrophil physiology
|
J:148947,
J:114699,
J:145331
|
| impaired neutrophil recruitment
|
J:148947
|
Ptentm1Hwu/Ptentm1Hwu
Tg(GZMB-cre)1Jcb/0
(involves: 129S4/SvJae * FVB/N)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:164425
|
Ptentm2.1Ppp/Ptentm2.1Ppp
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129S1/Sv * 129X1/SvJ)
|
increased IgG1 level
|
J:164283
|
Ptgdr2tm1Tasa/Ptgdr2tm1Tasa
(involves: 129/Sv * BALB/c)
|
impaired eosinophil recruitment
|
J:130892
|
Ptgdr2tm1Tasa/Ptgdr2tm1Tasa
(C.129-Ptgdr2tm1Tasa)
|
decreased IgE level
|
J:131146
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:131146
|
Ptgdr2tm1Tasa/Ptgdr2tm1Tasa
(B6.129-Ptgdr2tm1Tasa)
|
increased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Ptgdrtm1Sna/Ptgdrtm1Sna
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal macrophage activation involved in immune response
|
J:243958
|
| decreased microglial cell activation
|
J:243958
|
Ptgdrtm1Sna/Ptgdrtm1Sna
(B6.129P2-Ptgdrtm1Sna/Sna)
|
abnormal mast cell physiology
|
J:197334
|
| decreased mast cell degranulation
|
J:197334
|
| decreased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Ptgdstm1Ohy/Ptgdstm1Ohy
(B6.129P2-Ptgdstm1Ohy)
|
decreased mast cell degranulation
|
J:197334
|
| decreased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Ptger1tm1Sna/Ptger1tm1Sna
(B6CrSlc.129P2-Ptger1tm1Sna/Sna)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:128435
|
Ptger2tm1.1Kand/Ptger2tm1.1Kand
Tg(ITGAM-cre)2781Gkl/0
(involves: C57BL/6 * CBA)
|
abnormal microglial cell physiology
|
J:202677
|
Ptger2tm1Brey/Ptger2tm1Brey
(C.129S6-Ptger2tm1Brey)
|
abnormal microglial cell physiology
|
J:97062
|
Ptger3tm1Sna/Ptger3tm1Sna
(B6.129P2-Ptger3tm1Sna/Sna)
|
increased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Ptger4tm1Bhk/Ptger4tm1Bhk
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal macrophage physiology
|
J:78964
|
Ptger4tm1Sna/Ptger4tm1Sna
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal Langerhans cell physiology
|
J:83725
|
| abnormal osteoclast physiology
|
J:63070
|
| abnormal T cell activation
|
J:83725
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:83725
|
| decreased T cell proliferation
|
J:83725
|
Ptges2tm1Kymm/Ptges2tm1Kymm
(B6.Cg-Ptges2tm1Kymm)
|
increased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Ptgestm1.1Gaf/Ptgestm1.1Gaf
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * C57BL/6)
|
abnormal leukocyte physiology
|
J:210141
|
Ptgestm1Aki/Ptgestm1Aki
(involves: 129X1/SvJ * C57BL/6)
|
impaired macrophage chemotaxis
|
J:91821
|
Ptgestm1Aki/Ptgestm1Aki
(B6.129P2-Ptgestm1Aki)
|
increased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal macrophage physiology
|
J:29510
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(B6.129P2-Ptgs2tm1Unc)
|
abnormal class switch recombination
|
J:140698
|
| decreased IgG1 level
|
J:140698
|
| decreased IgG2a level
|
J:140698
|
| decreased IgG3 level
|
J:140698
|
| increased IgM level
|
J:140698
|
Ptgs2tm2(Ptgs1)Fun/Ptgs2tm2(Ptgs1)Fun
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal macrophage physiology
|
J:118171
|
Ptgs2tm2.1(Ptgs1)Fun/Ptgs2tm2.1(Ptgs1)Fun
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB)
|
abnormal macrophage physiology
|
J:118171
|
Ptk2btm1Schl/Ptk2btm1Schl
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal macrophage physiology
|
J:99741
|
| impaired macrophage chemotaxis
|
J:99741
|
Ptntm1Tmu/Ptntm1Tmu
(B6.Cg-Ptntm1Tmu)
|
impaired macrophage chemotaxis
|
J:102069
|
| impaired neutrophil recruitment
|
J:102069
|
Ptpn2tm1.1Kry/Ptpn2tm1.1Kry
Tg(Col1a1-cre)1Kry/0
(involves: 129 * C57BL/6J * FVB)
|
abnormal osteoclast physiology
|
J:183709
|
Ptpn6m1Anu/Ptpn6m1Anu
(C57BL/6JAnu-Ptpn6m1Anu)
|
decreased IgM level
|
J:225105
|
Ptpn6m1Btlr/Ptpn6m1Btlr
(C57BL/6J-Ptpn6m1Btlr/Mmucd)
|
increased IgM level
|
J:142845
|
Ptpn6M5Btlr/Ptpn6M5Btlr
(C57BL/6J-Ptpn6M5Btlr)
|
decreased IgD level
|
J:265075
|
| decreased IgM level
|
J:265075
|
Ptpn6me-B2/Ptpn6me-B2
(involves: BALB/c)
|
increased IgG level
|
J:169850
|
| increased IgM level
|
J:169850
|
Ptpn6me-v/Ptpn6me-v
(C57BL/6J-Ptpn6me-v)
|
abnormal immunoglobulin level
|
J:7665
|
| abnormal T cell physiology
|
J:1661
|
Ptpn6me/Ptpn6me
(C57BL/6J-Ptpn6me/J)
|
increased IgA level
|
J:5579
|
| increased IgG level
|
J:5579
|
| increased IgM level
|
J:5579
|
| increased immunoglobulin level
|
J:5579
|
Ptpn6me/Ptpn6me
(involves: C3H/HeN * C57BL/6J * NFS)
|
increased IgM level
|
J:30994
|
Ptpn6me/Ptpn6me
(C3FeLe.B6 a/a-Ptpn6me/J)
|
increased microglial cell activation
|
J:88807
|
Ptpn9tm1Dny/Ptpn9tm1Dny
(B6.129-Ptpn9tm1Dny)
|
decreased T cell proliferation
|
J:118880
|
Ptpn12tm1Vei/Ptpn12tm1Vei
Tg(Cd4-cre)1Cwi/0
(B6.Cg-Tg(Cd4-cre)1Cwi Ptpn12tm1Vei)
|
abnormal T cell physiology
|
J:163910
|
| decreased T cell proliferation
|
J:163910
|
Ptpn13tm1Gru/Ptpn13tm1Gru
(involves: C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:118426
|
Ptpn22tm1.1Draw/Ptpn22+
(involves: 129 * C57BL/6)
|
abnormal B cell physiology
|
J:201448
|
| abnormal T cell physiology
|
J:201448
|
| decreased B cell apoptosis
|
J:201448
|
| increased B cell proliferation
|
J:201448
|
| increased IgG1 level
|
J:201448
|
| increased T cell proliferation
|
J:201448
|
Ptpn22tm1.1Draw/Ptpn22tm1.1Draw
(involves: 129 * C57BL/6)
|
abnormal B cell activation
|
J:201448
|
| abnormal B cell physiology
|
J:201448
|
| abnormal T cell physiology
|
J:201448
|
| decreased B cell apoptosis
|
J:201448
|
| increased B cell proliferation
|
J:201448
|
| increased IgE level
|
J:201448
|
| increased IgG1 level
|
J:201448
|
| increased IgG3 level
|
J:201448
|
| increased IgM level
|
J:201448
|
| increased T cell proliferation
|
J:201448
|
Ptpn22tm1.1Kas/Ptpn22tm1.1Kas
(involves: C57BL/6)
|
abnormal dendritic cell physiology
|
J:176519
|
| increased B cell proliferation
|
J:176519
|
| increased IgG2a level
|
J:176519
|
| increased IgG3 level
|
J:176519
|
| increased IgM level
|
J:176519
|
| increased T cell proliferation
|
J:176519
|
Ptpn22tm1.1Kas/Ptpn22tm1.1Kas
Tg(TcraTcrb)425Cbn/0
(involves: BALB/c * C57BL/6)
|
increased T cell proliferation
|
J:176519
|
Ptpn22tm1Achn/Ptpn22tm1Achn
(involves: C57BL/6)
|
abnormal T cell physiology
|
J:90029
|
| increased IgE level
|
J:90029
|
| increased IgG1 level
|
J:90029
|
| increased IgG2a level
|
J:90029
|
Ptpn22tm2Achn/Ptpn22tm2Achn
(involves: C57BL/6)
|
abnormal T cell physiology
|
J:90029
|
| increased IgE level
|
J:90029
|
| increased IgG1 level
|
J:90029
|
| increased IgG2a level
|
J:90029
|
Ptpn22tm2Achn/Ptpn22tm2Achn
(B6.Cg-Ptpn22tm2Achn)
|
abnormal T cell activation
|
J:147129
|
| abnormal thymocyte activation
|
J:147129
|
Ptpn22tm2Achn/Ptpn22tm2Achn
Ptprctm1Weis/Ptprctm1Weis
(B6.Cg-Ptprctm1Weis Ptpn22tm2Achn)
|
abnormal B cell activation
|
J:147129
|
| abnormal follicular B cell physiology
|
J:147129
|
| abnormal T cell activation
|
J:147129
|
| abnormal thymocyte activation
|
J:147129
|
Ptprcloc/Ptprcloc
(C57BL/6JSfdAnu-Ptprcloc/AnuApb)
|
abnormal thymocyte activation
|
J:104190
|
PtprcM10Btlr/PtprcM10Btlr
(C57BL/6J-PtprcM10Btlr)
|
decreased IgE level
|
J:272777
|
Ptprctm1Mak/Ptprctm1Mak
(involves: 129/Sv * C57BL/6)
|
decreased B cell proliferation
|
J:13163
|
| decreased cytotoxic T cell cytolysis
|
J:13163
|
| decreased T cell proliferation
|
J:13163
|
Ptprctm1Mak/Ptprctm1Mak
(involves: 129)
|
abnormal osteoclast physiology
|
J:141275
|
| decreased mast cell degranulation
|
J:110782
|
| decreased susceptibility to type I hypersensitivity reaction
|
J:110782
|
Ptprctm1Mak/Ptprctm1Mak
(B6.Cg-Ptprctm1Mak)
|
abnormal NK cell physiology
|
J:109462
|
| decreased cytotoxic T cell cytolysis
|
J:111646
|
| increased T cell apoptosis
|
J:111646
|
Ptprctm1Mak/Ptprctm1Mak
Ptprjtm1.2Weis/Ptprjtm1.2Weis
(involves: 129/Sv * 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
abnormal B cell calcium ion homeostasis
|
J:131736
|
| impaired macrophage phagocytosis
|
J:131736
|
Ptprctm1Tyb/Ptprctm1Tyb
(C.129S2-Ptprctm1Tyb)
|
abnormal T cell physiology
|
J:57681
|
Ptprctm1Tyb/Ptprctm1Tyb
(B6.129S2-Ptprctm1Tyb)
|
abnormal NK cell physiology
|
J:98190
|
Ptprctm1Weis/Ptprc+
(involves: 129X1/SvJ * C57BL/6)
|
increased IgG2a level
|
J:66501
|
Ptprctm1Weis/Ptprctm1Weis
(involves: 129X1/SvJ * C57BL/6)
|
abnormal B cell activation
|
J:66501
|
| abnormal T cell activation
|
J:66501
|
| increased IgA level
|
J:66501
|
| increased IgG2a level
|
J:66501
|
Ptprctm1Weis/Ptprctm1Weis
(B6.129X1-Ptprctm1Weis)
|
abnormal B cell activation
|
J:147129
|
| abnormal follicular B cell physiology
|
J:147129
|
| abnormal T cell activation
|
J:147129
|
| abnormal thymocyte activation
|
J:147129
|
Ptprcaptm1Tkda/Ptprcaptm1Tkda
(involves: 129X1/SvJ)
|
abnormal cytotoxic T cell physiology
|
J:48387
|
| decreased B cell proliferation
|
J:48387
|
| decreased T cell proliferation
|
J:48387
|
Ptpretm1Ael/Ptpretm1Ael
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal osteoclast physiology
|
J:90031
|
Pttg1tm1Sme/Pttg1tm1Sme
(involves: 129S4/SvJae * C57BL/6)
|
decreased IgG level
|
J:72267
|
| decreased IgM level
|
J:72267
|
| decreased immunoglobulin level
|
J:72267
|
Ptx3tm1Mant/Ptx3tm1Mant
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal dendritic cell physiology
|
J:85080
|
| abnormal macrophage physiology
|
J:85080
|
| abnormal professional antigen presenting cell physiology
|
J:85080
|
| abnormal T-helper 1 physiology
|
J:85080
|
| impaired macrophage phagocytosis
|
J:85080
|
Pvrtm1Gbn/Pvrtm1Gbn
(either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * BALB/c))
|
decreased IgA level
|
J:123540
|
| decreased IgG1 level
|
J:123540
|
| decreased IgG2a level
|
J:123540
|
| decreased IgG2b level
|
J:123540
|
| decreased IgG level
|
J:123540
|
Pvrigtm1.2Sgng/Pvrigtm1.2Sgng
(B6(Cg)-Pvrigtm1.1Sgng)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:324171
|
| abnormal T cell physiology
|
J:324171
|
Pycardtm1Flv/Pycardtm1Flv
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal macrophage physiology
|
J:113333
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:113333
|
Pycardtm1Flv/Pycardtm1Flv
(B6.129S5-Pycardtm1Flv)
|
increased IgA level
|
J:173245
|
| increased IgG2c level
|
J:173245
|
Pycardtm1Vmd/Pycardtm1Vmd
(B6.129-Pycardtm1Vmd)
|
abnormal macrophage physiology
|
J:160545
|
QprtGt(OST337946)Lex/QprtGt(OST337946)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal macrophage physiology
|
J:282516
|
Rab7tm1.1Ale/Rab7tm1.1Ale
Tg(Cd4-cre)1Cwi/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal T cell physiology
|
J:211733
|
| decreased T cell proliferation
|
J:211733
|
Rab7btm1Ciphe/Rab7btm1Ciphe
Tg(Itgax-cre)1-1Reiz/0
(involves: C57BL/6N * CBA)
|
abnormal dendritic cell migration
|
J:321707
|
Rab13tm1.1Ktg/Rab13tm1.1Ktg
(involves: C57BL/6)
|
abnormal leukocyte adhesion
|
J:259093
|
| abnormal T cell physiology
|
J:259093
|
| decreased lymphocyte chemotaxis
|
J:259093
|
| impaired leukocyte migration
|
J:259093
|
Rab20tm1a(EUCOMM)Hmgu/Rab20tm1a(EUCOMM)Hmgu
(involves: C57BL/6N)
|
abnormal macrophage physiology
|
J:243883
|
Rab27aash/Rab27aash
(involves: C3H/HeDiSn)
|
abnormal NK cell degranulation
|
J:111253
|
| decreased cytotoxic T cell cytolysis
|
J:111253,
J:67600
|
| impaired natural killer cell mediated cytotoxicity
|
J:111253
|
Rab27aash/Rab27aash
(B6.C3Sn-Rab27aash)
|
abnormal cytotoxic T cell physiology
|
J:193137
|
| decreased cytotoxic T cell cytolysis
|
J:193137
|
| decreased NK cell degranulation
|
J:193137
|
Rab27acct/Rab27acct
(C57BL/6-Rab27acct)
|
abnormal neutrophil physiology
|
J:114299
|
Rab43tm1.2Kmm/Rab43tm1.2Kmm
(B6.129S(C)-Rab43tm1.2Kmm)
|
abnormal dendritic cell antigen presentation
|
J:101977
|
Rab44em1Rbrc/Rab44em1Rbrc
(Not Specified)
|
abnormal mast cell physiology
|
J:304506
|
| increased susceptibility to type I hypersensitivity reaction
|
J:304506
|
Rabgef1tm1Glli/Rabgef1tm1Glli
(either: (involves: 129P2/OlaHsd * 129S/SvEv) or (involves: 129P2/OlaHsd * C57BL/6))
|
increased IgE level
|
J:91790
|
Rabggtagm/Rabggta+
(C57BL/6J-Rabggtagm)
|
decreased cytotoxic T cell cytolysis
|
J:67600
|
Rabggtagm/Rabggtagm
(C57BL/6J-Rabggtagm)
|
decreased cytotoxic T cell cytolysis
|
J:67600
|
Rac1tm1Djk/Rac1tm1.1Djk
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
impaired neutrophil chemotaxis
|
J:83457
|
| impaired neutrophil recruitment
|
J:83457
|
Rac2m1Btlr/Rac2+
(C57BL/6J-Rac2m1Btlr)
|
decreased IgM level
|
J:221478
|
Rac2m1Btlr/Rac2m1Btlr
(C57BL/6J-Rac2m1Btlr)
|
decreased IgM level
|
J:221478
|
Rac2m3Btlr/Rac2m3Btlr
(C57BL/6J-Rac2m3Btlr)
|
decreased IgM level
|
J:236680
|
Rac2M4Btlr/Rac2+
(C57BL/6J-Rac2M4Btlr)
|
abnormal cytotoxic T cell physiology
|
J:255273
|
| decreased IgG level
|
J:255273
|
| decreased IgM level
|
J:255273
|
| impaired natural killer cell mediated cytotoxicity
|
J:255273
|
| increased IgM level
|
J:255273
|
Rac2M4Btlr/Rac2M4Btlr
(C57BL/6J-Rac2M4Btlr)
|
abnormal cytotoxic T cell physiology
|
J:255273
|
| decreased IgE level
|
J:255273
|
| decreased IgG level
|
J:255273
|
| decreased IgM level
|
J:255273
|
| impaired natural killer cell mediated cytotoxicity
|
J:255273
|
Rac2tm1Mddw/Rac2tm1Mddw
(involves: 129S/SvEv * C57BL/6)
|
abnormal neutrophil physiology
|
J:53362
|
| decreased T cell proliferation
|
J:119437
|
| impaired neutrophil chemotaxis
|
J:53362
|
Rac2tm1Mddw/Rac2tm1Mddw
(involves: 129S/SvEv)
|
abnormal neutrophil physiology
|
J:131305
|
Rac2tm1Mddw/Rac2tm1Mddw
(B6.129S-Rac2tm1Mddw)
|
abnormal neutrophil physiology
|
J:83457
|
Rac2tm1Mddw/Rac2tm1Mddw
Tg(TcrAND)53Hed/0
(involves: 129S/SvEv * C57BL/6 * SJL)
|
abnormal T cell activation
|
J:119437
|
| decreased T cell proliferation
|
J:119437
|
Rad21tm1.1Mmk/Rad21tm1.1Mmk
Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:175827
|
Rad50tm1Flv/Rad50tm1Flv
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal T-helper 2 physiology
|
J:94870
|
Rad50tm2.1Flv/Rad50tm2.2Flv
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal T-helper 1 physiology
|
J:165055
|
| abnormal T-helper 2 physiology
|
J:165055
|
| decreased IgE level
|
J:165055
|
Raet1dem1Dhr/Raet1dem1Dhr
Raet1eem1Dhr/Raet1eem1Dhr
(involves: C57BL/6)
|
increased natural killer cell mediated cytotoxicity
|
J:221188
|
Rag1m2Btlr/Rag1m2Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| decreased IgG level
|
J:185495
|
| decreased IgM level
|
J:185495
|
Rag1tm1Jsek/Rag1tm1Jsek
(involves: 129S6/SvEvTac)
|
abnormal immunoglobulin level
|
J:146912
|
Rag1tm1Mom/Rag1tm1Mom
(involves: 129S7/SvEvBrd * CD-1)
|
decreased IgM level
|
J:1934
|
Rag1tm1Mom/Rag1tm1Mom
(B6.129S7-Rag1tm1Mom)
|
decreased IgM level
|
J:78613
|
| decreased immunoglobulin level
|
J:111828
|
Rag1tm1Mom/Rag1tm1Mom
(NOD.129S7(B6)-Rag1tm1Mom)
|
decreased immunoglobulin level
|
J:109843
|
| impaired natural killer cell mediated cytotoxicity
|
J:109843
|
Rag1tm1Mom/Rag1tm1Mom
Prf1tm1Sdz/Prf1tm1Sdz
(NOD.Cg-Rag1tm1Mom Prf1tm1Sdz/Sz)
|
decreased immunoglobulin level
|
J:109843
|
| impaired natural killer cell mediated cytotoxicity
|
J:109843
|
Rag1tm1Mom/Rag1tm1Mom
Slc46a2tm1Moki/Slc46a2+
Tg(TcraB12,TcrbB12)1Rest/0
(involves: 129 * C57BL/6)
|
increased T cell apoptosis
|
J:140121
|
Rag1tm1Mom/Rag1tm1Mom
Tyrobptm1.1Viv/Tyrobptm1.1Viv
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * C57BL/10)
|
abnormal osteoclast physiology
|
J:129304
|
Rag2m1Btlr/Rag2m1Btlr
(C57BL/6J-Rag2m1Btlr)
|
decreased IgG level
|
J:203045
|
| decreased IgM level
|
J:203045
|
Rag2tm1Avla/Rag2tm1Avla
(involves: 129/Sv * C57BL/6)
|
abnormal B cell physiology
|
J:122108
|
| abnormal lymphocyte physiology
|
J:122108
|
| decreased IgA level
|
J:122108
|
| decreased IgG level
|
J:122108
|
| decreased T cell proliferation
|
J:122108
|
Rag2tm1Cgn/Rag2tm1.1Cgn
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal B cell activation
|
J:72214
|
Rag2tm1Cgn/Rag2tm1Cgn
Xrcc4tm1Fwa/Xrcc4tm2Fwa
Tg(Cr2-cre)3Cgn/?
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
|
abnormal class switch recombination
|
J:150339
|
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * MF1)
|
decreased IgM level
|
J:1935
|
| increased natural killer cell mediated cytotoxicity
|
J:1935
|
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv)
|
abnormal macrophage physiology
|
J:140483
|
| abnormal T-helper 1 physiology
|
J:116136
|
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:165513
|
Rag2tm1Fwa/Rag2tm1Fwa
Sos1tm1.1Les/Sos1tm1.1Les
Tg(Lck-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6)
|
decreased T cell proliferation
|
J:174536
|
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S/SvEv * C57BL/6J * DBA/2J)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:125259
|
| abnormal cytotoxic T cell physiology
|
J:66565
|
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcrHEL3A9)1Mmd/0
(involves: 129S/SvEv * C57BL/6)
|
abnormal T cell activation
|
J:78309
|
| abnormal T cell proliferation
|
J:78309
|
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcrHEL3A9)1Mmd/0
Tg(TLK2mHEL)2Ccg/0
(involves: 129S/SvEv * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:78309
|
| abnormal T cell activation
|
J:78309
|
| abnormal T cell proliferation
|
J:78309
|
Rag2tm1Libo/Rag2tm1Libo
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
abnormal B cell physiology
|
J:84563
|
Rap1atm1Laaq/Rap1atm1Laaq
(either: B6.Cg-Rap1atm1Laaq or (involves: C57BL/6))
|
abnormal leukocyte migration
|
J:140471
|
| abnormal macrophage physiology
|
J:140471
|
| abnormal neutrophil physiology
|
J:140471
|
Rap1atm1Tze/Rap1atm1Tze
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal leukocyte adhesion
|
J:144145
|
| decreased T cell proliferation
|
J:144145
|
Rap1gds1tm1Ytk/Rap1gds1tm1Ytk
(involves: 129X1/SvJ * C57BL/6 * DBA)
|
increased thymocyte apoptosis
|
J:62244
|
Rarres1tm1.2Mhl/Rarres1tm1.2Mhl
(involves: 129S1/SvImJ * C57BL/6 * FVB/N * NIH Black Swiss)
|
abnormal B cell activation
|
J:324270
|
| abnormal B cell physiology
|
J:324270
|
| decreased B cell apoptosis
|
J:324270
|
| increased B cell proliferation
|
J:324270
|
Rasa4tm1Ywh/Rasa4tm1Ywh
(B6.129S6-Rasa4tm1Ywh)
|
impaired macrophage phagocytosis
|
J:100455
|
Rasgrf2tm1Esn/Rasgrf2tm1Esn
Vav1tm1Tyb/Vav1tm1Tyb
(involves: 129S1/Sv * 129S2/SvPas * C57BL/10 * C57BR/cd)
|
abnormal T cell physiology
|
J:128985
|
| decreased T cell proliferation
|
J:128985
|
Rasgrp1lag/Rasgrp1lag
(involves: 129 * C57BL/6)
|
abnormal T cell physiology
|
J:85189
|
| decreased T cell proliferation
|
J:85189
|
| increased IgG level
|
J:85189
|
Rasgrp1m1Btlr/Rasgrp1m1Btlr
(C57BL/6J-Rasgrp1m1Btlr)
|
decreased IgM level
|
J:265163
|
| increased IgA level
|
J:265163
|
| increased IgE level
|
J:265163
|
| increased IgM level
|
J:265163
|
Rasgrp1m3Btlr/Rasgrp1m3Btlr
(C57BL/6J-Rasgrp1m3Btlr)
|
increased IgM level
|
J:265255
|
Rasgrp1tm1.1Wz/Rasgrp1tm1.1Wz
(B6.Cg-Rasgrp1tm1.1Wz)
|
abnormal immunoglobulin level
|
J:225109
|
| decreased T cell proliferation
|
J:225109
|
| increased IgE level
|
J:225109
|
| increased IgG1 level
|
J:225109
|
Rasgrp1tm1Jstn/Rasgrp1tm1Jstn
(involves: 129P3/J * C57BL/6J)
|
increased immunoglobulin level
|
J:108677
|
Rasgrp2tm1Amg/Rasgrp2tm1Amg
(Not Specified)
|
abnormal neutrophil physiology
|
J:122618
|
| impaired neutrophil recruitment
|
J:122618
|
Rasgrp3tm1Jstn/Rasgrp3tm1Jstn
(involves: 129P3/J * C57BL/6J)
|
decreased IgG1 level
|
J:108677
|
| decreased IgG2a level
|
J:108677
|
| decreased IgG level
|
J:108677
|
Rasgrp4tm1a(KOMP)Lste/Rasgrp4tm1a(KOMP)Lste
(involves: C57BL/6)
|
abnormal neutrophil physiology
|
J:186412
|
| impaired neutrophil chemotaxis
|
J:186412
|
Rasgrp4tm1d(KOMP)Lste/Rasgrp4tm1d(KOMP)Lste
(involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6)
|
abnormal neutrophil physiology
|
J:186412
|
| impaired neutrophil chemotaxis
|
J:186412
|
Rassf5tm1Kina/Rassf5tm1Kina
(involves: C57BL/6 * CBA * ICR)
|
abnormal dendritic cell physiology
|
J:92670
|
| abnormal leukocyte migration
|
J:92670
|
Rassf5tm1Kina/Rassf5tm1Kina
(B6.Cg-Rassf5tm1Kina)
|
abnormal lymphocyte physiology
|
J:168749
|
| increased B cell proliferation
|
J:168749
|
| increased IgG level
|
J:168749
|
| increased T cell proliferation
|
J:168749
|
Rbm4tm1a(EUCOMM)Hmgu/Rbm4+
(C57BL/6N-Rbm4tm1a(EUCOMM)Hmgu/Cnrm)
|
decreased IgG2b level
|
J:165965
|
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Lck-cre)19Hhan/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
abnormal regulatory T cell physiology
|
J:168475
|
| increased T cell proliferation
|
J:168475
|
Rc3h1san/Rc3h1+
(involves: C57BL/6JSfdAnu)
|
abnormal T follicular helper cell physiology
|
J:189087
|
| increased IgG level
|
J:189087
|
Rc3h1san/Rc3h1san
(involves: C57BL/6JSfdAnu)
|
increased T cell proliferation
|
J:199407
|
Rc3h1tm1.1Mass/Rc3h1tm1.1Mass
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca * NZB * SJL)
|
abnormal germinal center B cell physiology
|
J:177784
|
| decreased IgA level
|
J:177784
|
| decreased IgG1 level
|
J:177784
|
| decreased IgG3 level
|
J:177784
|
| increased IgG2b level
|
J:177784
|
Rc3h1tm1.1Mass/Rc3h1tm1.1Mass
Rc3h2tm1c(KOMP)Wtsi/Rc3h2tm1c(KOMP)Wtsi
Tg(Cd4-cre)1Cwi/?
(involves: C57BL/6N * DBA/2)
|
increased T cell proliferation
|
J:196136
|
Rc3h2tm1.2Cgv/Rc3h2tm1.2Cgv
(involves: C57BL/6)
|
increased macrophage cytokine production
|
J:196137
|
Rcan1tm1Fmc/Rcan1tm1Fmc
(involves: 129S4/SvJae)
|
abnormal T cell apoptosis
|
J:85148
|
| abnormal T-helper 1 physiology
|
J:85148
|
| decreased IgG2a level
|
J:85148
|
| decreased T cell proliferation
|
J:85148
|
Rcan1tm1Jmol/Rcan1tm1Jmol
Rcan2tm1Jmol/Rcan2tm1Jmol
(involves: 129 * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:109586
|
| decreased T cell proliferation
|
J:109586
|
Rcan1tm1Jmol/Rcan1tm1Jmol
Rcan2tm1Jmol/Rcan2tm1Jmol
Ppp3cbtm1Jmk/Ppp3cbtm1Jmk
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:109586
|
| decreased T cell proliferation
|
J:109586
|
Rcc1ltm1a(EUCOMM)Hmgu/Rcc1l+
(Not Specified)
|
decreased IgG1 level
|
J:165965
|
Reg3gtm1.1Lvh/Reg3gtm1.1Lvh
(B6.129-Reg3gtm1.1Lvh)
|
increased IgA level
|
J:177506
|
RelM1Btlr/Rel+
(C57BL/6J-RelM1Btlr)
|
decreased IgE level
|
J:236682
|
| decreased IgG level
|
J:236682
|
| decreased IgM level
|
J:236682
|
RelM1Btlr/RelM1Btlr
(C57BL/6J-RelM1Btlr)
|
decreased IgE level
|
J:236682
|
| decreased IgG level
|
J:236682
|
| decreased IgM level
|
J:236682
|
Relm3Btlr/Relm3Btlr
(C57BL/6J-Relm3Btlr)
|
decreased IgM level
|
J:272801
|
Reltm1Brv/Reltm1Brv
(involves: 129S1/Sv)
|
abnormal leukocyte physiology
|
J:46911
|
| abnormal macrophage physiology
|
J:46911
|
| abnormal T cell physiology
|
J:46911
|
| decreased IgG1 level
|
J:46911
|
| decreased IgG2b level
|
J:46911
|
| decreased IgG3 level
|
J:46911
|
| decreased IgG level
|
J:46911
|
| impaired macrophage chemotaxis
|
J:46911
|
| increased IgA level
|
J:46911
|
| increased IgG2a level
|
J:46911
|
| increased IgM level
|
J:46911
|
Reltm1Grd/Rel+
(involves: 129S1/Sv * C57BL/6)
|
decreased B cell proliferation
|
J:28435
|
Reltm1Grd/Reltm1Grd
(involves: 129S1/Sv * C57BL/6)
|
abnormal macrophage physiology
|
J:37541
|
| decreased B cell proliferation
|
J:28435
|
| decreased IgG1 level
|
J:28435
|
| decreased IgG2a level
|
J:28435
|
| decreased IgG2b level
|
J:28435
|
| decreased IgG3 level
|
J:28435
|
| decreased IgM level
|
J:28435
|
| decreased T cell proliferation
|
J:28435
|
Reltm1Hcl/Rel+
(involves: 129S4/SvJae * C57BL/6)
|
decreased T cell proliferation
|
J:53513
|
Reltm1Hcl/Reltm1Hcl
(involves: 129S4/SvJae * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:79107,
J:118907
|
| abnormal dendritic cell physiology
|
J:118907
|
| abnormal macrophage physiology
|
J:118907
|
| abnormal professional antigen presenting cell physiology
|
J:118907
|
| decreased B cell proliferation
|
J:75621
|
| decreased cytotoxic T cell cytolysis
|
J:53513
|
| decreased IgE level
|
J:58987
|
| decreased T cell proliferation
|
J:53513,
J:79107
|
Relatm1Yuo/Relatm1Yuo
(involves: 129S/SvEv)
|
abnormal lymphocyte physiology
|
J:63099
|
| decreased B cell proliferation
|
J:63099
|
| decreased IgA level
|
J:63099
|
| decreased IgG1 level
|
J:63099
|
| decreased T cell proliferation
|
J:63099
|
RelbTg(H2-K1/GH1)106Bri/RelbTg(H2-K1/GH1)106Bri
(C57BL/6-RelbTg(H2-K1/GH1)106Bri)
|
decreased T cell proliferation
|
J:76450
|
Relbtm1Brv/Relbtm1Brv
(involves: 129S2/SvPas * C57BL/6)
|
abnormal cytotoxic T cell physiology
|
J:40630
|
| abnormal immunoglobulin level
|
J:40630
|
| abnormal macrophage physiology
|
J:40630
|
| decreased B cell proliferation
|
J:40630
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:22675
|
| impaired neutrophil phagocytosis
|
J:40630
|
| increased IgE level
|
J:40630
|
| increased IgM level
|
J:40630
|
Relttm1Hlee/Relttm1Hlee
(Not Specified)
|
increased T cell proliferation
|
J:266480
|
Retnlatm1Mer/Retnlatm1Mer
(C57BL/6-Retnlatm1Mer)
|
impaired eosinophil recruitment
|
J:144784
|
Retnlatm1Mer/Retnlatm1Mer
(involves: C57BL/6)
|
abnormal macrophage physiology
|
J:147863
|
| abnormal T-helper 2 physiology
|
J:147863
|
| increased IgE level
|
J:147863
|
| increased IgG1 level
|
J:147863
|
Retnlbtm1Lex/Retnlbtm1Lex
(FVB.129S5-Retnlbtm1Lex)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:235058
|
Retnlbtm1Mer/Retnlbtm1Mer
(involves: 129S1/Sv)
|
decreased IgG2a level
|
J:141446
|
| increased IgG1 level
|
J:141446
|
Rev1tm1.1Jow/Rev1tm1.1Jow
(involves: C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:151700
|
Rev1tm1Ndew/Rev1tm1Ndew
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:119176
|
Rev3ltm1.1Kunk/Rev3ltm1.1Kunk
(involves: C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:188723
|
Rev3ltm1Rsky/Rev3ltm1.1Rsky
Tg(Cr2-cre)3Cgn/?
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:146453
|
| abnormal somatic hypermutation frequency
|
J:146453
|
| decreased B cell proliferation
|
J:146453
|
| decreased IgG1 level
|
J:146453
|
Rfktm1.1Jcbr/Rfktm1.1Jcbr
Tg(Mx1-cre)1Cgn/?
(involves: C57BL/6 * CBA)
|
decreased macrophage nitric oxide production
|
J:151999
|
Rftn1tm1Ayos/Rftn1tm1Ayos
(B6.Cg-Rftn1tm1Ayos)
|
decreased IgG2a level
|
J:150299
|
Rfx5tm1.1Ifo/Rfx5tm1.1Ifo
(involves: 129 * C57BL/6)
|
abnormal B lymphocyte antigen presentation
|
J:67941
|
| abnormal MHC II cell surface expression on macrophages
|
J:67941
|
| decreased IgG1 level
|
J:67941
|
| decreased IgM level
|
J:67941
|
Rfx5tm1Ifo/Rfx5tm1.1Ifo
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * C57BL/6 * C.B-20)
|
abnormal MHC II cell surface expression on macrophages
|
J:67924
|
Rfx7tm1.1Ggaur/Rfx7tm1.1Ggaur
Ncr1tm1.1(icre)Viv/Ncr1+
(involves: C57BL/6)
|
abnormal NK cell physiology
|
J:282535
|
Rgcctm1Hrus/Rgcctm1Hrus
(involves: 129S6/SvEvTac * C57BL/6)
|
increased T cell proliferation
|
J:279555
|
Rgs1tm1Jhk/Rgs1tm1Jhk
(B6.129P2-Rgs1tm1Jhk)
|
abnormal B cell calcium ion homeostasis
|
J:90780
|
| abnormal dendritic cell physiology
|
J:89680
|
| enhanced B cell migration
|
J:90780
|
| increased immunoglobulin level
|
J:90780
|
Rgs2tm1Pngr/Rgs2tm1Pngr
(involves: C57BL/6J)
|
abnormal T cell proliferation
|
J:77273
|
Rgs3tm1Ndul/Rgs3tm1Ndul
(B6.129-Rgs3tm1Ndul)
|
increased susceptibility to type I hypersensitivity reaction
|
J:210195
|
Rgs4tm1Sdlk/Rgs4tm1Sdlk
Tg(Myh11-icre/ERT2)1Soff/?
(involves: FVB/N)
|
abnormal macrophage chemotaxis
|
J:215588
|
Rgs13tm1.1Jhk/Rgs13tm1.1Jhk
(involves: C57BL/6)
|
increased IgA level
|
J:199530
|
| increased IgG1 level
|
J:199530
|
| increased IgG2b level
|
J:199530
|
| increased IgG2c level
|
J:199530
|
| increased IgG3 level
|
J:199530
|
| increased IgM level
|
J:199530
|
Rgs13tm1Drue/Rgs13tm1Drue
(B6.129S-Rgs13tm1Drue)
|
abnormal mast cell physiology
|
J:130209
|
| increased susceptibility to type I hypersensitivity reaction
|
J:130209
|
Rgs16tm1.1Drue/Rgs16tm1.1Drue
(involves: C57BL/6)
|
abnormal T-helper 1 physiology
|
J:188966
|
| abnormal T-helper 2 physiology
|
J:188966
|
Rgsc844/Rgsc844+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
abnormal neutrophil physiology
|
J:133634
|
Rgsc1045/Rgsc1045+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
abnormal neutrophil physiology
|
J:133634
|
Rgsc1354/Rgsc1354+
(involves: C3H * C57BL/6JJcl)
|
abnormal neutrophil physiology
|
J:133634
|
Rhbdd3tm1Caox/Rhbdd3tm1Caox
(B6.129S6-Rhbdd3tm1Caox)
|
abnormal dendritic cell physiology
|
J:197348
|
| increased natural killer cell mediated cytotoxicity
|
J:197348
|
Rhbdf2tm1Mak/Rhbdf2tm1Mak
(B6.129P2-Rhbdf2tm1Mak)
|
abnormal B cell physiology
|
J:179653
|
Rhbdf2tm1Mak/Rhbdf2tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal leukocyte physiology
|
J:221411
|
| abnormal microglial cell physiology
|
J:221411
|
Rhoatm1.1Tpal/Rhoa+
Tg(Cd4-cre/ERT2)11Gnri/0
(involves: C57BL/6)
|
increased T cell proliferation
|
J:257764
|
Rhogtm1Tnr/Rhogtm1Tnr
(involves: 129)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:87580
|
| abnormal leukocyte physiology
|
J:87580
|
| abnormal T-helper 2 physiology
|
J:87580
|
| increased B cell proliferation
|
J:87580
|
| increased immunoglobulin level
|
J:87580
|
Rhohtm1Brak/Rhohtm1Brak
(involves: 129/Sv * C57BL/6)
|
abnormal T cell proliferation
|
J:143161
|
| decreased T cell apoptosis
|
J:143161
|
| decreased T cell proliferation
|
J:143161
|
| increased T cell proliferation
|
J:143161
|
Rhohtm1Hasu/Rhohtm1Hasu
(B6.Cg-Rhohtm1Hasu)
|
abnormal mast cell physiology
|
J:143491
|
| decreased mast cell degranulation
|
J:143491
|
| decreased susceptibility to type I hypersensitivity reaction
|
J:143491
|
Rictortm1.1Klg/Rictortm1.1Klg
Tg(Mx1-cre)1Cgn/0
(B6.Cg-Rictortm1.1Klg Tg(Mx1-cre)1Cgn)
|
decreased T cell proliferation
|
J:189736
|
Rif1Gt(XT0278)Wtsi/Rif1Gt(XT0278)Wtsi
(involves: 129P2/OlaHsd * CD-1 * MF1)
|
abnormal class switch recombination
|
J:195061
|
| decreased IgA level
|
J:195061
|
| decreased IgG1 level
|
J:195061
|
| decreased IgG2b level
|
J:195061
|
| decreased IgG3 level
|
J:195061
|
| decreased IgG level
|
J:195061
|
Rigitm1Aki/Rigitm1Aki
(involves: 129/Sv * C57BL/6)
|
abnormal dendritic cell physiology
|
J:137522
|
Rigitm1Zgwg/Rigitm1Zgwg
(involves: 129S1/Sv)
|
abnormal granulocyte physiology
|
J:139016
|
Riok2tm1c(KOMP)Wtsi/Riok2+
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6N * C57BL/10 * CBA/Ca)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:305794
|
Riox2tm1Mtsun/Riox2tm1Mtsun
(B6CrSlc.Cg-Riox2tm1Mtsun)
|
abnormal immunoglobulin level
|
J:201871
|
Ripk1tm1.1Vmd/Ripk1tm1.1Vmd
(involves: C57BL/6N)
|
increased thymocyte apoptosis
|
J:209137
|
Ripk2tm1Cfl/Ripk2tm1Cfl
(involves: 129S5/SvEvBrd)
|
abnormal macrophage physiology
|
J:107130
|
Ripk2tm1Flv/Ripk2tm1Flv
(involves: 129S1/Sv)
|
abnormal T-helper 1 physiology
|
J:75400
|
| decreased T cell proliferation
|
J:75400
|
Ripk2tm1Flv/Ripk2tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
abnormal macrophage physiology
|
J:132126
|
Ripk2tm1Ghc/Ripk2tm1Ghc
(involves: 129S4/SvJae * C57BL/6)
|
decreased IgG2a level
|
J:75401
|
| decreased T cell proliferation
|
J:75401
|
Rnaseh2btm1c(EUCOMM)Wtsi/Rnaseh2btm1c(EUCOMM)Wtsi
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N * SJL)
|
decreased B cell proliferation
|
J:186986
|
Rnaseltm1Slvm/Rnaseltm1Slvm
(involves: 129P2/OlaHsd)
|
decreased T cell apoptosis
|
J:44292
|
Rnf8Gt(AS0574)Wtsi/Rnf8+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:161240
|
Rnf8Gt(AS0574)Wtsi/Rnf8Gt(AS0574)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:161240
|
| decreased IgG1 level
|
J:161240
|
| decreased IgG2b level
|
J:161240
|
| decreased IgG3 level
|
J:161240
|
| increased thymocyte apoptosis
|
J:161240
|
Rnf8Gt(RRR260)Byg/Rnf8Gt(RRR260)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:161240
|
| decreased IgG1 level
|
J:161240
|
| decreased IgG2b level
|
J:161240
|
| decreased IgG3 level
|
J:161240
|
| increased thymocyte apoptosis
|
J:161240
|
Rnf19btm1Jkorn/Rnf19btm1Jkorn
(B6.129S-Rnf19btm1Jkorn)
|
impaired natural killer cell mediated cytotoxicity
|
J:157393
|
Rnf20Gt(RRJ249)Byg/Rnf20+
(involves: 129P2/OlaHsd)
|
abnormal leukocyte physiology
|
J:268221
|
| abnormal T cell physiology
|
J:268221
|
Rnf31tm1.1Kiwa/Rnf31tm1.1Kiwa
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6NCrlj * CBA/JNCrlj)
|
decreased IgA level
|
J:201885
|
| decreased IgG1 level
|
J:201885
|
| decreased IgG2a level
|
J:201885
|
| decreased IgG2b level
|
J:201885
|
| decreased IgG3 level
|
J:201885
|
| decreased IgM level
|
J:201885
|
Rnf128tm1.1Flv/Y
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:153216
|
| increased T cell proliferation
|
J:153216
|
Rnf128tm1.1Flv/Y
Tg(TcraTcrb)425Cbn/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
|
decreased T cell proliferation
|
J:153216
|
Rnf128tm1.1Flv/Rnf128tm1.1Flv
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:153216
|
| increased T cell proliferation
|
J:153216
|
Rnf128tm1.1Flv/Rnf128tm1.1Flv
Tg(TcraTcrb)425Cbn/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
|
decreased T cell proliferation
|
J:153216
|
Rnf128tm1.2Cmse/Rnf128tm1.2Cmse
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal macrophage physiology
|
J:245025
|
Rnf128tm1Cdon/Rnf128tm1Cdon
(involves: C57BL/6)
|
increased T cell proliferation
|
J:160681
|
Rnf128tm1Cdon/Rnf128tm1Cdon
(involves: 129 * C57BL/6)
|
abnormal regulatory T cell physiology
|
J:160681
|
| increased IgG1 level
|
J:160681
|
| increased IgM level
|
J:160681
|
Rnf168Gt(156B6)Cmhd/Rnf168Gt(156B6)Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal class switch recombination
|
J:198260
|
| decreased IgG1 level
|
J:198260
|
| decreased IgG2a level
|
J:198260
|
| decreased IgG3 level
|
J:198260
|
| decreased IgG level
|
J:198260
|
Rnf168Gt(405F11)Cmhd/Rnf168Gt(405F11)Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal class switch recombination
|
J:198260
|
| decreased IgG1 level
|
J:198260
|
| decreased IgG2a level
|
J:198260
|
| decreased IgG3 level
|
J:198260
|
| decreased IgG level
|
J:198260
|
Ro60tm1Woln/Ro60+
(involves: 129S1/Sv * C57BL/6)
|
increased IgG2a level
|
J:84627
|
Ro60tm1Woln/Ro60tm1Woln
(involves: 129S1/Sv * C57BL/6)
|
increased IgG2a level
|
J:84627
|
| increased IgM level
|
J:84627
|
Rock1tm1Liao/Rock1+
(C57BL/6-Rock1tm1Liao)
|
abnormal leukocyte adhesion
|
J:135152
|
| abnormal leukocyte migration
|
J:135152
|
| impaired macrophage chemotaxis
|
J:135152
|
| impaired neutrophil recruitment
|
J:135152
|
Rorasg/Rorasg
(involves: C57BL/6)
|
abnormal macrophage physiology
|
J:28095
|
| increased IgE level
|
J:135863
|
Rorcm2Btlr/Rorcm2Btlr
(C57BL/6J-Rorcm2Btlr)
|
decreased IgM level
|
J:217792
|
Rorcm3Btlr/Rorcm3Btlr
(C57BL/6J-Rorcm3Btlr)
|
decreased IgG level
|
J:234257
|
| decreased IgM level
|
J:234257
|
Rorctm1Amj/Rorctm1Amj
(either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * C57BL/6 * DBA/2))
|
abnormal T cell physiology
|
J:64381
|
| increased T cell apoptosis
|
J:64381
|
Rorctm1Litt/Rorctm1Litt
(involves: 129P2/OlaHsd)
|
increased thymocyte apoptosis
|
J:248565
|
Rorctm2Litt/Rorctm2Litt
(involves: 129P2/OlaHsd)
|
increased thymocyte apoptosis
|
J:87395
|
Rosq1DBA/1J/Rosq1DBA/1J
(involves: DBA/1J * FVB/NJ)
|
abnormal neutrophil physiology
|
J:122919
|
Rosq1DBA/1J/Rosq1FVB/NJ
(involves: DBA/1J * FVB/NJ)
|
abnormal neutrophil physiology
|
J:122919
|
Rpl13atm1.1Mazu/Rpl13atm1.1Mazu
Lyz2tm1(cre)Ifo/Lyz2+
(involves: C57BL/6)
|
abnormal macrophage chemotaxis
|
J:194920
|
Rpl22Gt(GST000137)Lex/Rpl22Gt(GST000137)Lex
(involves: 129S5/SvEvBrd)
|
increased T cell apoptosis
|
J:123569
|
Rps6ka4tm1Jsca/Rps6ka4tm1Jsca
Rps6ka5tm1Jsca/Rps6ka5tm1Jsca
(Not Specified)
|
decreased T cell proliferation
|
J:124301
|
Rps27lGt(IST11658B7)Tigm/Rps27lGt(IST11658B7)Tigm
(C57BL/6-Rps27lGt(IST11658B7)Tigm)
|
increased thymocyte apoptosis
|
J:223276
|
Rr79em2Rtew/Rr79em2Rtew
(C57BL/6J-Rr79em2Rtew/J)
|
abnormal T cell activation
|
J:332957
|
| abnormal T cell physiology
|
J:332957
|
Rr79em2Rtew/Rr79em2Rtew
Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6J)
|
abnormal T cell activation
|
J:332957
|
Rr152tm2Cog/Rr152+
(involves: 129S2/SvPas * C57BL/6)
|
decreased IgG1 level
|
J:90548
|
| decreased IgG2b level
|
J:90548
|
| decreased IgG3 level
|
J:90548
|
| decreased IgG level
|
J:90548
|
Rr152tm2Cog/Rr152tm2Cog
(involves: 129S2/SvPas * C57BL/6)
|
decreased IgG1 level
|
J:90548
|
| decreased IgG2a level
|
J:90548
|
| decreased IgG2b level
|
J:90548
|
| decreased IgG3 level
|
J:90548
|
| decreased IgG level
|
J:90548
|
Rr152tm3.1Cog/Rr152tm3.1Cog
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal class switch recombination
|
J:71300
|
| decreased IgA level
|
J:71300
|
| decreased IgE level
|
J:71300
|
| decreased IgG2a level
|
J:71300
|
| decreased IgG2b level
|
J:71300
|
| decreased IgG3 level
|
J:71300
|
| decreased IgG level
|
J:71300
|
| decreased immunoglobulin level
|
J:71300
|
Rr152tm3Cog/Rr152tm3Cog
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:71300
|
| decreased IgA level
|
J:71300
|
| decreased IgE level
|
J:71300
|
| decreased IgG1 level
|
J:71300
|
| decreased IgG2a level
|
J:71300
|
| decreased IgG2b level
|
J:71300
|
| decreased IgG3 level
|
J:71300
|
| decreased IgG level
|
J:71300
|
| decreased IgM level
|
J:71300
|
| decreased immunoglobulin level
|
J:71300
|
Rr152tm5.1Cog/Rr152tm5.1Cog
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:164513
|
| abnormal somatic hypermutation frequency
|
J:164513,
J:333348
|
| decreased IgA level
|
J:164513
|
| decreased IgE level
|
J:164513
|
| decreased IgG2b level
|
J:164513
|
| decreased IgG3 level
|
J:164513
|
| decreased IgM level
|
J:164513
|
Rr155tm1.1Erpi/Rr155tm1.1Erpi
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal immunoglobulin level
|
J:160101
|
| decreased IgG1 level
|
J:160101
|
| decreased IgG2a level
|
J:160101
|
Rr156tm6.1Cog/Rr156tm6.1Cog
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased IgM level
|
J:165617
|
Rr156tm6Cog/Rr156tm6Cog
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased IgM level
|
J:165617
|
Rr160tm1Wtg/Rr160tm1Wtg
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal immunoglobulin level
|
J:134885
|
| abnormal somatic hypermutation frequency
|
J:134885
|
Rr166tm4.1Wtg/Rr166tm4.1Wtg
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
abnormal B cell physiology
|
J:193015
|
| abnormal immunoglobulin level
|
J:193015
|
Rr170tm1.1Iku/Rr170tm1.1Iku
(B6.Cg-Rr170tm1.1Iku)
|
decreased T cell proliferation
|
J:333539
|
| increased T cell apoptosis
|
J:333539
|
Rr253em1Kmm/Rr253em1Kmm
(C57BL/6-Rr253em1Kmm)
|
abnormal class switch recombination
|
J:316113
|
Rr253em6Kmm/Rr253em6Kmm
(C57BL/6J-Rr253em6Kmm)
|
abnormal T-helper 2 physiology
|
J:334296
|
Rr364tm1.1Aak/Rr364tm1.1Aak
(129.129S2(Cg)-Rr364tm1.1Aak)
|
abnormal class switch recombination
|
J:242276
|
| decreased IgG3 level
|
J:242276
|
| increased IgG2a level
|
J:242276
|
| increased IgG2b level
|
J:242276
|
Rr395em1Bhao/Rr395em1Bhao
(Not Specified)
|
increased thymocyte apoptosis
|
J:333961
|
Rr250409tm1Lky/Rr250409tm1Lky
(involves: 129X1/SvJ * BALB/c * C57BL/6 * FVB)
|
decreased IgE level
|
J:125684
|
Rragcem1Efe/Rragc+
(Not Specified)
|
abnormal B cell activation
|
J:320567
|
| abnormal B cell physiology
|
J:320567
|
| abnormal class switch recombination
|
J:320567
|
| decreased B cell proliferation
|
J:320567
|
| decreased IgG1 level
|
J:320567
|
| decreased IgM level
|
J:320567
|
Rras2Gt(OST361011)Lex/Rras2Gt(OST361011)Lex
(involves: 129S5/SvEvBrd)
|
abnormal B cell activation
|
J:151653
|
| abnormal B cell physiology
|
J:151653
|
| abnormal CD4-positive, alpha-beta T cell physiology
|
J:151653
|
| abnormal CD8-positive, alpha-beta T cell physiology
|
J:151653
|
| decreased B cell proliferation
|
J:151653
|
Rrastm1Itl/Rrastm1Itl
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal dendritic cell physiology
|
J:181730
|
Rsad2tm1Kchc/Rsad2tm1Kchc
(B6.129-Rsad2tm1Kchc)
|
decreased IgG1 level
|
J:148305
|
Rsph9em1Jwji/Rsph9em1Jwji
(B6.Cg-Rsph9em1Jwji)
|
increased microglial cell activation
|
J:294184
|
Rtcbtm1c(KOMP)Wtsi/Rtcbtm1c(KOMP)Wtsi
Tg(Fcer2a-cre)5Mbu/0
(involves: C57BL/6 * CBA * SJL)
|
abnormal B cell physiology
|
J:216740
|
| decreased IgM level
|
J:216740
|
Rubcnem1Dgre/Rubcnem1Dgre
(C57BL/6-Rubcnem1Dgre)
|
abnormal macrophage physiology
|
J:261225
|
Rubcnem1Dgre/Rubcnem1Dgre
(involves: C57BL/6 * C57BL/6N)
|
abnormal macrophage physiology
|
J:235399
|
| increased IgG level
|
J:235399
|
Rubcnem1Dgre/Rubcnem1Dgre
Tg(CAG-EGFP/Map1lc3b)53Nmz/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * C57BL/6NCrlj * DBA/2)
|
abnormal macrophage physiology
|
J:261225
|
Rubcnem1Dgre/Rubcnem1Dgre
Tg(CAG-EGFP/Map1lc3b)53Nmz/0
(involves: C57BL/6 * C57BL/6N * DBA/2)
|
abnormal macrophage physiology
|
J:235399
|
Runx1tm1Yg/Runx1tm1Yg
(either: (involves: 129/Sv * 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1))
|
increased thymocyte apoptosis
|
J:125830
|
Runx3tm1Itan/Runx3tm1Itan
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
increased IgA level
|
J:125953
|
Runx3tm1Yg/Runx3tm1Yg
(either: (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1))
|
abnormal dendritic cell physiology
|
J:88424,
J:100348
|
| increased IgE level
|
J:100348
|
Ruvbl2M1Btlr/Ruvbl2+
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| decreased IgG1 level
|
J:185495
|
| decreased IgG level
|
J:185495
|
| decreased IgM level
|
J:185495
|
Rxfp2tm1a(EUCOMM)Wtsi/Rxfp2tm1a(EUCOMM)Wtsi
(C57BL/6N-Rxfp2tm1a(EUCOMM)Wtsi/Ieg)
|
decreased IgE level
|
J:165965
|
Rxrapke/Rxrapke
(C57BL/6J-Rxrapke)
|
abnormal dendritic cell physiology
|
J:103186
|
| abnormal regulatory T cell physiology
|
J:103186
|
Rxratm1Ipc/Rxratm4Ipc
Rxrbtm1Mma/Rxrbtm1Pcn
Tg(KRT14-cre/ERT2)1Ipc/0
(involves: 129S2/SvPas)
|
increased immunoglobulin level
|
J:102470
|
Rxratm1Krc/Rxratm1Krc
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal macrophage activation involved in immune response
|
J:168799
|
| impaired macrophage phagocytosis
|
J:168799
|
| increased IgG level
|
J:168799
|
| increased IgM level
|
J:168799
|
S1pr1tm1.1Cys/S1pr1tm1.1Cys
(involves: 129P2/OlaHsd * C3H * C57BL/6)
|
abnormal B cell physiology
|
J:176118
|
S1pr1tm1.1Thla/S1pr1tm1.1Thla
(B6.Cg-S1pr1tm1.1Thla)
|
abnormal leukocyte migration
|
J:163389
|
| abnormal lymphocyte physiology
|
J:163389
|
S1pr1tm1Cys/S1pr1tm1Cys
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:176118
|
S1pr2tm1Rlp/S1pr2tm1Rlp
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased B cell apoptosis
|
J:174313
|
| increased B cell proliferation
|
J:174313
|
S1pr3tm1Rlp/S1pr3tm1Rlp
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal B cell physiology
|
J:91161
|
S1pr5tm1Club/S1pr5tm1Club
(B6.129P2-S1pr5tm1Club)
|
abnormal NK cell physiology
|
J:178789
|
S100a4tm1.1Abres/S100a4tm1.1Abres
(B6.Cg-S100a4tm1.1Abres)
|
abnormal eosinophil physiology
|
J:182865
|
| impaired macrophage chemotaxis
|
J:182865
|
S100a9tm1Hogg/S100a9tm1Hogg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal neutrophil physiology
|
J:82513
|
S100a9tm1Nck/S100a9tm1Nck
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal cellular extravasation
|
J:81642
|
Sac3d1tm1Hnaka/Sac3d1+
(involves: 129P2/OlaHsd)
|
abnormal mast cell physiology
|
J:144601
|
Sac3d1tm1Hnaka/Sac3d1tm1Hnaka
(involves: 129P2/OlaHsd)
|
abnormal B cell physiology
|
J:144601
|
| abnormal mast cell physiology
|
J:144601
|
| increased T cell proliferation
|
J:144601
|
Samsn1tm1Xyw/Samsn1tm1Xyw
(B6.129P2-Samsn1tm1Xyw)
|
abnormal dendritic cell physiology
|
J:158032
|
| abnormal T-helper 1 physiology
|
J:158032
|
| abnormal T-helper 2 physiology
|
J:158032
|
| increased B cell proliferation
|
J:158032
|
| increased IgG3 level
|
J:158032
|
| increased IgM level
|
J:158032
|
| increased T cell proliferation
|
J:158032
|
Sarm1tm1.1Diam/Sarm1tm1.1Diam
(involves: 129X1/SvJ * C57BL/6)
|
decreased microglial cell activation
|
J:200140
|
Sash3tm1Hlz/Sash3tm1Hlz
(B6.129P2-Sash3tm1Hlz)
|
abnormal B cell physiology
|
J:102171
|
| abnormal marginal zone B cell physiology
|
J:102171
|
| decreased IgG1 level
|
J:102171
|
| decreased IgG2a level
|
J:102171
|
| decreased IgG level
|
J:102171
|
| decreased IgM level
|
J:102171
|
| decreased T cell proliferation
|
J:102171
|
Satb1tm1Kos/Satb1tm1Kos
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell proliferation
|
J:61085
|
Sbno2tm1.1Aki/Sbno2tm1.1Aki
(involves: 129 * C57BL/6)
|
abnormal osteoclast physiology
|
J:202853
|
Sbsnem1Ham/Sbsnem1Ham
(C57BL/6N-Sbsnem1Ham)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:296400
|
| increased susceptibility to type IV hypersensitivity reaction
|
J:296400
|
Scarf1tm1Tkms/Scarf1tm1Tkms
(involves: C57BL/6)
|
abnormal B cell physiology
|
J:208237
|
| abnormal dendritic cell physiology
|
J:208237
|
| impaired macrophage phagocytosis
|
J:208237
|
| increased IgG level
|
J:208237
|
Scgb1a1tm1Abm/Scgb1a1+
(involves: 129S1/Sv * 129X1/SvJ)
|
increased IgA level
|
J:57504
|
Scgb1a1tm1Abm/Scgb1a1tm1Abm
(involves: 129S1/Sv * 129X1/SvJ)
|
increased IgA level
|
J:57504
|
Scintm1Glog/Scintm1Glog
Tg(Acp5-cre)4Rda/0
(either: (involves: 129 * C57BL/6) or (involves: 129 * C57BL/6 * CBA))
|
abnormal osteoclast physiology
|
J:223220
|
Sdc1tm1Cma/Sdc1tm1Cma
(involves: 129S4/SvJae)
|
decreased IgG1 level
|
J:107378
|
Sectm1aem1Gcfa/Sectm1aem1Gcfa
(C57BL/6-Sectm1aem1Gcfa)
|
abnormal macrophage physiology
|
J:317204
|
Seletm1Dmil/Seletm1Dmil
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal leukocyte adhesion
|
J:113169
|
Seletm1Hyn/Seletm1Hyn
Selltm1Hyn/Selltm1Hyn
Selptm1Hyn/Selptm1Hyn
(involves: 129S2/SvPas * C57BL/6)
|
impaired eosinophil recruitment
|
J:57973
|
| impaired leukocyte tethering or rolling
|
J:57973
|
| impaired neutrophil recruitment
|
J:57973
|
Seletm1Hyn/Seletm1Hyn
Selptm1Hyn/Selptm1Hyn
(involves: 129S2/SvPas)
|
impaired leukocyte tethering or rolling
|
J:31626
|
| impaired neutrophil recruitment
|
J:31626
|
Seletm1Hyn/Seletm1Hyn
Selptm1Hyn/Selptm1Hyn
(involves: 129S2/SvPas * C57BL/6)
|
impaired eosinophil recruitment
|
J:57973
|
| impaired leukocyte tethering or rolling
|
J:57973
|
| impaired neutrophil recruitment
|
J:57973
|
Seletm1Roml/Seletm1Roml
(involves: 129S1/Sv * C57BL/6)
|
abnormal T cell physiology
|
J:113536
|
Seletm1Roml/Seletm1Roml
(involves: 129S1/Sv)
|
abnormal T cell physiology
|
J:113536
|
Seletm2Alb/Seletm2Alb
Selltm2Alb/Selltm2Alb
Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal cellular extravasation
|
J:70682
|
| impaired leukocyte tethering or rolling
|
J:70682
|
Seletm2Alb/Seletm2Alb
Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal neutrophil physiology
|
J:112286
|
| impaired leukocyte tethering or rolling
|
J:70682
|
Seletm2Hyn/Seletm2Hyn
(involves: 129S2/SvPas * C57BL/6)
|
enhanced leukocyte tethering or rolling
|
J:57973
|
| impaired neutrophil recruitment
|
J:57973
|
Seletm2Hyn/Seletm2Hyn
(B6.129S2-Seletm2Hyn)
|
abnormal type IV hypersensitivity reaction
|
J:121083
|
Selenoktm1.2Itl/Selenoktm1.2Itl
(involves: BALB/cJ * C57BL/6)
|
abnormal macrophage physiology
|
J:169169
|
| abnormal neutrophil physiology
|
J:169169
|
| abnormal T cell physiology
|
J:169169
|
| decreased T cell proliferation
|
J:169169
|
| impaired neutrophil chemotaxis
|
J:169169
|
Selltm1.1Rpmc/Selltm1.1Rpmc
(involves: 129S1/Sv * C57BL/6J * FVB/N)
|
abnormal granulocyte physiology
|
J:249558
|
| abnormal neutrophil physiology
|
J:249558
|
Selltm1Flv/Selltm1Flv
(involves: 129S2/SvPas * C57BL/6)
|
abnormal type IV hypersensitivity reaction
|
J:89253
|
Selltm1Pest/Sell+
(involves: 129S4/SvJae * C57BL/6)
|
impaired leukocyte tethering or rolling
|
J:112550
|
Selltm1Pest/Selltm1Pest
(involves: 129S4/SvJae)
|
abnormal leukocyte adhesion
|
J:111233
|
| impaired leukocyte tethering or rolling
|
J:111233
|
| increased T cell proliferation
|
J:111233
|
Selltm1Pest/Selltm1Pest
(involves: 129S4/SvJae * C57BL/6)
|
abnormal dendritic cell physiology
|
J:112550
|
| abnormal leukocyte migration
|
J:112550
|
| decreased T cell proliferation
|
J:112550
|
| impaired leukocyte tethering or rolling
|
J:112550
|
Selltm1Tft/Selltm1Tft
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal cellular extravasation
|
J:25005
|
| abnormal leukocyte migration
|
J:25005
|
| impaired leukocyte tethering or rolling
|
J:25005
|
Selltm1Tft/Selltm1Tft
(B6.129-Selltm1Tft)
|
abnormal cellular extravasation
|
J:66107
|
| abnormal leukocyte migration
|
J:66107
|
Selltm1Tft/Selltm1Tft
(B6.129P2-Selltm1Tft)
|
abnormal cellular extravasation
|
J:48271
|
| abnormal regulatory T cell physiology
|
J:141931
|
| impaired leukocyte tethering or rolling
|
J:48271
|
Selltm2.1Tft/Selltm2.1Tft
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal neutrophil physiology
|
J:142184
|
Selltm2Hyn/Selltm2Hyn
(involves: 129S2/SvPas * C57BL/6)
|
impaired leukocyte tethering or rolling
|
J:57973
|
| impaired neutrophil recruitment
|
J:57973
|
Selltm2Hyn/Selltm2Hyn
(involves: 129S2/SvPas * BALB/c)
|
impaired leukocyte tethering or rolling
|
J:114317
|
Selltm2Tft/Selltm2.1Tft
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal leukocyte migration
|
J:142184
|
| abnormal neutrophil physiology
|
J:142184
|
| abnormal regulatory T cell physiology
|
J:141931
|
| impaired leukocyte tethering or rolling
|
J:142184
|
Selltm3Hyn/Selltm3Hyn
Selptm1Hyn/Selptm1Hyn
(involves: 129S2/SvPas * C57BL/6)
|
impaired eosinophil recruitment
|
J:57973
|
| impaired leukocyte tethering or rolling
|
J:57973
|
| impaired neutrophil recruitment
|
J:57973
|
Selltm4Hyn/Selltm4Hyn
Selptm1Hyn/Selptm1Hyn
(involves: 129S2/SvPas * C57BL/6)
|
impaired leukocyte tethering or rolling
|
J:57973
|
| impaired neutrophil recruitment
|
J:57973
|
Selptm1.1Rpmc/Selptm1.1Rpmc
(B6.129S1-Selptm1.1Rpmc)
|
impaired leukocyte tethering or rolling
|
J:230041
|
Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal leukocyte migration
|
J:24239
|
Selptm1Bay/Selptm1Bay
(D1.129S7(B6J)-Selptm1Bay)
|
increased IgG level
|
J:57086
|
Selptm1Bay/Selptm1Bay
(B6.129S7-Selptm1Bay/J)
|
abnormal T cell physiology
|
J:113536
|
Selptm1Bay/Selptm1Bay
(either: B6.129S7-Selptm1Bay or (involves: 129S7/SvEvBrd * C57BL/6))
|
abnormal leukocyte tethering or rolling
|
J:31374
|
Selptm1Bay/Selptm1Bay
(B6.129S7-Selptm1Bay)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:121083
|
Selptm1Hyn/Selptm1Hyn
(involves: 129S2/SvPas * C57BL/6J)
|
impaired leukocyte tethering or rolling
|
J:77329
|
| impaired neutrophil recruitment
|
J:77329
|
Selptm1Hyn/Selptm1Hyn
(involves: 129S2/SvPas)
|
impaired leukocyte tethering or rolling
|
J:29814
|
| impaired macrophage chemotaxis
|
J:29814
|
Selptm1Hyn/Selptm1Hyn
(involves: 129S2/SvPas * C57BL/6)
|
impaired eosinophil recruitment
|
J:57973
|
| impaired leukocyte tethering or rolling
|
J:57973
|
| impaired neutrophil recruitment
|
J:57973
|
Selptm2Hyn/Selptm2Hyn
(involves: 129S2/SvPas * C57BL/6J)
|
impaired leukocyte tethering or rolling
|
J:51068
|
| impaired neutrophil recruitment
|
J:51068
|
Selplgtm1Fur/Selplgtm1Fur
(involves: 129/Sv * C57BL/6J * SJL)
|
impaired leukocyte tethering or rolling
|
J:75412
|
| impaired neutrophil chemotaxis
|
J:75412
|
Selplgtm1Rpmc/Selplgtm1Rpmc
(involves: 129S1/Sv * C57BL/6J)
|
abnormal leukocyte adhesion
|
J:75829
|
| impaired leukocyte tethering or rolling
|
J:75829,
J:138731
|
Selplgtm2Rpmc/Selplgtm2Rpmc
(B6.Cg-Selplgtm2Rpmc)
|
impaired leukocyte tethering or rolling
|
J:138731
|
Sema3atm1.1Tyag/Sema3atm1.1Tyag
(involves: C57BL/6 * CBA)
|
abnormal dendritic cell physiology
|
J:161856
|
| abnormal T cell physiology
|
J:161856
|
Sema4atm1Kik/Sema4atm1Kik
(either: B6.Cg-Sema4atm1Kik or C.Cg-Sema4atm1Kik)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:97027
|
| abnormal dendritic cell antigen presentation
|
J:97027
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:97027
|
Sema4btm1Akum/Sema4btm1Akum
(either: B6.Cg-Sema4btm1Akum or C.Cg-Sema4btm1Akum)
|
increased IgE level
|
J:169386
|
| increased IgG1 level
|
J:169386
|
Sema4dtm1Kik/Sema4dtm1Kik
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal immunoglobulin level
|
J:66033
|
| decreased B cell proliferation
|
J:66033
|
Septin9tm2.1Emfu/Septin9tm2.1Emfu
Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA)
|
decreased T cell proliferation
|
J:205027
|
Serpina3gtm1.1Arp/Serpina3gtm1.1Arp
(involves: C57BL/6)
|
decreased T cell proliferation
|
J:189782
|
Serpina3gtm1.1Arp/Serpina3gtm1.1Arp
Tg(TcrLCMV)#Sdz/0
(involves: C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:189782
|
Serpinb1atm1.1Cben/Serpinb1atm1.1Cben
(129S6/SvEvTac-Serpinb1atm1.1Cben)
|
abnormal neutrophil physiology
|
J:125918
|
| impaired neutrophil chemotaxis
|
J:125918
|
Serpinb3atm1Gsil/Serpinb3atm1Gsil
(C.129-Serpinb3atm1Gsil)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:189949
|
Serpinb9tm1.1Pib/Serpinb9tm1.1Pib
(involves: BALB/cJ * C57BL/6J)
|
abnormal dendritic cell antigen presentation
|
J:252016
|
| decreased cytotoxic T cell apoptosis
|
J:252016
|
Serpinb9tm1Arp/Serpinb9tm1Arp
(involves: C57BL/6)
|
abnormal cytotoxic T cell physiology
|
J:113349
|
| decreased cytotoxic T cell cytolysis
|
J:113349
|
Sertad2Gt(OST98734)Lex/Sertad2Gt(OST98734)Lex
(B6.129S5-Sertad2Gt(OST98734)Lex)
|
abnormal macrophage physiology
|
J:194928
|
Sesn1tm1a(EUCOMM)Wtsi/Sesn1tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
abnormal class switch recombination
|
J:240602
|
| increased immunoglobulin level
|
J:240602
|
| increased T cell proliferation
|
J:240602
|
Setd4tm1b(KOMP)Wtsi/Setd4tm1b(KOMP)Wtsi
(involves: C57BL/6N)
|
decreased macrophage cytokine production
|
J:304151
|
Sfntm1Mak/Sfntm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased IgG level
|
J:168328
|
| decreased IgM level
|
J:168328
|
| increased B cell apoptosis
|
J:168328
|
| increased B cell proliferation
|
J:168328
|
Sftpdtm1Haw/Sftpdtm1Haw
(involves: C57BL/6J * CD-1)
|
abnormal macrophage physiology
|
J:98220
|
Sftpdtm1Jhf/Sftpdtm1Jhf
(involves: 129P2/OlaHsd * Black Swiss)
|
abnormal macrophage physiology
|
J:62282
|
| abnormal neutrophil physiology
|
J:72681
|
Sgms2tm1Jia/Sgms2tm1Jia
(involves: 129 * C57BL/6)
|
abnormal macrophage physiology
|
J:162192,
J:162226
|
Sgp5NZB/?
(involves: C57BL/6 * NZB * SB/Le)
|
increased susceptibility to type III hypersensitivity reaction
|
J:95829
|
Sgpl1Gt(ROSA)78Sor/Sgpl1Gt(ROSA)78Sor
(involves: 129S4/SvJaeSor * C57BL/6)
|
abnormal leukocyte migration
|
J:187619
|
| abnormal T cell physiology
|
J:187619
|
Sh2b2tm1Yeb/Sh2b2tm1Yeb
(involves: C57BL/6)
|
increased IgG3 level
|
J:88527
|
Sh2d1atm1.1Knic/Y
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129X1/SvJ * C57BL/6)
|
abnormal NK T cell physiology
|
J:196692
|
Sh2d1atm1.1Knic/Sh2d1atm1.1Knic
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129X1/SvJ * C57BL/6)
|
abnormal NK T cell physiology
|
J:196692
|
Sh2d1atm1Cpt/Y
(involves: 129S4/SvJae * C57BL/6)
|
abnormal germinal center B cell physiology
|
J:189126
|
| abnormal immunoglobulin level
|
J:189126
|
| abnormal NK T cell physiology
|
J:189126
|
| increased T cell proliferation
|
J:97756
|
Sh2d1atm1Cpt/Y
(involves: 129S4/SvJae * BALB/c)
|
decreased IgE level
|
J:97756
|
| decreased IgG level
|
J:189126
|
Sh2d1atm1Cpt/Y
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * BALB/c)
|
decreased IgG level
|
J:189126
|
Sh2d1atm1Cpt/Sh2d1a+
(involves: 129S4/SvJae * C57BL/6)
|
increased T cell proliferation
|
J:97756
|
Sh2d1atm1Cpt/Sh2d1atm1Cpt
(B6.129S4-Sh2d1atm1Cpt)
|
decreased IgG1 level
|
J:97388
|
| decreased IgM level
|
J:97388
|
| increased IgG2a level
|
J:97388
|
Sh2d1atm1Cpt/Sh2d1atm1Cpt
(C.129S4-Sh2d1atm1Cpt)
|
decreased IgG level
|
J:97388
|
| decreased IgM level
|
J:97388
|
Sh2d1atm1Cpt/Sh2d1atm1Cpt
(involves: 129S4/SvJae * C57BL/6)
|
abnormal germinal center B cell physiology
|
J:189126
|
| abnormal immunoglobulin level
|
J:189126
|
| abnormal NK T cell physiology
|
J:189126
|
| increased T cell proliferation
|
J:97756
|
Sh2d1atm1Cpt/Sh2d1atm1Cpt
(involves: 129S4/SvJae * BALB/c)
|
decreased IgE level
|
J:97756
|
| decreased IgG level
|
J:189126
|
Sh2d1atm1Cpt/Sh2d1atm1Cpt
(involves: 129S4/SvJae)
|
impaired natural killer cell mediated cytotoxicity
|
J:166054
|
Sh2d1atm1Cpt/Sh2d1atm1Cpt
Sh2d1b1/Sh2d1b2tm1.1Cpt/Sh2d1b1/Sh2d1b2tm1.1Cpt
(involves: 129S4/SvJae * BALB/cJ)
|
impaired natural killer cell mediated cytotoxicity
|
J:166054
|
Sh2d1atm1Cpt/Sh2d1atm1Cpt
Sh2d1b1/Sh2d1b2tm1.1Cpt/Sh2d1b1/Sh2d1b2tm1.1Cpt
(involves: 129S4/SvJae * BALB/cJ)
|
impaired natural killer cell mediated cytotoxicity
|
J:166054
|
Sh2d1atm1Cpt/Sh2d1atm1Cpt
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * BALB/c)
|
decreased IgG level
|
J:189126
|
Sh2d1atm1Lyin/Y
(involves: 129S2/SvPas * C57BL/6)
|
decreased IgE level
|
J:97346
|
| decreased IgG level
|
J:97346
|
| decreased immunoglobulin level
|
J:97346
|
Sh2d1atm1Lyin/Sh2d1atm1Lyin
(involves: 129S2/SvPas * C57BL/6)
|
decreased IgE level
|
J:97346
|
| decreased IgG level
|
J:97346
|
| decreased immunoglobulin level
|
J:97346
|
Sh2d1atm1Lyin/Sh2d1atm1Lyin
(involves: 129S1/Sv * 129X1/SvJ)
|
impaired natural killer cell mediated cytotoxicity
|
J:110195
|
Sh2d1atm1Pls/Y
(involves: 129S6/SvEvTac)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:157915
|
| abnormal cytotoxic T cell physiology
|
J:187431
|
| decreased IgG level
|
J:157915
|
Sh2d1atm1Pls/Sh2d1atm1Pls
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * C57BL/6))
|
decreased IgE level
|
J:70032
|
| increased T cell proliferation
|
J:70032
|
Sh2d1atm1Pls/Sh2d1atm1Pls
(B6.129S6-Sh2d1atm1Pls)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:93886
|
| abnormal NK cell physiology
|
J:187430
|
| decreased IgE level
|
J:93886
|
Sh2d1atm1Pls/Sh2d1atm1Pls
(involves: 129S6/SvEvTac)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:157915
|
| abnormal cytotoxic T cell physiology
|
J:187431
|
| decreased IgG level
|
J:157915
|
Sh2d1atm1Pls/Sh2d1atm1Pls
Sh2d1b1tm3Vei/Sh2d1b1tm3Vei
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal NK cell physiology
|
J:187430
|
Sh2d1atm1Pls/Sh2d1atm1Pls
Tg(TcraTcrb)425Cbn/?
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:157915
|
Sh2d1atm1Pls/Sh2d1atm1Pls
Tg(TcraTcrb)1100Mjb/0
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal cytotoxic T cell physiology
|
J:187431
|
| decreased cytotoxic T cell cytolysis
|
J:187431
|
Sh2d1atm1Vei/Sh2d1atm1Vei
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:93886
|
| abnormal memory T cell physiology
|
J:93886
|
| decreased IgE level
|
J:93886
|
Sh2d1atm1Vei/Sh2d1atm1Vei
(B6.129-Sh2d1atm1Vei)
|
abnormal NK cell physiology
|
J:187430
|
Sh2d1atm1Vei/Sh2d1atm1Vei
Sh2d1b1tm3Vei/Sh2d1b1tm3Vei
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal NK cell physiology
|
J:187430
|
Sh2d1atm2.1Cpt/Y
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal germinal center B cell physiology
|
J:189126
|
| decreased IgG level
|
J:189126
|
| decreased IgM level
|
J:189126
|
Sh2d1atm2.1Cpt/Sh2d1atm2.1Cpt
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal germinal center B cell physiology
|
J:189126
|
| decreased IgG level
|
J:189126
|
| decreased IgM level
|
J:189126
|
Sh2d1atm2.1Vei/Sh2d1atm2.1Vei
(involves: C57BL/6)
|
decreased IgE level
|
J:131618
|
| decreased IgG1 level
|
J:131618
|
| decreased IgG2a level
|
J:131618
|
| decreased IgG2b level
|
J:131618
|
| decreased IgG3 level
|
J:131618
|
| decreased IgM level
|
J:131618
|
Sh2d1atm2Vei/Sh2d1atm2Vei
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased IgE level
|
J:131618
|
| decreased IgG1 level
|
J:131618
|
| decreased IgG2a level
|
J:131618
|
| decreased IgG2b level
|
J:131618
|
| decreased IgG3 level
|
J:131618
|
| decreased IgM level
|
J:131618
|
Sh2d1atm2Vei/Sh2d1atm2Vei
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6)
|
decreased IgE level
|
J:131618
|
| decreased IgG1 level
|
J:131618
|
| decreased IgG2a level
|
J:131618
|
| decreased IgG2b level
|
J:131618
|
| decreased IgG3 level
|
J:131618
|
| decreased IgM level
|
J:131618
|
Sh2d1b1/Sh2d1b2tm1.1Cpt/Sh2d1b1/Sh2d1b2tm1.1Cpt
(involves: BALB/cJ)
|
impaired natural killer cell mediated cytotoxicity
|
J:166054
|
Sh2d1b1/Sh2d1b2tm1.1Cpt/Sh2d1b1/Sh2d1b2tm1.1Cpt
(involves: BALB/cJ)
|
impaired natural killer cell mediated cytotoxicity
|
J:166054
|
Sh2d1b1tm1.1Cpt/Sh2d1b1tm1.1Cpt
(involves: BALB/cJ * C57BL/6)
|
impaired natural killer cell mediated cytotoxicity
|
J:166054
|
Sh2d1b1tm1Vei/Sh2d1b1tm1Vei
(involves: 129S1/Sv * 129X1/SvJ)
|
increased natural killer cell mediated cytotoxicity
|
J:110195
|
Sh2d1b1tm2Vei/Sh2d1b1tm2Vei
Sh2d1b2tm1Vei/Sh2d1b2tm1Vei
(involves: 129S1/Sv * 129X1/SvJ)
|
impaired natural killer cell mediated cytotoxicity
|
J:145969
|
Sh2d1b1tm3Vei/Sh2d1b1tm3Vei
(involves: C57BL/6)
|
abnormal NK cell physiology
|
J:187430
|
Sh2d1b2tm1.1Cpt/Sh2d1b2tm1.1Cpt
(involves: BALB/cJ * C57BL/6)
|
impaired natural killer cell mediated cytotoxicity
|
J:166054
|
Sh2d1b2tm1Vei/Sh2d1b2tm1Vei
(involves: 129S1/Sv * 129X1/SvJ)
|
impaired natural killer cell mediated cytotoxicity
|
J:145969
|
| increased natural killer cell mediated cytotoxicity
|
J:110195
|
Sh2d2atm1Jbs/Sh2d2atm1Jbs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased T cell proliferation
|
J:64938
|
Sh2d3ctm1Lex/Sh2d3ctm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal B cell physiology
|
J:161448
|
| abnormal leukocyte migration
|
J:161448
|
| abnormal marginal zone B cell physiology
|
J:161448
|
| decreased IgG1 level
|
J:161448
|
| decreased IgG2b level
|
J:161448
|
| decreased IgG3 level
|
J:161448
|
| decreased IgM level
|
J:161448
|
Sh3bp2tm1.1Ics/Sh3bp2+
(involves: 129S2/SvPas * C57BL/6)
|
abnormal macrophage physiology
|
J:221901
|
Sh3bp2tm1Bjro/Sh3bp2+
(involves: 129S4/SvJae * BALB/cJ * C57BL/6J)
|
abnormal osteoclast physiology
|
J:117880
|
Sh3bp2tm1Bjro/Sh3bp2tm1Bjro
(involves: 129S4/SvJae * BALB/cJ * C57BL/6J)
|
abnormal macrophage physiology
|
J:117880
|
| abnormal osteoclast physiology
|
J:117880
|
Sh3bp2tm1Geha/Sh3bp2tm1Geha
(Not Specified)
|
abnormal B cell physiology
|
J:110319
|
| decreased B cell proliferation
|
J:110319
|
Sh3bp2tm1Rtpl/Sh3bp2tm1Rtpl
(B6.129P2-Sh3bp2tm1Rtpl)
|
abnormal marginal zone B cell physiology
|
J:121380
|
| decreased B cell proliferation
|
J:121380
|
| decreased IgA level
|
J:121380
|
| decreased IgG1 level
|
J:121380
|
| decreased IgG3 level
|
J:121380
|
| decreased IgM level
|
J:121380
|
| decreased immunoglobulin level
|
J:121380
|
| increased B cell apoptosis
|
J:121380
|
Sh3bp2tm1Rtpl/Sh3bp2tm1Rtpl
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal macrophage physiology
|
J:221901
|
| impaired macrophage phagocytosis
|
J:221901
|
Sh3kbp1tm1Kuro/Sh3kbp1tm1Kuro
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6 * NZB)
|
abnormal B cell physiology
|
J:176805
|
Sharpincpdm/Sharpincpdm
(C57BL/KaLawRij-Sharpincpdm)
|
decreased IgA level
|
J:53575
|
| decreased IgE level
|
J:31745,
J:53575
|
| decreased IgG level
|
J:53575
|
| decreased immunoglobulin level
|
J:53575
|
| increased IgM level
|
J:53575
|
Shld1em1Nus/Shld1em1Nus
(involves: C57BL/6NCrl)
|
abnormal class switch recombination
|
J:307190
|
Sigirrtm1Mant/Sigirrtm1Mant
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal dendritic cell physiology
|
J:88907
|
Siglec1tm1(HBEGF)Mtka/Siglec1tm1(HBEGF)Mtka
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/?
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal dendritic cell physiology
|
J:123958
|
| abnormal macrophage physiology
|
J:123958
|
Siglec1tm1Croc/Siglec1tm1Croc
(B6.129-Siglec1tm1Croc)
|
decreased IgM level
|
J:105546
|
| impaired macrophage phagocytosis
|
J:189854
|
Siglec1tm2.1Croc/Siglec1tm2.1Croc
(B6.129P2(C)-Siglec1tm2.1Croc)
|
impaired macrophage phagocytosis
|
J:189854
|
Siglecetm1Arte/Siglecetm1Arte
(involves: C57BL/6)
|
abnormal macrophage physiology
|
J:195429
|
| abnormal neutrophil physiology
|
J:195429
|
Siglecetm1Croc/Siglecetm1Croc
(B6.129P2-Siglecetm1Croc)
|
abnormal macrophage physiology
|
J:195429
|
| abnormal neutrophil physiology
|
J:195429
|
Siglecftm1.2Avrk/Siglecftm1.2Avrk
(B6.129(FVB)-Siglecftm1.2Avrk)
|
abnormal eosinophil physiology
|
J:204811
|
SiglecgM3Btlr/SiglecgM3Btlr
(C57BL/6J-SiglecgM3Btlr)
|
decreased IgM level
|
J:265185
|
Siglecgtm1Lnit/Siglecgtm1Lnit
(involves: BALB/c)
|
decreased IgG2a level
|
J:123353
|
| increased IgM level
|
J:123353
|
Siglecgtm1Yliu/Siglecgtm1Yliu
(C57BL/6-Siglecgtm1Yliu)
|
increased IgM level
|
J:130017
|
Siglechtm1.1Cfg/Siglechtm1.1Cfg
(involves: C57BL/6)
|
increased T cell proliferation
|
J:217719
|
Siglechtm1.1Ksat/Siglechtm1.1Ksat
(B6.Cg-Siglechtm1.1Ksat)
|
abnormal dendritic cell antigen presentation
|
J:179283
|
| abnormal plasmacytoid dendritic cell physiology
|
J:179283
|
Sirpatm1Nog/Sirpatm1Nog
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal Langerhans cell physiology
|
J:88694
|
| abnormal macrophage physiology
|
J:79592
|
Sirt1tm1Mcby/Sirt1tm1Mcby
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased immunoglobulin level
|
J:160869
|
Sit1tm1Lsmn/Sit1tm1Lsmn
(B6.Cg-Sit1tm1Lsmn)
|
increased T cell proliferation
|
J:100408
|
Skap1Gt713Lex/Skap1Gt713Lex
(B6.129S5-Skap1Gt713Lex)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:126545
|
| abnormal T cell physiology
|
J:126545
|
| decreased T cell proliferation
|
J:126545
|
Skap2Gt(VICTR20)21Lex/Skap2Gt(VICTR20)21Lex
(B6.129S5-Skap2Gt(VICTR20)21Lex)
|
abnormal B cell activation
|
J:101373
|
| abnormal dendritic cell antigen presentation
|
J:151350
|
| abnormal dendritic cell physiology
|
J:151350
|
| decreased B cell proliferation
|
J:101373
|
| decreased IgG2a level
|
J:101373
|
| decreased IgM level
|
J:101373
|
Skiltm1Spw/Skiltm1Spw
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
decreased T cell proliferation
|
J:84554
|
Skiltm2Spw/Skiltm2Spw
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
decreased T cell proliferation
|
J:84554
|
Slatm1Weis/Slatm1Weis
Sla2tm1Amch/Sla2tm1Amch
(involves: 129)
|
abnormal dendritic cell physiology
|
J:169170
|
Slamf1tm1Cpt/Slamf1tm1Cpt
(B6.129S4-Slamf1tm1Cpt)
|
abnormal macrophage physiology
|
J:90484
|
Slamf1tm1Cpt/Slamf1tm1Cpt
(C.129S4-Slamf1tm1Cpt)
|
abnormal macrophage physiology
|
J:90484
|
Slamf1tm1Vei/Slamf1tm1Vei
(involves: 129 * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:133047,
J:93886
|
Slamf6tm1Dhow/Slamf6tm1Dhow
(involves: 129/Sv * C57BL/6)
|
abnormal neutrophil physiology
|
J:98995
|
| abnormal T-helper 2 physiology
|
J:98995
|
| impaired granulocyte bactericidal activity
|
J:98995
|
Slamf7tm1Vei/Slamf7tm1Vei
(involves: 129S1/Sv * 129X1/SvJ)
|
impaired natural killer cell mediated cytotoxicity
|
J:145969
|
Slamf8tm1Mill/Slamf8tm1Mill
(involves: BALB/c)
|
abnormal macrophage physiology
|
J:188963
|
Slamf9em1Isha/Slamf9em1Isha
(involves: C57BL/6)
|
abnormal plasmacytoid dendritic cell physiology
|
J:279164
|
Slc1a5tm1Tac/Slc1a5tm1Tac
(involves: 129S/SvEv * C57BL/6)
|
abnormal T cell physiology
|
J:254980
|
Slc2a6em1Kusu/Slc2a6em1Kusu
(involves: C57BL/6JCrlj)
|
abnormal macrophage physiology
|
J:270487
|
Slc3a2tm1.1Yait/Slc3a2tm1.1Yait
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6NCrSlc)
|
abnormal macrophage antigen presentation
|
J:188365
|
| abnormal macrophage physiology
|
J:188365
|
| impaired macrophage phagocytosis
|
J:188365
|
Slc4a2tm1Ges/Slc4a2tm1Ges
(involves: 129S6/SvEvTac)
|
abnormal osteoclast physiology
|
J:193823
|
Slc4a2tm2Ges/Slc4a2tm2Ges
Ctsktm1(cre)Ska/Ctsk+
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal osteoclast physiology
|
J:193823
|
Slc4a2tm2Ges/Slc4a2tm2Ges
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal osteoclast physiology
|
J:193823
|
Slc6a14tm1Gana/Slc6a14tm1Gana
Tg(MMTV-PyVT)634Mul/0
(Not Specified)
|
abnormal immunoglobulin level
|
J:226105
|
Slc7a11m1Mtka/Slc7a11m1Mtka
(C57BL/6-Slc7a11m1Mtka)
|
abnormal dendritic cell physiology
|
J:159323
|
| abnormal macrophage physiology
|
J:159323
|
Slc29a3tm1Lex/Slc29a3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal macrophage physiology
|
J:179286
|
| increased macrophage apoptosis
|
J:179286
|
Slc30a2tm1Kgna/Slc30a2tm1Kgna
(involves: 129 * C57BL/6)
|
abnormal macrophage physiology
|
J:264481
|
Slc33a1tm1.1Lpu/Slc33a1+
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal T cell activation
|
J:211266
|
Slc35c1tm1Cknr/Slc35c1tm1Cknr
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
abnormal leukocyte adhesion
|
J:121151
|
| impaired leukocyte tethering or rolling
|
J:121151
|
Slc37a2tm1Dgen/Slc37a2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal macrophage physiology
|
J:311521
|
Slc37a4tm1Jyc/Slc37a4tm1Jyc
(involves: 129S4/SvJae * C57BL/6)
|
abnormal neutrophil physiology
|
J:86005
|
| impaired neutrophil chemotaxis
|
J:86005
|
Slc39a10tm1.1Tfk/Slc39a10tm1.1Tfk
Tg(Foxn1-cre)8Ghr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
increased thymocyte apoptosis
|
J:254216
|
Slc40a1ffe/Slc40a1+
(either: (involves: 129X1/SvJ * C57BL/6J) or (involves: C3H/HeJ * C57BL/6J))
|
abnormal macrophage physiology
|
J:118592
|
Slc48a1em1Ih/Slc48a1em1Ih
(involves: 129 * C57BL/6J)
|
abnormal macrophage physiology
|
J:282829
|
Sle1NZM2410/Aeg/Sle1NZM2410/Aeg
Sle3NZM2410/Aeg/Sle3NZM2410/Aeg
(B6;NZM-Sle1NZM2410/Aeg Sle2NZM2410/Aeg Sle3NZM2410/Aeg/LmoJ)
|
abnormal marginal zone B cell physiology
|
J:138314
|
Sle1NZW/Sle1NZW
Sles1NZW/Sles1NZW
(involves: C57BL/6 * NZW)
|
abnormal T cell physiology
|
J:100678
|
Sle1NZW/Sle1NZW
Tg(Tnfsf13b)1Fma/0
(involves: C57BL/6 * DBA/2J * NZW)
|
increased IgG level
|
J:134128
|
| increased IgM level
|
J:134128
|
Sle3NZM2410/Aeg/?
(involves: C57BL/6J * NZM2410/Aeg)
|
increased IgG level
|
J:52863
|
| increased IgM level
|
J:52863
|
Sle11BXSB/J/Sle11BXSB/J
(involves: BXSB/J * C57BL/10Ola)
|
increased IgG3 level
|
J:60445
|
Slfn2m1Btlr/Slfn2m1Btlr
(C57BL/6J-Slfn2m1Btlr)
|
abnormal leukocyte physiology
|
J:158985
|
| abnormal T cell activation
|
J:158985
|
| abnormal T cell proliferation
|
J:158985
|
| decreased T cell proliferation
|
J:158985
|
| increased T cell apoptosis
|
J:158985
|
Slfn2m2Btlr/Slfn2m2Btlr
(C57BL/6J-Slfn2m2Btlr)
|
decreased IgG level
|
J:234262
|
Slfn9em1Liudp/Slfn9em1Liudp
(C57BL/6-Slfn9em1Liudp)
|
abnormal macrophage activation involved in immune response
|
J:351319
|
Slpd1NZB/BlNJ/Slpd1NZB/BlNJ
(involves: DBA/2J * NZB/BlNJ)
|
increased B cell proliferation
|
J:124364
|
Slpitm1Nkw/Slpitm1Nkw
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal macrophage physiology
|
J:82214
|
| increased B cell proliferation
|
J:82214
|
Smad3tm1Cxd/Smad3tm1Cxd
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * NIH Black Swiss))
|
abnormal T cell activation
|
J:53510
|
| abnormal T cell physiology
|
J:53510
|
| impaired neutrophil chemotaxis
|
J:53510
|
Smad3tm1Cxd/Smad3tm1Cxd
(involves: 129S6/SvEvTac)
|
abnormal leukocyte physiology
|
J:59673
|
| decreased B cell apoptosis
|
J:140567
|
Smad3tm1Xfw/Smad3tm1Xfw
(involves: 129/Sv * C57BL/6)
|
abnormal B cell proliferation
|
J:53948
|
| abnormal T cell proliferation
|
J:53948
|
Smad7tm1.1Ink/Smad7tm1.1Ink
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:184670
|
Smad7tm1Rheu/Smad7tm1Rheu
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal class switch recombination
|
J:120714
|
| decreased B cell proliferation
|
J:120714
|
| increased B cell apoptosis
|
J:120714
|
Smarcc1tm2.1Rhs/Smarcc1tm2.1Rhs
Tg(Mx1-cre)1Cgn/0
(involves: BALB/c * C57BL/6 * CBA)
|
decreased B cell proliferation
|
J:184060
|
| increased B cell apoptosis
|
J:184060
|
Smc6tm1.1Arln/Smc6tm1.1Arln
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
decreased IgG2b level
|
J:220422
|
Smpd1tm1Esc/Smpd1tm1Esc
(involves: 129S1/Sv * C57BL/6J)
|
abnormal granulocyte physiology
|
J:81982
|
Snrnp40em1Btlr/Snrnp40swp
(C57BL/6J-Snrnp40em1Btlr/Snrnp40swp)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:282417
|
| abnormal CD8-positive, alpha-beta T cell physiology
|
J:282417
|
| decreased T cell proliferation
|
J:282417
|
| impaired natural killer cell mediated cytotoxicity
|
J:282417
|
Snx8tm1Hbsh/Snx8tm1Hbsh
(Not Specified)
|
abnormal dendritic cell physiology
|
J:254306
|
| abnormal macrophage physiology
|
J:254306
|
| decreased macrophage cytokine production
|
J:254306
|
Snx10em1Ael/Snx10em1Ael
(involves: 129 * C57BL/6J * C57BL/6JOlaHsd)
|
abnormal osteoclast physiology
|
J:289051
|
Snx10em2Ael/Snx10em2Ael
(involves: 129 * C57BL/6J * C57BL/6JOlaHsd)
|
abnormal osteoclast physiology
|
J:289051
|
Snx10tm1a(EUCOMM)Raba/Snx10tm1a(EUCOMM)Raba
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J)
|
abnormal osteoclast physiology
|
J:224711
|
Socs1tm1.1Ayr/Socs1tm1.1Ayr
(involves: C57BL/6)
|
abnormal T cell physiology
|
J:226678
|
Socs1tm1Ayos/Socs1tm1Ayos
Tg(Lck-cre)1Jtak/0
(involves: 129S4/SvJae * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:132905
|
Socs1tm1Kish/Socs1tm1Kish
(B6.129P2-Socs1tm1Kish)
|
abnormal lymphocyte physiology
|
J:69472
|
Socs1tm1Wehi/Socs1tm1Wehi
(involves: 129S1/Sv * C57BL/6)
|
abnormal macrophage physiology
|
J:57474
|
Socs1tm1Wehi/Socs1tm3Wehi
Tg(Lck-cre)I57Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * ICR)
|
abnormal T cell activation
|
J:83009
|
Socs2tm1Wehi/Socs2tm1Wehi
(involves: C57BL/6 * C57BL/6J)
|
abnormal macrophage physiology
|
J:186227
|
Socs3tm1Wsa/Socs3tm2Wsa
Lyz2tm1(cre)Ifo/?
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal macrophage physiology
|
J:83645
|
Socs4m1Nch/Socs4m1Nch
(C.C3Fe-Socs4m1Nch)
|
abnormal T cell activation
|
J:241977
|
Sonem1.1Bcgen/Son+
(B6(Cg)-Sonem1.1Bcgen)
|
decreased IgA level
|
J:347709
|
| decreased IgM level
|
J:347709
|
Sos1tm1.1Les/Sos1tm1.1Les
Tg(Lck-cre)1Cwi/0
(involves: 129 * C57BL/6)
|
decreased T cell proliferation
|
J:174536
|
Sox9em1(cre/ERT2)Smoc/Sox9+
Tnfsf18em1Pwan/Tnfsf18em1Pwan
(involves: C57BL/6J)
|
abnormal T cell activation
|
J:346395
|
Sox13tm1Jskg/Sox13tm1Jskg
(involves: C57BL/6)
|
increased T cell proliferation
|
J:117301
|
Sphk2tm1.1Stlp/Sphk2tm1.1Stlp
(involves: BALB/c)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:153014
|
Sphk2tm1Npa/Sphk2tm1Npa
(BALB/c-Sphk2tm1Npa)
|
abnormal B cell migration
|
J:129314
|
Spi1tm1.3Dgt/Spi1tm1.3Dgt
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)
|
increased IgM level
|
J:106040
|
Spi1tm1Sing/Spi1+
Spibtm1Mcs/Spib+
(involves: 129S/SvEv * 129X1/SvJ)
|
decreased B cell proliferation
|
J:88257
|
Spi1tm1Sing/Spi1+
Spibtm1Mcs/Spibtm1Mcs
(involves: 129S/SvEv * 129X1/SvJ)
|
decreased B cell proliferation
|
J:88257
|
| increased B cell apoptosis
|
J:88257
|
Spibtm1Mcs/Spibtm1Mcs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased B cell proliferation
|
J:88257
|
Spibtm1Mcs/Spibtm1Mcs
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased B cell proliferation
|
J:45245
|
| decreased IgG1 level
|
J:45245
|
| decreased IgG2a level
|
J:45245
|
| decreased IgG2b level
|
J:45245
|
| increased B cell apoptosis
|
J:45245
|
| increased IgM level
|
J:45245
|
Spictm1.1Kmm/Spictm1.1Kmm
(involves: 129S6/SvEvTac * C57BL/6)
|
impaired macrophage phagocytosis
|
J:143900
|
Spictm1Kmm/Spictm1Kmm
(involves: 129S6/SvEvTac * C57BL/6)
|
impaired macrophage phagocytosis
|
J:143900
|
Spntm1Bam/Spntm1Bam
(involves: 129S4/SvJae * C57BL/6)
|
abnormal T cell physiology
|
J:29272
|
| increased T cell proliferation
|
J:29272,
J:88252
|
Spns2tm1.1Nmoc/Spns2tm1.1Nmoc
Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * SJL)
|
abnormal B cell physiology
|
J:184558
|
| abnormal T cell physiology
|
J:184558
|
Spns2tm1.2Nmoc/Spns2tm1.2Nmoc
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal B cell physiology
|
J:184558
|
| abnormal T cell physiology
|
J:184558
|
Spns2tm1a(KOMP)Wtsi/Spns2tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased IgG1 level
|
J:188933
|
| decreased IgG level
|
J:188933
|
Spp1tm1.1Dhd/Spp1tm1.1Dhd
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal osteoclast physiology
|
J:237104
|
Spp1tm1Blh/Spp1+
(involves: 129S6/SvEvTac * Black Swiss)
|
abnormal leukocyte migration
|
J:86531
|
Spp1tm1Blh/Spp1tm1Blh
(involves: 129S6/SvEvTac * Black Swiss)
|
abnormal leukocyte migration
|
J:86531
|
| abnormal leukocyte physiology
|
J:86531
|
| abnormal macrophage chemotaxis
|
J:140014
|
| abnormal macrophage physiology
|
J:127389
|
Spp1tm1Blh/Spp1tm1Blh
(BKSW.129S6-Spp1tm1Blh)
|
impaired macrophage chemotaxis
|
J:113585
|
Spp1tm1Rit/Spp1tm1Rit
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal osteoclast physiology
|
J:68872,
J:56353
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:60284
|
Sppl2achompB/Sppl2achompB
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:194595
|
| decreased activation-induced B cell apoptosis
|
J:194595
|
| decreased B cell proliferation
|
J:194595
|
| decreased IgG1 level
|
J:194595
|
| decreased IgG2b level
|
J:194595
|
| decreased IgG3 level
|
J:194595
|
| decreased IgM level
|
J:194595
|
Sppl2am1Anu/Sppl2am1Anu
(involves: C57BL/6JAnu)
|
abnormal immunoglobulin level
|
J:194663
|
| decreased IgG1 level
|
J:194663
|
| decreased IgM level
|
J:194663
|
Sppl2am1Btlr/Sppl2am1Btlr
(C57BL/6J-Sppl2am1Btlr)
|
decreased IgG level
|
J:236687
|
Sppl2am2Btlr/Sppl2am2Btlr
(C57BL/6J-Sppl2am2Btlr)
|
decreased IgG level
|
J:236688
|
| decreased IgM level
|
J:236688
|
Sppl2atm1Basc/Sppl2atm1Basc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrl)
|
abnormal B cell calcium ion homeostasis
|
J:194664
|
| abnormal B cell physiology
|
J:194664
|
| decreased IgA level
|
J:194664
|
| decreased IgG1 level
|
J:194664
|
| decreased IgG2a level
|
J:194664
|
| decreased IgG2b level
|
J:194664
|
| decreased IgG3 level
|
J:194664
|
| decreased IgM level
|
J:194664
|
Sppl2atm1Basc/Sppl2atm1Basc
Sppl2bGt(Ayu21-T160)Imeg/Sppl2bGt(Ayu21-T160)Imeg
(B6N.Cg-Sppl2atm1Basc Sppl2bGt(Ayu21-T160)Imeg)
|
decreased immunoglobulin level
|
J:213519
|
Sppl2atm1Dgen/Sppl2atm1Dgen
(B6.129P2-Sppl2atm1Dgen)
|
decreased IgA level
|
J:194595
|
| decreased IgG1 level
|
J:194595
|
| decreased IgG2b level
|
J:194595
|
| decreased IgG3 level
|
J:194595
|
| decreased IgM level
|
J:194595
|
Sppl3tm1Itl/Sppl3tm1Itl
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129S/SvEv * C57BL/6 * C57BL/10 * CBA/Ca)
|
impaired natural killer cell mediated cytotoxicity
|
J:280182
|
Sppl3tm1Itl/Sppl3tm1Itl
Ncr1tm1.1(icre)Viv/Ncr1+
(involves: 129S/SvEv * C57BL/6)
|
abnormal NK cell physiology
|
J:280182
|
| impaired natural killer cell mediated cytotoxicity
|
J:280182
|
Spred1tm1.1Ayos/Spred1tm1.1Ayos
(involves: 129 * C57BL/6 * SJL)
|
increased mast cell degranulation
|
J:186742
|
Spred1tm1Hiin/Spred1tm1Hiin
(involves: C57BL/6)
|
abnormal eosinophil physiology
|
J:95263
|
Spta1sph-ha/Spta1sph-ha
(either: (B6.D1-Spta1sph-ha x WB.D1-Spta1sph-ha)F1 or (WB.D1-Spta1sph-ha x B6.D1-Spta1sph-ha)F1)
|
increased B cell proliferation
|
J:1967
|
| increased IgA level
|
J:12830
|
| increased IgG level
|
J:12830
|
| increased T cell proliferation
|
J:1967
|
Sptlc2tm1Yhir/Sptlc2tm1Yhir
Tg(KRT5-cre)1Tak/0
(involves: C3H * C57BL/6)
|
abnormal Langerhans cell physiology
|
J:202388
|
Sqstm1tm1Jjw/Sqstm1tm1Jjw
(involves: 129 * C57BL/6)
|
abnormal osteoclast physiology
|
J:141179
|
Sqstm1tm1Keta/Sqstm1tm1Keta
(involves: 129 * C57BL/6N)
|
abnormal osteoclast physiology
|
J:264183
|
SrrRgsc34/Srr+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
abnormal neutrophil physiology
|
J:133634
|
Ss18l1em1Zqi/Ss18l1+
(involves: C57BL/6)
|
increased microglial cell activation
|
J:278840
|
Ss18l1em1Zqi/Ss18l1em1Zqi
(involves: C57BL/6)
|
increased microglial cell activation
|
J:278840
|
Ss18l1em2Zqi/Ss18l1em2Zqi
(involves: C57BL/6)
|
increased microglial cell activation
|
J:278840
|
Ssbtm1Rjma/Ssbtm2.1Rjma
Cd79atm1(cre)Reth/Cd79a+
(involves: 129S/SvEv * BALB/c)
|
decreased IgG level
|
J:207687
|
| decreased IgM level
|
J:207687
|
Sstr4tm1Szo/Sstr4tm1Szo
(B6.129P2-Sstr4tm1Szo)
|
abnormal neutrophil physiology
|
J:152015
|
| increased susceptibility to type IV hypersensitivity reaction
|
J:152015
|
St3gal2tm1Jxm/St3gal2tm1Jxm
(Not Specified)
|
decreased T cell proliferation
|
J:217719
|
St3gal4tm1.1Jxm/St3gal4tm1.1Jxm
(B6.129-St3gal4tm1.1Jxm)
|
abnormal leukocyte tethering or rolling
|
J:117085
|
St3gal4tm1.1Jxm/St3gal4tm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal leukocyte migration
|
J:189086
|
St3gal4tm1.1Jxm/St3gal4tm1.1Jxm
St3gal6tm1.1Jxm/St3gal6tm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal leukocyte migration
|
J:189086
|
| impaired leukocyte tethering or rolling
|
J:189086
|
| impaired neutrophil recruitment
|
J:189086
|
St3gal6tm1.1Jxm/St3gal6tm1.1Jxm
(B6.Cg-St3gal6tm1.1Jxm)
|
impaired leukocyte tethering or rolling
|
J:189086
|
| impaired neutrophil recruitment
|
J:189086
|
St6gal1tm1Jlau/St6gal1tm1Jlau
(129S4/SvJae-St6gal1tm1Jlau)
|
abnormal neutrophil physiology
|
J:140702
|
St6gal1tm1Jlau/St6gal1tm1Jlau
(B6.129S4-St6gal1tm1Jlau)
|
abnormal neutrophil physiology
|
J:140547
|
St6gal1tm1Jxm/St6gal1tm1Jxm
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal dendritic cell physiology
|
J:132991
|
St6galnac2tm1.1Cfg/St6galnac2tm1.1Cfg
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased IgA level
|
J:217719
|
| increased B cell proliferation
|
J:217719
|
St8sia1tm1Kfk/St8sia1tm1Kfk
(Not Specified)
|
increased T cell proliferation
|
J:73818
|
St14tm1Bug/St14tm1Bug
(involves: 129P2/OlaHsd * Black Swiss)
|
increased thymocyte apoptosis
|
J:87125
|
Stamtm2Sug/Stamtm2Sug
Stam2tm1Sug/Stam2tm1Sug
Tg(Lck-cre)I57Jxm/0
(involves: 129S4/SvJae * C57BL/6 * ICR)
|
decreased T cell proliferation
|
J:80617
|
Stard7tm1a(EUCOMM)Wtsi/Stard7+
(involves: C57BL/6N)
|
increased susceptibility to type I hypersensitivity reaction
|
J:242746
|
Stat1fae/Stat1fae
(C57BL/6JSfdAnu-Stat1fae/Anu)
|
abnormal T cell activation
|
J:105311
|
| abnormal T-helper 2 physiology
|
J:105311
|
| increased IgG level
|
J:105311
|
Stat1m1Btlr/Stat1m1Btlr
(C57BL/6J-Stat1m1Btlr)
|
abnormal macrophage physiology
|
J:105543
|
Stat1m2Btlr/Stat1m2Btlr
(C57BL/6J-Stat1m2Btlr)
|
decreased NK cell degranulation
|
J:134096
|
| impaired natural killer cell mediated cytotoxicity
|
J:134096
|
Stat1m3Btlr/Stat1m3Btlr
(C57BL/6J-Stat1m3Btlr)
|
impaired natural killer cell mediated cytotoxicity
|
J:254835
|
Stat1m5Btlr/Stat1m5Btlr
(C57BL/6J-Stat1m5Btlr)
|
decreased cytotoxic T cell cytolysis
|
J:274938
|
Stat1tm1Dlv/Stat1tm1Dlv
(either: (involves: 129S/SvEv * C57BL/6) or (involves: 129S/SvEv * C57BL/6 * CD-1))
|
abnormal leukocyte physiology
|
J:31325
|
Stat1tm1Dlv/Stat1tm1Dlv
(involves: 129S/SvEv)
|
abnormal MHC II cell surface expression on macrophages
|
J:130622
|
Stat1tm1Dlv/Stat1tm1Dlv
(B6.129S-Stat1tm1Dlv)
|
abnormal NK cell physiology
|
J:79552
|
| impaired natural killer cell mediated cytotoxicity
|
J:79552
|
Stat1tm1Rds/Stat1tm1Rds
(129S6/SvEv-Stat1tm1Rds/Tac)
|
abnormal macrophage physiology
|
J:136368
|
Stat1tm1Tdec/Stat1tm1Tdec
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal macrophage physiology
|
J:130622
|
| abnormal MHC II cell surface expression on macrophages
|
J:130622
|
Stat1tm1Uvin/Stat1tm1Uvin
(involves: 129 * C57BL/6)
|
increased macrophage nitric oxide production
|
J:174863
|
Stat3tm1Dnl/Stat3tm1Dlv
(involves: C57BL/6)
|
increased thymocyte apoptosis
|
J:87599
|
Stat3tm1Flv/Stat3tm1Flv
Tg(Tek-cre)12Flv/0
(involves: 129 * C3H * C57BL/6)
|
abnormal T-helper 1 physiology
|
J:81973
|
Stat3tm1Vpo/Stat3tm1Vpo
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * BALB/cAn * C57BL/6 * CBA)
|
abnormal macrophage physiology
|
J:89194
|
Stat3tm1Vpo/Stat3tm2Vpo
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA * BALB/cAn)
|
abnormal macrophage physiology
|
J:89194
|
Stat3tm2Aki/Stat3tm2Aki
Tg(Lck-cre)1Jtak/0
(involves: 129P2/OlaHsd)
|
decreased T cell proliferation
|
J:50443
|
| increased T cell apoptosis
|
J:50443
|
Stat3tm3Vpo/Stat3tm3Vpo
(involves: C57BL/6 * CBA * BALB/cAn)
|
abnormal macrophage physiology
|
J:89194
|
Stat4tm1Gru/Stat4tm1Gru
(involves: 129S2/SvPas * BALB/c)
|
abnormal lymphocyte physiology
|
J:34059
|
| abnormal NK cell physiology
|
J:34059
|
| abnormal T cell proliferation
|
J:34059
|
| abnormal T-helper 1 physiology
|
J:34059
|
| abnormal T-helper 2 physiology
|
J:34059
|
Stat4tm1Gru/Stat4tm1Gru
Tg(Ins2-NP)25-3Olds/0
(involves: 129S2/SvPas * BALB/c * C57BL/6)
|
abnormal cytotoxic T cell physiology
|
J:107047
|
Stat4tm1Jni/Stat4tm1Jni
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal NK cell physiology
|
J:79552
|
Stat5atm1.1Wjl/Stat5atm1.1Wjl
Stat5btm2.1Wjl/Stat5btm2.1Wjl
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N)
|
abnormal regulatory T cell physiology
|
J:187325
|
| decreased T cell proliferation
|
J:187325
|
| increased T cell apoptosis
|
J:187325
|
Stat5atm1Jni/Stat5atm1Jni
Stat5btm2Jni/Stat5btm2Jni
(involves: 129 * C57BL/6)
|
abnormal mast cell physiology
|
J:84889
|
Stat5atm1Mam/Stat5atm1Mam
(involves: 129S6/SvEvTac * C57BL/6)
|
impaired natural killer cell mediated cytotoxicity
|
J:112035
|
Stat5atm2Mam/Stat5atm2Mam
Stat5btm1Mam/Stat5btm1Mam
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal neutrophil physiology
|
J:155489
|
Stat5btm1Hwd/Stat5btm1Hwd
(involves: C57BL/6)
|
decreased T cell proliferation
|
J:112035
|
| impaired natural killer cell mediated cytotoxicity
|
J:112035
|
Stat5btm1Mam/Stat5btm1Mam
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal neutrophil physiology
|
J:155489
|
Stat6tm1Aki/Stat6tm1Aki
(involves: 129P2/OlaHsd)
|
abnormal T-helper 2 physiology
|
J:32561
|
| decreased B cell proliferation
|
J:32561
|
| decreased IgE level
|
J:32561
|
| decreased IgG1 level
|
J:32561
|
| decreased T cell proliferation
|
J:32561
|
| increased IgA level
|
J:32561
|
| increased IgG level
|
J:32561
|
Stat6tm1Aki/Stat6tm1Aki
Tg(KRT14-CASP1)1Miz/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased IgE level
|
J:78602
|
| decreased IgG1 level
|
J:78602
|
Stat6tm1Gru/Stat6tm1Gru
(C.129S2-Stat6tm1Gru/J)
|
decreased IgA level
|
J:107370
|
| decreased IgG3 level
|
J:107370
|
| decreased IgM level
|
J:107370
|
Stat6tm1Gru/Stat6tm1Gru
(129S2/SvPas-Stat6tm1Gru)
|
decreased IgE level
|
J:31932
|
| decreased T cell proliferation
|
J:31932
|
Stat6tm1Gru/Stat6tm1Gru
(involves: 129S2/SvPas * BALB/c)
|
abnormal granulocyte physiology
|
J:85386
|
| abnormal macrophage physiology
|
J:85386
|
| impaired eosinophil chemotaxis
|
J:85386
|
| impaired neutrophil chemotaxis
|
J:85386
|
Stat6tm1Gru/Stat6tm1Gru
(C.129S2-Stat6tm1Gru)
|
abnormal cytotoxic T cell physiology
|
J:65894
|
| abnormal immunoglobulin level
|
J:66222
|
| abnormal leukocyte migration
|
J:74497
|
| abnormal leukocyte physiology
|
J:74497
|
| decreased IgE level
|
J:74497,
J:66222
|
| decreased IgG1 level
|
J:66222
|
| impaired eosinophil recruitment
|
J:66222
|
| increased IgG2a level
|
J:66222
|
Stat6tm1Jni/Stat6tm1Jni
(involves: 129S/SvEv)
|
abnormal B cell physiology
|
J:32607
|
| abnormal B cell proliferation
|
J:32607
|
| abnormal class switch recombination
|
J:32607
|
| increased B cell apoptosis
|
J:146533
|
Stat6tm1Jni/Stat6tm1Jni
(involves: 129S/SvEv * C57BL/6)
|
decreased IgE level
|
J:51096
|
| decreased IgG1 level
|
J:51096
|
| increased IgE level
|
J:110429
|
| increased IgG1 level
|
J:110429
|
| increased IgG2a level
|
J:51096
|
Stim1tm1.1Kuro/Stim1+
(C57BL/6-Stim1tm1.1Kuro)
|
decreased susceptibility to type I hypersensitivity reaction
|
J:130477
|
Stim1tm1.1Kuro/Stim1tm1.1Kuro
(C57BL/6-Stim1tm1.1Kuro)
|
decreased mast cell degranulation
|
J:130477
|
Stim1tm1Kuro/Stim1tm1Kuro
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6)
|
abnormal B cell calcium ion homeostasis
|
J:172608
|
| decreased B cell proliferation
|
J:172608
|
Stim1tm1Kuro/Stim1tm1Kuro
Stim2tm1.1Kuro/Stim2tm1.1Kuro
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6)
|
abnormal B cell calcium ion homeostasis
|
J:172608
|
| abnormal B cell physiology
|
J:172608
|
| decreased B cell proliferation
|
J:172608
|
Stim1tm1Rao/Stim1tm1Rao
Stim2tm1Rao/Stim2tm1Rao
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:133262
|
| decreased T cell proliferation
|
J:133262
|
| increased IgG1 level
|
J:133262
|
Stim1tm1Rao/Stim1tm1Rao
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:133262
|
Stim2tm1.1Kuro/Stim2tm1.1Kuro
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6)
|
abnormal B cell calcium ion homeostasis
|
J:172608
|
Stim2tm1Rao/Stim2tm1Rao
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:133262
|
| abnormal T-helper 1 physiology
|
J:133262
|
| abnormal T-helper 2 physiology
|
J:133262
|
Sting1em1Jmin/Sting1+
(involves: C57BL/6N)
|
increased IgM level
|
J:251372
|
Sting1gt/Sting1gt
(C57BL/6-Sting1gt)
|
abnormal dendritic cell physiology
|
J:201167
|
| abnormal macrophage physiology
|
J:201167
|
| abnormal plasmacytoid dendritic cell physiology
|
J:201167
|
Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi
(B6.129P2-Stk4Gt(AJ0315)Wtsi)
|
increased T cell apoptosis
|
J:142674
|
| increased T cell proliferation
|
J:142674
|
Stk4m1Btlr/Stk4m1Btlr
(C57BL/6J-Stk4m1Btlr)
|
decreased IgD level
|
J:265233
|
| increased IgE level
|
J:265233
|
| increased IgM level
|
J:265233
|
Stk4m2Btlr/Stk4m2Btlr
(C57BL/6J-Stk4m2Btlr)
|
decreased IgD level
|
J:265237
|
| increased IgE level
|
J:265237
|
Stk4m4Btlr/Stk4m4Btlr
(C57BL/6J-Stk4m4Btlr)
|
decreased IgD level
|
J:272536
|
| decreased IgG level
|
J:272536
|
Stk4tm1.1Kina/Stk4tm1.1Kina
(involves: C57BL/6)
|
abnormal B cell physiology
|
J:148791
|
| abnormal dendritic cell physiology
|
J:148791
|
| abnormal leukocyte adhesion
|
J:148791
|
| abnormal leukocyte migration
|
J:148791
|
| abnormal T cell physiology
|
J:148791
|
| increased T cell proliferation
|
J:148791
|
Stk4tm1.2Wtao/Stk4tm1.2Wtao
(involves: 129S4/SvJaeSor * 129S6/SvEvTac)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:152323
|
| abnormal CD8-positive, alpha-beta T cell physiology
|
J:152323
|
| abnormal T cell physiology
|
J:152323
|
Stk4tm1Dlim/Stk4tm1Dlim
(Not Specified)
|
abnormal T cell physiology
|
J:155001
|
Stk10tm1Hkar/Stk10tm1Hkar
(involves: 129S1/Sv)
|
abnormal T cell physiology
|
J:60738
|
Stk17btm1Hed/Stk17btm1Hed
(involves: 129X1/SvJ * C57BL/6)
|
increased T cell proliferation
|
J:94685
|
Stk17btm1Hed/Stk17btm1Hed
(B6.129X1-Stk17btm1Hed)
|
increased T cell proliferation
|
J:94685
|
Stk24Gt(AM0826)Wtsi/Stk24Gt(AM0826)Wtsi
(B6.129P2-Stk24Gt(AM0826)Wtsi)
|
abnormal neutrophil physiology
|
J:256076
|
Stk38tm1Hem/Stk38tm1Hem
(involves: 129P2/Ola * C57BL/6)
|
abnormal T cell physiology
|
J:185408
|
| decreased thymocyte apoptosis
|
J:185408
|
Stub1tm1Cpat/Stub1tm1Cpat
(involves: 129S/SvEv * C57BL/6)
|
increased thymocyte apoptosis
|
J:86213
|
Stx3Gt(EUCE320f12)1.1Hmgu/Stx3Gt(EUCE320f12)1.1Hmgu
Tg(Cma1-cre)ARoer/0
(B6.Cg-Stx3Gt(EUCE320f12)1.1Hmgu Tg(Cma1-cre)ARoer)
|
abnormal mast cell degranulation
|
J:275367
|
| decreased mast cell degranulation
|
J:275367
|
Stx3Gt(EUCE320f12)1.2Hmgu/Stx3+
(B6.129P2(Cg)-Stx3Gt(EUCE320f12)1.2Hmgu)
|
abnormal mast cell degranulation
|
J:275367
|
Stx11tm1.2Ics/Stx11tm1.2Ics
(involves: C57BL/6NTac)
|
abnormal cytotoxic T cell physiology
|
J:193137
|
| decreased cytotoxic T cell cytolysis
|
J:193137
|
| decreased NK cell degranulation
|
J:193137
|
Stx11tm1Bupa/Stx11tm1Bupa
(B6.129-Stx11tm1Bupa)
|
abnormal lymphocyte physiology
|
J:191103
|
| abnormal neutrophil physiology
|
J:191103
|
| impaired natural killer cell mediated cytotoxicity
|
J:191103
|
Stxbp2tm1Bdic/Stxbp2+
(involves: 129S * C57BL/6)
|
decreased mast cell degranulation
|
J:188931
|
| decreased susceptibility to type I hypersensitivity reaction
|
J:188931
|
Sucnr1tm1Dgen/Sucnr1tm1Dgen
(B6.129P2-Sucnr1tm1Dgen)
|
abnormal dendritic cell physiology
|
J:143337
|
| abnormal Langerhans cell physiology
|
J:143337
|
| abnormal T cell activation
|
J:143337
|
| decreased T cell proliferation
|
J:143337
|
SucoGt(KST050)Byg/SucoGt(KST050)Byg
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
abnormal osteoclast physiology
|
J:159823
|
Susd4tm1Lex/Susd4tm1Lex
(B6.129S5-Susd4tm1Lex)
|
increased microglial cell activation
|
J:306852
|
Suv39h1tm1Jnw/Suv39h1tm1Jnw
(involves: 129)
|
abnormal T-helper 2 physiology
|
J:186702
|
| decreased susceptibility to type I hypersensitivity reaction
|
J:186702
|
Swap70tm1Jess/Swap70tm1Jess
(involves: 129T2/SvEms * 129X1/SvJ)
|
abnormal class switch recombination
|
J:71160
|
| decreased IgE level
|
J:71160
|
Swrl1NZB/Swrl1NZB
(involves: NZB * SWR)
|
abnormal type II hypersensitivity reaction
|
J:73097
|
Swrl1NZB/Swrl1SWR
(involves: NZB * SWR)
|
abnormal type II hypersensitivity reaction
|
J:73097
|
Swrl1SWR/Swrl1SWR
(involves: NZB * SWR)
|
increased IgG3 level
|
J:96263
|
Syktm1.1Tara/Syktm1.1Tara
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell proliferation
|
J:114816
|
Syktm1Tyb/Syktm1.2Tara
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
abnormal neutrophil physiology
|
J:155479
|
| impaired granulocyte bactericidal activity
|
J:155479
|
Syktm1Tyb/Syktm1.2Tara
Tg(S100A8-cre,-EGFP)1Ilw/0
(involves: 129P2/OlaHsd * 129S2/SvPas * C3H * C57BL/6)
|
impaired granulocyte bactericidal activity
|
J:155479
|
Syktm1Tyb/Syktm1Tyb
(involves: 129S2/SvPas)
|
abnormal dendritic cell antigen presentation
|
J:147472
|
| abnormal neutrophil physiology
|
J:155479
|
| impaired granulocyte bactericidal activity
|
J:155479
|
| impaired neutrophil phagocytosis
|
J:155479
|
Syktm2.1(ZAP70)Fkfr/Syktm2.1(ZAP70)Fkfr
(B6.129-Syktm2.1(ZAP70)Fkfr)
|
abnormal B cell physiology
|
J:188422
|
| abnormal neutrophil physiology
|
J:188422
|
| decreased IgG1 level
|
J:188422
|
| decreased IgG2a level
|
J:188422
|
| decreased IgG2b level
|
J:188422
|
| increased B cell apoptosis
|
J:188422
|
| increased IgM level
|
J:188422
|
Sytl1tm1a(KOMP)Wtsi/Sytl1tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased IgG2b level
|
J:213427
|
Tab2tm2.1Aki/Tab2tm2.1Aki
Tab3tm1Aki/Tab3tm1Aki
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:195289
|
| decreased B cell proliferation
|
J:195289
|
| decreased IgD level
|
J:195289
|
| decreased IgE level
|
J:195289
|
| decreased IgG level
|
J:195289
|
| decreased immunoglobulin level
|
J:195289
|
| increased B cell apoptosis
|
J:195289
|
Tacr1tm1Nge/Tacr1tm1Nge
(involves: 129S4/SvJae * C57BL)
|
abnormal mast cell physiology
|
J:84660
|
Taf7tm1.1Dss/Taf7tm1.2Dss
Tg(Cd8a*-cre)B8Asin/0
(involves: C57BL/6)
|
decreased T cell proliferation
|
J:185745
|
Tagln2tm1Cdj/Tagln2tm1Cdj
(involves: 129S4/SvJae * C57BL/6)
|
abnormal cytotoxic T cell physiology
|
J:256656
|
| abnormal T cell physiology
|
J:256656
|
Tagln2tm1Cdj/Tagln2tm1Cdj
Tg(TcraTcrb)425Cbn/0
(involves: 129S4/SvJae * C57BL/6)
|
abnormal T cell activation
|
J:256656
|
Tagln2tm1Cdj/Tagln2tm1Cdj
Tg(TcraTcrb)1100Mjb/0
(involves: 129S4/SvJae * C57BL/6)
|
abnormal T cell activation
|
J:256656
|
Tanktm1Aki/Tanktm1Aki
(involves: 129/Sv * C57BL/6)
|
abnormal dendritic cell physiology
|
J:151757
|
| abnormal macrophage physiology
|
J:151757
|
| abnormal plasmacytoid dendritic cell physiology
|
J:151757
|
| increased B cell proliferation
|
J:151757
|
| increased IgA level
|
J:151757
|
| increased IgG1 level
|
J:151757
|
| increased IgG2a level
|
J:151757
|
| increased IgG2b level
|
J:151757
|
| increased IgM level
|
J:151757
|
Tap1tm1Arp/Tap1tm1Arp
(involves: 129S2/SvPas * C57BL/6)
|
abnormal dendritic cell antigen presentation
|
J:112436
|
| abnormal lymphocyte physiology
|
J:122479
|
Tap1tm1Arp/Tap1tm1Arp
(involves: 129S2/SvPas)
|
abnormal dendritic cell antigen presentation
|
J:64349
|
| decreased cytotoxic T cell cytolysis
|
J:64349
|
Tap2m1Btlr/Tap2m1Btlr
(C57BL/6J-Tap2m1Btlr)
|
abnormal cytotoxic T cell physiology
|
J:159355
|
| abnormal NK cell physiology
|
J:159355
|
Tapbptm1Gjh/Tapbptm1Gjh
(involves: 129S2/SvPas)
|
abnormal dendritic cell antigen presentation
|
J:64349
|
| abnormal NK cell physiology
|
J:64349
|
| decreased cytotoxic T cell cytolysis
|
J:64349
|
Tapbptm1Luc/Tapbptm1Luc
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal lymphocyte physiology
|
J:122479
|
Tapbptm1Luc/Tapbptm1Luc
(involves: 129S6/SvEvTac)
|
abnormal cytotoxic T cell physiology
|
J:64177
|
Tarm1tm1Yiw/Tarm1tm1Yiw
(involves: C57BL/6 * C57BL/6NSlc)
|
abnormal dendritic cell antigen presentation
|
J:301164
|
| abnormal lymphocyte physiology
|
J:301164
|
| decreased IgG2a level
|
J:301164
|
| decreased IgG2b level
|
J:301164
|
| decreased IgG3 level
|
J:301164
|
| decreased T cell proliferation
|
J:301164
|
Tax1bp1tm1Ktj/Tax1bp1tm1Ktj
(B6.129P2-Tax1bp1tm1Ktj)
|
abnormal leukocyte physiology
|
J:131849
|
| abnormal macrophage chemotaxis
|
J:131849
|
| abnormal neutrophil physiology
|
J:131849
|
| abnormal T cell physiology
|
J:131849
|
Tbc1d10ctm1.1Psou/Tbc1d10ctm1.2Psou
Cd79atm1(cre)Reth/Cd79a+
(involves: 129S2/SvPas * BALB/c * C57BL/6J)
|
abnormal B cell physiology
|
J:211913
|
| increased IgG level
|
J:211913
|
| increased IgM level
|
J:211913
|
Tbc1d10ctm1.2Psou/Tbc1d10ctm1.2Psou
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal B cell physiology
|
J:211913
|
| abnormal T cell activation
|
J:211913
|
| increased IgG level
|
J:211913
|
| increased T cell proliferation
|
J:211913
|
Tbk1M1Btlr/Tbk1+
(involves: C57BL/6J)
|
abnormal macrophage physiology
|
J:188770
|
Tbk1tm1.1Lex/Tbk1tm1.1Lex
(involves: 129S4/SvJae * 129S5/SvEvBrd)
|
increased IgA level
|
J:166476
|
Tbk1tm1Aki/Tbk1tm1Aki
Tnftm1Sek/Tnftm1Sek
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal cytotoxic T cell physiology
|
J:132662
|
| decreased cytotoxic T cell cytolysis
|
J:132662
|
| decreased IgG1 level
|
J:132662
|
| decreased IgG2a level
|
J:132662
|
| decreased IgG level
|
J:132662
|
Tbk1tm1Arte/Tbk1tm1Arte
Cd19tm1(cre)Cgn/Cd19+
(involves: 129/SvEv * 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:188560
|
| abnormal class switch recombination
|
J:188560
|
| increased IgA level
|
J:188560
|
| increased IgM level
|
J:188560
|
Tbk1tm1Arte/Tbk1tm1Arte
Map3k14tm1Rds/Map3k14tm1Rds
Cd19tm1(cre)Cgn/Cd19+
(involves: 129/SvEv * 129P2/OlaHsd * C57BL/6)
|
abnormal immunoglobulin level
|
J:188560
|
Tbptm1.1Ees/Tbptm1.1Ees
(B6.129X1(Cg)-Tbptm1.1Ees)
|
hemophagocytosis
|
J:77714
|
Tbx21m1Btlr/Tbx21m1Btlr
(C57BL/6J-Tbx21m1Btlr)
|
increased IgM level
|
J:267478
|
Tbx21tm1Glm/Tbx21+
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal NK cell physiology
|
J:73833
|
Tbx21tm1Glm/Tbx21tm1Glm
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal immunoglobulin level
|
J:73833
|
| abnormal NK cell physiology
|
J:73833
|
| impaired natural killer cell mediated cytotoxicity
|
J:73833
|
| increased natural killer cell mediated cytotoxicity
|
J:73833
|
Tbx21tm1Glm/Tbx21tm1Glm
(C.129S6-Tbx21tm1Glm/J)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:111932
|
Tbx21tm1Glm/Tbx21tm1Glm
(involves: 129S6/SvEvTac)
|
abnormal leukocyte migration
|
J:163822
|
Tbxa2rtm1Sna/Tbxa2rtm1Sna
(either: (involves: 129/Ola * BALB/c) or (involves: 129/Ola * C57BL/6))
|
abnormal type I hypersensitivity reaction
|
J:84085
|
Tbxa2rtm1Sna/Tbxa2rtm1Sna
(B6.Cg-Tbxa2rtm1Sna)
|
increased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Tcf3tm1(PBX1)Mlc/Tcf3+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:226241
|
Tcf3tm1Xhsu/Tcf3tm1Xhsu
Tg(Lck-Stat5b*)1Mafa/0
(involves: 129X1/SvJ * C57BL/6 * FVB/N)
|
increased B cell proliferation
|
J:132669
|
Tcf4tm1.1Hmb/Tcf4tm1.1Hmb
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal T cell physiology
|
J:136143
|
Tcf7tm1Cle/Tcf7tm1Cle
(involves: 129P2/OlaHsd)
|
abnormal memory T cell physiology
|
J:189838
|
Tcf12tm3Zhu/Tcf12tm3Zhu
Tcf3tm4Zhu/Tcf3tm4Zhu
Tg(Lck-cre)#Zhu/0
(involves: 129S4/SvJae * C57BL/6 * SJL/J)
|
increased T cell proliferation
|
J:129570
|
Tcirg1M1Jeau/Tcirg1+
(either: (involves: C3H/HeJ * C57BL/6) or (involves: C3H/HeJ * C57BL/6 * FVB/N))
|
abnormal osteoclast physiology
|
J:196503
|
Tcirg1tm1.2Ywd/Tcirg1tm1.2Ywd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N * SJL)
|
abnormal macrophage physiology
|
J:150327
|
Tcirg1tm1Utku/Tcirg1tm1Utku
(involves: 129X1/SvJ * C57BL/6)
|
increased IgG1 level
|
J:92730
|
| increased IgG2a level
|
J:92730
|
| increased IgM level
|
J:92730
|
| increased immunoglobulin level
|
J:92730
|
Tcirg1tm1Ypl/Tcirg1tm1Ypl
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal osteoclast physiology
|
J:58795
|
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
(B6.129-Tcra-Jtm1Tgi)
|
decreased IgE level
|
J:121037
|
| decreased IgG level
|
J:99107
|
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
(involves: 129S1/Sv * 129X1/SvJ * BALB/c)
|
decreased IgE level
|
J:84720
|
TcraLn1Ogu/Tcra+
(involves: 129/Sv * C57BL/6)
|
decreased IgG2a level
|
J:152041
|
| increased IgG1 level
|
J:152041
|
Tcratm1Cgn/Tcratm1Mass
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal T cell physiology
|
J:201417
|
Tcratm1Mjo/Tcra+
(NOD.129P2-Tcratm1Mjo)
|
abnormal T cell physiology
|
J:108590
|
Tcratm1Mjo/Tcratm1Mjo
(involves: 129P2/OlaHsd * BALB/c)
|
increased IgE level
|
J:111129
|
| increased IgG1 level
|
J:111129
|
| increased immunoglobulin level
|
J:111129
|
Tcratm1Mjo/Tcratm1Mjo
(involves: 129P2/OlaHsd)
|
decreased T cell proliferation
|
J:110898
|
Tcratm1Mom/Tcratm1Mom
(involves: 129S2/SvPas * C57BL/6)
|
decreased IgG level
|
J:119344
|
Tcratm1Mom/Tcratm1Mom
Tcrgtm1.1Hish/Tcrgtm1.1Hish
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
impaired macrophage chemotaxis
|
J:135597
|
| impaired neutrophil recruitment
|
J:135597
|
Tcratm1Mom/Tcratm1Mom
Tg(TcraAV19AJ33)1Shima/?
(involves: 129S2/SvPas * C57BL/6)
|
abnormal NK T cell physiology
|
J:140924
|
Tcrbtm1Mom/Tcrb+
Tg(SOD1*G93A)1Gur/0
(B6.Cg-Tcrbtm1Mom Tg(SOD1*G93A)1Gur/J)
|
abnormal microglial cell physiology
|
J:143173
|
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased IgG level
|
J:119344
|
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
(B6.129P2-Tcrbtm1Mom Tcrdtm1Mom/J)
|
decreased IgE level
|
J:125656
|
| decreased IgG1 level
|
J:125656
|
| decreased IgG level
|
J:125656,
J:187766
|
| increased IgM level
|
J:187766
|
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
(involves: 129P2/OlaHsd)
|
decreased IgA level
|
J:97824
|
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
Traf3ip2tm1.1Lix/Traf3ip2tm1.1Lix
(B6.129-Tcrbtm1Mom Traf3ip2tm1.1Lix Tcrdtm1Mom)
|
decreased IgG level
|
J:187766
|
| increased IgM level
|
J:187766
|
Tcrbtm1Mom/Tcrbtm1Mom
Tg(KRT5-rtTA)1Glk/0
Tg(tetO/CMV-Tslp)#Sfz/0
(involves: 129P2/OlaHsd * C3H * C57BL/6 * FVB/N)
|
decreased IgE level
|
J:100506
|
Tcrdtm1Mom/Tcrdtm1Mom
(FVB.129P2-Tcrdtm1Mom)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:75915
|
Tcrgtm1Scar/Tcrgtm1Scar
(B6.Cg-Tcrgtm1Scar)
|
impaired granulocyte bactericidal activity
|
J:105477
|
Tdrd3Gt(RRK474)Byg/Tdrd3Gt(RRK474)Byg
(involves: 129P2/OlaHsd)
|
abnormal B cell physiology
|
J:210647
|
Tent5cem1Adki/Tent5cem1Adki
(involves: C57BL/6J * CBA)
|
decreased B cell proliferation
|
J:252302
|
Terctm1Rdp/Terctm1Rdp
(involves: 129/Sv * C57BL/6J * SJL)
|
decreased B cell proliferation
|
J:60223
|
| decreased T cell proliferation
|
J:60223
|
| increased B cell apoptosis
|
J:60223
|
Tespa1tm1Smoc/Tespa1tm1Smoc
(B6.129-Tespa1tmSmoc)
|
decreased T cell proliferation
|
J:186446
|
| increased T cell proliferation
|
J:186446
|
Tff2tm1Blin/Tff2tm1Blin
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal adaptive immunity
|
J:105277
|
Tg(ACTB-Eif4e)#Ppp/0
Tg(IghMyc)22Bri/0
(involves: C57BL * SJL)
|
decreased B cell apoptosis
|
J:89878
|
Tg(ACTB-Fpr2)#Jimw/0
(involves: FVB)
|
abnormal dendritic cell physiology
|
J:160074
|
Tg(ACTB-TNFRSF6B)754Jwu/?
(B6.Cg-Tg(Actb-TNFRSF6B)754Jwu)
|
abnormal type IV hypersensitivity reaction
|
J:148162
|
| increased IgE level
|
J:148162
|
| increased IgG1 level
|
J:148162
|
| increased IgG2b level
|
J:148162
|
Tg(Actb-Tnfsf4)1Nish/0
(B6.D2-Tg(Actb-Tnfsf4)1Nish)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:80214
|
| increased T cell proliferation
|
J:80214
|
Tg(Alb1-GP33/H2-Kb)1Hpi/0
(B6.Cg-Tg(Alb1-GP33/H2-Kb)1Hpi)
|
abnormal cytotoxic T cell physiology
|
J:162605
|
| decreased cytotoxic T cell cytolysis
|
J:162605
|
Tg(Amy1TAg)501Knw/0
(involves: C57BL/6)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:84288
|
Tg(APOC1)1Lmh/Tg(APOC1)1Lmh
(involves: C57BL/6)
|
increased IgE level
|
J:135501
|
| increased mast cell degranulation
|
J:135501
|
Tg(APPSwFlLon,PSEN1*M146L*L286V)6799Vas/?
(involves: C57BL/6 * SJL)
|
increased microglial cell activation
|
J:208030
|
Tg(B2M)55Hpl/?
Tg(CD8aCD8b)57Scr/?
Tg(HLA-B)22Hpl/?
(involves: C57BL/6 * C57BL/LiA * CBA)
|
abnormal cytotoxic T cell physiology
|
J:127813
|
Tg(BCL2)22Wehi/0
(involves: C57BL/6JWehi * SJL/JWehi)
|
abnormal B cell physiology
|
J:93111
|
Tg(BCL2)25Wehi/0
(involves: C57BL/6JWehi * SJL/JWehi)
|
abnormal T cell physiology
|
J:93111
|
Tg(BCL2)36Wehi/0
(involves: C57BL/6JWehi * SJL/JWehi)
|
abnormal B cell physiology
|
J:93111
|
| abnormal T cell physiology
|
J:93111
|
| increased immunoglobulin level
|
J:93111
|
Tg(BCL2)36Wehi/?
(B6.Cg-Tg(BCL2)36Wehi/J)
|
abnormal B cell proliferation
|
J:90963
|
| decreased B cell apoptosis
|
J:90963
|
Tg(BCL2/IGH)1Tjd/?
(involves: C3H/He * C57BL/6)
|
abnormal B cell physiology
|
J:81147
|
Tg(BCL2/IGH)#Jcre/0
Tg(H2-K/Igh-Traf2*)#Ywc/0
(involves: BALB/c * C57BL/6 * CBA/J * FVB/N * SJL/J * SWR/J)
|
decreased B cell apoptosis
|
J:94116
|
Tg(BCL2/IGH)M23Tjd/?
(involves: C3H/He * C57BL/6)
|
abnormal B cell physiology
|
J:81147
|
Tg(CAG-C1qtnf6)#Yiw/0
(involves: C57BL/6JJcl)
|
decreased IgG level
|
J:227217
|
Tg(CAG-DPP4)52Ctkt/0
(involves: C3H/HeJ * C57BL/6J)
|
increased microglial cell activation
|
J:227925
|
Tg(CAG-Has2)99Nita/0
Tg(MMTV-cre)4Mam/0
Tg(MMTVneu)202Mul/0
(FVB.Cg-Tg(CAG-Has2)99Nita Tg(MMTV-cre)4Mam Tg(MMTVneu)202Mul)
|
impaired macrophage chemotaxis
|
J:164205
|
Tg(CAG-OVAL)916Jen/?
(C57BL/6-Tg(CAG-OVAL)916Jen)
|
abnormal dendritic cell antigen presentation
|
J:91742
|
Tg(CAG-PLA2G3)#aMurm/0
(Not Specified)
|
increased mast cell degranulation
|
J:197334
|
| increased susceptibility to type I hypersensitivity reaction
|
J:197334
|
Tg(CD2-Ccdc86)1Hfuj/?
(B6.FVB-Tg(CD2-Ccdc86)1Hfuj)
|
increased T cell apoptosis
|
J:151722
|
Tg(CD2-Ceacam1*4L)1Rsb/0
(involves: C57BL/6)
|
abnormal T cell physiology
|
J:116136
|
| decreased T cell proliferation
|
J:116136
|
Tg(CD2-Ceacam1*4L)1Rsb/0
Tg(TcraTcrb)425Cbn/0
(involves: BALB/c * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:116136
|
Tg(CD2-Foxj1)#Stlp/0
(C57BL/6-Tg(CD2-Foxj1)#Stlp)
|
abnormal T cell physiology
|
J:122222
|
Tg(CD2-Ifngr2)1Pbro/?
(B6.Cg-Tg(CD2-Ifngr2)1Pbro)
|
abnormal T-helper 1 physiology
|
J:134448
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:134448
|
Tg(CD2-Ifngr2)2Pbro/?
(B6.Cg-Tg(CD2-Ifngr2)2Pbro)
|
abnormal T-helper 1 physiology
|
J:134448
|
Tg(CD2-Ifngr2)2Pbro/?
(NOD.Cg-Tg(CD2-Ifngr2)2Pbro)
|
abnormal T-helper 1 physiology
|
J:81981
|
Tg(CD2-LAT2)1Wz/0
(Not Specified)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:116157
|
Tg(CD2-Lrch1)#Liux/0
(involves: C57BL/6)
|
abnormal cellular extravasation
|
J:238772
|
Tg(CD2-Myb/en)2Kmw/?
(involves: C57BL/10 * CBA)
|
decreased T cell proliferation
|
J:126456
|
Tg(CD2-Myb/en)2Kmw/Tg(CD2-Myb/en)2Kmw
(involves: C57BL/10 * CBA)
|
decreased T cell proliferation
|
J:126456
|
Tg(CD2-Nfat5)1Snh/0
(involves: BALB/c * C57BL/6)
|
abnormal cytotoxic T cell physiology
|
J:80066
|
| abnormal T cell physiology
|
J:80066
|
| decreased T cell proliferation
|
J:80066
|
Tg(CD2-Rorc)#Staka/0
(involves: C57BL/6)
|
abnormal T-helper 17 cell physiology
|
J:236222
|
| decreased IgG2c level
|
J:236222
|
| decreased IgG3 level
|
J:236222
|
| decreased IgG level
|
J:236222
|
Tg(CD2-S1PR1)1Ejg/?
(involves: C57BL/6 * DBA/2)
|
abnormal lymphocyte chemotaxis
|
J:96558
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:96558
|
| decreased T cell proliferation
|
J:96558
|
| impaired leukocyte migration
|
J:96558
|
| increased IgE level
|
J:96558
|
Tg(CD2-Sh2d1a)#Vei/0
(involves: 129S1/Sv * 129X1/SvJ)
|
increased natural killer cell mediated cytotoxicity
|
J:110195
|
Tg(CD2-Sh2d1b1)#Vei/0
(B6.Cg-Tg(CD2-Sh2d1b1)#Vei)
|
impaired natural killer cell mediated cytotoxicity
|
J:110195
|
Tg(CD2-Sh2d1b2)#Vei/0
(B6.Cg-Tg(CD2-Sh2d1b2)#Vei)
|
impaired natural killer cell mediated cytotoxicity
|
J:110195
|
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6 * C57BL/10)
|
decreased thymocyte apoptosis
|
J:217939
|
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0
Tg(LCKprBCL2)36Sjk/0
(involves: C57BL/6 * C57BL/10)
|
decreased thymocyte apoptosis
|
J:217939
|
Tg(CD2-Tgfbr2)1Grs/0
(C57BL/6-Tg(CD2-Tgfbr2)1Grs/Nci)
|
increased T cell proliferation
|
J:97523
|
Tg(CD2-Tgfbr2)1Grs/?
(C57BL/6-Tg(CD2-Tgfbr2)1Grs/Nci)
|
increased T cell proliferation
|
J:93665
|
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6)
|
abnormal T cell proliferation
|
J:217939
|
| decreased thymocyte apoptosis
|
J:217939
|
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6 * CBA/J)
|
decreased thymocyte apoptosis
|
J:217939
|
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
Tg(Nr4a1-EGFP/cre)820Khog/0
(involves: C57BL/6 * C57BL/6J)
|
decreased thymocyte apoptosis
|
J:217939
|
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * C57BL/6J * DBA/2J)
|
decreased thymocyte apoptosis
|
J:217939
|
Tg(Cd4-cre)1Cwi/0
Trmt6em1Hbgl/Trmt6em1Hbgl
(involves: C57BL/6 * DBA/2J)
|
decreased T cell proliferation
|
J:336736
|
Tg(Cd4-cre)1Cwi/0
Trmt61aem1Hbgl/Trmt61aem1Hbgl
(involves: C57BL/6 * DBA/2J)
|
abnormal T cell activation
|
J:336736
|
| decreased T cell proliferation
|
J:336736
|
Tg(Cd4-Dtx1)1Mzl/?
(involves: C57BL/6)
|
abnormal T cell activation
|
J:151605
|
| abnormal thymocyte activation
|
J:151605
|
| decreased T cell proliferation
|
J:151605
|
Tg(Cd4-Il17rb)#Cdon/?
(involves: C57BL/6)
|
increased susceptibility to type I hypersensitivity reaction
|
J:158594
|
Tg(Cd4-NPM/ALK)N1Ingh/0
(either: (involves: BALB/c * Swiss Webster) or (involves: C57BL/6 * Swiss Webster))
|
increased immunoglobulin level
|
J:82127
|
Tg(Cd4-TGFBR2)16Flv/?
(involves: C3H * C57BL/6 * C57BL/10 * C57BR/cd)
|
abnormal T cell activation
|
J:97554
|
| abnormal T cell proliferation
|
J:97554
|
| increased IgA level
|
J:97554
|
| increased IgG1 level
|
J:97554
|
| increased IgG2a level
|
J:97554
|
| increased immunoglobulin level
|
J:97554
|
Tg(Cd4-TGFBR2)16Flv/?
(involves: C3H * C57BL/6)
|
abnormal T cell proliferation
|
J:134473
|
Tg(CD8aCD8b)57Scr/?
(B6;SJL-Tg(CD8aCD8b)57Scr/J)
|
abnormal cytotoxic T cell physiology
|
J:92994
|
Tg(CD19)1Tft/0
(involves: C57BL/6 * C57BL/6J * SJL)
|
increased B cell proliferation
|
J:27236
|
Tg(CD19)1Tft/Tg(CD19)1Tft
(involves: C57BL/6 * C57BL/6J * SJL)
|
decreased IgG1 level
|
J:27236
|
| decreased IgG3 level
|
J:27236
|
| increased B cell proliferation
|
J:27236
|
| increased IgG2a level
|
J:27236
|
| increased IgG2b level
|
J:27236
|
| increased IgM level
|
J:27236
|
Tg(CD46)2Gsv/0
(involves: C57BL/6 * FVB/N)
|
decreased cytotoxic T cell cytolysis
|
J:109895
|
Tg(Cd68-BCL2)535Medz/0
(involves: 129 * C57BL/6)
|
abnormal dendritic cell physiology
|
J:211458
|
| decreased dendritic cell apoptosis
|
J:211458
|
Tg(Cd79b-TCL1A)BKTeit/0
(involves: C3H * C57BL/6)
|
decreased B cell apoptosis
|
J:79703
|
| decreased T cell apoptosis
|
J:79703
|
| increased B cell proliferation
|
J:79703
|
| increased T cell proliferation
|
J:79703
|
Tg(CD207-Dta)312Dhka/?
(FVB-Tg(CD207-Dta)312Dhka)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:113309
|
Tg(CLEC4C-HBEGF)956Cln/0
(C57BL/6-Tg(CLEC4C-HBEGF)956Cln)
|
abnormal cytotoxic T cell physiology
|
J:166504
|
| abnormal NK cell physiology
|
J:166504
|
| abnormal NK T cell physiology
|
J:166504
|
| impaired natural killer cell mediated cytotoxicity
|
J:166504
|
Tg(Col1a1-Dkk1)1Hmk/?
(B6.FVB-Tg(Col1a1-Dkk1)1Hmk)
|
abnormal osteoclast physiology
|
J:158620
|
Tg(Cr2-cre)3Cgn/?
Xrcc4tm1Fwa/Xrcc4tm2Fwa
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:150339
|
Tg(CYP1A1-PPARD)#Jfoe/0
(involves: C57BL/6J * CBA)
|
increased T cell proliferation
|
J:158907
|
Tg(Emu-TXLNA)1Amjr/0
(B6.Cg-Tg(Emu-TXLNA)1Amjr)
|
abnormal B cell physiology
|
J:117018
|
| increased IgA level
|
J:117018
|
| increased IgG2a level
|
J:117018
|
| increased IgM level
|
J:117018
|
| increased immunoglobulin level
|
J:117018
|
Tg(EmuSR-HDAC9)1468Kpet/0
(involves: C57BL/6 * CBA)
|
abnormal lymphocyte physiology
|
J:237420
|
| increased B cell proliferation
|
J:237420
|
Tg(Fabp2-Arg1)1Wla/Tg(Fabp2-Arg1)1Wla
(involves: FVB)
|
decreased IgM level
|
J:80204
|
Tg(Fabp4-Angptl2)5Yo/0
(involves: C57BL/6)
|
abnormal macrophage chemotaxis
|
J:152387
|
Tg(FCGR2A)11Mkz/Tg(FCGR2A)11Mkz
(involves: C57BL/6 * SJL)
|
abnormal macrophage physiology
|
J:136516
|
| increased IgG2a level
|
J:136516
|
Tg(Foxp3-HBEGF/EGFP)23.2Spar/0
(involves: C57BL/6NCrl)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:125295
|
Tg(Gfap-rtTA,tetO-MAOB,-lacZ)1Jkan/0
(involves: C57BL/6)
|
abnormal microglial cell activation
|
J:132679
|
Tg(H2-Aa)26Dim/?
Tg(H2-Ab1)62Dim/?
(B6.Cg-Tg(H2-Aa)26Dim Tg(H2-Ab1)62Dim)
|
increased immunoglobulin level
|
J:110897
|
Tg(H2-D-Il15)3304Clgr/?
(FVB/N-Tg(H2-D-Il15)3304Clgr)
|
abnormal lymphocyte physiology
|
J:67478
|
Tg(H2-Ea)16Dim/?
(involves: C57BL/6 * SJL)
|
increased immunoglobulin level
|
J:111128
|
Tg(H2-Ea-G6pc2)69Tkay/?
(NOD-Tg(H2-Ea-G6pc2)69Tkay)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:117352
|
| decreased T cell proliferation
|
J:117352
|
Tg(H2-Ea-HA)HACIIAjca/0
Tg(Tcra/Tcrb)1Vbo/0
(C.Cg-Tg(H2-Ea-HA)HACIIAjca Tg(Tcra/Tcrb)1Vbo)
|
increased IgG level
|
J:209872
|
Tg(H2-Ea-HA)HACIIAjca/0
Tg(TcraS106-1,TcrbS106-1)TS1SWAjca/0
(C.Cg-Tg(H2-Ea-HA)HACIIAjca Tg(TcraS106-1,TcrbS106-1)TS1SWAjca)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:209872
|
| increased IgG level
|
J:209872
|
Tg(H2-Ea-Ins2)1Wehi/0
(NOD/ShiLtJWehi-Tg(H2-Ea-Ins2)1Wehi)
|
abnormal T cell proliferation
|
J:100232
|
Tg(H2-Ea-Ins2)1Wehi/Tg(H2-Ea-Ins2)1Wehi
(NOD/ShiLtJWehi-Tg(H2-Ea-Ins2)1Wehi)
|
decreased T cell proliferation
|
J:117352
|
Tg(H2-Ea-LACK)1Ngkh/0
(C.Cg-Tg(H2-Ea-LACK)1Ngkh)
|
abnormal T-helper 1 physiology
|
J:181384
|
| abnormal T-helper 2 physiology
|
J:181384
|
Tg(H2-Ea-Tnfsf9)16Lpc/0
(involves: C57BL/6)
|
abnormal B cell physiology
|
J:132372
|
| decreased IgG level
|
J:132372
|
Tg(H2-K-DUSP5)21Wjl/0
(involves: C57BL/6J * CBA)
|
decreased T cell proliferation
|
J:138077
|
Tg(H2-K-HLA-G,B2M)1Alm/0
(CBA/Ca-Tg(H2-K-HLA-G,B2M)1Alm/CmwJ)
|
abnormal cytotoxic T cell physiology
|
J:140016
|
| increased T cell proliferation
|
J:140016
|
Tg(H2-K-IL6)2Srj/0
(B6.Cg-Tg(H2-K-IL6)2Srj)
|
increased IgG level
|
J:185153
|
Tg(H2-K-MC159/EGFP)13Fkmc/0
(involves: C57BL/6)
|
decreased B cell apoptosis
|
J:138050
|
| decreased T cell apoptosis
|
J:138050
|
| increased B cell proliferation
|
J:138050
|
Tg(H2-K-MC159/EGFP)13Fkmc/Tg(H2-K-MC159/EGFP)13Fkmc
(involves: C57BL/6)
|
increased IgG2b level
|
J:138050
|
Tg(H2-Kb-IL21)5Wjl/0
(involves: 129)
|
abnormal class switch recombination
|
J:93740
|
| increased B cell apoptosis
|
J:93740
|
| increased IgG1 level
|
J:93740
|
| increased IgM level
|
J:93740
|
Tg(H2-L-IL6)1Kish/Tg(H2-L-IL6)1Kish
(C57BL/6-Tg(H2-L-IL6)1Kish)
|
increased IgG1 level
|
J:128016
|
Tg(H2-L-IL6)46Kish/Tg(H2-L-IL6)46Kish
(C57BL/6-Tg(H2-L-IL6)46Kish)
|
increased immunoglobulin level
|
J:40405
|
Tg(H2-L-IL6)46Kish/Tg(H2-L-IL6)46Kish
(involves: BALB/c * C57BL/6)
|
increased IgA level
|
J:40405
|
| increased immunoglobulin level
|
J:40405
|
Tg(H2-L-IL6)46Kish/Tg(H2-L-IL6)46Kish
(C.B6-Tg(H2-L-IL6)46Kish)
|
increased IgG1 level
|
J:74377
|
| increased IgG2b level
|
J:74377
|
| increased IgG level
|
J:74377
|
Tg(H2KmPCC)2939Stoe/0
Tg(Tcra2B4)1Mmd/0
Tg(Tcrb2B4)1Mmd/0
(involves: C3H/HeJ * C57BL/6 * SJL)
|
decreased T cell proliferation
|
J:50143
|
Tg(HBV)10Imeg/0
(involves: C57BL/6)
|
abnormal dendritic cell physiology
|
J:95283
|
Tg(HCRT-tTA)1Ahky/0
Tg(tetO-DTA)1Gfi/0
(B6.Cg-Tg(HCRT-tTA)1Ahky Tg(tetO-DTA)1Gfi)
|
increased microglial cell activation
|
J:211045
|
Tg(HLA-A2/H2-K)1Scr/?
(involves: C57BL/6)
|
abnormal cytotoxic T cell physiology
|
J:127813
|
Tg(HLA-DRA*0101,HLA-DRB1*0101)1Dmz/Tg(HLA-DRA*0101,HLA-DRB1*0101)1Dmz
(involves: C57BL/6 * C57BL/10Sn * SJL/J)
|
abnormal T cell physiology
|
J:108635
|
Tg(Igh3H9)41Mwg/?
(involves: C57BL/6 * SJL)
|
decreased IgD level
|
J:119625
|
Tg(Igh*-Mir125b-1)116Toki/0
(Not Specified)
|
decreased B cell apoptosis
|
J:178816
|
Tg(Igh-6-Cd80)1Gjf/0
(involves: FVB)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:44271
|
| abnormal T cell activation
|
J:44271
|
| decreased immunoglobulin level
|
J:112474
|
Tg(Igh-6-Cd80)1Gjf/0
(NOD.FVB-Tg(Igh-6-Cd80)1Gjf/JbsJ)
|
abnormal B cell activation
|
J:131077
|
| abnormal CD8-positive, alpha-beta T cell physiology
|
J:131077
|
| decreased IgG1 level
|
J:131077
|
| decreased IgG2b level
|
J:131077
|
| decreased IgG3 level
|
J:131077
|
| decreased IgM level
|
J:131077
|
| decreased immunoglobulin level
|
J:131077
|
Tg(Igh-6-Cd86)1Akab/0
(involves: FVB)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:44271
|
Tg(Igh-HMGA2)#Cro/0
(FVB/N-Tg(Igh-HMGA2)#Cro)
|
decreased IgG1 level
|
J:233225
|
| decreased IgG2a level
|
J:233225
|
| decreased IgG2b level
|
J:233225
|
| decreased IgG3 level
|
J:233225
|
Tg(Igh-Lmp2a)ERlon/0
(involves: C57BL/6 * SJL)
|
abnormal B cell proliferation
|
J:129571
|
Tg(Igh-Maf)68Staka/0
(C57BL/6-Tg(Igh-Maf)68Staka)
|
increased IgG level
|
J:168074
|
| increased IgM level
|
J:168074
|
| increased immunoglobulin level
|
J:168074
|
Tg(Igh-Maf)524Staka/0
(involves: C57BL/6 * C57BL/6J * DBA/2)
|
increased IgG level
|
J:168074
|
| increased IgM level
|
J:168074
|
| increased immunoglobulin level
|
J:168074
|
Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro/0
(FVB/N-Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro)
|
abnormal B cell physiology
|
J:162077
|
| decreased IgG1 level
|
J:162077
|
| decreased IgG2a level
|
J:162077
|
| decreased IgG2b level
|
J:162077
|
| increased B cell proliferation
|
J:162077
|
Tg(Igh-Mir155)8Cro/0
(involves: FVB/N)
|
increased B cell proliferation
|
J:109591
|
Tg(Igh-Mir210)#aKgcs/Tg(Igh-Mir210)#aKgcs
(B6.Cg-Tg(Igh-Mir210)#aKgcs)
|
abnormal class switch recombination
|
J:205868
|
| decreased IgA level
|
J:205868
|
| decreased IgG1 level
|
J:205868
|
| decreased IgG2a level
|
J:205868
|
| decreased IgG2b level
|
J:205868
|
| decreased IgG3 level
|
J:205868
|
Tg(Igh-TCL1A)1Ypek/0
(FVB/N-Tg(Igh-TCL1A)1Ypek)
|
abnormal lymphocyte physiology
|
J:160184
|
| decreased IgG1 level
|
J:160184
|
| decreased IgG2a level
|
J:160184
|
| decreased IgG2b level
|
J:160184
|
| decreased IgG3 level
|
J:160184
|
| decreased IgM level
|
J:160184
|
Tg(Igh-V-CD40lg)#Tsub/0
(involves: C57BL/6)
|
increased IgG level
|
J:89855
|
| increased IgM level
|
J:89855
|
Tg(IGH@yH1)2BJkbv/0
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin level
|
J:23827
|
Tg(IGH@yH1)2BJkbv/0
Tg(IGK@yK1)9.2CJkbv/0
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin level
|
J:23827
|
Tg(IghelMD4)4Ccg/0
(involves: C57BL/6)
|
abnormal B cell activation
|
J:73608
|
Tg(IghelMD4)4Ccg/0
(C57BL/6-Tg(IghelMD4)4Ccg)
|
increased IgG2b level
|
J:132538
|
| increased IgM level
|
J:78308,
J:132538
|
Tg(IghelMD4)4Ccg/0
Tg(ML5sHEL)5Ccg/0
(NOD.B6-Tg(IghelMD4)4Ccg Tg(ML5sHEL)5Ccg/Dvs)
|
decreased IgM level
|
J:89156
|
Tg(IghelMD4)4Ccg/0
Tg(ML5sHEL)5Ccg/0
(C57BL/6-Tg(IghelMD4)4Ccg Tg(ML5sHEL)5Ccg)
|
decreased IgM level
|
J:89156,
J:78308
|
Tg(IghelMD4)4Ccg/0
Tg(ML5sHEL)5Ccg/0
(involves: C57BL/6)
|
abnormal B cell physiology
|
J:76134
|
Tg(IghelMD4)4Ccg/Tg(IghelMD4)4Ccg
(NOD.B6-Tg(IghelMD4)4Ccg/DvsJ)
|
abnormal T cell proliferation
|
J:80859
|
Tg(Ighm-Ctla4Ig/Cd80)1Jbs/0
(involves: FVB/N)
|
abnormal B cell physiology
|
J:113109
|
Tg(IghMyc)22Bri/0
(involves: C57BL/6N * SJL)
|
increased B cell apoptosis
|
J:214383
|
Tg(IghMyc)22Bri/0
Xiaptm1Hs/Xiaptm1Hs
(B6.Cg-Xiaptm1Hs Tg(IghMyc)22Bri)
|
decreased B cell proliferation
|
J:138979
|
| increased B cell apoptosis
|
J:138979
|
Tg(Igk-V21-Bax)1967Bvn/0
(involves: FVB/N)
|
increased IgA level
|
J:89049
|
| increased IgE level
|
J:89049
|
| increased IgG1 level
|
J:89049
|
| increased IgG2a level
|
J:89049
|
| increased IgG level
|
J:89049,
J:90901
|
| increased IgM level
|
J:89049
|
| increased immunoglobulin level
|
J:89049
|
Tg(IGK@yK1)9.2CJkbv/0
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin level
|
J:23827
|
Tg(Igkv3-5*-MYC)24Plbe/0
(C57BL/6J-Tg(Igkv3-5*-MYC)DLoxP4Plbe/PlbeMmmh)
|
abnormal immunoglobulin level
|
J:131912
|
| increased IgG1 level
|
J:131912
|
| increased IgG3 level
|
J:131912
|
Tg(Igl-2MOPC315)1275Ust/?
(C57BL/6-Tg(Igl-2MOPC315)1275Ust)
|
decreased IgM level
|
J:134666
|
Tg(ILK3mHEL)3Ccg/0
Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6JSfd * C57BL/10Sg * C57BR/cd)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:78309
|
| abnormal T cell activation
|
J:78309
|
| abnormal T cell proliferation
|
J:78309
|
Tg(Ins2-GP)34-20Olds/0
(involves: BALB/c * C57BL/6)
|
abnormal lymphocyte physiology
|
J:81287
|
| abnormal T cell physiology
|
J:81287
|
Tg(Ins2-HA)165Bri/0
(B10.Cg- H2d Tg(Ins2-HA)165Bri/ShrmJ)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:86430
|
| decreased T cell proliferation
|
J:86430
|
Tg(Ins2-OVA)59Wehi/?
(involves: BALB/c * C57BL/6)
|
abnormal T cell activation
|
J:99560
|
Tg(Ins2-TFRC/OVA)296Wehi/0
(involves: C57BL/6)
|
abnormal leukocyte migration
|
J:98589
|
Tg(Ins2-TFRC/OVA)296Wehi/0
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(involves: C57BL/6 * FVB)
|
decreased T cell proliferation
|
J:122114
|
Tg(Itgam-FCAR)83Rcmo/0
(involves: C57BL/6 * NOD)
|
increased IgA level
|
J:120534
|
Tg(IVL-KLK5)#Hov/0
(involves: C57BL/6 * CBA)
|
increased IgE level
|
J:210758
|
Tg(K18-ACE2)2Prlmn/0
(B6.Cg-Tg(K18-ACE2)2Prlmn/J)
|
increased IgG level
|
J:302313
|
| increased IgM level
|
J:302313
|
Tg(KRT5-rtTA)1Glk/0
Tg(tetO-Tfrc/EGFP/Ova)#Sfz/0
Tg(tetO/CMV-Tslp)#Sfz/0
(involves: C3H * C57BL/6 * FVB/N)
|
increased T cell proliferation
|
J:199558
|
Tg(KRT5-rtTA)1Glk/0
Tg(tetO/CMV-Tslp)#Sfz/0
(involves: C3H * C57BL/6 * FVB/N)
|
decreased IgG2a level
|
J:100506
|
| increased IgE level
|
J:100506
|
| increased IgG1 level
|
J:100506
|
Tg(KRT5-rtTA)1Glk/0
Tg(tetO/CMV-Tslp)#Sfz/0
(C.Cg-Tg(KRT5-rtTA)1Glk Tg(tetO/CMV-Tslp)#Sfz)
|
abnormal B cell activation
|
J:182756
|
| increased B cell proliferation
|
J:182756
|
Tg(KRT5-TGFB1)F2020Xjw/0
(involves: C57BL/6 * DBA/2 * ICR)
|
abnormal Langerhans cell physiology
|
J:90118
|
Tg(KRT5-tTA)1216Glk/0
Tg(tetO-Il13)1Tazh/0
(B6.Cg-Tg(KRT5-tTA)1216Glk Tg(tetO-Il13)1Tazh)
|
increased IgE level
|
J:150232
|
| increased IgG1 level
|
J:150232
|
Tg(KRT14-CASP1)1Miz/0
(involves: C57BL/6)
|
abnormal T cell physiology
|
J:78602
|
| increased IgE level
|
J:78602
|
| increased IgG1 level
|
J:78602
|
Tg(KRT14-Il4)#Lsch/0
(involves: BALB/cBy * C57BL/6)
|
decreased IgG2a level
|
J:126285
|
| increased IgE level
|
J:126285
|
| increased IgG1 level
|
J:126285
|
| increased mast cell degranulation
|
J:126285
|
Tg(KRT14-Il18)#Knak/0
(C57BL/6-Tg(KRT14-Il18)#Knak)
|
abnormal T cell physiology
|
J:78602
|
| increased IgE level
|
J:78602
|
| increased IgG1 level
|
J:78602
|
Tg(KRT14-Tslp)1Pcn/0
(involves: C57BL/6 * SJL)
|
abnormal lymphocyte physiology
|
J:102470
|
| increased immunoglobulin level
|
J:102470
|
Tg(KRT14-Vegfa)3Dtm/0
(FVB/N-Tg(KRT14-Vegfa)3Dtm)
|
abnormal leukocyte adhesion
|
J:104245
|
| enhanced leukocyte tethering or rolling
|
J:104245
|
Tg(KRT14-VP16/NR1I2)13Sdub/?
(involves: C57BL/6)
|
abnormal dendritic cell migration
|
J:258435
|
| increased IgE level
|
J:258435
|
| increased IgG1 level
|
J:258435
|
Tg(LANA,vFLIP,vCYC)801Dtmr/?
(involves: C57BL/6)
|
abnormal B cell activation
|
J:196403
|
| abnormal germinal center B cell physiology
|
J:196403
|
| abnormal marginal zone B cell physiology
|
J:196403
|
| increased B cell proliferation
|
J:196403
|
| increased IgG1 level
|
J:196403
|
| increased IgG3 level
|
J:196403
|
Tg(Lck-Bcl2l1)1Cant/?
(B6.Cg-Tg(Lck-Bcl2l1)1Cant)
|
increased T cell proliferation
|
J:77507
|
Tg(Lck-cre)548Jxm/?
Tgfb1tm2.1Doe/Tgfb1tm2.1Doe
(involves: 129S6/SvEvTac * Black Swiss * C57BL/6 * CBA)
|
abnormal T cell activation
|
J:150024
|
Tg(Lck-cre)I57Jxm/?
Traf3tm1Rbr/Traf3tm1Rbr
(involves: C57BL/6 * ICR * SJL)
|
abnormal T cell physiology
|
J:132877
|
Tg(Lck-CrmA)1Hed/0
(involves: BALB/c * C57BL/6J)
|
decreased T cell apoptosis
|
J:100451
|
Tg(Lck-CrmA)1Hed/?
(involves: BALB/c * C57BL/6J)
|
decreased thymocyte apoptosis
|
J:100451
|
Tg(Lck-Cxadr)1Jdgr/0
(FVB-Tg(Lck-Cxadr)1Jdgr)
|
abnormal T cell physiology
|
J:109884
|
| decreased T cell apoptosis
|
J:109884
|
| decreased T cell proliferation
|
J:109884
|
Tg(Lck-FADD)1Hed/0
(involves: BALB/c * C57BL/6)
|
abnormal T cell proliferation
|
J:100451
|
Tg(Lck-FADD)1Hed/?
(involves: BALB/c * C57BL/6)
|
abnormal T cell physiology
|
J:100451
|
| decreased thymocyte apoptosis
|
J:100451
|
Tg(LCK-NFKBIA)5Dwb/0
(involves: C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:93003
|
| increased T cell apoptosis
|
J:93003
|
Tg(LCK-NFKBIA)5Dwb/?
(involves: BALB/c * C57BL/6 * DBA/2)
|
abnormal T-helper 1 physiology
|
J:145531
|
| decreased susceptibility to type I hypersensitivity reaction
|
J:145531
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:145531
|
Tg(Lck-Socs3)1Kubo/0
(Not Specified)
|
decreased T cell proliferation
|
J:128797
|
Tg(Lck-Sox13)#Jskg/0
(involves: C57BL/6)
|
decreased T cell proliferation
|
J:117301
|
| increased thymocyte apoptosis
|
J:117301
|
Tg(Lck-Stat5b*)1Mafa/0
(Not Specified)
|
increased B cell proliferation
|
J:132669
|
Tg(Lck-Stk17b)26.1Wals/?
(B6.Cg-Tg(Lck-Stk17b)26.1Wals)
|
increased T cell proliferation
|
J:149973
|
Tg(Lck-Tnfsf4)1Nish/0
(B6.Cg-Tg(Lck-Tnfsf4)1Nish)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:194882
|
| increased susceptibility to type IV hypersensitivity reaction
|
J:80214
|
| increased T cell proliferation
|
J:80214
|
Tg(Lck-Tnfsf4)1Nish/0
(C.Cg-Tg(Lck-Tnfsf4)1Nish)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:194882
|
Tg(Lck-TNFSF13)3919Mhah/0
(B6.Cg-Tg(Lck-TNFSF13)3919Mhah)
|
decreased B cell apoptosis
|
J:94628
|
| increased IgA level
|
J:94628
|
Tg(Lck-Tnfsf14)24Yxf/?
(C57BL/6-Tg(Lck-Tnfsf14)24Yxf)
|
abnormal T cell physiology
|
J:120962,
J:129951
|
| increased IgA level
|
J:128976
|
| increased IgG level
|
J:128976
|
| increased T cell proliferation
|
J:129951
|
Tg(Lck-Tslp)1Chea/0
(B6.Cg-Tg(Lck-Tslp)1Chea)
|
increased immunoglobulin level
|
J:72982
|
Tg(Lck-VIPR2)1Ejg/0
(C57BL/6-Tg(Lck-VIPR2)1Ejg)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:127974
|
| increased IgE level
|
J:127974
|
| increased IgG1 level
|
J:127974
|
| increased susceptibility to type I hypersensitivity reaction
|
J:127974
|
Tg(Lck/Emu-Rftn1)1Ayos/?
(involves: C57BL/6)
|
increased IgG1 level
|
J:150299
|
| increased IgG2a level
|
J:150299
|
| increased IgG3 level
|
J:150299
|
| increased IgM level
|
J:150299
|
| increased T cell proliferation
|
J:150299
|
Tg(LckIl4)1315Dbl/0
(involves: C57BL/6J * DBA/2J)
|
abnormal osteoclast physiology
|
J:107359
|
| abnormal T cell activation
|
J:92453
|
| abnormal thymocyte activation
|
J:92453
|
| increased IgG2a level
|
J:92453
|
Tg(LCKprBCL2)36Sjk/?
(involves: C3H * C57BL/6)
|
decreased T cell apoptosis
|
J:11548
|
Tg(LCKprBCL2)36Sjk/0
(involves: C57BL/6 * CBA/J)
|
decreased thymocyte apoptosis
|
J:217939
|
Tg(LCKprBCL2)36Sjk/0
Tg(Nr4a1-EGFP/cre)820Khog/0
(involves: C57BL/6 * C57BL/6J)
|
decreased thymocyte apoptosis
|
J:217939
|
Tg(LCKprBCL2)36Sjk/0
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * C57BL/6J * DBA/2J)
|
decreased thymocyte apoptosis
|
J:217939
|
Tg(Ly6a-GCSAM)102AIsg/0
(involves: C57BL/6J * CBA)
|
increased B cell proliferation
|
J:221238
|
| increased IgG level
|
J:221238
|
Tg(Ly6a-SET/NUP214)2969Gcg/0
(involves: FVB/NJ)
|
increased B cell apoptosis
|
J:142938
|
Tg(MCL1)8Caig/0
(involves: C57BL/6 * SJL)
|
abnormal leukocyte physiology
|
J:50604
|
| abnormal macrophage apoptosis
|
J:95913
|
| decreased B cell apoptosis
|
J:50604
|
| decreased T cell apoptosis
|
J:50604
|
Tg(ML5sHEL)5Ccg/0
Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:78309
|
| abnormal T cell activation
|
J:78309
|
| abnormal T cell proliferation
|
J:78309
|
Tg(ML5sHEL)5Ccg/0
Tg(TcrHEL3A9)1Mmd/0
Tg(TLK2mHEL)2Ccg/0
(involves: C57BL/6JSfd * C57BL/10 * C57BR/cd)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:78309
|
| abnormal T cell activation
|
J:78309
|
| abnormal T cell proliferation
|
J:78309
|
Tg(MMTV-PyVT)#Mul/0
(B6.FVB-Tg(MMTV-PyVT)#Mul)
|
abnormal T cell physiology
|
J:147923
|
| decreased B cell proliferation
|
J:147923
|
| decreased T cell proliferation
|
J:147923
|
Tg(MMTV-Scgb1a1)#Abm/0
(involves: C57BL/6 * SJL)
|
increased IgA level
|
J:57504
|
Tg(Msr1-MMP9)#Apar/0
(B6.Cg-Tg(Msr1-MMP9)#Apar)
|
abnormal macrophage physiology
|
J:136830
|
Tg(Mt1-IL6)28Gci/0
(involves: C57BL/6 * DBA/2)
|
increased IgG1 level
|
J:18424
|
| increased IgG level
|
J:177825,
J:18424
|
Tg(MUC1)79.24Gend/0
(involves: C57BL/6)
|
increased IgG level
|
J:154046
|
| increased IgM level
|
J:154046
|
Tg(Myl1-SOD1*G93A)#Amu/0
(FVB/NJ-Tg(Myl1-SOD1*G93A)#Amu)
|
increased microglial cell activation
|
J:143747
|
Tg(Nlrp1b)1Die/0
(involves: 129S1/SvImJ * C57BL/6 * SJL)
|
abnormal macrophage physiology
|
J:99748
|
Tg(Pgk1-HA)1.1Vbo/?
Tg(Tcra/Tcrb)1Vbo/?
(C.Cg-Tg(Pgk1-HA)1.1Vbo Tg(Tcra/Tcrb)1Vbo)
|
abnormal regulatory T cell physiology
|
J:112603
|
Tg(Pim1-Il9)5Jcrd/0
(involves: BALB/c * FVB/N)
|
increased susceptibility to type I hypersensitivity reaction
|
J:100568
|
Tg(Pim1-Il9)5Jcrd/0
(involves: FVB/N)
|
increased susceptibility to type I hypersensitivity reaction
|
J:100568
|
Tg(Prdx6)153Pgn/0
(C57BL/6-Tg(Prdx6)153Pgn/Pgn)
|
abnormal macrophage physiology
|
J:86528
|
Tg(Psp-Rbbp4)1Yoha/0
(involves: C57BL/6)
|
abnormal T cell activation
|
J:141378
|
Tg(Scgb1a1-Il13)2Eli/?
(involves: C57BL/6 * CBA)
|
abnormal leukocyte physiology
|
J:53612
|
Tg(Scgb1a1-rtTA,-tTS,tetO-CHI3L1)1Eli/0
(Not Specified)
|
decreased T cell apoptosis
|
J:148490
|
Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/0
(involves: C57BL/6 * CBA)
|
abnormal T-helper 2 physiology
|
J:148490
|
Tg(SERPINA1-IGHG1/Il1rl1)423Zbz/?
(involves: C3H * C57BL/6)
|
abnormal eosinophil physiology
|
J:63507
|
Tg(SOD1*G93A)1Gur/0
(B6.Cg-Tg(SOD1*G93A)1Gur/J)
|
abnormal T cell physiology
|
J:138237
|
Tg(Stat3*)9199Alau/0
(involves: C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:210877
|
| decreased IgG1 level
|
J:210877
|
| decreased IgG3 level
|
J:210877
|
| increased IgE level
|
J:210877
|
Tg(Tcra2C,Tcrb2C)1Dlo/?
(involves: C57L * DBA/2 * SJL)
|
abnormal memory T cell physiology
|
J:95380
|
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell proliferation
|
J:189919
|
| increased T cell apoptosis
|
J:189919
|
| increased T cell proliferation
|
J:189919
|
Tg(Tcra5CC7,Tcrb5CC7)IWep/0
(involves: C57BL/6)
|
abnormal T cell activation
|
J:73608
|
Tg(Tcra,Tcrb)3Ayr/0
(involves: C57BL/6 * DBA/2)
|
decreased T cell proliferation
|
J:80775
|
Tg(Tcra,Tcrb)24Efro/0
(D1.Cg-Tg(Tcra,Tcrb)24Efro)
|
decreased T cell proliferation
|
J:104243
|
| increased T cell proliferation
|
J:104243
|
Tg(Tcra,Tcrb)HRCAll/0
(B6.Cg-Tg(Tcra,Tcrb)HRCAll)
|
decreased cytotoxic T cell cytolysis
|
J:131347
|
Tg(TcraAI4)1Dvs/0
Tg(TcrbAI4)1Dvs/0
(NOD-Tg(TcraAI4)1Dvs Tg(TcrbAI4)1Dvs)
|
abnormal cytotoxic T cell physiology
|
J:94192
|
Tg(TcraAV19AJ33)1Shima/?
(involves: 129S4/SvJae * C57BL/6)
|
abnormal NK T cell physiology
|
J:112657
|
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6 * DBA/2J)
|
abnormal cytotoxic T cell physiology
|
J:66565
|
Tg(TcrAND)53Hed/?
(involves: A/WySnSg * C57BL/6 * C57BL/10SnSg * SJL)
|
abnormal T cell proliferation
|
J:85777
|
| abnormal thymocyte activation
|
J:85777
|
Tg(TcraR28,TcrbR28)KRNDim/0
(involves: C57BL/6 * NOD * SJL)
|
abnormal macrophage chemotaxis
|
J:36815
|
| abnormal T cell activation
|
J:36815
|
| abnormal T cell proliferation
|
J:36815
|
| impaired neutrophil recruitment
|
J:36815
|
| increased IgG1 level
|
J:36815
|
Tg(TcraTcrb)8Rest/?
(C57BL/6-Tg(TcraTcrb)8Rest)
|
abnormal cytotoxic T cell physiology
|
J:85058
|
Tg(TcraTcrb)425Cbn/0
Trim30atm1Yjk/Trim30atm1Yjk
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
increased T cell proliferation
|
J:215171
|
Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6)
|
abnormal cytotoxic T cell physiology
|
J:92867,
J:133645
|
| increased T cell proliferation
|
J:92867
|
Tg(Tcrb)93Vbo/0
(involves: C57BL/6 * C57BL/LiA * CBA/BrA)
|
abnormal cytotoxic T cell physiology
|
J:66565
|
Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6)
|
abnormal T cell activation
|
J:73608
|
| increased T cell proliferation
|
J:73608
|
Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
|
abnormal T cell activation
|
J:78309
|
| abnormal T cell proliferation
|
J:78309
|
Tg(TcrHEL3A9)1Mmd/0
Tg(TLK2mHEL)2Ccg/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:78309
|
| abnormal T cell activation
|
J:78309
|
| abnormal T cell proliferation
|
J:78309
|
Tg(TcrLCMV)1Aox/?
(C57BL/6-Tg(TcrLCMV)1Aox)
|
abnormal cytotoxic T cell physiology
|
J:92228
|
| increased IgG level
|
J:92228
|
Tg(TcrLCMV)2Aox/?
(C57BL/6-Tg(TcrLCMV)2Aox)
|
abnormal cytotoxic T cell physiology
|
J:92228
|
Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6 * DBA/2)
|
decreased cytotoxic T cell cytolysis
|
J:77696
|
| decreased T cell proliferation
|
J:77696
|
Tg(Tek-Jam3)1Maal/?
(B6.Cg-Tg(Tek-Jam3)1Maal)
|
abnormal cellular extravasation
|
J:99020
|
| abnormal leukocyte adhesion
|
J:99020
|
| abnormal leukocyte physiology
|
J:99020
|
| impaired neutrophil chemotaxis
|
J:99020
|
Tg(tetO/CMV-CD200)1Rmgo/Tg(tetO/CMV-CD200)1Rmgo
(involves: C57BL/6)
|
abnormal dendritic cell physiology
|
J:134313
|
Tg(Th-SNCA)5Eric/Tg(Th-SNCA)5Eric
(involves: C57BL/6)
|
abnormal microglial cell physiology
|
J:140907
|
Tg(Thy1-APPSwDutIowa)BWevn/0
(involves: C57BL/6)
|
abnormal microglial cell physiology
|
J:124911
|
Tg(Thy1-Fcer2a)2431Putt/?
(involves: BALB/c * C57BL/6)
|
decreased IgE level
|
J:20421
|
| decreased IgG1 level
|
J:20421
|
Tg(Thy1-SNCA)61Ema/0
(involves: C57BL/6 * DBA/2)
|
abnormal microglial cell activation
|
J:238066
|
Tg(Thy1-UBQLN2*P497S)3Mont/?
(involves: C3H * C57BL/6 * C57BL/6J)
|
increased microglial cell activation
|
J:239510
|
Tg(Thy1-UBQLN2*P506T)6Mont/?
(involves: C3H * C57BL/6 * C57BL/6J)
|
decreased microglial cell activation
|
J:239510
|
Tg(Thy1/THY1)T12Gsv/0
(involves: C57BL/10 * CBA)
|
increased IgG level
|
J:133943
|
| increased IgM level
|
J:133943
|
Tg(Tk1-DPP4)27Ysj/0
(involves: C57BL/6 * FVB/N)
|
abnormal macrophage activation involved in immune response
|
J:290259
|
X/Tg(Tlr7)6Boll
(involves: C57BL/6)
|
abnormal B cell activation
|
J:127600
|
| abnormal T cell activation
|
J:127600
|
Tg(Tnfsf13b)1Fma/0
(involves: C57BL/6 * DBA/2J)
|
abnormal B cell physiology
|
J:58798
|
| abnormal T cell physiology
|
J:58798
|
| increased IgG level
|
J:58798
|
| increased IgM level
|
J:58798
|
| increased immunoglobulin level
|
J:58798
|
Tg(Tnfsf13b)1Fma/0
(B6.Cg-Tg(Tnfsf13b)1Fma)
|
increased IgA level
|
J:114782
|
Tg(Tnfsf13b)1Fma/?
(B6.Cg-Tg(Tnfsf13b)1Fma)
|
abnormal B cell activation
|
J:113556
|
| abnormal marginal zone B cell physiology
|
J:113556
|
Tg(Tnfsf13b)1Fma/?
Tnfrsf13btm1Rjb/Tnfrsf13btm1Rjb
(B6.Cg-Tnfrsf13btm1Rjb Tg(Tnfsf13b)1Fma)
|
abnormal class switch recombination
|
J:113556
|
Tg(Tnfsf13b)1Fma/?
Tnfrsf13ctm1Mass/Tnfrsf13ctm1Mass
(B6.Cg-Tnfrsf13ctm1Mass Tg(Tnfsf13b)1Fma)
|
abnormal class switch recombination
|
J:113556
|
Tg(Tnfsf13b)1Fma/0
Tnfsf14tm1Kpf/Tnfsf14tm1Kpf
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2J)
|
increased IgA level
|
J:114782
|
Tg(Tnfsf13b)1Fma/Tg(Tnfsf13b)1Fma
(involves: C57BL/6 * DBA/2)
|
abnormal immunoglobulin level
|
J:178227
|
| increased IgA level
|
J:178227
|
| increased IgM level
|
J:178227
|
| increased immunoglobulin level
|
J:178227
|
Tg(Trp53)1Srn/0
(involves: C57BL/6 * CBA)
|
increased thymocyte apoptosis
|
J:80311
|
Tg(Trp53)1Srn/0
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
decreased thymocyte apoptosis
|
J:80311
|
Tg(Trp53)bSrn/0
(involves: C57BL/6 * CBA)
|
increased thymocyte apoptosis
|
J:80311
|
Tg(UBC-scFv)2Nemz/0
(involves: C57BL/6 * DBA/2)
|
abnormal immunoglobulin level
|
J:96759
|
Tg(Vav1-Lin28b)C3Apla/0
(involves: C57BL/6)
|
increased IgG level
|
J:189197
|
| increased T cell proliferation
|
J:189197
|
Tg(Vav1-STAT5B*N642H)726Biat/0
(C57BL/6NCrl-Tg(Vav1-STAT5B*N642H)726Biat)
|
increased T cell proliferation
|
J:257519
|
Tg(Vav-BCL2)69Jad/0
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:88565
|
| abnormal somatic hypermutation frequency
|
J:88565
|
Tg(Vil1-cre)997Gum/0
Tnfrsf11atm1.1Irw/Tnfrsf11atm1.1Irw
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac * SJL)
|
decreased IgA level
|
J:226603
|
Tgm3Btlr/Tgm3Btlr
(C57BL/6J-Tgm3Btlr)
|
decreased IgE level
|
J:265197
|
Tgm4Btlr/Tgm4Btlr
(C57BL/6J-Tgm4Btlr)
|
increased IgE level
|
J:272522
|
Tgfb2tm1Doe/Tgfb2tm1Doe
(involves: 129P2/OlaHsd * Black Swiss)
|
abnormal macrophage physiology
|
J:73681
|
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal T cell activation
|
J:148747
|
Tgm2tm1.1Rmgr/Tgm2tm1.1Rmgr
(involves: 129S1/SvImJ * C57BL/6)
|
abnormal T cell physiology
|
J:95130
|
Tgm2tm1Gml/Tgm2tm1Gml
(involves: C57BL/6 * DBA/1LacJ)
|
impaired macrophage phagocytosis
|
J:132254
|
TgTn(pb-CAG-Gm614)#Cya/0
(involves: C57BL/6)
|
decreased B cell apoptosis
|
J:307345
|
TgTn(pb-CAG-Gm40600)#Rew/0
(C57BL/6-TgTn(pb-CAG-Gm40600)#Rew)
|
decreased IgA level
|
J:311878
|
| decreased IgE level
|
J:311878
|
| decreased IgG1 level
|
J:311878
|
| decreased IgG2b level
|
J:311878
|
| decreased IgG2c level
|
J:311878
|
| decreased IgG3 level
|
J:311878
|
| decreased IgG level
|
J:311878
|
| decreased IgM level
|
J:311878
|
| increased IgA level
|
J:311878
|
| increased IgE level
|
J:311878
|
| increased IgG1 level
|
J:311878
|
| increased IgG2b level
|
J:311878
|
| increased IgG2c level
|
J:311878
|
| increased IgG3 level
|
J:311878
|
| increased IgG level
|
J:311878
|
| increased IgM level
|
J:311878
|
Thbdtm2.1Emc/Thbdtm2.1Emc
(involves: 129/Sv * BALB/c * C57BL/6)
|
abnormal leukocyte adhesion
|
J:118000
|
| abnormal leukocyte physiology
|
J:118000
|
Thbdtm2Emc/Thbdtm2Emc
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal leukocyte physiology
|
J:118000
|
Thbs1tm1Hyn/Thbs1tm1Hyn
Thbs2tm1Bst/Thbs2tm1Bst
(involves: 129T2/SvEms * 129X1/SvJ)
|
impaired macrophage chemotaxis
|
J:78876
|
Themistm1Gasc/Themistm1Gasc
(B6.129S-Themistm1Gasc)
|
decreased T cell proliferation
|
J:151074
|
Themistm1Hasu/Themistm1Hasu
(involves: C57BL/6 * CBA)
|
increased T cell proliferation
|
J:153235
|
Thratm1Syc/Thra+
(involves: 129S6/SvEvTac * C57BL/6J * NIH Black Swiss)
|
abnormal osteoclast physiology
|
J:217018
|
Thratm2Jas/Thratm2Jas
(involves: 129)
|
abnormal osteoclast physiology
|
J:120899
|
Thratm2Ven/Thratm2Ven
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal osteoclast physiology
|
J:72959
|
Thrbtm1Olc/Thrbtm1Olc
(involves: 129)
|
abnormal osteoclast physiology
|
J:120899
|
Thypr1DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
increased T cell proliferation
|
J:76931
|
Thypr2DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
increased T cell proliferation
|
J:76931
|
Tia1tm1Andp/Tia1tm1Andp
(C.129S2-Tia1tm1Andp)
|
abnormal macrophage physiology
|
J:88770
|
Tia1tm1Andp/Tia1tm1Andp
Zfp36tm1Pjb/Zfp36tm1Pjb
(B6.Cg-Tia1tm1Andp Zfp36tm1Pjb)
|
abnormal macrophage physiology
|
J:88443
|
Ticam1Lps2/Ticam1Lps2
(involves: C57BL/6)
|
abnormal macrophage physiology
|
J:84896
|
| decreased macrophage apoptosis
|
J:84896,
J:92674
|
| decreased macrophage cytokine production
|
J:84896
|
| decreased macrophage nitric oxide production
|
J:84896
|
Ticam1Lps2/Ticam1Lps2
Myd88tm1Aki/Myd88tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal macrophage physiology
|
J:84896
|
Ticam1M2Btlr/Ticam1+
(C57BL/6J-Ticam1M2Btlr)
|
abnormal macrophage physiology
|
J:234240
|
| decreased macrophage cytokine production
|
J:234240
|
Ticam1M2Btlr/Ticam1M2Btlr
(C57BL/6J-Ticam1M2Btlr)
|
abnormal macrophage physiology
|
J:234240
|
| decreased macrophage cytokine production
|
J:234240
|
Ticam1tm1Aki/Ticam1tm1Aki
(involves: 129P2/OlaHsd)
|
abnormal B cell activation
|
J:174941
|
| abnormal B cell physiology
|
J:84679
|
| abnormal dendritic cell physiology
|
J:174941
|
| abnormal macrophage physiology
|
J:174941,
J:84679
|
| abnormal microglial cell physiology
|
J:185198
|
| abnormal NK cell physiology
|
J:174941
|
| abnormal NK T cell physiology
|
J:174941
|
| impaired macrophage phagocytosis
|
J:185198
|
Ticam1tm1Aki/Ticam1tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased IgG2a level
|
J:130954
|
| decreased IgG level
|
J:130954
|
| decreased susceptibility to type I hypersensitivity reaction
|
J:161445
|
Ticam1tm1Aki/Ticam1tm1Aki
(B6.129P2-Ticam1tm1Aki)
|
decreased macrophage cytokine production
|
J:144301
|
| impaired neutrophil recruitment
|
J:144301
|
Ticam1tm1Tsse/Ticam1tm1Tsse
(B6.129-Ticam1tm1Tsse)
|
impaired natural killer cell mediated cytotoxicity
|
J:118750
|
Tigittm1Sdl/Tigittm1Sdl
(involves: C57BL/6)
|
abnormal professional antigen presenting cell physiology
|
J:168902
|
| increased T cell proliferation
|
J:168902
|
Timd4tm1Kuch/Timd4tm1Kuch
(C57BL/6-Timd4tm1Kuch)
|
abnormal B cell physiology
|
J:160747
|
| abnormal macrophage physiology
|
J:160747
|
| increased IgA level
|
J:160747
|
| increased IgG2a level
|
J:160747
|
| increased IgG2b level
|
J:160747
|
Timd4tm1Osa/Timd4tm1Osa
(involves: C57BL/6)
|
impaired macrophage phagocytosis
|
J:187181
|
Timd4tm1Wouy/Timd4tm1Wouy
(involves: 129)
|
abnormal macrophage physiology
|
J:160304
|
| impaired macrophage phagocytosis
|
J:160304
|
| increased IgG2a level
|
J:160304
|
Tiraptm1Aki/Tiraptm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased IgG3 level
|
J:137066
|
Tiraptm1Aki/Tiraptm1Aki
(B6.129P2-Tiraptm1Aki)
|
abnormal dendritic cell physiology
|
J:118954
|
Tiraptm1Medz/Tiraptm1Medz
(involves: 129S1/Sv * C57BL/6)
|
abnormal dendritic cell physiology
|
J:96773
|
| abnormal macrophage physiology
|
J:96773
|
| decreased B cell proliferation
|
J:96773
|
Tiraptm1Medz/Tiraptm1Medz
(involves: 129S1/Sv)
|
abnormal macrophage physiology
|
J:96018
|
Tle4tm1.2Dasw/Tle4tm1.2Dasw
(B6.129S6(Cg)-Tle4tm1.2Dasw)
|
increased thymocyte apoptosis
|
J:219243
|
Tlr1tm1Flv/Tlr1tm1Flv
(involves: 129S1/Sv)
|
abnormal macrophage physiology
|
J:95726
|
| decreased immunoglobulin level
|
J:95726
|
Tlr2lngd/Tlr2lngd
(C57BL/6J-Tlr2lngd)
|
abnormal macrophage physiology
|
J:94077
|
Tlr2tm1Aki/Tlr2tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal macrophage physiology
|
J:76115,
J:95726
|
| decreased immunoglobulin level
|
J:95726
|
| decreased microglial cell activation
|
J:122551
|
Tlr2tm1Aki/Tlr2tm1Aki
(B6.129P2-Tlr2tm1Aki)
|
abnormal dendritic cell physiology
|
J:118954
|
Tlr2tm1Aki/Tlr2tm1Aki
(involves: 129P2/OlaHsd)
|
abnormal leukocyte migration
|
J:171379
|
| abnormal macrophage physiology
|
J:103464,
J:130138,
J:70578
|
| abnormal osteoclast physiology
|
J:130138
|
| increased B cell apoptosis
|
J:135830
|
Tlr2tm1Aki/Tlr2tm1Aki
Tlr4tm1Aki/Tlr4tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal macrophage physiology
|
J:117688
|
| decreased IgG3 level
|
J:117688
|
Tlr2tm1Kir/Tlr2tm1Kir
(either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * C57BL/6 * C57BL/6J))
|
abnormal macrophage physiology
|
J:85323
|
| decreased macrophage cytokine production
|
J:85323
|
| decreased macrophage nitric oxide production
|
J:85323
|
Tlr2tm1Kir/Tlr2tm1Kir
(Not Specified)
|
abnormal macrophage physiology
|
J:96018
|
Tlr2tm1Kir/Tlr2tm1Kir
(B6.129-Tlr2tm1Kir)
|
abnormal cellular extravasation
|
J:171028
|
Tlr2tm1Kir/Tlr2tm1Kir
Tlr4Lps-d/Tlr4Lps-d
(C3.Cg-Tlr2tm1Kir Tlr4Lps-d)
|
abnormal macrophage physiology
|
J:121930
|
Tlr3M1Btlr/Tlr3+
(C57BL/6J-Tlr3M1Btlr)
|
decreased macrophage cytokine production
|
J:224670
|
Tlr3M1Btlr/Tlr3M1Btlr
(C57BL/6J-Tlr3M1Btlr)
|
decreased macrophage cytokine production
|
J:224670
|
Tlr3tm1Aki/Tlr3tm1Aki
(involves: 129P2/OlaHsd)
|
abnormal dendritic cell physiology
|
J:114555
|
Tlr3tm1Flv/Tlr3tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
abnormal B cell physiology
|
J:72167
|
| abnormal macrophage physiology
|
J:72167
|
Tlr3tm1Flv/Tlr3tm1Flv
(involves: C57BL/6)
|
abnormal macrophage physiology
|
J:86617
|
Tlr3tm1Flv/Tlr3tm1Flv
(Not Specified)
|
abnormal NK cell physiology
|
J:88906
|
| abnormal NK T cell physiology
|
J:88906
|
Tlr4lps-4Btlr/Tlr4+
(C57BL/6J-Tlr4lps-4Btlr)
|
decreased macrophage cytokine production
|
J:224664
|
Tlr4lps-4Btlr/Tlr4lps-4Btlr
(C57BL/6J-Tlr4lps-4Btlr)
|
decreased macrophage apoptosis
|
J:224664
|
| decreased macrophage cytokine production
|
J:224664
|
Tlr4lps-5Btlr/Tlr4lps-5Btlr
(C57BL/6J-Tlr4lps-5Btlr)
|
decreased macrophage cytokine production
|
J:224666
|
Tlr4Lps-6Btlr/Tlr4+
(C57BL/6J-Tlr4Lps-6Btlr)
|
decreased macrophage cytokine production
|
J:224667
|
Tlr4Lps-6Btlr/Tlr4Lps-6Btlr
(C57BL/6J-Tlr4Lps-6Btlr)
|
decreased macrophage cytokine production
|
J:224667
|
Tlr4lps-7Btlr/Tlr4+
(C57BL/6J-Tlr4Lps-7Btlr)
|
decreased macrophage cytokine production
|
J:234239
|
Tlr4lps-7Btlr/Tlr4lps-7Btlr
(C57BL/6J-Tlr4Lps-7Btlr)
|
decreased macrophage cytokine production
|
J:234239
|
Tlr4Lps-8Btlr/Tlr4+
(C57BL/6J-Tlr4Lps-8Btlr)
|
decreased macrophage cytokine production
|
J:234241
|
Tlr4Lps-8Btlr/Tlr4Lps-8Btlr
(C57BL/6J-Tlr4Lps-8Btlr)
|
decreased macrophage cytokine production
|
J:234241
|
Tlr4lps-Btlr/Tlr4lps-Btlr
(C57BL/6J-Tlr4lps-Btlr)
|
abnormal macrophage physiology
|
J:128416
|
Tlr4Lps-d/Tlr4Lps-d
(involves: C3H/HeJ)
|
abnormal T-helper 2 physiology
|
J:96356
|
Tlr4Lps-d/Tlr4Lps-d
(C3H/HeJ-Tlr4Lps-d)
|
abnormal macrophage chemotaxis
|
J:122597
|
| abnormal microglial cell physiology
|
J:99051
|
Tlr4lps-del/Tlr4lps-del
(C57BL/10ScCr)
|
abnormal macrophage physiology
|
J:88996
|
Tlr4tm1Aki/Tlr4tm1Aki
(involves: 129P2/OlaHsd * C57BL/6J)
|
impaired neutrophil chemotaxis
|
J:98224
|
Tlr4tm1Aki/Tlr4tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal macrophage physiology
|
J:76115
|
| decreased B cell proliferation
|
J:76115
|
Tlr5tm1Aki/Tlr5tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal macrophage physiology
|
J:112671
|
Tlr5tm1Flv/Tlr5tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
abnormal dendritic cell physiology
|
J:111778
|
Tlr5tm1Flv/Tlr5tm1Flv
(involves: 129S1/Sv)
|
abnormal leukocyte migration
|
J:171379
|
Tlr6int/Tlr6int
(C57BL/6-Tlr6int)
|
abnormal adaptive immunity
|
J:110094
|
| abnormal macrophage physiology
|
J:110094
|
Tlr6m2Btlr/Tlr6m2Btlr
(C57BL/6J-Tlr6m2Btlr)
|
abnormal macrophage physiology
|
J:144166
|
Tlr6m3Btlr/Tlr6m3Btlr
(C57BL/6J-Tlr6m3Btlr)
|
abnormal macrophage physiology
|
J:144167
|
Tlr6m4Btlr/Tlr6m4Btlr
(C57BL/6J-Tlr6m4Btlr)
|
abnormal macrophage physiology
|
J:144168
|
Tlr6tm1Aki/Tlr6tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal macrophage physiology
|
J:70578
|
Tlr7em2Anu/Y
(C57BL/6NCrl-Tlr7em2Anu)
|
abnormal B cell physiology
|
J:324448
|
| abnormal macrophage physiology
|
J:324448
|
| decreased B cell apoptosis
|
J:324448
|
| decreased B cell proliferation
|
J:324448
|
Tlr7em2Anu/Tlr7+
(C57BL/6NCrl-Tlr7em2Anu)
|
abnormal plasmacytoid dendritic cell physiology
|
J:324448
|
Tlr7em2Anu/Tlr7em2Anu
(C57BL/6NCrl-Tlr7em2Anu)
|
abnormal plasmacytoid dendritic cell physiology
|
J:324448
|
Tlr7rsq1/Y
(C57BL/6J-Tlr7rsq1)
|
abnormal macrophage physiology
|
J:128404
|
Tlr7rsq1/Tlr7rsq1
(C57BL/6J-Tlr7rsq1)
|
abnormal macrophage physiology
|
J:128404
|
Tlr7rsq2/Y
(C57BL/6J-Tlr7rsq2)
|
abnormal macrophage physiology
|
J:140020
|
Tlr7tm1Aki/Tlr7tm1Aki
(B6.129P2-Tlr7tm1Aki)
|
abnormal dendritic cell physiology
|
J:118954
|
Tlr7tm1Flv/Tlr7tm1Flv
(B6.129S1-Tlr7tm1Flv)
|
decreased IgG1 level
|
J:165267
|
| decreased IgG2a level
|
J:165267
|
| decreased IgG level
|
J:165267
|
| decreased IgM level
|
J:165267
|
Tlr8/Tlr7tm1Vlcg/Tlr7+
Tlr8/Tlr7tm1Vlcg/Tlr8tm1Vlcg
(B6.Cg-Tlr8/Tlr7tm1Vlcg Tlr8tm1Vlcg)
|
decreased IgG level
|
J:165267
|
| decreased IgM level
|
J:165267
|
| increased IgG level
|
J:165267
|
| increased IgM level
|
J:165267
|
Tlr8tm1Vlcg/Tlr8tm1Vlcg
(B6.129S1-Tlr8tm1Vlcg)
|
decreased IgG1 level
|
J:165267
|
| increased IgG2a level
|
J:165267
|
| increased IgG level
|
J:165267
|
| increased IgM level
|
J:165267
|
Tlr9M1Btlr/Tlr9M1Btlr
(involves: C57BL/6)
|
abnormal macrophage physiology
|
J:88906
|
| abnormal NK cell physiology
|
J:88906
|
| abnormal NK T cell physiology
|
J:88906
|
Tlr9M2Btlr/Tlr9+
(C57BL/6J-Tlr9M2Btlr)
|
abnormal macrophage physiology
|
J:128405
|
Tlr9M2Btlr/Tlr9M2Btlr
(C57BL/6J-Tlr9M2Btlr)
|
abnormal macrophage physiology
|
J:128405
|
Tlr9m3Btlr/Tlr9m3Btlr
(C57BL/6J-Tlr9m3Btlr)
|
abnormal macrophage physiology
|
J:128406
|
| decreased B cell proliferation
|
J:128406
|
Tlr9m4Btlr/Tlr9+
(C57BL/6J-Tlr9m4Btlr)
|
abnormal macrophage physiology
|
J:132489
|
| abnormal plasmacytoid dendritic cell physiology
|
J:132489
|
| decreased B cell proliferation
|
J:132489
|
Tlr9M5Btlr/?
(C57BL/6J-Tlr9M5Btlr)
|
abnormal macrophage physiology
|
J:147856
|
Tlr9tm1Aki/Tlr9tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell physiology
|
J:66049
|
| abnormal dendritic cell physiology
|
J:66049
|
| abnormal macrophage physiology
|
J:117688,
J:66049
|
| abnormal T-helper 1 physiology
|
J:66049
|
Tlr9tm1Aki/Tlr9tm1Aki
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal dendritic cell physiology
|
J:88244
|
Tlr9tm1Aki/Tlr9tm1Aki
(B6.129P2-Tlr9tm1Aki)
|
impaired natural killer cell mediated cytotoxicity
|
J:125611
|
Tlr9tm1Aki/Tlr9tm1Aki
(involves: 129P2/OlaHsd)
|
abnormal leukocyte migration
|
J:171379
|
Tlr12tm1Gho/Tlr12tm1Gho
(Not Specified)
|
abnormal macrophage physiology
|
J:89754
|
Tm4sf19em1Sjkm/Tm4sf19em1Sjkm
(C57BL/6J-Tm4sf19em1Sjkm)
|
abnormal osteoclast physiology
|
J:343322
|
Tm4sf19em2Sjkm/Tm4sf19em2Sjkm
(C57BL/6J-Tm4sf19em2Sjkm)
|
abnormal osteoclast physiology
|
J:343322
|
Tmem79ma/Tmem79ma
(B6.CBACaGr-Tmem79ma/J)
|
increased IgE level
|
J:202453
|
Tmem102tm1.1Jyen/Tmem102tm1.1Jyen
(B6.Cg-Tmem102tm1.1Jyen)
|
abnormal leukocyte adhesion
|
J:200103
|
| impaired leukocyte migration
|
J:200103
|
Tmem109tm1Yamt/Tmem109tm1Yamt
(B6.Cg-Tmem109tm1Yamt)
|
decreased thymocyte apoptosis
|
J:157864
|
Tmem178tm1Lex/Tmem178tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal osteoclast physiology
|
J:228311
|
Tmem219tm1(KOMP)Vlcg/Tmem219tm1(KOMP)Vlcg
(B6J.B6N-Tmem219tm1(KOMP)Vlcg)
|
increased IgE level
|
J:236976
|
Tmem234tm1Lex/Tmem234tm1Lex
(B6;129S5-Tmem234tm1Lex/Mmucd)
|
increased IgG2a level
|
J:171883
|
Tmem268em1Cheyy/Tmem268em1Cheyy
(involves: C57BL/6)
|
abnormal leukocyte adhesion
|
J:350812
|
| abnormal leukocyte physiology
|
J:350812
|
| abnormal macrophage physiology
|
J:350812
|
| impaired leukocyte migration
|
J:350812
|
| impaired macrophage phagocytosis
|
J:350812
|
| impaired neutrophil phagocytosis
|
J:350812
|
TnfM2Btlr/Tnf+
(C57BL/6J-TnfM2Btlr)
|
decreased macrophage cytokine production
|
J:213047
|
Tnftm1Gkl/Tnftm1Gkl
(involves: 129S/SvEv * C57BL/6)
|
abnormal lymphocyte physiology
|
J:114740
|
| abnormal macrophage physiology
|
J:114740
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:47673
|
Tnftm1Ljo/Tnftm1Ljo
(involves: 129S1/Sv)
|
decreased IgG level
|
J:41992
|
Tnftm1Ljo/Tnftm1Ljo
(involves: 129S1/Sv * C57BL/6)
|
abnormal neutrophil physiology
|
J:127028
|
| decreased immunoglobulin level
|
J:127028
|
Tnftm1Sek/Tnftm1Sek
(B6.Cg-Tnftm1Sek)
|
abnormal macrophage physiology
|
J:44841
|
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:136667
|
| abnormal T cell physiology
|
J:136667
|
| abnormal T-helper 17 cell physiology
|
J:204922
|
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * C57BL/6J)
|
abnormal cytotoxic T cell physiology
|
J:108572
|
Tnftm2Gkl/Tnf+
(B6.129S-Tnftm2Gkl/Jarn)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:145626
|
Tnftm2Jods/Tnftm2Jods
(involves: C57BL/6)
|
decreased immunoglobulin level
|
J:127028
|
Tnftm3Gkl/Tnftm3Gkl
(involves: 129S/SvEv * C57BL/6)
|
abnormal lymphocyte physiology
|
J:114740
|
| decreased IgG1 level
|
J:114740
|
Tnfaip3m1Apb/Tnfaip3m1Apb
(C57BL/6-Tnfaip3m1Apb)
|
increased microglial cell activation
|
J:324062
|
Tnfaip3tm2Ama/Tnfaip3tm2Ama
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell activation
|
J:163917
|
| decreased B cell apoptosis
|
J:163917
|
| increased B cell proliferation
|
J:163917
|
| increased IgG level
|
J:163917
|
| increased IgM level
|
J:163917
|
| increased immunoglobulin level
|
J:163917
|
Tnfaip8l2tm1Yhcn/Tnfaip8l2tm1Yhcn
(129S6/SvEvTac-Tnfaip8l2tm1Yhcn)
|
abnormal B cell activation
|
J:139785
|
| abnormal B cell physiology
|
J:139785
|
| abnormal CD4-positive, alpha-beta T cell physiology
|
J:139785
|
| abnormal cytotoxic T cell physiology
|
J:139785
|
| abnormal macrophage activation involved in immune response
|
J:139785
|
| abnormal T cell apoptosis
|
J:139785
|
| decreased IgG2a level
|
J:139785
|
| decreased IgG2b level
|
J:139785
|
Tnfrsf1atm1Blt/Tnfrsf1atm1Blt
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased IgG1 level
|
J:115225
|
| increased susceptibility to type I hypersensitivity reaction
|
J:92307
|
Tnfrsf1atm1Blt/Tnfrsf1atm1Blt
Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
decreased IgG1 level
|
J:115225
|
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(C57BL/6-Tnfrsf1atm1Imx/J)
|
abnormal macrophage physiology
|
J:160543
|
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased microglial cell activation
|
J:33864
|
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
(involves: 129S2/SvPas)
|
decreased IgG level
|
J:139030
|
Tnfrsf1atm1Rsie/Tnfrsf1atm1Rsie
(B6.Cg-Tnfrsf1atm1Rsie)
|
abnormal macrophage physiology
|
J:160543
|
Tnfrsf1atm2.1Rsie/Tnfrsf1a+
(B6.Cg-Tnfrsf1atm2.1Rsie)
|
abnormal macrophage physiology
|
J:160543
|
Tnfrsf1atm2.1Rsie/Tnfrsf1atm2.1Rsie
(B6.Cg-Tnfrsf1atm2.1Rsie)
|
abnormal macrophage physiology
|
J:160543
|
Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(B6.129S2-Tnfrsf1btm1Mwm/J)
|
decreased T cell proliferation
|
J:107039
|
Tnfrsf4tm1Mfb/Tnfrsf4tm1Mfb
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:59204
|
Tnfrsf4tm1Nik/Tnfrsf4tm1Nik
(involves: 129S4/SvJae * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:64552
|
| abnormal T-helper 2 physiology
|
J:68588
|
| decreased susceptibility to type I hypersensitivity reaction
|
J:68588
|
| decreased T cell proliferation
|
J:58979,
J:64552
|
Tnfrsf9em1Ygch/Tnfrsf9em1Ygch
(NOD/ShiLtDvs-Tnfrsf9em1Ygch)
|
abnormal T cell physiology
|
J:208927
|
Tnfrsf9em2Ygch/Tnfrsf9em2Ygch
(NOD/ShiLtDvs-Tnfrsf9em2Ygch)
|
abnormal T cell physiology
|
J:208927
|
Tnfrsf9tm1Byk/Tnfrsf9tm1Byk
(B6.Cg-Tnfrsf9tm1Byk)
|
abnormal cytotoxic T cell physiology
|
J:83996
|
| decreased IgG2a level
|
J:83996
|
| decreased IgG3 level
|
J:83996
|
| increased T cell proliferation
|
J:83996
|
Tnfrsf9tm1Byk/Tnfrsf9tm1Byk
(C.Cg-Tnfrsf9tm1Byk)
|
abnormal cytotoxic T cell physiology
|
J:83722
|
| abnormal immunoglobulin level
|
J:83996
|
| decreased IgG2a level
|
J:83996
|
| decreased IgG3 level
|
J:83996
|
| increased IgA level
|
J:83722
|
| increased IgG2a level
|
J:83722
|
| increased IgG2b level
|
J:83722
|
| increased T cell proliferation
|
J:83996
|
Tnfrsf9tm1Lpc/Tnfrsf9tm1Lpc
(B6.129-Tnfrsf9tm1Lpc)
|
abnormal memory T cell physiology
|
J:145439
|
Tnfrsf11atm1.1Sral/Tnfrsf11a+
(B6.129P2(Cg)-Tnfrsf11atm1.1Sral)
|
abnormal osteoclast physiology
|
J:312215
|
Tnfrsf11btm1Eac/Tnfrsf11btm1Eac
(involves: 129S4/SvJaeSor)
|
abnormal dendritic cell antigen presentation
|
J:67105
|
| abnormal immunoglobulin level
|
J:67105
|
Tnfrsf11btm1Khs/Tnfrsf11btm1Khs
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal osteoclast physiology
|
J:111153
|
Tnfrsf13btm1Rjb/Tnfrsf13btm1Rjb
(involves: 129X1/SvJ * C57BL/6)
|
abnormal B cell activation
|
J:69474
|
| decreased IgA level
|
J:69474
|
| decreased IgM level
|
J:69474
|
| increased B cell proliferation
|
J:69474
|
Tnfrsf13btm1Rjb/Tnfrsf13btm1Rjb
(involves: 129X1/SvJ)
|
abnormal class switch recombination
|
J:95288
|
| decreased IgA level
|
J:95288
|
| decreased IgE level
|
J:95288
|
| decreased IgG1 level
|
J:95288
|
Tnfrsf13btm1Vmd/Tnfrsf13btm1Vmd
(involves: C57BL/6)
|
abnormal immunoglobulin level
|
J:70172
|
| increased B cell proliferation
|
J:70172
|
| increased IgG1 level
|
J:70172
|
Tnfrsf13cBcmd1/Tnfrsf13cBcmd1
(A/WySnJ)
|
abnormal lymphocyte physiology
|
J:92334
|
| decreased B cell proliferation
|
J:122315
|
| decreased IgG level
|
J:122315
|
| decreased T cell proliferation
|
J:92334
|
Tnfrsf13ctm1Mass/Tnfrsf13ctm1Mass
(C57BL/6-Tnfrsf13ctm1Mass)
|
abnormal B cell physiology
|
J:113556
|
| decreased IgG1 level
|
J:92732
|
| decreased IgG2a level
|
J:92732
|
| decreased IgG2b level
|
J:92732
|
| decreased IgG3 level
|
J:92732
|
| decreased IgG level
|
J:92732
|
| decreased IgM level
|
J:92732
|
Tnfrsf13ctm1Msc/Tnfrsf13ctm1Msc
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased IgD level
|
J:92676
|
| decreased IgG1 level
|
J:92676
|
| decreased IgG level
|
J:92676
|
| decreased IgM level
|
J:92676
|
Tnfrsf14tm1Kpf/Tnfrsf14tm1Kpf
(B6.129P2-Tnfrsf14tm1Kpf)
|
abnormal T cell physiology
|
J:99456
|
| increased T cell proliferation
|
J:99456
|
Tnfrsf18tm1Ppp/Tnfrsf18tm1Ppp
(involves: 129/Sv * C57BL/6)
|
abnormal T cell activation
|
J:77393
|
| increased T cell apoptosis
|
J:77393
|
| increased T cell proliferation
|
J:77393
|
Tnfrsf21tm1Ddy/Tnfrsf21tm1Ddy
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal T-helper 1 physiology
|
J:70594
|
| abnormal T-helper 2 physiology
|
J:70594
|
| increased B cell proliferation
|
J:109341
|
| increased IgG1 level
|
J:109341
|
| increased IgG2a level
|
J:109341
|
| increased IgG2b level
|
J:109341
|
| increased IgG3 level
|
J:109341
|
| increased IgM level
|
J:109341
|
| increased T cell proliferation
|
J:70594
|
Tnfrsf21tm1Vmd/Tnfrsf21tm1Vmd
(involves: C57BL/6)
|
abnormal T-helper 2 physiology
|
J:72761
|
| increased IgE level
|
J:72761
|
| increased IgG1 level
|
J:72761
|
| increased IgG2a level
|
J:72761
|
| increased IgM level
|
J:72761
|
| increased T cell proliferation
|
J:72761
|
Tnfrsf25tm1Mjo/Tnfrsf25tm1Mjo
(involves: 129P2/OlaHsd)
|
decreased T cell apoptosis
|
J:84536
|
Tnfsf4tm1Shr/Tnfsf4tm1Shr
(involves: 129S4/SvJae)
|
abnormal dendritic cell antigen presentation
|
J:59203
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:59203
|
| decreased T cell proliferation
|
J:59203
|
Tnfsf4tm1Shr/Tnfsf4tm1Shr
(C.129S4-Tnfsf4tm1Shr)
|
abnormal dendritic cell antigen presentation
|
J:59203
|
Tnfsf4tm1Sug/Tnfsf4tm1Sug
(B6.129S4-Tnfsf4tm1Sug)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:80214
|
| decreased T cell proliferation
|
J:80214
|
Tnfsf9tm1Thw/Tnfsf9tm1Thw
(involves: 129 * C57BL/6)
|
abnormal cytotoxic T cell physiology
|
J:76373
|
Tnfsf10tm1Mjs/Tnfsf10tm1Mjs
(C.129-Tnfsf10tm1Mjs)
|
impaired natural killer cell mediated cytotoxicity
|
J:73948
|
Tnfsf10tm1Mjs/Tnfsf10tm1Mjs
(B6.129-Tnfsf10tm1Mjs)
|
increased IgG1 level
|
J:82145
|
| increased IgG2a level
|
J:82145
|
Tnfsf13tm1Geha/Tnfsf13tm1Geha
(involves: 129S4/SvJae)
|
abnormal class switch recombination
|
J:88910
|
| decreased IgA level
|
J:88910
|
| decreased IgM level
|
J:88910
|
| increased IgG level
|
J:88910
|
Tnfsf13tm1Pod/Tnfsf13+
(B6.Cg-Tnfsf13tm1Pod)
|
decreased IgA level
|
J:141374
|
Tnfsf13tm1Pod/Tnfsf13tm1Pod
(B6.Cg-Tnfsf13tm1Pod)
|
decreased IgA level
|
J:141374
|
| decreased IgG2a level
|
J:141374
|
| increased IgG1 level
|
J:141374
|
| increased T cell proliferation
|
J:141374
|
Tnfsf13bM1Btlr/Tnfsf13b+
(C57BL/6J-Tnfsf13bM1Btlr)
|
decreased IgG level
|
J:220069
|
| decreased IgM level
|
J:220069
|
Tnfsf13bM1Btlr/Tnfsf13bM1Btlr
(C57BL/6J-Tnfsf13bM1Btlr)
|
decreased IgG level
|
J:220069
|
| decreased IgM level
|
J:220069
|
Tnfsf13bm2Btlr/Tnfsf13bm2Btlr
(C57BL/6J-Tnfsf13bm2Btlr)
|
decreased IgG level
|
J:220070
|
Tnfsf13btm1Cleg/Tnfsf13btm1Cleg
(involves: 129S5/SvEvBrd)
|
abnormal B cell physiology
|
J:71301
|
| decreased IgG level
|
J:71301
|
| decreased IgM level
|
J:71301
|
Tnfsf13btm1Msc/Tnfsf13b+
(involves: 129S2/SvPas * C57BL/6)
|
decreased immunoglobulin level
|
J:71681
|
Tnfsf13btm1Msc/Tnfsf13btm1Msc
(involves: 129S2/SvPas * C57BL/6)
|
decreased immunoglobulin level
|
J:71681
|
Tnfsf13btm1Msc/Tnfsf13btm1Msc
(involves: 129S2/SvPas)
|
decreased T cell proliferation
|
J:92334
|
Tnfsf14tm1Ddy/Tnfsf14tm1Ddy
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal cytotoxic T cell physiology
|
J:84366
|
| abnormal T cell activation
|
J:84366
|
| decreased T cell proliferation
|
J:84366
|
Tnfsf14tm1Kpf/Tnfsf14tm1Kpf
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased cytotoxic T cell cytolysis
|
J:77250
|
| decreased T cell proliferation
|
J:77250
|
Tnfsf14tm1Lpc/Tnfsf14tm1Lpc
(involves: 129X1/SvJ * C57BL/6)
|
abnormal cytotoxic T cell physiology
|
J:76414
|
| decreased cytotoxic T cell cytolysis
|
J:76414
|
Tnfsf15tm1Hluo/Tnfsf15tm1Hluo
(D1LacJ.129(B6)-Tnfsf15tm1Hluo)
|
decreased IgG2a level
|
J:207029
|
| decreased IgG2b level
|
J:207029
|
| decreased IgG level
|
J:207029
|
Tnip1Gt(E059E05)Wrst/Tnip1Gt(E059E05)Wrst
(involves: 129P2/OlaHsd * C57BL/6)
|
increased IgA level
|
J:180054
|
| increased IgG1 level
|
J:180054
|
| increased IgG2b level
|
J:180054
|
| increased IgM level
|
J:180054
|
Tnip1m1Btlr/Tnip1m1Btlr
(C57BL/6J-Tnip1m1Btlr)
|
increased IgA level
|
J:265175
|
| increased IgE level
|
J:265175
|
Tnip1tm1.1Pcoh/Tnip1tm1.1Pcoh
(involves: 129P2/OlaHsd * C57BL/6)
|
increased B cell proliferation
|
J:176826
|
| increased IgA level
|
J:176826
|
| increased IgE level
|
J:176826
|
| increased IgG1 level
|
J:176826
|
| increased IgG2a level
|
J:176826
|
| increased IgG2b level
|
J:176826
|
| increased IgG3 level
|
J:176826
|
| increased IgG level
|
J:176826
|
| increased IgM level
|
J:176826
|
| increased immunoglobulin level
|
J:176826
|
Tnip2tm1.1Sley/Tnip2tm1.1Sley
(involves: 129S4/SvJae * 129S8/SvEv * C57BL/6)
|
abnormal macrophage physiology
|
J:112395
|
Tnk2tm1.2Npma/Tnk2tm1.2Npma
(B6(Cg)-Tnk2tm1.2Npma)
|
abnormal T cell physiology
|
J:341740
|
Tob2tm1Tya/Tob2tm1Tya
(involves: 129S4/SvJae * C57BL/6)
|
abnormal osteoclast physiology
|
J:134287
|
Toxtm1.1Kay/Toxtm1.1Kay
(involves: 129S6/SvEvTac)
|
decreased cytotoxic T cell cytolysis
|
J:131287
|
Tpcn1tm1.1Dren/Tpcn1tm1.1Dren
Tpcn2tm1.1Dren/Tpcn2tm1.1Dren
(Not Specified)
|
abnormal macrophage physiology
|
J:189070
|
Tpp2tm1.1Gnie/Tpp2tm1.1Gnie
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal cytotoxic T cell physiology
|
J:133572
|
| increased T cell apoptosis
|
J:133572
|
Tpp2tm1.1Gnie/Tpp2tm1.1Gnie
(involves: 129S6/SvEvTac)
|
abnormal lymphocyte physiology
|
J:221205
|
Tpsb2tm1.1Mfg/Tpsb2tm1.1Mfg
(B6.129-Tpsb2tm1.1Mfg)
|
impaired eosinophil recruitment
|
J:133373
|
| impaired neutrophil chemotaxis
|
J:142880
|
Traddtm1.1Mpa/Traddtm1.1Mpa
(involves: BALB/cJ * C57BL/6)
|
decreased IgG level
|
J:139030
|
Traf1tm1Tsi/Traf1tm1Tsi
(involves: 129S4/SvJae * C57BL/6)
|
increased T cell proliferation
|
J:72327
|
Traf2tm1Mak/Traf2tm1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * BALB/c * C57BL/6J))
|
increased thymocyte apoptosis
|
J:44360
|
Traf3m2Btlr/Traf3m2Btlr
(C57BL/6J-Traf3m2Btlr)
|
decreased IgG level
|
J:217797
|
Traf3tm1Bal/Traf3tm1Bal
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal T cell physiology
|
J:37065
|
Traf3tm1Bshp/Traf3tm1Bshp
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal adaptive immunity
|
J:124329
|
| decreased B cell apoptosis
|
J:124329
|
| increased IgA level
|
J:124329
|
| increased IgG2a level
|
J:124329
|
| increased IgG2b level
|
J:124329
|
| increased IgG3 level
|
J:124329
|
| increased IgG level
|
J:124329
|
| increased IgM level
|
J:124329
|
Traf3ip2adjm/Traf3ip2adjm
(KOR-Traf3ip2adjm)
|
increased IgE level
|
J:162859
|
Traf3ip2adjm/Traf3ip2adjm
(A.KOR-Traf3ip2adjm)
|
increased IgE level
|
J:162859
|
Traf3ip2adjm/Traf3ip2adjm
(B6.KOR-Traf3ip2adjm)
|
increased IgE level
|
J:162859
|
Traf3ip2adjm/Traf3ip2adjm
(C.KOR-Traf3ip2adjm)
|
increased IgE level
|
J:162859
|
Traf3ip2adjm/Traf3ip2adjm
(AK.KOR-Traf3ip2adjm)
|
increased IgE level
|
J:162859
|
Traf3ip2tm1.1Lix/Traf3ip2tm1.1Lix
(involves: 129/Sv * BALB/c)
|
increased IgE level
|
J:93923
|
| increased IgG level
|
J:93923
|
| increased immunoglobulin level
|
J:93923
|
Traf3ip2tm1.1Lix/Traf3ip2tm1.1Lix
(B6.129-Traf3ip2tm1.1Lix)
|
increased IgG1 level
|
J:187766
|
| increased IgG2c level
|
J:187766
|
| increased IgG level
|
J:187766
|
Traf3ip2tm1Lix/Traf3ip2tm1.1Lix
Tg(CD19-cre/ERT2)1Cgn/0
(involves: 129/Sv * BALB/c)
|
increased immunoglobulin level
|
J:93923
|
Traf3ip2tm1Sbn/Traf3ip2tm1Sbn
(either: B6.129-Traf3ip2tm1Sbn or (involves: 129) or (involves: 129 * BALB/c))
|
impaired eosinophil recruitment
|
J:144320
|
| impaired macrophage chemotaxis
|
J:144320
|
| impaired neutrophil recruitment
|
J:144320
|
Traf4tm1Mrio/Traf4tm1Mrio
(involves: 129X1/SvJ)
|
abnormal dendritic cell physiology
|
J:142780
|
Traf5tm1Hna/Traf5tm1Hna
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal B cell proliferation
|
J:57114
|
| abnormal T cell proliferation
|
J:57114
|
| decreased IgG1 level
|
J:57114
|
| decreased IgM level
|
J:57114
|
Traf6tm1Mak/Traf6tm1Mak
(involves: 129P3/J)
|
abnormal macrophage physiology
|
J:54467
|
| abnormal osteoclast physiology
|
J:54467
|
| decreased B cell proliferation
|
J:54467
|
Traf6tm1Ywc/Traf6tm1Ywc
(Not Specified)
|
abnormal dendritic cell physiology
|
J:85808
|
Trem2em2Bwef/Trem2em2Bwef
(involves: C57BL/6J * DBA/2J * FVB/N)
|
decreased macrophage proliferation
|
J:242126
|
| decreased microglial cell activation
|
J:242126
|
| impaired macrophage phagocytosis
|
J:242126
|
| increased macrophage apoptosis
|
J:242126
|
Trem2tm1(KOMP)Vlcg/Trem2tm1(KOMP)Vlcg
(C57BL/6N-Trem2tm1(KOMP)Vlcg)
|
abnormal microglial cell physiology
|
J:239381
|
| decreased microglial cell activation
|
J:239381
|
Trex1tm1.1Fwpe/Trex1tm1.1Fwpe
(involves: 129S1/SvImJ * 129S4/SvJae * 129S6/SvEvTac)
|
abnormal T cell activation
|
J:220965
|
| increased IgG level
|
J:220965
|
Trex1tm1Tld/Trex1tm1Tld
(involves: 129P2/OlaHsd * C57BL/6)
|
increased IgG level
|
J:181257
|
Tria4STS/A/?
(involves: BALB/c * STS/A)
|
abnormal leukocyte physiology
|
J:56029
|
Tria5STS/A/?
(involves: BALB/cHeA * STS/A)
|
abnormal leukocyte physiology
|
J:56029
|
Trib3tm1Tord/Trib3tm1Tord
(involves: C57BL/6)
|
abnormal mast cell physiology
|
J:192615
|
| decreased mast cell degranulation
|
J:192615
|
Trim8tm1Hbsh/Trim8tm1Hbsh
(involves: 129S6/SvEvTac)
|
increased macrophage cytokine production
|
J:251270
|
Trim21tm1Mwah/Trim21tm1Mwah
(C57BL/6-Trim21tm1Mwah)
|
abnormal T cell activation
|
J:151775
|
Trim27Gt(345D11)Cmhd/Trim27Gt(345D11)Cmhd
(B6.129-Trim27Gt(345D11)Cmhd)
|
abnormal T-helper 1 physiology
|
J:180433
|
| abnormal T-helper 2 physiology
|
J:180433
|
Trim29tm1c(EUCOMM)Wtsi/Trim29tm1c(EUCOMM)Wtsi
Tg(Myh6-cre)2182Mds/0
(involves: C57BL/6J * C57BL/6N * C57BL/6NTac)
|
increased T cell proliferation
|
J:349246
|
Trim30atm1Yjk/Trim30atm1Yjk
(B6.129P2-Trim30atm1Yjk)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:215171
|
| increased T cell proliferation
|
J:215171
|
Trim35em1Smoc/Trim35em1Smoc
(C57BL/6J-Trim35em1Smoc)
|
decreased macrophage cytokine production
|
J:303214
|
Trim40em1Caox/Trim40em1Caox
(involves: C57BL/6J)
|
abnormal macrophage physiology
|
J:255265
|
Trip10tm1.1Geha/Trip10tm1.1Geha
(B6.129S1-Trip10tm1.1Geha)
|
abnormal T cell physiology
|
J:164363
|
| decreased IgE level
|
J:164363
|
| decreased IgG level
|
J:164363
|
| decreased susceptibility to type IV hypersensitivity reaction
|
J:164363
|
Trmq3FVB/N/?
(involves: DBA/1J * FVB/N)
|
abnormal T cell proliferation
|
J:94347
|
Trp53tm1.1Awbr/Trp53tm1.1Awbr
(involves: C57BL/6)
|
decreased thymocyte apoptosis
|
J:173271
|
Trp53tm1.1Thst/Trp53tm1.1Thst
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
decreased thymocyte apoptosis
|
J:198482
|
Trp53tm1.1Tldo/Trp53tm1.1Tldo
(involves: 129S2/SvPas * BALB/c * C57BL/6)
|
increased thymocyte apoptosis
|
J:199308
|
Trp53tm1.1Wgu/Trp53tm1.1Wgu
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased thymocyte apoptosis
|
J:186159
|
Trp53tm1.2Awbr/Trp53tm1.2Awbr
(involves: C57BL/6)
|
decreased thymocyte apoptosis
|
J:173271
|
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd)
|
decreased thymocyte apoptosis
|
J:186159
|
Trp53tm1Brd/Trp53tm1Brd
Trp73tm2Mak/Trp73tm2Mak
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)
|
decreased thymocyte apoptosis
|
J:157905
|
Trp53tm1Glo/Trp53tm1Glo
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased thymocyte apoptosis
|
J:172038
|
Trp53tm1Holl/Trp53tm7.1Xu
(involves: 129P2/OlaHsd)
|
decreased thymocyte apoptosis
|
J:160414
|
Trp53tm1Thst/Trp53tm1Thst
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased thymocyte apoptosis
|
J:198482
|
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas)
|
decreased thymocyte apoptosis
|
J:158953
|
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
decreased thymocyte apoptosis
|
J:80311
|
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas)
|
decreased T cell apoptosis
|
J:109354
|
| decreased thymocyte apoptosis
|
J:158953,
J:195018,
J:126920
|
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
decreased thymocyte apoptosis
|
J:80311
|
Trp53tm1Xu/Trp53tm1Xu
(involves: 129S4/SvJae)
|
abnormal thymocyte apoptosis
|
J:86185
|
Trp53tm2.1Wgu/Trp53tm2.1Wgu
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased thymocyte apoptosis
|
J:186159
|
Trp53tm2Xu/Trp53tm2Xu
(involves: 129S6/SvEvTac)
|
decreased T cell apoptosis
|
J:109354
|
| decreased T cell proliferation
|
J:109354
|
Trp53tm3.1Holl/Trp53tm3.1Holl
(Not Specified)
|
increased thymocyte apoptosis
|
J:191183
|
Trp53tm7.1Xu/Trp53tm7.1Xu
(Not Specified)
|
decreased thymocyte apoptosis
|
J:160414
|
Trp53bp1m2Btlr/Trp53bp1m2Btlr
(C57BL/6J-Trp53bp1m2Btlr)
|
decreased IgD level
|
J:254841
|
| decreased IgG level
|
J:254841
|
Trp53bp1m3Btlr/Trp53bp1m3Btlr
(C57BL/6J-Trp53bp1m3Btlr)
|
decreased IgD level
|
J:254848
|
Trp53bp1m4Btlr/Trp53bp1m4Btlr
(C57BL/6J-Trp53bp1m4Btlr)
|
decreased IgD level
|
J:254852
|
Trp53bp1m5Btlr/Trp53bp1m5Btlr
(C57BL/6J-Trp53bp1m5Btlr)
|
decreased IgD level
|
J:272848
|
Trp53bp1tm1Jc/Trp53bp1tm1Jc
(involves: 129)
|
abnormal class switch recombination
|
J:194603,
J:231089,
J:307190
|
Trp53bp2tm1Cdlo/Trp53bp2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell physiology
|
J:146764
|
Trp73tm2Mak/Trp73tm2Mak
(either: B6.129P2-Trp73tm2Mak or (involves: 129P2/OlaHsd * C57BL/6J))
|
increased thymocyte apoptosis
|
J:157905
|
Trpm2tm1Lhj/Trpm2tm1Lhj
(Not Specified)
|
abnormal macrophage physiology
|
J:202791
|
Trpm2tm1Yamo/Trpm2tm1Yamo
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal leukocyte physiology
|
J:137676
|
| abnormal macrophage physiology
|
J:137676
|
| impaired neutrophil recruitment
|
J:137676
|
Trpm4tm1.1Knt/Trpm4tm1.1Knt
(Not Specified)
|
abnormal dendritic cell physiology
|
J:140991
|
Trpm4tm1.1Knt/Trpm4tm1.1Knt
Trpm5tm1Csz/Trpm5tm1Csz
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal dendritic cell physiology
|
J:140991
|
Trpm4tm1.1Mfre/Trpm4tm1.1Mfre
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ)
|
increased susceptibility to type I hypersensitivity reaction
|
J:118679
|
Trpm7tm1Agry/Trpm7+
(involves: 129)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:205665
|
Trpm7tm1Clph/Trpm7tm1.1Clph
Tg(Lck-cre)548Jxm/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal T cell physiology
|
J:140630
|
Trpv2tm1Mijc/Trpv2tm1Mijc
(involves: 129S6/SvEvTac * C57BL/6)
|
impaired macrophage chemotaxis
|
J:158505
|
| impaired macrophage phagocytosis
|
J:158505
|
Tsc22d3tm1.2Efmd/Y
(Not Specified)
|
increased susceptibility to type IV hypersensitivity reaction
|
J:201728
|
Tslptm1(KOMP)Vlcg/Tslptm1(KOMP)Vlcg
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal immunoglobulin level
|
J:187770
|
Tslptm1.1Pcn/Tslptm1.1Pcn
Tg(KRT14-cre)1Ipc/0
(involves: 129 * C57BL/6 * SJL)
|
decreased IgE level
|
J:146511
|
Tslptm1Sfz/Tslptm1Sfz
(involves: 129)
|
abnormal T-helper 2 physiology
|
J:197193
|
Tspan32Gt(pMS-1)1Jmt/Tspan32Gt(pMS-1)1Jmt
(involves: 129S1/Sv)
|
increased T cell proliferation
|
J:78033
|
Tubtub/Tubtub
(C57BL/6J-Tubtub)
|
abnormal Langerhans cell physiology
|
J:13772
|
Tusc2tm1Avi/Tusc2tm1Avi
(involves: 129S1/Sv)
|
decreased T cell proliferation
|
J:309768
|
Twsg1tm1Nosa/Twsg1tm1Nosa
(involves: 129P2/OlaHsd * C57BL/6)
|
increased thymocyte apoptosis
|
J:82738
|
Txniptm1Yu/Txniptm1Yu
(involves: 129)
|
abnormal NK cell physiology
|
J:96677
|
| increased T cell proliferation
|
J:96677
|
Tyk2E775K/Tyk2E775K
(B10.D1-H2q/SgJ)
|
abnormal T-helper 1 physiology
|
J:69051
|
| decreased IgG1 level
|
J:69051
|
| decreased IgG2a level
|
J:69051
|
| decreased IgG level
|
J:69051
|
Tyk2tm1Biat/Tyk2tm1Biat
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased macrophage nitric oxide production
|
J:65408
|
Tyk2tm1Shmd/Tyk2tm1Shmd
(involves: 129P2/OlaHsd)
|
abnormal T cell physiology
|
J:65409
|
Tyrobptm1.1Viv/Tyrobptm1.1Viv
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
decreased susceptibility to type IV hypersensitivity reaction
|
J:64764
|
| impaired natural killer cell mediated cytotoxicity
|
J:64764
|
Tyrobptm1.1Viv/Tyrobptm1.1Viv
(B6.129P2-Tyrobptm1.1Viv)
|
abnormal osteoclast physiology
|
J:129304,
J:95232
|
Tyrobptm1Lll/Tyrobptm1Lll
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased T cell proliferation
|
J:64763
|
| impaired natural killer cell mediated cytotoxicity
|
J:64763
|
| increased natural killer cell mediated cytotoxicity
|
J:64763
|
Tyrobptm1Lll/Tyrobptm1Lll
(B6.129P2-Tyrobptm1Lll)
|
abnormal NK T cell physiology
|
J:147867
|
Tyrobptm1Ttk/Tyrobptm1Ttk
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal dendritic cell physiology
|
J:110786
|
| abnormal osteoclast physiology
|
J:81823
|
Tyrobptm1Ttk/Tyrobptm1Ttk
(B6.129P2-Tyrobptm1Ttk)
|
increased B cell proliferation
|
J:177613
|
| increased IgG2a level
|
J:177613
|
| increased IgG3 level
|
J:177613
|
Ubash3btm1Jni/Ubash3btm1Jni
Ubash3atm1Jni/Ubash3atm1Jni
(Not Specified)
|
increased T cell proliferation
|
J:89761
|
Ubdtm1Smwe/Ubdtm1Smwe
(B6.129S6-Ubdtm1Smwe)
|
abnormal lymphocyte physiology
|
J:110321
|
Ube2nGt(OST374154)Lex/Ube2n+
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal leukocyte physiology
|
J:120846
|
| abnormal macrophage physiology
|
J:120846
|
| decreased B cell proliferation
|
J:120846
|
| decreased T cell proliferation
|
J:120846
|
Ube2ntm1Aki/Ube2ntm1Aki
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal macrophage physiology
|
J:112287
|
Ube2stm1.1Smoc/Ube2stm1.1Smoc
(involves: C57BL/6)
|
abnormal macrophage physiology
|
J:306461
|
Ucp2tm1Rcq/Ucp2tm1Rcq
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal macrophage physiology
|
J:66262
|
Unc13dJinx/Unc13dJinx
(C57BL/6J-Unc13dJinx/Mmucd)
|
abnormal macrophage physiology
|
J:105543
|
| abnormal NK cell physiology
|
J:119974
|
| decreased cytotoxic T cell cytolysis
|
J:119974
|
| hemophagocytosis
|
J:119974
|
Unc93b13d/Unc93b13d
(C57BL/6J-Unc93b13d)
|
abnormal dendritic cell antigen presentation
|
J:105484
|
| abnormal macrophage physiology
|
J:105484
|
Unc93b13d/Unc93b13d
(C57BL/6-Unc93b13d)
|
abnormal dendritic cell antigen presentation
|
J:159599
|
Unc93b1tm1(KOMP)Vlcg/Unc93b1tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal dendritic cell antigen presentation
|
J:211069
|
| abnormal dendritic cell physiology
|
J:211069
|
Unc93b1tm1.1Kmiy/Unc93b1tm1.1Kmiy
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased B cell proliferation
|
J:174308
|
| increased B cell proliferation
|
J:174308
|
| increased IgG2a level
|
J:174308
|
| increased IgG2b level
|
J:174308
|
Ungtm1Tld/Ungtm1Tld
(Not Specified)
|
abnormal class switch recombination
|
J:79590
|
| decreased IgG3 level
|
J:79590
|
| increased IgM level
|
J:79590
|
Ungtm1Tld/Ungtm1Tld
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:306598
|
| abnormal somatic hypermutation frequency
|
J:155454
|
Upf2tm1Btp/Upf2tm1Btp
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased T cell proliferation
|
J:134765
|
Urahplt2/Urahplt2
(C57BL/6-Urahplt2)
|
increased T cell proliferation
|
J:267227
|
Usp4tm1Xilu/Usp4tm1Xilu
(B6.129-Usp4tm1Xilu)
|
increased thymocyte apoptosis
|
J:173192
|
Usp12tm1a(EUCOMM)Hmgu/Usp12tm1a(EUCOMM)Hmgu
(Not Specified)
|
decreased IgA level
|
J:165965
|
Usp15em1Peih/Usp15em1Peih
(involves: C57BL/6)
|
abnormal macrophage physiology
|
J:306461
|
Usp15L749R/Usp15L749R
(involves: 129S1/SvImJ * C57BL/6J)
|
abnormal T-helper 1 physiology
|
J:259382
|
Uxs1tm1Lex/Uxs1+
(B6;129S5-Uxs1tm1Lex/Mmucd)
|
increased IgG1 level
|
J:171883
|
Vamp8Gt(OST20346)Lex/Vamp8Gt(OST20346)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal mast cell physiology
|
J:131926
|
Vamp8tm1Hong/Vamp8tm1Hong
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal dendritic cell physiology
|
J:131528
|
| abnormal type I hypersensitivity reaction
|
J:133439
|
| decreased mast cell degranulation
|
J:133439
|
Vav1m1Btlr/Vav1m1Btlr
(C57BL/6J-Vav1m1Btlr)
|
decreased IgD level
|
J:265128
|
| decreased IgG level
|
J:265128
|
| increased IgM level
|
J:265128
|
Vav1M3Btlr/Vav1M3Btlr
(C57BL/6J-Vav1M3Btlr)
|
decreased IgG level
|
J:272527
|
Vav1tm1Tyb/Vav1tm1Tyb
(involves: 129S2/SvPas * 129S8/SvEv)
|
abnormal T cell physiology
|
J:113270
|
| decreased T cell proliferation
|
J:113270
|
Vav1tm1Tyb/Vav1tm1Tyb
(involves: 129S2/SvPas)
|
abnormal T cell physiology
|
J:86654,
J:79323
|
| decreased T cell proliferation
|
J:86654
|
Vav1tm1Tyb/Vav1tm1Tyb
(involves: 129S2/SvPas * C57BL/10 * C57BR/cd)
|
abnormal T cell physiology
|
J:128985
|
| decreased T cell proliferation
|
J:128985
|
Vav1tm1Tyb/Vav1tm1Tyb
(either: (involves: 129S4/SvJae * 129S8/SvEv) or (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd))
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:190087
|
Vav1tm1Tyb/Vav1tm1Tyb
Vav2tm1Kdf/Vav2tm1Kdf
(involves: 129S1/Sv * 129S2/SvPas)
|
decreased B cell proliferation
|
J:86654
|
| decreased T cell proliferation
|
J:86654
|
Vav1tm1Tyb/Vav1tm1Tyb
Vav2tm1Kdf/Vav2tm1Kdf
Vav3tm1Swat/Vav3tm1Swat
(involves: 129S1/Sv * 129S2/SvPas * 129S6/SvEvTac * C57BL/6)
|
abnormal B cell calcium ion homeostasis
|
J:86654
|
| abnormal T cell physiology
|
J:86654
|
| decreased B cell proliferation
|
J:86654
|
| decreased IgG1 level
|
J:86654
|
| decreased IgG2b level
|
J:86654
|
| decreased IgG3 level
|
J:86654
|
| decreased IgM level
|
J:86654
|
| decreased immunoglobulin level
|
J:86654
|
| decreased T cell proliferation
|
J:86654
|
Vav1tm1Tyb/Vav1tm1Tyb
Vav2tm1Kdf/Vav2tm1Kdf
Vav3tm1Swat/Vav3tm1Swat
(involves: 129S1/Sv * 129S2/SvPas * 129S6/SvEvTac)
|
abnormal macrophage physiology
|
J:145345
|
| abnormal neutrophil physiology
|
J:145345
|
| abnormal NK cell physiology
|
J:187430
|
Vav1tm1Tyb/Vav1tm1Tyb
Vav2tm1Tnr/Vav2tm1Tnr
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal B cell calcium ion homeostasis
|
J:69807
|
| decreased B cell proliferation
|
J:69807
|
Vav1tm1Tyb/Vav1tm1Tyb
Vav3tm1Swat/Vav3tm1Swat
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6)
|
decreased B cell proliferation
|
J:86654
|
| decreased T cell proliferation
|
J:86654
|
Vav1tm2Bbd/Vav1tm2Bbd
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal T cell activation
|
J:47596
|
| decreased T cell proliferation
|
J:47596
|
Vav1tm2Bbd/Vav1tm2Bbd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased B cell proliferation
|
J:55647,
J:69806
|
| decreased IgG1 level
|
J:55647
|
| decreased IgG2a level
|
J:55647
|
| decreased IgG3 level
|
J:69806
|
| decreased IgG level
|
J:55647
|
Vav1tm2Bbd/Vav1tm2Bbd
(B6.129-Vav1tm2Bbd)
|
abnormal T cell physiology
|
J:141390
|
| impaired natural killer cell mediated cytotoxicity
|
J:71161
|
Vav1tm2Bbd/Vav1tm2Bbd
Vav2tm1Kdf/Vav2tm1Kdf
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell activation
|
J:69806
|
| decreased B cell proliferation
|
J:69806
|
| decreased IgG1 level
|
J:69806
|
| decreased IgG2b level
|
J:69806
|
| decreased IgG3 level
|
J:69806
|
| decreased IgM level
|
J:69806
|
| decreased immunoglobulin level
|
J:69806
|
Vav1tm2Tyb/Vav1tm2Tyb
(involves: 129S4/SvJae * 129S8/SvEv)
|
abnormal T cell physiology
|
J:113270
|
| decreased T cell proliferation
|
J:113270
|
Vav1tm4Tyb/Vav1tm4Tyb
(either: 129S8.129S4-Vav1tm4Tyb or (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd))
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:190087
|
| abnormal CD8-positive, alpha-beta T cell physiology
|
J:190087
|
| abnormal T cell physiology
|
J:190087
|
Vav2tm1Kdf/Vav2tm1Kdf
(involves: 129S1/Sv * C57BL/6)
|
decreased B cell proliferation
|
J:69806
|
| decreased IgG3 level
|
J:69806
|
Vav2tm1Tnr/Vav2tm1Tnr
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:69807
|
| decreased B cell proliferation
|
J:69807
|
| decreased IgG1 level
|
J:69807
|
| decreased IgG2b level
|
J:69807
|
| decreased IgG3 level
|
J:69807
|
| decreased IgM level
|
J:69807
|
Vcam1tm2Flv/Vcam1tm3Flv
Tg(Tek-cre)12Flv/0
(involves: 129S1/Sv * C3H * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:68147
|
| abnormal CD8-positive, alpha-beta T cell physiology
|
J:68147
|
| abnormal lymphocyte physiology
|
J:68147
|
| impaired B cell migration
|
J:68147
|
Vdac2tm1.1Ehyc/Vdac2tm1.1Ehyc
Tg(Lck-cre)1Cwi/?
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal thymocyte apoptosis
|
J:220951
|
Vdrtm1Rge/Vdrtm1Rge
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal macrophage physiology
|
J:134827
|
Vdrtm1Ska/Vdrtm1Ska
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal macrophage chemotaxis
|
J:112519
|
Vimtm1Cba/Vimtm1Cba
(involves: 129S2/SvPas * C57BL/6)
|
abnormal cellular extravasation
|
J:129405
|
| abnormal leukocyte adhesion
|
J:129405
|
| abnormal leukocyte migration
|
J:129405
|
| abnormal leukocyte tethering or rolling
|
J:129405
|
Vipr2tm1Ajh/Vipr2tm1Ajh
(B6.129P2-Vipr2tm1Ajh)
|
decreased IgE level
|
J:72933
|
| decreased susceptibility to type I hypersensitivity reaction
|
J:72933
|
| increased susceptibility to type IV hypersensitivity reaction
|
J:72933
|
Vpreb1atm1Ilm/Vpreb1atm1Ilm
Vpreb1btm1Ilm/Vpreb1btm1Ilm
(B6.129P2-Vpreb1atm1Ilm Vpreb1btm1Ilm)
|
decreased IgG level
|
J:67609
|
Vps54wr/Vps54wr
(involves: C57BL/6J * C57BL/Fa)
|
increased microglial cell activation
|
J:181019
|
Vsig4tm1Gne/Vsig4tm1Gne
(C57BL/6-Vsig4tm1Gne)
|
abnormal macrophage physiology
|
J:281762
|
Vsirtm1Lex/Vsirtm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal T cell activation
|
J:222944
|
| increased IgA level
|
J:222944
|
| increased IgM level
|
J:222944
|
Wastm1Itl/Y
(Not Specified)
|
abnormal dendritic cell physiology
|
J:153247
|
| decreased T cell proliferation
|
J:153247
|
Wastm1Itl/Wastm1Itl
(Not Specified)
|
abnormal dendritic cell physiology
|
J:153247
|
| decreased T cell proliferation
|
J:153247
|
Wastm1Sbs/Y
(involves: 129S6/SvEvTac)
|
abnormal dendritic cell physiology
|
J:153247
|
| decreased T cell proliferation
|
J:153247
|
Wastm1Sbs/Y
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal B cell physiology
|
J:182528
|
| increased IgA level
|
J:182528
|
| increased IgE level
|
J:182528
|
| increased IgM level
|
J:182528
|
Wastm1Sbs/Wastm1Sbs
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6))
|
decreased T cell proliferation
|
J:48836
|
Wastm1Sbs/Wastm1Sbs
(involves: C57BL/6 * CBA)
|
abnormal B cell physiology
|
J:95909
|
Wastm1Sbs/Wastm1Sbs
(involves: 129S/SvEv)
|
abnormal mast cell physiology
|
J:86835
|
| abnormal osteoclast physiology
|
J:90542
|
Wastm1Sbs/Wastm1Sbs
(involves: BALB/c)
|
abnormal dendritic cell antigen presentation
|
J:84131
|
| decreased T cell proliferation
|
J:84131
|
Wastm1Sbs/Wastm1Sbs
(involves: 129S6/SvEvTac)
|
abnormal dendritic cell physiology
|
J:153247
|
| abnormal thymocyte activation
|
J:125309
|
| decreased T cell proliferation
|
J:153247
|
Wastm1Sbs/Wastm1Sbs
(129S6/SvEvTac-Wastm1Sbs/J)
|
increased IgA level
|
J:180407
|
| increased IgM level
|
J:180407
|
Wastm1Sbs/Wastm1Sbs
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal B cell physiology
|
J:182528
|
| increased IgA level
|
J:182528
|
| increased IgE level
|
J:182528
|
| increased IgM level
|
J:182528
|
Wastm1Sbs/Wastm1Sbs
Wasltm2Sbs/Wasltm2Sbs
Tg(Lck-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal thymocyte activation
|
J:125309
|
Wastm2Itl/Y
(Not Specified)
|
abnormal dendritic cell physiology
|
J:153247
|
| decreased T cell proliferation
|
J:153247
|
Wastm2Itl/Wastm2Itl
(Not Specified)
|
abnormal dendritic cell physiology
|
J:153247
|
| decreased T cell proliferation
|
J:153247
|
Wdr1rede/Wdr1rede
(C57BL/6-Wdr1rede)
|
abnormal osteoclast physiology
|
J:134092
|
| impaired neutrophil chemotaxis
|
J:134092
|
Wipf1tm1Geha/Wipf1tm1Geha
(involves: 129S6/SvEvTac)
|
abnormal T cell physiology
|
J:74719
|
| decreased T cell proliferation
|
J:74719
|
| increased B cell proliferation
|
J:74719
|
| increased IgE level
|
J:74719
|
| increased IgM level
|
J:74719
|
Wipf1tm1Geha/Wipf1tm1Geha
(involves: 129S6/SvEvTac * C57BL/6)
|
increased IgA level
|
J:116168
|
Wlstm1.1Arte/Wlstm1.1Arte
Krt14tm1(cre)Wbm/Krt14+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell physiology
|
J:202499
|
| increased T cell proliferation
|
J:202499
|
Wwoxtm1Ria/Wwoxtm1Ria
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal osteoclast physiology
|
J:138140
|
Xbp1tm1a(EUCOMM)Wtsi/Xbp1+
(C57BL/6N-Xbp1tm1a(EUCOMM)Wtsi/Ics)
|
decreased IgG1 level
|
J:165965
|
Xcl1tm1Rakr/Xcl1tm1Rakr
(B6.129-Xcl1tm1Rakr)
|
decreased cytotoxic T cell cytolysis
|
J:155297
|
Xcl1tm1Rakr/Xcl1tm1Rakr
Tg(TcraTcrb)1100Mjb/0
(involves: 129/Sv * C57BL/6)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:155297
|
| decreased cytotoxic T cell cytolysis
|
J:155297
|
Xcr1tm1Dgen/Xcr1tm1Dgen
(B6.129P2-Xcr1tm1Dgen/J)
|
abnormal dendritic cell physiology
|
J:155297
|
Xcr1tm2(HBEGF/Venus)Ksho/Xcr1+
(involves: C57BL/6 * C57BL/6J)
|
abnormal CD8-positive, alpha-beta T cell physiology
|
J:204851
|
Xpatm1Tnka/Xpatm1Tnka
(involves: C57BL/6 * CBA)
|
abnormal Langerhans cell physiology
|
J:35054
|
| abnormal lymphocyte physiology
|
J:55739
|
| abnormal NK cell physiology
|
J:55739
|
Xrcc5tm1Nus/Xrcc5tm1Nus
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal class switch recombination
|
J:120658
|
Xrcc6tm1Fwa/Xrcc6tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased IgM level
|
J:44361
|
X/Yaa
(BXSB/MpJ)
|
increased IgG1 level
|
J:179430,
J:93740
|
| increased IgG2a level
|
J:179430
|
| increased IgG2b level
|
J:179430
|
| increased IgG3 level
|
J:93740
|
X/Yaa
(BXSB/MpJScr)
|
increased IgG level
|
J:10973
|
Yeats4em1Zfa/Yeats4em1Zfa
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal lymphocyte physiology
|
J:282740
|
Yod1em1Smoc/Yod1em1Smoc
(C57BL/6JSmoc-Yod1em1Smoc/Smoc)
|
abnormal macrophage physiology
|
J:350806
|
| increased macrophage cytokine production
|
J:350806
|
Ythdf3em1Caox/Ythdf3em1Caox
(involves: C57BL/6J)
|
abnormal macrophage physiology
|
J:276397
|
Zap70m1Btlr/Zap70m1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| decreased IgG level
|
J:185495
|
Zap70m1Saka/Zap70m1Saka
(involves: BALB/c)
|
abnormal thymocyte activation
|
J:154166
|
| decreased T cell proliferation
|
J:154166,
J:86607
|
| increased immunoglobulin level
|
J:86607
|
Zap70m1Saka/Zap70m1Saka
Tg(DO11.10)10Dlo/0
(involves: BALB/c * C3H * C57BL/6)
|
decreased T cell proliferation
|
J:86607
|
Zap70m3Btlr/Zap70m3Btlr
(C57BL/6J-Zap70m3Btlr)
|
decreased IgG level
|
J:225043
|
Zap70m5Btlr/Zap70m5Btlr
(C57BL/6J-Zap70m5Btlr)
|
decreased IgG level
|
J:254830
|
Zap70m6Btlr/Zap70m6Btlr
(C57BL/6J-Zap70m6Btlr)
|
decreased IgG level
|
J:254831
|
Zap70m6Hefl/Zap70m6Hefl
(C3HeB/FeJ-Zap70m6Hefl)
|
increased IgE level
|
J:137446
|
| increased IgG1 level
|
J:137446
|
Zap70m6Hefl/Zap70tm1Weis
(involves: 129X1/SvJ * C3HeB/FeJ * C57BL/10 * DBA/2)
|
increased IgE level
|
J:137446
|
Zap70m7Btlr/Zap70m7Btlr
(C57BL/6J-Zap70m7Btlr)
|
decreased IgG level
|
J:254832
|
Zap70mur/Zap70mur
(C57BL/6Apb-Zap70mur/ApbH)
|
abnormal T cell activation
|
J:104190
|
| abnormal T cell physiology
|
J:104190
|
| increased IgG2b level
|
J:104190
|
Zap70st/Zap70st
(involves: C57BL/6)
|
abnormal T cell physiology
|
J:41170
|
Zap70tm1.1Mmal/Zap70tm1.1Mmal
Tg(TcrLCMV)327Sdz/0
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * DBA/2)
|
abnormal T cell proliferation
|
J:71099
|
Zap70tm2.1Weis/Zap70tm2.1Weis
(C.129S4-Zap70tm2.1Weis)
|
abnormal regulatory T cell physiology
|
J:154166
|
| abnormal thymocyte activation
|
J:154166
|
| decreased T cell proliferation
|
J:154166
|
Zbtb7btm1Itan/Zbtb7btm1Tani
(involves: 129 * C57BL/6)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:141142
|
Zbtb17tm1Cksn/Zbtb17tm1Cksn
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(B6.Cg-Zbtb17tm1Cksn Commd10Tg(Vav1-icre)A2Kio)
|
increased T cell apoptosis
|
J:170508
|
Zbtb32tm1Iho/Zbtb32tm1Iho
(involves: BALB/c)
|
increased T cell proliferation
|
J:94944
|
Zbtb32tm1Iho/Zbtb32tm1Iho
(involves: C57BL/6)
|
increased T cell proliferation
|
J:94944
|
Zbtb32tm2Ppp/Zbtb32tm2Ppp
(involves: 129S1/Sv)
|
increased T cell proliferation
|
J:95119
|
Zbtb46tm1(HBEGF)Mnz/Zbtb46+
(C57BL/6-Zbtb46tm1(HBEGF)Mnz)
|
abnormal memory T cell physiology
|
J:189122
|
| abnormal T-helper 1 physiology
|
J:189122
|
Zbtb46tm1Kmm/Zbtb46tm1Kmm
(129S/SvEv-Zbtb46tm1Kmm)
|
abnormal dendritic cell physiology
|
J:184205
|
Zc3h7aitem1Caox/Zc3h7aitem1Caox
(C57BL/6J-Zc3h7aitem1Caox)
|
abnormal macrophage activation involved in immune response
|
J:282488
|
Zc3h12atm1Aki/Zc3h12atm1Aki
(involves: 129X1/SvJ * C57BL/6)
|
abnormal class switch recombination
|
J:147868
|
| increased IgA level
|
J:147868
|
| increased IgG1 level
|
J:147868
|
| increased IgG2a level
|
J:147868
|
| increased IgG2b level
|
J:147868
|
| increased IgG3 level
|
J:147868
|
| increased IgM level
|
J:147868
|
| increased immunoglobulin level
|
J:147868
|
Zc3h12atm1c(EUCOMM)Hmgu/Zc3h12atm1c(EUCOMM)Hmgu
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * DBA)
|
increased IgG level
|
J:304105
|
| increased IgM level
|
J:304105
|
Zc3h12ctm2d(EUCOMM)Hmgu/Zc3h12ctm2d(EUCOMM)Hmgu
(involves: 129S4/SvJaeSor * C57BL/6N)
|
increased IgA level
|
J:277714
|
| increased IgG level
|
J:277714
|
| increased IgM level
|
J:277714
|
Zc3h12dtm1Tom/Zc3h12dtm1Tom
(B6.Cg-Zc3h12dtm1Tom)
|
increased T cell proliferation
|
J:209383
|
Zdhhc2em1Eko/Zdhhc2em1Eko
(C57BL/6-Zdhhc2em1Eko)
|
abnormal plasmacytoid dendritic cell physiology
|
J:303593
|
| abnormal T cell activation
|
J:303593
|
Zdhhc9tm1Lex/Y
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal leukocyte physiology
|
J:231488
|
Zeb1m1Btlr/Zeb1m1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| abnormal memory B cell physiology
|
J:185495
|
| decreased B cell proliferation
|
J:185495
|
| decreased IgG1 level
|
J:185495
|
| decreased IgG level
|
J:185495
|
| decreased IgM level
|
J:185495
|
Zfattm2.1Sawa/Zfattm2.1Sawa
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6JJcl * C57BL/6NCrSlc * DBA/2)
|
abnormal CD4-positive, alpha-beta T cell physiology
|
J:187164
|
| decreased T cell proliferation
|
J:187164
|
| increased T cell apoptosis
|
J:187164
|
Zfp36tm1Pjb/Zfp36tm1Pjb
(B6.Cg-Zfp36tm1Pjb)
|
abnormal macrophage physiology
|
J:88443
|
Zfp131tm1.1Mytk/Zfp131tm1.1Mytk
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6N * DBA/2)
|
abnormal thymocyte activation
|
J:271921
|
| decreased T cell proliferation
|
J:271921
|
Zfp131tm1.1Mytk/Zfp131tm1.2Mytk
Tg(Lck-cre)1Jtak/0
(involves: C57BL/6N * FVB/N)
|
decreased T cell proliferation
|
J:271921
|
Zfp318m1Anu/Zfp318+
(C57BL/6JAnu-Zfp318m1Anu)
|
decreased IgD level
|
J:207375
|
| increased IgM level
|
J:207375
|
Zfp318m1Anu/Zfp318m1Anu
(C57BL/6JAnu-Zfp318m1Anu)
|
abnormal follicular B cell physiology
|
J:207375
|
| abnormal marginal zone B cell physiology
|
J:207375
|
| decreased IgD level
|
J:207375,
J:104190
|
| increased IgM level
|
J:207375,
J:104190
|
Zfp318M1Btlr/Zfp318+
(C57BL/6J-Zfp318M1Btlr)
|
decreased IgD level
|
J:218965
|
Zfp318M1Btlr/Zfp318M1Btlr
(C57BL/6J-Zfp318M1Btlr)
|
decreased IgD level
|
J:218965
|
Zfp318tm1.1Jhws/Zfp318tm1.1Jhws
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(B6.Cg-Zfp318tm1.1Jhws TgVav1-creA2Kio)
|
decreased IgD level
|
J:215815
|
| increased IgM level
|
J:215815
|
Zfp318tm1Hhag/Zfp318tm1Hhag
(involves: 129 * C57BL/6)
|
decreased IgD level
|
J:207375
|
| increased IgM level
|
J:207375
|
Zfp467tm1.1(KOMP)Vlcg/Zfp467tm1.1(KOMP)Vlcg
(B6(Cg)-Zfp467tm1.1(KOMP)Vlcg)
|
abnormal osteoclast physiology
|
J:302865
|
Zfp760tm1a(EUCOMM)Hmgu/Zfp760+
(C57BL/6N-Zfp760tm1a(EUCOMM)Hmgu/Ieg)
|
decreased IgE level
|
J:165965
|
Zfyve16tm2a(KOMP)Wtsi/Zfyve16tm2a(KOMP)Wtsi
(C57BL/6N-Zfyve16tm2a(KOMP)Wtsi)
|
decreased B cell proliferation
|
J:302014
|
Zranb1tm1c(EUCOMM)Hmgu/Zranb1tm1c(EUCOMM)Hmgu
Tg(Itgax-cre)1-1Reiz/0
(involves: 129S4/SvJaeSor * C57BL/6N * CBA)
|
abnormal dendritic cell physiology
|
J:235701
|
Zscan10Gt(285B6)1.1Cmhd/Zscan10Gt(285B6)1.1Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal IgG level
|
J:221010
|
| increased IgG1 level
|
J:221010
|
| increased IgG2b level
|
J:221010
|
Zup1em1Lisi/Zup1em1Lisi
(involves: C57BL/6J)
|
abnormal macrophage physiology
|
J:350802
|
Analysis Tools